PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cacace, F; de Petris, G; Troiani, A				Cacace, F; de Petris, G; Troiani, A			Experimental detection of tetranitrogen	SCIENCE			English	Article							EXCITED-STATES; GROUND-STATE; AB-INITIO; N-4; TETRAAZATETRAHEDRANE; NEUTRALIZATION; MOLECULES; TETRAZETE; RADICALS; CLUSTER	Tetranitrogen (N-4), which has been the subject of great theoretical interest, has been prepared from the N-4(+) cation and positively detected as a gaseous metastable molecule with a lifetime exceeding 1 microsecond in experiments based on neutralization-reionization mass spectrometry. An examination of the geometry of N-4(+) and the fragmentation pattern of the N-14(2) N-15(2) neutral molecule has revealed that the latter is characterized by an open-chain geometry with two distinct, closely bound N-2 units joined by a longer weaker bond.	Univ Roma La Sapienza, Dipartimento Studi Chim & Tecnol Sostanze Biol At, I-00185 Rome, Italy	Sapienza University Rome	Cacace, F (corresponding author), Univ Roma La Sapienza, Dipartimento Studi Chim & Tecnol Sostanze Biol At, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	fulvio.cacace@uniroma1.it	de Petris, Giulia/I-1581-2012	DE PETRIS, GIULIA/0000-0002-3175-1347; Troiani, Anna/0000-0002-6412-9407				Aquilanti V, 2001, PHYS CHEM CHEM PHYS, V3, P3891, DOI 10.1039/b106672m; Bittererova M, 2001, CHEM PHYS LETT, V340, P597, DOI 10.1016/S0009-2614(01)00454-7; Bittererova M, 2001, CHEM PHYS LETT, V347, P220, DOI 10.1016/S0009-2614(01)01002-8; Bittererova M, 2000, J PHYS CHEM A, V104, P11999, DOI 10.1021/jp002651n; BOHRINGER H, 1983, INT J MASS SPECTROM, V52, P25, DOI 10.1016/0020-7381(83)85089-X; Cacace F, 1999, SCIENCE, V285, P81, DOI 10.1126/science.285.5424.81; Cacace F, 2001, ANGEW CHEM INT EDIT, V40, P4062, DOI 10.1002/1521-3773(20011105)40:21<4062::AID-ANIE4062>3.0.CO;2-X; Cacace F, 2000, ANGEW CHEM INT EDIT, V39, P367; DECASTRO SC, 1981, J CHEM PHYS, V74, P550, DOI 10.1063/1.440808; DUNN KM, 1995, J CHEM PHYS, V102, P4904, DOI 10.1063/1.469538; FRANCL MM, 1990, J PHYS CHEM-US, V94, P526, DOI 10.1021/j100365a008; Glukhovtsev MN, 1996, J PHYS CHEM-US, V100, P1569, DOI 10.1021/jp952026w; Glukhovtsev MN, 1996, INORG CHEM, V35, P7124, DOI 10.1021/ic9606237; HOLMES JL, 1989, MASS SPECTROM REV, V8, P513, DOI 10.1002/mas.1280080604; JARROLD MF, 1984, J CHEM PHYS, V81, P214, DOI 10.1063/1.447365; KEMISTER G, 1993, ORG MASS SPECTROM, V28, P311, DOI 10.1002/oms.1210280408; KNIGHT LB, 1987, J CHEM PHYS, V87, P885, DOI 10.1063/1.453243; Korkin AA, 1996, J PHYS CHEM-US, V100, P5702, DOI 10.1021/jp960125j; Langenberg JH, 1997, CHEM PHYS, V221, P225, DOI 10.1016/S0301-0104(97)00143-2; LAUDERDALE WJ, 1992, J PHYS CHEM-US, V96, P1173, DOI 10.1021/j100182a029; LEE TJ, 1991, J CHEM PHYS, V94, P1215, DOI 10.1063/1.460029; Lee TJ, 2001, CHEM PHYS LETT, V345, P295, DOI 10.1016/S0009-2614(01)00866-1; Leonard C, 1999, J PHYS CHEM A, V103, P1846, DOI 10.1021/jp984062b; LINDINGER W, 1978, J CHEM PHYS, V68, P2607, DOI 10.1063/1.436118; Perera SA, 1999, CHEM PHYS LETT, V314, P381, DOI 10.1016/S0009-2614(99)01186-0; PRIESTLEY J, 1772, PHIL T, V62, P164; Ruchti T, 1996, J CHEM PHYS, V105, P2591, DOI 10.1063/1.472124; Schalley CA, 1998, CHEM SOC REV, V27, P91; SOHLBERG K, 1995, J MOL STRUC-THEOCHEM, V339, P195, DOI 10.1016/0166-1280(95)04140-2; THOMPSON WE, 1990, J CHEM PHYS, V93, P3856, DOI 10.1063/1.458771; THRUSH BA, 1956, PROC R SOC LON SER-A, V235, P143, DOI 10.1098/rspa.1956.0071; Tosi P, 2001, J CHEM PHYS, V114, P2149, DOI 10.1063/1.1336808; WESDEMIOTIS C, 1987, CHEM REV, V87, P485, DOI 10.1021/cr00079a001; YARKONY DR, 1992, J AM CHEM SOC, V114, P5406, DOI 10.1021/ja00039a061; Zheng JP, 2000, CHEM PHYS LETT, V328, P227, DOI 10.1016/S0009-2614(00)00926-X	35	178	195	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					480	481		10.1126/science.1067681	http://dx.doi.org/10.1126/science.1067681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799238				2022-12-28	WOS:000173350700044
J	D'Amico, DJ; Dryja, T				D'Amico, DJ; Dryja, T			A 58-year-old woman with unilateral loss of vision and postmenopausal bleeding - Bilateral, diffuse uveal melanocytic proliferation. Widely metastatic endometrial carcinoma, mixed epithelioid type, with endometrioid, mucinous and undifferentiated patterns.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER-ASSOCIATED RETINOPATHY; CELL-CARCINOMA; MELANOMA; TUMORS; HYPERPLASIA; BLINDNESS; LESIONS; PROTEIN		Massachusetts Eye & Ear Infirm, Diabet Retinopathy Unit, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	D'Amico, DJ (corresponding author), Massachusetts Eye & Ear Infirm, Diabet Retinopathy Unit, Boston, MA 02114 USA.							BARONDES MJ, 1991, AM J OPHTHALMOL, V112, P460, DOI 10.1016/S0002-9394(14)76260-9; BARR CC, 1982, ARCH OPHTHALMOL-CHIC, V100, P249, DOI 10.1001/archopht.1982.01030030251003; BERSON EL, 1988, AM J OPHTHALMOL, V106, P307, DOI 10.1016/0002-9394(88)90366-2; BORRUAT FX, 1992, OPHTHALMOLOGY, V99, P1698; Brink H, 1997, GRAEF ARCH CLIN EXP, V235, P59, DOI 10.1007/BF01007839; Chahud F, 2001, AM J SURG PATHOL, V25, P212, DOI 10.1097/00000478-200102000-00009; Ciulla TA, 1997, SURV OPHTHALMOL, V41, P467, DOI 10.1016/S0039-6257(97)00015-5; Cockerham GC, 2000, OPHTHALMOLOGY, V107, P151, DOI 10.1016/S0161-6420(99)00025-1; Cook BE, 2000, RETINA-J RET VIT DIS, V20, P1, DOI 10.1097/00006982-200001000-00001; DEWOLFFROUENDAAL D, 1985, INT OPHTHALMOL, V7, P149, DOI 10.1007/BF00128361; Donovan JT, 1999, GYNECOL ONCOL, V73, P424, DOI 10.1006/gyno.1998.5332; FILIPIC M, 1986, AUST NZ J OPHTHALMOL, V14, P293, DOI 10.1111/j.1442-9071.1986.tb00463.x; GASS JDM, 1991, BRIT J OPHTHALMOL, V75, P693, DOI 10.1136/bjo.75.11.693; GASS JDM, 1984, RETINA-J RET VIT DIS, V4, P135, DOI 10.1097/00006982-198400430-00001; GASS JDM, 1982, OPHTHALMOLOGY, V89, P1018; GASS JDM, 1990, ARCH OPHTHALMOL-CHIC, V108, P527, DOI 10.1001/archopht.1990.01070060075053; Goldstein SM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1641; Jumper JM, 2000, RETINA-J RET VIT DIS, V20, P190, DOI 10.1097/00006982-200003000-00012; LAFAUT BA, 1994, J FR OPHTALMOL, V17, P208; LEYS AM, 1991, ARCH OPHTHALMOL-CHIC, V109, P1590, DOI 10.1001/archopht.1991.01080110126050; LUBIN JR, 1980, OPHTHALMOLOGY, V87, P109; Machemer R, 1966, Klin Monbl Augenheilkd, V148, P641; Margo CE, 1997, RETINA-J RET VIT DIS, V17, P434; MARGO CE, 1987, RETINA-J RET VIT DIS, V7, P137, DOI 10.1097/00006982-198700730-00001; McCluskey PJ, 1999, OPHTHALMOLOGY, V106, P2380, DOI 10.1016/S0161-6420(99)90543-2; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; MUKAI S, 2000, PRINCIPLES PRACTICE, V6, P5017; MULLANEY J, 1984, BRIT J OPHTHALMOL, V68, P261, DOI 10.1136/bjo.68.4.261; Murphy MA, 1997, J NEURO-OPHTHALMOL, V17, P166; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; PRAUSE JU, 1984, OPHTHALMOLOGICA, V189, P221, DOI 10.1159/000309413; PRUSINER PE, 1983, ANN OPHTHALMOL, V15, P653; Ritland JS, 2000, ACTA OPHTHALMOL SCAN, V78, P366, DOI 10.1034/j.1600-0420.2000.078003366.x; ROHRBACH JM, 1990, AM J OPHTHALMOL, V110, P49, DOI 10.1016/S0002-9394(14)76937-5; RYLL DL, 1980, OPHTHALMOLOGY, V87, P1181; SHIELDS CL, 1988, SURV OPHTHALMOL, V33, P17, DOI 10.1016/0039-6257(88)90069-0; Shields CL, 1997, OPHTHALMOLOGY, V104, P1265, DOI 10.1016/S0161-6420(97)30148-1; Singh AD, 1996, OPHTHALMOLOGY, V103, P256; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; TO KW, 2000, PRINCIPLES PRACTICE, V2, P1315; TSUKAHARA S, 1986, BRIT J OPHTHALMOL, V70, P33, DOI 10.1136/bjo.70.1.33	41	0	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					189	195		10.1056/NEJMcpc020002	http://dx.doi.org/10.1056/NEJMcpc020002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796854				2022-12-28	WOS:000173273600008
J	Weeks, JC; Nelson, H; Gelber, S; Sargent, D; Schroeder, G				Weeks, JC; Nelson, H; Gelber, S; Sargent, D; Schroeder, G		COST Study Grp	Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; SURGERY; CHOLECYSTECTOMY	Context Laparoscopic-assisted colectomy (LAC) has emerged as the preferred minimally invasive surgical strategy for diseases of the colon. The safety and efficacy of LAC for colon cancer are unknown, and the nature and magnitude of any quality-of-life (QOL) benefit resulting from LAC for colon cancer is also unknown. Objective To compare short-term QOL outcomes after LAC vs open colectomy for colon cancer. Design, Setting, and Participants Multicenter, randomized controlled trial (Clinical Outcomes of Surgical Therapy [COST]). Between September 1994 and February 1999, 37 of 48 centers provided data for the QOL component of the trial for 449 consecutive patients with clinically resectable colon cancer. Main Outcome Measures Scores on the Symptoms Distress Scale (SIDS), Quality of Life Index, and a single-item global rating scale at 2 days, 2 weeks, and 2 months postoperative; duration of postoperative in-hospital analgesic use; and length of stay. Results Of 449 patients, 428 provided QOL data. In an intention-to-treat analysis comparing SDS pain intensity, SDS summary, QOL Index summary, and global rating scale scores at each time point, the only statistically significant difference observed between groups was the global rating scale score for 2 weeks postsurgery. The mean (median) global rating scale scores for 2 weeks postsurgery were 76.9 (80) for LAC vs 74.4 (75) for open colectomy (P=.009). While in the hospital, patients assigned to LAC required fewer days of both parenteral analgesics compared with patients assigned to open colectomy (mean [median], 3.2 [3] vs 4.0 [4] days; P<.001) and oral analgesics (mean [median], 1.9 [1] vs 2.2 [2] days; P=.03). Conclusion Only minimal short-term QOL benefits were found with LAC for colon cancer compared with standard open colectomy. Until ongoing trials establish that LAC is as effective as open colectomy in preventing recurrence and death from colon cancer, this procedure should not be offered to patients with colon cancer.	Mayo Clin, Dept Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Biostat, Rochester, MN USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Mayo Clinic; Mayo Clinic; Harvard University; Dana-Farber Cancer Institute	Nelson, H (corresponding author), Mayo Clin, Dept Surg, 200 1st St SW, Rochester, MN 55905 USA.	jane_weeks@dfci.harvard.edu; nelsonh@mayo.edu		Sargent, Daniel/0000-0002-2684-4741	NCI NIH HHS [CA12027, CA21115, U01 CA65157, CA21661, CA25244, CA32102, CA31946] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA032102, U10CA021661, U10CA012027, U01CA065157, U10CA031946, U10CA021115] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM SOC COL RECT S, 1994, DIS COLON RECTUM, V37, P8; BARKUN JS, 1995, SURGERY, V118, P703, DOI 10.1016/S0039-6060(05)80038-8; BERENDS FJ, 1994, LANCET, V344, P58, DOI 10.1016/S0140-6736(94)91079-0; Corbitt J D Jr, 1992, Surg Laparosc Endosc, V2, P79; Dubois F, 1991, Surg Laparosc Endosc, V1, P52; Ellstrom M, 1998, OBSTET GYNECOL, V91, P30, DOI 10.1016/S0029-7844(97)00579-6; ESCARCE JJ, 1995, MED CARE, V33, P256, DOI 10.1097/00005650-199503000-00005; Escarce JJ, 1996, J HEALTH ECON, V15, P715, DOI 10.1016/S0167-6296(96)00501-2; FALK PM, 1993, DIS COLON RECTUM, V36, P28, DOI 10.1007/BF02050298; Fleshman JW, 1996, DIS COLON RECTUM, V39, pS53, DOI 10.1007/BF02053806; Heikkinen TJ, 1999, J AM COLL SURGEONS, V188, P368, DOI 10.1016/S1072-7515(98)00328-7; Hewett PJ, 1996, DIS COLON RECTUM, V39, pS62, DOI 10.1007/BF02053808; Jacobs M, 1991, Surg Laparosc Endosc, V1, P144; KEATS AS, 1978, ANESTHESIOLOGY, V49, P233, DOI 10.1097/00000542-197810000-00001; Kelling Georg, 1902, MUNCHEN MED WOCHEN, V52, P21; LEGORRETA AP, 1993, JAMA-J AM MED ASSOC, V270, P1429, DOI 10.1001/jama.270.12.1429; MCCORKLE R, 1983, SOC SCI MED, V17, P431, DOI 10.1016/0277-9536(83)90348-9; MONSON JRT, 1992, LANCET, V340, P831, DOI 10.1016/0140-6736(92)92694-B; Nelson H, 1995, J Natl Cancer Inst Monogr, P51; PHILLIPS EH, 1992, ANN SURG, V216, P703, DOI 10.1097/00000658-199212000-00015; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Reilly WT, 1996, DIS COLON RECTUM, V39, P200; SAS Institute Inc, 1989, SAS STAT US GUID VER; Schwenk W, 1998, SURG ENDOSC, V12, P1131, DOI 10.1007/s004649900799; Slim K, 1997, BRIT J SURG, V84, P610, DOI 10.1002/bjs.1800840508; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; STEINER CA, 1994, NEW ENGL J MED, V330, P403, DOI 10.1056/NEJM199402103300607; Stocchi L, 2000, DIS COLON RECTUM, V43, P326, DOI 10.1007/BF02258297; Stocchi L, 1998, J SURG ONCOL, V68, P255, DOI 10.1002/(SICI)1096-9098(199808)68:4<255::AID-JSO10>3.0.CO;2-Z; TSEVAT J, 1990, J CLIN EPIDEMIOL, V43, pS73, DOI 10.1016/0895-4356(90)90224-D; Velanovich V, 2000, SURG ENDOSC-ULTRAS, V14, P16, DOI 10.1007/s004649900003; Young-Fadok TM, 2000, DIS COLON RECTUM, V43, P267, DOI 10.1007/BF02236994; Young-Fadok TM, 2000, MAYO CLIN PROC, V75, P344, DOI 10.4065/75.4.344	34	562	582	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					321	328		10.1001/jama.287.3.321	http://dx.doi.org/10.1001/jama.287.3.321			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790211	Bronze			2022-12-28	WOS:000173294700026
J	Badyaev, AV; Hill, GE; Beck, ML; Dervan, AA; Duckworth, RA; McGraw, KJ; Nolan, PM; Whittingham, LA				Badyaev, AV; Hill, GE; Beck, ML; Dervan, AA; Duckworth, RA; McGraw, KJ; Nolan, PM; Whittingham, LA			Sex-biased hatching order and adaptive population divergence in a passerine bird	SCIENCE			English	Article							HOUSE FINCH; EGG-YOLKS; TESTOSTERONE; RATIO; DIMORPHISM; EVOLUTION; SELECTION; MUSCLE	Most species of birds can lay only one egg per day until a clutch is complete, and the order in which eggs are laid often has strong and sex-specific effects on offspring growth and survival. In two recently established populations of the house finch (Carpodacus mexicanus) in Montana and Alabama, breeding females simultaneously adjusted the sex and growth of offspring in relation to their position in the laying order, thereby reducing the mortality of sons and daughters by 10 to 20% in both environments. We show experimentally that the reduction in mortality is produced by persistent and sex-specific maternal effects on the growth and morphology of offspring, These strong parental effects may have facilitated the rapid adaptive divergence among populations of house finches.	Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Auburn University System; Auburn University; Duke University; Cornell University; University of Wisconsin System; University of Wisconsin Milwaukee; University of Montana System; University of Montana	Badyaev, AV (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.		Hill, Geoffrey E./R-7354-2019	Hill, Geoffrey E./0000-0001-8864-6495				ADKINSREGAN E, 1995, J EXP ZOOL, V271, P466, DOI 10.1002/jez.1402710608; Badyaev AV, 2001, EVOLUTION, V55, P2534; Badyaev AV, 2000, EVOLUTION, V54, P2134, DOI 10.1111/j.0014-3820.2000.tb01255.x; Badyaev AV, 2001, EVOLUTION, V55, P176; Badyaev AV, 2000, EVOLUTION, V54, P987; Badyaev AV, 2000, EVOLUTION, V54, P1784; BORTOLOTTI GR, 1986, AM NAT, V127, P495, DOI 10.1086/284498; Bradbury RB, 1997, J AVIAN BIOL, V28, P255, DOI 10.2307/3676977; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Fear KK, 1998, OIKOS, V82, P440, DOI 10.2307/3546365; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Henry MH, 1999, POULTRY SCI, V78, P1006, DOI 10.1093/ps/78.7.1006; KRACKOW S, 1995, J THEOR BIOL, V176, P273, DOI 10.1006/jtbi.1995.0197; LANDE R, 1976, EVOLUTION, V30, P314, DOI [10.1111/j.1558-5646.1976.tb00911.x, 10.2307/2407703]; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Petrie M, 2001, NATURE, V412, P498, DOI 10.1038/35087652; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; SLAGSVOLD T, 1990, EVOLUTION, V44, P1009, DOI 10.1111/j.1558-5646.1990.tb03821.x; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085; WINKLER DW, 1993, P NATL ACAD SCI USA, V90, P11439, DOI 10.1073/pnas.90.24.11439	25	196	198	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					316	318		10.1126/science.1066651	http://dx.doi.org/10.1126/science.1066651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786641				2022-12-28	WOS:000173278600046
J	Gerstein, M; Lan, N; Jansen, R				Gerstein, M; Lan, N; Jansen, R			Proteomics - Integrating interactomes	SCIENCE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS; GENOME EXPRESSION DATA; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; YEAST GENOME; SEQUENCES; PATTERNS; NETWORK; SCALE		Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Gerstein, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.							Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gerstein M, 2000, CURR OPIN STRUC BIOL, V10, P574, DOI 10.1016/S0959-440X(00)00134-2; Greenbaum D, 2001, GENOME RES, V11, P1463, DOI 10.1101/gr.207401; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2000, NUCLEIC ACIDS RES, V28, P1481, DOI 10.1093/nar/28.6.1481; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Qian J, 2001, J MOL BIOL, V314, P1053, DOI 10.1006/jmbi.2000.5219; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; INTERACTION DATA BIO	31	66	69	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					284	+		10.1126/science.1068664	http://dx.doi.org/10.1126/science.1068664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786630				2022-12-28	WOS:000173278600034
J	Mellor, J; Nicoll, RA; Schmitz, D				Mellor, J; Nicoll, RA; Schmitz, D			Mediation of hippocampal mossy fiber long-term potentiation by presynaptic I-h channels	SCIENCE			English	Article							INWARD RECTIFYING CURRENT; GYRUS GRANULE CELLS; SYNAPTIC TRANSMISSION; ADENYLATE-CYCLASE; CATION CURRENT; CYCLIC-AMP; 2 FORMS; NEURONS; EXPRESSION; PACEMAKER	Hippocampal mossy fiber long-term potentiation (LTP) is expressed presynaptically, but the exact mechanisms remain unknown. Here, we demonstrate the involvement of the hyperpolarization-activated cation channel (I-h) in the expression of mossy fiber LTP. Established LTP was blocked and reversed by I-h. channel antagonists. Whole-cell recording from granule cells revealed that repetitive stimulation causes a calcium- and I-h-dependent long-lasting depolarization mediated by protein kinase A. Depolarization at the terminals would be expected to enhance transmitter release, whereas somatic depolarization would enhance the responsiveness of granule cells to afferent input. Thus, I-h channels play an important rote in the long-lasting control of transmitter release and neuronal excitability.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Accili EA, 1997, J PHYSIOL-LONDON, V500, P643, DOI 10.1113/jphysiol.1997.sp022049; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CASTILLO PE, 2000, SOC NEUR ABSTR, V27; CHANG F, 1991, J PHYSIOL-LONDON, V440, P367, DOI 10.1113/jphysiol.1991.sp018713; Chen CF, 1997, J NEUROSCI, V17, P8687; FROEMKE RC, 2000, SOC NEUR ABSTR, V27; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Janigro D, 1997, J MEMBRANE BIOL, V160, P101, DOI 10.1007/s002329900299; KOCSIS JD, 1983, J PHYSIOL-LONDON, V334, P225, DOI 10.1113/jphysiol.1983.sp014491; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; STABEL J, 1992, NEUROSCI LETT, V135, P231, DOI 10.1016/0304-3940(92)90443-B; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	41	128	134	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					143	147		10.1126/science.1064285	http://dx.doi.org/10.1126/science.1064285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778053				2022-12-28	WOS:000173143100054
J	Haas, W; Shepard, BD; Gilmore, MS				Haas, W; Shepard, BD; Gilmore, MS			Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction	NATURE			English	Article							MEMBRANE-PROTEINS; TOXIN; IDENTIFICATION; ACTIVATION; PREDICTION	Bacteria of the genus Enterococcus are the main causes of highly antibiotic-resistant infections that are acquired in hospitals(1,2). Many clinical isolates of Enterococcus faecalis produce an exotoxin called cytolysin that contributes to bacterial virulence(3). In addition to its toxin activity, the cytolysin is bactericidal for nearly all Gram-positive organisms(4). An understanding of conditions that regulate cytolysin expression has advanced little since its initial description(5). Here we show that the products of two genes, cylR1 and cylR2, which lack homologues of known function, work together to repress transcription of cytolysin genes. Derepression occurs at a specific cell density when one of the cytolysin subunits reaches an extracellular threshold concentration. These observations form the basis of a model for the autoinduction of the cytolysin by a quorum-sensing mechanism involving a two-component regulatory system.	Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gilmore, MS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, 975 NE 10th St, Oklahoma City, OK 73104 USA.							Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BROCK TD, 1963, J BACTERIOL, V86, P702, DOI 10.1128/JB.86.4.702-707.1963; Coburn PS, 1999, INFECT IMMUN, V67, P3339, DOI 10.1128/IAI.67.7.3339-3347.1999; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; DUNNY GM, 1999, CELL CELL SIGNALING; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; Gerberding J, 2000, AM J INFECT CONTROL, V28, P429, DOI 10.1067/mic.2000.110544; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; GILMORE MS, 1990, INFECT IMMUN, V58, P3914, DOI 10.1128/IAI.58.12.3914-3923.1990; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; IKE Y, 1984, J BACTERIOL, V158, P777, DOI 10.1128/JB.158.3.777-783.1984; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Sambrook J., 2001, MOL CLONING; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shepard BD, 1999, APPL ENVIRON MICROB, V65, P1470; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; [No title captured]	24	159	168	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					84	87		10.1038/415084a	http://dx.doi.org/10.1038/415084a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780122				2022-12-28	WOS:000173028800045
J	Ma, YJ; Hendershot, LM				Ma, YJ; Hendershot, LM			The unfolding tale of the unfolded protein response	CELL			English	Review							ENDOPLASMIC-RETICULUM; TRANSCRIPTIONAL INDUCTION; TRANSMEMBRANE PROTEIN; TRANSLATIONAL CONTROL; MAMMALIAN-CELLS; MESSENGER-RNA; ER STRESS; KINASE; REQUIRES; NUCLEUS	Surface and secreted proteins are synthesized in the endoplasmic reticulum where they must fold and assemble before being transported. Changes in the ER that interfere with their proper maturation initiate the unfolded protein response pathway. New studies have filled in a missing link between the yeast and mammalian pathways.	St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018; Longo, Kenneth A/A-5631-2010	Hendershot, Linda/0000-0002-5473-0274; 				Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; MORI K, 1993, CELL, V74, P743; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	19	330	348	4	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					827	830		10.1016/S0092-8674(01)00623-7	http://dx.doi.org/10.1016/S0092-8674(01)00623-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779459	Bronze			2022-12-28	WOS:000173024200004
J	Narasimha, R				Narasimha, R			Sines in terse verse - Coding large numbers in synthetic words made them easier to memorize.	NATURE			English	Editorial Material									Natl Inst Adv Studies, Bangalore 560012, Karnataka, India		Narasimha, R (corresponding author), Natl Inst Adv Studies, Indian Inst Sci Campus, Bangalore 560012, Karnataka, India.							SHUKLA KS, 1976, ARYA BHATIYA ARYABHA; Yano Michio, 1977, INDIAN J HIST SCI, V12, P83	2	5	5	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					851	851		10.1038/414851a	http://dx.doi.org/10.1038/414851a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780041	Bronze			2022-12-28	WOS:000172813300026
J	Glorieux, FH				Glorieux, FH			A disease of the osteoblast	LANCET			English	Article									Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada; McGill Univ, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Glorieux, FH (corresponding author), Shriners Hosp Children, Genet Unit, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.								0	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S45	S45						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784594				2022-12-28	WOS:000172907200045
J	Rivers, E; Nguyen, B; Havstad, S; Ressler, J; Muzzin, A; Knoblich, B; Peterson, E; Tomlanovich, M				Rivers, E; Nguyen, B; Havstad, S; Ressler, J; Muzzin, A; Knoblich, B; Peterson, E; Tomlanovich, M		Early Goal-Directed Therapy Collab	Early goal-directed therapy in the treatment of severe sepsis and septic shock.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENOUS OXYGEN-SATURATION; SYSTEMIC INFLAMMATORY RESPONSE; CRITICALLY-ILL; CARE; EPIDEMIOLOGY; MORTALITY; SCORE	Background: Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit. This approach involves adjustments of cardiac preload, afterload, and contractility to balance oxygen delivery with oxygen demand. The purpose of this study was to evaluate the efficacy of early goal-directed therapy before admission to the intensive care unit. Methods: We randomly assigned patients who arrived at an urban emergency department with severe sepsis or septic shock to receive either six hours of early goal-directed therapy or standard therapy (as a control) before admission to the intensive care unit. Clinicians who subsequently assumed the care of the patients were blinded to the treatment assignment. In-hospital mortality (the primary efficacy outcome), end points with respect to resuscitation, and Acute Physiology and Chronic Health Evaluation (APACHE II) scores were obtained serially for 72 hours and compared between the study groups. Results: Of the 263 enrolled patients, 130 were randomly assigned to early goal-directed therapy and 133 to standard therapy; there were no significant differences between the groups with respect to base-line characteristics. In-hospital mortality was 30.5 percent in the group assigned to early goal-directed therapy, as compared with 46.5 percent in the group assigned to standard therapy (P=0.009). During the interval from 7 to 72 hours, the patients assigned to early goal-directed therapy had a significantly higher mean (+/-SD) central venous oxygen saturation (70.4+/-10.7 percent vs. 65.3+/-11.4 percent), a lower lactate concentration (3.0+/-4.4 vs. 3.9+/-4.4 mmol per liter), a lower base deficit (2.0+/-6.6 vs. 5.1+/-6.7 mmol per liter), and a higher pH (7.40+/-0.12 vs. 7.36+/-0.12) than the patients assigned to standard therapy (P lessthan/equal 0.02 for all comparisons). During the same period, mean APACHE II scores were significantly lower, indicating less severe organ dysfunction, in the patients assigned to early goal-directed therapy than in those assigned to standard therapy (13.0+/-6.3 vs. 15.9+/-6.4, P<0.001). Conclusions: Early goal-directed therapy provides significant benefits with respect to outcome in patients with severe sepsis and septic shock.	Case Western Reserve Univ, Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI USA; Case Western Reserve Univ, Henry Ford Hlth Syst, Dept Surg, Detroit, MI USA; Case Western Reserve Univ, Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; Case Western Reserve Univ, Henry Ford Hlth Syst, Dept Biostat & Epidemiol, Detroit, MI USA	Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital; Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital; Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital; Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital	Rivers, E (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 W Grand Blvd, Detroit, MI 48202 USA.	erivers1@hfhs.org		NOIRI, Eisei/0000-0002-9515-7582				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; CORTEZ A, 1977, ARCH SURG-CHICAGO, V112, P471; DAHN MS, 1988, INTENS CARE MED, V14, P373, DOI 10.1007/BF00262891; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Edwards JD, 1998, CRIT CARE MED, V26, P1356, DOI 10.1097/00003246-199808000-00020; Elliott DC, 1998, J AM COLL SURGEONS, V187, P536, DOI 10.1016/S1072-7515(98)00232-4; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Haupt MT, 1996, NEW ENGL J MED, V334, P799; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Heiselman D, 1986, J Clin Monit, V2, P237, DOI 10.1007/BF02851172; HINDS C, 1995, NEW ENGL J MED, V333, P1074, DOI 10.1056/NEJM199510193331609; Hollenberg SM, 1999, CRIT CARE MED, V27, P639; Karimova A, 2001, INTENS CARE MED, V27, P19, DOI 10.1007/s001340000790; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; KRAFFT P, 1993, CHEST, V103, P900, DOI 10.1378/chest.103.3.900; LEE J, 1972, ANESTHESIOLOGY, V36, P472, DOI 10.1097/00000542-197205000-00012; Lefrant JY, 2000, CRIT CARE MED, V28, P355, DOI 10.1097/00003246-200002000-00011; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V27, P1321; Lundberg JS, 1998, CRIT CARE MED, V26, P1020, DOI 10.1097/00003246-199806000-00019; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Nguyen HB, 2000, ACAD EMERG MED, V7, P1354, DOI 10.1111/j.1553-2712.2000.tb00492.x; Opal SM, 1999, INFECT DIS CLIN N AM, V13, P285, DOI 10.1016/S0891-5520(05)70075-1; PITTET D, 1993, INTENS CARE MED, V19, P265, DOI 10.1007/BF01690546; Rady MY, 1996, AM J EMERG MED, V14, P218, DOI 10.1016/S0735-6757(96)90136-9; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; REINHART K, 1989, CHEST, V95, P1216, DOI 10.1378/chest.95.6.1216; RUTTER CM, 1994, STAT MED, V13, P1211, DOI 10.1002/sim.4780131204; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; SCHEINMAN MM, 1969, CIRCULATION, V40, P165, DOI 10.1161/01.CIR.40.2.165; Shoemaker WC, 1996, NEW ENGL J MED, V334, P799	37	6459	7061	6	372	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1368	1377		10.1056/NEJMoa010307	http://dx.doi.org/10.1056/NEJMoa010307			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794169	Bronze			2022-12-28	WOS:000172014200002
J	Sokolove, PE; Offerman, SR				Sokolove, PE; Offerman, SR			Pulmonary embolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Sokolove, PE (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.								0	3	3	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1311	1311		10.1056/NEJMicm0000019	http://dx.doi.org/10.1056/NEJMicm0000019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794150				2022-12-28	WOS:000171896300004
J	Hornbaker, DJ; Kahng, SJ; Misra, S; Smith, BW; Johnson, AT; Mele, EJ; Luzzi, DE; Yazdani, A				Hornbaker, DJ; Kahng, SJ; Misra, S; Smith, BW; Johnson, AT; Mele, EJ; Luzzi, DE; Yazdani, A			Mapping the one-dimensional electronic states of nanotube peapod structures	SCIENCE			English	Article							CARBON NANOTUBES; MECHANISM	Arrays of C-60 molecules nested inside single-walled nanotubes represent a class of nanoscale materials having tunable properties. We report electronic measurements of this system made with a scanning tunneling microscope and demonstrate that the encapsulated C-60 molecules modify the local electronic structure of the nanotube. Our measurements and calculations also show that a periodic array of C-60 molecules gives rise to a hybrid electronic band, which derives its character from both the nanotube states and the C-60 molecular orbitals.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; Univ Penn, Res Struct Matter Lab, Philadelphia, PA 19104 USA; Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Yazdani, A (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.			Hornbaker, Daniel/0000-0002-0746-1614; Yazdani, Ali/0000-0003-4996-8904; Mele, Eugene/0000-0001-7140-5353				Antonov RD, 1999, PHYS REV LETT, V83, P3274, DOI 10.1103/PhysRevLett.83.3274; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; Dresselhaus M. S., 2001, CARBON NANOTUBES SYN; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Hirahara K, 2000, PHYS REV LETT, V85, P5384, DOI 10.1103/PhysRevLett.85.5384; HOMBAKER DJ, 2001, 11 INT C SCANN TUNN; KITTEL C, 1996, INTRO SOLID STATE PH, P180; Nikolaev P, 1997, CHEM PHYS LETT, V266, P422, DOI 10.1016/S0009-2614(97)00053-5; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Okada S, 2001, PHYS REV LETT, V86, P3835, DOI 10.1103/PhysRevLett.86.3835; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; SAITO R, 1992, APPL PHYS LETT, V60, P2204, DOI 10.1063/1.107080; SAITO S, 1991, PHYS REV LETT, V66, P2637, DOI 10.1103/PhysRevLett.66.2637; Smith BW, 2000, CHEM PHYS LETT, V331, P137, DOI 10.1016/S0009-2614(00)01008-3; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Smith BW, 2000, CHEM PHYS LETT, V321, P169, DOI 10.1016/S0009-2614(00)00307-9; Smith BW, 1999, CHEM PHYS LETT, V315, P31, DOI 10.1016/S0009-2614(99)00896-9; Suenaga K, 2000, SCIENCE, V290, P2280, DOI 10.1126/science.290.5500.2280; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Yang L, 2000, PHYS REV LETT, V85, P154, DOI 10.1103/PhysRevLett.85.154; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Zhou CW, 2000, SCIENCE, V290, P1552, DOI 10.1126/science.290.5496.1552	25	346	358	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					828	831		10.1126/science.1068133	http://dx.doi.org/10.1126/science.1068133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11778011				2022-12-28	WOS:000173733000037
J	Reef, SE; Frey, TK; Theall, K; Abernathy, E; Burnett, CL; Icenogle, J; McCauley, MM; Wharton, M				Reef, SE; Frey, TK; Theall, K; Abernathy, E; Burnett, CL; Icenogle, J; McCauley, MM; Wharton, M			The changing epidemiology of rubella in the 1990s - On the verge of elimination and new challenges for control and prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WORKPLACE	Context In 1989, the United States established a goal to eliminate indigenous rubella and congenital rubella syndrome (CRS) by 2000. Reported rubella cases are at record low levels; however, cases and outbreaks have occurred, primarily among unvaccinated foreign-born adults. Objective To evaluate the current epidemiology of rubella and CRS and assess progress toward elimination. Design, Setting, and Subjects Analysis of rubella cases reported to the National Notifiable Diseases Surveillance System from 1990 through 1999 and CRS cases reported to the National Congenital Rubella Syndrome Registry from 1990 through 1999. Since 1996, US and international viral isolates have been sequenced. Main Outcome Measures incidence and characteristics of rubella and CRS cases; molecular typing of virus isolates. Results Annually from 1990 through 1999, the median number of reported rubella cases was 232 (range, 128-1412), and between 1992 and 1999, fewer than 300 rubella cases were reported annually, except in 1998. During the 1990s, the incidence of rubella in children younger than 15 years decreased (0.63 vs 0.06 per 100000 in 1990 vs 1999), whereas the incidence in adults aged 15 to 44 years increased (0.13 vs 0.24 per 100000). In 1992, incidence among Hispanics was 0.06 per 100000 and increased to a high in 1998 of 0.97 per 100000. From 1997 through 1999, 20 (83%) of 24 CRS infants were born to Hispanic mothers, and 21 (91%) of 23 CRS infants were born to foreign-born mothers. Molecular typing identified 3 statistically distinct genotypic groups. In group 1, the close relatedness of viruses suggests that a single imported source seeded an outbreak that did not spread beyond the Northeast. Similarly, within groups 2 and 3, relatedness of viruses obtained from clusters of cases suggests that single imported sources seeded each one. Diversity of viruses found in 1 state is consistent with the conclusion that several viruses were imported. Moreover, the similarity of viruses found across the country, combined with a lack of epidemiologic evidence of endemic transmission, support the conclusion that some viruses that are common abroad, particularly in Latin America and the Carribean, were introduced into the United States on several separate occasions. Conclusions The epidemiology of rubella and CRS has changed significantly in the last decade. These changes and molecular typing suggest that the United States is on the verge of elimination of the disease. To prevent future rubella outbreaks and CRS, current strategies must be enhanced and new strategies developed.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Georgia State Univ, Atlanta, GA 30303 USA; Emory Univ, Sch Publ Hlth, Atlanta, GA USA; Utah Dept Hlth, Salt Lake City, UT 84116 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; Emory University	Reef, SE (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,MS E-61, Atlanta, GA 30333 USA.	sreef@cdc.gov						*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P30; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P560; *CDCP, 1985, MMWR-MORBID MORTAL W, V34, P228; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P225; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1137; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P770; Centers for Disease Control and Prevention, 1980, MMWR-MORBID MORTAL W, V29, P517; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P57; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V46, P1247; Centers for Disease Control and Prevention (CDC), 1985, MMWR-MORBID MORTAL W, V34, P615; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P173; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P349; Centers for Disease Control & Prevention, 1991, MMWR-MORBID MORTAL W, V40, P93; Danovaro-Holliday MC, 2000, JAMA-J AM MED ASSOC, V284, P2733, DOI 10.1001/jama.284.21.2733; DOUGHERTY N, 1995, IMMUNICATION ACTION, V1, P2; Frey TK, 1998, J INFECT DIS, V178, P642, DOI 10.1086/515370; GOODMAN AK, 1987, AM J PUBLIC HEALTH, V77, P725, DOI 10.2105/AJPH.77.6.725; LEE SH, 1992, JAMA-J AM MED ASSOC, V267, P2616, DOI 10.1001/jama.267.19.2616; LINDEGREN ML, 1991, EPIDEMIOL REV, V13, P341, DOI 10.1093/oxfordjournals.epirev.a036077; MELLINGER AK, 1995, PEDIATR INFECT DIS J, V14, P573, DOI 10.1097/00006454-199507000-00004; *NAT CTR HLTH STAT, 1997, HLTH PEOPL 1996 97 I; *PAN AM HLTH ORG, 2001, EPI NEWSLETTER, V23, P3; *PHS, 1991, US DEP HHS PHS PUBLI; Preblud S R, 1980, Epidemiol Rev, V2, P171; Rangel Maria C., 1999, Ethnicity and Disease, V9, P230; REEF S, 1999, MANUAL SURVEILLIANCE; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928	27	95	100	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					464	472		10.1001/jama.287.4.464	http://dx.doi.org/10.1001/jama.287.4.464			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798368	Bronze			2022-12-28	WOS:000173401900023
J	Eddaoudi, M; Kim, J; Rosi, N; Vodak, D; Wachter, J; O'Keeffe, M; Yaghi, OM				Eddaoudi, M; Kim, J; Rosi, N; Vodak, D; Wachter, J; O'Keeffe, M; Yaghi, OM			Systematic design of pore size and functionality in isoreticular MOFs and their application in methane storage	SCIENCE			English	Article							SECONDARY BUILDING UNITS; FRAMEWORKS; NETWORKS; CHEMISTRY	A strategy based on reticulating metal ions and organic carboxylate links into extended networks has been advanced to a point that allowed the design of porous structures in which pore size and functionality could be varied systematically. Metal-organic framework (MOF-5), a prototype of a new class of porous materials and one that is constructed from octahedral Zn-O-C clusters and benzene links, was used to demonstrate that its three-dimensional porous system can be functionalized with the organic groups -Br, -NH2, -OC3H7, -OC5H11,-C2H4, and -C4H4 and that its pore size, can be expanded with the tong molecular struts biphenyl, tetrahydropyrene, pyrene, and terphenyl. We synthesized an isoreticutar series (one that has the same framework topology) of 16 highly crystalline materials whose open space represented up to 91.1% of the crystal volume, as well as homogeneous periodic pores that can be incrementally varied from 3.8 to 28.8 angstroms. One member of this series exhibited a high capacity for methane storage (240 cubic centimeters at standard temperature and pressure per gram at 36 atmospheres and ambient temperature), and others the lowest densities (0.41 to 0.21 gram per cubic centimeter) for a crystalline material at room temperature.	Univ Michigan, Dept Chem, Mat Design & Discovery Grp, Ann Arbor, MI 48109 USA; Arizona State Univ, Dept Chem, Mat Design & Discovery Grp, Tempe, AZ 85287 USA	University of Michigan System; University of Michigan; Arizona State University; Arizona State University-Tempe	Yaghi, OM (corresponding author), Univ Michigan, Dept Chem, Mat Design & Discovery Grp, Ann Arbor, MI 48109 USA.	oyaghi@umich.edu	Yaghi, Omar M/C-6749-2013; Eddaoudi, Mohamed/D-2298-2009	Eddaoudi, Mohamed/0000-0003-1916-9837				BENNETT JM, 1968, MATER RES BULL, V3, P633, DOI 10.1016/0025-5408(68)90112-8; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Eddaoudi M, 2000, J AM CHEM SOC, V122, P1391, DOI 10.1021/ja9933386; Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b; FAGAN PJ, 1992, SCI AM, V267, P48, DOI 10.1038/scientificamerican0792-48; HOSKINS BF, 1989, J AM CHEM SOC, V111, P5962, DOI 10.1021/ja00197a079; Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I; Kiang YH, 1999, J AM CHEM SOC, V121, P8204, DOI 10.1021/ja991100b; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Menon VC, 1998, J POROUS MAT, V5, P43, DOI 10.1023/A:1009673830619; Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082; OKEEFFE M, 1996, CRYSTAL STRUCTURES, V1; Reineke TM, 2000, J AM CHEM SOC, V122, P4843, DOI 10.1021/ja000363z; Russell VA, 1997, SCIENCE, V276, P575, DOI 10.1126/science.276.5312.575; Seki K, 2001, CHEM COMMUN, P1496, DOI 10.1039/b104204c; SEKI K, Patent No. 5862796; Serpaggi F, 1998, J MATER CHEM, V8, P2749, DOI 10.1039/a802715c; STEIN A, 1993, SCIENCE, V259, P1558, DOI 10.1126/science.259.5101.1558; Yaghi OM, 2000, J SOLID STATE CHEM, V152, P1, DOI 10.1006/jssc.2000.8733	19	6569	6773	195	6792	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					469	472		10.1126/science.1067208	http://dx.doi.org/10.1126/science.1067208			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799235				2022-12-28	WOS:000173350700041
J	Lake, B; Ronnow, HM; Christensen, NB; Aeppli, G; Lefmann, K; McMorrow, DF; Vorderwisch, P; Smeibidl, P; Mangkorntong, N; Sasagawa, T; Nohara, M; Takagi, H; Mason, TE				Lake, B; Ronnow, HM; Christensen, NB; Aeppli, G; Lefmann, K; McMorrow, DF; Vorderwisch, P; Smeibidl, P; Mangkorntong, N; Sasagawa, T; Nohara, M; Takagi, H; Mason, TE			Antiferromagnetic order induced by an applied magnetic field in a high-temperature superconductor	NATURE			English	Article							NEUTRON-SCATTERING; LA2-XSRXCUO4; STATE; LINES	One view of the high-transition-temperature (high-T-c) copper oxide superconductors is that they are conventional superconductors where the pairing occurs between weakly interacting quasi-particles (corresponding to the electrons in ordinary metals), although the theory has to be pushed to its limit(1). An alternative view is that the electrons organize into collective textures (for example, charge and spin stripes) which cannot be 'mapped' onto the electrons in ordinary metals. Understanding the properties of the material would then need quantum field theories of objects such as textures and strings, rather than point-like electrons(2-6). In an external magnetic field, magnetic flux penetrates type II superconductors via vortices, each carrying one flux quantum(7). The vortices form lattices of resistive material embedded in the non-resistive superconductor, and can reveal the nature of the ground state-for example, a conventional metal or an ordered, striped phase-which would have appeared had superconductivity not intervened, and which provides the best starting point for a pairing theory. Here we report that for one high-T-c superconductor, the applied field that imposes the vortex lattice also induces 'striped' antiferromagnetic order. Ordinary quasiparticle models can account for neither the strength of the order nor the nearly field-independent antiferromagnetic transition temperature observed in our measurements.	Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Oxford, Clarendon Lab, Dept Condensed Matter Phys, Oxford OX1 3PU, England; CEA, MDN, SPSMS, DRFMC, F-38054 Grenoble 9, France; Riso Natl Lab, Mat Res Dept, DK-4000 Roskilde, Denmark; APG, Niels Bohr Inst, Orsted Lab, DK-2100 Copenhagen, Denmark; NEC Res Inst, Princeton, NJ 08540 USA; Hahn Meitner Inst Berlin GmbH, BENSC, D-14109 Berlin, Germany; Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Spallat Neutron Source, Expt Facil Div, Oak Ridge, TN 37830 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Oxford; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Technical University of Denmark; University of Copenhagen; Niels Bohr Institute; NEC Corporation; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Tokyo; United States Department of Energy (DOE); Oak Ridge National Laboratory; Spallation Neutron Source	Lake, B (corresponding author), Oak Ridge Natl Lab, POB 2008 MS 6430, Oak Ridge, TN 37831 USA.	bella.lake@physics.ox.ac.uk	Mason, Thomas/M-5809-2014; McMorrow, Desmond Francis/M-9036-2019; Lefmann, Kim/M-9228-2014; Christensen, Niels B/A-3947-2012; Ronnow, Henrik M/A-4953-2009; Lake, Bella/A-6264-2011; Takagi, Hidenori/B-2935-2010; TAKAGI, HIDENORI/Q-1041-2019; Sasagawa, Takao/E-6666-2014; NOHARA, Minoru/B-1476-2011; Vorderwisch, Peter/AAH-9366-2021; McMorrow, Desmond/C-2655-2008	Mason, Thomas/0000-0003-1880-3971; McMorrow, Desmond Francis/0000-0002-4947-7788; Lefmann, Kim/0000-0003-4282-756X; Christensen, Niels B/0000-0001-6443-2142; Ronnow, Henrik M/0000-0002-8832-8865; Lake, Bella/0000-0003-0034-0964; TAKAGI, HIDENORI/0000-0001-5700-3761; Sasagawa, Takao/0000-0003-0149-6696; NOHARA, Minoru/0000-0003-1931-9903; McMorrow, Desmond/0000-0002-4947-7788				Aeppli G, 1997, SCIENCE, V278, P1432, DOI 10.1126/science.278.5342.1432; Ando Y, 1999, PHYS REV B, V60, P12475, DOI 10.1103/PhysRevB.60.12475; Arovas DP, 1997, PHYS REV LETT, V79, P2871, DOI 10.1103/PhysRevLett.79.2871; Boebinger GS, 1996, PHYS REV LETT, V77, P5417, DOI 10.1103/PhysRevLett.77.5417; Demler E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067202; HEDEGARD P, 2001, CONDMAT0102070; HU JP, 2001, CONDMAT0108273; Katano S, 2000, PHYS REV B, V62, P14677, DOI 10.1103/PhysRevB.62.R14677; Kimura H, 1999, PHYS REV B, V59, P6517, DOI 10.1103/PhysRevB.59.6517; KITTEL C, 1986, INTRO SOLID STATE PH, P426; KITTEL C, 1986, INTRO SOLID STATE PH, P317; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lake B, 1999, NATURE, V400, P43, DOI 10.1038/21840; Lake B, 2001, SCIENCE, V291, P1759, DOI 10.1126/science.1056986; LAKE B, 2001, CONDMAT0104026; Lee YS, 1999, PHYS REV B, V60, P3643, DOI 10.1103/PhysRevB.60.3643; MONTHOUX P, 1992, PHYS REV B, V46, P14803, DOI 10.1103/PhysRevB.46.14803; Nohara M, 2000, J PHYS SOC JPN, V69, P1602, DOI 10.1143/JPSJ.69.1602; Savici AT, 2000, PHYSICA B, V289, P338, DOI 10.1016/S0921-4526(00)00406-3; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; VAKNIN D, 1987, PHYS REV LETT, V58, P2802, DOI 10.1103/PhysRevLett.58.2802; Wakimoto S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.172501; Zaanen J, 2000, NATURE, V404, P714, DOI 10.1038/35008176; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zaanen J, 1998, PHYS REV B, V58, pR11868, DOI 10.1103/PhysRevB.58.R11868	26	467	470	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					299	302		10.1038/415299a	http://dx.doi.org/10.1038/415299a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797002	Green Submitted			2022-12-28	WOS:000173293500037
J	Laporte, RE; Sekikawa, A; Sa, ER; Linkov, F; Lovalekar, M				Laporte, RE; Sekikawa, A; Sa, ER; Linkov, F; Lovalekar, M			Infopoints - Whisking research into the classroom	BRITISH MEDICAL JOURNAL			English	Article																		[Anonymous], 2000, Nat Med, V6, P358	1	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					99	99		10.1136/bmj.324.7329.99	http://dx.doi.org/10.1136/bmj.324.7329.99			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786456	Bronze, Green Published			2022-12-28	WOS:000173325400024
J	Cheng, HYM; Pitcher, GM; Laviolette, SR; Whishaw, IQ; Tong, KI; Kockeritz, LK; Wada, T; Joza, NA; Crackower, M; Goncalves, J; Sarosi, I; Woodgett, JR; Oliveira-dos-Santos, AJ; Ikura, M; van der Kooy, D; Salter, MW; Penninger, JM				Cheng, HYM; Pitcher, GM; Laviolette, SR; Whishaw, IQ; Tong, KI; Kockeritz, LK; Wada, T; Joza, NA; Crackower, M; Goncalves, J; Sarosi, I; Woodgett, JR; Oliveira-dos-Santos, AJ; Ikura, M; van der Kooy, D; Salter, MW; Penninger, JM			DREAM is a critical transcriptional repressor for pain modulation	CELL			English	Article							KAPPA-OPIOID RECEPTOR; LONG-LASTING ALLODYNIA; SPINAL-CORD NEURONS; DYNORPHIN-A; NEUROPATHIC PAIN; ADMINISTERED DYNORPHIN; PRODYNORPHIN GENE; RAT; NMDA; MECHANISMS	Control and treatment of chronic pain remain major clinical challenges. Progress may be facilitated by a greater understanding of the mechanisms underlying pain processing. Here we show that the calcium-sensing protein DREAM is a transcriptional repressor involved in modulating pain. dream(-/-) mice displayed markedly reduced responses in models of acute thermal, mechanical, and visceral pain. dream(-/-) mice also exhibited reduced pain behaviors in models of chronic neuropathic and inflammatory pain. However, dream(-/-) mice showed no major defects in motor function or learning and memory. Mice lacking DREAM had elevated levels of prodynorphin mRNA and dynorphin A peptides in the spinal cord, and the reduction of pain behaviors in dream(-/-) mice was mediated through dynorphin-selective kappa (kappa)-opiate receptors. Thus, DREAM appears to be a critical transcriptional repressor in pain processing.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Ctr Study Pain, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada; NeuroDetect Inc, Lethbridge, AB T1K 3M4, Canada; Amgen Inc, Dept Pharmacol & Pathol, Thousand Oaks, CA 91320 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Amgen	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	jpenning@amgen.com	Penninger, Josef M/I-6860-2013; Woodgett, Jim/F-1087-2010	Penninger, Josef M/0000-0002-8194-3777; Woodgett, Jim/0000-0003-3731-5797				AKIL H, 1976, SCIENCE, V191, P961, DOI 10.1126/science.1251210; Akil H, 1996, NIDA Res Monogr, V161, P127; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Appleyard SM, 1997, J NEUROCHEM, V69, P2405; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CAUDLE RM, 1994, J NEUROSCI, V14, P5580; Chen L, 1998, J PHARMACOL EXP THER, V284, P826; CHEN L, 1995, J NEUROSCI, V15, P4602; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; DawsonBasoa ME, 1996, PAIN, V64, P607, DOI 10.1016/0304-3959(96)87175-2; DICKENSON AH, 1991, BRIT MED BULL, V47, P690, DOI 10.1093/oxfordjournals.bmb.a072501; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GRUDT TJ, 1993, P NATL ACAD SCI USA, V90, P11429, DOI 10.1073/pnas.90.23.11429; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Ho J, 1997, J PHARMACOL EXP THER, V281, P136; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; IADAROLA MJ, 1988, PAIN, V35, P313, DOI 10.1016/0304-3959(88)90141-8; Jevtovic-Todorovic V, 1998, BRAIN RES, V781, P202, DOI 10.1016/S0006-8993(97)01247-X; Jo DG, 2001, FASEB J, V15, P589; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016/0196-9781(90)90187-A; Lai SL, 1998, NEUROSCI LETT, V247, P115, DOI 10.1016/S0304-3940(98)00293-6; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Laughlin TM, 2001, J PHARMACOL EXP THER, V299, P6; LUCAS JJ, 1993, NEURON, V10, P599, DOI 10.1016/0896-6273(93)90163-L; Lutfy K, 1997, PAIN, V70, P31, DOI 10.1016/S0304-3959(96)03290-3; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; Mason DJ, 1999, EUR J PHARMACOL, V378, P237, DOI 10.1016/S0014-2999(99)00479-3; MESSERSMITH DJ, 1994, MOL CELL NEUROSCI, V5, P238, DOI 10.1006/mcne.1994.1028; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Ogura M, 2000, J NEUROPHYSIOL, V83, P3366, DOI 10.1152/jn.2000.83.6.3366; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; RANDIC M, 1995, J NEUROSCI, V15, P6809; Rusin KI, 1997, J NEUROSCI, V17, P6565; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; Spreafico F, 2001, MOL CELL NEUROSCI, V17, P1, DOI 10.1006/mcne.2000.0913; Suzuki R, 1999, PAIN, V80, P215, DOI 10.1016/S0304-3959(98)00208-5; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; TanNo K, 1996, EUR J PHARMACOL, V314, P61, DOI 10.1016/S0014-2999(96)00518-3; Vaccarino AL, 2000, PEPTIDES, V21, P1975, DOI 10.1016/S0196-9781(00)00345-4; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wickenden AD, 1999, CIRC RES, V85, P1067; Wiley JW, 1997, J NEUROPHYSIOL, V77, P1338, DOI 10.1152/jn.1997.77.3.1338; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zachariou V, 1997, EUR J PHARMACOL, V323, P159, DOI 10.1016/S0014-2999(97)00038-1	58	225	242	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					31	43		10.1016/S0092-8674(01)00629-8	http://dx.doi.org/10.1016/S0092-8674(01)00629-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792319	Bronze			2022-12-28	WOS:000173280700006
J	Lin, JF; Heinz, DL; Campbell, AJ; Devine, JM; Shen, GY				Lin, JF; Heinz, DL; Campbell, AJ; Devine, JM; Shen, GY			Iron-silicon alloy in Earth's core?	SCIENCE			English	Article							HIGH-PRESSURES; HIGH-TEMPERATURE; SYSTEM FE; EQUATION; STATE; COMPRESSION; CALIBRATION; PHASE; NACL	We have investigated the phase relations in the iron-rich portion of the iron-silicon (Fe-Si) alloys at high pressures and temperatures. Our study indicates that Si alloyed with Fe can stabilize the body-centered cubic (bcc) phase up to at least 84 gigapascals (compared to similar to10 gigapascals for pure Fe) and 2400 kelvin. Earth's inner core may be composed of hexagonal close-packed (hcp) Fe with up to 4 weight percent Si, but it is also conceivable that the inner core could be a mixture of a Si-rich bcc phase and a Si-poor hcp phase.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Consortium Adv Radiat Sources, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Lin, JF (corresponding author), Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA.		Shen, Guoyin/D-6527-2011; Lin, Jung-Fu/B-4917-2011	Shen, Guoyin/0000-0001-5146-1147; Lin, Jung-Fu/0000-0002-0163-5329; Campbell, Andrew/0000-0003-3716-9435				BALCHAN AS, 1966, J GEOPHYS RES, V71, P3577, DOI 10.1029/JZ071i014p03577; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; BIRCH F, 1986, J GEOPHYS RES-SOLID, V91, P4949, DOI 10.1029/JB091iB05p04949; FEI YW, 1995, SCIENCE, V268, P1892, DOI 10.1126/science.268.5219.1892; HEINZ DL, 1984, PHYS REV B, V30, P6045, DOI 10.1103/PhysRevB.30.6045; HEINZ DL, 1984, J APPL PHYS, V55, P885, DOI 10.1063/1.333139; Hemley RJ, 2001, INT GEOL REV, V43, P1; Hillgren V.J., 2000, ORIGIN EARTH MOON PP, P245, DOI DOI 10.2307/J.CTV1V7ZDRP.20; KNITTLE E, 1995, GEOPHYS RES LETT, V22, P445, DOI 10.1029/94GL03346; KUBASCHEWSKI O, 1982, IRON BINARY PHASE DI; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; Mao HK, 2001, SCIENCE, V292, P914, DOI 10.1126/science.1057670; RINGWOOD AE, 1990, PHYS CHEM MINER, V17, P313; Sanloup C, 2000, EUROPHYS LETT, V52, P151, DOI 10.1209/epl/i2000-00417-3; Shen GY, 1998, GEOPHYS RES LETT, V25, P373, DOI 10.1029/97GL03776; Shen GY, 2001, REV SCI INSTRUM, V72, P1273, DOI 10.1063/1.1343867; Speziale S, 2001, J GEOPHYS RES-SOL EA, V106, P515, DOI 10.1029/2000JB900318; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P24729, DOI 10.1029/97JB02125; Tromp J, 2001, ANNU REV EARTH PL SC, V29, P47, DOI 10.1146/annurev.earth.29.1.47; Wang Y., 1998, REV HIGH PRESS SCI T, V15, P1490, DOI [10.4131/jshpreview.7.1490, DOI 10.4131/JSHPREVIEW.7.1490]; Zhang J, 1999, PHYS CHEM MINER, V26, P419, DOI 10.1007/s002690050203; Zhang J, 1999, PHYS CHEM MINER, V26, P206, DOI 10.1007/s002690050178	23	118	119	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					313	315		10.1126/science.1066932	http://dx.doi.org/10.1126/science.1066932			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786640				2022-12-28	WOS:000173278600045
J	Nattel, S				Nattel, S			New ideas about atrial fibrillation 50 years on	NATURE			English	Review							RECTIFIER K+ CURRENT; ANGIOTENSIN-CONVERTING ENZYME; MESSENGER-RNA; CANINE MODEL; ELECTROPHYSIOLOGICAL CHARACTERISTICS; CONTRACTILE DYSFUNCTION; POTENTIAL PROPERTIES; IONIC MECHANISMS; CALCIUM-CHANNEL; PULMONARY VEINS	Atrial fibrillation is a condition in which control of heart rhythm is taken away from the normal sinus node pacemaker by rapid activity in different areas within the upper chambers (atria) of the heart. This results in rapid and irregular atrial activity and, instead of contracting, the atria only quiver. It is the most common cardiac rhythm disturbance and contributes substantially to cardiac morbidity and mortality. For over 50 years, the prevailing model of atrial fibrillation involved multiple simultaneous re-entrant waves, but in light of new discoveries this hypothesis is now undergoing re-evaluation.	Montreal Heart Inst, Dept Med, Res Ctr, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Nattel, S (corresponding author), Montreal Heart Inst, Dept Med, Res Ctr, Montreal, PQ H1T 1C8, Canada.	nattel@icm.umontreal.ca		Nattel, Stanley/0000-0002-5565-3311				Aime-Sempe C, 1999, J AM COLL CARDIOL, V34, P1577, DOI 10.1016/S0735-1097(99)00382-4; ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; Athill CA, 1998, CIRCULATION, V98, P1556, DOI 10.1161/01.CIR.98.15.1556; Ausma J, 1997, CIRCULATION, V96, P3157, DOI 10.1161/01.CIR.96.9.3157; Beaumont J, 1998, BIOPHYS J, V75, P1, DOI 10.1016/S0006-3495(98)77490-9; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BEYER F, 1993, Z KARDIOL, V82, P674; BLACK IW, 1994, CIRCULATION, V89, P2509, DOI 10.1161/01.CIR.89.6.2509; Bode F, 2001, NATURE, V409, P35, DOI 10.1038/35051165; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Brundel BJJM, 1999, CARDIOVASC RES, V42, P443, DOI 10.1016/S0008-6363(99)00045-0; Cardin S, 2001, CIRCULATION, V104, P77; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Chen YJ, 2000, CARDIOVASC RES, V48, P265, DOI 10.1016/S0008-6363(00)00179-6; CHEUNG DW, 1981, J PHYSIOL-LONDON, V314, P445, DOI 10.1113/jphysiol.1981.sp013718; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Cox J L, 2000, Semin Thorac Cardiovasc Surg, V12, P68; Daoud EG, 1997, CIRCULATION, V96, P1542, DOI 10.1161/01.CIR.96.5.1542; Derakhchan K, 2001, J CARDIOVASC ELECTR, V12, P548, DOI 10.1046/j.1540-8167.2001.00548.x; Doshi RN, 1999, CIRCULATION, V100, P876, DOI 10.1161/01.CIR.100.8.876; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Elvan A, 1997, CIRCULATION, V96, P1675, DOI 10.1161/01.CIR.96.5.1675; Fareh S, 1999, CIRCULATION, V100, P2191, DOI 10.1161/01.CIR.100.21.2191; Fareh S, 2001, CARDIOVASC RES, V49, P762, DOI 10.1016/S0008-6363(00)00288-1; Fenelon G, 1996, PACE, V19, P95, DOI 10.1111/j.1540-8159.1996.tb04796.x; FENELON G, 1999, CIRCULATION, V96, P237; Feng JL, 1997, CIRC RES, V80, P572, DOI 10.1161/01.RES.80.4.572; Garrey WE, 1924, PHYSIOL REV, V4, P215, DOI 10.1152/physrev.1924.4.2.215; Gaspo R, 1997, CIRCULATION, V96, P4027; Gaspo R, 1997, CIRC RES, V81, P1045; Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Hagendorff A, 1999, CIRCULATION, V99, P1508, DOI 10.1161/01.CIR.99.11.1508; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hart RG, 2001, STROKE, V32, P803, DOI 10.1161/01.STR.32.3.803; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hobbs WJC, 1999, J CARDIOVASC ELECTR, V10, P866, DOI 10.1111/j.1540-8167.1999.tb00268.x; Kneller J, 2001, CIRCULATION, V104, P5; Kumagai K, 2000, PACE, V23, P1823; Lai LP, 1999, J AM COLL CARDIOL, V33, P1231, DOI 10.1016/S0735-1097(99)00008-X; Lee SH, 2000, CIRCULATION, V101, P200, DOI 10.1161/01.CIR.101.2.200; Lendeckel U, 2001, J MOL CELL CARDIOL, V33, P1273, DOI 10.1006/jmcc.2001.1389; Li DS, 2000, CIRCULATION, V101, P2631, DOI 10.1161/01.CIR.101.22.2631; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Li DS, 2001, CIRC RES, V88, P1168, DOI 10.1161/hh1101.091266; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 1997, AM J PHYSIOL-HEART C, V272, pH227, DOI 10.1152/ajpheart.1997.272.1.H227; Mandapati R, 2000, CIRCULATION, V101, P194, DOI 10.1161/01.CIR.101.2.194; Mansour M, 2001, CIRCULATION, V103, P2631; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Nattel S, 1998, CARDIOVASC RES, V37, P567, DOI 10.1016/S0008-6363(97)00293-9; Nattel S, 2000, ANNU REV PHYSIOL, V62, P51, DOI 10.1146/annurev.physiol.62.1.51; NATTEL S, 1995, AM HEART J, V130, P1094, DOI 10.1016/0002-8703(95)90214-7; Ohkusa T, 1999, J AM COLL CARDIOL, V34, P255, DOI 10.1016/S0735-1097(99)00169-2; Pedersen OD, 1999, CIRCULATION, V100, P376, DOI 10.1161/01.CIR.100.4.376; RAIESDANA A, 2001, PACE, V24, P549; RENSMA PL, 1988, CIRC RES, V62, P395, DOI 10.1161/01.RES.62.2.395; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Shi WM, 1999, CIRC RES, V85, pE1; Sueda T, 2001, ANN THORAC SURG, V71, P1189, DOI 10.1016/S0003-4975(00)02606-0; Sun H, 2001, CARDIOVASC RES, V49, P751, DOI 10.1016/S0008-6363(00)00294-7; Sun H, 1998, CIRCULATION, V98, P719, DOI 10.1161/01.CIR.98.7.719; Tieleman RG, 1997, CIRCULATION, V95, P1945; Tsai CF, 2000, CIRCULATION, V102, P67, DOI 10.1161/01.CIR.102.1.67; van der Velden HMW, 2000, CARDIOVASC RES, V46, P476, DOI 10.1016/S0008-6363(00)00026-2; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; VanWagoner DR, 1997, CIRC RES, V80, P772; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Wijffels MCEF, 2000, CIRCULATION, V102, P260, DOI 10.1161/01.CIR.102.2.260; Wijffels MCEF, 1997, CIRCULATION, V96, P3710; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wu TJ, 2001, CIRCULATION, V103, P1157, DOI 10.1161/01.CIR.103.8.1157; Yu WC, 1998, CIRCULATION, V97, P2331, DOI 10.1161/01.CIR.97.23.2331; Yue LX, 1999, CIRC RES, V84, P776; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	80	1103	1163	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					219	226		10.1038/415219a	http://dx.doi.org/10.1038/415219a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805846				2022-12-28	WOS:000173159300052
J	Peichel, CL; Nereng, KS; Ohgi, KA; Cole, BLE; Colosimo, PF; Buerkle, CA; Schluter, D; Kingsley, DM				Peichel, CL; Nereng, KS; Ohgi, KA; Cole, BLE; Colosimo, PF; Buerkle, CA; Schluter, D; Kingsley, DM			The genetic architecture of divergence between threespine stickleback species	NATURE			English	Article							GASTEROSTEUS-ACULEATUS; NATURAL-SELECTION; SPECIATION; ADAPTATION; EVOLUTION; PREDATION; ECOLOGY; PAIR; SIZE	The genetic and molecular basis of morphological evolution is poorly understood, particularly in vertebrates. Genetic studies of the differences between naturally occurring vertebrate species have been limited by the expense and difficulty of raising large numbers of animals and the absence of molecular linkage maps for all but a handful of laboratory and domesticated animals. We have developed a genome-wide linkage map for the three-spined stickleback (Gasterosteus aculeatus), an extensively studied teleost fish that has undergone rapid divergence and speciation since the melting of glaciers 15,000 years ago(1). Here we use this map to analyse the genetic basis of recently evolved changes in skeletal armour and feeding morphologies seen in the benthic and limnetic stickleback species from Priest Lake, British Columbia. Substantial alterations in spine length, armour plate number, and gill raker number are controlled by genetic factors that map to independent chromosome regions. Further study of these regions will help to define the number and type of genetic changes that underlie morphological diversification during vertebrate evolution.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biol, Eau Claire, WI 54702 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1ZT, Canada; Univ British Columbia, Ctr Biodivers, Vancouver, BC V6T 1ZT, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Wisconsin System; University of British Columbia; University of British Columbia	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.			Buerkle, Alex/0000-0003-4222-8858; Schluter, Dolph/0000-0003-1683-7836; Peichel, Catherine/0000-0002-7731-8944				Ahn DG, 1999, EVOL DEV, V1, P100, DOI 10.1046/j.1525-142x.1999.99009.x; Beavis William D., 1998, P145; Bell M.A., 1984, P431; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; CHEN TR, 1970, CYTOGENETICS, V9, P321, DOI 10.1159/000130102; HAGEN DW, 1972, EVOLUTION, V26, P32, DOI 10.1111/j.1558-5646.1972.tb00172.x; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Largiader CR, 1999, MOL ECOL, V8, P342; Lynch M., 1998, GENETICS ANAL QUANTI; McPhail J.D., 1994, P399; MOODIE GEE, 1972, HEREDITY, V28, P155, DOI 10.1038/hdy.1972.21; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; Reimchen TE, 1995, BEHAVIOUR, V132, P1079, DOI 10.1163/156853995X00469; RICO C, 1993, MOL ECOL, V2, P271, DOI 10.1111/j.1365-294X.1993.tb00017.x; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; ROZEN S, 1997, PRIMER3; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Stam P., 1995, JOINMAP VERSION 2 0; SWAIN DP, 1992, EVOLUTION, V46, P998, DOI 10.1111/j.1558-5646.1992.tb00615.x; Taylor AC, 1998, MOL ECOL, V7, P925; Vamosi SM, 1999, EVOLUTION, V53, P874, DOI 10.1111/j.1558-5646.1999.tb05381.x; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; [No title captured]	30	401	414	1	189	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					901	905		10.1038/414901a	http://dx.doi.org/10.1038/414901a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780061	Green Accepted			2022-12-28	WOS:000172813300044
J	Schuster, MA; Stein, BD; Jaycox, LH; Collins, RL; Marshall, GN; Elliott, MN; Zhou, AJ; Kanouse, DE; Morrison, JL; Berry, SH				Schuster, MA; Stein, BD; Jaycox, LH; Collins, RL; Marshall, GN; Elliott, MN; Zhou, AJ; Kanouse, DE; Morrison, JL; Berry, SH			A national survey of stress reactions after the September 11, 2001, terrorist attacks	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISORDER; POPULATION; COMMUNITY; SYMPTOMS; CHILDREN; DISASTER; DISTANT; IV	Background: People who are not present at a traumatic event may experience stress reactions. We assessed the immediate mental health effects of the terrorist attacks on September 11, 2001. Methods: Using random-digit dialing three to five days after September 11, we interviewed a nationally representative sample of 560 U.S. adults about their reactions to the terrorist attacks and their perceptions of their children's reactions. Results: Forty-four percent of the adults reported one or more substantial symptoms of stress; 90 percent had one or more symptoms to at least some degree. Respondents throughout the country reported stress symptoms. They coped by talking with others (98 percent), turning to religion (90 percent), participating in group activities (60 percent), and making donations (36 percent). Eighty-four percent of parents reported that they or other adults in the household had talked to their children about the attacks for an hour or more; 34 percent restricted their children's television viewing. Thirty-five percent of children had one or more stress symptoms, and 47 percent were worried about their own safety or the safety of loved ones. Conclusions: After the September 11 terrorist attacks, Americans across the country, including children, had substantial symptoms of stress. Even clinicians who practice in regions that are far from the recent attacks should be prepared to assist people with trauma-related symptoms of stress.	RAND Corp, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schuster, MA (corresponding author), RAND Corp, 1700 Main St, Santa Monica, CA 90407 USA.	schuster@rand.org	Stein, Bradley/A-7978-2009; Stein, Bradley/O-8403-2019		NATIONAL INSTITUTE OF MENTAL HEALTH [K12MH000990] Funding Source: NIH RePORTER; NIMH NIH HHS [K12/MH00990] Funding Source: Medline; PHS HHS [U48/CCU915773] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AAP, 2001, AAP OFF ADV COMM CHI; *AM AC CHILD AD PS, 1999, TALK CHILDR PAR DIS; *AM RED CROSS, 2001, HELP YOUNG CHILDR CO; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; BARRINGER F, 2001, NY TIMES        0912, pA25; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; *BUR CENS, 2001, CURR POP SURV ANN DE; Cantor J, 2000, J ADOLESCENT HEALTH, V27, P30, DOI 10.1016/S1054-139X(00)00129-4; CANTOR J, 1982, J COMMUN, V32, P87, DOI 10.1111/j.1460-2466.1982.tb00480.x; Cantor J., 1993, DESERT STORM MASS ME, P325; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; DIXON P, 1993, BRIT J MED PSYCHOL, V66, P193, DOI 10.1111/j.2044-8341.1993.tb01741.x; FOA EB, 1999, CLIN PRAC, P23; FREEDY JR, 1994, J TRAUMA STRESS, V7, P257, DOI 10.1002/jts.2490070207; Goff DC, 1998, ARCH INTERN MED, V158, P2329, DOI 10.1001/archinte.158.21.2329; HELZER JE, 1987, NEW ENGL J MED, V317, P1630, DOI 10.1056/NEJM198712243172604; KAKUTANI M, 2001, NY TIMES        0918, pB11; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KISER L, 1993, AM J PSYCHIAT, V150, P87; Lazarus R.S., 1991, EMOTION ADAPTATION; Lazarus RS., 1984, STRESS APPRAISAL COP; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Pfefferbaum B, 1999, AM J PSYCHIAT, V156, P1069; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; PFEFFERBAUM B, IN PRESS PSYCHIATRY; SCHWARZ ED, 1991, J AM ACAD CHILD PSY, V30, P936, DOI 10.1097/00004583-199111000-00011; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shales Tom, 2001, WASHINGTON POST 1005, pC1; SHORE JH, 1986, AM J PSYCHIAT, V143, P590; *STAT CORP, 2001, STAT STAT SOFTW REL; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Sturm R, 2001, J BEHAV HEALTH SER R, V28, P81, DOI 10.1007/BF02287236; Terr LC, 1999, AM J PSYCHIAT, V156, P1536, DOI 10.1176/ajp.156.10.1536; Turner R.H., 1986, WAITING DISASTER EAR; *USDHHS, 1983, EP CATCHM AR PROGR L; YACOUBIAN VV, 1989, B MENNINGER CLIN, V53, P331; 2001, NY TIMES        0916, P10	39	1020	1037	3	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1507	1512		10.1056/NEJM200111153452024	http://dx.doi.org/10.1056/NEJM200111153452024			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491WH	11794216				2022-12-28	WOS:000172132700029
J	Eriksson, BI; Bauer, KA; Lassen, MR; Turpie, AGG				Eriksson, BI; Bauer, KA; Lassen, MR; Turpie, AGG		Steering Comm Pentasaccharide Hip	Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Hematology	DEC 01-05, 2000	SAN FRANCISCO, CA	Amer Soc Hematol			LOW-MOLECULAR-WEIGHT; DEEP-VEIN THROMBOSIS; FACTOR XA INHIBITOR; LOW-DOSE HEPARIN; DOUBLE-BLIND; SYNTHETIC PENTASACCHARIDE; RECOMBINANT HIRUDIN; PULMONARY-EMBOLISM; FEMORAL-NECK; PROPHYLAXIS	Background: Surgery for hip fracture carries a high risk of venous thromboembolism, despite the use of current thromboprophylactic treatments. Fondaparinux, a synthetic pentasaccharide, is a new antithrombotic agent that may reduce this risk. Methods: In a double-blind study, we randomly assigned 1711 consecutive patients undergoing surgery for fracture of the upper third of the femur to receive subcutaneous doses of either 2.5 mg of fondaparinux once daily, initiated postoperatively, or 40 mg of enoxaparin once daily, initiated preoperatively, for at least five days. The primary efficacy outcome was venous thromboembolism up to postoperative day 11. Venous thromboembolism was defined as deep-vein thrombosis detected by mandatory bilateral venography, documented symptomatic deep-vein thrombosis, or documented symptomatic pulmonary embolism. The main safety outcomes were major bleeding and mortality from all causes. The duration of follow-up was six weeks. Results: The incidence of venous thromboembolism by day 11 was 8.3 percent (52 of 626 patients) in the fondaparinux group and 19.1 percent (119 of 624 patients) in the enoxaparin group (P<0.001). The reduction in risk with fondaparinux was 56.4 percent (95 percent confidence interval, 39.0 to 70.3 percent). There were no significant differences between the two groups in the incidence of death or clinically relevant bleeding. Conclusions: In patients undergoing surgery for hip fracture, fondaparinux was more effective than enoxaparin in preventing venous thromboembolism and was equally safe. (N Engl J Med 2001;345:1298-304.) Copyright (C) 2001 Massachusetts Medical Society.	Sahlgrens Univ Hosp, Dept Orthoped, S-41685 Gothenburg, Sweden; Vet Affairs Boston Healthcare Syst, Dept Med, Boston, MA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Hillerod Univ, Dept Orthoped, Hillerod, Denmark; Hamilton Hlth Sci Corp, Gen Div, Dept Med, Hamilton, ON, Canada	Sahlgrenska University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Beth Israel Deaconess Medical Center; University of Copenhagen; McMaster University	Eriksson, BI (corresponding author), Sahlgrens Univ Hosp, Dept Orthoped, S-41685 Gothenburg, Sweden.	b.eriksson@orthop.gu.se		Eriksson, Bengt/0000-0001-6894-7434				AGNELLI G, 1992, THROMB HAEMOSTASIS, V67, P203; Barsotti J, 1990, J Orthop Trauma, V4, P371, DOI 10.1097/00005131-199012000-00001; Bauer K, 2000, BLOOD, V96, p490A; BERGQUIS.E, 1972, ACTA CHIR SCAND, V138, P689; BERGQVIST D, 1991, SURGERY, V109, P617; Bergqvist D, 1999, HAEMOSTASIS, V29, P310; BORGSTROEM S, 1965, Acta Chir Scand, V129, P500; BORRIS LC, 1995, THROMB HAEMOSTASIS, V73, P1104; BRONGE A, 1971, ACTA CHIR SCAND, V137, P29; Cimminiello C, 2000, LANCET, V356, P247, DOI 10.1016/S0140-6736(00)02493-4; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; ERIKSSON BI, 1991, J BONE JOINT SURG AM, V73A, P484, DOI 10.2106/00004623-199173040-00002; Eriksson BI, 1997, NEW ENGL J MED, V337, P1329, DOI 10.1056/NEJM199711063371901; Eriksson BI, 1996, LANCET, V347, P635, DOI 10.1016/S0140-6736(96)91200-3; FISHER CG, 1995, J ORTHOP TRAUMA, V9, P1, DOI 10.1097/00005131-199502000-00001; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Gent M, 1996, CIRCULATION, V93, P80, DOI 10.1161/01.CIR.93.1.80; GERHART TN, 1991, J BONE JOINT SURG AM, V73A, P494, DOI 10.2106/00004623-199173040-00003; HAMILTON H W, 1970, Journal of Bone and Joint Surgery British Volume, V52, P268; HARTMAN JT, 1982, J BONE JOINT SURG AM, V64, P1059, DOI 10.2106/00004623-198264070-00016; HAVIG O, 1977, ACTA CHIR SCAND, P1; Hull RD, 2000, ARCH INTERN MED, V160, P2199, DOI 10.1001/archinte.160.14.2199; Jorgensen PS, 1998, CLIN APPL THROMB-HEM, V4, P140, DOI 10.1177/107602969800400213; Lassen MR, 2000, BLOOD, V96, p490A; Lormeau JC, 1995, THROMB HAEMOSTASIS, V74, P1474; MONREAL M, 1989, J TRAUMA, V29, P873, DOI 10.1097/00005373-198906000-00028; MOSER KM, 1981, ANN INTERN MED, V94, P439, DOI 10.7326/0003-4819-94-4-439; MOSKOVITZ PA, 1978, J BONE JOINT SURG AM, V60, P1065, DOI 10.2106/00004623-197860080-00008; Nicolaides AN, 2001, INT ANGIOL, V20, P1; O'Brien J, 2000, LANCET, V355, P1295; PETITOU M, 1991, NATURE, V350, P30; POWERS PJ, 1989, ARCH INTERN MED, V149, P771, DOI 10.1001/archinte.149.4.771; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Sors H, 2000, LANCET, V355, P1288, DOI 10.1016/S0140-6736(00)02104-8; Turpie AGG, 2001, NEW ENGL J MED, V344, P619, DOI 10.1056/NEJM200103013440901; Turpie G, 2000, BLOOD, V96, p491A; VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; WALENGA JM, 1988, THROMB RES, V51, P23, DOI 10.1016/0049-3848(88)90279-4	39	506	524	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1298	1304		10.1056/NEJMoa011100	http://dx.doi.org/10.1056/NEJMoa011100			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	487UX	11794148				2022-12-28	WOS:000171896300002
J	Lai, LX; Kolber-Simonds, D; Park, KW; Cheong, HT; Greenstein, JL; Im, GS; Samuel, M; Bonk, A; Rieke, A; Day, BN; Murphy, CN; Carter, DB; Hawley, RJ; Prather, RS				Lai, LX; Kolber-Simonds, D; Park, KW; Cheong, HT; Greenstein, JL; Im, GS; Samuel, M; Bonk, A; Rieke, A; Day, BN; Murphy, CN; Carter, DB; Hawley, RJ; Prather, RS			Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer coning	SCIENCE			English	Article							CLONED TRANSGENIC CALVES; SOMATIC-CELLS	The presence of galactose alpha-1,3-galactose residues on the surface of pig cells is a major obstacle to successful xenotransplantation. Here, we report the production of four live pigs in which one allele of the alpha-1,3-galactosyltransferase locus has been knocked out. These pigs were produced by nuclear transfer technology; clonal fetal fibroblast cell lines were used as nuclear donors for embryos reconstructed with enucleated pig oocytes.	Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Immerge BioTherapeut Inc, Charlestown, MA 02129 USA; Kangwon Natl Univ, Coll Anim Resource Sci, Dept Vet Med, Chunchon 200701, South Korea; Natl Livestock Res Inst, Suwon 441350, South Korea	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Kangwon National University	Prather, RS (corresponding author), Univ Missouri, Dept Anim Sci, Columbia, MO 65211 USA.	pratherR@missouri.edu	Prather, Randall S/B-4528-2012; Lai, Liangxue/H-4545-2011	Prather, Randall/0000-0002-6012-4035	NATIONAL CENTER FOR RESEARCH RESOURCES [R44RR015198, T32RR007004] Funding Source: NIH RePORTER; NCRR NIH HHS [R44 RR15198, T32 RR07004] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bondioli K, 2001, MOL REPROD DEV, V60, P189, DOI 10.1002/mrd.1076; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Costa C, 1999, FASEB J, V13, P1762, DOI 10.1096/fasebj.13.13.1762; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Evans RW, 2001, XENOTRANSPLANTATION, P29; GALILI U, 2001, CURR OPIN ORGAN T, V6; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; LAI L, UNPUB; Lambrigts D, 1998, TRANSPLANTATION, V66, P547, DOI 10.1097/00007890-199809150-00001; Martin Michael J., 1994, P315; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Miyagawa S, 2001, J BIOL CHEM, V276, P39310, DOI 10.1074/jbc.M104359200; OLDMIXON BA, UNPUB; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; POLGE C, 1966, J REPROD FERTIL, V12, P395, DOI 10.1530/jrf.0.0120395; POLGE C, 1981, CONTROL PIG REPROD, P283; Pope W F, 1990, J Reprod Fertil Suppl, V40, P251; SACHS DH, 1976, TRANSPLANTATION, V22, P559, DOI 10.1097/00007890-197612000-00004; Tao T, 2000, ZYGOTE, V8, P69, DOI 10.1017/S0967199400000848; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996	24	1022	1254	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1089	1092		10.1126/science.1068228	http://dx.doi.org/10.1126/science.1068228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11778012				2022-12-28	WOS:000173793000071
J	Doran, PT; Priscu, JC; Lyons, WB; Walsh, JE; Fountain, AG; McKnight, DM; Moorhead, DL; Virginia, RA; Wall, DH; Clow, GD; Fritsen, CH; McKay, CP; Parsons, AN				Doran, PT; Priscu, JC; Lyons, WB; Walsh, JE; Fountain, AG; McKnight, DM; Moorhead, DL; Virginia, RA; Wall, DH; Clow, GD; Fritsen, CH; McKay, CP; Parsons, AN			Antarctic climate cooling and terrestrial ecosystem response	NATURE			English	Article							TAYLOR-VALLEY; DRY VALLEYS; COMMUNITIES; TEMPERATURE	The average air temperature at the Earth's surface has increased by 0.06degreesC per decade during the 20th century(1), and by 0.19degreesC per decade from 1979 to 1998(2). Climate models generally predict amplified warming in polar regions(3,4), as observed in Antarctica's peninsula region over the second half of the 20th century(5-9). Although previous reports suggest slight recent continental warming(9,10), our spatial analysis of Antarctic meteorological data demonstrates a net cooling on the Antarctic continent between 1966 and 2000, particularly during summer and autumn. The McMurdo Dry Valleys have cooled by 0.7degreesC per decade between 1986 and 2000, with similar pronounced seasonal trends. Summer cooling is particularly important to Antarctic terrestrial ecosystems that are poised at the interface of ice and water. Here we present data from the dry valleys representing evidence of rapid terrestrial ecosystem response to climate cooling in Antarctica, including decreased primary productivity of lakes (6-9% per year) and declining numbers of soil invertebrates (more than 10% per year). Continental Antarctic cooling, especially the seasonality of cooling, poses challenges to models of climate and ecosystem change.	Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA; Montana State Univ, Bozeman, MT 59717 USA; Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Portland State Univ, Dept Geol, Portland, OR 97207 USA; Univ Toledo, Dept Earth Ecol & Environm Sci, Toledo, OH 43606 USA; Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; US Geol Survey, Climate Program, Denver, CO 80225 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89512 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Portland State University; University System of Ohio; University of Toledo; Dartmouth College; Colorado State University; United States Department of the Interior; United States Geological Survey; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Doran, PT (corresponding author), Univ Illinois, Dept Earth & Environm Sci, 845 W Taylor St, Chicago, IL 60607 USA.		Wall, Diana H/F-5491-2011	Walsh, John/0000-0001-9541-5927; MCKNIGHT, DIANE/0000-0002-4171-1533				Bromley A. M., 1985, INFORMATION PUBLICAT, V11; BROMWICH DH, 1998, ANTARCTICA BAROMETER; CATTLE H, 1995, PHILOS T R SOC A, V352, P201, DOI 10.1098/rsta.1995.0064; CHEN CTA, 1986, ANNU REV EARTH PL SC, V14, P201, DOI 10.1146/annurev.ea.14.050186.001221; CHINN TJH, 1993, ANTARCT RES SER, V59, P1, DOI DOI 10.1029/AR059P0001; Clow GD, 1988, J CLIMATE, V1, P715, DOI 10.1175/1520-0442(1988)001<0715:COAPSR>2.0.CO;2; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; DORAN P. T., 1995, ANTARCT J US, V30, P276; DORAN PT, UNPUB J CLIM; Fountain AG, 1999, BIOSCIENCE, V49, P961, DOI 10.2307/1313730; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jacka TH, 1998, ANN GLACIOL, V27, P553; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; MCKAY CP, 1993, ANTARCT RES SER, V61, P201; McKnight DM, 1999, BIOSCIENCE, V49, P985, DOI 10.2307/1313732; National Research Council, 2000, REC OBS GLOB TEMP CH; Parish TR, 2001, J APPL METEOROL, V40, P810, DOI 10.1175/1520-0450(2001)040<0810:FOTWAB>2.0.CO;2; PORAZINSKA DL, IN PRESS ARCTIC ANTA; Powers LE, 1998, ARCTIC ALPINE RES, V30, P133, DOI 10.2307/1552128; PRISCU JC, 1995, FRESHWATER BIOL, V34, P215, DOI 10.1111/j.1365-2427.1995.tb00882.x; Priscu JC, 1999, BIOSCIENCE, V49, P997, DOI 10.2307/1313733; RIORDAN A. J, 1973, CLIMATE ARCTIC, P268; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Virginia RA, 1999, BIOSCIENCE, V49, P973, DOI 10.2307/1313731; Weller G, 1998, ANN GLACIOL, V27, P543; WHARTON RA, 1992, J GEOPHYS RES-OCEANS, V97, P3503, DOI 10.1029/91JC03106	29	335	346	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					517	520		10.1038/nature710	http://dx.doi.org/10.1038/nature710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11793010				2022-12-28	WOS:000173564300044
J	Abramson, JS; Pickering, LK				Abramson, JS; Pickering, LK			US immunization policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERTUSSIS; MEASLES; IMPACT; MUMPS; RISK		Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27157 USA; Amer Acad Pediat, Comm Infect Dis, Elk Grove Village, IL USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Wake Forest University; Wake Forest Baptist Medical Center; American Academy of Pediatrics; Centers for Disease Control & Prevention - USA; Emory University	Abramson, JS (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	jabrams@wfubmc.edu						Ascherio A, 2001, NEW ENGL J MED, V344, P327, DOI 10.1056/NEJM200102013440502; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1140; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P418; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P427; *CDCP, 1997, MMWR-MORBID MORTAL W, V277, P525; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P637; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P582; Decker AD, 2000, J PEDIATR-US, V137, P291, DOI 10.1067/mpd.2000.109026; Dittmann S, 2000, J INFECT DIS, V181, pS10, DOI 10.1086/315534; Edwards KP, 2000, JAMA-J AM MED ASSOC, V284, P3171, DOI 10.1001/jama.284.24.3171; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; GARDNER P, IN PRESS CLIN INFECT; Gerber MA, 2001, PEDIATRICS, V107, P612, DOI 10.1542/peds.107.5.e84; KATTWINKEL J, 1992, PEDIATRICS, V89, P1120; Mahoney F.J., 1999, VACCINES, P158; Mason BW, 2000, J EPIDEMIOL COMMUN H, V54, P473, DOI 10.1136/jech.54.6.473; Miller E, 2001, ARCH DIS CHILD, V84, P227, DOI 10.1136/adc.84.3.227; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; PACE B, 2000, JAMA-J AM MED ASSOC, V284, P1336; STRATTON K, 2001, I MED IMMUNIZATION S; TATZLANDREW EJ, 1994, COST BENEFIT ANAL ME, P1; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; WOODIN KA, 1995, ARCH PEDIAT ADOL MED, V149, P845, DOI 10.1001/archpedi.1995.02170210019003	26	16	16	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					505	509		10.1001/jama.287.4.505	http://dx.doi.org/10.1001/jama.287.4.505			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798374				2022-12-28	WOS:000173401900029
J	Castillo, PE; Schoch, S; Schmitz, F; Sudhof, TC; Malenka, RC				Castillo, PE; Schoch, S; Schmitz, F; Sudhof, TC; Malenka, RC			RIM1 alpha is required for presynaptic long-term potentiation	NATURE			English	Article							MOSSY FIBER SYNAPSES; CYCLIC-AMP; SYNAPTIC TRANSMISSION; CAMP; LTP; HIPPOCAMPUS; MICE; RAB3; ENHANCEMENT; ACTIVATION	Two main forms of long-term potentiation (LTP)-a prominent model for the cellular mechanism of learning and memory-have been distinguished in the mammalian brain(1). One requires activation of postsynaptic NMDA (N-methyl D-aspartate) receptors, whereas the other, called mossy fibre LTP, has a principal presynaptic component. Mossy fibre LTP is expressed in hippocampal mossy fibre synapses(1,2), cerebellar parallel fibre synapses(3,4) and corticothalamic synapses(5), where it apparently operates by a mechanism that requires activation of protein kinase A. Thus, presynaptic substrates of protein kinase A are probably essential in mediating this form of long-term synaptic plasticity. Studies of knockout mice have shown that the synaptic vesicle protein Rab3A is required for mossy fibre LTP6, but the protein kinase A substrates rabphilin, synapsin I and synapsin II are dispensable(7,8). Here we report that mossy fibre LTP in the hippocampus and the cerebellum is abolished in mice lacking RIM1alpha, an active zone protein that binds to Rab3A and that is also a protein kinase A substrate(9,10). Our results indicate that the long-term increase in neurotransmitter release during mossy fibre LTP may be mediated by a unitary mechanism that involves the GTP-dependent interaction of Rab3A with RIM1alpha at the interface of synaptic vesicles and the active zone.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA.		Schoch, Susanne/F-7741-2012	Castillo, Pablo/0000-0002-9834-1801				Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Linden DJ, 1999, J NEUROSCI, V19, P10221; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	29	287	301	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					327	330		10.1038/415327a	http://dx.doi.org/10.1038/415327a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797010				2022-12-28	WOS:000173293500045
J	Burton, EA; Davies, KE				Burton, EA; Davies, KE			Muscular dystrophy - Reason for optimism?	CELL			English	Review							ALPHA-DYSTROBREVIN; DYSTROGLYCAN; EXPRESSION; GLYCOSYLTRANSFERASE; GLYCOSYLATION; DEFICIENCY; MUTATIONS; GENE		Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England; Univ Oxford, Dept Clin Neurol, Oxford OX1 3QX, England; Univ Oxford, MRC, Funct Genet Unit, Oxford OX1 3QX, England	University of Oxford; University of Oxford; University of Oxford	Davies, KE (corresponding author), Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England.	kay.davies@anat.ox.ac.uk	Burton, Edward/AAO-9677-2021; Burton, Edward/ABB-1324-2021	Burton, Edward/0000-0002-8072-4636				BLAKE DJ, 2001, IN PRESS PHYSL REV; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Burton EA, 2001, CONT NEUROS, P239; Bushby KMD, 1999, BRAIN, V122, P1403, DOI 10.1093/brain/122.8.1403; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagano A, 2000, CURR OPIN NEUROL, V13, P533, DOI 10.1097/00019052-200010000-00005; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; POON EN, 2001, J BIOL CHEM, V1, P1; Tapscott SJ, 2001, SCIENCE, V293, P816, DOI 10.1126/science.1063517; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	19	46	49	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					5	8		10.1016/S0092-8674(01)00626-2	http://dx.doi.org/10.1016/S0092-8674(01)00626-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792315	Bronze			2022-12-28	WOS:000173280700002
J	Zhang, S; Xu, L; Lee, J; Xu, T				Zhang, S; Xu, L; Lee, J; Xu, T			Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes	CELL			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; EVEN-SKIPPED PROTEIN; REPRESSES TRANSCRIPTION; GENE-PRODUCT; EMBRYO; PATTERN; SEGMENTATION; EXPRESSION; REPEAT; HAIRY	Dentatorubral-pallidoluysian atrophy is a progressive neurodegenerative disease caused by the expansion of a polyglutamine repeats within the Atrophin-1 protein. The In vivo function of Atrophin-1 is unknown. We have characterized a Drosophila gene encoding an Atrophin family protein. Analysis of mutant phenotypes indicates that Drosophila Atrophin is required in diverse developmental processes including early embryonic patterning. Drosophila Atrophin genetically interacts with the transcription repressor even-skipped and is required for its repressive function in vivo. Drosophila Atrophin directly binds to Even-skipped in vitro. Furthermore, both human Atrophin-1 and Drosophila Atrophin repress transcription in vivo when tethered to DNA, and poly-Q expansion in Atrophin-1 reduces this repressive activity. We propose that Atrophin proteins function as versatile transcriptional corepressors and discuss a model that deregulation of transcription may contribute to the pathogenesis of neurodegeneration.	Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.				NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER; NCI NIH HHS [CA69408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; CHOU TB, 1992, GENETICS, V131, P643; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; FRASCH M, 1988, GENE DEV, V2, P1824, DOI 10.1101/gad.2.12b.1824; Fujioka M, 1999, DEVELOPMENT, V126, P2527; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LA SA, 1991, NATURE, V352, P77; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MANOUKIAN AS, 1992, GENE DEV, V6, P1740, DOI 10.1101/gad.6.9.1740; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Seki N, 1997, DNA Res, V4, P345, DOI 10.1093/dnares/4.5.345; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; STJOHNSTON D, 1992, CELL, V68, P201; WEIGEL D, 1990, SCIENCE, V248, P495, DOI 10.1126/science.2158673; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; XU TA, 1995, DEVELOPMENT, V121, P1053; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; ZHENG L, 1995, DEVELOPMENT, V121, P3045; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	35	119	119	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					45	56		10.1016/S0092-8674(01)00630-4	http://dx.doi.org/10.1016/S0092-8674(01)00630-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792320	Bronze			2022-12-28	WOS:000173280700007
J	Ischenko, AA; Saparbaev, MK				Ischenko, AA; Saparbaev, MK			Alternative nucleotide incision repair pathway for oxidative DNA damage	NATURE			English	Article							COLI ENDONUCLEASE-IV; BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; STRUCTURAL GENE; GLYCOSYLASE; ENZYMES; RECONSTITUTION; SUBSTRATE; ADDUCT; SITE	The DNA glycosylase pathway(1), which requires the sequential action of two enzymes for the incision of DNA(2), presents a serious problem for the efficient repair of oxidative DNA damage, because it generates genotoxic intermediates such as abasic sites and/or blocking 3'-end groups that must be eliminated by additional steps before DNA repair synthesis can be initiated. Besides the logistical problems, biological evidence hints at the existence of an alternative repair pathway. Mutants of Escherichia coli(3) and mice (ref. 4 and M. Takao et al., personal communication) that are deficient in DNA glycosylases that remove oxidized bases are not sensitive to reactive oxygen species, and the E. coli triple mutant nei, nth, fpg is more radioresistant than the wild-type strain(5). Here we show that Nfo-like endonucleases nick DNA on the 5' side of various oxidatively damaged bases, generating 3'-hydroxyl and 5'-phosphate termini. Nfo-like endonucleases function next to each of the modified bases that we tested, including 5,6-dihydrothymine, 5,6-dihydrouracil, 5-hydroxyuracil and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine residues. The 3'-hydroxyl terminus provides the proper end for DNA repair synthesis; the dangling damaged nucleotide on the 5' side is then a good substrate for human flap-structure endonuclease(6) and for DNA polymerase I of E. coli.	Inst Gustave Roussy, LBPA ENS Cachan, Grp Reparat ADN, CNRS,UMR 8532, F-94805 Villejuif, France; Russian Acad Sci, Novosibirsk Bioorgan Chem Inst, Siberian Div, Novosibirsk 630090, Russia	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Saparbaev, MK (corresponding author), Inst Gustave Roussy, LBPA ENS Cachan, Grp Reparat ADN, CNRS,UMR 8532, Rue Camille Desmoulins, F-94805 Villejuif, France.		Saparbaev, Murat/AAC-5478-2020; Saparbaev, Murat K/N-3225-2015; Ishchenko, Alexander/D-4133-2013	Saparbaev, Murat/0000-0002-4630-1074; Saparbaev, Murat K/0000-0002-4630-1074; Ishchenko, Alexander/0000-0002-0488-8858				Alleva JL, 2000, BIOCHEMISTRY-US, V39, P2659, DOI 10.1021/bi992751n; BAILLY V, 1989, BIOCHEM J, V259, P761, DOI 10.1042/bj2590761; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Blaisdell JO, 2001, P NATL ACAD SCI USA, V98, P7426, DOI 10.1073/pnas.131077798; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; CHAN E, 1987, P NATL ACAD SCI USA, V84, P3189, DOI 10.1073/pnas.84.10.3189; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P10450; FURLONG EA, 1986, BIOCHEMISTRY-US, V25, P4344, DOI 10.1021/bi00363a025; Gonzalez-Flecha B, 2000, ANN NY ACAD SCI, V899, P69; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; LAVAL J, 1977, NATURE, V269, P829, DOI 10.1038/269829a0; LINDAHL T, 1976, NATURE, V259, P64, DOI 10.1038/259064a0; Maksimenko AV, 1999, NUCLEOS NUCLEOT, V18, P2071, DOI 10.1080/07328319908044865; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; RAMOTAR D, 1991, MOL MICROBIOL, V5, P149, DOI 10.1111/j.1365-2958.1991.tb01835.x; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROGERS SG, 1980, GENE, V11, P187, DOI 10.1016/0378-1119(80)90059-1; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Yasui A, 1998, BIOESSAYS, V20, P291, DOI 10.1002/(SICI)1521-1878(199804)20:4<291::AID-BIES5>3.0.CO;2-T	29	206	223	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					183	187		10.1038/415183a	http://dx.doi.org/10.1038/415183a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805838				2022-12-28	WOS:000173159300045
J	Shiu, PKT; Raju, NB; Zickler, D; Metzenberg, RL				Shiu, PKT; Raju, NB; Zickler, D; Metzenberg, RL			Meiotic silencing by unpaired DNA	CELL			English	Article							DIRECTED RNA-POLYMERASE; INDUCED POINT MUTATION; DOUBLE-STRANDED-RNA; NEUROSPORA-CRASSA; MATING-TYPE; GENETIC INTERFERENCE; EXPRESSION; TRANSVECTION; RECOGNITION; INSTABILITY	The silencing of gene expression by segments of DNA present in excess of the normal number is called cosuppression in plants and quelling in fungi. We describe a related process, meiotic silencing by unpaired DNA (MSUD). DNA unpaired in meiosis causes silencing of all DNA homologous to it, including genes that are themselves paired. A semidominant Neurospora mutant, Sad-1, fails to perform MSUD. Sad-1 suppresses the sexual phenotypes of many ascus-dominant mutants. MSUD may provide insights into the function of genes necessary for meiosis, including genes for which ablation in vegetative life would be lethal. It may also contribute to reproductive isolation of species within the genus Neurospora. The wild-type allele, sad-1(+), encodes a putative RNA-directed RNA polymerase.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France	Stanford University; UDICE-French Research Universities; Universite Paris Saclay	Shiu, PKT (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.	ktshiu@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM008995, R37GM008995] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 08995] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1990, FUNGAL GENET NEWSL, DOI [DOI 10.4148/1941-4765.1472, 10.4148/1941-4765.1472]; Aramayo R, 1996, GENETICS, V144, P991; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; BUTLER DK, 1993, CHROMOSOMA, V102, P519, DOI 10.1007/BF00368345; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Coppin E, 2000, GENETICS, V155, P657; CRISP TM, 1992, MUTAT RES, V296, P89, DOI 10.1016/0165-1110(92)90034-7; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Margolin B.S., 1997, FUNGAL GENET REP, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Mitchell M. B, 1966, NEUROSPORA NEWSL, V10, P6; Noubissi FK, 2000, FUNGAL GENET BIOL, V31, P91, DOI 10.1006/fgbi.2000.1235; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PERKINS DD, 1988, EXP MYCOL, V12, P91, DOI 10.1016/0147-5975(88)90001-1; Perkins DD, 1997, GENETICS, V147, P125; Perkins DD, 1997, ADV GENET, V36, P239, DOI 10.1016/S0065-2660(08)60311-9; PERKINS DD, 2001, NEUROSPORA COMPENDIU, P92; RAJU NB, 1977, EXP MYCOL, V1, P152, DOI 10.1016/S0147-5975(77)80040-6; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; RAJU NB, 1978, CAN J GENET CYTOL, V20, P41, DOI 10.1139/g78-007; RANDALL TA, 1995, GENETICS, V141, P119; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHROEDER AL, 1986, CURR GENET, V10, P381, DOI 10.1007/BF00418410; SCHROEDER AL, 1975, MOL MECHANISMS REP B, P567; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; Shiu PKT, 2000, CURR OPIN MICROBIOL, V3, P183, DOI 10.1016/S1369-5274(00)00073-4; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Svoboda P, 2000, DEVELOPMENT, V127, P4147; THOMPSONCOFFE C, 1994, DEV BIOL, V165, P257, DOI 10.1006/dbio.1994.1251; Tinsley JH, 1998, MOL GEN GENET, V259, P601, DOI 10.1007/s004380050853; TOPPER VM, 1972, THESIS CORNELL U; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	54	339	360	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					905	916		10.1016/S0092-8674(01)00609-2	http://dx.doi.org/10.1016/S0092-8674(01)00609-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779466	Bronze			2022-12-28	WOS:000173024200011
J	Macilwain, C				Macilwain, C			The big picture - Science in a changed world	NATURE			English	Editorial Material																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					836	837		10.1038/414836a	http://dx.doi.org/10.1038/414836a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780022				2022-12-28	WOS:000172813300009
J	Rycroft, B				Rycroft, B			My adventure with breast cancer	LANCET			English	Article											Rycroft, B (corresponding author), POB 24002, ZA-7735 Claremont, South Africa.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S6	S6		10.1016/S0140-6736(01)07019-2	http://dx.doi.org/10.1016/S0140-6736(01)07019-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784555				2022-12-28	WOS:000172907200006
J	Murphy, MB; Murray, C; Shorten, GD				Murphy, MB; Murray, C; Shorten, GD			Drug therapy - Fenoldopam - A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE-RENAL-FAILURE; INTRAOCULAR-PRESSURE; INTRAVENOUS FENOLDOPAM; SODIUM-NITROPRUSSIDE; AMPHOTERICIN-B; ANGIOTENSIN-II; BLOOD-FLOW; DOSE DOPAMINE; STIMULATION; NICARDIPINE		Natl Univ Ireland Univ Coll Cork, Dept Pharmacol, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Therapeut, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Anesthesia, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Intens Care Med, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork	Murphy, MB (corresponding author), Cork Univ Hosp, Dept Pharmacol & Therapeut, Clin Sci Bldg, Cork, Ireland.	mmurphy@medicine.ucc.ie	Murphy, Michael B/A-1310-2011	Murphy, Michael/0000-0001-6722-7080				[Anonymous], 2000, PHYS DESK REF, P655; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; ANTONIPILLAI I, 1989, HYPERTENSION, V13, P463, DOI 10.1161/01.HYP.13.5.463; APERIA A, 1991, P NATL ACAD SCI USA, V88, P2798, DOI 10.1073/pnas.88.7.2798; BAKIR AA, 1986, AM J MED, V80, P172, DOI 10.1016/0002-9343(86)90005-7; Bakris GL, 1999, KIDNEY INT, V56, P206, DOI 10.1046/j.1523-1755.1999.00528.x; BARNETT R, 1986, CIRC RES, V59, P529, DOI 10.1161/01.RES.59.5.529; BARRETT RJ, 1987, LIFE SCI, V40, P1499, DOI 10.1016/0024-3205(87)90382-1; BERTORELLO A, 1990, AM J PHYSIOL, V259, pF924, DOI 10.1152/ajprenal.1990.259.6.F924; Black HR, 1998, ARCH INTERN MED, V158, P573; BRENNER BM, 1973, J CLIN INVEST, V52, P190, DOI 10.1172/JCI107164; Brogden RN, 1997, DRUGS, V54, P634, DOI 10.2165/00003495-199754040-00008; BROOKS DP, 1990, J PHARMACOL EXP THER, V254, P375; BROOKS DP, 1991, J PHARMACOL EXP THER, V257, P1243; CAMPESE VM, 1981, DRUGS, V22, P257, DOI 10.2165/00003495-198122040-00001; CAREY RM, 1984, J CLIN INVEST, V74, P2198, DOI 10.1172/JCI111646; Chang A, 1999, EUR J ENDOCRINOL, V141, P387, DOI 10.1530/eje.0.1410387; CHEN CJ, 1991, J PHARMACOL EXP THER, V256, P486; CHEN CJ, 1995, N-S ARCH PHARMACOL, V352, P194; Chertow GM, 1996, AM J MED, V101, P49, DOI 10.1016/S0002-9343(96)00075-7; CRYONAK M, 1987, CLIN PHARMACOL THER, V41, P236; Denton MD, 1996, KIDNEY INT, V50, P4, DOI 10.1038/ki.1996.280; *DEP HLTH HUM SERV, 1985, NAT HLTH SURV; Desai JK, 1999, J PHARM PHARMACOL, V51, P187, DOI 10.1211/0022357991772123; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOMINIC JA, 1981, J CARDIOVASC PHARM, V3, P25, DOI 10.1097/00005344-198101000-00003; ELLIOTT WJ, 1990, CIRCULATION, V81, P970, DOI 10.1161/01.CIR.81.3.970; ELLIOTT WJ, 1991, CLIN PHARMACOL THER, V49, P285, DOI 10.1038/clpt.1991.30; Everitt DE, 1997, J CLIN PHARMACOL, V37, P312, DOI 10.1002/j.1552-4604.1997.tb04308.x; FELDER CC, 1990, AM J PHYSIOL, V259, pF297, DOI 10.1152/ajprenal.1990.259.2.F297; FLAHARTY K K, 1991, Pharmacotherapy, V11, P278; GESEK FA, 1990, AM J PHYSIOL, V258, pF514, DOI 10.1152/ajprenal.1990.258.3.F514; GIRBES ARJ, 1990, NEPHRON, V56, P179, DOI 10.1159/000186129; GLUCK Z, 1987, HYPERTENSION, V10, P43, DOI 10.1161/01.HYP.10.1.43; GOLDBERG LI, 1984, AM J MED, V77, P37, DOI 10.1016/S0002-9343(84)80036-4; GOLDBERG LI, 1977, P ROY SOC MED, V70, P7, DOI 10.1177/00359157770700S203; GOLDBERG LI, 1959, J PHARMACOL EXP THER, V127, P212; GOLDBERG LI, 1990, CARDIOVASCULAR DRUG, P1083; GOLDBERG ME, 1993, J CLIN ANESTH, V5, P386, DOI 10.1016/0952-8180(93)90102-K; Gombotz H, 1998, ACTA ANAESTH SCAND, V42, P834, DOI 10.1111/j.1399-6576.1998.tb05330.x; GRETLER DD, 1992, ARCH INTERN MED, V152, P2445, DOI 10.1001/archinte.152.12.2445; HAHN RA, 1982, J PHARMACOL EXP THER, V223, P305; HARVEY JN, 1986, BRIT J CLIN PHARMACO, V21, P53, DOI 10.1111/j.1365-2125.1986.tb02822.x; HIGUCHI S, 1980, XENOBIOTICA, V10, P447, DOI 10.3109/00498258009033779; Hill A J, 1993, J Cardiothorac Vasc Anesth, V7, P279, DOI 10.1016/1053-0770(93)90005-6; HSU WH, 1986, LIFE SCI, V39, P1021, DOI 10.1016/0024-3205(86)90291-2; HUGHES JM, 1988, J CLIN ENDOCR METAB, V66, P518, DOI 10.1210/jcem-66-3-518; HUGHES JM, 1986, J HYPERTENS, V4, pS106; HUO TH, 1991, AM J PHYSIOL, V261, pF647, DOI 10.1152/ajprenal.1991.261.4.F647; JORKASKY DK, 1992, AM J KIDNEY DIS, V19, P567, DOI 10.1016/S0272-6386(12)80836-5; JOSE PA, 1992, J AM SOC NEPHROL, V2, P1265; KARNEZIS TA, 1988, EXP EYE RES, V47, P689, DOI 10.1016/0014-4835(88)90036-X; KAWABATA K, 1994, ANESTH ANALG, V79, P1159; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kim KS, 1998, ANAESTHESIA, V53, P140, DOI 10.1046/j.1365-2044.1998.00283.x; LOKHANDWALA MF, 1982, J AUTON PHARMACOL, V2, P189, DOI 10.1111/j.1474-8673.1982.tb00489.x; MANN SJ, 1995, HYPERTENSION PATHOPH, V2, P3009; Mathur VS, 1999, CRIT CARE MED, V27, P1832, DOI 10.1097/00003246-199909000-00021; *MED EC, 2000, P9HYS DESK REF, P3223; *MED EC, 2000, PHYS DESK REF, P1983; MILLER CL, 1978, ANAESTH INTENS CARE, V6, P290, DOI 10.1177/0310057X7800600402; MOYER JH, 1953, ARCH INTERN MED, V91, P419, DOI 10.1001/archinte.1953.00240160005002; Mukai M, 1996, J PHARMACOL EXP THER, V279, P822; MURPHY MB, 1987, CIRCULATION, V76, P1312, DOI 10.1161/01.CIR.76.6.1312; Ng SSW, 2000, BRIT J PHARMACOL, V129, P853, DOI 10.1038/sj.bjp.0703119; NICHOLS AJ, 1992, J PHARMACOL EXP THER, V260, P269; Nishiyama T, 1997, CAN J ANAESTH, V44, P1071, DOI 10.1007/BF03019228; PANACEK EA, 1995, ACAD EMERG MED, V2, P959; Piltz JR, 1998, J OCUL PHARMACOL TH, V14, P203, DOI 10.1089/jop.1998.14.203; POINSOT O, 1993, ANESTHESIOLOGY, V79, P680, DOI 10.1097/00000542-199310000-00008; POLLOCK DM, 1990, AM J PHYSIOL, V258, pF627, DOI 10.1152/ajprenal.1990.258.3.F627; Power DA, 1999, CLIN EXP PHARMACOL P, V26, pS23; Preston RA, 1999, J HUM HYPERTENS, V13, P249, DOI 10.1038/sj.jhh.1000796; REISIN E, 1990, HYPERTENSION, V15, pI59, DOI 10.1161/01.HYP.15.2_Suppl.I59; SABRA R, 1990, J PHARMACOL EXP THER, V253, P34; Sheinbaum R, 2000, ANESTH ANALG, V90, pSCA31; SHULTZ PJ, 1987, AM J PHYSIOL, V253, pH358, DOI 10.1152/ajpheart.1987.253.2.H358; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SQUARA P, 1994, CHEST, V106, P52, DOI 10.1378/chest.106.1.52; STONE JG, 1988, BRIT J ANAESTH, V61, P675, DOI 10.1093/bja/61.6.675; STROCCHI E, 1989, EUR J CLIN PHARMACOL, V37, P395, DOI 10.1007/BF00558507; Taylor AA, 1999, J CLIN PHARMACOL, V39, P471; Taylor AA, 1999, AM J HYPERTENS, V12, P906, DOI 10.1016/S0895-7061(99)00068-0; Tempe D K, 1999, Indian Heart J, V51, P294; TEMPE DK, 1999, INDIAN HEART J, V51, P431; Tumlin JA, 2000, ACAD EMERG MED, V7, P653; VENTURA HO, 1984, CIRCULATION, V69, P1142, DOI 10.1161/01.CIR.69.6.1142; VESEY CJ, 1990, BRIT J ANAESTH, V64, P704, DOI 10.1093/bja/64.6.704; WEBER RR, 1988, BRIT J CLIN PHARMACO, V25, P17, DOI 10.1111/j.1365-2125.1988.tb03276.x; WIEST D, 1995, CLIN PHARMACOKINET, V28, P190, DOI 10.2165/00003088-199528030-00002; WINAVER J, 1990, KIDNEY INT, V38, P1133, DOI 10.1038/ki.1990.323; WOOD AJJ, 1990, DRUGS ANESTHESIA, P435; YAQOOB M, 1991, POSTGRAD MED J, V67, P829, DOI 10.1136/pgmj.67.791.829; ZIEMNIAK JA, 1987, CLIN PHARMACOL THER, V41, P275, DOI 10.1038/clpt.1987.28; ZIEMNIAK JA, 1989, PHARMACEUT RES, V6, P702, DOI 10.1023/A:1015990506743	95	131	139	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1548	1557		10.1056/NEJMra010253	http://dx.doi.org/10.1056/NEJMra010253			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794223				2022-12-28	WOS:000172265200007
J	Harding, KG; Morris, HL; Patel, GK				Harding, KG; Morris, HL; Patel, GK			Science, medicine, and the future - Healing chronic wounds	BRITISH MEDICAL JOURNAL			English	Review							VENOUS ULCERS; GROWTH-FACTOR; DERMAL FIBROBLASTS; LEG ULCERS; ULCERATION; CARE		Univ Wales Coll Cardiff, Coll Med, Wound Healing Res Unit, Cardiff CF14 4UJ, S Glam, Wales	Cardiff University	Harding, KG (corresponding author), Univ Wales Coll Cardiff, Coll Med, Wound Healing Res Unit, Heath Pk, Cardiff CF14 4UJ, S Glam, Wales.		Patel, Girish/N-7075-2013; Harding, Keith/J-5605-2013	Harding, Keith/0000-0003-0048-3279				Agren MS, 1999, J INVEST DERMATOL, V112, P463, DOI 10.1046/j.1523-1747.1999.00549.x; Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x; BOULTON AJM, 1986, DIABETES CARE, V9, P149, DOI 10.2337/diacare.9.2.149; Bucalo Brian, 1993, Wound Repair and Regeneration, V1, P181, DOI 10.1046/j.1524-475X.1993.10308.x; CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3; Colin D, 1996, Adv Wound Care, V9, P25; COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012; Currie CJ, 1998, DIABETES CARE, V21, P42, DOI 10.2337/diacare.21.1.42; ELDAD A, 1987, BURNS, V13, P173, DOI 10.1016/0305-4179(87)90161-6; FALANGA V, 1992, J DERMATOL SURG ONC, V18, P604, DOI 10.1111/j.1524-4725.1992.tb03514.x; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; Fletcher A, 1997, BRIT MED J, V315, P576; Gentzkow GD, 1996, DIABETES CARE, V19, P350, DOI 10.2337/diacare.19.4.350; GOUGH A, 1997, LANCET, V350, P833; HANSBROUGH JF, 1997, J BURN CARE REHABI S, V18, P25; Harding KJ, 1998, WOUNDS BIOL MANAGEME, P191; Hasan A, 1997, J DERMATOL SCI, V16, P59, DOI 10.1016/S0923-1811(97)00622-1; HIGLEY HR, 1995, BRIT J DERMATOL, V132, P79, DOI 10.1111/j.1365-2133.1995.tb08629.x; HUNT TK, 1990, J TRAUMA, V30, P122; MAUCH C, 1994, ARCH DERMATOL RES, V287, P107, DOI 10.1007/BF00370728; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; REIBER GE, 1992, DIABETES CARE, V15, P29, DOI 10.2337/diacare.15.1.S29; ROBSON MC, 1992, ANN SURG, V216, P401, DOI 10.1097/00000658-199210000-00002; Ruckley CV, 1997, ANGIOLOGY, V48, P67, DOI 10.1177/000331979704800111; Stanley AC, 1997, J VASC SURG, V26, P994, DOI 10.1016/S0741-5214(97)70012-0; Taub PJ, 2000, PLAST RECONSTR SURG, V105, P1034, DOI 10.1097/00006534-200003000-00031; Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290; Waterlow J, 1988, Nurs Times, V84, P69; WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0; Yamada K.M., 1996, MOL CELLULAR BIOL WO, P51	30	379	406	0	77	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					160	163		10.1136/bmj.324.7330.160	http://dx.doi.org/10.1136/bmj.324.7330.160			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799036	Green Published			2022-12-28	WOS:000173470600023
J	Smits, PBA; Verbeek, JHAM; de Buisonje, CD				Smits, PBA; Verbeek, JHAM; de Buisonje, CD			Problem based learning in continuing medical education: a review of controlled evaluation studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CURRICULA		Netherlands Sch Occupat Hlth, NL-1000 CN Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Coronel Inst, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Smits, PBA (corresponding author), Netherlands Sch Occupat Hlth, POB 2557, NL-1000 CN Amsterdam, Netherlands.	p.b.smits@amc.uva.nl	Verbeek, Jos H.A.M./F-8382-2013	Verbeek, Jos H.A.M./0000-0002-6537-6100				Albanese M, 2000, MED EDUC, V34, P729, DOI 10.1046/j.1365-2923.2000.00753.x; ALBANESE MA, 1993, ACAD MED, V68, P52, DOI 10.1097/00001888-199301000-00012; BARROWS HS, 1986, MED EDUC, V20, P481, DOI 10.1111/j.1365-2923.1986.tb01386.x; Benjamin EM, 1999, DIABETES CARE, V22, P1672, DOI 10.2337/diacare.22.10.1672; Bennett NL, 2000, ACAD MED, V75, P1167, DOI 10.1097/00001888-200012000-00007; BERKSON L, 1993, ACAD MED, V68, pS79, DOI 10.1097/00001888-199310000-00053; Chan DH, 1999, M D COMPUT, V16, P54; Colliver JA, 2000, ACAD MED, V75, P259, DOI 10.1097/00001888-200003000-00017; David TJ, 1998, J ROY SOC MED, V91, P626, DOI 10.1177/014107689809101204; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Dolmans D, 1996, POSTGRAD MED J, V72, P535, DOI 10.1136/pgmj.72.851.535; Doucet MD, 1998, MED EDUC, V32, P590; Grol R, 2000, FAM PRACT, V17, pS32, DOI 10.1093/fampra/17.suppl_1.S32; HEALE J, 1988, P ANN C RES MED ED, V27, P72; Maudsley G, 1999, ACAD MED, V74, P178, DOI 10.1097/00001888-199902000-00016; Moran JA, 1996, CAN FAM PHYSICIAN, V42, P272; NORMAN GR, 1992, ACAD MED, V67, P557, DOI 10.1097/00001888-199209000-00002; Norman GR, 2000, MED EDUC, V34, P721, DOI 10.1046/j.1365-2923.2000.00749.x; PREMI J, 1994, ACAD MED, V69, P800, DOI 10.1097/00001888-199410000-00002; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; SANCI LA, 2000, BMJ-BRIT MED J, V20, P224; Ten Cate O, 2001, ADV HEALTH SCI EDUC, V6, P81, DOI 10.1023/A:1009874100973; VERNON DTA, 1993, ACAD MED, V68, P550, DOI 10.1097/00001888-199307000-00015; Wolf FM, 2001, TEACH LEARN MED, V13, P54, DOI 10.1207/S15328015TLM1301_11	24	152	159	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2002	324	7330					153	156		10.1136/bmj.324.7330.153	http://dx.doi.org/10.1136/bmj.324.7330.153			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799034	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000173470600021
J	Alley, RB				Alley, RB			On thickening ice?	SCIENCE			English	Editorial Material							SHEET; ANTARCTICA; STREAM; RISE; MASS		Penn State Univ, EMS Environm Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Alley, RB (corresponding author), Penn State Univ, EMS Environm Inst, University Pk, PA 16802 USA.							Alley R.B., 2001, W ANTARCTIC ICE SHEE, V77, P1, DOI [10.1029/AR077p0001, DOI 10.1029/AR077P0001]; Anderson J.B., 2001, ANTARCT RES SER, V77, P45, DOI DOI 10.1029/AR077P0045; Bindschadler R, 1998, SCIENCE, V279, P689, DOI 10.1126/science.279.5351.689; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; DOAKE CSM, 2001, ANTARCT RES SER, V77, P221; Engelhardt H, 1997, J GLACIOL, V43, P207, DOI 10.3189/S0022143000003166; HUGHES TJ, 1981, J GLACIOL, V27, P518, DOI 10.3189/S002214300001159X; Joughin I, 2002, SCIENCE, V295, P476, DOI 10.1126/science.1066875; MACAYEAL DR, 1987, J GLACIOL, V33, P218, DOI 10.3189/S0022143000008728; PARIZEK BR, 2000, W ANT IC SHEET WORKS; Scherer RP, 1998, SCIENCE, V281, P82, DOI 10.1126/science.281.5373.82; SHABTAIE S, 1987, J GEOPHYS RES-SOLID, V92, P1311, DOI 10.1029/JB092iB02p01311; Tulaczyk S, 2000, J GEOPHYS RES-SOL EA, V105, P483, DOI 10.1029/1999JB900328; Vaughan D. G., 2001, ANTARCT RES SER, V77, P237, DOI DOI 10.1029/AR077P0237	15	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					451	452		10.1126/science.1068919	http://dx.doi.org/10.1126/science.1068919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799228				2022-12-28	WOS:000173350700034
J	Banda, E				Banda, E			Science in Europe - Implementing the European research area	SCIENCE			English	Editorial Material									European Sci Fdn, F-67080 Strasbourg, France		Banda, E (corresponding author), European Sci Fdn, F-67080 Strasbourg, France.								0	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					443	443						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799223				2022-12-28	WOS:000173350700027
J	Park, ST; Kim, SK; Kim, MS				Park, ST; Kim, SK; Kim, MS			Observation of conformation-specific pathways in the photodissociation of 1-iodopropane ions	NATURE			English	Article							PROTONATED CYCLOPROPANE; LASER CONTROL; DYNAMICS; PULSES	Many molecules can rotate freely around single bonds and thereby interconvert between different conformations, such as gauche and anti 1,2-disubstituted ethane, a classic example of conformational isomerism(1-3). Even though rotation occurs rapidly at room temperature, the product selectivity seen in some reactions has been explained by conformation-dependent reaction mechanisms 4,5 : if reactant molecules differing only in their conformation are located at different positions on the reaction path, they may undergo different reactions. But a direct verification of this effect is difficult, because the energy barrier separating conformational isomers is so low that under ambient conditions reactants with more than one conformation will be present(1). But by using temperatures low enough to suppress the interconversion between different conformations, gauche-1-iodopropane ions and anti-1-iodopropane ions have been selectively generated(6). Here we show that the kinetic energy released during the photodissociation of 1-iodopropane ions depends strongly on the conformation of the ions. Thermodynamic arguments and ab initio calculations indicate that this difference in kinetic energy release results from differences in the reaction mechanism, with gauche-1-iodopropane ions forming 2-propyl ions and anti-1-iodopropane ions forming protonated cyclopropane ions. These findings suggest that the well-known concept of conformation selection forms the basis of a simple scheme for reaction control, thus providing in some cases an attractive alternative for more involved schemes that utilize the phase and pulse shape of laser beams to control chemical reactions(7-10).	Seoul Natl Univ, Natl Creat Res Initiat Control React Dynam, Seoul 151742, South Korea; Seoul Natl Univ, Sch Chem, Seoul 151742, South Korea; Inha Univ, Dept Chem, Inchon 402751, South Korea	Seoul National University (SNU); Seoul National University (SNU); Inha University	Kim, MS (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Control React Dynam, Seoul 151742, South Korea.		Park, Sang Tae/E-2743-2010; Kim, Sang Kyu/C-1613-2011					Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; BRAND WA, 1983, CHEM PHYS, V76, P111, DOI 10.1016/0301-0104(83)85055-1; BRUMER P, 1992, ANNU REV PHYS CHEM, V43, P257, DOI 10.1146/annurev.pc.43.100192.001353; CHASE MW, 1985, J PHYS CHEM REF DATA, V14, P1; CHONG SL, 1972, J AM CHEM SOC, V94, P6347, DOI 10.1021/ja00773a016; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, P597; ELIEL EL, 1957, J AM CHEM SOC, V79, P5986, DOI 10.1021/ja01579a038; FRISCH MJ, 1998, GAUSSIAN98 REVISION; HILBER G, 1987, J OPT SOC AM B, V4, P1753, DOI 10.1364/JOSAB.4.001753; JARROLD MF, 1984, J CHEM PHYS, V81, P214, DOI 10.1063/1.447365; Kim DY, 2000, J CHEM PHYS, V113, P1714, DOI 10.1063/1.481973; Kimura K., 1981, HDB HEI PHOTOELECTRO, P87; KIRBY AJ, 1996, STEREOELECTRONIC EFF, P24; KOCH W, 1989, J AM CHEM SOC, V111, P3479, DOI 10.1021/ja00191a082; KOSLOFF R, 1989, CHEM PHYS, V139, P201, DOI 10.1016/0301-0104(89)90012-8; LEVSEN K, 1978, FUNDAMENTAL ASPECTS, P166; LIAS SG, 1970, J AM CHEM SOC, V92, P6430, DOI 10.1021/ja00725a008; Park ST, 2001, J CHEM PHYS, V114, P5568, DOI 10.1063/1.1353548; Pedley J.B., 1986, THERMOCHEMICAL DATA, V2; RAMSAY OB, 1981, STEREOCHEMISTRY, P1; SCHLAG EW, 1998, ZEKE SPECTROSCOPY, P112; Vogel P, 1985, CARBOCATION CHEM, P331; WINSTEIN S, 1955, J AM CHEM SOC, V77, P5562, DOI 10.1021/ja01626a037; ZHU LC, 1995, SCIENCE, V270, P77, DOI 10.1126/science.270.5233.77	24	114	114	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					306	308		10.1038/415306a	http://dx.doi.org/10.1038/415306a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797004				2022-12-28	WOS:000173293500039
J	Tatarakis, M; Watts, I; Beg, FN; Clark, EL; Dangor, AE; Gopal, A; Haines, MG; Norreys, PA; Wagner, U; Wei, MS; Zepf, M; Krushelnick, K				Tatarakis, M; Watts, I; Beg, FN; Clark, EL; Dangor, AE; Gopal, A; Haines, MG; Norreys, PA; Wagner, U; Wei, MS; Zepf, M; Krushelnick, K			Laser technology - Measuring huge magnetic fields	NATURE			English	Article							PLASMA; PULSE; GENERATION; TARGETS		Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London SW7 2BZ, England; Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	Imperial College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Tatarakis, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Prince Consort Rd, London SW7 2BZ, England.		Zepf, Matt/M-1232-2014; Gopal, Amrutha/B-5478-2019; Krushelnick, Karl/AAZ-3028-2020; Tatarakis, Michael/AAM-5311-2021	Gopal, Amrutha/0000-0001-5117-1342; Tatarakis, Michael/0000-0003-4285-3784; Clark, Eugene/0000-0001-8877-8316				Borghesi M, 1998, PHYS REV LETT, V80, P5137, DOI 10.1103/PhysRevLett.80.5137; Clark EL, 2000, PHYS REV LETT, V84, P670, DOI 10.1103/PhysRevLett.84.670; Lai D, 1997, ASTROPHYS J, V491, P270, DOI 10.1086/304937; Mason RJ, 1998, PHYS REV LETT, V80, P524, DOI 10.1103/PhysRevLett.80.524; Norreys PA, 1996, PHYS REV LETT, V76, P1832, DOI 10.1103/PhysRevLett.76.1832; PERRY MD, 1994, SCIENCE, V264, P917, DOI 10.1126/science.264.5161.917; Pukhov A, 1996, PHYS REV LETT, V76, P3975, DOI 10.1103/PhysRevLett.76.3975; SUDAN RN, 1993, PHYS REV LETT, V70, P3075, DOI 10.1103/PhysRevLett.70.3075; Tatarakis M, 1998, PHYS REV LETT, V81, P999, DOI 10.1103/PhysRevLett.81.999; WILKS SC, 1992, PHYS REV LETT, V69, P1383, DOI 10.1103/PhysRevLett.69.1383	10	166	170	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					280	280		10.1038/415280a	http://dx.doi.org/10.1038/415280a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796997	Bronze			2022-12-28	WOS:000173293500032
J	Booton, R; Jacob, BK				Booton, R; Jacob, BK			Bronchoalveolar-cell carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Christie Natl Hlth Serv Trust, Manchester M20 4BX, Lancs, England; Bradford Natl Hlth Serv Trust, Bradford BD9 6RJ, W Yorkshire, England	Christie NHS Foundation Trust	Booton, R (corresponding author), Christie Natl Hlth Serv Trust, Manchester M20 4BX, Lancs, England.			Booton, Richard/0000-0003-4512-2899					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					107	107		10.1056/NEJMicm010088	http://dx.doi.org/10.1056/NEJMicm010088			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784877				2022-12-28	WOS:000173133400006
J	Germain, P; Iyer, J; Zechel, C; Gronemeyer, H				Germain, P; Iyer, J; Zechel, C; Gronemeyer, H			Co-regulator recruitment and the mechanism of retinoic acid receptor synergy	NATURE			English	Article							NUCLEAR HORMONE RECEPTORS; LIGAND-BINDING DOMAINS; HETERODIMERIC COMPLEX; RESPONSE PATHWAYS; X-RECEPTOR; RAR; RXR; ACTIVATION; TIF2; TRANSACTIVATION	Crystal structure and co-regulator interaction studies have led to a general mechanistic view of the initial steps of nuclear receptor (NR) action. Agonist-induced transconformation of the ligand-binding domain (holo-LBD) leads to the formation of co-activator complexes, and destabilizes the co-repressor complexes bound to the ligand-free (apo) LBD1-3. However, the molecular basis of retinoid-X receptor (RXR) 'subordination' in heterodimers, an essential mechanism to avoid signalling pathway promiscuity, has remained elusive. RXR, in contrast to its heterodimer partner, cannot autonomously induce transcription on binding of cognate agonists(4-7). Here we show that RXR can bind ligand and recruit co-activators as a heterodimer with apo-retinoic-acid receptor (apo-RAR). However, in the usual cellular environment co-repressors do not dissociate and they prohibit co-activator access because co-regulator binding is mutually exclusive. Accordingly, RXR subordination can be overcome in heterodimers that bind co-repressor weakly or in cells with a high co-activator content. We identify two types of RAR antagonists that differentially modulate co-regulator interaction, and we demonstrate that synergy between RAR ligands and RXR agonists(6,8) results from increased interaction efficiency of a single p160 with the heterodimer, requiring two intact receptor-binding surfaces on the co-activator.	Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, CU Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gronemeyer, H (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	hg@igbmc.u-strasbg.fr	Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/H-7002-2016; Gronemeyer, Hinrich/AAH-5575-2019	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Germain, Pierre/0000-0003-2962-9593				Alen P, 1999, MOL CELL BIOL, V19, P6085; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Bourguet W, 2000, PROTEIN EXPRES PURIF, V19, P284, DOI 10.1006/prep.2000.1248; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Iyer J, 1999, PROTEIN EXPRES PURIF, V16, P308, DOI 10.1006/prep.1999.1053; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Vivat V, 1997, EMBO J, V16, P5697, DOI 10.1093/emboj/16.18.5697; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yang W, 1999, J BIOL CHEM, V274, P16838, DOI 10.1074/jbc.274.24.16838	30	248	256	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					187	192		10.1038/415187a	http://dx.doi.org/10.1038/415187a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805839				2022-12-28	WOS:000173159300046
J	Ambros, V				Ambros, V			microRNAs: Tiny regulators with great potential	CELL			English	Review							RNA-INTERFERENCE; C-ELEGANS; GENES; INITIATION; EXPRESSION; LIN-14; DICER	Animal genomes contain an abundance of small genes that produce regulatory RNAs of about 22 nucleotides in length. These microRNAs are diverse in sequence and expression patterns, and are evolutionarily widespread, suggesting that they may participate in a wide range of genetic regulatory pathways.	Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College	Ambros, V (corresponding author), Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA.	vra@dartmouth.edu						Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rougvie AE, 2001, NAT REV GENET, V2, P690, DOI 10.1038/35088566; SEGGERSON K, 2002, IN PRESS DEV BIOL; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	20	1350	1473	5	117	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					823	826		10.1016/S0092-8674(01)00616-X	http://dx.doi.org/10.1016/S0092-8674(01)00616-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779458	Bronze			2022-12-28	WOS:000173024200003
J	Lee, C; Etchegaray, JP; Cagampang, FRA; Loudon, ASI; Reppert, SM				Lee, C; Etchegaray, JP; Cagampang, FRA; Loudon, ASI; Reppert, SM			Posttranslational mechanisms regulate the mammalian circadian clock	CELL			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NUCLEAR ENTRY; DOUBLE-TIME; PHOSPHORYLATION; PROTEIN; PERIOD; RHYTHMS; MUTATION	We have examined posttranslational regulation of clock proteins in mouse liver in vivo. The mouse PERIOD proteins (mPER1 and mPER2), CLOCK, and BMAL1 undergo robust circadian changes in phosphorylation. These proteins, the cryptochromes (mCRY1 and mCRY2), and casein kinase I epsilon (CKI epsilon) form multimeric complexes that are bound to DNA during negative transcriptional feedback. CLOCK:BMAL1 heterodimers remain bound to DNA over the circadian cycle. The temporal increase in mPER abundance controls the negative feedback interactions. Analysis of clock proteins in mCRY-deficient mice shows that the mCRYs are necessary for stabilizing phosphorylated mPER2 and for the nuclear accumulation of mPER1, mPER2, and CKI epsilon. We also provide in vivo evidence that casein kinase I delta is a second clock relevant kinase.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Massachusetts System; University of Massachusetts Worcester; University of Manchester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 55 Lake Ave N, Worcester, MA 01655 USA.	steven.reppert@umassmed.edu	Cagampang, Felino/AAG-5141-2019	Cagampang, Felino/0000-0003-4404-9853; Loudon, Andrew/0000-0003-3648-445X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD 14427] Funding Source: Medline; NINDS NIH HHS [R01 NS 39303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 1999, ENDOCRINOLOGY, V140, P758, DOI 10.1210/en.140.2.758; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Park SK, 2000, ARCH BIOCHEM BIOPHYS, V381, P302, DOI 10.1006/abbi.2000.1999; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, GENE DEV, V14, P1353; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zhang JH, 2000, J BIOL CHEM, V275, P8895, DOI 10.1074/jbc.275.12.8895; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	45	865	890	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					855	867		10.1016/S0092-8674(01)00610-9	http://dx.doi.org/10.1016/S0092-8674(01)00610-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779462	Bronze			2022-12-28	WOS:000173024200007
J	de Costa, C				de Costa, C			Flora's legacy	LANCET			English	Article									Cairns Base Hosp, Dept Obstet & Gynaecol, Cairns, Qld 4870, Australia		de Costa, C (corresponding author), Cairns Base Hosp, Dept Obstet & Gynaecol, POB 902, Cairns, Qld 4870, Australia.								0	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2162	2163		10.1016/S0140-6736(01)07228-2	http://dx.doi.org/10.1016/S0140-6736(01)07228-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784650				2022-12-28	WOS:000172905800033
J	Roberts, R				Roberts, R			Muscular dystrophy through an evolutionary lens	LANCET			English	Article									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Roberts, R (corresponding author), Guys Hosp, GKT Med Sch, Div Med & Mol Genet, 8th Floor,Guys Tower, London SE1 9RT, England.	roland.roberts@kcl.ac.uk	Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S25	S25		10.1016/S0140-6736(01)07038-6	http://dx.doi.org/10.1016/S0140-6736(01)07038-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784574				2022-12-28	WOS:000172907200025
J	Berg, KD; Brinster, NK; Huhn, KM; Goggins, MG; Jones, RJ; Makary, A; Murphy, KM; Griffin, CA; Rosenblum-Vos, LS; Borowitz, MJ; Nousari, HC; Eshleman, JR				Berg, KD; Brinster, NK; Huhn, KM; Goggins, MG; Jones, RJ; Makary, A; Murphy, KM; Griffin, CA; Rosenblum-Vos, LS; Borowitz, MJ; Nousari, HC; Eshleman, JR			Brief report: Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CUTANEOUS LYMPHOMA; APLASTIC-ANEMIA; NEOPLASMS; LEUKEMIA; CLASSIFICATION; CANCERS		Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Geisinger Med Ctr, Dept Hematol & Oncol, Danville, PA 17822 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Geisinger Medical Center	Eshleman, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 632 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.							AGOSTI JM, 1988, NEW ENGL J MED, V319, P1623, DOI 10.1056/NEJM198812223192502; BENHATTAR J, 1995, DIAGN MOL PATHOL, V4, P108, DOI 10.1097/00019606-199506000-00006; Bodo I, 1999, NEW ENGL J MED, V341, P807, DOI 10.1056/NEJM199909093411105; BOURGUIN A, 1990, P NATL ACAD SCI USA, V87, P8536, DOI 10.1073/pnas.87.21.8536; BROWNE PV, 1991, NEW ENGL J MED, V325, P710, DOI 10.1056/NEJM199109053251007; Curtis RE, 1999, BLOOD, V94, P2208; Curtis RE, 1997, NEW ENGL J MED, V336, P897, DOI 10.1056/NEJM199703273361301; Deeg HJ, 1998, BLOOD, V91, P1833, DOI 10.1182/blood.V91.6.1833.1833_1833_1844; Donadieu J, 1996, CANCER, V77, P1571, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1571::AID-CNCR22>3.0.CO;2-W; Frank S, 1998, LANCET, V352, P31, DOI 10.1016/S0140-6736(98)24027-X; Frank S, 1998, LANCET, V352, P1316; GONZALEZ CL, 1991, AM J SURG PATHOL, V15, P17, DOI 10.1097/00000478-199101000-00002; Healey PJ, 1998, LANCET, V352, P2, DOI 10.1016/S0140-6736(98)22027-7; HEYLL A, 1994, BONE MARROW TRANSPL, V14, P161; HUCK S, 1988, EMBO J, V7, P719, DOI 10.1002/j.1460-2075.1988.tb02868.x; Kozuru M, 1996, CANCER, V78, P1119, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1119::AID-CNCR24>3.0.CO;2-4; Kumar S, 1998, HUM PATHOL, V29, P397, DOI 10.1016/S0046-8177(98)90122-8; Lee SC, 2000, J MOL DIAGN, V2, P145, DOI 10.1016/S1525-1578(10)60630-7; NIEDERWIESER DW, 1990, NEW ENGL J MED, V322, P1794, DOI 10.1056/NEJM199006213222507; Norton AJ, 1999, AM J DERMATOPATH, V21, P279, DOI 10.1097/00000372-199906000-00013; Salhany KE, 1998, AM J SURG PATHOL, V22, P881, DOI 10.1097/00000478-199807000-00010; Sambrook J., 2002, MOL CLONING LAB MANU; SHPILBERG O, 1994, BRIT J HAEMATOL, V87, P75, DOI 10.1111/j.1365-2141.1994.tb04873.x; Wang CYE, 1996, INT J DERMATOL, V35, P1; Willemze R, 1997, BLOOD, V90, P354; WITHERSPOON RP, 1989, NEW ENGL J MED, V321, P784, DOI 10.1056/NEJM198909213211203	26	61	62	1	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1458	1463		10.1056/NEJMoa010041	http://dx.doi.org/10.1056/NEJMoa010041			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794194				2022-12-28	WOS:000172132700004
J	Lois, C; Hong, EJ; Pease, S; Brown, EJ; Baltimore, D				Lois, C; Hong, EJ; Pease, S; Brown, EJ; Baltimore, D			Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors	SCIENCE			English	Article							RETROVIRAL VECTORS; HIGH-TITER; MICE; MOUSE; METHYLATION; ELEMENT; VIRUS; CELLS; LINE; DNA	Single-cell mouse embryos were infected in vitro with recombinant lentiviral vectors to generate transgenic mice carrying the green fluorescent protein (GFP) gene driven by a ubiquitously expressing promoter. Eighty percent of founder mice carried at least one copy of the transgene, and 90% of these expressed GFP at high levels. Progeny inherited the transgene(s) and displayed green fluorescence. Mice generated using lentiviral vectors with muscle-specific and T lymphocyte-specific promoters expressed high levels of GFP only in the appropriate cell types. We have also generated transgenic rats that express GFP at high levels, suggesting that this technique can be used to produce other transgenic animal species.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Coffin J, 1997, RETROVIRUSES; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hogan B, 1994, MANIPULATING MOUSE E; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; MCBURNEY MW, 1994, DEV DYNAM, V200, P278, DOI 10.1002/aja.1002000403; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; NAITO K, 1992, HUM REPROD, V7, P281, DOI 10.1093/oxfordjournals.humrep.a137633; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Petitte JN, 1997, POULTRY SCI, V76, P1084, DOI 10.1093/ps/76.8.1084; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; YEE JK, 1994, METHOD CELL BIOL, V43, P99; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	22	1526	1689	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					868	872		10.1126/science.1067081	http://dx.doi.org/10.1126/science.1067081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11786607				2022-12-28	WOS:000173733000049
J	Coiffier, B; Lepage, E; Briere, J; Herbrecht, R; Tilly, H; Bouabdallah, R; Morel, P; Van den Neste, E; Salles, G; Gaulard, P; Reyes, F; Gisselbrecht, C				Coiffier, B; Lepage, E; Briere, J; Herbrecht, R; Tilly, H; Bouabdallah, R; Morel, P; Van den Neste, E; Salles, G; Gaulard, P; Reyes, F; Gisselbrecht, C			CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; NON-HODGKINS-LYMPHOMA; STANDARD REGIMEN CHOP; DETUDE DES LYMPHOMES; PHASE-II; AGGRESSIVE LYMPHOMA; COMBINATION; THERAPY; GRADE; IDEC-C2B8	Background: The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conducted a randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. Methods: Previously untreated patients with diffuse large-B-cell lymphoma, 60 to 80 years old, were randomly assigned to receive either eight cycles of CHOP every three weeks (197 patients) or eight cycles of CHOP plus rituximab given on day 1 of each cycle (202 patients). Results: The rate of complete response was significantly higher in the group that received CHOP plus rituximab than in the group that received CHOP alone (76 percent vs. 63 percent, P=0.005). With a median follow-up of two years, event-free and overall survival times were significantly higher in the CHOP-plus-rituximab group (P<0.001 and P=0.007, respectively). The addition of rituximab to standard CHOP chemotherapy significantly reduced the risk of treatment failure and death (risk ratios, 0.58 [95 percent confidence interval, 0.44 to 0.77] and 0.64 [0.45 to 0.89], respectively). Clinically relevant toxicity was not significantly greater with CHOP plus rituximab. Conclusions: The addition of rituximab to the CHOP regimen increases the complete-response rate and prolongs event-free and overall survival in elderly patients with diffuse large-B-cell lymphoma, without a clinically significant increase in toxicity. (N Engl J Med 2002;346:235-42.) Copyright (C) 2002 Massachusetts Medical Society.	Hospices Civils Lyon, Lyon, France; Univ Lyon 1, F-69365 Lyon, France; Hop Henri Mondor, Paris, France; Hop St Louis, Assistance Publ Hop Paris, Paris, France; Hop Hautepierre, Strasbourg, France; Inst J Paoli I Calmettes, F-13009 Marseille, France; Ctr Henri Becquerel, F-76038 Rouen, France; Ctr Hosp Lens, Lens, France; Catholic Univ Louvain, Brussels, Belgium	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Centre Henri Becquerel; Universite Catholique Louvain	Coiffier, B (corresponding author), Ctr Hosp Lyon Sud, Hematol Serv, F-69495 Pierre Benite, France.	bertrand.coiffier@chu-lyon.fr	Herbrecht, Raoul/D-3471-2013; Herbrecht, Raoul/GVU-1333-2022; Herbrecht, Raoul/AAT-1763-2021; Salles, Gilles/Z-2336-2019	Herbrecht, Raoul/0000-0002-9381-4876; Salles, Gilles/0000-0002-9541-8666				Bastion YB, 1997, J CLIN ONCOL, V15, P2945, DOI 10.1200/JCO.1997.15.8.2945; Chan WC, 1997, BLOOD, V89, P3909; Chan WC, 1997, ANN ONCOL, V8, P973; Cheson, 2000, J CLIN ONCOL, V18, P2351; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; COIFFIER B, 1994, ANN ONCOL, V5, P873; Coiffier B, 1998, BLOOD, V92, P1927; Coiffier B, 2000, BLOOD, V96, p223A; COIFFIER B, 1997, TXB MED ONCOLOGY, P265; Czuczman MS, 1999, J CLIN ONCOL, V17, P268, DOI 10.1200/JCO.1999.17.1.268; DIXON DO, 1986, J CLIN ONCOL, V4, P295, DOI 10.1200/JCO.1986.4.3.295; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Foran JM, 2000, J CLIN ONCOL, V18, P317, DOI 10.1200/JCO.2000.18.2.317; GORDON LI, 1992, NEW ENGL J MED, V327, P1342, DOI 10.1056/NEJM199211053271903; Haioun C, 2000, J CLIN ONCOL, V18, P3025, DOI 10.1200/JCO.2000.18.16.3025; HARRIS NL, 1994, BLOOD, V84, P1361; Jaffe ES, 2001, WHO CLASSIFICATION T; Jerkeman M, 1999, ANN ONCOL, V10, P1079, DOI 10.1023/A:1008392528248; MALONEY DG, 1994, BLOOD, V84, P2457; Maloney DG, 1997, BLOOD, V90, P2188; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; MEYER RM, 1995, J CLIN ONCOL, V13, P2386, DOI 10.1200/JCO.1995.13.9.2386; *NCI, 1998, CANC THER EV PROGR C; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; SONNEVELD P, 1995, J CLIN ONCOL, V13, P2530, DOI 10.1200/JCO.1995.13.10.2530; Tilly H, 2000, BLOOD, V96, p832A; Tirelli U, 1998, J CLIN ONCOL, V16, P27, DOI 10.1200/JCO.1998.16.1.27; Vose JM, 2001, J CLIN ONCOL, V19, P389, DOI 10.1200/JCO.2001.19.2.389; Zinzani PL, 1999, BLOOD, V94, P33; 1994, GOOD CLIN PRACT J S, V1	30	3949	4149	7	187	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					235	242		10.1056/NEJMoa011795	http://dx.doi.org/10.1056/NEJMoa011795			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807147				2022-12-28	WOS:000173398900003
J	Wang, X; Chen, HF; Yin, H; Kim, SS; Tan, SL; Gosden, RG				Wang, X; Chen, HF; Yin, H; Kim, SS; Tan, SL; Gosden, RG			Fertility after intact ovary transplantation	NATURE			English	Article							KIDNEYS		Ctr Hosp Univ Montreal, Notre Dame Hosp, Expt Surg Lab, Montreal, PQ H2L 4M1, Canada; McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98105 USA	Universite de Montreal; McGill University; Royal Victoria Hospital; University of Washington; University of Washington Seattle	Wang, X (corresponding author), Ctr Hosp Univ Montreal, Notre Dame Hosp, Expt Surg Lab, Montreal, PQ H2L 4M1, Canada.							CORNIER E, 1985, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V14, P567; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GUTTMAN FM, 1977, CRYOBIOLOGY, V14, P559, DOI 10.1016/0011-2240(77)90166-3; JACOBSEN IA, 1984, CRYOBIOLOGY, V21, P637, DOI 10.1016/0011-2240(84)90223-2; LEE S, 1974, J RES I MED SCI KORE, V6, P112; Picton HM, 2000, BRIT MED BULL, V56, P603, DOI 10.1258/0007142001903418; Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X; Song YC, 2000, NAT BIOTECHNOL, V18, P296, DOI 10.1038/73737	8	163	180	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					385	385		10.1038/415385a	http://dx.doi.org/10.1038/415385a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807540				2022-12-28	WOS:000173433600035
J	Feachem, RGA; Sekhri, NK; White, KL				Feachem, RGA; Sekhri, NK; White, KL			Getting more for their dollar: a comparison of the NHS with California's Kaiser Permanente	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MANAGED CARE; QUALITY	Objective To compare the costs and performance of the NHS with those of air integrated system for financing and delivery health services (Kaiser Permanente) in California, Methods The adjusted costs of the two systems and their performance were compared with respect to inputs, use, access to services, responsiveness, and limited quality indicators. Results The per capita costs of the two systems, adjusted for differences in benefits, special activities, population characteristics, and the cost environment, were similar to within 10%. Some aspects of performance differed. In particular, Kaiser members experience more comprehensive and convenient primary care services and much more rapid access to specialist services and hospital admissions. Age adjusted rates of use of acute hospital services in Kaiser were one third of those in the NHS. Conclusions The widely held beliefs that the NHS is efficient and that poor performance in certain areas is largely explained by underinvestment are not supported by this analysis. Kaiser achieved better performance at roughly the same cost as the NHS because of integration throughout the system, efficient management of hospital use, the benefits of competition, and greater investment in information technology.	Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94105 USA; Univ Calif Berkeley, Inst Global Hlth, Berkeley, CA 94720 USA; Healthcare Redesign Grp, Alameda, CA 94502 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Feachem, RGA (corresponding author), Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94105 USA.	rfeachem@psg.ucsf.edu						Anderson G, 2001, HEALTH AFFAIR, V20, P219, DOI 10.1377/hlthaff.20.3.219; *ASS BRIT INS, PRIV MED INS MARK; Ayanian JZ, 2001, HEALTH AFFAIR, V20, P55, DOI 10.1377/hlthaff.20.3.55; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Blendon RJ, 2001, HEALTH AFFAIR, V20, P33, DOI 10.1377/hlthaff.20.2.33; *BRIT MED ASS, 2000 DDRB AW KEY FAC; *CAL COOP HEALTHC, 2000, 2000 REP QUAL CAL HL; *CAL HEALTHC FDN F, 1999, BUY NOT BUY PROF CAL; CORVARI RJ, 1998, TRENDS PATENTED DRUG; *CTR HLTH STAT HLT, 1999, LEAD HLTH IND CAL; Danzon PM, 2000, J HEALTH ECON, V19, P159, DOI 10.1016/S0167-6296(99)00039-9; *DEP HLTH, STAT DIV; *DEP HLTH, 2001, STAT PRESS NOT NHS W; *DEP HLTH, 2001, NHS EX WAIT TIM DAT; *DEP HLTH, 2000, B DEP HLTH; *DEP HLTH, 2001, GOV EXP PLANS 2001 2; Department of Health, 2000, NHS PLAN PLAN INV PL; Dudley RA, 2001, NEW ENGL J MED, V344, P1087, DOI 10.1056/NEJM200104053441410; EMMERSON C, 2000, PRESSURES UK HEALTHC; GANTENBEIN D, 2000, BUSINESS WEEK ONLINE; *HEDIS 2000, MAK INF CHOIC HEDIS; *HLTH CAR FIN ADM, 1980 1998 STAT HLTH; *INSURECOM, HLTH INS LAWS BEN TO; Kohn KT, 2000, ERR IS HUMAN BUILDIN; LAING, PRIVATE MED INSURANC; LAKIN C, 2001, EFFECTS TAX BENEFITS; Miller RH, 1997, HEALTH AFFAIR, V16, P7, DOI 10.1377/hlthaff.16.5.7; *NAT HLTH SERV, OV MOD NAT PROGR NSC; *OFF HLTH EC, 2000, COMP HLTH STAT; *OFF NAT STAT, STATB DAT; *ORG EC COOP DEV, 2000, HLTH DAT 2000 COMP A; PEABODY JN, 2001, J GEN INT MED S, V16, P153; *RAND CAL, POP DEM STAT; ROBINSON J, 2001, HLTH AFF         MAY; Sekhri NK, 2000, B WORLD HEALTH ORGAN, V78, P830; The World Bank, 2001, WORLD DEV IND 2000; *US GEN ACC OFF, 1992, PRESCR DRUGS CO TYP; World Health Organization, 2000, WORLD HLTH REP 2000	38	208	214	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2002	324	7330					135	141		10.1136/bmj.324.7330.135	http://dx.doi.org/10.1136/bmj.324.7330.135			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799029	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000173470600012
J	Arantes-Oliveira, N; Apfeld, J; Dillin, A; Kenyon, C				Arantes-Oliveira, N; Apfeld, J; Dillin, A; Kenyon, C			Regulation of life-span by germ-line stem cells in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; GENE; GLP-1; SPERMATOGENESIS; DROSOPHILA; RECEPTORS; EMBRYOS; MUTANT; STRESS; LAG-2	The germ line of the nematode Caenorhabditis elegans influences life-span; when the germ-line precursor cells are removed, life-span is increased dramatically. We find that neither sperm, nor oocytes, nor meiotic precursor cells are responsible for this effect. Rather life-span is influenced by the proliferating germ-line stem cells. These cells, as well as a downstream transcriptional regulator, act in the adult to influence aging, indicating that the aging process remains plastic during adulthood. We propose that the germ-line stem cells affect life-span by influencing the production of, or the response to, a steroid hormone that promotes longevity.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Apfeld, Javier/0000-0001-9897-5671; Kenyon, Cynthia/0000-0003-3446-2636				Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARTON MK, 1990, GENETICS, V125, P29; Berry LW, 1997, DEVELOPMENT, V124, P925; ELLIS RE, 1995, GENETICS, V139, P561; FRANCIS R, 1995, GENETICS, V139, P579; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Karashima T, 2000, DEVELOPMENT, V127, P1069; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; SCHEDL T, 1988, GENETICS, V119, P43; SCHEDL T, 1997, C ELEGANS, V2, P241; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; STROME S, 1995, DEVELOPMENT, V121, P2961; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605	24	335	351	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					502	505		10.1126/science.1065768	http://dx.doi.org/10.1126/science.1065768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799246				2022-12-28	WOS:000173350700052
J	Lazaris, A; Arcidiacono, S; Huang, Y; Zhou, JF; Duguay, F; Chretien, N; Welsh, EA; Soares, JW; Karatzas, CN				Lazaris, A; Arcidiacono, S; Huang, Y; Zhou, JF; Duguay, F; Chretien, N; Welsh, EA; Soares, JW; Karatzas, CN			Spider silk fibers spun from soluble recombinant silk produced in mammalian cells	SCIENCE			English	Article							FORCE-ELONGATION BEHAVIOR; DRAGLINE SILK; FIBROIN; PROTEIN; EXPRESSION; PURIFICATION; SEQUENCE; DESIGN	Spider silks are protein-based "biopolymer" filaments or threads secreted by specialized epithelia[ cells as concentrated soluble precursors of highly repetitive primary sequences. Spider dragline silk is a flexible, lightweight fiber of extraordinary strength and toughness comparable to that of synthetic high-performance fibers. We sought to "biomimic" the process of spider silk production by expressing in mammalian cells the dragline silk genes (ADF-3/MaSpll and MaSpl) of two spider species. We produced soluble recombinant (rc)-dragline silk proteins with molecular masses of 60 to 140 kilodaltons. We demonstrated the wet spinning of silk monofilaments spun from a concentrated aqueous solution of soluble rc-spider silk protein (ADF-3; 60 kilodaltons) under modest shear and coagulation conditions. The spun fibers were water insoluble with a fine diameter (10 to 40 micrometers) and exhibited toughness and modulus values comparable to those of native dragline silks but with tower tenacity. Dope solutions with rc-silk protein concentrations >20% and postspinning draw were necessary to achieve improved mechanical properties of the spun fibers. Fiber properties correlated with finer fiber diameter and increased birefringence.	Nexia Biotechnol, Quebec City, PQ J7V 8P5, Canada; USA, Soldier Biol Chem Command, Mat Sci Team, Natick, MA 01760 USA		Lazaris, A (corresponding author), Nexia Biotechnol, Quebec City, PQ J7V 8P5, Canada.	alazaris@nexiabiotech.com						Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U; DENNY M, 1976, J EXP BIOL, V65, P483; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; FAHNESTOCK SR, 1994, Patent No. 9429450; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HINMAN M, 1992, BIOPOLYMERS, P227; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; KAPLAN D, 1994, ACS SYM SER, V544, P2; KOOVER J, 1987, ECOPHYSIOLOGY SPIDER, P160; Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060; LILVAK O, 1998, MACROMOLECULES, V31, P2947; LIZARDI PM, 1979, P NATL ACAD SCI USA, V76, P6211, DOI 10.1073/pnas.76.12.6211; Lock, 1993, Process for Making Silk Fibroin Fibers, Patent No. [US5252285A, 5252285]; LUCAS FRED, 1964, DISCOVERY, V25, P20; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j; TERMONIA Y, 2000, PERG MAT SER, V4, P271; TERMONIA Y, 2000, PERG MAT SER, V4, P337; Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860; Viney C., 1994, SILK POLYM MAT SCI B, P120; VINEY C, 2000, PERG MAT SER, V4, P295; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; ZEMLIN JC, 1968, 6929CM US ARM NAT LA	38	499	604	13	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					472	476		10.1126/science.1065780	http://dx.doi.org/10.1126/science.1065780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799236				2022-12-28	WOS:000173350700042
J	Zhu, Y; Bian, Z; Lu, P; Karas, RH; Bao, L; Cox, D; Hodgin, J; Shaul, PW; Thoren, P; Smithies, O; Gustafsson, JA; Mendelsohn, ME				Zhu, Y; Bian, Z; Lu, P; Karas, RH; Bao, L; Cox, D; Hodgin, J; Shaul, PW; Thoren, P; Smithies, O; Gustafsson, JA; Mendelsohn, ME			Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASES; SMOOTH-MUSCLE; RESPONSES; ARTERIES; CLONING	Blood vessels express estrogen receptors, but their rote in cardiovascular physiology is not wet[ understood. We show that vascular smooth muscle cells and blood vessels from estrogen receptor beta (ERbeta)-deficient mice exhibit multiple functional abnormalities. In wild-type mouse blood vessels, estrogen attenuates vasoconstriction by an ERbeta-mediated increase in inducible nitric oxide synthase expression. In contrast, estrogen augments vasoconstriction in blood vessels from ERbeta-deficient mice. Vascular smooth muscle cells isolated from ERbeta-deficient mice show multiple abnormalities of ion channel function. Furthermore, ERbeta-deficient mice develop sustained systolic and diastolic hypertension as they age. These data support an essential role for ERbeta in the regulation of vascular function and blood pressure.	Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Huddinge Univ Hosp, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Novum, Ctr Biotechnol, S-14186 Huddinge, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA	Tufts Medical Center; Tufts University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mendelsohn, ME (corresponding author), Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056069, R01HL061298, P50HL063494, R01HL053546, R01HL055309, R29HL056235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020069, R37GM020069] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL63494, R01 HL55309, HL53546, HL56235, R01 HL61298, R01 HL56069] Funding Source: Medline; NICHD NIH HHS [HD30276] Funding Source: Medline; NIGMS NIH HHS [GM20069] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; Binko J, 1998, AM J PHYSIOL-HEART C, V274, pH853, DOI 10.1152/ajpheart.1998.274.3.H853; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Guetta V, 1997, CIRCULATION, V96, P2795, DOI 10.1161/01.CIR.96.9.2795; Kauser K, 1997, J VASC RES, V34, P229, DOI 10.1159/000159227; Kolyada AY, 1996, BIOCHEM BIOPH RES CO, V220, P600, DOI 10.1006/bbrc.1996.0449; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LANTINHERMOSO RL, 1997, AM J PHYSIOL, V273, P119; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0; Mendelsohn ME, 2000, CIRC RES, V87, P956, DOI 10.1161/01.RES.87.11.956; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mugge A, 1997, PHARMACOLOGY, V54, P162, DOI 10.1159/000139483; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; WILLIAMS JK, 1992, J AM COLL CARDIOL, V20, P452, DOI 10.1016/0735-1097(92)90116-5; [No title captured]	24	389	403	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					505	508		10.1126/science.1065250	http://dx.doi.org/10.1126/science.1065250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799247				2022-12-28	WOS:000173350700053
J	Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH				Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH			A longitudinal study of abnormalities on MRI and disability from multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPTIC NEURITIS; FOLLOW-UP; SPINAL-CORD; NATURAL-HISTORY; CLINICAL COURSE; AXONAL DAMAGE; BRAIN-STEM; EARLY RISK; LESIONS; PROGRESSION	Background: In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T(2)-weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that multiple sclerosis will develop. We sought to determine the relation between early lesion volume, changes in volume, and long-term disability. Methods: Seventy-one patients in a serial MRI study of patients with isolated syndromes were reassessed after a mean of 14.1 years. Disability was measured with the use of Kurtzke's Expanded Disability Status Scale (EDSS; possible range, 0 to 10, with a higher score indicating a greater degree of disability). Results: Clinically definite multiple sclerosis developed in 44 of the 50 patients (88 percent) with abnormal results on MRI at presentation and in 4 of 21 patients (19 percent) with normal results on MRI. The median EDSS score at follow-up for those with multiple sclerosis was 3.25 (range, 0 to 10); 31 percent had an EDSS score of 6 or more (including three patients whose deaths were due to multiple sclerosis). The EDSS score at 14 years correlated moderately with lesion volume on MRI at 5 years (r=0.60) and with the increase in lesion volume over the first 5 years (r=0.61). Conclusions: In patients who first present with isolated syndromes suggestive of multiple sclerosis, the increases in the volume of the lesions seen on magnetic resonance imaging of the brain in the first five years correlate with the degree of long-term disability from multiple sclerosis. This relation is only moderate, so the volume of the lesions alone may not be an adequate basis for decisions about the use of disease-modifying treatment. (N Engl J Med 2002;346:158-64.) Copyright (C) 2002 Massachusetts Medical Society.	UCL Inst Neurol, NMR Res Unit, London WC1N 3BG, England; Ninewells Hosp, Tayside Multiple Sclerosis Res Unit, Dundee DD1 9SY, Scotland; Otto Von Guericke Univ, Magdeburg, Germany	University of London; University College London; University of Dundee; Otto von Guericke University	Miller, DH (corresponding author), UCL Inst Neurol, NMR Res Unit, Queen Sq, London WC1N 3BG, England.		Calabrese, Massimiliano/I-6195-2012; Thompson, Alan J/C-2654-2008	Thompson, Alan J/0000-0002-4333-8496; O'Riordan, Jonathan/0000-0001-6774-2488	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		ALTMAN DG, 1991, PRACTICAL STAT MED R, P293; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brodsky M, 1997, NEUROLOGY, V49, P1404; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; CONFAVREUX C, 1980, BRAIN, V103, P281, DOI 10.1093/brain/103.2.281; Efron B., 1994, MONOGRAPHS STAT APPL; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filippi M, 1997, NEUROLOGY, V49, P371, DOI 10.1212/WNL.49.2.371; FRANCIS DA, 1987, J NEUROL NEUROSUR PS, V50, P758, DOI 10.1136/jnnp.50.6.758; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Ghezzi A, 1999, J NEUROL, V246, P770, DOI 10.1007/s004150050453; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; Katz-Levy Y, 2000, J IMMUNOL, V165, P5304, DOI 10.4049/jimmunol.165.9.5304; KURTZKE JF, 1977, J CHRON DIS, V30, P819, DOI 10.1016/0021-9681(77)90010-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LASSMANN H, 1994, ANN NEUROL, V36, pS42, DOI 10.1002/ana.410360713; LECHNERSCOTT J, IN PRESS CAN EXPANDE; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MILLER DH, 1988, J NEUROL NEUROSUR PS, V51, P1569, DOI 10.1136/jnnp.51.12.1569; MILLER DH, 1989, ANN NEUROL, V26, P635, DOI 10.1002/ana.410260508; MILLER DH, 1988, BRAIN, V111, P927, DOI 10.1093/brain/111.4.927; MILLER DH, 1987, ANN NEUROL, V22, P714, DOI 10.1002/ana.410220607; Molyneux PD, 1998, AM J NEURORADIOL, V19, P1715; MORRISSEY SP, 1993, BRAIN, V116, P135, DOI 10.1093/brain/116.1.135; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; ORMEROD IEC, 1986, J NEUROL NEUROSUR PS, V49, P124, DOI 10.1136/jnnp.49.2.124; ORMEROD IEC, 1986, J NEUROL NEUROSUR PS, V49, P737, DOI 10.1136/jnnp.49.7.737; PATY DW, 1993, NEUROLOGY, V43, P6627; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Riordan T, 1998, EPIDEMIOL INFECT, V121, P495, DOI 10.1017/S0950268898001496; RIZZO JF, 1988, NEUROLOGY, V38, P185, DOI 10.1212/WNL.38.2.185; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Sailer M, 1999, NEUROLOGY, V52, P599, DOI 10.1212/WNL.52.3.599; SANDBERG-WOLLHEIM M, 1990, Annals of Neurology, V27, P386, DOI 10.1002/ana.410270406; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STEWART WA, 1984, LANCET, V2, P412; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419	42	630	653	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					158	164		10.1056/NEJMoa011341	http://dx.doi.org/10.1056/NEJMoa011341			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796849	Green Published, Bronze			2022-12-28	WOS:000173273600003
J	Greene, MF				Greene, MF			Perspective - Outcomes of very low birth weight in young adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Greene, MF (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	14	15	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					146	148		10.1056/NEJM200201173460302	http://dx.doi.org/10.1056/NEJM200201173460302			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796847				2022-12-28	WOS:000173273600001
J	Hack, M; Flannery, DJ; Schluchter, M; Cartar, L; Borawski, E; Klein, N				Hack, M; Flannery, DJ; Schluchter, M; Cartar, L; Borawski, E; Klein, N			Outcomes in young adulthood for very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN BORN; FOLLOW-UP; HEALTH; RISK; AGE; INTELLIGENCE; ABILITIES; COHORT; BOYS; SEX	Background: Very-low-birth-weight infants (those weighing less than 1500 g) born during the initial years of neonatal intensive care have now reached young adulthood. Methods: We compared a cohort of 242 survivors among very-low-birth-weight infants born between 1977 and 1979 (mean birth weight, 1179 g; mean gestational age at birth, 29.7 weeks) with 233 controls from the same population in Cleveland who had normal birth weights. We assessed the level of education, cognitive and academic achievement, and rates of chronic illness and risk-taking behavior at 20 years of age. Outcomes were adjusted for sex and sociodemographic status. Results: Fewer very-low-birth-weight young adults than normal-birth-weight young adults had graduated from high school (74 percent vs. 83 percent, P=0.04). Very-low-birth-weight men, but not women, were significantly less likely than normal-birth-weight controls to be enrolled in postsecondary study (30 percent vs. 53 percent, P=0.002). Very-low-birth-weight participants had a lower mean IQ (87 vs. 92) and lower academic achievement scores (P<0.001 for both comparisons). They had higher rates of neurosensory impairments (10 percent vs. <1 percent, P<0.001) and subnormal height (10 percent vs. 5 percent, P=0.04). The very-low-birth-weight group reported less alcohol and drug use and had lower rates of pregnancy than normal-birth-weight controls; these differences persisted when comparisons were restricted to the participants without neurosensory impairment. Conclusions: Educational disadvantage associated with very low birth weight persists into early adulthood. (N Engl J Med 2002;346:149-57.) Copyright (C) 2002 Massachusetts Medical Society.	Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Cleveland State Univ, Dept Special Educ, Cleveland, OH 44115 USA; Kent State Univ, Inst Study & Prevent Violence, Kent, OH 44242 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Hack, M (corresponding author), Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	mxh7@po.cwru.edu	Fahimifar, Sepideh/M-5303-2019; Borawski, Elaine/R-9959-2019	Borawski, Elaine/0000-0001-7629-6889	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00080] Funding Source: Medline; NICHD NIH HHS [R01 HD34177] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS PF, 1994, VITAL HLTH STAT, V10; [Anonymous], J ADOLESCENT RES, DOI DOI 10.1177/074355489381003; ARAM DM, 1991, J SPEECH HEAR RES, V34, P1169, DOI 10.1044/jshr.3405.1169; AYLWARD GP, 1985, J DEV BEHAV PEDIATR, V6, P3; Bacharach VR, 1998, J PEDIATR PSYCHOL, V23, P197, DOI 10.1093/jpepsy/23.3.197; Belcher HME, 1998, ARCH PEDIAT ADOL MED, V152, P952; Bjerager M, 1995, ACTA PAEDIATR, V84, P1339, DOI 10.1111/j.1651-2227.1995.tb13565.x; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; CHILCOAT HD, 1995, AM J EPIDEMIOL, V141, P25, DOI 10.1093/oxfordjournals.aje.a117340; Chilcoat HD, 1999, J AM ACAD CHILD PSY, V38, P1347, DOI 10.1097/00004583-199911000-00008; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Ericson A, 1998, ARCH DIS CHILD-FETAL, V78, pF171, DOI 10.1136/fn.78.3.F171; *FED INT FOR CHILD, 2000, AM CHILDR KEY NAT IN; Flannery DJ, 1999, AM J ORTHOPSYCHIAT, V69, P247, DOI 10.1037/h0080426; FLANNERY DJ, 1994, J YOUTH ADOLESCENCE, V23, P195, DOI 10.1007/BF01537445; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; HACK M, 1992, J DEV BEHAV PEDIATR, V13, P412; Hack M, 1996, ARCH PEDIAT ADOL MED, V150, P1122, DOI 10.1001/archpedi.1996.02170360012002; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HACK M, 1991, NEW ENGL J MED, V325, P231, DOI 10.1056/NEJM199107253250403; Halpern CT, 2000, J ADOLESCENT HEALTH, V26, P213, DOI 10.1016/S1054-139X(99)00061-0; Hardy JB, 1997, PEDIATRICS, V99, P80, DOI 10.1542/peds.99.1.80; HESS JH, 1953, PEDIATRICS, V11, P425; Johnson EO, 2000, BIOL PSYCHIAT, V47, P490, DOI 10.1016/S0006-3223(99)00223-1; KANN L, 2000, CDC SURVEILLANCE SUM, V49, P1; KUCZMARSKI RJ, 2000, DHHS PUBLICATION; MACKAY AP, 2000, DHHS PUBLICATION; Mazurier E, 1999, PEDIATR RES, V45, p250A, DOI 10.1203/00006450-199904020-01487; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; Moss N, 1997, AM J PUBLIC HEALTH, V87, P1411, DOI 10.2105/AJPH.87.9.1411; Piecuch RE, 1998, CLIN PEDIATR, V37, P537, DOI 10.1177/000992289803700903; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2000, Semin Neonatol, V5, P107, DOI 10.1053/siny.1999.0003; Sattler J., 1992, ASSESSMENT CHILDREN; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; *US C, 1987, OTA PUBL; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 1981, WAIS R MANUAL WECHSL; WOLKE D, 1995, LANCET, V345, P447, DOI 10.1016/S0140-6736(95)90425-5; Woodcock R. W., 1989, WJ R TESTS ACHIEVEME; Xu BZ, 1998, EPIDEMIOLOGY, V9, P662, DOI 10.1097/00001648-199811000-00017; 1994, MMWR MORB MORTAL WKL, V43, P231	45	777	794	1	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					149	157		10.1056/NEJMoa010856	http://dx.doi.org/10.1056/NEJMoa010856			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511NZ	11796848				2022-12-28	WOS:000173273600002
J	Jaswal, SS; Sohl, JL; Davis, JH; Agard, DA				Jaswal, SS; Sohl, JL; Davis, JH; Agard, DA			Energetic landscape of alpha-lytic protease optimizes longevity through kinetic stability	NATURE			English	Article							ENGINEERING SUBSTRATE-SPECIFICITY; LINEAR EXTRAPOLATION METHOD; HYDROGEN-EXCHANGE; INFLUENZA HEMAGGLUTININ; CONFORMATIONS; CORE	During the evolution of proteins the pressure to optimize biological activity is moderated by a need for efficient folding. For most proteins, this is accomplished through spontaneous folding to a thermodynamically stable and active native state. However, in the extracellular bacterial alpha-lytic protease (alphaLP) these two processes have become decoupled. The native state of alphaLP is thermodynamically unstable, and when denatured, requires millennia (t(1/2), similar to 1,800 years)(1) to refold. Folding is made possible by an attached folding catalyst, the pro-region, which is degraded on completion of folding, leaving alphaLP trapped in its native state by a large kinetic unfolding barrier (t(1/2) similar to1.2 years)(1). alphaLP faces two very different folding landscapes: one in the presence of the pro-region controlling folding, and one in its absence restricting unfolding. Here we demonstrate that this separation of folding and unfolding pathways has removed constraints placed on the folding of thermodynamically stable proteins, and allowed the evolution of a native state having markedly reduced dynamic fluctuations. This, in turn, has led to a significant extension of the functional lifetime of alphaLP by the optimal suppression of proteolytic sensitivity.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.							BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chamberlain AK, 1997, STRUCTURE, V5, P859, DOI 10.1016/S0969-2126(97)00240-2; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Halfon S, 1996, J AM CHEM SOC, V118, P1227, DOI 10.1021/ja9533813; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; MACE JE, 1995, J MOL BIOL, V254, P720, DOI 10.1006/jmbi.1995.0650; Orosz A, 1996, MOL CELL BIOL, V16, P7018; PERONA JJ, 1995, PROTEIN SCI, V4, P337; RUPLEY JA, 1967, METHOD ENZYMOL, V11, P905; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wang L, 1998, PROTEIN SCI, V7, P2460, DOI 10.1002/pro.5560071124; 1988, J MOL GRAPH, V6, P13; [No title captured]	24	144	146	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					343	346		10.1038/415343a	http://dx.doi.org/10.1038/415343a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797014				2022-12-28	WOS:000173293500049
J	Motani, R				Motani, R			Scaling effects in caudal fin propulsion and the speed of ichthyosaurs	NATURE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; LARGE WATER TUNNEL; TUNA SWIMMING PERFORMANCE; POWER OUTPUT; ENERGY-EXPENDITURE; OSCILLATING FOILS; FISH PROPULSION; KINEMATICS; MACKEREL; SIZE	Four unrelated groups of large cruising vertebrates (tunas, whales, lamnid sharks and parvipelvian ichthyosaurs) evolved tuna-shaped (thunniform) body plans(1,2). Stringent physical constraints, imposed by the surrounding fluids, are probably responsible for this example of evolutionary convergence(1,2). Here I present a mathematical model of swimming kinematics and fluid mechanics that specifies and quantifies such constraints, and test the model with empirical data. The test shows quantitatively that morphology, kinematics, and physiology indeed covary tightly in large cruisers. The model enables calculations of optimal cruising speed from external measurements, and also predicts that wide caudal fin spans, typical of thunniform swimmers, are necessary for large cruisers. This finding is contrary to a popular yet rather teleological view that thunniform tails were selected for their high aspect ratios that increased propulsive efrciency(1,2). I also show by calculation that Stenopterygius, a Jurassic ichthyosaur, probably had optimal cruising speeds and basal metabolic rates similar to living tunas.	Royal Ontario Museum, Dept Paleobiol, Toronto, ON M5S 2C6, Canada	Royal Ontario Museum	Motani, R (corresponding author), Royal Ontario Museum, Dept Paleobiol, 100 Queens Pk, Toronto, ON M5S 2C6, Canada.		Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053				ALTRINGHAM JD, 1990, J EXP BIOL, V151, P453; ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; Arata Jr G. F, 1954, B MAR SCI GULF CARIB, V4, P183; Barrett DS, 1999, J FLUID MECH, V392, P183, DOI 10.1017/S0022112099005455; BLIX AS, 1995, ACTA PHYSIOL SCAND, V153, P61, DOI 10.1111/j.1748-1716.1995.tb09834.x; BLOCK BA, 1992, J EXP BIOL, V166, P267; BOSE N, 1990, P ROY SOC B-BIOL SCI, V242, P163, DOI 10.1098/rspb.1990.0120; BOSE N, 1989, PROC R SOC SER B-BIO, V237, P175, DOI 10.1098/rspb.1989.0043; DEWAR H, 1994, J EXP BIOL, V192, P13; DEWAR H, 1994, J EXP BIOL, V192, P45; Drucker EG, 1996, AM ZOOL, V36, P555; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1993, J EXP BIOL, V185, P179; Gibb AC, 1999, J EXP BIOL, V202, P2433; GRAHAM JB, 1990, J EXP BIOL, V151, P175; Hind AT, 1997, J EXP BIOL, V200, P531; HUNTER JR, 1971, FISH BULL NATL OC AT, V69, P253; Martill D.M., 1987, Modern Geology, V11, P265; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; MCGOWAN C, 1991, DINOAURS SPITFIRES S; MOTANI R, UNPUB PALEOBIOLOGY; Nakamura I., 1985, FAO FISH SYNOPSIS, V125, P1; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Vogel S, 1994, LIFE MOVING FLUIDS; WEBB PW, 1984, J EXP BIOL, V109, P77; WILLIAMS TM, 1993, J EXP BIOL, V179, P31; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303; Yazdi P, 1999, MAR BIOL, V134, P601, DOI 10.1007/s002270050575	30	54	55	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					309	312		10.1038/415309a	http://dx.doi.org/10.1038/415309a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797005				2022-12-28	WOS:000173293500040
J	Beaudouin, J; Gerlich, D; Daigle, N; Eils, R; Ellenberg, J				Beaudouin, J; Gerlich, D; Daigle, N; Eils, R; Ellenberg, J			Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina	CELL			English	Article							CYTOPLASMIC DYNEIN; FUNCTIONAL-ORGANIZATION; ENDOPLASMIC-RETICULUM; PHOSPHORYLATION SITES; MEMBRANE-PROTEIN; SEA-URCHIN; MITOSIS; CELL; INTERPHASE; DYNAMICS	The mechanism of nuclear envelope breakdown (NEBD) was investigated in live cells. Early spindle microtubules caused folds and invaginations in the NE up to one hour prior to NEBD, creating mechanical tension in the nuclear lamina. The first gap in the NE appeared before lamin B depolymerization, at the site of maximal tension, by a tearing mechanism. Gap formation relaxed this tension and dramatically accelerated the rate of chromosome condensation. The hole produced in the NE then rapidly expanded over the nuclear surface. NE fragments remaining on chromosomes were removed toward the centrosomes in a microtubule-dependent manner, suggesting a mechanism mediated by a minus-end-directed motor.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Biophys Programme, D-69117 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany.	jan.ellenberg@embl-heidelberg.de	Ellenberg, Jan/I-4688-2014; Eils, Roland/B-6121-2009; Gerlich, Daniel Wolfram W/A-6991-2016	Ellenberg, Jan/0000-0001-5909-701X; Eils, Roland/0000-0002-0034-4036; Gerlich, Daniel Wolfram W/0000-0003-1637-3365				Alberts B., 1994, MOL BIOL CELL; BAJER A, 1969, CHROMOSOMA, V27, P448, DOI 10.1007/BF00325682; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Buendia B, 1997, EXP CELL RES, V230, P133, DOI 10.1006/excr.1996.3395; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; ELLENBERG J, 1997, CELLS LAB MANUAL; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973; FOLSNER R, 1993, CELL, V73, P1267; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HAMAGUCHI Y, 1993, BIOIMAGES, V1, P129; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Kiseleva E, 2001, J CELL SCI, V114, P3607; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Marshall ICB, 1997, TRENDS CELL BIOL, V7, P69, DOI 10.1016/S0962-8924(96)10047-7; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; PAWELETZ N, 1988, EUR J CELL BIOL, V47, P334; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinsch S, 1998, J CELL SCI, V111, P2283; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasagawa S, 1999, EUR J CELL BIOL, V78, P593, DOI 10.1016/S0171-9335(99)80025-9; STICK R, 1988, J CELL BIOL, V107, P397, DOI 10.1083/jcb.107.2.397; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; YE Q, 1994, J BIOL CHEM, V269, P11306; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; ZATSEPINA OV, 1977, CYTOBIOLOGIE, V16, P130	54	337	348	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					83	96		10.1016/S0092-8674(01)00627-4	http://dx.doi.org/10.1016/S0092-8674(01)00627-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792323	Bronze			2022-12-28	WOS:000173280700010
J	Tahirov, TH; Sato, K; Ichikawa-Iwata, E; Sasaki, M; Inoue-Bungo, T; Shiina, M; Kimura, K; Takata, S; Fujikawa, A; Morii, H; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K				Tahirov, TH; Sato, K; Ichikawa-Iwata, E; Sasaki, M; Inoue-Bungo, T; Shiina, M; Kimura, K; Takata, S; Fujikawa, A; Morii, H; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K			Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter	CELL			English	Article							DNA-BINDING DOMAIN; V-MYB; TRANSCRIPTIONAL ACTIVATION; MIM-1 GENE; IN-VITRO; SYNERGISTIC ACTIVATION; PROTOONCOGENE PRODUCT; MYELOMONOCYTIC CELLS; ONCOGENE PRODUCT; HYDROPHOBIC CORE	c-Myb, but not avian myeloblastosis virus (AMV) v-Myb, cooperates with C/EBPbeta to regulate transcription of myeloid-specific genes. To assess the structural basis for that difference, we determined the crystal structures of complexes comprised of the c-Myb or AMV v-Myb DNA-binding domain (DBD), the C/EBPbeta DBD, and a promoter DNA fragment. Within the c-Myb complex, a DNA-bound C/EBPbeta interacts with R2 of c-Myb bound to a different DNA fragment; point mutations in v-Myb R2 eliminate such interaction within the v-Myb complex. GST pull-down assays, luciferase trans-activation assays, and atomic force microscopy confirmed that the interaction of c-Myb and C/EBPbeta observed in crystal mimics their long range interaction on the promoter, which is accompanied by intervening DNA looping.	Kanagawa Acad Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biol Struct, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Urol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; Japan Sci & Technol Corp, CREST Res Project, Tsukuba, Ibaraki 3050074, Japan; Natl Inst Adv Ind Sci & Technol, Prot Dynam Grp, Cent 6, Tsukuba, Ibaraki 3058566, Japan; RIKEN, Harima Inst, SPring 8, Biocrystallog Technol Div, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst, SPring 8, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan	Kanagawa Academy Science & Technology; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; RIKEN; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; RIKEN	Tahirov, TH (corresponding author), Kanagawa Acad Sci & Technol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.		Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Ishii, Shunsuke/A-5271-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Ishii, Shunsuke/0000-0002-6530-2478; Tahirov, Tahir/0000-0002-1238-0069; Watanabe, Shioka/0000-0003-2411-1891				BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Brendeford EM, 1998, FEBS LETT, V425, P52, DOI 10.1016/S0014-5793(98)00196-3; Brendeford EM, 1997, J BIOL CHEM, V272, P4436, DOI 10.1074/jbc.272.7.4436; BRISTOSBRAY M, 1997, MOL CELL BIOL, V17, P5127; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; DINI PW, 1993, MOL CELL BIOL, V13, P7334, DOI 10.1128/MCB.13.12.7334; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Fong IC, 2000, MOL IMMUNOL, V37, P391, DOI 10.1016/S0161-5890(00)00056-0; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Ganter B, 1999, FEBS LETT, V460, P401, DOI 10.1016/S0014-5793(99)01373-3; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; KaneiIshii C, 1997, SCIENCE, V277, P246, DOI 10.1126/science.277.5323.246; KANEIISHII C, 1990, J BIOL CHEM, V265, P19990; KLEMPNAUER KH, 1993, ONCOGENE, V8, P111; KowenzLeutz E, 1997, CELL, V91, P185, DOI 10.1016/S0092-8674(00)80401-8; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Lutz PG, 2001, BLOOD, V97, P2449, DOI 10.1182/blood.V97.8.2449; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mink S, 1996, MOL CELL BIOL, V16, P1316; Morii H, 1999, J MOL BIOL, V292, P909, DOI 10.1006/jmbi.1999.3099; NAKAGOSHI H, 1990, J BIOL CHEM, V265, P3479; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oda M, 1997, PROTEIN ENG, V10, P1407, DOI 10.1093/protein/10.12.1407; OELGESCHLAGER M, 1996, EMBO J, V15, P277; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; Ording E, 1996, ONCOGENE, V13, P1043; ORDING E, 1994, EUR J BIOCHEM, V222, P113, DOI 10.1111/j.1432-1033.1994.tb18848.x; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sasaki M, 2000, J BIOCHEM-TOKYO, V127, P945, DOI 10.1093/oxfordjournals.jbchem.a022710; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tahirov TH, 2001, ACTA CRYSTALLOGR D, V57, P1655, DOI 10.1107/S0907444901011982; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Wolberger C, 1998, CURR OPIN GENET DEV, V8, P552, DOI 10.1016/S0959-437X(98)80010-5; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; Zhang XH, 1997, J BIOL CHEM, V272, P29272, DOI 10.1074/jbc.272.46.29272	54	132	138	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					57	70		10.1016/S0092-8674(01)00636-5	http://dx.doi.org/10.1016/S0092-8674(01)00636-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792321	Bronze			2022-12-28	WOS:000173280700008
J	Martin, SJ; Beekman, M; Wossler, TC; Ratnieks, FLW				Martin, SJ; Beekman, M; Wossler, TC; Ratnieks, FLW			Parasitic Cape honeybee workers, Apis mellifera capensis, evade policing	NATURE			English	Article							BEE; REMOVAL	Relocation of the Cape honeybee, Apis mellifera capensis, by bee-keepers from southern to northern South Africa in 1990 has caused widespread death of managed African honeybee, A. m. scutellata, colonies(1). Apis mellifera capensis worker bees are able to lay diploid, female eggs without mating by means of automictic thelytoky(2) (meiosis followed by fusion of two meiotic products to restore egg diploidy), whereas workers of other honeybee subspecies are able to lay only haploid, male eggs. The A. m. capensis workers, which are parasitizing and killing A. m. scutellata colonies in northern South Africa, are the asexual offspring of a single, original worker in which the small amount of genetic variation observed is due to crossing over during meiosis(3) (P. Kryger, personal communication). Here we elucidate two principal mechanisms underlying this parasitism. Parasitic A. m. capensis workers activate their ovaries in host colonies that have a queen present (queenright colonies), and they lay eggs that evade being killed by other workers (worker policing)-the normal fate of worker-laid eggs in colonies with a queen(4-8). This unique parasitism by workers is an instance in which a society is unable to control the selfish actions of its members.	Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Sheffield; University of Pretoria	Ratnieks, FLW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	F.Ratnieks@Shefreld.ac.uk	Beekman, Madeleine/A-3983-2011; Beekman, Madeleine/AAF-8574-2019; martin, stephen/B-5254-2009	Beekman, Madeleine/0000-0002-9040-3756; Beekman, Madeleine/0000-0002-9040-3756; Wossler, Theresa/0000-0003-3725-6133				ALLSOPP MH, 1993, AM BEE J, V133, P121; Barron AB, 2001, BEHAV ECOL SOCIOBIOL, V50, P199, DOI 10.1007/s002650100362; BEEKMAN M, UNPUB INSECTES SOCIA; Downs SG, 2001, BEHAV ECOL, V12, P47, DOI 10.1093/oxfordjournals.beheco.a000377; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; KRYGER P, 2001, P 13 ENT C S AFR, P38; MARTIN S, IN PRESS APIDOLOGIE; Neumann P, 2000, APIDOLOGIE, V31, P67, DOI 10.1051/apido:2000107; Nunney L, 1999, MG BEH ECOL, P238; Oldroyd BP, 2000, BEHAV ECOL SOCIOBIOL, V47, P268, DOI 10.1007/s002650050665; OLDROYD BP, 1994, NATURE, V371, P749, DOI 10.1038/371749a0; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1993, BEHAV ECOL SOCIOBIOL, V32, P191, DOI 10.1007/BF00173777; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Visscher PK, 1996, BEHAV ECOL SOCIOBIOL, V39, P237, DOI 10.1007/s002650050286	18	101	107	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					163	165		10.1038/415163a	http://dx.doi.org/10.1038/415163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805832	Green Accepted			2022-12-28	WOS:000173159300039
J	Crutzen, PJ				Crutzen, PJ			Geology of mankind	NATURE			English	Editorial Material									Max Planck Inst Chem, D-55020 Mainz, Germany; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego; Scripps Institution of Oceanography	Crutzen, PJ (corresponding author), Max Planck Inst Chem, POB 3060, D-55020 Mainz, Germany.		Crutzen, Paul J/F-6044-2012; Quinn, Patrick/B-5489-2010					Berger A, 1996, CR ACAD SCI II A, V323, P1; CLARK WC, 1986, SUSTAINABLE DEV BIOS, pCH1; Crutzen P. J, 2000, IGBP NEWSLETTER, V41; Houghton J. T., 2001, CLIMATE CHANGE 2001; Marsh G. P., 1864, MAN NATURE; McNeill John R, 2000, FACE NATURAL HIST; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; Turner B., 1990, EARTH TRANSFORMED HU; VERNADSKI VI, 1998, BIOSPHERE	9	2201	2293	35	625	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					23	23		10.1038/415023a	http://dx.doi.org/10.1038/415023a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780095	Bronze			2022-12-28	WOS:000173028800020
J	Hoang, C; Ferre-D'Amare, AR				Hoang, C; Ferre-D'Amare, AR			Cocrystal structure of a tRNA Psi 55 pseudouridine synthase: Nucleotide flipping by an RNA-modifying enzyme	CELL			English	Article							CRYSTAL-STRUCTURE; DYSKERATOSIS-CONGENITA; ESCHERICHIA-COLI; RESOLUTION; PROTEINS; BASE; RECOGNITION; SYNTHETASE; TRNA(PHE); MUTATIONS	Pseudouridine (Psi) synthases catalyze the isomerization of specific uridines in cellular RNAs to pseudouridines and may function as RNA chaperones. TruB is responsible for the Psi residue present in the T loops of virtually all tRNAs. The close homolog Cbf5/dyskerin is the catalytic subunit of box H/ACA snoRNPs. These carry out the pseudouridylation of eukaryotic rRNA and snRNAs. The 1.85 Angstrom resolution structure of TruB bound to RNA reveals that this enzyme recognizes the preformed three-dimensional structure of the T loop, primarily through shape complementarity. It accesses its substrate uridyl residue by flipping out the nucleotide and disrupts the tertiary structure of tRNA. Structural comparisons with TruB demonstrate that all Psi synthases are descended from a common molecular ancestor.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			NCRR NIH HHS [RR 15943] Funding Source: Medline; NIGMS NIH HHS [GM 63576] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BENESCH RE, 1953, SCIENCE, V118, P447, DOI 10.1126/science.118.3068.447; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CUSACK S, 1998, MANY FACES RNA, P55; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Dirheimer G., 1995, P93; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Foster PG, 2000, NAT STRUCT BIOL, V7, P23; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Koshlap KM, 1999, BIOCHEMISTRY-US, V38, P8647, DOI 10.1021/bi990118w; MAIZELS N, 1993, RNA WORLD, P577; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NURSE K, 1995, RNA, V1, P102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SAMUELSSON T, 1991, NUCLEIC ACIDS RES, V19, P6139, DOI 10.1093/nar/19.22.6139; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; VIDHYASHANKAR R, 1999, J BIOL CHEM, V274, P22225; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Watanabe Y, 2000, NUCLEIC ACIDS RES, V28, P2342, DOI 10.1093/nar/28.12.2342; Yang XJ, 2001, NAT STRUCT BIOL, V8, P968, DOI 10.1038/nsb1101-968; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	48	228	233	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					929	939		10.1016/S0092-8674(01)00618-3	http://dx.doi.org/10.1016/S0092-8674(01)00618-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779468	Bronze			2022-12-28	WOS:000173024200013
J	Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; Almeida, JP; Babbage, AK; Bagguley, CL; Bailey, J; Barlow, KF; Bates, KN; Beard, LM; Beare, DM; Beasley, OP; Bird, CP; Blakey, SE; Bridgeman, AM; Brown, AJ; Buck, D; Burrill, W; Butler, AP; Carder, C; Carter, NP; Chapman, JC; Clamp, M; Clark, G; Clark, LN; Clark, SY; Clee, CM; Clegg, S; Cobley, VE; Collier, RE; Connor, R; Corby, NR; Coulson, A; Coville, GJ; Deadman, R; Dhami, P; Dunn, M; Ellington, AG; Frankland, JA; Fraser, A; French, L; Garner, P; Grafham, DV; Griffiths, C; Griffiths, ND; Gwilliam, R; Hall, RE; Hammond, S; Harley, JL; Heath, PD; Ho, S; Holden, JL; Howden, PJ; Huckle, E; Hunt, AR; Hunt, SE; Jekosch, K; Johnson, CM; Johnson, D; Kay, MP; Kimberley, AM; King, A; Knights, A; Laird, GK; Lawlor, S; Lehvaslaiho, MH; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, JD; Marsh, VL; Martin, SL; McConnachie, LJ; McLay, K; McMurray, AA; Milne, S; Mistry, D; Moore, MJF; Mullikin, JC; Nickerson, T; Oliver, K; Parker, A; Patel, R; Pearce, TAV; Peck, AI; Phillimore, BJCT; Prathalingam, SR; Plumb, RW; Ramsay, H; Rice, CM; Ross, MT; Scott, CE; Sehra, HK; Shownkeen, R; Sims, S; Skuce, CD; Smith, ML; Soderlund, C; Steward, CA; Sulston, JE; Swann, M; Sycamore, N; Taylor, R; Tee, L; Thomas, DW; Thorpe, A; Tracey, A; Tromans, AC; Vaudin, M; Wall, M; Wallis, JM; Whitehead, SL; Whittaker, P; Willey, DL; Williams, L; Williams, SA; Wilming, L; Wray, PW; Hubbard, T; Durbin, RM; Bentley, DR; Beck, S; Rogers, J				Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; Almeida, JP; Babbage, AK; Bagguley, CL; Bailey, J; Barlow, KF; Bates, KN; Beard, LM; Beare, DM; Beasley, OP; Bird, CP; Blakey, SE; Bridgeman, AM; Brown, AJ; Buck, D; Burrill, W; Butler, AP; Carder, C; Carter, NP; Chapman, JC; Clamp, M; Clark, G; Clark, LN; Clark, SY; Clee, CM; Clegg, S; Cobley, VE; Collier, RE; Connor, R; Corby, NR; Coulson, A; Coville, GJ; Deadman, R; Dhami, P; Dunn, M; Ellington, AG; Frankland, JA; Fraser, A; French, L; Garner, P; Grafham, DV; Griffiths, C; Griffiths, ND; Gwilliam, R; Hall, RE; Hammond, S; Harley, JL; Heath, PD; Ho, S; Holden, JL; Howden, PJ; Huckle, E; Hunt, AR; Hunt, SE; Jekosch, K; Johnson, CM; Johnson, D; Kay, MP; Kimberley, AM; King, A; Knights, A; Laird, GK; Lawlor, S; Lehvaslaiho, MH; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, JD; Marsh, VL; Martin, SL; McConnachie, LJ; McLay, K; McMurray, AA; Milne, S; Mistry, D; Moore, MJF; Mullikin, JC; Nickerson, T; Oliver, K; Parker, A; Patel, R; Pearce, TAV; Peck, AI; Phillimore, BJCT; Prathalingam, SR; Plumb, RW; Ramsay, H; Rice, CM; Ross, MT; Scott, CE; Sehra, HK; Shownkeen, R; Sims, S; Skuce, CD; Smith, ML; Soderlund, C; Steward, CA; Sulston, JE; Swann, M; Sycamore, N; Taylor, R; Tee, L; Thomas, DW; Thorpe, A; Tracey, A; Tromans, AC; Vaudin, M; Wall, M; Wallis, JM; Whitehead, SL; Whittaker, P; Willey, DL; Williams, L; Williams, SA; Wilming, L; Wray, PW; Hubbard, T; Durbin, RM; Bentley, DR; Beck, S; Rogers, J			The DNA sequence and comparative analysis of human chromosome 20	NATURE			English	Article							COMMON DELETED REGION; HUMAN-GENOME; PHYSICAL MAPS; GENE; CHROMOSOME-20; IDENTIFICATION; PROGRAM; NUMBER; LOCUS; MOUSE	The finished sequence of human chromosome 20 comprises 59,187,298 base pairs (bp) and represents 99.4% of the euchromatic DNA. A single contig of 26 megabases (Mb) spans the entire short arm, and five contigs separated by gaps totalling 320 kb span the long arm of this metacentric chromosome. An additional 234,339 bp of sequence has been determined within the pericentromeric region of the long arm. We annotated 727 genes and 168 pseudogenes in the sequence. About 64% of these genes have a 59 and a 39 untranslated region and a complete open reading frame. Comparative analysis of the sequence of chromosome 20 to whole-genome shotgun-sequence data of two other vertebrates, the mouse Mus musculus and the puffer fish Tetraodon nigroviridis, provides an independent measure of the efficiency of gene annotation, and indicates that this analysis may account for more than 95% of all coding exons and almost all genes.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Deloukas, P (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	panos@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Johnson, David/A-3907-2011; Durbin, Richard/AAE-7178-2019	Deloukas, Panos/0000-0001-9251-070X; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Johnson, David/0000-0003-0887-3343; Durbin, Richard/0000-0002-9130-1006; Fosker, Christine/0000-0002-3799-9474; Gilbert, James/0000-0001-8079-3159; Martin, Sancha/0000-0001-6213-5259; Wilming, Laurens/0000-0002-4154-7358; Davidson, Claire/0000-0002-4910-8202; Kay, Mike/0000-0002-3282-0834; Hunt, Adrienne/0000-0002-1227-0310; Hunt, Sarah/0000-0002-8350-1235; Steward, Charles/0000-0001-8829-5349; Howe, Kerstin/0000-0003-2237-513X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bench AJ, 1998, GENOMICS, V49, P351, DOI 10.1006/geno.1998.5231; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHUTE I, 1997, GENOMICS, V41, P51; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenfeld A, 1999, GENOME RES, V9, P1; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Rigaud G, 2001, CANCER RES, V61, P285; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zheng SL, 2001, HUM GENET, V108, P430, DOI 10.1007/s004390100513; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	38	166	736	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					865	U3		10.1038/414865a	http://dx.doi.org/10.1038/414865a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780052	Bronze			2022-12-28	WOS:000172813300035
J	Ohta, A; Sitkovsky, M				Ohta, A; Sitkovsky, M			Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage	NATURE			English	Article							T-CELL-ACTIVATION; RELEASE; MECHANISMS; INHIBITOR; ARTHRITIS	Inappropriate or prolonged inflammation is the main cause of many diseases(1); for this reason it is important to understand the physiological mechanisms that terminate inflammation in vivo(2). Agonists for several G(s)-protein-coupled receptors(3), including cell-surface adenosine purinergic receptors(4-7), can increase levels of immunosuppressive cyclic AMP in immune cells(8-15); however, it was unknown whether any of these receptors regulates inflammation in vivo. Here we show that A2a adenosine receptors have a non-redundant role in the attenuation of inflammation and tissue damage in vivo. Sub-threshold doses of an inflammatory stimulus(16,17) that caused minimal tissue damage in wild-type mice were sufficient to induce extensive tissue damage, more prolonged and higher levels of pro-inflammatory cytokines, and death of male animals deficient in the A2a adenosine receptor. Similar observations were made in studies of three different models of inflammation and liver damage as well as during bacterial endotoxin-induced septic shock. We suggest that A2a adenosine receptors are a critical part of the physiological negative feedback mechanism for limitation and termination of both tissue-specific and systemic inflammatory responses.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sitkovsky, M (corresponding author), NIAID, Immunol Lab, NIH, 10 Ctr Dr,Room 10-11N311, Bethesda, MD 20892 USA.	mvsitkov@helix.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000626] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apasov SG, 2000, BRIT J PHARMACOL, V131, P43, DOI 10.1038/sj.bjp.0703532; Armstrong JM, 2001, BIOCHEM J, V354, P123, DOI 10.1042/0264-6021:3540123; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Cheng P, 1999, J POROUS MEDIA, V2, P19, DOI 10.1615/JPorMedia.v2.i1.20; CRONSTEIN BN, 1995, J INVEST MED, V43, P50; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Eigler A, 1997, SCAND J IMMUNOL, V45, P132, DOI 10.1046/j.1365-3083.1997.d01-377.x; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; FIRESTEIN GS, 1994, J IMMUNOL, V152, P5853; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HOSKIN DW, 1994, INT J CANCER, V59, P854, DOI 10.1002/ijc.2910590625; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ji X D, 1999, Drug Des Discov, V16, P217; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Luster MI, 2001, TOXICOL LETT, V120, P317, DOI 10.1016/S0378-4274(01)00284-3; Malfait AM, 1999, J IMMUNOL, V162, P6278; MARQUARDT DL, 1984, P NATL ACAD SCI-BIOL, V81, P6192, DOI 10.1073/pnas.81.19.6192; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Schumann J, 1998, J IMMUNOL, V161, P5745; Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591, DOI 10.1002/jlb.67.5.591; Tarkowski A, 1998, MOL MED TODAY, V4, P15, DOI 10.1016/S1357-4310(97)80540-0; Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176; van der Pouw Kraan TCTM, 1998, J CLIN INVEST, V102, P1866, DOI 10.1172/JCI3692; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; WINN HR, 1981, AM J PHYSIOL, V241, pH235, DOI 10.1152/ajpheart.1981.241.2.H235	30	977	1019	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					916	920		10.1038/414916a	http://dx.doi.org/10.1038/414916a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780065	Green Published			2022-12-28	WOS:000172813300048
J	Sui, HX; Han, BG; Lee, JK; Walian, P; Jap, BK				Sui, HX; Han, BG; Lee, JK; Walian, P; Jap, BK			Structural basis of water-specific transport through the AQP1 water channel	NATURE			English	Article							ELECTRON CRYSTALLOGRAPHY; PROTEIN; GLYCEROL; CONDUCTION; CHAIN; CHIP; PORE	Water channels facilitate the rapid transport of water across cell membranes in response to osmotic gradients. These channels are believed to be involved in many physiological processes that include renal water conservation, neuro-homeostasis, digestion, regulation of body temperature and reproduction. Members of the water channel superfamily have been found in a range of cell types from bacteria to human. In mammals, there are currently 10 families of water channels, referred to as aquaporins (AQP): AQP0-AQP9. Here we report the structure of the aquaporin 1 (AQP1) water channel to 2.2 Angstrom resolution. The channel consists of three topological elements, an extracellular and a cytoplasmic vestibule connected by an extended narrow pore or selectivity filter. Within the selectivity filter, four bound waters are localized along three hydrophilic nodes, which punctuate an otherwise extremely hydrophobic pore segment. This unusual combination of a long hydrophobic pore and a minimal number of solute binding sites facilitates rapid water transport. Residues of the constriction region, in particular histidine 182, which is conserved among all known water-specific channels, are critical in establishing water specificity. Our analysis of the AQP1 pore also indicates that the transport of protons through this channel is highly energetically unfavourable.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Comparat Biochem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Walian, P (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	PJWalian@lbl.gov; BKJap@lbl.gov	Sui, Haixin/L-4265-2017; Han, Bong-Gyoon/J-9120-2012	Sui, Haixin/0000-0002-5560-4325; 				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; AGRE P, 1993, AM J PHYSIOL, V265, pF463; BACIOU L, 1995, BIOCHEMISTRY-US, V34, P7967, DOI 10.1021/bi00025a001; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Pomes R, 1998, BIOPHYS J, V75, P33, DOI 10.1016/S0006-3495(98)77492-2; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Sui HX, 2000, ACTA CRYSTALLOGR D, V56, P1198, DOI 10.1107/S0907444900008143; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERKMAN AS, 1992, ANNU REV PHYSIOL, V54, P97, DOI 10.1146/annurev.physiol.54.1.97; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631	39	864	917	7	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					872	878		10.1038/414872a	http://dx.doi.org/10.1038/414872a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780053	Green Submitted			2022-12-28	WOS:000172813300036
J	Frenette, PS				Frenette, PS			Locking a leukocyte integrin with statins.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; PRAVASTATIN; THERAPY; BINDING		Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.		Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922				Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; ALBERTS AW, 1988, AM J CARDIOL, V62, P10; Bellosta S, 2000, ANN MED, V32, P164, DOI 10.3109/07853890008998823; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	7	46	55	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1419	1421		10.1056/NEJM200111083451911	http://dx.doi.org/10.1056/NEJM200111083451911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794177				2022-12-28	WOS:000172014200010
J	Meshorer, E; Erb, C; Gazit, R; Pavlovsky, L; Kaufer, D; Friedman, A; Glick, D; Ben-Arie, N; Soreq, H				Meshorer, E; Erb, C; Gazit, R; Pavlovsky, L; Kaufer, D; Friedman, A; Glick, D; Ben-Arie, N; Soreq, H			Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity	SCIENCE			English	Article							ACETYLCHOLINE-RELEASE; DENDRITIC TRANSPORT; PROTEIN-SYNTHESIS; STRESS; RESPONSES; TRANSCRIPTS; EXPRESSION; STABILITY; MEMORY; SITES	To explore neuronal mechanisms underlying long-term consequences of stress, we studied stress-induced changes in the neuritic translocation of acetylcholinesterase (AChE) splice variants. Under normal conditions, we found the synaptic AChE-S mRNA and protein in neurites, Corticosterone, anticholinesterases, and forced swim, each facilitated a rapid (minutes), yet long-lasting (weeks), shift from AChE-S to the normally rare AChE-R mRNA, promoted AChE-R mRNA translocation into neurites, and induced enzyme secretion, Weeks after stress, electrophysiological measurements in hippocampus slices displayed apparently normal evoked synaptic responses but extreme hypersensitivity to both anticholinesterases and atropine. Our findings suggest that neuronal hypersensitivity under stress involves neuritic replacement of AChE-S with AChE-R.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Eric Roland Ctr Neurodegenerat Dis, IL-91904 Jerusalem, Israel; Ben Gurion Univ Negev, Zlotowsky Ctr Neurosci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowsky Ctr Neurosci, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	soreq@shum.huji.ac.il	Gazit, Roi/J-3352-2017; Pavlovsky, Lev/AAD-1348-2021; Ben-Arie, Nissim/K-4997-2012	Soreq, Hermona/0000-0002-0955-526X; Gazit, Roi/0000-0002-0548-2147; Pavlovsky, Lev/0000-0001-8400-9587; Meshorer, Eran/0000-0003-4777-986X				Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Chan RYY, 1998, J BIOL CHEM, V273, P9727, DOI 10.1074/jbc.273.16.9727; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DAVIS L, 1990, J NEUROSCI, V10, P3056; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Foster JA, 1996, J NEUROSCI RES, V46, P652; Friedman A, 1998, J PHYSIOLOGY-PARIS, V92, P329, DOI 10.1016/S0928-4257(98)80042-9; Galyam N, 2001, ANTISENSE NUCLEIC A, V11, P51, DOI 10.1089/108729001750072128; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; IMPERATO A, 1991, BRAIN RES, V538, P111, DOI 10.1016/0006-8993(91)90384-8; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Luo ZD, 1999, MOL PHARMACOL, V56, P886, DOI 10.1124/mol.56.5.886; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mezey G, 2001, BRIT MED J, V323, P561, DOI 10.1136/bmj.323.7312.561; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Shapira M, 2000, HUM MOL GENET, V9, P1273, DOI 10.1093/hmg/9.9.1273; SOREQ H, 1984, EMBO J, V3, P1371, DOI 10.1002/j.1460-2075.1984.tb01979.x; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Wallace CS, 1998, J NEUROSCI, V18, P26; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443	30	196	206	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					508	512		10.1126/science.1066752	http://dx.doi.org/10.1126/science.1066752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799248				2022-12-28	WOS:000173350700054
J	Sachdev, S; Zhang, SC				Sachdev, S; Zhang, SC			Tuning order in cuprate superconductors	SCIENCE			English	Editorial Material							STRIPE PHASES; NORMAL-STATE; QUANTUM		Yale Univ, Dept Phys, New Haven, CT 06520 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Yale University; Stanford University	Sachdev, S (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.		Zhang, Shou-Cheng/B-2794-2010; Sachdev, Subir/A-8781-2013; Sachdev, Subir/Y-3037-2019	Sachdev, Subir/0000-0002-2432-7070; Sachdev, Subir/0000-0002-2432-7070				Aeppli G, 1997, SCIENCE, V278, P1432, DOI 10.1126/science.278.5342.1432; Anderson PW, 1997, PHYS TODAY, V50, P42, DOI 10.1063/1.881959; Arovas DP, 1997, PHYS REV LETT, V79, P2871, DOI 10.1103/PhysRevLett.79.2871; Boebinger GS, 1996, PHYS REV LETT, V77, P5417, DOI 10.1103/PhysRevLett.77.5417; Bonn DA, 2001, NATURE, V414, P887, DOI 10.1038/414887a; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; CHUBUKOV AV, 1994, PHYS REV B, V49, P11919, DOI 10.1103/PhysRevB.49.11919; Demler E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067202; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Ivanov DA, 2000, PHYS REV LETT, V84, P3958, DOI 10.1103/PhysRevLett.84.3958; KHAYKOVICH B, UNPUB; Lake B, 2001, SCIENCE, V291, P1759, DOI 10.1126/science.1056986; LAKE B, IN PRESS NATURE; Mitrovic VF, 2001, NATURE, V413, P501, DOI 10.1038/35097039; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Senthil T, 2001, PHYS REV LETT, V86, P292, DOI 10.1103/PhysRevLett.86.292; Varma CM, 1999, PHYS REV LETT, V83, P3538, DOI 10.1103/PhysRevLett.83.3538; Wynn JC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.197002; Zaanen J, 2000, NATURE, V404, P714, DOI 10.1038/35008176; Zhang SC, 1997, SCIENCE, V275, P1089, DOI 10.1126/science.275.5303.1089	23	42	43	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					452	454		10.1126/science.1068718	http://dx.doi.org/10.1126/science.1068718			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799229	Green Submitted			2022-12-28	WOS:000173350700035
J	Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH				Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH		US Preventive Serv Task Force	Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW-DOSE ASPIRIN; DISEASE; RISK	This statement summarizes the recommendation of the third U.S. Preventive Services Task Force (USPSTF) for aspirin for the primary prevention of cardiovascular events, as well as the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, can be found in a companion article in this issue. Copies of this document, the summary of the evidence, and the systematic evidence review can be obtained through the USPSTF Web site (www.ahrq.gov/clinic/uspstfix.htm) and in print: through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).	Univ Washington, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA; TriCty Family Med, Cohocton, NY USA; Univ Rochester, Sch Med, Rochester, NY 14627 USA; Natl Initiat Childrens Healthcare Qual, Boston, MA USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; Harvard Univ, Pilgrim Hlth Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78284 USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA; Univ Michigan, Ann Arbor, MI 48109 USA; CUNY Mt Sinai Sch Med, New York, NY 10029 USA; Mt Sinai Med Ctr, New York, NY 10029 USA; Merck & Co Inc, West Point, PA USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; Virginia Commonwealth Univ, Med Coll Virginia, Fairfax, VA USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio; University of Rochester; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Robert Wood Johnson Foundation (RWJF); Women & Infants Hospital Rhode Island; University of Michigan System; University of Michigan; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Merck & Company; Columbia University; Virginia Commonwealth University	Berg, AO (corresponding author), Univ Washington, Seattle, WA 98195 USA.							ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS62; ANDERSON G, 1994, CANADIAN TASK FORCE, P680; Dickinson JP, 1998, QJM-INT J MED, V91, P523, DOI 10.1093/qjmed/91.8.523; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Hoyert Donna L., 1999, DEATHS FINAL DATA 19; Meade TW, 1998, LANCET, V351, P233; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; STALNIKOWICZDARVASI R, 1995, J CLIN GASTROENTEROL, V21, P13; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, EUR HEART J, V19, P1434	16	242	247	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					157	160		10.7326/0003-4819-136-2-200201150-00015	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790071				2022-12-28	WOS:000173333900010
J	Bers, DM				Bers, DM			Cardiac excitation-contraction coupling	NATURE			English	Review							BETA-ADRENERGIC STIMULATION; CA2+-INDUCED CA2+ RELEASE; SODIUM-CALCIUM EXCHANGE; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTORS; VENTRICULAR MYOCYTES; NA+-CA2+ EXCHANGER; ACTION-POTENTIALS; NA+ CHANNELS; TROPONIN-I	Of the ions involved in the intricate workings of the heart, calcium is considered perhaps the most important. It is crucial to the very process that enables the chambers of the heart to contract and relax, a process called excitation-contraction coupling. It is important to understand in quantitative detail exactly how calcium is moved around the various organelles of the myocyte in order to bring about excitation-contraction coupling if we are to understand the basic physiology of heart function. Furthermore, spatial microdomains within the cell are important in localizing the molecular players that orchestrate cardiac function.	Loyola Univ, Stritch Sch Med, Dept Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Bers, DM (corresponding author), Loyola Univ, Stritch Sch Med, Dept Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	dbers@lumc.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483				Aggarwal R, 1997, J PHYSIOL-LONDON, V505, P353, DOI 10.1111/j.1469-7793.1997.353bb.x; Aprigliano O, 1997, AM J PHYSIOL-HEART C, V272, pH2726, DOI 10.1152/ajpheart.1997.272.6.H2726; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Bers DM, 2001, CIRC RES, V89, P373, DOI 10.1161/res.89.5.373; Bers DM, 2001, EXCITATION CONTRACTI; BOUCHARD RA, 1993, J PHYSIOL-LONDON, V472, P391, DOI 10.1113/jphysiol.1993.sp019953; Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82; Bridge JHB, 1999, J PHYSIOL-LONDON, V518, P469, DOI 10.1111/j.1469-7793.1999.0469p.x; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; BROWN J H, 1986, P245; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Chandra R, 1999, CARDIOVASC RES, V42, P490, DOI 10.1016/S0008-6363(99)00042-5; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CRUZ IDS, 1999, SCIENCE, V284, pA711; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Delbridge LMD, 1996, AM J PHYSIOL-CELL PH, V270, pC192, DOI 10.1152/ajpcell.1996.270.1.C192; DelPrincipe F, 2000, J PHYSIOL-LONDON, V527, P455, DOI 10.1111/j.1469-7793.2000.00455.x; Dipla K, 1999, CIRC RES, V84, P435, DOI 10.1161/01.RES.84.4.435; Egger M, 2000, J PHYSIOL-LONDON, V523, P353, DOI 10.1111/j.1469-7793.2000.t01-1-00353.x; Eisner DA, 2000, CIRC RES, V87, P1087, DOI 10.1161/01.RES.87.12.1087; Endoh M, 1996, NEUROCHEM RES, V21, P217, DOI 10.1007/BF02529138; FABIATO A, 1985, J GEN PHYSIOL, V85, P189, DOI 10.1085/jgp.85.2.189; Ferrier GR, 2001, AM J PHYSIOL-HEART C, V280, pH1928, DOI 10.1152/ajpheart.2001.280.5.H1928; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Fruen BR, 2000, AM J PHYSIOL-CELL PH, V279, pC724, DOI 10.1152/ajpcell.2000.279.3.C724; Fujioka Y, 2000, J PHYSIOL-LONDON, V523, P339, DOI 10.1111/j.1469-7793.2000.t01-2-00339.x; Fukuda N, 2001, CIRCULATION, V104, P1639, DOI 10.1161/hc3901.095898; Gambassi G, 1998, AM J PHYSIOL-HEART C, V274, pH1152, DOI 10.1152/ajpheart.1998.274.4.H1152; Ginsburg KS, 2001, BIOPHYS J, V80, p590A; GYORKE S, 1993, SCIENCE, V260, P807, DOI 10.1126/science.8387229; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; HOVEMADSEN L, 1993, CIRC RES, V73, P820, DOI 10.1161/01.RES.73.5.820; KENTISH JC, 1990, AM J PHYSIOL, V258, pH610, DOI 10.1152/ajpheart.1990.258.2.H610; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kuschel M, 1999, CIRCULATION, V99, P2458, DOI 10.1161/01.CIR.99.18.2458; Langer GA, 1996, BIOPHYS J, V70, P1169, DOI 10.1016/S0006-3495(96)79677-7; LEBLANC N, 1990, SCIENCE, V248, P372, DOI 10.1126/science.2158146; LEMAIRE S, 1995, RECEPTOR CHANNEL, V3, P71; LEVESQUE PC, 1994, CARDIOVASC RES, V28, P370, DOI 10.1093/cvr/28.3.370; LEVI AJ, 1994, AM J PHYSIOL, V266, pH1422, DOI 10.1152/ajpheart.1994.266.4.H1422; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Li YX, 2001, CIRCULATION, V104, P131; Lipp P, 2000, CURR BIOL, V10, P939, DOI 10.1016/S0960-9822(00)00624-2; LIPP P, 1994, J PHYSIOL-LONDON, V474, P439, DOI 10.1113/jphysiol.1994.sp020035; Litwin SE, 1998, BIOPHYS J, V75, P359, DOI 10.1016/S0006-3495(98)77520-4; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Lukyanenko V, 2000, BIOPHYS J, V79, P1273, DOI 10.1016/S0006-3495(00)76381-8; Lukyanenko V, 1998, J PHYSIOL-LONDON, V507, P667, DOI 10.1111/j.1469-7793.1998.667bs.x; Lukyanenko V, 1996, PFLUG ARCH EUR J PHY, V432, P1047, DOI 10.1007/s004240050233; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; MOSS RL, 2001, HDB PHYSL, P420; NUSS HB, 1999, SCIENCE, V284, P711; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Petroff MGV, 2001, CIRC RES, V89, P445, DOI 10.1161/hh1701.095716; Piacentino V, 2000, J PHYSIOL-LONDON, V523, P533, DOI 10.1111/j.1469-7793.2000.t01-1-00533.x; POGGIOLI J, 1986, FEBS LETT, V206, P292, DOI 10.1016/0014-5793(86)80999-1; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Puglisi JL, 1999, CIRC RES, V85, pE7, DOI 10.1161/01.RES.85.6.e7; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; Rybin VO, 1999, CIRC RES, V84, P980, DOI 10.1161/01.RES.84.9.980; Santana LF, 1998, SCIENCE, V279, P1027, DOI 10.1126/science.279.5353.1027; Satoh H, 1997, AM J PHYSIOL-HEART C, V272, pH657, DOI 10.1152/ajpheart.1997.272.2.H657; Schiefer A, 1995, J PHYSIOL-LONDON, V489, P337, DOI 10.1113/jphysiol.1995.sp021055; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; SHAM JSK, 1992, SCIENCE, V255, P850, DOI 10.1126/science.1311127; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Sipido KR, 1997, CIRC RES, V81, P1034; Sipido KR, 1998, J PHYSIOL-LONDON, V508, P439, DOI 10.1111/j.1469-7793.1998.439bq.x; SIPIDO KR, 1995, J PHYSIOL-LONDON, V489, P1; SITSAPESAN R, 1995, CIRC RES, V77, P765, DOI 10.1161/01.RES.77.4.765; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Solaro RJ, 1998, CIRC RES, V83, P471, DOI 10.1161/01.RES.83.5.471; Song LS, 2001, CIRC RES, V88, P794, DOI 10.1161/hh0801.090461; STERN MD, 1992, BIOPHYS J, V63, P497, DOI 10.1016/S0006-3495(92)81615-6; TRAFFORD AW, 1995, J PHYSIOL-LONDON, V488, P577, DOI 10.1113/jphysiol.1995.sp020991; Trafford AW, 1997, CIRC RES, V81, P477, DOI 10.1161/01.RES.81.4.477; Valderrama CA, 1997, DES AUTOM EMBED SYST, V2, P267, DOI 10.1023/A:1008829719142; Viatchenko-Karpinski S, 2001, J PHYSIOL-LONDON, V533, P837, DOI 10.1111/j.1469-7793.2001.t01-1-00837.x; WEBER CR, IN PRESS CIRC RES; Wier WG, 1999, CIRC RES, V85, P770, DOI 10.1161/01.RES.85.9.770; Zahradnikova A, 1999, J GEN PHYSIOL, V114, P787, DOI 10.1085/jgp.114.6.787; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhou ZF, 1998, BIOPHYS J, V74, P1830, DOI 10.1016/S0006-3495(98)77893-2; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	92	3071	3218	8	397	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					198	205		10.1038/415198a	http://dx.doi.org/10.1038/415198a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805843				2022-12-28	WOS:000173159300049
J	Wang, W; Thornton, K; Berry, A; Long, MY				Wang, W; Thornton, K; Berry, A; Long, MY			Nucleotide variation along the Drosophila melanogaster fourth chromosome	SCIENCE			English	Article							DNA POLYMORPHISM; SELECTION; DIVERGENCE; PATTERNS; COMPLEX; MODEL; GENES	The Drosophila melanogaster fourth chromosome, believed to be nonrecombining and invariable, is a classic example of the effect of natural selection in eliminating genetic variation in linked loci. However, in a chromosome-wide assay of nucleotide variation in natural populations, we have observed a high level of polymorphism in a similar to 200-kilobase region and marked levels of polymorphism in several other fragments interspersed with regions of little variation, suggesting different evolutionary histories in different chromosomal domains. Statistical tests of neutral evolution showed that a few haplotypes predominate in the 200-kilobase polymorphic region. Finally, contrary to the expectation of no recombination, we identified six recombination events within the chromosome. Thus, positive Darwinian selection and recombination have affected the evolution of this chromosome.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Chicago; University of Chicago; Harvard University	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Wang, Wen/AAP-9873-2020; Wang, Wei/B-5617-2019	Wang, Wen/0000-0002-7801-2066; Thornton, Kevin/0000-0003-0743-4445				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2000, GENETICS, V156, P257; Ashburner M., 1989, LAB HDB; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; BERRY AJ, 1991, GENETICS, V129, P1111; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH B, 1992, NATURE, V356, P475, DOI 10.1038/356475a0; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Dobzhansky T, 1943, GENETICS, V28, P162; Freeman S, 1998, EVOLUTIONARY ANAL; HILTON H, 1994, EVOLUTION, V48, P1900, DOI 10.1111/j.1558-5646.1994.tb02222.x; Hochman B., 1976, GENET BIOL DROSOPHIL, V1b, P903; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1985, GENETICS, V111, P147; Kimura M., 1983, NEUTRAL THEORY MOL E; KREITMAN M, 1991, GENETICS, V127, P565; MAYANRDSMITH J, 1976, GENET RES, V23, P23; Nurminsky D, 2001, SCIENCE, V291, P128, DOI 10.1126/science.291.5501.128; Powell J. R., 1997, PROGR PROSPECTS EVOL; TAJIMA F, 1989, GENETICS, V123, P585; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413	24	66	74	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					134	137		10.1126/science.1064521	http://dx.doi.org/10.1126/science.1064521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778050				2022-12-28	WOS:000173143100051
J	Mel'nikov, AS; Vinokur, VM				Mel'nikov, AS; Vinokur, VM			Mesoscopic superconductor as a ballistic quantum switch	NATURE			English	Article							STATES	Several key experiments(1-3) have revealed a rich variety of vortex structures in mesoscopic superconductors in which only a few quanta of magnetic flux are trapped: these structures are polygon-like vortex 'molecules' and multi-quanta giant vortices. Ginzburg-Landau calculations(4) confirmed second-order phase transitions between the giant vortex states and stable molecule-like configurations(5). Here we study theoretically the electronic structure and the related phase-coherent transport properties of such mesoscopic superconductor systems. The quasiparticle excitations in the vortices form coherent quantum-mechanical states that offer the possibility of controlling the phase-coherent transport through the sample by changing the number of trapped flux quanta and their configuration. The sample conductance measured in the direction of the applied magnetic field is determined by the transparency of multi-vortex configurations, which form a set of quantum channels. The transmission coefficient for each channel is controlled by multiple Andreev reflections within the vortex cores and at the sample edge. These interference phenomena result in a stepwise behaviour of the conductance as a function of the applied magnetic field, and we propose to exploit this effect to realize a vortex-based quantum switch where the magnetic field plays the role of the gate voltage.	Argonne Natl Lab, Argonne, IL 60439 USA; Russian Acad Sci, Inst Phys Microstruct, Nizhnii Novgorod 603950, Russia	United States Department of Energy (DOE); Argonne National Laboratory; Russian Academy of Sciences	Vinokur, VM (corresponding author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.		Vinokur, Valerii M/J-7299-2013; Mel'nikov, Alexander S/E-8099-2017	Mel'nikov, Alexander S/0000-0002-4241-467X				AZBEL MY, 1969, JETP LETT-USSR, V10, P32; Boato G, 1965, SOLID STATE COMMUN, V3, P173, DOI 10.1016/0038-1098(65)90285-1; CAROLI C, 1964, PHYS LETT, V9, P307, DOI 10.1016/0031-9163(64)90375-0; Chibotaru LF, 2000, NATURE, V408, P833, DOI 10.1038/35048521; Geim AK, 2000, PHYS REV LETT, V85, P1528, DOI 10.1103/PhysRevLett.85.1528; Giaever I., 1969, Tunneling phenomena in solids, P255; HESS HF, 1989, PHYS REV LETT, V62, P214, DOI 10.1103/PhysRevLett.62.214; MCLACHLAN DS, 1970, SOLID STATE COMMUN, V8, P1589, DOI 10.1016/0038-1098(70)90470-9; PINCUS P, 1967, PHYS REV, V158, P346, DOI 10.1103/PhysRev.158.346; Schweigert VA, 1998, PHYS REV LETT, V81, P2783, DOI 10.1103/PhysRevLett.81.2783; TANAKA Y, 1993, SOLID STATE COMMUN, V85, P321, DOI 10.1016/0038-1098(93)90024-H; Virtanen SMM, 1999, PHYS REV B, V60, P14581, DOI 10.1103/PhysRevB.60.14581; VOLOVIK GE, 1993, JETP LETT+, V57, P244	13	64	64	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					60	62		10.1038/415060a	http://dx.doi.org/10.1038/415060a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780114				2022-12-28	WOS:000173028800037
J	Bonn, DA; Wynn, JC; Gardner, BW; Lin, YJ; Liang, R; Hardy, WN; Kirtley, JR; Moler, KA				Bonn, DA; Wynn, JC; Gardner, BW; Lin, YJ; Liang, R; Hardy, WN; Kirtley, JR; Moler, KA			A limit on spin-charge separation in high-T-c superconductors from the absence of a vortex-memory effect	NATURE			English	Article								There is a long-standing debate about whether spin-charge separation is the root cause of the peculiar normal-state properties and high superconducting transition temperatures of the high-Tc materials. In the proposed(1) state of matter, the elementary excitations are not electron-like, as in conventional metals, but rather the electron 'fractionalizes' to give excitations that are chargeless spin-1/2 fermions (spinons) and charge +e bosons (chargons). Although spin-charge separation has been well established in one dimension, the theoretical situation for two dimensions is controversial and experimental evidence for it in the high-Tc materials is indirect. A model(2) with sharp experimental tests for a particular type of separation in two dimensions has recently been proposed. Here we report the results of those experimental tests, placing a conservative upper limit of 190 K on the energy of the proposed topological defects known as visons. There is still debate(3) about the extent to which this experiment can settle the issue of spin-charge separation in the high-T-c copper oxides, because some forms of the separation are able to avoid the need for visons. But at least one class(4-6) of theories that all predict a vortex-memory effect now are unlikely models for the copper oxides.	Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	University of British Columbia; Stanford University; Stanford University; International Business Machines (IBM)	Bonn, DA (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.		Moler, Kathryn A/F-2541-2011; Hardy, Walter Newbold/AAN-7827-2020; Guikema, Janice/A-5931-2009	Guikema, Janice/0000-0002-8287-4814; Moler, Kathryn/0000-0002-0233-8123; MacDonald, Allan/0000-0003-3561-3379				ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; BEASLEY MR, 1969, PHYS REV, V181, P682, DOI 10.1103/PhysRev.181.682; FRANZ M, 2000, CONDMAT0010436; Gardner BW, 2001, REV SCI INSTRUM, V72, P2361, DOI 10.1063/1.1364668; GOUGH CE, 1987, NATURE, V326, P855, DOI 10.1038/326855a0; LIANG R, UNPUB PHYSICA C; MOESSNER R, 2001, CONDMAT0103396; SEDGEWICK RD, 2000, CONDMAT0012028; Senthil T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214511; Senthil T, 2001, PHYS REV LETT, V86, P292, DOI 10.1103/PhysRevLett.86.292; Senthil T, 2000, PHYS REV B, V62, P7850, DOI 10.1103/PhysRevB.62.7850; Wynn JC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.197002	12	48	49	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					887	889		10.1038/414887a	http://dx.doi.org/10.1038/414887a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780056				2022-12-28	WOS:000172813300039
J	Lee, SH; Fu, KK; Hui, JN; Richman, JM				Lee, SH; Fu, KK; Hui, JN; Richman, JM			Noggin and retinoic acid transform the identity of avian facial prominences	NATURE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; BONE MORPHOGENETIC PROTEIN-4; NEURAL CREST; CHICK-EMBRYOS; LIMB BUDS; SONIC HEDGEHOG; EXPRESSION; PRIMORDIA; OUTGROWTH; BMP-4	The signals that determine body part identity in vertebrate embryos are largely unknown, with some exceptions such as those for teeth and digits(1,2). The vertebrate face is derived from small buds of tissue, facial prominences, that surround the embryonic oral cavity(3). In chicken embryos, the skeleton of the upper beak is derived from the frontonasal mass and maxillary prominences(4). Here we show that bone morphogenetic proteins (Bmps) and the vitamin A derivative, retinoic acid (RA), are used to specify the identity of the frontonasal mass and maxillary prominences. Implanting two beads adjacent to the stage-15 presumptive maxillary field, one soaked in the Bmp antagonist Noggin(5) and one soaked in RA, induces a duplicate set of frontonasal mass skeletal elements in place of maxillary bones. We also show that the duplicated beak is due to transformation of the maxillary prominence into a second frontonasal mass and not due to ectopic migration of cells or splitting of the normal frontonasal mass. Thus the levels of Bmp and RA determine whether specific regions of the face form maxillary or frontonasal mass derivatives.	Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada; Gyeongsang Natl Univ, Coll Med, Dept Dent, Chinju, South Korea	University of British Columbia; Gyeongsang National University	Richman, JM (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada.		Richman, Joy M./C-3111-2018; Richman, Joy/AAD-9445-2020	Richman, Joy M./0000-0002-1409-8163; Richman, Joy/0000-0002-1409-8163; /0000-0002-9438-2489				Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Barlow AJ, 1997, DEVELOPMENT, V124, P391; BROWN JM, 1993, DEVELOPMENT, V119, P41; Couly G, 1998, DEVELOPMENT, V125, P3445; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; EICHELE G, 1984, ANAL BIOCHEM, V142, P542, DOI 10.1016/0003-2697(84)90504-9; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FRANCISWEST PH, 1994, DEV DYNAM, V201, P168, DOI 10.1002/aja.1002010207; Haeckel E., 1886, EVOLUTION MAN POPULA; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hu D, 1999, DEVELOPMENT, V126, P4873; LELIEVRE CS, 1978, J EMBRYOL EXP MORPH, V47, P17; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; RICHMAN JM, 1992, DEV BIOL, V154, P299, DOI 10.1016/0012-1606(92)90069-S; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; WALL NA, 1995, MECH DEVELOP, V53, P383, DOI 10.1016/0925-4773(95)00453-X; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	26	98	101	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					909	912		10.1038/414909a	http://dx.doi.org/10.1038/414909a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780063				2022-12-28	WOS:000172813300046
J	Bartelink, H; Horiot, J; Poortmans, P; Struikmans, H; Van den Bogaert, W; Barillot, I; Fourquet, A; Borger, J; Jager, J; Hoogenraad, W; Collette, L; Pierart, M				Bartelink, H; Horiot, J; Poortmans, P; Struikmans, H; Van den Bogaert, W; Barillot, I; Fourquet, A; Borger, J; Jager, J; Hoogenraad, W; Collette, L; Pierart, M		European Org Res Treatment Canc Gr	Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; CONSERVING THERAPY; CONSERVATIVE TREATMENT; POSTOPERATIVE RADIOTHERAPY; EUROPEAN ORGANIZATION; PREMENOPAUSAL WOMEN; EORTC-RADIOTHERAPY; QUALITY ASSURANCE; RISK-FACTORS; MASTECTOMY	Background: Radiotherapy prevents local recurrence of breast cancer after breast-conserving surgery. We evaluated the effect of a supplementary dose of radiation to the tumor bed on the rates of local recurrence among patients who received radiotherapy after breast-conserving surgery for early breast cancer. Methods: After lumpectomy and axillary dissection, patients with stage I or II breast cancer received 50 Gy of radiation to the whole breast in 2-Gy fractions over a five-week period. Patients with a microscopically complete excision were randomly assigned to receive either no further local treatment (2657 patients) or an additional localized dose of 16 Gy, usually given in eight fractions by means of an external electron beam (2661 patients). Results: During a median follow-up period of 5.1 years, local recurrences were observed in 182 of the 2657 patients in the standard-treatment group and 109 of the 2661 patients in the additional-radiation group. The five-year actuarial rates of local recurrence were 7.3 percent (95 percent confidence interval, 6.8 to 7.6 percent) and 4.3 percent (95 percent confidence interval, 3.8 to 4.7 percent), respectively (P<0.001), yielding a hazard ratio for local recurrence of 0.59 (99 percent confidence interval, 0.43 to 0.81) associated with an additional dose. Patients 40 years old or younger benefited most; at five years, their rate of local recurrence was 19.5 percent with standard treatment and 10.2 percent with additional radiation (hazard ratio, 0.46 [99 percent confidence interval, 0.23 to 0.89]; P=0.002). At five years in the age group 41 to 50 years old, no differences were found in rates of metastasis or overall survival (which were 87 and 91 percent, respectively). Conclusions: In patients with early breast cancer who undergo breast-conserving surgery and receive 50 Gy of radiation to the whole breast, an additional dose of 16 Gy of radiation to the tumor bed reduces the risk of local recurrence, especially in patients younger than 50 years of age.	Netherlands Canc Inst, Dept Radiat Oncol, NL-1066 CX Amsterdam, Netherlands; Dr Bernard Verbeeten Inst, Dept Radiat Oncol, Tilburg, Netherlands; Univ Utrecht Hosp, Dept Radiat Oncol, Utrecht, Netherlands; Radiotherapeut Inst Limburg, Dept Radiat Oncol, Heerlen, Netherlands; St Radboud Hosp, Joint Ctr Radiotherapy Arnhem Nijmegen, Dept Radiat Oncol, Nijmegen, Netherlands; Ctr Georges Francois Leclerc, Dept Radiat Oncol, Dijon, France; Inst Curie, Dept Radiat Oncol, Paris, France; Univ Hosp Gasthuisberg, Dept Radiat Oncol, B-3000 Louvain, Belgium; European Org Res Treatment Canc, Brussels, Belgium	Netherlands Cancer Institute; Instituut Verbeeten; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; UNICANCER; Centre Georges-Francois Leclerc; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; KU Leuven; University Hospital Leuven; European Organisation for Research & Treatment of Cancer	Bartelink, H (corresponding author), Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	h.bartelink@nki.nl	Poortmans, P.M.P./L-4581-2015	Collette, Laurence/0000-0003-2518-7281	NCI NIH HHS [5R10-CA11488, 5U10-CA11488-30] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA011488] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE O, 1995, NEW ENGL J MED, V333, P1444; Abe O, 1996, NEW ENGL J MED, V334, P1003; ALBAIN KS, 1994, MONOGR NATL CANC I, V16, P35; [Anonymous], 1993, 50 INT COMM RAD UN M; BARTELINK H, 1991, RADIOTHER ONCOL, V22, P323, DOI 10.1016/0167-8140(91)90172-D; Blichert-Toft M, 1992, J Natl Cancer Inst Monogr, P19; BORGER J, 1994, J CLIN ONCOL, V12, P653, DOI 10.1200/JCO.1994.12.4.653; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; Cox D. R., 1984, ANAL SURVIVAL DATA; Curran D, 1998, EUR J CANCER, V34, P307, DOI 10.1016/S0959-8049(97)00312-2; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; Elkhuizen PHM, 2000, J CLIN ONCOL, V18, P1075, DOI 10.1200/JCO.2000.18.5.1075; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; Forrest AP, 1996, LANCET, V348, P708, DOI 10.1016/S0140-6736(96)02133-2; HAMERS HP, 1991, RADIOTHER ONCOL, V22, P280, DOI 10.1016/0167-8140(91)90163-B; HEUKELOM S, 1991, RADIOTHER ONCOL, V22, P269, DOI 10.1016/0167-8140(91)90162-A; HOLMBERG L, 1990, J NATL CANCER I, V82, P277; Huang J, 2001, CANCER, V92, P172, DOI 10.1002/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K; *INT UN CANC, 1987, TNM CLASS MAL TUM, P95; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Romestaing P, 1997, J CLIN ONCOL, V15, P963, DOI 10.1200/JCO.1997.15.3.963; SARRAZIN D, 1989, RADIOTHER ONCOL, V14, P177, DOI 10.1016/0167-8140(89)90165-5; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; VANTIENHOVEN G, 1991, RADIOTHER ONCOL, V22, P290, DOI 10.1016/0167-8140(91)90165-D; VANTIENHOVEN G, 1992, RADIOTHER ONCOL S, V24, pS35; VERONESI U, 1995, EUR J CANCER, V31A, P1574, DOI 10.1016/0959-8049(95)00271-J; VERONESI U, 1993, NEW ENGL J MED, V328, P1587, DOI 10.1056/NEJM199306033282202; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Vrieling C, 1999, INT J RADIAT ONCOL, V45, P677, DOI 10.1016/S0360-3016(99)00211-4; Vrieling C, 2000, RADIOTHER ONCOL, V55, P219, DOI 10.1016/S0167-8140(00)00210-3; Whelan TJ, 1998, CAN MED ASSOC J, V158, pS35	36	671	708	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1378	1387		10.1056/NEJMoa010874	http://dx.doi.org/10.1056/NEJMoa010874			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794170	Bronze			2022-12-28	WOS:000172014200003
J	Kukushkin, IV; Smet, JH; von Klitzing, K; Wegscheider, W				Kukushkin, IV; Smet, JH; von Klitzing, K; Wegscheider, W			Cyclotron resonance of composite fermions	NATURE			English	Article							OSCILLATIONS	It is occasionally possible to interpret strongly interacting many-body systems within a single-particle framework by introducing suitable fictitious entities, or 'quasi-particles'. A notable recent example of the successful application of such an approach is for a two-dimensional electron system that is exposed to a strong perpendicular magnetic field. The conduction properties of the system are governed by electron-electron interactions, which cause the fractional quantum Hall effect(1). Composite fermions, electrons that are dressed with magnetic flux quanta pointing opposite to the applied magnetic field, were identified as apposite quasi-particles that simplify our understanding of the fractional quantum Hall effect(2,3). They precess, like electrons, along circular cyclotron orbits, but with a diameter determined by a reduced effective magnetic field(4-10). The frequency of their cyclotron motion has hitherto remained enigmatic, as the effective mass is no longer related to the band mass of the original electrons and is entirely generated from electron-electron interactions. Here we demonstrate enhanced absorption of a microwave field in the composite fermion regime, and interpret it as a resonance with the frequency of their circular motion. From this inferred cyclotron resonance, we derive a composite fermion effective mass that varies from 0.7 to 1.2 times that of the electron mass in vacuum as their density is tuned from 0.6 x 10(11) cm(-2) to 1.2 x 10(11) cm(-2).	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Russia; Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany; Univ Regensburg, Inst Expt & Angew Phys, D-93040 Regensburg, Germany	Max Planck Society; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; Technical University of Munich; University of Regensburg	Smet, JH (corresponding author), Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany.	jhsmet@klizix.mpi-stuttgart.mpg.de	Wegscheider, Werner H/D-1493-2010					ALLEN SJ, 1983, PHYS REV B, V28, P4875, DOI 10.1103/PhysRevB.28.4875; Das Sarma S., 1996, PERSPECTIVES QUANTUM; DU RR, 1993, PHYS REV LETT, V70, P2944, DOI 10.1103/PhysRevLett.70.2944; DU RR, 1995, PHYS REV LETT, V75, P3926, DOI 10.1103/PhysRevLett.75.3926; GOLDMAN VJ, 1994, PHYS REV LETT, V72, P2065, DOI 10.1103/PhysRevLett.72.2065; Gubarev SI, 2000, JETP LETT+, V72, P324, DOI 10.1134/1.1328448; HALPERIN BI, 1993, PHYS REV B, V47, P7312, DOI 10.1103/PhysRevB.47.7312; HEINOMEN O, 1998, COMPOSITE FERMIONS; Jain JK, 2007, COMPOSITE FERMIONS, P1; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Jain JK, 2000, PHYS TODAY, V53, P39, DOI 10.1063/1.883035; KOHN W, 1961, PHYS REV, V123, P1242, DOI 10.1103/PhysRev.123.1242; SHILTON JM, 1995, PHYS REV B, V51, P14770, DOI 10.1103/PhysRevB.51.14770; Smet JH, 1996, PHYS REV LETT, V77, P2272, DOI 10.1103/PhysRevLett.77.2272; Willet R., 1998, COMPOSITE FERMIONS, P349; WILLETT RL, 1993, PHYS REV LETT, V71, P3846, DOI 10.1103/PhysRevLett.71.3846	18	66	67	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					409	412		10.1038/415409a	http://dx.doi.org/10.1038/415409a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807549				2022-12-28	WOS:000173433600044
J	Moore, JP				Moore, JP			On the trail of two trials	NATURE			English	Editorial Material									Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.								0	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					365	366		10.1038/415365a	http://dx.doi.org/10.1038/415365a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807523				2022-12-28	WOS:000173433600020
J	Marx, SO; Kurokawa, J; Reiken, S; Motoike, H; D'Armiento, J; Marks, AR; Kass, RS				Marx, SO; Kurokawa, J; Reiken, S; Motoike, H; D'Armiento, J; Marks, AR; Kass, RS			Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; NMDA RECEPTOR; ION CHANNELS; K(V)LQT1; YOTIAO; HEART; FORM	Sympathetic nervous system (SNS) regulation of cardiac action potential duration (APD) is mediated by beta adrenergic receptor (betaAR) activation, which increases the stow outward potassium ion current (I-Ks). Mutations in two human I-Ks channel subunits, hKCNQ1 and hKCNE1, prolong APD and cause inherited cardiac arrhythmias known as LQTS (long QT syndrome). We show that PAR modulation of I-Ks requires targeting of adenosine 3',5'-monophosphate (cAMP)dependent protein kinase (PKA) and protein phosphatase 1 (PP1) to hKCNQ1 through the targeting protein yotiao. Yotiao binds to hKCNQ1 by a leucine zipper motif, which is disrupted by an LQTS mutation (hKCNQ1-G589D). Identification of the hKCNQ1 macromolecular complex provides a mechanism for SNS modulation of cardiac APD through I-Ks.	Columbia Univ Coll Phys & Surg, Dept Med, Ctr Mol Cardiol, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Ctr Mol Cardiol, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	rsk20@columbia.edu	Kurokawa, Junko/ABF-7557-2021; Kurokawa, Junko/Q-6287-2017	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908	NHLBI NIH HHS [R01-HL44365-07, R01-HL56810-05, P01HL67849-01, R01-HL61503, R01-HL56180, R01-HL68093] Funding Source: Medline; NIAID NIH HHS [R01-AI39794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, R01HL056180, R01HL056810, P01HL067849, R01HL068093, R01HL044365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An RH, 1999, J PHYSIOL-LONDON, V516, P19, DOI 10.1111/j.1469-7793.1999.019aa.x; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Feliciello A, 1999, FEBS LETT, V464, P174, DOI 10.1016/S0014-5793(99)01585-9; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; GULICK J, 1991, J BIOL CHEM, V266, P9180; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 2000, CARDIAC ELECTROPHYSI, pCH11; Lin JW, 1998, J NEUROSCI, V18, P2017; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MARX SO, UNPUB; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Paavonen KJ, 2001, HEART, V86, P39, DOI 10.1136/heart.86.1.39; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schwartz PJ, 2001, CIRCULATION, V103, P89; Scott JN, 2000, SCI AM, V282, P72, DOI 10.1038/scientificamerican0600-72; Towbin JA, 2001, DRUG METAB DISPOS, V29, P574; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069	20	545	576	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					496	499		10.1126/science.1066843	http://dx.doi.org/10.1126/science.1066843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799244				2022-12-28	WOS:000173350700050
J	Takasu, MA; Dalva, MB; Zigmond, RE; Greenberg, ME				Takasu, MA; Dalva, MB; Zigmond, RE; Greenberg, ME			Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors	SCIENCE			English	Article							D-ASPARTATE RECEPTOR; INCREASES TYROSINE PHOSPHORYLATION; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; CELL-CONTACT; SUBUNIT 2B; KINASES; ACTIVATION; GROWTH; SITES	Protein-protein interactions and calcium entry through the N-methyl-D-aspartate (NMDA)-type glutamate receptor regulate synaptic development and plasticity in the central nervous system. The EphB receptor tyrosine kinases are localized at excitatory synapses where they cluster and associate with NMDA receptors. We identified a mechanism whereby EphBs modulate NMDA receptor function. EphrinB2 activation of EphB in primary cortical neurons potentiates NMDA receptor-dependent influx of calcium. Treatment of cells with ephrinB2 led to NMDA receptor tyrosine phosphorylation through activation of the Src family of tyrosine kinases. These ephrinB2-dependent events result in enhanced NMDA receptor-dependent gene expression. Our findings indicate that ephrin-B2 stimulation of EphB modulates the functional consequences of NMDA receptor activation and suggest a mechanism whereby activity-independent and activity-dependent signals converge to regulate the development and remodeling of synaptic connections.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@tch.harvard.edu		Dalva, Matthew/0000-0002-7737-8787	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017512, R01NS012651, R01NS045500] Funding Source: NIH RePORTER; NCI NIH HHS [CA43855] Funding Source: Medline; NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS12651, R01 NS045500, NS17512] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DALVA MB, UNPUB; Di Luca M, 2001, NEUROREPORT, V12, P1301, DOI 10.1097/00001756-200105080-00049; Ellis C, 1996, ONCOGENE, V12, P1727; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; TAKASU MA, UNPUB; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; [No title captured]	32	389	410	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					491	495		10.1126/science.1065983	http://dx.doi.org/10.1126/science.1065983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799243				2022-12-28	WOS:000173350700049
J	Minokoshi, Y; Kim, YB; Peroni, OD; Fryer, LGD; Muller, C; Carling, D; Kahn, BB				Minokoshi, Y; Kim, YB; Peroni, OD; Fryer, LGD; Muller, C; Carling, D; Kahn, BB			Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase	NATURE			English	Article							INCREASES GLUCOSE-UPTAKE; SKELETAL-MUSCLE; INSULIN; COA; MECHANISM; OBESITY; STRESS; MICE	Leptin is a hormone secreted by adipocytes that plays a pivotal role in regulating food intake, energy expenditure and neuroendocrine function(1). Leptin stimulates the oxidation of fatty acids(2) and the uptake of glucose(3,4), and prevents the accumulation of lipids in nonadipose tissues, which can lead to functional impairments known as "lipotoxicity''(5). The signalling pathways that mediate the metabolic effects of leptin remain undefined. The 5'-AMP-activated protein kinase (AMPK) potently stimulates fatty-acid oxidation in muscle by inhibiting the activity of acetyl coenzyme A carboxylase (ACC)(6,7). AMPK is a heterotrimeric enzyme that is conserved from yeast to humans and functions as a 'fuel gauge' to monitor the status of cellular energy(6). Here we show that leptin selectively stimulates phosphorylation and activation of the alpha2 catalytic subunit of AMPK (alpha2 AMPK) in skeletal muscle, thus establishing a previously unknown signalling pathway for leptin. Early activation of AMPK occurs by leptin acting directly on muscle, whereas later activation depends on leptin functioning through the hypothalamic-sympathetic nervous system axis. In parallel with its activation of AMPK, leptin suppresses the activity of ACC, thereby stimulating the oxidation of fatty acids in muscle. Blocking AMPK activation inhibits the phosphorylation of ACC stimulated by leptin. Our data identify AMPK as a principal mediator of the effects of leptin on fatty-acid metabolism in muscle.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Cellular Stress Grp, London W12 0NN, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Imperial College London	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@caregroup.harvard.edu	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Minokoshi, Yasuhiko/0000-0002-7119-4805				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; AKAIKE N, 1981, SCIENCE, V213, P1252, DOI 10.1126/science.6267696; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Goodwin GW, 1999, AM J PHYSIOL-ENDOC M, V277, pE772, DOI 10.1152/ajpendo.1999.277.4.E772; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; MARTIN WH, 1990, AM J PHYSIOL, V259, pH1402, DOI 10.1152/ajpheart.1990.259.5.H1402; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Oakes ND, 1999, J LIPID RES, V40, P1155; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STAFFORD IL, 1990, J NEUROSCI, V10, P91; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4	29	1547	1636	3	160	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					339	343		10.1038/415339a	http://dx.doi.org/10.1038/415339a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797013				2022-12-28	WOS:000173293500048
J	Wilczek, F				Wilczek, F			Setting standards	NATURE			English	Editorial Material									MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wilczek, F (corresponding author), MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA.							Guth Alan, 1997, INFLATIONARY UNIVERS; WEINBERG S, 1992, DREAMS FINAL THEORY	3	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					265	265		10.1038/415265a	http://dx.doi.org/10.1038/415265a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796985	Bronze			2022-12-28	WOS:000173293500022
J	White, TW				White, TW			Unique and redundant connexin contributions to lens development	SCIENCE			English	Article							MOLECULAR-FEATURES; ALPHA(3) CONNEXIN; MICE; DIFFERENTIATION; EYE	Connexin genes encode intercellular channels that help to coordinate development. In mice, the targeted deletion of different connexins produces disparate effects on ocular growth and differentiation in the tens, and the need for multiple channel subunits is poorly understood. Knockout of Cx46 causes a loss of homeostasis and cataracts. Deletion of Cx50 results in reduced ocular growth and cataracts. Targeted replacement of Cx50 with Cx46 by genetic knock-in corrected defects in cellular differentiation and prevented cataracts, but did not restore normal growth. These data show that intrinsic properties of Cx50 were required for cellular growth, whereas nonspecific restoration of communication by Cx46 maintained differentiation.	SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	White, TW (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.		White, Thomas/GPG-4026-2022; White, Thomas W./R-3605-2019	White, Thomas/0000-0002-3285-7434; 	NEI NIH HHS [EY02430, EY13163] Funding Source: Medline; NIGMS NIH HHS [GM37751] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002430, R01EY013163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037751] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Hopperstad MG, 2000, BIOPHYS J, V79, P1954, DOI 10.1016/S0006-3495(00)76444-7; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Plum A, 2000, CURR BIOL, V10, P1083, DOI 10.1016/S0960-9822(00)00690-4; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; WHITE T, UNPUB; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2000, BRAIN RES REV, V32, P130, DOI 10.1016/S0165-0173(99)00072-7; Wride MA, 1996, DIFFERENTIATION, V61, P77, DOI 10.1046/j.1432-0436.1996.6120077.x	15	192	196	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					319	320		10.1126/science.1067582	http://dx.doi.org/10.1126/science.1067582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786642				2022-12-28	WOS:000173278600047
J	Borghi, L; Schianchi, T; Meschi, T; Guerra, A; Allegri, F; Maggiore, U; Novarini, A				Borghi, L; Schianchi, T; Meschi, T; Guerra, A; Allegri, F; Maggiore, U; Novarini, A			Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-INDUCED HYPERCALCIURIA; URINARY CALCIUM EXCRETION; KIDNEY-STONES; ANIMAL PROTEIN; NEPHROLITHIASIS; UROLITHIASIS; SODIUM; THIAZIDE; RISK; PROPHYLAXIS	Background A low-calcium diet is recommended to prevent recurrent stones in patients with idiopathic hypercalciuria, yet long-term data on the efficacy of a low-calcium diet are lacking. Recently, the efficacy of a low-calcium diet has been questioned, and greater emphasis has been placed on reducing the intake of animal protein and salt, but again, long-term data are unavailable. Methods We conducted a five-year randomized trial comparing the effect of two diets in 120 men with recurrent calcium oxalate stones and hypercalciuria. Sixty men were assigned to a diet containing a normal amount of calcium (30 mmol per day) but reduced amounts of animal protein (52 g per day) and salt (50 mmol of sodium chloride per day); the other 60 men were assigned to the traditional low-calcium diet, which contained 10 mmol of calcium per day. Results At five years, 12 of the 60 men on the normal-calcium, low-animal-protein, low-salt diet and 23 of the 60 men on the low-calcium diet had had relapses. The unadjusted relative risk of a recurrence for the group on the first diet, as compared with the group on the second diet, was 0.49 (95 percent confidence interval, 0.24 to 0.98; P=0.04). During follow-up, urinary calcium levels dropped significantly in both groups by approximately 170 mg per day (4.2 mmol per day). However, urinary oxalate excretion increased in the men on the low-calcium diet (by an average of 5.4 mg per day [60 mu mol per day]) but decreased in those on the normal-calcium, low-animal-protein, low-salt diet (by an average of 7.2 mg per day [80 mu mol per day]). Conclusions In men with recurrent calcium oxalate stones and hypercalciuria, restricted intake of animal protein and salt, combined with a normal calcium intake, provides greater protection than the traditional low-calcium diet. (N Engl J Med 2002;346:77-84.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Parma, Dept Clin Sci, I-43100 Parma, Italy; Univ Parma, Dept Internal Med & Nephrol, I-43100 Parma, Italy	University of Parma; University of Parma	Borghi, L (corresponding author), Univ Parma, Dept Clin Sci, Via Gramsci 14, I-43100 Parma, Italy.		Meschi, Tiziana/K-5032-2016	Meschi, Tiziana/0000-0002-7538-6863; Maggiore, Umberto/0000-0002-7468-9600				ALLEN LH, 1979, AM J CLIN NUTR, V32, P741, DOI 10.1093/ajcn/32.4.741; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; BORGHI L, 1990, BRIT J UROL, V65, P231, DOI 10.1111/j.1464-410X.1990.tb14716.x; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; BRESLAU NA, 1982, J CLIN ENDOCR METAB, V55, P369, DOI 10.1210/jcem-55-2-369; BRESLAU NA, 1988, J CLIN ENDOCR METAB, V66, P140, DOI 10.1210/jcem-66-1-140; BROADUS AE, 1984, NEW ENGL J MED, V311, P73, DOI 10.1056/NEJM198407123110201; BROCKS P, 1981, LANCET, V2, P124, DOI 10.1016/S0140-6736(81)90302-0; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; COE FL, 1977, JAMA-J AM MED ASSOC, V238, P1519, DOI 10.1001/jama.238.14.1519; COE FL, 1974, NEW ENGL J MED, V291, P1344; CONYERS RAJ, 1990, CLIN CHEM, V36, P1717; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; EPSTEIN FH, 1968, AM J MED, V45, P700, DOI 10.1016/0002-9343(68)90206-4; ETTINGER B, 1988, J UROLOGY, V139, P679, DOI 10.1016/S0022-5347(17)42599-7; ETTINGER B, 1976, AM J MED, V61, P200, DOI 10.1016/0002-9343(76)90170-4; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Hiatt RA, 1996, AM J EPIDEMIOL, V144, P25, DOI 10.1093/oxfordjournals.aje.a008851; KLEEMAN CR, 1964, P SOC EXP BIOL MED, V115, P29, DOI 10.3181/00379727-115-28821; LAERUM E, 1984, ACTA MED SCAND, V215, P383; LEMANN J, 1993, NEW ENGL J MED, V328, P880, DOI 10.1056/NEJM199303253281212; Lemann J, 1996, KIDNEY INT, V50, P341; LEMANN J, 1986, KIDNEY INT, V29, P743, DOI 10.1038/ki.1986.60; Lemann JJ, 1989, UROLITHIASIS, P435; LJUNGHALL S, 1984, BRIT J UROL, V56, P122, DOI 10.1111/j.1464-410X.1984.tb05346.x; MARSHALL RW, 1972, CLIN SCI, V43, P91, DOI 10.1042/cs0430091; MCCARRON DA, 1981, AM J NEPHROL, V1, P84, DOI 10.1159/000166496; MCCARRON DA, 1991, CONTRIB NEPHROL, V90, P2; MULDOWNEY FP, 1982, KIDNEY INT, V22, P292, DOI 10.1038/ki.1982.168; NAKADA T, 1988, EUR UROL, V15, P264; OHKAWA M, 1992, BRIT J UROL, V69, P571, DOI 10.1111/j.1464-410X.1992.tb15624.x; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; PARKS JH, 1994, KIDNEY INT, V45, P1722, DOI 10.1038/ki.1994.224; PHILLIPS MJ, 1967, LANCET, V1, P1354; ROBERTSON WG, 1979, CLIN SCI, V57, P285, DOI 10.1042/cs0570285; SCHOLZ D, 1982, J UROLOGY, V128, P903, DOI 10.1016/S0022-5347(17)53269-3; SILVER J, 1983, LANCET, V2, P484; STRAUSS AL, 1982, AM J MED, V72, P17, DOI 10.1016/0002-9343(82)90566-6; WILLIAMS R E, 1963, Br J Urol, V35, P416, DOI 10.1111/j.1464-410X.1963.tb11762.x; YENDT ER, 1978, KIDNEY INT, V13, P397, DOI 10.1038/ki.1978.58; ZAREMBSK.PM, 1969, CLIN CHIM ACTA, V25, P1, DOI 10.1016/0009-8981(69)90218-6; ZEMEL MB, 1981, J NUTR, V111, P545, DOI 10.1093/jn/111.3.545	45	580	611	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					77	84		10.1056/NEJMoa010369	http://dx.doi.org/10.1056/NEJMoa010369			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784873				2022-12-28	WOS:000173133400002
J	Nutman, TB; Kradin, RL; Scully, RE; Ryan, ET				Nutman, TB; Kradin, RL; Scully, RE; Ryan, ET			A 24-year-old woman with paresthesias and muscle cramps after a stay in Africa - Infection with Loa loa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EOSINOPHILIA-MYALGIA-SYNDROME; HYPEREOSINOPHILIC SYNDROME; BANCROFTIAN FILARIASIS; NONENDEMIC POPULATIONS; CLINICAL PRESENTATION; ANGIOEDEMA; DIETHYLCARBAMAZINE; ONCHOCERCIASIS; LOIASIS; MANIFESTATIONS		NIAID, Parasit Dis Lab, Helminth Immunol Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nutman, TB (corresponding author), NIAID, Parasit Dis Lab, Helminth Immunol Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000439, ZIAAI000439] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABERER W, 1988, J AM ACAD DERMATOL, V18, P105, DOI 10.1016/S0190-9622(88)70016-X; ADOLPH PE, 1962, AM J TROP MED HYG, V11, P76, DOI 10.4269/ajtmh.1962.11.76; BEAVER PC, 1981, AM J TROP MED HYG, V30, P625, DOI 10.4269/ajtmh.1981.30.625; CARME B, 1991, AM J TROP MED HYG, V44, P684, DOI 10.4269/ajtmh.1991.44.684; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GLEICH GJ, 1984, NEW ENGL J MED, V310, P1621, DOI 10.1056/NEJM198406213102501; GLICKMAN LT, 1981, EPIDEMIOL REV, V3, P230, DOI 10.1093/oxfordjournals.epirev.a036235; HERTZMAN PA, 1990, NEW ENGL J MED, V322, P869, DOI 10.1056/NEJM199003293221301; HSU SM, 1994, CRIT REV ONCOGENESIS, V5, P213, DOI 10.1615/CritRevOncog.v5.i2-3.60; KAUFMAN LD, 1991, RHEUM DIS CLIN N AM, V17, P427; KAZMIEROWSKI JA, 1978, ARCH DERMATOL, V114, P531, DOI 10.1001/archderm.114.4.531; KILBOURNE EM, 1991, J AM COLL CARDIOL, V18, P711, DOI 10.1016/0735-1097(91)90794-A; King Boyd G., 1944, AMER JOUR TROP MED, V24, P285; KLION AD, 1991, J INFECT DIS, V163, P1318, DOI 10.1093/infdis/163.6.1318; LEIFERMAN KM, 1995, SEMIN DERMATOL, V14, P122, DOI 10.1016/S1085-5629(05)80007-0; MAZZOTI L., 1948, REV INST SALUBRIDAD Y ENFERM TROP, V9, P235; MCAULEY JB, 1991, J INFECT DIS, V164, P1013, DOI 10.1093/infdis/164.5.1013; MCCARTHY JS, 1994, J INFECT DIS, V170, P736, DOI 10.1093/infdis/170.3.736; Moore TA, 1996, CLIN INFECT DIS, V23, P1007, DOI 10.1093/clinids/23.5.1007; Moore TA, 1998, INFECT DIS CLIN N AM, V12, P503, DOI 10.1016/S0891-5520(05)70016-7; MORE SJ, 1990, TROP MED PARASITOL, V41, P403; Nozais JP, 1997, B SOC PATHOL EXOT, V90, P335; NUTMAN TB, 1986, J INFECT DIS, V154, P10, DOI 10.1093/infdis/154.1.10; NUTMAN TB, 1988, NEW ENGL J MED, V319, P752, DOI 10.1056/NEJM198809223191204; RAKITA RM, 1993, CLIN INFECT DIS, V17, P691, DOI 10.1093/clinids/17.4.691; RAMACHANDRAN CP, 1993, PARASITOL TODAY, V9, P76; RUBIN RH, 1975, J INFECT DIS, V131, pS98, DOI 10.1093/infdis/131.Supplement.S98; RUSNAK JM, 1993, CLIN INFECT DIS, V16, P33, DOI 10.1093/clinids/16.1.33; SCHOFIELD F. D., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P588, DOI 10.1016/0035-9203(55)90033-X; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Skiest DJ, 1997, AM J MED, V102, P449, DOI 10.1016/S0002-9343(97)00048-X; VANDELLEN RG, 1985, JAMA-J AM MED ASSOC, V253, P1924, DOI 10.1001/jama.253.13.1924; WARTMAN WB, 1947, MEDICINE, V26, P333, DOI 10.1097/00005792-194712000-00001; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; WELLER P, 1995, CLIN IMMUNOLOGY PRIN, P1022; WELLER PF, 1994, BLOOD, V83, P2759, DOI 10.1182/blood.V83.10.2759.2759; WELLER PF, 1992, MED CLIN N AM, V76, P1413, DOI 10.1016/S0025-7125(16)30294-2; WILSON M, 1991, EOSINOPHILIA WORLD G, P164	39	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					115	122		10.1056/NEJMcpc010140	http://dx.doi.org/10.1056/NEJMcpc010140			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784879				2022-12-28	WOS:000173133400008
J	Coursin, DB; Wood, KE				Coursin, DB; Wood, KE			Corticosteroid supplementation for adrenal insufficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PNEUMOCYSTIS-CARINII-PNEUMONIA; RESPIRATORY-DISTRESS-SYNDROME; SPINAL-CORD-INJURY; SEPTIC SHOCK; ADJUNCTIVE THERAPY; CATECHOLAMINE DEPENDENCY; SEVERE SEPSIS; DOUBLE-BLIND; METHYLPREDNISOLONE; METAANALYSIS		Univ Wisconsin, Sch Med, Dept Anesthesiol, Madison, WI 53792 USA; Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Coursin, DB (corresponding author), Univ Wisconsin, Sch Med, Dept Anesthesiol, 600 Highland Ave,B6-319 Clin Sci Ctr, Madison, WI 53792 USA.	dcoursin@facstaff.wisc.edu						Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2000, CRIT CARE MED, V28, pA46; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; Bollaert PE, 2000, INTENS CARE MED, V26, P3, DOI 10.1007/s001340050002; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Carlet J, 1999, CRIT CARE MED, V27, P672, DOI 10.1097/00003246-199904000-00003; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; DIEDERICH S, 1994, DEUT MED WOCHENSCHR, V119, P595, DOI 10.1055/s-2008-1058735; DRUCKER D, 1985, CRIT CARE MED, V13, P477, DOI 10.1097/00003246-198506000-00007; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; FRASER CG, 1952, JAMA-J AM MED ASSOC, V149, P1542, DOI 10.1001/jama.1952.72930340001009; GAGNON S, 1990, NEW ENGL J MED, V323, P1444, DOI 10.1056/NEJM199011223232103; HENCH PS, 1950, JAMA-J AM MED ASSOC, V144, P1327, DOI 10.1001/jama.1950.02920160001001; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; LAROCHELLE GE, 1993, AM J MED, V95, P258, DOI 10.1016/0002-9343(93)90277-V; *LAT STER RESC STU, 2001, ARDS NETW WEB SIT; LEFERING R, 1995, CRIT CARE MED, V23, P1294, DOI 10.1097/00003246-199507000-00021; LEWIS L, 1953, ANN INTERN MED, V39, P116, DOI 10.7326/0003-4819-39-1-116; MACFADDEN DK, 1987, LANCET, V1, P1477, DOI 10.1016/S0140-6736(87)92219-7; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Meduri GU, 1998, CHEST, V114, P355, DOI 10.1378/chest.114.2.355-a; Meduri GU, 1998, CRIT CARE MED, V26, P630, DOI 10.1097/00003246-199804000-00003; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Meduri GU, 1999, CHEST, V116, p116S, DOI 10.1378/chest.116.suppl_1.116S; Nieboer P, 2000, INTENS CARE MED, V26, P125, DOI 10.1007/s001340050024; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Oelkers W, 1998, EUR J ENDOCRINOL, V139, P567, DOI 10.1530/eje.0.1390567; ORTH DN, 1998, WILLIAMS TXB ENDOCRI, P517; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; Richards ML, 1999, SURGERY, V125, P431, DOI 10.1016/S0039-6060(99)70011-5; Rivers EP, 2001, CHEST, V119, P889, DOI 10.1378/chest.119.3.889; SAITO T, 1995, INTENS CARE MED, V21, P204, DOI 10.1007/BF01701473; SALEM M, 1994, ANN SURG, V219, P416, DOI 10.1097/00000658-199404000-00013; Schroeder S, 2001, CRIT CARE MED, V29, P310, DOI 10.1097/00003246-200102000-00017; Shenker Y, 2001, AM J RESP CRIT CARE, V163, P1520, DOI 10.1164/ajrccm.163.7.2012022; STRECK WF, 1979, AM J MED, V66, P910, DOI 10.1016/0002-9343(79)90444-3; WILLIAMS GH, 1998, HARRISONS PRINCIPLES, P2055; Zaloga GP, 2001, SURGICAL INTENSIVE CARE MEDICINE, P547; Zaloga GP, 2001, CRIT CARE CLIN, V17, P25, DOI 10.1016/S0749-0704(05)70150-0	46	121	131	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					236	240		10.1001/jama.287.2.236	http://dx.doi.org/10.1001/jama.287.2.236			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779267				2022-12-28	WOS:000173114900027
J	Ranson, NA; Farr, GW; Roseman, AM; Gowen, B; Fenton, WA; Horwich, AL; Saibil, HR				Ranson, NA; Farr, GW; Roseman, AM; Gowen, B; Fenton, WA; Horwich, AL; Saibil, HR			ATP-bound states of GroEL captured by cryo-electron microscopy	CELL			English	Article							OLIGOMERIC CHAPERONIN GROEL; CRYSTAL-STRUCTURE; CRYOELECTRON MICROSCOPY; ESCHERICHIA-COLI; KINETIC-ANALYSIS; PROTEIN; BINDING; CYCLE; MECHANISM; POLYPEPTIDE	The chaperonin GroEL drives its protein-folding cycle by cooperatively binding ATP to one of its two rings, priming that ring to become folding-active upon GroES binding, while simultaneously discharging the previous folding chamber from the opposite ring. The GroEL-ATP structure, determined by cryo-EM and atomic structure fitting, shows that the intermediate domains rotate downward, switching their intersubunit salt bridge contacts from substrate binding to ATP binding domains. These observations, together with the effects of ATP binding to a GroEL-GroES-ADP complex, suggest structural models for the ATP-induced reduction in affinity for polypeptide and for cooperativity. The model for cooperativity, based on switching of intersubunit salt bridge interactions around the GroEL ring, may provide general insight into cooperativity in other ring complexes and molecular machines.	Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University of London; Birkbeck University London; Imperial College London; Howard Hughes Medical Institute; Yale University; Yale University	Ranson, NA (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.		Roseman, Alan/AAE-6689-2019	Roseman, Alan/0000-0002-4783-2619; Ranson, Neil/0000-0002-3640-5275				Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Roseman AM, 2001, J STRUCT BIOL, V135, P115, DOI 10.1006/jsbi.2001.4374; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; STANIFORTH RA, 1994, BIOCHEM J, V300, P651, DOI 10.1042/bj3000651; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; White HE, 1997, NAT STRUCT BIOL, V4, P690, DOI 10.1038/nsb0997-690; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 1998, J AM CHEM SOC, V120, P13262, DOI 10.1021/ja983136u	46	233	234	2	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					869	879		10.1016/S0092-8674(01)00617-1	http://dx.doi.org/10.1016/S0092-8674(01)00617-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779463	Bronze			2022-12-28	WOS:000173024200008
J	Vallance, P				Vallance, P			Importance of asymmetrical dimethylarginine in cardiovascular risk	LANCET			English	Editorial Material							NITRIC-OXIDE SYNTHESIS; METHYLARGININES; IDENTIFICATION; ACCUMULATION; INHIBITORS; ARGININE		UCL, Dept Med, Ctr Clin Pharmacol & Therapeut, London WC1E 6JJ, England	University of London; University College London	Vallance, P (corresponding author), UCL, Dept Med, Ctr Clin Pharmacol & Therapeut, London WC1E 6JJ, England.	rmhapav@ucl.ac.uk						AZUMA H, 1995, BRIT J PHARMACOL, V115, P1001, DOI 10.1111/j.1476-5381.1995.tb15910.x; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; VALLANCE P, 1992, LANCET, V339, P572	8	86	88	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2096	2097		10.1016/S0140-6736(01)07229-4	http://dx.doi.org/10.1016/S0140-6736(01)07229-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784617				2022-12-28	WOS:000172905800002
J	Ando, J; Shibata, Y; Okajima, Y; Kanagawa, K; Furusho, M; Tomioka, N				Ando, J; Shibata, Y; Okajima, Y; Kanagawa, K; Furusho, M; Tomioka, N			Striped iron zoning of olivine induced by dislocation creep in deformed peridotites	NATURE			English	Article							DEEP-FOCUS EARTHQUAKES; SYSTEM MG2SIO4-FE2SIO4; MODIFIED SPINEL; TRANSFORMATION; LITHOSPHERE; MECHANISM; STRESS	Deformation of solid materials affects not only their microstructures, but also their microchemistries(1-5). Although chemical unmixing of initially homogeneous multicomponent solids is known to occur during deformation by diffusion creep(4,5), there has been no report on their chemical zoning due to deformation by dislocation creep, in either natural samples or laboratory experiments. Here we report striped iron zoning of olivine ((Mg,Fe)(2)SiO4) in deformed peridotites, where the iron concentration increases at subgrain boundaries composed of edge dislocations. We infer that this zoning is probably formed by alignment of edge dislocations dragging a so-called Cottrell 'atmosphere' of solute atoms(3,6,7) (iron in this case) into subgrain boundaries during deformation of the olivine by dislocation creep. We have found that the iron zoning does not develop in laboratory experiments of high strain rates where dislocations move too fast to drag the Cottrell atmosphere. This phenomenon might have important implications for the generation of deep-focus earthquakes, as transformation of olivine to high-pressure phases preferentially occurs in high-iron regions, and therefore along subgrain boundaries which would be preferentially aligned in plastically deformed mantle peridotites.	Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; Chiba Univ, Dept Earth Sci, Chiba 2638522, Japan; OYO Corp, Hyogo Ku, Kobe, Hyogo 6520807, Japan; Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan	Hiroshima University; Chiba University; OYO Corporation; Kobe University	Ando, J (corresponding author), Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan.		Tomioka, Naotaka/AID-3472-2022; Tomioka, Naotaka/B-1888-2011	Tomioka, Naotaka/0000-0001-5725-9513				AKAOGI M, 1989, J GEOPHYS RES-SOLID, V94, P15671, DOI 10.1029/JB094iB11p15671; BANFIELD JF, 1992, AM MINERAL, V77, P977; Ben Ismail W, 1998, TECTONOPHYSICS, V296, P145; Blavette D, 1999, SCIENCE, V286, P2317, DOI 10.1126/science.286.5448.2317; BURNLEY PC, 1991, J GEOPHYS RES-SOLID, V96, P425, DOI 10.1029/90JB01937; CARTER NL, 1970, GEOL SOC AM BULL, V81, P2181, DOI 10.1130/0016-7606(1970)81[2181:HTFODA]2.0.CO;2; Cottrell A.H., 1948, REPORT STRENGTH SOLI, P30; DIMOS D, 1988, ACTA METALL MATER, V36, P1543, DOI 10.1016/0001-6160(88)90222-2; Furusho M, 1999, TECTONOPHYSICS, V313, P411, DOI 10.1016/S0040-1951(99)00215-2; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; GREEN HW, 1980, PHILOS MAG A, V41, P637, DOI 10.1080/01418618008239339; IIDAKA T, 1994, SCIENCE, V263, P1116, DOI 10.1126/science.263.5150.1116; ITO E, 1992, HIGH PRESSURE RES AP, P257; KARATO S, 1987, PHYS CHEM MINER, V14, P245, DOI 10.1007/BF00307989; KATSURA T, 1989, J GEOPHYS RES-SOLID, V94, P15663, DOI 10.1029/JB094iB11p15663; KAWASAKI T, 1994, AM MINERAL, V79, P461; Kerschhofer L, 2000, PHYS EARTH PLANET IN, V121, P59, DOI 10.1016/S0031-9201(00)00160-6; KIRBY SH, 1991, SCIENCE, V252, P216, DOI 10.1126/science.252.5003.216; KIRBY SH, 1987, J GEOPHYS RES-SOLID, V92, P13789, DOI 10.1029/JB092iB13p13789; Kirby SH, 1996, REV GEOPHYS, V34, P261, DOI 10.1029/96RG01050; KITAMURA M, 1986, P JPN ACAD B-PHYS, V62, P149, DOI 10.2183/pjab.62.149; KOHLSTEDT DL, 1976, SCIENCE, V191, P1045, DOI 10.1126/science.191.4231.1045; LI JCM, 1971, ACTA METALL MATER, V19, P749, DOI 10.1016/0001-6160(71)90130-1; MCGUIRE AV, 1991, CONTRIB MINERAL PETR, V109, P252, DOI 10.1007/BF00306483; OZAWA K, 1989, NATURE, V338, P141, DOI 10.1038/338141a0; Ozawa K., 1986, JOUR FS U TOKYO, V21, P115; Poirier J. P., 1981, ANELASTICITY EARTH, V4, P113; POIRIER JP, 1985, CREEP CRYSTALS, P62; TINGLE TN, 1993, J STRUCT GEOL, V15, P1249, DOI 10.1016/0191-8141(93)90167-9; YOSHINAGA H, 1989, RHEOLOGY SOLIDS EART, P29	30	31	33	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					893	895		10.1038/414893a	http://dx.doi.org/10.1038/414893a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780058				2022-12-28	WOS:000172813300041
J	Barsky, AJ				Barsky, AJ			The patient with hypochondriasis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COGNITIVE-BEHAVIORAL TREATMENT; PSYCHIATRIC-CONSULTATION; SOMATIZATION DISORDER; SYMPTOM SYNDROMES; CONTROLLED TRIAL; PANIC DISORDER; OUTCOMES; THERAPY; COMPLAINTS; COSTS		Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Barsky, AJ (corresponding author), Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA.							BARSKY AJ, 1991, ARCH INTERN MED, V151, P84, DOI 10.1001/archinte.151.1.84; Barsky AJ, 1997, JAMA-J AM MED ASSOC, V278, P673, DOI 10.1001/jama.278.8.673; BARSKY AJ, 1992, ARCH GEN PSYCHIAT, V49, P101; Barsky AJ, 1999, PSYCHOSOMATICS, V40, P396, DOI 10.1016/S0033-3182(99)71204-1; BARSKY AJ, 1991, J GEN INTERN MED, V6, P413, DOI 10.1007/BF02598162; Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; Escobar JI, 1998, GEN HOSP PSYCHIAT, V20, P155, DOI 10.1016/S0163-8343(98)00018-8; Fallon BA, 1996, PSYCHOPHARMACOL BULL, V32, P607; FERGUSON JM, 1993, PSYCHIAT ANN, P20; FORD CV, 1983, SOMATIZING DISORDERS; HELLMAN CJC, 1990, BEHAV MED, V16, P165, DOI 10.1080/08964289.1990.9934605; Keeley R, 2000, ARCH FAM MED, V9, P46, DOI 10.1001/archfami.9.1.46; Kellner R., 1986, SOMATIZATION HYPOCHO; Kroenke K, 1994, Arch Fam Med, V3, P774; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; Lidbeck J, 1997, ACTA PSYCHIAT SCAND, V96, P14, DOI 10.1111/j.1600-0447.1997.tb09899.x; Lucock MP, 1997, BRIT MED J, V315, P572; Mayou R, 1995, TREATMENT FUNCTIONAL; MCNAIR DM, 1970, ARCH GEN PSYCHIAT, V22, P128; NOYES R, 1986, BRIT J PSYCHIAT, V149, P631, DOI 10.1192/bjp.149.5.631; Noyes R Jr, 1995, Arch Fam Med, V4, P790, DOI 10.1001/archfami.4.9.790; O'Malley PG, 1999, J FAM PRACTICE, V48, P980; POTTS SG, 1993, Q J MED, V86, P583; ROST K, 1994, GEN HOSP PSYCHIAT, V16, P381, DOI 10.1016/0163-8343(94)90113-9; Sharpe M, 1995, TREATMENT OF FUNCTIONAL SOMATIC SYMPTOMS, P122; Shinoda N, 1999, COMPR PSYCHIAT, V40, P39, DOI 10.1016/S0010-440X(99)90075-5; Simon G E, 1992, Psychiatr Med, V10, P49; SMITH GR, 1986, NEW ENGL J MED, V314, P1407, DOI 10.1056/NEJM198605293142203; SMITH GR, 1995, ARCH GEN PSYCHIAT, V52, P238; Starcevic V., 2001, HYPOCHONDRIASIS MODE, P89; STERN R, 1991, BRIT MED J, V303, P1229, DOI 10.1136/bmj.303.6812.1229; Warwick HMC, 1996, BRIT J PSYCHIAT, V169, P189, DOI 10.1192/bjp.169.2.189; Weber BE, 1996, AM J MED, V100, P138, DOI 10.1016/S0002-9343(97)89451-X; Weber BE, 1997, AM J MED, V103, P86; WILSON L, 1994, PAIN, V57, P55, DOI 10.1016/0304-3959(94)90107-4	35	38	43	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1395	1399		10.1056/NEJMcp002896	http://dx.doi.org/10.1056/NEJMcp002896			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489VY	11794173				2022-12-28	WOS:000172014200006
J	Brundtland, GH				Brundtland, GH			The war against disease - Investing in health, investing in our common future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Brundtland, GH (corresponding author), WHO, CH-1211 Geneva, Switzerland.								0	5	5	5	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					444	444		10.1001/jama.287.4.444	http://dx.doi.org/10.1001/jama.287.4.444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798352				2022-12-28	WOS:000173401900006
J	Grant, J				Grant, J			Learning needs assessment: assessing the need	BRITISH MEDICAL JOURNAL			English	Article									Open Univ, Ctr Educ Med, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Grant, J (corresponding author), Open Univ, Ctr Educ Med, Milton Keynes MK7 6AA, Bucks, England.							Aeschlimann A, 2001, ANN RHEUM DIS, V60, P740, DOI 10.1136/ard.60.8.740; BATSTONE G, 1996, TXB MANAGEMENT DOCTO, P341; Campbell C, 1999, ACAD MED, V74, pS34, DOI 10.1097/00001888-199910000-00033; *DEP HLTH, 1997, CM3807; *DEP HLTH, 1998, 1 CLASS SERV QUAL NE; Department of Health, 1989, CM555; Eve R., 2000, ED GEN PRACT, V11, P73; Gillam S.J., 1996, 73 ROYAL COLL GEN PR; Glazebrook R, 2001, J Contin Educ Health Prof, V21, P140, DOI 10.1002/chp.1340210304; GRANT J, 2000, EFFECTIVENESS CONTIN; Grant JCE., 1999, GOOD CPD GUIDE; JULY B, 1997, GOOD ASSESSMENT GUID; Knowles M.S., 1975, SELF DIRECTED LEARNI; KNOWLES MS, 1986, USING LEARNING CONTR; Knowles N., 1990, ADULT LEARNER NEGLEC; Kolb D., 1979, ORG PSYCHOL EXPT APP; Lockyer J., 1998, J CONTIN EDUC HEALTH, V18, P190; MACDONALD MM, 1998, THESIS OPEN U MILTON; McClaren J., 1998, J CONTIN EDUC HEALTH, V18, P107, DOI [10.1002/chp.1340180207, DOI 10.1002/CHP.1340180207]; Moore DE., 1998, J CONTIN EDUC HEALTH, V18, P133, DOI [10.1002/chp.1340180302, DOI 10.1002/CHP.1340180302]; Myers P, 1999, BRIT J GEN PRACT, V49, P303; PAGET NS, 1996, J CONTINUING ED HLTH, V16, P103; PARBOOSINGH IJT, 1993, ANN R COLL PHYSICIAN, V26, P512; PRINGLE M, 2000, CLIN GOVERNANCE PRIM, P105; Pyatt R S, 1997, J CONTIN EDUC HEALTH, V17, P239; RAMSEY PG, 1989, ANN INTERN MED, V110, P719, DOI 10.7326/0003-4819-110-9-719; Schon D.A., 1987, ED REFLECTIVE PRACTI; Stufflebeam D., 1985, CONDUCTING ED NEEDS; [No title captured]	29	190	193	4	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					156	159		10.1136/bmj.324.7330.156	http://dx.doi.org/10.1136/bmj.324.7330.156			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799035	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000173470600022
J	Thisse, C; Zon, LI				Thisse, C; Zon, LI			Development - Organogenesis - Heart and wood formation from the zebrafish point of view	SCIENCE			English	Review							PRIMORDIAL GERM-CELLS; MUTATIONS AFFECTING DEVELOPMENT; DORSOVENTRAL PATTERN-FORMATION; BRANCHIAL ARCH MUTANTS; EMBRYONIC STEM-CELLS; MYOSIN HEAVY-CHAINS; DANIO-RERIO; INSERTIONAL MUTAGENESIS; CARDIOVASCULAR-SYSTEM; RETINITIS-PIGMENTOSA	Organs are specialized tissues used for enhanced physiology and environmental adaptation. The cells of the embryo are genetically programmed to establish organ form and function through conserved developmental modules. The zebrafish is a powerful model system that is poised to contribute to our basic understanding of vertebrate organogenesis. This review develops the theme of modules and illustrates how zebrafish have been particularly useful for understanding heart and blood formation.	Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France; Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Thisse, C (corresponding author), Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, INSERM, 1 Rue Laurent Fries,BP 163, F-67404 Illkirch Graffenstaden, France.			THISSE, Christine/0000-0002-8684-1681	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, P50DK049216] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL-48801] Funding Source: Medline; NIDDK NIH HHS [DK49216] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Amatruda JF, 1999, DEV BIOL, V216, P1, DOI 10.1006/dbio.1999.9462; AMSTERDAM A, 1995, DEV BIOL, V171, P123, DOI 10.1006/dbio.1995.1265; Baier H, 1996, DEVELOPMENT, V123, P415; Becker TS, 1998, DEVELOPMENT, V125, P4369; BEDDINGTON RSP, 1993, CURR OPIN GENET DEV, V3, P655, DOI 10.1016/0959-437X(93)90103-V; BODMER R, 1993, DEVELOPMENT, V118, P719; Brockerhoff SE, 1997, J NEUROSCI, V17, P4236; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Chen JN, 1996, DEVELOPMENT, V123, P293; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chen JN, 1996, DEVELOPMENT, V122, P3809; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Choi K, 1998, DEVELOPMENT, V125, P725; Connors SA, 1999, DEVELOPMENT, V126, P3119; Davidson AJ, 2000, CURR TOP DEV BIOL, V50, P45, DOI 10.1016/S0070-2153(00)50003-9; DEROBERTIS EM, 1991, DEVELOPMENT, V112, P669; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Dick A, 2000, DEVELOPMENT, V127, P343; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DONOVAN A, 2001, UNPUB; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Dudley AT, 1997, DEV DYNAM, V208, P349; Ferrucci S, 1998, OPTOMETRY VISION SCI, V75, P560, DOI 10.1097/00006324-199808000-00021; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; FISHER S, UNPUB; Fishman MC, 1997, CELL, V91, P153, DOI 10.1016/S0092-8674(00)80397-9; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Haffter P, 1996, DEVELOPMENT, V123, P1; Hidaka M, 1999, P NATL ACAD SCI USA, V96, P7370, DOI 10.1073/pnas.96.13.7370; Hild M, 1999, DEVELOPMENT, V126, P2149; His W, 1900, ABHANDL KS GES WISS, V22, P171; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Huxley J.S., 1934, ELEMENTS EXPT EMBRYO; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Ivics Z, 1997, BIOTECHNIQUES, V22, P254, DOI 10.2144/97222bm12; IZSVAK Z, 1995, MOL GEN GENET, V247, P312, DOI 10.1007/BF00293199; JOHNSON SL, 1995, DEV BIOL, V167, P27, DOI 10.1006/dbio.1995.1004; Karlstrom RO, 1997, TRENDS NEUROSCI, V20, P3, DOI 10.1016/S0166-2236(96)40005-4; Kawakami K, 2000, CURR BIOL, V10, P463, DOI 10.1016/S0960-9822(00)00444-9; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kikuchi Y, 2000, GENE DEV, V14, P1279; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lam WL, 1996, P NATL ACAD SCI USA, V93, P10870, DOI 10.1073/pnas.93.20.10870; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao EC, 2000, DEVELOPMENT, V127, P5123; Liao W, 1997, DEVELOPMENT, V124, P381; LIEM KF, 1988, AM ZOOL, V28, P739; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Long QM, 1997, DEVELOPMENT, V124, P4105; Malicki J, 1996, DEVELOPMENT, V123, P263; Malicki Jarema, 2000, Results and Problems in Cell Differentiation, V31, P257; Miller CT, 2000, DEVELOPMENT, V127, P3815; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Pack M, 1996, DEVELOPMENT, V123, P321; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Porcher C, 1999, DEVELOPMENT, V126, P4603; Ransom DG, 1996, DEVELOPMENT, V123, P311; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Reiter JF, 2001, DEVELOPMENT, V128, P125; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; RUSHBROOK JI, 1979, P NATL ACAD SCI USA, V76, P4331, DOI 10.1073/pnas.76.9.4331; Schilling TF, 1996, DEVELOPMENT, V123, P329; Schmid B, 2000, DEVELOPMENT, V127, P957; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; SEDDON J, 1994, PRINCIPLES PRACTICE; Serbedzija GN, 1998, DEVELOPMENT, V125, P1095; Serluca FC, 1999, METHOD CELL BIOL, V59, P359; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SPEMANN H, 1921, W ROUX ARCH ENTW MEC, V48, P533, DOI DOI 10.1007/BF02554578; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; STAMATOYANNOPOULOS G, 1987, DEV BIOL, V123, P191, DOI 10.1016/0012-1606(87)90441-6; THISSE B, COMMUNICATION; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Traboulsi E I, 1998, J AAPOS, V2, P317, DOI 10.1016/S1091-8531(98)90024-6; UMEDA PK, 1983, J BIOL CHEM, V258, P5206; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Warga RM, 1999, DEVELOPMENT, V126, P827; Weidinger G, 1999, DEVELOPMENT, V126, P5295; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; YAGASAKI K, 1989, ARCH OPHTHALMOL-CHIC, V107, P701, DOI 10.1001/archopht.1989.01070010719034; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang X, 1999, DEVELOPMENT, V126, P1571; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; ZON LI, 1995, BLOOD, V86, P2876	117	178	194	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					457	462		10.1126/science.1063654	http://dx.doi.org/10.1126/science.1063654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799232				2022-12-28	WOS:000173350700038
J	Annas, GJ				Annas, GJ			Medical privacy and medical research - Judging the new federal regulations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Annas, George/0000-0001-5836-7831				Annas GJ, 2001, JAMA-J AM MED ASSOC, V286, P2326, DOI 10.1001/jama.286.18.2326; BARNES M, 2001, BNAS HLTH LAW R 0628, P1026; *BIOT IND ORG, 2000, COMM PROP STAND PRIV; Kaiser J, 2001, SCIENCE, V294, P2070, DOI 10.1126/science.294.5549.2070; Kulynych J, 2002, NEW ENGL J MED, V346, P201, DOI 10.1056/NEJM200201173460312; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; *NAT RES COUNC, 1997, REC PROT EL HLTH INF; National Bioethics Advisory Commission, 2001, ETH POL ISS RES INV; Office of Civil Rights U. S. Departmrnt of Health and Human Services, 2000, FED REGISTER, V65, P82462; PEAR R, 2000, NY TIMES        1224, pD2; *PHOEN HLTH SYST, 2001, RES PRIV RUL CREAT O; SIEGLER M, 1982, NEW ENGL J MED, V307, P1518, DOI 10.1056/NEJM198212093072411; SOUTHWICK R, 2001, CHRONICLE HIGHE 0427, P31; Welch CA, 2001, NEW ENGL J MED, V345, P371, DOI 10.1056/NEJM200108023450512; YAWN B, 1997, NAT CTR HLTH STAT C	15	48	49	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					216	220		10.1056/NEJM200201173460320	http://dx.doi.org/10.1056/NEJM200201173460320			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796863	Green Published			2022-12-28	WOS:000173273600027
J	Goldfarb, DJ; Glasser, BJ; Shinbrot, T				Goldfarb, DJ; Glasser, BJ; Shinbrot, T			Shear instabilities in granular flows	NATURE			English	Article							STRESS FLUCTUATIONS; DYNAMICS; MOTION	Unstable waves have been long studied in fluid shear layers(1-3). These waves affect transport in the atmosphere and oceans, in addition to slipstream stability behind ships, aeroplanes and heat-transfer devices. Corresponding instabilities in granular flows have not been previously documented 4, despite the importance of these flows in geophysical and industrial systems(5-7). Here we report that breaking waves can form at the interface between two streams of identical grains flowing on an inclined plane downstream of a splitter plate. Changes in either the shear rate or the angle of incline cause such waves to appear abruptly. We analyse a granular flow model that agrees qualitatively with our experimental data; the model suggests that the waves result from competition between shear and extensional strains in the flowing granular bed. We propose a dimensionless shear number that governs the transition between steady and wavy flows.	Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Glasser, BJ (corresponding author), Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA.	bglasser@sol.rutgers.edu						Aider JL, 1999, PHYS REV E, V59, P778, DOI 10.1103/PhysRevE.59.778; BAGNOLD RA, 2001, P ROY SOC LOND A MAT, V157, P594; CHAN K, 2001, PHYS REV E; Chandrasekhar S, 2013, HYDRODYNAMIC HYDROMA; Chen Y Y, 2010, HYDRODYNAMICS, V42, P1; Davies CE, 1999, POWDER TECHNOL, V106, P1, DOI 10.1016/S0032-5910(99)00038-8; Denlinger RP, 2001, J GEOPHYS RES-SOL EA, V106, P553, DOI 10.1029/2000JB900330; Forterre Y, 2001, PHYS REV LETT, V86, P5886, DOI 10.1103/PhysRevLett86.5886; Goddard JD, 1999, PARTICUL SCI TECHNOL, V17, P69, DOI 10.1080/02726359908906806; Hanes DM, 2000, POWDER TECHNOL, V109, P133, DOI 10.1016/S0032-5910(99)00232-6; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Iverson RM, 1997, REV GEOPHYS, V35, P245, DOI 10.1029/97RG00426; JOHNSON PC, 1990, J FLUID MECH, V210, P501, DOI 10.1017/S0022112090001380; Kadanoff LP, 1999, REV MOD PHYS, V71, P435, DOI 10.1103/RevModPhys.71.435; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Losert W, 2000, PHYS REV LETT, V85, P1428, DOI 10.1103/PhysRevLett.85.1428; Louge MY, 2001, PHYS FLUIDS, V13, P1213, DOI 10.1063/1.1358870; Lueptow RM, 2000, EXP FLUIDS, V28, P183, DOI 10.1007/s003480050023; Melosh HJ, 1996, NATURE, V379, P601, DOI 10.1038/379601a0; Menon N, 1997, SCIENCE, V275, P1920, DOI 10.1126/science.275.5308.1920; Mueth DM, 2000, NATURE, V406, P385, DOI 10.1038/35019032; Natarajan VVR, 1995, J FLUID MECH, V304, P1, DOI 10.1017/S0022112095004320; Pouliquen O, 1996, PHYS REV E, V53, P552, DOI 10.1103/PhysRevE.53.552; Pouliquen O, 1997, NATURE, V386, P816, DOI 10.1038/386816a0; Rericha EC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.014302; SAVAGE SB, 1989, J FLUID MECH, V199, P177, DOI 10.1017/S0022112089000340; Scott DR, 1996, NATURE, V381, P592, DOI 10.1038/381592a0; Shinbrot T, 2000, PHYS TODAY, V53, P25, DOI 10.1063/1.883018; THORPE SA, 1969, J FLUID MECH, V39, P25, DOI 10.1017/S0022112069002023; Wang CH, 1997, J FLUID MECH, V342, P179, DOI 10.1017/S0022112097005648	30	52	53	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					302	305		10.1038/415302a	http://dx.doi.org/10.1038/415302a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797003				2022-12-28	WOS:000173293500038
J	Hyde, PS; Knudsen, EI				Hyde, PS; Knudsen, EI			The optic tectum controls visually guided adaptive plasticity in the owl's auditory space map	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; FREQUENCY-SPECIFIC ADJUSTMENTS; SUPERIOR COLLICULAR MAP; BARN OWL; INFERIOR COLLICULUS; NEURAL REPRESENTATION; LOCALIZATION CUES; GUINEA-PIG; CALIBRATION; DEPRIVATION	The midbrain contains an auditory map of space that is shaped by visual experience(1-3). When barn owls are raised wearing spectacles that horizontally displace the visual field, the auditory space map in the external nucleus of the inferior colliculus (ICX) shifts according to the optical displacement of the prisms(4). Topographic visual activity in the optic tectum could serve as the template that instructs the auditory space map(5). We studied the effects of a restricted, unilateral lesion in the portion of the optic tectum that represents frontal space. Here we show that such a lesion eliminates adaptive adjustments specifically in the portion of the auditory map that represents frontal space on the same side of the brain, while the rest of the map continues to adjust adaptively. Thus, activity in the tectum calibrates the auditory space map in a location-specific manner. Because the site of adaptive changes is the ICX4,6,7, the results also indicate that the tectum provides a topographic instructive signal that controls adaptive auditory plasticity in the ICX.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.							Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Feldman DE, 1997, J NEUROSCI, V17, P6820; Gold JI, 2000, J NEUROSCI, V20, P3469, DOI 10.1523/JNEUROSCI.20-09-03469.2000; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; HYDE PS, IN PRESS J NEUROSCI; KING AJ, 1993, EXP BRAIN RES, V94, P444; KING AJ, 1993, EXP PHYSIOL, V78, P559, DOI 10.1113/expphysiol.1993.sp003708; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; KNUDSEN EI, 1983, J COMP NEUROL, V218, P187, DOI 10.1002/cne.902180206; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; KNUDSEN EI, 1992, J NEUROSCI, V12, P3485; LUSCH H, 2000, J NEUROSCI, V20, P1; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; Stein BE., 1993, MERGING SENSES; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P682, DOI 10.1111/j.1460-9568.1990.tb00458.x; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	30	45	45	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					73	76		10.1038/415073a	http://dx.doi.org/10.1038/415073a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780119				2022-12-28	WOS:000173028800042
J	Richardson, R				Richardson, R			Coroner Wakley: two remarkable eyewitness accounts	LANCET			English	Article									Lancet, London WC1X 8RR, England		Richardson, R (corresponding author), Lancet, London WC1X 8RR, England.							[Anonymous], 1846, LANCET, Vii, P172; BROOKS CW, 1945, BATTLING SURG LIFE T; BURNEY IA, 2000, BODIES EVIDENCE, P40; CARLTON WJ, 1956, DICKENSIAN, V52, P65; DICKENS C, 1863, ALL YEAR ROUND, V11, P279; FORBES T, 1977, J HIST MED, V32, P393; HOPKINS H, 1977, STRANGE DEATH PRIVAT, P106; Hostettler J, 1993, T WAKLEY IMPROBABLE; HOUSE M, 1969, LETT C DICKENS, V2, P9; JACKSON P, 1987, G SCHARFS LONDON, P8; SCHARF G, 1844, MS FINE 1862 61 0226; SPRIGGE SS, 1897, LIFE TIMES T WAKLEY, P378; Wilson E., 1846, LANCET, Vii, P540; 1844, TIMES           0227, P6	14	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2150	2154		10.1016/S0140-6736(01)07223-3	http://dx.doi.org/10.1016/S0140-6736(01)07223-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784646				2022-12-28	WOS:000172905800030
J	Bromley, PJ; Keller, FS				Bromley, PJ; Keller, FS			Courvoisier's gallbladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Oregon Hlth Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Bromley, PJ (corresponding author), Oregon Hlth Sci Univ, Portland, OR 97201 USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1542	1542		10.1056/NEJMicm010360	http://dx.doi.org/10.1056/NEJMicm010360			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794221				2022-12-28	WOS:000172265200005
J	Henshilwood, CS; d'Errico, F; Yates, R; Jacobs, Z; Tribolo, C; Duller, GAT; Mercier, N; Sealy, JC; Valladas, H; Watts, I; Wintle, AG				Henshilwood, CS; d'Errico, F; Yates, R; Jacobs, Z; Tribolo, C; Duller, GAT; Mercier, N; Sealy, JC; Valladas, H; Watts, I; Wintle, AG			Emergence of modern human behavior: Middle Stone Age engravings from South Africa	SCIENCE			English	Article							LUMINESCENCE	In the Eurasian Upper Paleotithic after about 35,000 years ago, abstract or depictional images provide evidence for cognitive abilities considered integral to modern human behavior. Here we report on two abstract representations engraved on pieces of red ochre recovered from the Middle Stone Age layers at Blombos Cave in South Africa. A mean date of 77,000 years was obtained for the layers containing the engraved ochres by thermoluminescence dating of burnt lithics, and the stratigraphic integrity was confirmed by an optically stimulated luminescence age of 70,000 years on an overlying dune. These engravings support the emergence of modern human behavior in Africa at least 35,000 years before the start of the Upper Paleolithic.	S African Museum, Iziko Museums Cape Town, ZA-8000 Cape Town, South Africa; SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; Univ Bergen, Ctr Dev Studies, N-5007 Bergen, Norway; CNRS, UMR 5808, Inst Prehist & Geol Quanternaire, F-33405 Talence, France; Univ Wales, Inst Geog & Earth Sci, Luminescence Dating Lab, Aberystwyth SY23 3DB, Dyfed, Wales; CEA, CNRS, UMR, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Bergen; Centre National de la Recherche Scientifique (CNRS); Aberystwyth University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Cape Town	Henshilwood, CS (corresponding author), S African Museum, Iziko Museums Cape Town, POB 61, ZA-8000 Cape Town, South Africa.		Duller, Geoffrey/AAR-7494-2020; Henshilwood, Christopher S/K-3806-2014; Duller, Geoffrey A.T./D-5110-2015; Jacobs, Zenobia/B-2721-2012	Duller, Geoffrey/0000-0002-2694-4590; Henshilwood, Christopher S/0000-0002-2818-293X; Duller, Geoffrey A.T./0000-0002-2694-4590; Jacobs, Zenobia/0000-0001-5424-5837; TRIBOLO, Chantal/0000-0003-0506-2430; Mercier, Norbert/0000-0002-6375-9108; Sealy, Judith/0000-0001-5071-8211				AIELLO L, 1998, ORIGIN DIVERSIFICATI; BAHN P, 1997, J ICE AGE; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; DEACON HJ, 1999, HUMAN BEGINNINGS S; DErrico F, 1997, J HUM EVOL, V33, P1, DOI 10.1006/jhev.1997.0141; Gibson K., 1996, MODELLING EARLY HUMA; Henshilwood C, 1997, CURR ANTHROPOL, V38, P890, DOI 10.1086/204678; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Joron J.-L., 1974, THESIS U PARIS SUD; Klein R.G., 1999, HUMAN CAREER; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mercier N., 1992, ANCIENT TL, V10, P28; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718; *SCAND COL I, 1999, NAT COL SYST IND; Stringer C.B., 1996, CONT ISSUES HUMAN EV, V21, P115; VALLADAS H, 1992, QUATERNARY SCI REV, V11, P1, DOI 10.1016/0277-3791(92)90034-6; Vogel JC, 1999, J ARCHAEOL SCI, V26, P729, DOI 10.1006/jasc.1999.0450; VOGEL JC, 2000, HUMANITY AFRICAN NAI, P261; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; WATTS J, 1999, EVOLUTION CULTURE, P113; Willermet C. M., 1997, CONCEPTUAL ISSUES MO; WURZ S, 2000, THESIS STELLENBOSCH; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100	26	547	565	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1278	1280		10.1126/science.1067575	http://dx.doi.org/10.1126/science.1067575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522ZC	11786608				2022-12-28	WOS:000173926000039
J	Kouroukis, CT; Browman, GP; Esmail, R; Meyer, RM				Kouroukis, CT; Browman, GP; Esmail, R; Meyer, RM			Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: A systematic review	ANNALS OF INTERNAL MEDICINE			English	Review							COLONY-STIMULATING FACTOR; STANDARD REGIMEN CHOP; FACTOR G-CSF; ELDERLY-PATIENTS; RANDOMIZED-TRIAL; INTERMEDIATE-GRADE; MACOP-B; MULTICENTER; MANAGEMENT; PROGNOSIS	Purpose: To conduct a systematic review assessing chemotherapeutic regimens in patients at least 60 years of age with previously untreated, advanced-stage, aggressive-histology non-Hodgkin lymphoma. Data Sources: Computerized databases were searched for reports from 1966 to April 2000. Relevant journals, textbooks, and reference lists of published articles were hand searched. Abstract reports were not considered. Study Selection: Randomized trials comparing different chemotherapy regimens were selected. Two independent assessors, who were blinded to authors, institution, and results of the report, reviewed the retrieved citations. Data Extraction: One author abstracted data on patient characteristics, study quality score, survival, disease response and control, toxicity, and quality of life; pooling was not done because of study heterogeneity. Data Synthesis: 12 randomized trials that compared chemotherapeutic regimens were reviewed. Progression-free and overall survival were improved when anthracycline-containing regimens, such as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) or CTVP (cyclophosphamide, pirarubicin, vincristine, and prednisone), were compared with other regimens. Conclusions: For treatment of older patients with advanced-stage, aggressive-histology lymphoma who do not have significant comorbid illnesses, an anthracycline-containing regimen, such as CHOP, given in standard doses and schedule, provides for superior outcomes compared with other regimens.	Hamilton Reg Canc Ctr, Hamilton, ON L8V 5C2, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Meyer, RM (corresponding author), Hamilton Reg Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada.	ralph.meyer@hrec.on.ca						[Anonymous], 1994, J CLIN ONCOL, V12, P2471; Aoki S, 1998, J EXP CLIN CANC RES, V17, P465; Aviles A, 1997, ANTI-CANCER DRUG, V8, P937, DOI 10.1097/00001813-199711000-00004; Balducci L, 1997, CANCER, V80, P1317, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1317::AID-CNCR18>3.3.CO;2-I; Bastion YB, 1997, J CLIN ONCOL, V15, P2945, DOI 10.1200/JCO.1997.15.8.2945; *BELL HOW INF LEAR, 1997, DIG DISS UMI PROQ; Bjorkholm M, 1999, BLOOD, V94, p599A; Chan WC, 1997, ANN ONCOL, V8, P973; Chen CI, 2000, LEUKEMIA LYMPHOMA, V38, P327, DOI 10.3109/10428190009087023; Coiffier B, 2000, BLOOD, V96, p223A; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; COOPER IA, 1994, J CLIN ONCOL, V12, P769, DOI 10.1200/JCO.1994.12.4.769; DELENA M, 1989, MED ONCOL TUMOR PHAR, V6, P163, DOI 10.1007/BF02985240; Doorduijn JK, 2000, BLOOD, V96, p133A; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; GORDON LI, 1992, NEW ENGL J MED, V327, P1342, DOI 10.1056/NEJM199211053271903; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Greil R, 1998, ONCOLOGY-BASEL, V55, P189, DOI 10.1159/000011855; GREINER TC, 1995, CANCER-AM CANCER SOC, V75, P370, DOI 10.1002/1097-0142(19950101)75:1+<370::AID-CNCR2820751319>3.0.CO;2-Q; Haioun C, 1997, J CLIN ONCOL, V15, P1131, DOI 10.1200/JCO.1997.15.3.1131; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jelic S, 1999, NEOPLASMA, V46, P394; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lichtman SM, 2000, CRIT REV ONCOL HEMAT, V33, P119, DOI 10.1016/S1040-8428(99)00061-X; Martelli M, 1997, DRUGS, V53, P957, DOI 10.2165/00003495-199753060-00005; MCKELVEY EM, 1976, CANCER, V38, P1484, DOI 10.1002/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I; MEYER RM, 1995, J CLIN ONCOL, V13, P2386, DOI 10.1200/JCO.1995.13.9.2386; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Montserrat E, 1996, EUR J HAEMATOL, V57, P377; OReilly SE, 1997, CLIN GERIATR MED, V13, P251; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; ROSENBERG SA, 1982, CANCER, V49, P2112; Rusthoven J, 1998, Cancer Prev Control, V2, P179; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; SILINGARDI V, 1995, LEUKEMIA LYMPHOMA, V17, P313, DOI 10.3109/10428199509056837; SONNEVELD P, 1995, J CLIN ONCOL, V13, P2530, DOI 10.1200/JCO.1995.13.10.2530; Sweetenham J W, 1987, Baillieres Clin Haematol, V1, P493, DOI 10.1016/S0950-3536(87)80010-0; Tirelli U, 1998, J CLIN ONCOL, V16, P27, DOI 10.1200/JCO.1998.16.1.27; Tirellki Umberto, 1997, Rays (Rome), V22, P24; *US CENS BUR, 1996, P251130 US CENS BUR; van Spronsen DJ, 1999, ANN HEMATOL, V78, P315, DOI 10.1007/s002770050521; WALTER SD, 1988, PC AGREE VERSION 2 5; Zinzani PL, 1997, BLOOD, V89, P3974	43	34	35	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					144	152		10.7326/0003-4819-136-2-200201150-00012	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790067				2022-12-28	WOS:000173333900007
J	Jones, WD				Jones, WD			Synthetic chemistry - The key to successful organic synthesis is...	SCIENCE			English	Editorial Material									Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester	Jones, WD (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.							BANNWARTH W, 2001, GIT LABOR FACHZ, V45, P974; BROWNING AW, 1997, TRANSITION METALS OR, P35; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Cho JY, 2000, J AM CHEM SOC, V122, P12868, DOI 10.1021/ja0013069; Cornils B, 1999, J MOL CATAL A-CHEM, V143, P1, DOI 10.1016/S1381-1169(98)00357-4; Franzen R, 2000, CAN J CHEM, V78, P957, DOI 10.1139/cjc-78-7-957; Kawamura K, 2001, J AM CHEM SOC, V123, P8422, DOI 10.1021/ja015975d; Li J.J., 1999, ALKAL CHEM, V14, P437; Lloyd-Williams P, 2001, CHEM SOC REV, V30, P145, DOI 10.1039/b001971m; SASAKI M, 2001, UKI GOSEI KAGAKU KYO, V59, P193; Schluter AD, 2001, J POLYM SCI POL CHEM, V39, P1533, DOI 10.1002/pola.1130; Suzuki A, 1999, J ORGANOMET CHEM, V576, P147, DOI 10.1016/S0022-328X(98)01055-9	12	12	13	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					289	290		10.1126/science.1068158	http://dx.doi.org/10.1126/science.1068158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786633				2022-12-28	WOS:000173278600037
J	Szabo, SJ; Sullivan, BM; Stemmann, C; Satoskar, AR; Sleckman, BP; Glimcher, LH				Szabo, SJ; Sullivan, BM; Stemmann, C; Satoskar, AR; Sleckman, BP; Glimcher, LH			Distinct effects of T-bet in T(H)1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells	SCIENCE			English	Article							INTERFERON-GAMMA; TARGETED DISRUPTION; RECEPTOR DEFICIENCY; LEISHMANIA-MAJOR; MICE; INFECTION; STAT1; GENE; ACTIVATION; EXPRESSION	T-bet is a member of the T-box family of transcription factors that appears to regulate lineage commitment in CD4 T helper (T-H) lymphocytes in part by activating the hallmark T(H)1 cytokine, interferon-gamma (IFN-gamma), IFN-gamma is aLso produced by natural killer (NK) cells and most prominently by CD8 cytotoxic T cells, and is vital. for the control of microbial pathogens. Although T-bet is expressed in all these cell types, it is required for control of IFN-gamma production in CD4 and NK cells, but not in CD8 cells. This difference is aLso apparent in the function of these cell subsets. Thus, the regulation of a single cytokine, IFN-gamma, is controlled by distinct transcriptional mechanisms within the T cell lineage.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Washington University (WUSTL)	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.		Satoskar, Abhay/AAB-7748-2019					Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; COICO R, 1994, PROTOCOLS IMMUNOLOGY; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Monteforte GM, 2000, J IMMUNOL, V164, P5890, DOI 10.4049/jimmunol.164.11.5890; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; SZABO S, UNPUB; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2	30	933	1011	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					338	342		10.1126/science.1065543	http://dx.doi.org/10.1126/science.1065543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786644				2022-12-28	WOS:000173278600053
J	Hamad-Schifferli, K; Schwartz, JJ; Santos, AT; Zhang, SG; Jacobson, JM				Hamad-Schifferli, K; Schwartz, JJ; Santos, AT; Zhang, SG; Jacobson, JM			Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna	NATURE			English	Article							SINGLE-MOLECULE; SPECIFICITY; AZOBENZENE; PROBES; DESIGN	Increasingly detailed structural(1) and dynamic(2,3) studies are highlighting the precision with which biomolecules execute often complex tasks at the molecular scale. The efficiency and versatility of these processes have inspired many attempts to mimic or harness them. To date, biomolecules have been used to perform computational operations(4) and actuation(5), to construct artificial transcriptional loops that behave like simple circuit elements(6,7) and to direct the assembly of nanocrystals(8). Further development of these approaches requires new tools for the physical and chemical manipulation of biological systems. Biomolecular activity has been triggered optically through the use of chromophores(9-14), but direct electronic control over biomolecular 'machinery' in a specific and fully reversible manner has not yet been achieved. Here we demonstrate remote electronic control over the hybridization behaviour of DNA molecules, by inductive coupling of a radio-frequency magnetic field to a metal nanocrystal covalently linked to DNA(15). Inductive coupling to the nanocrystal increases the local temperature of the bound DNA, thereby inducing denaturation while leaving surrounding molecules relatively unaffected. Moreover, because dissolved biomolecules dissipate heat in less than 50 picoseconds (ref. 16), the switching is fully reversible. Inductive heating of macroscopic samples is widely used(17-19), but the present approach should allow extension of this concept to the control of hybridization and thus of a broad range of biological functions on the molecular scale.	MIT, Media Lab, Cambridge, MA 02139 USA; MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; Engenos, Waltham, MA 02451 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jacobson, JM (corresponding author), MIT, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Jacobson, Joseph/0000-0002-1332-3197; Zhang, Shuguang/0000-0002-3856-3752				Asanuma H, 1999, TETRAHEDRON LETT, V40, P7995, DOI 10.1016/S0040-4039(99)01547-6; Ashkenazi G, 1997, BIOSENS BIOELECTRON, V12, P85, DOI 10.1016/S0956-5663(97)87054-6; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Cantor C.R., 1980, BIOPHYS CHEM; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; HAMADSCHIFFERLI K, 2001, MAT RES SOC P; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ; LIAN TQ, 1994, J PHYS CHEM-US, V98, P11648, DOI 10.1021/j100096a005; Liu D, 1997, BIOORG MED CHEM LETT, V7, P2677, DOI 10.1016/S0960-894X(97)10044-0; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; McAdams HH, 2000, CURR BIOL, V10, pR318, DOI 10.1016/S0960-9822(00)00440-1; Monroe WT, 1999, J BIOL CHEM, V274, P20895, DOI 10.1074/jbc.274.30.20895; Orfeuil M., 1987, ELECT PROCESS HEATIN; Probst JC, 2000, METHODS, V22, P271, DOI 10.1006/meth.2000.1079; REARDON JE, 1984, BIOCHEMISTRY-US, V23, P3849, DOI 10.1021/bi00312a009; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Telford JR, 1998, ACCOUNTS CHEM RES, V31, P755, DOI 10.1021/ar970078t; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e; Zinn S., 1988, ELEMENTS INDUCTION H	30	317	335	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					152	155		10.1038/415152a	http://dx.doi.org/10.1038/415152a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805829				2022-12-28	WOS:000173159300036
J	Elliott, T				Elliott, T			Geophysics - Caught offside	SCIENCE			English	Editorial Material							EAST PACIFIC RISE; MID-OCEAN RIDGES; MELT EXTRACTION; MANTLE; BENEATH; 2-D		Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Elliott, T (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.			Elliott, Tim/0000-0002-0984-0191				Batiza R, 1996, GEOPHYS RES LETT, V23, P221; Bourdon B, 1996, NATURE, V384, P231, DOI 10.1038/384231a0; BOURDON B, 2000, GEOCHEM GEOPHYS GEOS, V1; BUCK WR, 1989, GEOPHYS RES LETT, V16, P641, DOI 10.1029/GL016i007p00641; CARBOTTE S, 1992, J GEOPHYS RES-SOL EA, V97, P6959, DOI 10.1029/91JB03065; CHRISTESON GL, 1992, GEOPHYS RES LETT, V19, P1045, DOI 10.1029/91GL00971; GOLDSTEIN SJ, 1994, NATURE, V367, P157, DOI 10.1038/367157a0; HARDING AJ, 1993, J GEOPHYS RES-SOL EA, V98, P13925, DOI 10.1029/93JB00886; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; SPARKS DW, 1991, EARTH PLANET SC LETT, V105, P368, DOI 10.1016/0012-821X(91)90178-K; Spiegelman M, 1996, EARTH PLANET SC LETT, V139, P115, DOI 10.1016/0012-821X(96)00008-8; Spiegelman M, 1999, NATURE, V402, P282, DOI 10.1038/46260; SPIEGELMAN M, 1987, EARTH PLANET SC LETT, V83, P137, DOI 10.1016/0012-821X(87)90057-4; Zou HB, 2002, SCIENCE, V295, P107, DOI 10.1126/science.1064295	14	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					55	+		10.1126/science.1066318	http://dx.doi.org/10.1126/science.1066318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778031				2022-12-28	WOS:000173143100029
J	Menzel, D				Menzel, D			Surface science - Water on a metal surface	SCIENCE			English	Editorial Material							RU(001)		Tech Univ Munich, Dept Phys, D-85747 Garching, Germany	Technical University of Munich	Menzel, D (corresponding author), Tech Univ Munich, Dept Phys, D-85747 Garching, Germany.			Menzel, Dietrich/0000-0002-7188-8532				Feibelman PJ, 2002, SCIENCE, V295, P99, DOI 10.1126/science.1065483; Glebov A, 1997, J CHEM PHYS, V106, P9382, DOI 10.1063/1.474008; HELD G, 1995, PHYS REV LETT, V74, P4221, DOI 10.1103/PhysRevLett.74.4221; HELD G, 1994, SURF SCI, V316, P92, DOI 10.1016/0039-6028(94)91131-2; HELD G, 1995, SURF SCI, V327, P301, DOI 10.1016/0039-6028(94)00836-1; Held G, 1996, REV SCI INSTRUM, V67, P378, DOI 10.1063/1.1146599; Michaelides A, 2001, J CHEM PHYS, V114, P513, DOI 10.1063/1.1328746; Seitsonen AP, 2001, J AM CHEM SOC, V123, P7347, DOI 10.1021/ja015525l; THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X	9	67	69	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					58	59		10.1126/science.1067922	http://dx.doi.org/10.1126/science.1067922			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778032				2022-12-28	WOS:000173143100030
J	Peng, LC; Kawagoe, Y; Hogan, P; Delmer, D				Peng, LC; Kawagoe, Y; Hogan, P; Delmer, D			Sitosterol-beta-glucoside as primer for cellulose synthesis in plants	SCIENCE			English	Article							MOLECULAR DIRECTIONALITY; SYNTHASE; ARABIDOPSIS; ENDO-1,4-BETA-GLUCANASE; BIOSYNTHESIS; HERBICIDES; KORRIGAN	Cellulose synthesis in plants requires beta -1,4-glucan chain initiation, elongation, and termination. The process of chain elongation is likely to be distinct from the process of chain initiation. We demonstrate that a CesA glucosyltransferase initiates glucan polymerization by using sitosterol-beta -glucoside (SG) as primer. Cotton fiber membranes synthesize sitosterol-cellodextrins (SCDs) from SG and uridine 5'-diphosphate-glucose (UDP-Glc) under conditions that also favor cellulose synthesis. The cellulase encoded by the Korrigan (Kor) gene, required for cellulose synthesis in plants, may function to cleave SG from the growing polymer chain.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Delmer, D (corresponding author), Univ Calif Davis, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	dpdelmer@ucdavis.edu						BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BULONE V, 1995, PLANT J, V8, P213, DOI 10.1046/j.1365-313X.1995.08020213.x; CALLAGHAN T, 1988, PLANT PHYSIOL, V86, P1104, DOI 10.1104/pp.86.4.1104; Cantatore JL, 2000, BIOCHEM SOC T, V28, P748, DOI 10.1042/BST0280748; DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; ELBEIN AD, 1975, LIPIDS, V10, P427, DOI 10.1007/BF02532449; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; FUJINO Y, 1979, BIOCHIM BIOPHYS ACTA, V574, P94; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; PENG L, UNPUB; Peng LC, 2001, PLANT PHYSIOL, V126, P981, DOI 10.1104/pp.126.3.981; Perrin RM, 2001, CURR BIOL, V11, pR213, DOI 10.1016/S0960-9822(01)00108-7; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Sabba RP, 1999, WEED SCI, V47, P757, DOI 10.1017/S004317450009144X; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schaeffer A, 2001, PLANT J, V25, P605, DOI 10.1046/j.1365-313x.2001.00994.x; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schrick K, 2000, GENE DEV, V14, P1471; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6	25	297	337	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					147	150		10.1126/science.1064281	http://dx.doi.org/10.1126/science.1064281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778054				2022-12-28	WOS:000173143100055
J	Read, SM; Bacic, T				Read, SM; Bacic, T			Plant biology - Prime time for cellulose	SCIENCE			English	Editorial Material							DICTYOSTELIUM; BIOSYNTHESIS; GENE		Univ Melbourne, Sch Resource Management, Creswick, Vic 3363, Australia; Univ Melbourne, Forest Sci Ctr, Creswick, Vic 3363, Australia; Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Read, SM (corresponding author), Univ Melbourne, Sch Resource Management, Creswick, Vic 3363, Australia.							Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Brown RM, 2000, PLANT PHYSIOL BIOCH, V38, P57, DOI 10.1016/S0981-9428(00)00168-6; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Dhugga KS, 2001, CURR OPIN PLANT BIOL, V4, P488, DOI 10.1016/S1369-5266(00)00205-3; Doblin MS, 2001, PLANT PHYSIOL, V125, P2040, DOI 10.1104/pp.125.4.2040; HAZEN SP, IN PRESS PLANT PHYSL; Holland N, 2000, PLANT PHYSIOL, V123, P1313, DOI 10.1104/pp.123.4.1313; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Peng LC, 2001, PLANT PHYSIOL, V126, P981, DOI 10.1104/pp.126.3.981; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Vergara CE, 2001, PLANT MOL BIOL, V47, P145, DOI 10.1023/A:1010631431620; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048	16	65	72	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					59	60		10.1126/science.1068155	http://dx.doi.org/10.1126/science.1068155			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778033				2022-12-28	WOS:000173143100031
J	Rees, MJ				Rees, MJ			Cosmology - How the cosmic dark age ended	SCIENCE			English	Editorial Material							FRAGMENTATION		Univ Cambridge, Kings Coll, Cambridge CB2 1ST, England	University of Cambridge	Rees, MJ (corresponding author), Univ Cambridge, Kings Coll, Cambridge CB2 1ST, England.	mjr@ast.cam.ac.uk						Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Abel T, 2000, ASTROPHYS J, V540, P39, DOI 10.1086/309295; Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; BECKER RH, IN PRESS ASTROPHYS J; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; FAN XW, UNPUB; HEGER A, IN PRESS ASTROPHYS J; Madau P, 2001, ASTROPHYS J, V551, pL27, DOI 10.1086/319848	9	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					51	+		10.1126/science.1065713	http://dx.doi.org/10.1126/science.1065713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778028				2022-12-28	WOS:000173143100026
J	Calfon, M; Zeng, HQ; Urano, F; Till, JH; Hubbard, SR; Harding, HP; Clark, SG; Ron, D				Calfon, M; Zeng, HQ; Urano, F; Till, JH; Hubbard, SR; Harding, HP; Clark, SG; Ron, D			IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; STRESS; ER; REQUIRES; COORDINATION; INDUCTION; CLEAVAGE; PATHWAY; ATF6	The unfolded protein response (UPR), caused by stress, matches the folding capacity of endoplasmic reticulum (ER) to the load of client proteins in the organelle(1,2). In yeast, processing of HAC1 mRNA by activated Ire1 leads to synthesis of the transcription factor Hac1 and activation of the UPR3. The responses to activated IRE1 in metazoans are less well understood. Here we demonstrate that mutations in either ire-1 or the transcription-factor-encoding xbp-1 gene abolished the UPR in Caenorhabditis elegans. Mammalian XBP-1 is essential for immunoglobulin secretion and development of plasma cells(4), and high levels of XBP-1 messenger RNA are found in specialized secretory cells(5). Activation of the UPR causes IRE1-dependent splicing of a small intron from the XBP-1 mRNA both in C. elegans and mice. The protein encoded by the processed murine XBP-1 mRNA accumulated during the UPR, whereas the protein encoded by unprocessed mRNA did not. Purified mouse IRE1 accurately cleaved XBP-1 mRNA in vitro, indicating that XBP-1 mRNA is a direct target of IRE1 endonucleolytic activity. Our findings suggest that physiological ER load regulates a developmental decision in higher eukaryotes.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Ron, D (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	ron@saturn.med.nyu.edu	Urano, Fumihiko/AAF-4492-2020; Longo, Kenneth A/A-5631-2010	Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636				Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; CLARK SG, 1994, GENETICS, V137, P987; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shamu CE, 1998, CURR BIOL, V8, pR121, DOI 10.1016/S0960-9822(98)70986-8; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	21	2022	2107	6	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					92	96		10.1038/415092a	http://dx.doi.org/10.1038/415092a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780124				2022-12-28	WOS:000173028800047
J	Gestwicki, JE; Kiessling, LL				Gestwicki, JE; Kiessling, LL			Inter-receptor communication through arrays of bacterial chemoreceptors	NATURE			English	Article							SINGLE CYTOPLASMIC DOMAIN; ESCHERICHIA-COLI; KINASE ACTIVATION; CHEMOTAXIS; COMPLEX; DIMER; SENSITIVITY; MECHANISM; LOCATION; LATTICE	The sensing mechanisms of chemotactic bacteria allow them to respond sensitively to stimuli. Escherichia coli, for example, respond to changes in chemoattractant concentration of less than 10% over a range spanning six orders of magnitude(1,2). Sensitivity over this range depends on a nonlinear relationship between ligand concentration and output response(3). At low ligand concentrations, substantial amplification of the chemotactic signal is required; however, the mechanism responsible for this amplification remains unclear. Here we demonstrate that inter-receptor communication within a lattice(4,5) acts to amplify and integrate sensory information. Synthetic multivalent ligands that interact through the low-abundance, galactose-sensing receptor Trg stabilize large clusters of chemoreceptors and markedly enhance signal output from these enforced clusters. On treatment with multivalent ligands, the response to the attractant serine is amplified by at least 100-fold. This amplification requires a full complement of chemoreceptors; deletion of the aspartate (Tar) or dipeptide (Tap) receptors diminishes the amplification of the serine response. These results demonstrate that the entire array is involved in sensing. This mode of information exchange has general implications for the processing of signals by cellular receptors.	Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA.		Kiessling, Laura L/A-4074-2008	Kiessling, Laura/0000-0001-6829-1500				ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Gestwicki JE, 2000, J BACTERIOL, V182, P6499, DOI 10.1128/JB.182.22.6499-6502.2000; Gestwicki JE, 2000, CHEM BIOL, V7, P583, DOI 10.1016/S1074-5521(00)00002-8; Gestwicki JE, 2001, BIOORGAN MED CHEM, V9, P2387, DOI 10.1016/S0968-0896(01)00162-6; HAZELBAU.GL, 1969, P NATL ACAD SCI USA, V64, P1300, DOI 10.1073/pnas.64.4.1300; HAZELBAUER GL, 1981, J BACTERIOL, V145, P35, DOI 10.1128/JB.145.1.35-42.1981; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; MADDOCK JR, 1993, SCIENCE, V259, P1717; Matsuuchi L, 2001, CURR OPIN IMMUNOL, V13, P270, DOI 10.1016/S0952-7915(00)00215-6; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; SAGER BM, 1988, ANAL BIOCHEM, V173, P271, DOI 10.1016/0003-2697(88)90189-3; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SLOCUM MK, 1983, J BACTERIOL, V155, P565, DOI 10.1128/JB.155.2.565-577.1983; Tatsuno I, 1996, SCIENCE, V274, P423, DOI 10.1126/science.274.5286.423; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; YEH JI, 1993, J BIOL CHEM, V268, P9787; Yin CC, 2000, NAT CELL BIOL, V2, P669, DOI 10.1038/35023625	30	205	207	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					81	84		10.1038/415081a	http://dx.doi.org/10.1038/415081a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780121				2022-12-28	WOS:000173028800044
J	Cooper, G; Kimmich, N; Belisle, W; Sarinana, J; Brabham, K; Garrel, L				Cooper, G; Kimmich, N; Belisle, W; Sarinana, J; Brabham, K; Garrel, L			Carbonaceous meteorites as a source of sugar-related organic compounds for the early Earth	NATURE			English	Article							MURCHISON METEORITE; MASS SPECTROMETRY; CARBOXYLIC-ACIDS; AMINO-ACIDS; CHROMATOGRAPHY; DERIVATIVES; EVOLUTION; COMETS	The much-studied Murchison meteorite is generally used as the standard reference for organic compounds in extraterrestrial material. Amino acids and other organic compounds(1) important in contemporary biochemistry are thought to have been delivered to the early Earth by asteroids and comets, where they may have played a role in the origin of life(2-4). Polyhydroxylated compounds (polyols) such as sugars, sugar alcohols and sugar acids are vital to all known lifeforms-they are components of nucleic acids (RNA, DNA), cell membranes and also act as energy sources. But there has hitherto been no conclusive evidence for the existence of polyols in meteorites, leaving a gap in our understanding of the origins of biologically important organic compounds on Earth. Here we report that a variety of polyols are present in, and indigenous to, the Murchison and Murray meteorites in amounts comparable to amino acids. Analyses of water extracts indicate that extraterrestrial processes including photolysis and formaldehyde chemistry could account for the observed compounds. We conclude from this that polyols were present on the early Earth and therefore at least available for incorporation into the first forms of life.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ G DAnnunzio, IRSPS, I-65127 Pescara, Italy	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; G d'Annunzio University of Chieti-Pescara	Cooper, G (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	gcooper@mail.arc.nasa.gov						AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; Amelung W, 1996, SOIL BIOL BIOCHEM, V28, P1631, DOI 10.1016/S0038-0717(96)00248-9; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; BRIMACOMBE JS, 1972, CARBOHYDRATES CHEM B, P479; Bruijn J.M.de, 1986, SUGAR TECHN REV, V13, P21; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CODY GD, 1999, LUNAR PLANET SCI C, V30, P1582; COLEMAN ML, 1978, ANAL CHEM, V50, P1594, DOI 10.1021/ac50033a056; COOPER GW, 1995, GEOCHIM COSMOCHIM AC, V59, P1003, DOI 10.1016/0016-7037(95)00018-6; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; DEGENS ET, 1962, NATURWISSENSCHAFTEN, V49, P605, DOI 10.1007/BF01178050; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; GILBART J, 1987, EUR J CLIN MICROBIOL, V6, P715, DOI 10.1007/BF02013084; HAYES JM, 1967, GEOCHIM COSMOCHIM AC, V31, P1395, DOI 10.1016/0016-7037(67)90019-1; Hollis JM, 2000, ASTROPHYS J, V540, pL107, DOI 10.1086/312881; Irvine WM, 1999, SPACE SCI REV, V90, P203, DOI 10.1023/A:1005258300558; Jungclaus G. A., 1976, Meteoritics, V11, P231, DOI 10.1111/j.1945-5100.1976.tb00324.x; KAPLAN IR, 1963, GEOCHIM COSMOCHIM AC, V27, P805, DOI 10.1016/0016-7037(63)90045-0; Langenbeck W, 1942, NATURWISSENSCHAFTEN, V30, P30, DOI 10.1007/BF01475765; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; LOWENDAHL L, 1976, TAPPI, V59, P118; McDonald GD, 1996, ICARUS, V122, P107, DOI 10.1006/icar.1996.0112; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PETERSSO.G, 1970, TETRAHEDRON, V26, P3413, DOI 10.1016/S0040-4020(01)92918-7; Pigman W., 1972, CARBOHYDRATES CHEM A, V1, P165; WEBER AL, 1992, J MOL EVOL, V35, P1, DOI 10.1007/BF00160255; Zolensky M., 1988, METEORITES EARLY SOL, P114	29	316	321	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					879	883		10.1038/414879a	http://dx.doi.org/10.1038/414879a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780054	Green Published			2022-12-28	WOS:000172813300037
J	Roger, T; David, J; Glauser, MP; Calandra, T				Roger, T; David, J; Glauser, MP; Calandra, T			MIF regulates innate immune responses through modulation of Toll-like receptor 4	NATURE			English	Article							MIGRATION-INHIBITORY FACTOR; BINDING-PROTEIN; CUTTING EDGE; LIPOPOLYSACCHARIDE-BINDING; LETHAL ENDOTOXEMIA; MACROPHAGE; GENE; LPS; EXPRESSION; ACTIVATION	Macrophages are pivotal effector cells of the innate immune system, which is vital for recognizing and eliminating invasive microbial pathogens(1,2). When microbial products bind to pathogen-recognition receptors, macrophages become activated and release a broad array of cytokines(3) that orchestrate the host innate and adaptive immune responses. Initially identified as a T-cell cytokine(4,5), macrophage migration inhibitory factor (MIF) is also a macrophage cytokine and an important mediator of inflammation and sepsis(6-12). Here we report that MIF is an essential regulator of macrophage responses to endotoxin (lipopolysaccharide) and Gram-negative bacteria. Compared with wild-type cells, MIF-deficient macrophages are hyporesponsive to lipopolysaccharide and Gram-negative bacteria, as shown by a profound reduction in the activity of NF-kappaB and the production of tumour-necrosis factor-alpha. This reduction is due to a downregulation of Toll-like receptor 4 (TLR4), the signal-transducing molecule of the lipopolysaccharide receptor complex, and is associated with decreased activity of transcription factor PU.1, which is required for optimal expression of the Tlr4 gene in myeloid cells. These findings identify an important role for MIF in innate immunity and provide a molecular basis for the resistance of MIF-dercient mice to endotoxic shock.	CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Harvard T.H. Chan School of Public Health	Calandra, T (corresponding author), CHU Vaudois, Dept Internal Med, Div Infect Dis, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.		Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Calandra, Thierry/0000-0003-3051-1285				Adachi Y, 1999, J ENDOTOXIN RES, V5, P139, DOI 10.1179/096805199101531642; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Heine H, 1999, J IMMUNOL, V162, P6971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Le Roy D, 1999, J IMMUNOL, V162, P7454; Matsumura I, 2000, BLOOD, V96, P2440; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	30	471	502	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					920	924		10.1038/414920a	http://dx.doi.org/10.1038/414920a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780066				2022-12-28	WOS:000172813300049
J	Zinkernagel, RM				Zinkernagel, RM			Advances in immunology: Maternal antibodies, childhood infections, and autoimmune diseases.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION; VACCINE; IMMUNITY; CELL; STRATEGIES; HEPATITIS; TETANUS; MEMORY		Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Zinkernagel, RM (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland.	rolf.zinkernagel@pty.usz.ch						Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; [Anonymous], 1995, J Infect Dis, V171, P1097; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BILLETER MA, 1994, ANN NY ACAD SCI, V724, P367, DOI 10.1111/j.1749-6632.1994.tb38934.x; BLACK FL, 1974, AM J EPIDEMIOL, V100, P230, DOI 10.1093/oxfordjournals.aje.a112032; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BOOY R, 1992, LANCET, V339, P507, DOI 10.1016/0140-6736(92)90336-2; BRADLEY LM, 1993, IMMUNOL TODAY, V14, P197, DOI 10.1016/0167-5699(93)90161-D; BRAMBELL RWR, 1970, TRANSMISSION IMMUNIT; Brent Leslie, 1997, HIST TRANSPLANTATION; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; COLLINS FM, 1966, J EXP MED, V124, P601, DOI 10.1084/jem.124.4.601; DAHLQUIST G, 1995, DIABETOLOGIA, V38, P1371; Englund J, 1998, VACCINE, V16, P1456, DOI 10.1016/S0264-410X(98)00108-X; GITLIN D, 1956, J CLIN INVEST, V35, P1199, DOI 10.1172/JCI103374; GOOD RA, 1956, PEDIATRICS, V18, P109; GRAHAM DG, 1983, J CLIN LAB IMMUNOL, V10, P117; Holmgren J, 1996, VACCINE, V14, P644; KATAYAMA Y, 1995, J GEN VIROL, V76, P3201, DOI 10.1099/0022-1317-76-12-3201; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.immunol.11.1.129; Ludewig B, 2000, J EXP MED, V191, P795, DOI 10.1084/jem.191.5.795; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; MACKAY CR, 1993, ADV IMMUNOL, V53, P217, DOI 10.1016/S0065-2776(08)60501-5; MACKAY IR, 1983, HEPATOLOGY, V3, P724; MALFAIT P, 1994, PEDIATR INFECT DIS J, V13, P38, DOI 10.1097/00006454-199401000-00009; Mims C. A., 1987, PATHOGENESIS INFECT; NATHANSON N, 1990, FIELDS VIROLOGY, V1, P267; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Ruprecht RM, 1999, IMMUNOL REV, V170, P135, DOI 10.1111/j.1600-065X.1999.tb01335.x; SABIN AB, 1983, JAMA-J AM MED ASSOC, V249, P2651, DOI 10.1001/jama.249.19.2651; SARVAS H, 1992, J INFECT DIS, V165, P977, DOI 10.1093/infdis/165.5.977; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333; Zinkernagel RM, 2000, PHILOS T R SOC B, V355, P369, DOI 10.1098/rstb.2000.0576	35	199	209	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1331	1335		10.1056/NEJMra012493	http://dx.doi.org/10.1056/NEJMra012493			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794153				2022-12-28	WOS:000171896300008
J	Parker, RA; Hartman, EE				Parker, RA; Hartman, EE			An 8-year-old boy with autism, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Rapin I, 2001, JAMA-J AM MED ASSOC, V285, P1749, DOI 10.1001/jama.285.13.1749	1	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					504	504		10.1001/jama.287.4.504	http://dx.doi.org/10.1001/jama.287.4.504			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798373				2022-12-28	WOS:000173401900028
J	Kaufman, DW; Kelly, JP; Rosenberg, L; Anderson, TE; Mitchell, AA				Kaufman, DW; Kelly, JP; Rosenberg, L; Anderson, TE; Mitchell, AA			Recent patterns of medication use in the ambulatory adult population of the United States - The Slone survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG-REACTIONS; SUPPLEMENT USE; PRESCRIPTION; MEDICINE; EPESE	Context Data on the range of prescription and over-the-counter drug use in the United States are not available. Objective To provide recent population-based information on use of all medications, including prescription and over-the-counter drugs, vitamins and minerals, and herbal preparations/natural supplements in the United States. Design, Setting, and Participants Ongoing telephone survey of a random sample of the noninstitutionalized US population in the 48 continental states and the District of Columbia; data analyzed here were collected from February 1998 through December 1999. Main Outcome Measure Use of medications, by type, during the preceding week, compared by demographic characteristics. Results Among 2590 participants aged at least 18 years, 81% used at least 1 medication in the preceding week; 50% took at least 1 prescription drug; and 7% took 5 or more. The highest overall prevalence of medication use was among women aged at least 65 years, of whom 12% took at least 10 medications and 23% took at least 5 prescription drugs. Herbals/supplements were taken by 14% of the population. Among prescription drug users, 16% also took an herbal/supplement; the rate of concurrent use was highest for fluoxetine users, at 22%. Reasons for drug use varied widely, with hypertension and headache mentioned most often (9% for each). Vitamins/minerals were frequently used for nonspecific reasons such as "health" (35%); herbals/supplements were also most commonly used for "health" (16%). Conclusions In any given week, most US adults take at least 1 medication, and many take multiple agents. The substantial overlap between use of prescription medications and herbals/supplements raises concern about unintended interactions. Documentation of usage patterns can provide a basis for improving the safety of medication use.	Boston Univ, Sch Publ Hlth, Slone Epidemiol Unit, Boston, MA 02215 USA	Boston University	Kaufman, DW (corresponding author), Boston Univ, Sch Publ Hlth, Slone Epidemiol Unit, 1010 Commonwealth Ave, Boston, MA 02215 USA.			Rosenberg, Lynn/0000-0003-2760-2987; Mitchell, Allen/0000-0003-0950-6799; Kaufman, David/0000-0002-2150-5070				Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; Bates DW, 1998, JAMA-J AM MED ASSOC, V279, P1216, DOI 10.1001/jama.279.15.1216; Baugh DK, 1999, HEALTH CARE FINANC R, V20, P79; Caces MF, 1998, J SUBST ABUSE, V10, P115, DOI 10.1016/S0899-3289(99)80128-X; COPELAND C, 1999, EBRI ISSUE BRIEF, V208, P1; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, EUR J CLIN PHARMACOL, V56, P523, DOI 10.1007/s002280000194; Ervin RB., 1999, USE DIETARY SUPPLEME; Espino DV, 1998, J AM GERIATR SOC, V46, P1228, DOI 10.1111/j.1532-5415.1998.tb04538.x; Gotto Antonio M., 1999, American Journal of Medicine, V107, p36S; Gray SL, 1996, PHARMACOTHERAPY, V16, P715; Handa VL, 1996, J AM GERIATR SOC, V44, P1; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Lassila HC, 1996, ANN PHARMACOTHER, V30, P589, DOI 10.1177/106002809603000604; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Mehl B, 2000, AM J HEALTH-SYST PH, V57, P129, DOI 10.1093/ajhp/57.2.129; OROURKE D, 1999, SURVEY RES, V30, P1; Petrini J. R., 1999, Morbidity and Mortality Weekly Report, V48, P325; Pradel FG, 1999, ANN PHARMACOTHER, V33, P400, DOI 10.1345/aph.18247; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Stoehr GP, 1997, J AM GERIATR SOC, V45, P158, DOI 10.1111/j.1532-5415.1997.tb04501.x; THORNBERRY OT, 1987, VITAL HLTH STAT, V2, P106; *US CENS BUR, 2000, CURR POP REP 1998; *US CENS BUR, 2000, HOUS TYP SEL CHAR 19; *US CENS BUR, 2001, NAT POP PROJ 2000 HI; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; *US CENS BUR, 2000, CURR POP REP MON INC; *US DEP COMM EC ST, 1993, 1990 CENS POP HOUS S; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; 2000, SCOTTLEVINS SOURCE P; 2000, IMS AM NPA 20K MONTH	32	1294	1335	0	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					337	344		10.1001/jama.287.3.337	http://dx.doi.org/10.1001/jama.287.3.337			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511YQ	11790213	Bronze			2022-12-28	WOS:000173294700028
J	Rhee, JS; Betz, A; Pyott, S; Reim, K; Varoqueaux, F; Augustin, I; Hesse, D; Sudhof, TC; Takahashi, M; Rosenmund, C; Brose, N				Rhee, JS; Betz, A; Pyott, S; Reim, K; Varoqueaux, F; Augustin, I; Hesse, D; Sudhof, TC; Takahashi, M; Rosenmund, C; Brose, N			beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs	CELL			English	Article							PROTEIN-KINASE-C; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; HIPPOCAMPAL SYNAPSES; PROBABILITY; UNC-13; POTENTIATION; VESICLES; CELLS; POOL	Munc13-1 is a presynaptic protein with an essential role in synaptic vesicle priming. It contains a diacylglycerol (DAG)/beta phorbol ester binding C-1 domain and is a potential target of the DAG second messenger pathway that may act in parallel with PKCs. Using genetically modified mice that express a DAG/beta phorbol ester binding-deficient Munc13-1(H567K) variant instead of the wild-type protein, we determined the relative contribution of PKCs and Munc13-1 to DAG/beta phorbol ester-dependent regulation of neurotransmitter release. We show that Munc13s are the main presynaptic DAG/beta phorbol ester receptors in hippocampal neurons. Modulation of Munc13-1 activity by second messengers via the DAG/beta phorbol ester binding C-1 domain is essential for use-dependent alterations of synaptic efficacy and survival.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Abt Neurogenet, D-37075 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan	Max Planck Society; Max Planck Society; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Pyott, Sonja/AAW-8789-2020; Varoqueaux, Frederique/AAC-1834-2021; Rosenmund, Christian/AAC-3596-2020	Varoqueaux, Frederique/0000-0002-3614-3121; Rosenmund, Christian/0000-0002-3905-2444; Pyott, Sonja/0000-0001-7750-2437				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; DEGRAAN PNE, 1994, NEUROTOXICOLOGY, V15, P41; FABBRI M, 1994, J BIOL CHEM, V269, P26848; Goda Y, 1996, LEARN MEMORY, V3, P182, DOI 10.1101/lm.3.2-3.182; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Honda I, 2000, J PHYSIOL-LONDON, V529, P763, DOI 10.1111/j.1469-7793.2000.00763.x; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; NAYAK A, 1999, ADV NEUROL, V79, P6545; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Oleskevich S, 2000, J PHYSIOL-LONDON, V526, P349, DOI 10.1111/j.1469-7793.2000.t01-1-00349.x; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Redman RS, 1997, J PHYSIOL-LONDON, V501, P41, DOI 10.1111/j.1469-7793.1997.041bo.x; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; ROSENMUND C, 2002, IN PRESS NEURON; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; SKABA T, 2001, P NATL ACAD SCI USA, V98, P331; Song Y, 1998, KIDNEY INT, V53, P1689, DOI 10.1046/j.1523-1755.1998.00942.x; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Waters J, 2000, J NEUROSCI, V20, P7863; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Yawo H, 1999, J PHYSIOL-LONDON, V516, P461, DOI 10.1111/j.1469-7793.1999.0461v.x	48	365	377	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					121	133		10.1016/S0092-8674(01)00635-3	http://dx.doi.org/10.1016/S0092-8674(01)00635-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792326	Bronze			2022-12-28	WOS:000173280700013
J	Ganeshram, RS; Pedersen, TF; Calvert, SE; Francois, R				Ganeshram, RS; Pedersen, TF; Calvert, SE; Francois, R			Reduced nitrogen fixation in the glacial ocean inferred from changes in marine nitrogen and phosphorus inventories	NATURE			English	Article							CONTINENTAL-MARGIN SEDIMENTS; ARABIAN SEA; INTERGLACIAL VARIABILITY; DENITRIFICATION; ACCUMULATION; PACIFIC; APATITE; PERU	To explain the lower atmospheric CO(2) concentrations during glacial periods, it has been suggested that the productivity of marine phytoplankton was stimulated by an increased flux of iron-bearing dust to the oceans(1,2). One component of this theory is that iron-an essential element/nutrient for nitrogen-fixing organisms-will increase the rate of marine nitrogen fixation, fuelling the growth of other marine phytoplankton and increasing CO(2) uptake. Here we present data that questions this hypothesis. From a sediment core off the northwestern continental margin of Mexico, we show that denitrification and phosphorite formation-processes that occur in oxygen-deficient upwelling regions, removing respectively nitrogen and phosphorus from the ocean-declined in glacial periods, thus increasing marine inventories of nitrogen and phosphorus. But increases in phosphorus were smaller and less rapid, leading to increased N/P ratios in the oceans. Acknowledging that phytoplankton require nitrogen and phosphorus in constant proportions, the Redfield ratio(3), and that N/P ratios greater than the Redfield ratio are likely to suppress nitrogen fixation(4,5), we suggest therefore that marine productivity did not increase in glacial periods in response to either increased nutrient inventories or greater iron supply.	Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02540 USA	University of Edinburgh; University of British Columbia; Woods Hole Oceanographic Institution	Ganeshram, RS (corresponding author), Univ Edinburgh, Dept Geol & Geophys, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	Raja.Ganeshram@glg.ed.ac.uk						ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BURNETT WC, 1980, J GEOL SOC LONDON, V137, P757, DOI 10.1144/gsjgs.137.6.0757; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; FALKOWSKI P. G., 1997, NATURE, V342, P637; Filippelli GM, 1997, MAR GEOL, V139, P231, DOI 10.1016/S0025-3227(96)00113-2; FROELICH PN, 1988, MAR GEOL, V80, P309, DOI 10.1016/0025-3227(88)90095-3; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 1998, PALEOCEANOGRAPHY, V13, P634, DOI 10.1029/98PA02508; Garrison R.E., 1990, P OCEAN DRILLING PRO, V112, P111, DOI DOI 10.2973/ODP.PROC.SR.112.145.1990.; Heggie D., 1988, EOS T AM GEOPHYS UN, V69, P2, DOI DOI 10.1029/88E000007; HOOD RR, 2000, EOS, V81, P1; JAHNKE RA, 1983, GEOCHIM COSMOCHIM AC, V47, P259, DOI 10.1016/0016-7037(83)90138-2; LAMBOURN L, 1991, 110 U WASH SCH OC; PRICE NB, 1978, CHEM GEOL, V23, P151, DOI 10.1016/0009-2541(78)90072-4; REDFIELD AC, 1963, SEA, V2, P36; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Schenau S, 2000, MAR GEOL, V169, P1, DOI 10.1016/S0025-3227(00)00083-9; Schuffert JD, 1998, MAR GEOL, V146, P21, DOI 10.1016/S0025-3227(97)00122-9; SHIMMIELD G, 1991, P OCEAN DRILLING PRO, V0117; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941	26	106	124	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					156	159		10.1038/415156a	http://dx.doi.org/10.1038/415156a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805830				2022-12-28	WOS:000173159300037
J	Tegus, O; Bruck, E; Buschow, KHJ; de Boer, FR				Tegus, O; Bruck, E; Buschow, KHJ; de Boer, FR			Transition-metal-based magnetic refrigerants for room-temperature applications	NATURE			English	Article							MAGNETOELASTIC TRANSITION; GD-5(SI2GE2)	Magnetic refrigeration techniques based on the magnetocaloric effect (MCE) have recently been demonstrated as a promising alternative to conventional vapour-cycle refrigeration(1). In a material displaying the MCE, the alignment of randomly oriented magnetic moments by an external magnetic field results in heating. This heat can then be removed from the MCE material to the ambient atmosphere by heat transfer. If the magnetic field is subsequently turned off, the magnetic moments randomize again, which leads to cooling of the material below the ambient temperature. Here we report the discovery of a large magnetic entropy change in MnFeP0.45As0.55, a material that has a Curie temperature of about 300 K and which allows magnetic refrigeration at room temperature. The magnetic entropy changes reach values of 14.5 J K-1 kg(-1) and 18 J K-1 kg(-1) for field changes of 2 T and 5 T, respectively. The so-called giant-MCE material Gd5Ge2Si2 (ref. 2) displays similar entropy changes, but can only be used below room temperature. The refrigerant capacity of our material is also significantly greater than that of Gd (ref. 3). The large entropy change is attributed to a field-induced first-order phase transition enhancing the effect of the applied magnetic field.	Univ Amsterdam, Van der Waals Zeeman Inst, NL-1018 XE Amsterdam, Netherlands	University of Amsterdam	Bruck, E (corresponding author), Univ Amsterdam, Van der Waals Zeeman Inst, Valckenierstr 65, NL-1018 XE Amsterdam, Netherlands.		Bruck, Ekkes H/E-3365-2014	Bruck, Ekkes/0000-0002-5063-3338				BACMANN M, 1994, J MAGN MAGN MATER, V134, P59, DOI 10.1016/0304-8853(94)90073-6; Beckman O., 1991, HDB MAGNETIC MAT, V6, P181; Choe W, 2000, PHYS REV LETT, V84, P4617, DOI 10.1103/PhysRevLett.84.4617; Giguere A, 1999, PHYS REV LETT, V83, P2262, DOI 10.1103/PhysRevLett.83.2262; Glanz J, 1998, SCIENCE, V279, P2045, DOI 10.1126/science.279.5359.2045; Gschneidner KA, 1999, MATER SCI FORUM, V315-3, P69, DOI 10.4028/www.scientific.net/MSF.315-317.69; Morellon L, 2000, PHYS REV B, V62, P1022, DOI 10.1103/PhysRevB.62.1022; Pecharsky VK, 1997, PHYS REV LETT, V78, P4494, DOI 10.1103/PhysRevLett.78.4494; PYTLIK L, 1985, J MAGN MAGN MATER, V51, P199, DOI 10.1016/0304-8853(85)90018-6; Tishin AM, 1999, HANDB MAG M, V12, P395, DOI 10.1016/S1567-2719(99)12008-0; ZACH R, 1990, J MAGN MAGN MATER, V89, P221, DOI 10.1016/0304-8853(90)90730-E; Zimm C, 1998, ADV CRYOG ENG, V43, P1759	12	2295	2410	22	684	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					150	152		10.1038/415150a	http://dx.doi.org/10.1038/415150a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805828				2022-12-28	WOS:000173159300035
J	Osmond, DH; Buchbinder, S; Cheng, A; Graves, A; Vittinghoff, E; Cossen, CK; Forghani, B; Martin, JN				Osmond, DH; Buchbinder, S; Cheng, A; Graves, A; Vittinghoff, E; Cossen, CK; Forghani, B; Martin, JN			Prevalence of kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BISEXUAL MEN; SEXUAL TRANSMISSION; RISK-FACTORS; HUMAN-HERPESVIRUS-8; SEROCONVERSION; COHORT; HEALTH; ANTIBODIES; RATES	Context Some studies have inferred that an epidemic of Kaposi sarcoma-associated herpesvirus (KSHV) infection in homosexual men in the United States occurred concurrently with that of human immunodeficiency virus (HIV), but there have been no direct measurements of KSHV prevalence at the beginning of the HIV epidemic. Objectives To determine the prevalence of KSHV infection in homosexual men in San Francisco, Calif, at the beginning of the HIV epidemic in 1978 and 1979 and to examine changes in prevalence of KSHV at time points from 1978 through 1996 in light of changes in sexual behavior. Design, Setting, and Participants Analysis of a clinic-based sample (n=398) derived from the San Francisco City Clinic Cohort (ages 18-66 years) (n=2666 for analyses herein) and from population-based samples from the San Francisco Men's Health Study (MHS) (ages 25-54 years) (n=825 and 252) and the San Francisco Young Men's Health Study (YMHS) (ages 18-29 years) (n=428-976, and 557); behavioral studies were longitudinal and KSHV prevalence studies were cross-sectional. Main Outcome Measures Antibodies against KSHV and HIV; sexual behaviors. Results The prevalence of KSHV infection in 1978 and 1979 was 26.5% of 235 (a random sample) overall (weighted for HIV infection) vs 6.9% (128/1842) for HIV in the San Francisco City Clinic Cohort sample. The prevalence of KSHV infection remained essentially unchanged between an MHS sample of 252 in 1984 and 1985 (29.6%) and a YMHS sample of 557 in 1995 and 1996 (26.4%), while HIV prevalence dropped from 49.5% of 825 in 1984 and 1985 (MHS) to 17.6% of 428 in 1992 and 1993 (YMHS). The proportion of men practicing unprotected receptive anal intercourse with 1 or more partners declined from 54% to 11% during the 1984 through 1993 period (MHS) with similar though slightly higher values in the YMHS in 1992 and 1993; whereas for unprotected oral intercourse it ranged between 60% and 90% in the 1984 through 1996 period (PANS and YMHS). Conclusions Infection with KSHV was already highly prevalent in homosexual men when the HIV epidemic began in San Francisco, and its prevalence has been maintained at a nearly constant level. Any declines in the incidence of Kaposi sarcoma do not appear to be caused by a decline in KSHV transmission.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Calif Dept Hlth Serv, Div Communicable Dis Control, Viral & Rickettsial Dis Lab, Viral Immunoserol Sect, Richmond, CA USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; California Department of Health Care Services	Osmond, DH (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Box 0886, San Francisco, CA 94143 USA.				NCI NIH HHS [U01 CA78124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA078124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Diamond C, 1997, J INFECT DIS, V176, P775, DOI 10.1086/517299; Dore GJ, 1996, AIDS, V10, P1401, DOI 10.1097/00002030-199610000-00013; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Fusaro RE, 1996, BIOMETRICS, V52, P211, DOI 10.2307/2533157; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Grulich AE, 1997, AM J EPIDEMIOL, V145, P673, DOI 10.1093/aje/145.8.673; Hayward GS, 1999, SEMIN CANCER BIOL, V9, P187, DOI 10.1006/scbi.1998.0116; Jacobson L.P., 2000, 3 INT WORKSH KAP SAR; Jones JL, 1999, J ACQ IMMUN DEF SYND, V21, pS11; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; MARTIN J, 2000, 3 INT WORKSH KAP SAR; Martin JN, 2000, J CLIN MICROBIOL, V38, P696, DOI 10.1128/JCM.38.2.696-701.2000; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; RUTHERFORD GW, 1990, BRIT MED J, V301, P1183, DOI 10.1136/bmj.301.6762.1183; RUTHERFORD GW, 1990, J ACQ IMMUN DEF SYND, V3, pS4; SAMUEL MC, 1993, J ACQ IMMUN DEF SYND, V6, P303; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; VEUGELERS PJ, 1995, EPIDEMIOLOGY, V6, P382, DOI 10.1097/00001648-199507000-00009; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	30	71	72	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					221	225		10.1001/jama.287.2.221	http://dx.doi.org/10.1001/jama.287.2.221			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779265				2022-12-28	WOS:000173114900025
J	Said, R				Said, R			Geoarchaeology: Did Nile flooding sink two ancient cities?	NATURE			English	Article									Geol Survey Egypt, Annandale, VA 22003 USA									Fraedrich K, 1997, INT J CLIMATOL, V17, P1301, DOI 10.1002/(SICI)1097-0088(199710)17:12<1301::AID-JOC196>3.0.CO;2-W; NUR AM, 2000, EOS T AM GEOPHYS UN, V81, pF21; PAIN S, 2001, NEW SCI         1020, P43; Popper W., 1951, CAIRO NILOMETER; REUSSING G, 1994, BERLINER GEOWISSEN D, V7; SAID R, 1993, RIVER NILE GOLOGY HY; Stanley JD, 2001, NATURE, V412, P293, DOI 10.1038/35085628; TOUSSOUN O, 1922, MEM I EGYPT, V4, P1	8	2	2	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					37	38		10.1038/415037a	http://dx.doi.org/10.1038/415037a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780107				2022-12-28	WOS:000173028800030
J	Gortmaker, SL; Hughes, M; Cervia, J; Brady, M; Johnson, GM; Seage, GR; Song, LY; Dankner, WM; Oleske, JM				Gortmaker, SL; Hughes, M; Cervia, J; Brady, M; Johnson, GM; Seage, GR; Song, LY; Dankner, WM; Oleske, JM		Pediat AIDS Clin Trials Grp Protoc	Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; CONTROLLED-TRIAL; MEDICAL-CARE; SURVIVAL; LIPODYSTROPHY; PERCENTAGE; RITONAVIR; ADHERENCE; INDINAVIR	Background: Combination therapy including protease inhibitors has been shown to be effective in treating adults infected with human immunodeficiency virus type 1 (HIV-1), but there are only limited data regarding the treatment of children and adolescents. Methods: A cohort of 1028 HIV-1-infected children and adolescents, from birth through 20 years of age, who were enrolled in research clinics in the United States before 1996 was followed prospectively through 1999. We used proportional-hazards regression models to estimate the effect on mortality of combination therapy including protease inhibitors. Results: Seven percent of the subjects were receiving combination therapy including protease inhibitors in 1996; by 1999, 73 percent were receiving such therapy. In univariate analyses, a higher base-line percentage of lymphocytes that were CD4-positive, a higher weight for age, a higher height for age, black race, Hispanic ethnic background, younger age, and perinatally acquired infection were associated with a longer median time to the initiation of this type of therapy (P<0.001). After adjustment for covariates, the differences among racial and ethnic groups in the time to initiation were not statistically significant. Mortality declined from 5.3 percent in 1996 to 2.1 percent in 1997, 0.9 percent in 1998, and 0.7 percent in 1999 (P for trend <0.001). There were reductions in mortality in all subgroups defined according to age, sex, percentage of CD4+ lymphocytes, educational level of the parent or guardian, and race or ethnic background. In adjusted analyses, the initiation of combination therapy including protease inhibitors was independently associated with reduced mortality (hazard ratio for death, 0.33; 95 percent confidence interval, 0.19 to 0.58; P<0.001). Conclusions: The use of combination therapy including protease inhibitors has markedly reduced mortality among children and adolescents infected with HIV-1. (N Engl J Med 2001;345:1522-8.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA; Columbus Childrens Hosp, Columbus, OH USA; Med Univ S Carolina, Charleston, SC 29425 USA; Parexel Int, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Med & Dent New Jersey, Dept Pediat, Newark, NJ 07103 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Northwell Health; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Medical University of South Carolina; Parexel International; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gortmaker, SL (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, 665 Huntington Ave, Boston, MA 02115 USA.		Cervia, Joseph Steven/Q-7219-2019; Oleske, James M/C-1951-2016; Cervia, Joseph/AAE-4389-2020	Oleske, James M/0000-0003-2305-5605; Cervia, Joseph/0000-0002-8286-0009				[Anonymous], 1998, MMWR Recomm Rep, V47, P43; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; Arpadi SM, 2001, J ACQ IMMUN DEF SYND, V27, P30, DOI 10.1097/00126334-200105010-00005; Buchacz K, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e72; Canani RB, 1999, AIDS, V13, P1005, DOI 10.1097/00002030-199905280-00026; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Cunningham WE, 2000, J HEALTH CARE POOR U, V11, P163; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; de Martino M, 2000, JAMA-J AM MED ASSOC, V284, P190, DOI 10.1001/jama.284.2.190; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; GAUGHAN DM, 2001, 8 C RETR OPP INF CHI, P686; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Huang H, 1998, J ACQ IMMUN DEF SYND, V18, P495, DOI 10.1097/00042560-199808150-00012; MACARTHUR RD, 2001, 8 C RETR OPP INF CHI, P203; MCKINNEY RE, 1992, PEDIATR INFECT DIS J, V11, P639; Melvin AJ, 1997, PEDIATR INFECT DIS J, V16, P968, DOI 10.1097/00006454-199710000-00013; Mofenson LM, 1999, AIDS, V13, P31, DOI 10.1097/00002030-199901140-00005; Mueller BU, 1998, PEDIATRICS, V102, P101, DOI 10.1542/peds.102.1.101; Nachman SA, 2000, JAMA-J AM MED ASSOC, V283, P492, DOI 10.1001/jama.283.4.492; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palumbo PE, 1998, JAMA-J AM MED ASSOC, V279, P756, DOI 10.1001/jama.279.10.756; Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010; *SAS I, 1996, SAS VERS 6 12; SEAGE GR, 1993, AM J PUBLIC HEALTH, V83, P72, DOI 10.2105/AJPH.83.1.72; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; Turner BJ, 2000, ARCH INTERN MED, V160, P2614, DOI 10.1001/archinte.160.17.2614; Walker AM, 1996, EPIDEMIOLOGY, V7, P335; Wiznia A, 2000, AIDS RES HUM RETROV, V16, P1113, DOI 10.1089/088922200414956; 1998, MMWR MORB MORTAL WKL, V47, P619; 1998, MMWR MORB MORTAL WKL, V47, P315	37	355	369	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1522	1528		10.1056/NEJMoa011157	http://dx.doi.org/10.1056/NEJMoa011157			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794218				2022-12-28	WOS:000172265200002
J	Patricelli, GL; Uy, JAC; Walsh, G; Borgia, G				Patricelli, GL; Uy, JAC; Walsh, G; Borgia, G			Male displays adjusted to female's response - Macho courtship by the satin bowerbird is tempered to avoid frightening the female.	NATURE			English	Article							PTILONORHYNCHUS-VIOLACEUS; THREAT REDUCTION; TRAITS		Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Patricelli, GL (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	borgia@umail.umd.edu	Patricelli, Gail L/L-3730-2017	Uy, J. Albert C./0000-0002-8437-5525; Patricelli, Gail/0000-0003-3397-8390				Andersson Malte, 1994; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; BORGIA G, 1985, ANIM BEHAV, V33, P266, DOI 10.1016/S0003-3472(85)80140-8; BORGIA G, 1995, EMU, V95, P1, DOI 10.1071/MU9950001; Borgia G, 1998, ANIM BEHAV, V56, P1121, DOI 10.1006/anbe.1998.0908; BORGIA G, 1995, AM SCI, V83, P542; Borgia G., 1979, SEXUAL SELECTION REP, P27; Mateos C, 1999, BEHAV ECOL SOCIOBIOL, V45, P235, DOI 10.1007/s002650050558; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994	9	214	216	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					279	280		10.1038/415279a	http://dx.doi.org/10.1038/415279a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796996				2022-12-28	WOS:000173293500031
J	Hajek, P; Taylor, TZ; Mills, P				Hajek, P; Taylor, TZ; Mills, P			Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CESSATION; SYSTEM; RISK	Objective To evaluate a smoking cessation intervention that can be routinely delivered to smokers admitted with cardiac problems. Design Randomised controlled trial of usual care compared with intervention delivered on hospital wards by cardiac rehabilitation nurses. Setting Inpatient wards in 17 hospitals in England. Participants 540 smokers admitted to hospital after myocardial infarction or for cardiac bypass surgery who expressed interest in stopping smoking. Intervention Brief verbal advice and standard booklet (usual care). Intervention lasting 20-30 minutes including carbon monoxide reading, special booklet, quiz, contact with other people giving up, declaration of commitment to give up, sticker in patient's notes (intervention group). Main outcome measures Continuous abstinence at six weeks and 12 months determined by self report and by biochemical validation at these end points. Feasibility of the intervention and delivery of its components. Results After six weeks 151 (59%) and 159 (60%) patients remained abstinent in the control and intervention group, respectively (P=0.84). After 12 months the figures were 102 (41%) and 94 (37%) (P=0.40). Recruitment was slow, and delivery of die intervention was inconsistent, raising concerns about the feasibility of the intervention within routine care. Patients who received the declaration of commitment component were almost twice as likely to remain abstinent than those who did not receive it (P < 0.01). Low dependence on tobacco and high motivation to give up were the main independent predictors of positive outcome. Patients who had had bypass surgery were over twice as likely to return to smoking than patients who had had a myocardial infarction. Conclusions Single session interventions delivered within routine care may have insufficient power to influence highly dependent smokers.	Barts & London Queen Marys Sch Med & Dent, Barts & London, Dept Human Sci & Med Eth, London E1 2AD, England; London Chest Hosp, London E2 9JA, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Hajek, P (corresponding author), Barts & London Queen Marys Sch Med & Dent, Barts & London, Dept Human Sci & Med Eth, London E1 2AD, England.	p.hajek@qmul.ac.uk						CAVENDER JB, 1992, J AM COLL CARDIOL, V20, P287, DOI 10.1016/0735-1097(92)90092-2; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; DOBSON AJ, 1991, J CLIN EPIDEMIOL, V44, P1247, DOI 10.1016/0895-4356(91)90157-5; Dornelas EA, 2000, PREV MED, V30, P261, DOI 10.1006/pmed.2000.0644; Hajek P, 2001, ADDICTION, V96, P485, DOI 10.1046/j.1360-0443.2001.96348511.x; JONES RM, 1987, ANAESTHESIA, V42, P1, DOI 10.1111/j.1365-2044.1987.tb02935.x; Klesges RC, 1999, J CONSULT CLIN PSYCH, V67, P952; OCKENE J, 1992, HEALTH PSYCHOL, V11, P119, DOI 10.1037//0278-6133.11.5.277; RIGOTTI NA, 1991, J GEN INTERN MED, V6, P305, DOI 10.1007/BF02597426; RIGOTTI NA, 1994, ANN INTERN MED, V120, P287, DOI 10.7326/0003-4819-120-4-199402150-00005; Saks M, 2021, REPORT ROYAL COLL PO, DOI [10.1111/add.14502, DOI 10.1111/ADD.14502]; Stevens VJ, 2000, MED CARE, V38, P451, DOI 10.1097/00005650-200005000-00002; TAYLOR CB, 1990, ANN INTERN MED, V113, P118, DOI 10.7326/0003-4819-113-2-118; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; West R, 1998, ADDICTION, V93, P1007, DOI 10.1046/j.1360-0443.1998.93710075.x; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939	17	120	121	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2002	324	7329					87	89		10.1136/bmj.324.7329.87	http://dx.doi.org/10.1136/bmj.324.7329.87			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786452	Bronze, Green Published			2022-12-28	WOS:000173325400017
J	Deo, RC; Groft, CM; Rajashankar, KR; Burley, SK				Deo, RC; Groft, CM; Rajashankar, KR; Burley, SK			Recognition of the rotavirus mRNA 3 ' consensus by an asymmetric NSP3 homodimer	CELL			English	Article							POLY(A) BINDING-PROTEIN; ANGSTROM RESOLUTION; CONSENSUS SEQUENCE; CRYSTAL-STRUCTURE; 3 END; TRANSLATION; DOMAINS; NS34; DNA; EQUIVALENT	Rotaviruses, the cause of life-threatening diarrhea in humans and cattle, utilize a functional homolog of poly(A) binding protein (PABP) known as nonstructural protein 3 (NSP3) for translation of viral mRNAs. NSP3 binds to viral mRNA 3' consensus sequences and circularizes the mRNA via interactions with eIF4G. The X-ray structure of the NSP3 RNA binding domain bound to a rotaviral mRNA 3' end has been determined. NSP3 is a novel, heart-shaped homodimer with a medial RNA binding cleft. The homodimer is asymmetric, and contains two similar N-terminal segments plus two structurally different C-terminal segments that intertwine to create a tunnel enveloping the mRNA 31 end. Biophysical studies demonstrate high affinity binding leading to increased thermal stability and slow dissociation kinetics, consistent with NSP3 function.	Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Burley, SK (corresponding author), Rockefeller Univ, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu		Burley, Stephen K./0000-0002-2487-9713				Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; BICAN P, 1982, J VIROL, V43, P1113, DOI 10.1128/JVI.43.3.1113-1117.1982; BOTH GW, 1984, NUCLEIC ACIDS RES, V12, P1621, DOI 10.1093/nar/12.3.1621; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN GM, 1985, LANCET, V2, P1123; Deardorff JA, 1997, J MOL BIOL, V269, P67, DOI 10.1006/jmbi.1997.1013; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; EIDEN JJ, 1993, VIROLOGY, V196, P298, DOI 10.1006/viro.1993.1479; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Estes M.K., 1996, FIELDS VIROLOGY, P1625; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; King DA, 1999, NAT STRUCT BIOL, V6, P64; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Miller RT, 1996, FASEB J, V10, P171, DOI 10.1096/fasebj.10.1.8566539; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Patton JT, 2001, J VIROL, V75, P2076, DOI 10.1128/JVI.75.5.2076-2086.2001; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; PONCET D, 1993, J VIROL, V67, P3159, DOI 10.1128/JVI.67.6.3159-3165.1993; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; QIAN Y, 1991, VIROLOGY, V184, P752, DOI 10.1016/0042-6822(91)90446-I; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SILVERSTEIN SC, 1976, ANNU REV BIOCHEM, V45, P375, DOI 10.1146/annurev.bi.45.070176.002111; Valdar WSJ, 2001, PROTEINS, V42, P108; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	45	84	90	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					71	81		10.1016/S0092-8674(01)00632-8	http://dx.doi.org/10.1016/S0092-8674(01)00632-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792322	Bronze			2022-12-28	WOS:000173280700009
J	Marban, E				Marban, E			Cardiac channelopathies	NATURE			English	Review							LONG-QT SYNDROME; HUMAN VENTRICULAR MYOCYTES; TRANSIENT OUTWARD CURRENT; TERMINAL HEART-FAILURE; TORSADES-DE-POINTES; POTASSIUM CHANNEL; EARLY AFTERDEPOLARIZATIONS; GENE-TRANSFER; BRUGADA-SYNDROME; IONIC MECHANISM	Genetic alterations of various ion channels produce heritable cardiac arrhythmias that predispose affected individuals to sudden death. The investigation of such 'channelopathies' continues to yield remarkable insights into the molecular basis of cardiac excitability. The concept of channelopathies is not restricted to genetic disorders; notably, changes in the expression or post-translational modification of ion channels underlie the fatal arrhythmias associated with heart failure. Recognizing the fundamental defects in channelopathies provides the basis for new strategies of treatment, including tailored pharmacotherapy and gene therapy.	Johns Hopkins Univ, Inst Mol Cardiobiol, Baltimore, MD 21205 USA	Johns Hopkins University	Marban, E (corresponding author), Johns Hopkins Univ, Inst Mol Cardiobiol, Ross 844, Baltimore, MD 21205 USA.		Marban, Eduardo/GWC-8514-2022					Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Antzelevitch C, 2001, J CARDIOVASC ELECTR, V12, P268, DOI 10.1046/j.1540-8167.2001.00268.x; Benhorin J, 2000, CIRCULATION, V101, P1698; Berenfeld O, 1998, CIRC RES, V82, P1063, DOI 10.1161/01.RES.82.10.1063; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Camm AJ, 2000, EUR HEART J, V21, P1232, DOI 10.1053/euhj.2000.2222; Catterall WA, 1996, J BIOENERG BIOMEMBR, V28, P219, DOI 10.1007/BF02110697; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Compton SJ, 1996, CIRCULATION, V94, P1018, DOI 10.1161/01.CIR.94.5.1018; CRANEFIELD PF, 1991, CARDIOVASC DRUG THER, V5, P531, DOI 10.1007/BF03029780; Donahue JK, 2000, NAT MED, V6, P1395; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; Dumaine R, 1996, CIRC RES, V78, P916, DOI 10.1161/01.RES.78.5.916; HOFFMAN BF, 1981, CIRC RES, V49, P1, DOI 10.1161/01.RES.49.1.1; Hoppe UC, 2000, J CLIN INVEST, V105, P1077, DOI 10.1172/JCI8757; Hoppe UC, 1999, CIRC RES, V84, P964; Hoppe UC, 2001, P NATL ACAD SCI USA, V98, P5335, DOI 10.1073/pnas.091239098; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kim D, 1998, CIRC RES, V82, P513, DOI 10.1161/01.RES.82.4.513; Koster OF, 1999, CARDIOVASC RES, V41, P175, DOI 10.1016/S0008-6363(98)00202-8; Liu XK, 1999, J CARDIOVASC PHARM, V34, P287, DOI 10.1097/00005344-199908000-00015; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Marban E, 1999, J CARDIOVASC ELECTR, V10, P1425, DOI 10.1111/j.1540-8167.1999.tb00199.x; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; Mazhari R, 2001, CIRC RES, V89, P33, DOI 10.1161/hh1301.093633; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; NABAUER M, 1993, CIRC RES, V73, P386, DOI 10.1161/01.RES.73.2.386; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; NICHOLS CG, 1991, CIRC RES, V68, P280, DOI 10.1161/01.RES.68.1.280; Nuss HB, 1996, GENE THER, V3, P900; Nuss HB, 1999, J CLIN INVEST, V103, P889, DOI 10.1172/JCI5073; PAPP Z, 1995, J PHYSIOL-LONDON, V483, P319, DOI 10.1113/jphysiol.1995.sp020588; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roden DM, 2001, CARDIOVASC RES, V50, P224, DOI 10.1016/S0008-6363(00)00302-3; Roden DM, 1999, J CARDIOVASC ELECTR, V10, P1664, DOI 10.1111/j.1540-8167.1999.tb00231.x; Rook MB, 1999, CARDIOVASC RES, V44, P507, DOI 10.1016/S0008-6363(99)00350-8; Saffitz JE, 2000, CIRC RES, V86, P723, DOI 10.1161/01.RES.86.7.723; Samie FH, 2001, CARDIOVASC RES, V50, P242, DOI 10.1016/S0008-6363(00)00289-3; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Schwartz PJ, 2001, CIRCULATION, V103, P89; Shimizu W, 1998, CIRCULATION, V97, P1581, DOI 10.1161/01.CIR.97.16.1581; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Y, 2000, AM J PHYSIOL-HEART C, V278, pH1019, DOI 10.1152/ajpheart.2000.278.4.H1019; WEIDMANN S, 1952, J PHYSIOL-LONDON, V118, P348, DOI 10.1113/jphysiol.1952.sp004799; Windle JR, 2001, ANN NONINVAS ELECTRO, V6, P153, DOI 10.1111/j.1542-474X.2001.tb00100.x; Winslow RL, 1998, PROG BIOPHYS MOL BIO, V69, P497, DOI 10.1016/S0079-6107(98)00022-4; Winslow RL, 1999, CIRC RES, V84, P571, DOI 10.1161/01.RES.84.5.571; YUE DT, 1988, PFLUG ARCH EUR J PHY, V413, P127, DOI 10.1007/BF00582522; ZENG JL, 1995, BIOPHYS J, V68, P949, DOI 10.1016/S0006-3495(95)80271-7	64	277	311	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					213	218		10.1038/415213a	http://dx.doi.org/10.1038/415213a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805845				2022-12-28	WOS:000173159300051
J	Toth, LJ; Assad, JA				Toth, LJ; Assad, JA			Dynamic coding of behaviourally relevant stimuli in parietal cortex	NATURE			English	Article							PRIMATE PREFRONTAL CORTEX; NEURAL ACTIVITY; AREA LIP; MOTOR; TRANSFORMATIONS; REPRESENTATION; SELECTIVITY; MOVEMENTS; MACAQUES; SPACE	A general function of cerebral cortex is to allow the flexible association of sensory stimuli with specific behaviours. Many neurons in parietal(1,2), prefrontal(3,4) and motor(5-7) cortical areas are activated both by particular movements and by sensory cues that trigger these movements, suggesting a role in linking sensation to action. For example, neurons in the lateral intraparietal area (LIP) encode both the location of visual stimuli and the direction of saccadic eye movements(8,9). LIP is not believed to encode nonspatial stimulus attributes such as colour(10,11). Here we investigated whether LIP would encode colour if colour was behaviourally linked to the eye movement. We trained monkeys to make an eye movement in one of two directions based alternately on the colour or location of a visual cue. When cue colour was relevant for directing eye movement, we found a substantial fraction of LIP neurons selective for cue colour. However, when cue location was relevant, colour selectivity was virtually absent in LIP. These results demonstrate that selectivity of cortical neurons can change as a function of the required behaviour.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Toth, LJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Toth, Louis/0000-0003-4986-7046				ABRAMSON N, 1963, INFORMATION THEORY C; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097	22	208	210	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					165	168		10.1038/415165a	http://dx.doi.org/10.1038/415165a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805833				2022-12-28	WOS:000173159300040
J	Kroupa, P				Kroupa, P			The initial mass function of stars: Evidence for uniformity in variable systems	SCIENCE			English	Review							STELLAR LUMINOSITY FUNCTION; ORION NEBULA CLUSTER; DWARF SPHEROIDAL GALAXY; GLOBULAR-CLUSTERS; BROWN DWARFS; SOLAR NEIGHBORHOOD; DYNAMICAL EVOLUTION; CIRCUMSTELLAR GAS; GALACTIC DISC; POPULATION	The distribution of stellar masses that form in one star formation event in a given volume of space is called the initial mass function (IMF). The IMF has been estimated from low-mass brown dwarfs to very massive stars. Combining IMF estimates for different populations in which the stars can be observed individually unveils an extraordinary uniformity of the IMF. This general insight appears to hold for populations including present-day star formation in small molecular clouds, rich and dense massive star-clusters forming in giant clouds, through to ancient and metal-poor exotic stellar populations that may be dominated by dark matter. This apparent universality of the IMF is a challenge for star formation theory, because elementary considerations suggest that the IMF ought to systematically vary with star-forming conditions.	Univ Kiel, Inst Theoret Phys & Astrophys, D-24098 Kiel, Germany	University of Kiel	Kroupa, P (corresponding author), Univ Kiel, Inst Theoret Phys & Astrophys, Olshaussenstr 40, D-24098 Kiel, Germany.		Kroupa, Pavel/H-5190-2012	Kroupa, Pavel/0000-0002-7301-3377				Adams FC, 1996, ASTROPHYS J, V468, P586, DOI 10.1086/177717; ANDERSEN J, 1991, ASTRON ASTROPHYS REV, V3, P91, DOI 10.1007/BF00873538; BAHCALL JN, 1984, ASTROPHYS J, V287, P926, DOI 10.1086/162750; Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; Basri G, 2000, ANNU REV ASTRON ASTR, V38, P485, DOI 10.1146/annurev.astro.38.1.485; BEERS TC, IN PRESS 1 STARS; Bejar VJS, 2001, ASTROPHYS J, V556, P830, DOI 10.1086/321621; Belikov AN, 1998, ASTRON ASTROPHYS, V332, P575; BEUZIT JL, UNPUB ASTRON ASTROPH; Binney J, 2000, MON NOT R ASTRON SOC, V318, P658, DOI 10.1046/j.1365-8711.2000.03720.x; Bonnell IA, 1998, MON NOT R ASTRON SOC, V298, P93, DOI 10.1046/j.1365-8711.1998.01590.x; Bonnell IA, 2001, MON NOT R ASTRON SOC, V324, P573, DOI 10.1046/j.1365-8711.2001.04311.x; Bonnell IA, 2001, MON NOT R ASTRON SOC, V322, P859, DOI 10.1046/j.1365-8711.2001.04171.x; Bontemps S, 2001, ASTRON ASTROPHYS, V372, P173, DOI 10.1051/0004-6361:20010474; BROMM V, IN PRESS MON NOT R A; Casassus S, 2000, ASTRON ASTROPHYS, V358, P514; Chabrier G, 1997, ASTRON ASTROPHYS, V327, P1039; Chabrier G, 2000, ANNU REV ASTRON ASTR, V38, P337, DOI 10.1146/annurev.astro.38.1.337; CHABRIER G, IN PRESS ASTROPHYS J; Chappell D, 2001, MON NOT R ASTRON SOC, V325, P1, DOI 10.1046/j.1365-8711.2001.04196.x; Delfosse X, 2000, ASTRON ASTROPHYS, V364, P217; Delfosse X, 1999, ASTRON ASTROPHYS, V344, P897; DEMARCHI G, 1995, ASTRON ASTROPHYS, V304, P211; DEMARCHI G, 1995, ASTRON ASTROPHYS, V304, P202; Duchene G, 2001, ASTRON ASTROPHYS, V379, P147, DOI 10.1051/0004-6361:20011305; Elmegreen BG, 2000, ASTROPHYS J, V530, P277, DOI 10.1086/308361; Feltzing S, 1999, ASTROPHYS J, V516, pL17, DOI 10.1086/311988; FLYNN C, 1994, MON NOT R ASTRON SOC, V270, P471, DOI 10.1093/mnras/270.3.471; GarciaSegura G, 1996, ASTRON ASTROPHYS, V316, P133; GarciaSegura G, 1996, ASTRON ASTROPHYS, V305, P229; Gizis JE, 2001, ASTROPHYS J, V551, pL163, DOI 10.1086/320017; Gould A, 1997, ASTROPHYS J, V482, P913, DOI 10.1086/304194; Gould A, 1998, ASTROPHYS J, V503, P798, DOI 10.1086/306023; Grillmair CJ, 1998, ASTRON J, V115, P144, DOI 10.1086/300169; Halbwachs JL, 2000, ASTRON ASTROPHYS, V355, P581; Hambly NC, 1999, MON NOT R ASTRON SOC, V303, P835, DOI 10.1046/j.1365-8711.1999.02283.x; HAMBLY NC, 1991, MON NOT R ASTRON SOC, V253, P1; HAYASHI C, 1963, PROG THEOR PHYS, V30, P460, DOI 10.1143/PTP.30.460; Henry TJ, 1997, ASTRON J, V114, P388, DOI 10.1086/118482; Hensler G, 1999, ASTROPHYS SPACE SCI, V265, P397, DOI 10.1023/A:1002129825950; Hillenbrand LA, 2000, ASTROPHYS J, V540, P236, DOI 10.1086/309309; Hillenbrand LA, 1997, ASTRON J, V113, P1733, DOI 10.1086/118389; Holtzman JA, 1998, ASTRON J, V115, P1946, DOI 10.1086/300336; Izotova I, 2000, NEW ASTRON REV, V44, P283, DOI 10.1016/S1387-6473(00)00045-2; Jahreiss H, 1997, ESA SP PUBL, V402, P675; JAHREISS H, 1994, SCI ASTRONOMICAL NEA, P63; Klessen RS, 2001, ASTROPHYS J, V550, pL77, DOI 10.1086/319488; Klessen RS, 2001, ASTROPHYS J, V556, P837, DOI 10.1086/321626; KROUPA P, 1991, MON NOT R ASTRON SOC, V251, P293, DOI 10.1093/mnras/251.2.293; KROUPA P, 1990, MON NOT R ASTRON SOC, V244, P76; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; KROUPA P, 1993, MON NOT R ASTRON SOC, V262, P545, DOI 10.1093/mnras/262.3.545; KROUPA P, 1995, ASTROPHYS J, V453, P350, DOI 10.1086/176394; Kroupa P, 1995, MON NOT R ASTRON SOC, V277, P1491, DOI 10.1093/mnras/277.4.1491; Kroupa P, 2001, MON NOT R ASTRON SOC, V321, P699, DOI 10.1046/j.1365-8711.2001.04050.x; Kroupa P, 1997, MON NOT R ASTRON SOC, V287, P402, DOI 10.1093/mnras/287.2.402; KROUPA P, IN PRESS ASP C SERIE; Kudritzki RP, 2000, ANNU REV ASTRON ASTR, V38, P613, DOI 10.1146/annurev.astro.38.1.613; KUIJKEN K, 1991, ASTROPHYS J, V372, P125, DOI 10.1086/169959; Larson RB, 1998, MON NOT R ASTRON SOC, V301, P569, DOI 10.1046/j.1365-8711.1998.02045.x; Lucas PW, 2000, MON NOT R ASTRON SOC, V314, P858, DOI 10.1046/j.1365-8711.2000.03515.x; Lucas PW, 2001, MON NOT R ASTRON SOC, V326, P695, DOI 10.1046/j.1365-8711.2001.04666.x; Luhman KL, 2000, ASTROPHYS J, V540, P1016, DOI 10.1086/309365; Luhman KL, 1998, ASTROPHYS J, V508, P347, DOI 10.1086/306393; Luhman KL, 2000, ASTROPHYS J, V544, P1044, DOI 10.1086/317232; LUTZ TE, 1973, PUBL ASTRON SOC PAC, V85, P573, DOI 10.1086/129506; Maeder A, 2000, ANNU REV ASTRON ASTR, V38, P143, DOI 10.1146/annurev.astro.38.1.143; MAEDER A, IN PRESS PASP; Malkov O, 2001, MON NOT R ASTRON SOC, V321, P149, DOI 10.1046/j.1365-8711.2001.04015.x; Marcos RD, 1998, ASTRON ASTROPHYS, V333, pL27; MARTIN EL, IN PRESS ASTROPHYS J; Massey P, 1998, ASTR SOC P, V142, P17; MILLER GE, 1979, ASTROPHYS J SUPPL S, V41, P513, DOI 10.1086/190629; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; Muench AA, 2000, ASTROPHYS J, V533, P358, DOI 10.1086/308638; Navascues DBY, 2001, ASTROPHYS J, V546, P1006, DOI 10.1086/318283; NAVASCUES DBY, IN PRESS ASTRON ASTR; PARESCE F, 1995, ASTROPHYS J, V440, P216, DOI 10.1086/175263; Piotto G, 1999, ASTRON ASTROPHYS, V345, P485; Preibisch T, 1999, NEW ASTRON, V4, P531, DOI 10.1016/S1384-1076(99)00042-1; RAMSPECK M, IN PRESS ASTRON ASTR; REID N, 1982, MON NOT R ASTRON SOC, V201, P73, DOI 10.1093/mnras/201.1.73; Reid N., 1997, AJ, V113, P2246; Reipurth B, 2001, ASTRON J, V122, P432, DOI 10.1086/321121; Reyle C, 2001, ASTRON ASTROPHYS, V373, P886, DOI 10.1051/0004-6361:20010680; SAGAR R, 1991, ASTRON ASTROPHYS, V250, P324; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SANTOS NC, IN PRESS COOL STARS; Scalo J, 1998, ASTR SOC P, V142, P201; Scalo J. M., 1986, Fundamentals of Cosmic Physics, V11, P1; SCALO JM, 1978, PROTOSTARS PLANETS, P265; Siess L, 2000, ASTRON ASTROPHYS, V358, P593; Sirianni M, 2000, ASTROPHYS J, V533, P203, DOI 10.1086/308628; Smith LJ, 2001, MON NOT R ASTRON SOC, V326, P1027, DOI 10.1046/j.1365-8711.2001.04627.x; STOBIE RS, 1989, MON NOT R ASTRON SOC, V238, P709, DOI 10.1093/mnras/238.3.709; Tsuru TG, 1997, PUBL ASTRON SOC JPN, V49, P619, DOI 10.1093/pasj/49.6.619; UMEDA H, IN PRESS ASTROPHYS J; Vesperini E, 1997, MON NOT R ASTRON SOC, V289, P898, DOI 10.1093/mnras/289.4.898; VOGT SS, UNPUB ASTROPHYS J; Wuchterl G, 2001, ASTROPHYS J, V560, pL185, DOI 10.1086/324307; Zheng Z, 2001, ASTROPHYS J, V555, P393, DOI 10.1086/321485; [No title captured]; [No title captured]	104	1280	1281	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					82	91		10.1126/science.1067524	http://dx.doi.org/10.1126/science.1067524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778039				2022-12-28	WOS:000173143100037
J	Echtay, KS; Roussel, D; St-Pierre, J; Jekabsons, MB; Cadenas, S; Stuart, JA; Harper, JA; Roebuck, SJ; Morrison, A; Pickering, S; Clapham, JC; Brand, MD				Echtay, KS; Roussel, D; St-Pierre, J; Jekabsons, MB; Cadenas, S; Stuart, JA; Harper, JA; Roebuck, SJ; Morrison, A; Pickering, S; Clapham, JC; Brand, MD			Superoxide activates mitochondrial uncoupling proteins	NATURE			English	Article							BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; FATTY-ACIDS; RAT; NUCLEOTIDES; EXPRESSION; GENERATION; GENE; MICE; UCP2	Uncoupling protein 1 (UCP1) diverts energy from ATP synthesis to thermogenesis in the mitochondria of brown adipose tissue by catalysing a regulated leak of protons across the inner membrane(1,2). The functions of its homologues, UCP2 and UCP3, in other tissues are debated(3,4). UCP2 and UCP3 are present at much lower abundance than UCP1, and the uncoupling with which they are associated is not significantly thermogenic(5,6). Mild uncoupling would, however, decrease the mitochondrial production of reactive oxygen species, which are important mediators of oxidative damage(7,8). Here we show that superoxide increases mitochondrial proton conductance through effects on UCP1, UCP2 and UCP3. Superoxide-induced uncoupling requires fatty acids and is inhibited by purine nucleotides. It correlates with the tissue expression of UCPs, appears in mitochondria from yeast expressing UCP1, and is absent in skeletal muscle mitochondria from UCP3 knockout mice. Our findings indicate that the interaction of superoxide with UCPs may be a mechanism for decreasing the concentrations of reactive oxygen species inside mitochondria.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; GlaxoSmithKline, Dept Comparat Genome, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Dept Vasc Biol, Harlow CM19 5AW, Essex, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; GlaxoSmithKline; GlaxoSmithKline	Brand, MD (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.		Clapham, John/AAK-4715-2020; St-Pierre, Julie/AGB-3651-2022; Cadenas, Susana/D-1523-2016; Brand, Martin D/A-9423-2012	St-Pierre, Julie/0000-0002-2815-7099; Brand, Martin D/0000-0003-4418-6153; Cadenas, Susana/0000-0003-0726-0369; Roussel, Damien/0000-0002-8865-5428				Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BATHGATE B, 1992, MOL MICROBIOL, V6, P363, DOI 10.1111/j.1365-2958.1992.tb01479.x; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Echtay KS, 2001, BIOCHEM SOC T, V29, P763; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; JEZEK P, 1994, J BIOL CHEM, V269, P26184; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Pastore D, 2000, FEBS LETT, V470, P88, DOI 10.1016/S0014-5793(00)01292-8; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Stuart JA, 2001, BBA-BIOENERGETICS, V1504, P144, DOI 10.1016/S0005-2728(00)00243-7; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	30	1081	1130	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					96	99		10.1038/415096a	http://dx.doi.org/10.1038/415096a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780125				2022-12-28	WOS:000173028800048
J	Kerp, H				Kerp, H			Palaeobotany - Atmospheric CO2 from fossil plant cuticles	NATURE			English	Article							PERMIAN PALEOBOTANY; PALYNOLOGY		Univ Munster, Inst Geol & Palaeontol, Forschungsstelle Palaobot, D-48143 Munster, Germany	University of Munster	Kerp, H (corresponding author), Univ Munster, Inst Geol & Palaeontol, Forschungsstelle Palaobot, D-48143 Munster, Germany.		Kerp, Hans/AAJ-1102-2020					BARTHEL M., 1980, SCHRIFTENREIHE GEOLO, V16, P49; Boy J.A., 1982, Z DTSCH GEOL GES, V133, P607; KERP H, 1993, REV PALAEOBOT PALYNO, V78, P1, DOI 10.1016/0034-6667(93)90014-L; KERP JHF, 1988, REV PALAEOBOT PALYNO, V54, P249, DOI 10.1016/0034-6667(88)90017-6; LIPPOLT HJ, 1989, JB GEOL PALAONT MH, P553; Naugolnykh SV, 1996, REV PALAEOBOT PALYNO, V91, P35, DOI 10.1016/0034-6667(95)00066-6; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; Poole I, 2000, NEW PHYTOL, V145, P511, DOI 10.1046/j.1469-8137.2000.00589.x; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041	9	7	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					38	38		10.1038/415038a	http://dx.doi.org/10.1038/415038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780108	Bronze			2022-12-28	WOS:000173028800031
J	Prives, C; Manley, JL				Prives, C; Manley, JL			Why is p53 acetylated?	CELL			English	Review							HISTONE DEACETYLASES; DNA-DAMAGE; PHOSPHORYLATION; ACTIVATION	Recent studies suggest that acetylation of the p53 tumor suppressor protein is not important for its DNA binding activity, as was previously thought. We discuss here a number of theories as to how this modification may serve to regulate the protein's functions.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Manley, James/0000-0002-8341-1459				Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X	20	178	181	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					815	818		10.1016/S0092-8674(01)00619-5	http://dx.doi.org/10.1016/S0092-8674(01)00619-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779456	Bronze			2022-12-28	WOS:000173024200001
J	Horton, R				Horton, R			Ghana: defining the African challenge	LANCET			English	Article								In 1957, Ghana became the first African nation to achieve Independence from its colonial ruler. But since then Ghana has suffered mixed political and economic fortunes. The health of Ghana's people and the country's progress in modernising its health-care system have fluctuated according to peaks and troughs in West African history. Some critics see Ghana's course since independence as a promise unfulfilled. Others view Ghana as a model for North-South cooperation, which could be rolled out across the whole of Africa. In November, 2001, 1 visited hospitals and health centres in both rural and urban settings to investigate the present state of Ghanaian medicine. The picture I saw was one of a country clear about what it wants to do but divided about how it should achieve its goals. If Ghana is to be a model for Africa, it is more a model of problems to be faced than solutions discovered.	Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, 84 Theobalds Rd, London WC1X 8RR, England.							[Anonymous], 2001, LANCET, V358, P1471; Cammack P., 2002, DEV THEORY PRACTICE, P157; Cappuccio FP, 2000, LANCET, V356, P677, DOI 10.1016/S0140-6736(05)73821-6; Crook R.C., 1998, DEMOCRACY DECENTRALI; de Rivero Oswaldo, 2001, MYTH DEV; EASMON CO, 1969, GHANA MED J, V8, P208; Eastwood JB, 2001, QJM-MON J ASSOC PHYS, V94, P637, DOI 10.1093/qjmed/94.11.637; ENSOR T, 2001, GEOGRAPHICAL RESOURC; Fentiman A, 2001, SOC SCI MED, V52, P429, DOI 10.1016/S0277-9536(00)00152-0; Hodgson A, 2001, T ROY SOC TROP MED H, V95, P477, DOI 10.1016/S0035-9203(01)90007-0; KONOTEYAHULU FID, 1969, GHANA MED J, V8, P172; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; *MIN HLTH, 2001, HLTH NAT; NKRUMAH K, 1962, GHANA MED J, V1, P1; Omari T. P., 2000, K NKRUMAH ANATOMY AF; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; Pakenham Thomas, 1992, SCRAMBLE AFRICA; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; World Bank, 2002, WORLD DEV REP; 2001, HUMAN DEV REPORT 200; 1964, GHANA MED J, V3, P183; 2001, GHANA MED J, V35, P4	22	19	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2141	2149		10.1016/S0140-6736(01)07221-X	http://dx.doi.org/10.1016/S0140-6736(01)07221-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784645				2022-12-28	WOS:000172905800029
J	Castro, M; Dozor, A; Fish, J; Irvin, C; Scharf, S; Scheipeter, ME; Holbrook, J; Tonascia, J; Wise, R				Castro, M; Dozor, A; Fish, J; Irvin, C; Scharf, S; Scheipeter, ME; Holbrook, J; Tonascia, J; Wise, R		Amer Lung Assoc Asthma Clinical R	The safety of inactivated influenza vaccine in adults and children with asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; WORKING ADULTS; VIRUS VACCINE; UNITED-STATES; EFFICACY; HEALTHY; HOSPITALIZATION; EXACERBATIONS; IMMUNIZATION; PREDNISONE	Background: Influenza causes substantial morbidity in adults and children with asthma, and vaccination can prevent influenza and its complications. However, there is concern that vaccination may cause exacerbations of asthma. Methods: To investigate the safety of the inactivated trivalent split-virus influenza vaccine in adults and children with asthma, we conducted a multicenter, randomized, double-blind, placebo-controlled, crossover trial in 2032 patients with asthma (age range, 3 to 64 years). The order of injection of vaccine and placebo was assigned randomly, with a mean of 22 days between the injections. Each day during the two weeks after each injection, the patients recorded peak expiratory flow rates, symptoms thought to be related to the injection, use of asthma medications, unscheduled health care visits for asthma, and asthma-related absences from school or work. The primary outcome measure was an exacerbation of asthma in the two weeks after the injections. Results: The frequency of exacerbations of asthma was similar in the two weeks after the influenza vaccination and after placebo injection (28.8 percent and 27.7 percent, respectively; absolute difference, 1.1 percent; 95 percent confidence interval, -1.4 percent to 3.6 percent). The exacerbation rates were similar in subgroups defined according to age, severity of asthma, and other factors. Among symptoms thought to be associated with the injection, only body aches were more frequent after the vaccine injection than after placebo injection (25.1 percent vs. 20.8 percent, P<0.001). Conclusions: The inactivated influenza vaccine is safe to administer to adults and children with asthma, including those with severe asthma. Given the morbidity of influenza, all those with asthma should receive the vaccine annually. (N Engl J Med 2001;345:1529-36.) Copyright (C) 2001 Massachusetts Medical Society.	Washington Univ, Sch Med, St Louis, MO 63110 USA; Westchester Cty Med Ctr, Childrens Hosp, Valhalla, NY 10595 USA; New York Med Coll, Valhalla, NY 10595 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; N Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA; Univ Vermont, Vermont Lung Ctr, Colchester, VT USA; St Louis Asthma Clin Res Ctr, St Louis, MO USA; St Louis Univ, St Louis, MO 63103 USA; Clin Res Ctr, St Louis, MO USA; Johns Hopkins Univ, Data Coordinating Ctr, Ctr Clin Trials, Baltimore, MD USA	Washington University (WUSTL); Westchester Medical Center; New York Medical College; Jefferson University; Northwell Health; University of Vermont; Saint Louis University; Johns Hopkins University	Castro, M (corresponding author), Washington Univ, Sch Med, Box 8052,660 S Euclid Ave, St Louis, MO 63110 USA.			Wise, Robert/0000-0002-8353-2349				Armitage P., 1987, STAT METHODS MED RES; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; BELL TD, 1978, CHEST, V73, P140, DOI 10.1378/chest.73.2.140; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; CATES C, 1999, INFLUENZA VACCINATIO; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Elashoff JD, 2000, NQUERY ADVISOR USERS; Fairchok MP, 1998, ARCH PEDIAT ADOL MED, V152, P1191; FOX J, 1996, ASM NEWS, V63, P29; GARDNER MJ, 1989, STAT CONFIDENCE CONF; *GLAX WELLC, 1998, ASTHM AM EX SUMM; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Innes A, 2000, BRIT J GEN PRACT, V50, P27; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KEITEL WA, 1988, AM J EPIDEMIOL, V127, P353, DOI 10.1093/oxfordjournals.aje.a114809; KONDO S, 1991, CHEST, V100, P1235, DOI 10.1378/chest.100.5.1235; Kramarz P, 2001, J PEDIATR-US, V138, P306, DOI 10.1067/mpd.2001.112168; Kramarz P, 2000, ARCH FAM MED, V9, P617, DOI 10.1001/archfami.9.7.617; *NAT ASTHM ED PREV, 1998, NIH PUBL; National Council for Interior Design Qualificaion, 2000, NCIDQ EX STUD GUID, P22; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2001, J PEDIATR-US, V138, P301, DOI 10.1067/mpd.2001.113101; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Nicholson KG, 1998, LANCET, V351, P326, DOI 10.1016/S0140-6736(97)07468-0; Park CL, 1996, PEDIATRICS, V98, P196; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Rosner B, 1998, J PEDIATR-US, V132, P211, DOI 10.1016/S0022-3476(98)70434-2; SAS Institute, 1999, SAS STAT US GUID; STENIUSAARNIALA B, 1986, CHEST, V89, P786, DOI 10.1378/chest.89.6.786; SUGAYA N, 1994, JAMA-J AM MED ASSOC, V272, P1122, DOI 10.1001/jama.272.14.1122; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; Szefler S, 2000, NEW ENGL J MED, V343, P1054; SZILAGYI PG, 1992, PEDIATRICS, V90, P871; Watson JM, 1997, THORAX, V52, P190, DOI 10.1136/thx.52.2.190; WILLIAMS WW, 1988, ANN INTERN MED, V109, P348, DOI 10.7326/0003-4819-109-4-348_2; 1998, MMWR CDC SURVEILL SU, V47, P1	41	152	161	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1529	1536						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794219	Bronze			2022-12-28	WOS:000172265200003
J	Norwitz, ER; Schust, DJ; Fisher, SJ				Norwitz, ER; Schust, DJ; Fisher, SJ			Mechanisms of disease - Implantation and the survival of early pregnancy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN CYTOTROPHOBLAST DIFFERENTIATION; LEUKEMIA INHIBITORY FACTOR; ENDOMETRIAL STROMAL CELLS; HEPATOCYTE GROWTH-FACTOR; INVASION IN-VITRO; EMBRYO IMPLANTATION; TROPHOBLAST INVASION; MOUSE UTERUS; PLACENTAL DEVELOPMENT; UTERINE RECEPTIVITY		Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Maternal Fetal Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Norwitz, ER (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Maternal Fetal Med, 75 Francis St, Boston, MA 02115 USA.				NHLBI NIH HHS [HL64597] Funding Source: Medline; NICHD NIH HHS [HD26732, HD30367, HD00840, HD00849] Funding Source: Medline; PHS HHS [6RT-0304] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849, P01HD030367] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD026732] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064597] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABEL MH, 1980, J ENDOCRINOL, V85, P379, DOI 10.1677/joe.0.0850379; Afonso S, 1997, DEVELOPMENT, V124, P3415; Allan DSJ, 1999, J EXP MED, V189, P1149, DOI 10.1084/jem.189.7.1149; Athanassiades A, 1998, BIOL REPROD, V59, P643, DOI 10.1095/biolreprod59.3.643; Bainbridge DRJ, 1999, J IMMUNOL, V163, P2023; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bass KE, 1997, DEV GENET, V21, P61, DOI 10.1002/(SICI)1520-6408(1997)21:1<61::AID-DVG7>3.0.CO;2-6; BENIRSCHKE K, 1991, PATHOLOGY HUMAN PLAC, P13; BERGH PA, 1992, FERTIL STERIL, V58, P537; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BROSENS IA, 1977, CLIN OBSTET GYNAECOL, V4, P573; Bustillo M, 1999, FERTIL STERIL, V71, P798; CAMPBELL S, 1995, HUM REPROD, V10, P1571, DOI 10.1093/HUMREP/10.6.1571; Chaouat G, 1995, HUM REPROD, V10, P55, DOI 10.1093/humrep/10.suppl_2.55; Cohen PE, 1997, BIOL REPROD, V56, P110, DOI 10.1095/biolreprod56.1.110; Csapo A I, 1978, Obstet Gynecol Surv, V33, P69, DOI 10.1097/00006254-197802000-00001; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; Damsky CH, 1998, CURR OPIN CELL BIOL, V10, P660, DOI 10.1016/S0955-0674(98)80043-4; Das SK, 1997, DEV BIOL, V190, P178, DOI 10.1006/dbio.1997.8694; DAS SK, 1994, DEVELOPMENT, V120, P1071; DENIZ G, 1994, J IMMUNOL, V152, P4255; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Enders AC, 1999, ANAT RECORD, V256, P279, DOI 10.1002/(SICI)1097-0185(19991101)256:3<279::AID-AR7>3.0.CO;2-O; Enders AC, 2000, SEMIN REPROD MED, V18, P255, DOI 10.1055/s-2000-12563; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Genbacev O, 2001, DEV BIOL, V233, P526, DOI 10.1006/dbio.2001.0231; Giudice LC, 1999, SEMIN REPROD ENDOCR, V17, P13, DOI 10.1055/s-2007-1016207; Godkin JD, 1998, REV REPROD, V3, P1; Hemberger M, 2001, TRENDS ENDOCRIN MET, V12, P162, DOI 10.1016/S1043-2760(01)00375-7; HERTIG AT, 1959, PEDIATRICS, V23, P202; Huang JC, 1998, J CLIN ENDOCR METAB, V83, P538, DOI 10.1210/jc.83.2.538; Huppertz B, 1998, CELL TISSUE RES, V291, P133; Janatpour MJ, 1999, DEV GENET, V25, P146, DOI 10.1002/(SICI)1520-6408(1999)25:2<146::AID-DVG9>3.0.CO;2-K; Janatpour MJ, 2000, DEVELOPMENT, V127, P549; JASCHEVATZKY OE, 1983, BRIT J OBSTET GYNAEC, V90, P958, DOI 10.1111/j.1471-0528.1983.tb06770.x; KAMIMURA S, 1991, ACTA MED OKAYAMA, V45, P135; King A, 1998, HUM REPROD UPDATE, V4, P480, DOI 10.1093/humupd/4.5.480; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; Lessey BA, 1998, HUM REPROD, V13, P247, DOI 10.1093/humrep/13.suppl_3.247; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Liu LM, 1996, J BIOL CHEM, V271, P16683, DOI 10.1074/jbc.271.28.16683; MAATHUIS JB, 1978, J ENDOCRINOL, V77, P361, DOI 10.1677/joe.0.0770361; Marions L, 1999, MOL HUM REPROD, V5, P961, DOI 10.1093/molehr/5.10.961; Martin KL, 1998, HUM REPROD, V13, P1645, DOI 10.1093/humrep/13.6.1645; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Miller WL, 1998, CLIN PERINATOL, V25, P799, DOI 10.1016/S0095-5108(18)30084-8; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nasu K, 1999, BIOL REPROD, V60, P1183, DOI 10.1095/biolreprod60.5.1183; Norwitz ER, 2000, AM J OBSTET GYNECOL, V183, P108, DOI 10.1067/mob.2000.105636; Norwitz ER, 1999, CLIN OBSTET GYNECOL, V42, P436, DOI 10.1097/00003081-199909000-00003; NORWITZ ER, 1998, INFERTIL REPROD MED, V9, P351; Paria B C, 1998, Adv Pharmacol, V42, P840; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; PAVIA C, 1979, J REPROD IMMUNOL, V1, P33, DOI 10.1016/0165-0378(79)90027-5; PEYRON R, 1993, NEW ENGL J MED, V328, P1509, DOI 10.1056/NEJM199305273282101; PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2; PIJNENBORG R, 1981, PLACENTA, V2, P303, DOI 10.1016/S0143-4004(81)80027-6; PSYCHOYOS A, 1986, ANN NY ACAD SCI, V476, P36, DOI 10.1111/j.1749-6632.1986.tb20920.x; REDMAN CWG, 1983, AM J REPROD IMMUNOL, V3, P175, DOI 10.1111/j.1600-0897.1983.tb00241.x; Roberts RM, 1999, PLACENTA, V20, P259, DOI 10.1053/plac.1998.0381; Roth I, 1996, J EXP MED, V184, P539, DOI 10.1084/jem.184.2.539; SAITO S, 1995, J BIOCHEM-TOKYO, V117, P671, DOI 10.1093/oxfordjournals.jbchem.a124761; SAUER MV, 1992, JAMA-J AM MED ASSOC, V268, P1275, DOI 10.1001/jama.268.10.1275; SAUER MV, 1993, JAMA-J AM MED ASSOC, V269, P476; Schatz F, 1999, SEMIN REPROD ENDOCR, V17, P3, DOI 10.1055/s-2007-1016206; Schrocksnadel H, 1996, OBSTET GYNECOL, V88, P47, DOI 10.1016/0029-7844(96)00084-1; Schust DJ, 1996, HUM REPROD, V11, P980; SHETH KV, 1991, FERTIL STERIL, V55, P952; Simon C, 1996, J REPROD IMMUNOL, V31, P165, DOI 10.1016/0165-0378(96)00982-5; SIMPSON JL, 1980, FERTIL STERIL, V33, P107; SLOWEY MJ, 1994, J SOC GYNECOL INVEST, V1, P277, DOI 10.1177/107155769400100406; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Spandorfer S., 1999, EMBRYO IMPLANTATION, P12; STARKEY PM, 1988, IMMUNOLOGY, V65, P129; Stewart CL, 1997, DEV GENET, V21, P91, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;91::AID-DVG11&gt;3.0.CO;2-D; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wang J, 2000, DEVELOPMENT, V127, P33; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; WILSON T, 1986, PROSTAGLANDINS, V31, P343, DOI 10.1016/0090-6980(86)90059-6; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	88	787	834	4	99	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1400	1408		10.1056/NEJMra000763	http://dx.doi.org/10.1056/NEJMra000763			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794174				2022-12-28	WOS:000172014200007
J	Masumoto, H; Muramatsu, S; Kamimura, Y; Araki, H				Masumoto, H; Muramatsu, S; Kamimura, Y; Araki, H			S-Cdk-dependent phosphorylation of Sld2 essential for chromosomal DNA replication in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; POLYMERASE-ALPHA; SHUTTLE VECTORS; KINASE; PHASE; ORIGINS; COMPLEX; PROTEIN; CDC45P	Cyclin-dependent protein kinases (Cdks) in eukaryotic cells work as a key enzyme at various points in the cell cycle(1,2). At the onset of S phase, active S-phase Cdks (S-Cdks) are essential for chromosomal DNA replication(3). Although several replication proteins are phosphorylated in a Cdk-dependent manner(3), the biological effects of phosphorylation of these proteins on the activation of DNA replication have not been elucidated. Here we show that Sld2 (ref. 4) (also known as Drc1; ref. 5), one of the replication proteins of budding yeast (Saccharomyces cerevisiae), is phosphorylated in S phase in an S-Cdk-dependent manner, and mutant Sld2 lacking all the preferred Cdk phosphorylation sites (All-A) is defective in chromosomal DNA replication. Moreover, the complex that contains, at least, Sld2 and Dpb11 (ref. 6) (the Sld2-Dpb11 complex(4)) is formed predominantly in S phase; the All-A protein is defective in this complex formation. Because this complex is suggested to be essential for chromosomal DNA replication 4,5, it seems likely that S-Cdk positively regulates formation of the Sld2-Dpb11 complex and, consequently, chromosomal DNA replication.	Grad Univ Adv Studies, Dept Genet, Natl Inst Genet, Div Microbial Genet, Shizuoka 4118540, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Araki, H (corresponding author), Grad Univ Adv Studies, Dept Genet, Natl Inst Genet, Div Microbial Genet, Yata 1111, Shizuoka 4118540, Japan.	hiaraki@lab.nig.ac.jp	Kamimura, Yoichiro/M-2585-2017					Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Diffley JFX, 1995, J CELL SCI, P67; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PONDAVEN P, 1990, GENE DEV, V4, P9, DOI 10.1101/gad.4.1.9; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	30	164	169	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					651	655		10.1038/nature713	http://dx.doi.org/10.1038/nature713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11807498				2022-12-28	WOS:000173709100049
J	Ferguson, NM; Ghani, AC; Donnelly, CA; Hagenaars, TJ; Anderson, RM				Ferguson, NM; Ghani, AC; Donnelly, CA; Hagenaars, TJ; Anderson, RM			Estimating the human health risk from possible BSE infection of the British sheep flock	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; GREAT-BRITAIN; PRION PROTEIN; SCRAPIE; EPIDEMIOLOGY; TRANSMISSION; ACCUMULATION; DYNAMICS; VCJD	Following the controversial failure of a recent study(1) and the small numbers of animals yet screened for infection(2), it remains uncertain whether bovine spongiform encephalopathy (BSE) was transmitted to sheep in the past via feed supplements and whether it is still present. Well grounded mathematical and statistical models are therefore essential to integrate the limited and disparate data, to explore uncertainty, and to define data-collection priorities. We analysed the implications of different scenarios of BSE spread in sheep for relative human exposure levels and variant Creutzfeldt-Jakob disease (vCJD) incidence. Here we show that, if BSE entered the sheep population and a degree of transmission occurred, then ongoing public health risks from ovine BSE are likely to be greater than those from cattle, but that any such risk could be reduced by up to 90% through additional restrictions on sheep products entering the food supply. Extending the analysis to consider absolute risk, we estimate the 95% confidence interval for future vCJD mortality to be 50 to 50,000 human deaths considering exposure to bovine BSE alone, with the upper bound increasing to 150,000 once we include exposure from the worst-case ovine BSE scenario examined.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@ic.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Anderson, Roy/0000-0002-9528-3175; Donnelly, Christl/0000-0002-0195-2463; Ghani, Azra/0000-0002-0007-4910				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; d'Aignaux JNH, 2001, SCIENCE, V294, P1729, DOI 10.1126/science.1064748; DONNELLY CA, 2000, STAT ASPECTS BSE VCI; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Frankish H, 2001, LANCET, V358, P1436, DOI 10.1016/S0140-6736(01)06544-8; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Gravenor MB, 2001, P ROY SOC B-BIOL SCI, V268, P587, DOI 10.1098/rspb.2000.1462; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hart R. J, 1997, AUDIT BOVINE OVINE S; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hoinville LJ, 2000, VET REC, V146, P455, DOI 10.1136/vr.146.16.455; Hunter N, 2000, ARCH VIROL, P181; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; JEFFREY M, UNPUB J COMP PATHOL; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; *MEAT LIV COMM, 1998, C782506 MEAT LIV COM; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; van Keulen LJM, 2000, ARCH VIROL, P57; WELLS GAH, 1994, VET REC, V135, P40, DOI 10.1136/vr.135.2.40; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427	29	81	82	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					420	424		10.1038/nature709	http://dx.doi.org/10.1038/nature709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11786878				2022-12-28	WOS:000173433600047
J	Boyd, J				Boyd, J			Robotic laboratory automation	SCIENCE			English	Article							JAPAN		Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Boyd, J (corresponding author), Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA 22908 USA.							Boyd JC, 1996, CLIN CHEM, V42, P1901; Devol GC, 1961, U.S. Patent, Patent No. [2,988,237, 2988237]; FELDER RA, 1995, ARCH PATHOL LAB MED, V119, P948; Felder RA, 1998, CLIN CHIM ACTA, V278, P257, DOI 10.1016/S0009-8981(98)00151-X; Fineberg SE, 2001, DIABETES CARE, V24, P1217, DOI 10.2337/diacare.24.7.1217; GODOLPHIN W, 1983, ADV LABORATORY AUTOM, V2, P553; Hawker CD, 2000, CLIN CHEM, V46, P746; Markin RS, 2000, CLIN CHEM, V46, P764; Rutherford M L, 2001, Curr Opin Drug Discov Devel, V4, P343; Sasaki M, 1998, CLIN CHIM ACTA, V278, P217, DOI 10.1016/S0009-8981(98)00148-X; Tatsumi N, 1999, CLIN CHIM ACTA, V290, P93, DOI 10.1016/S0009-8981(99)00179-5	11	28	29	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					517	518		10.1126/science.295.5554.517	http://dx.doi.org/10.1126/science.295.5554.517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799250				2022-12-28	WOS:000173350700056
J	Matsumoto, Y; Maller, JL				Matsumoto, Y; Maller, JL			Calcium, calmodulin, and CaMKII requirement for initiation of centrosome duplication in Xenopus egg extracts	SCIENCE			English	Article							PROTEIN-KINASE-II; MAMMALIAN-CELLS	Aberrant centrosome duplication is observed in many tumor cells and may contribute to genomic instability through the formation of multipolar mitotic spindles. Cyclin-dependent kinase 2 (Cdk2) is required for multiple rounds of centrosome duplication in Xenopus egg extracts but not for the initial round of replication. Egg extracts undergo periodic oscillations in the level of free calcium. We show here that chelation of calcium in egg extracts or specific inactivation of calcium/calmodulin-dependent protein kinase 11 (CaMKII) blocks even initial centrosome duplication, whereas inactivation of Cdk2 does not. Duplication can be restored to inhibited extracts by addition of CaMKII and calmodulin. These results indicate that calcium, calmodulin, and CaMKII are required for an essential step in initiation of centrosome duplication. Our data suggest that calcium oscillations in the cell cycle may be linked to centrosome duplication.	Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA.				NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NCI NIH HHS [CA46934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Kim SH, 1999, DEV BIOL, V212, P381, DOI 10.1006/dbio.1999.9361; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y., UNPUB; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; OHTA Y, 1990, P NATL ACAD SCI USA, V87, P5341, DOI 10.1073/pnas.87.14.5341; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; PIETROMONACO SF, 1995, BLOOD CELL MOL DIS, V21, P34, DOI 10.1006/bcmd.1995.0006; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; SU JY, 1995, P NATL ACAD SCI USA, V92, P10187, DOI 10.1073/pnas.92.22.10187; Swanson CA, 1997, P NATL ACAD SCI USA, V94, P1194, DOI 10.1073/pnas.94.4.1194; Tokmakov AA, 2001, J CELL BIOCHEM, V82, P89, DOI 10.1002/jcb.1140.abs; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018	27	79	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					499	502		10.1126/science.1065693	http://dx.doi.org/10.1126/science.1065693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799245				2022-12-28	WOS:000173350700051
J	Chang, A; Tourtellotte, WW; Rudick, R; Trapp, BD				Chang, A; Tourtellotte, WW; Rudick, R; Trapp, BD			Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAT OPTIC-NERVE; GLIAL PROGENITOR-CELL; PDGF ALPHA-RECEPTOR; ADULT HUMAN CNS; NG2 PROTEOGLYCAN; PRECURSOR CELLS; SPINAL-CORD; REMYELINATION; SURVIVAL; BRAIN	Background: Multiple sclerosis is an inflammatory disease of the central nervous system that destroys myelin, oligodendrocytes, and axons. Since most of the lesions of multiple sclerosis are not remyelinated, enhancement of remyelination is a possible therapeutic strategy that could perhaps be achieved with the transplantation of oligodendrocyte-producing cells into the lesions. We investigated the frequency distribution and configuration of oligodendrocytes in chronic lesions of multiple sclerosis to determine whether these factors limit remyelination. Methods: Forty-eight chronic lesions obtained at autopsy from 10 patients with multiple sclerosis were examined immunocytochemically for oligodendrocytes and oligodendrocyte progenitor cells. Using confocal microscopy, we examined the three-dimensional relations between axons and the processes of premyelinating oligodendrocytes. Results: Thirty-four of the 48 chronic lesions of multiple sclerosis contained oligodendrocytes with multiple extended processes that associated with demyelinated axons but failed to myelinate them. These axons were dystrophic and contained multiple swellings. In some regions, the densities of premyelinating oligodendrocytes (25 per square millimeter of tissue) were similar to those in the developing rodent brain (23 per square millimeter). In the patients with disease of long duration (more than 20 years), there were fewer lesions with premyelinating oligodendrocytes (P<0.001). Conclusions: Premyelinating oligodendrocytes are present in chronic lesions of multiple sclerosis, so remyelination is not limited by an absence of oligodendrocyte progenitors or their failure to generate oligodendrocytes. Our findings suggest that in the chronic lesions of multiple sclerosis, the axons are not receptive for remyelination. Understanding the cellular interactions between premyelinating oligodendrocytes, axons, and the microenvironment of lesions of multiple sclerosis may lead to effective strategies for enhancing remyelination. (N Engl J Med 2002;346:165-73.) Copyright (C) 2002 Massachusetts Medical Society.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44195 USA; W Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA 90073 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Trapp, BD (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Messier, Claude/A-2322-2008; Calabrese, Massimiliano/I-6195-2012	Messier, Claude/0000-0002-4791-1763; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038667, R01NS035058] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS35058, P01 NS38667] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BRUCK W, 1994, ANN NEUROL, V35, P65, DOI 10.1002/ana.410350111; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Duncan ID, 1997, MOL MED TODAY, V3, P554, DOI 10.1016/S1357-4310(97)01162-3; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; GOGATE N, 1994, J NEUROSCI, V14, P4571; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Murray PD, 2001, BRAIN, V124, P1403, DOI 10.1093/brain/124.7.1403; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; PRINEAS JW, 1989, LAB INVEST, V61, P489; PRINEAS JW, 1984, ANN NY ACAD SCI, V436, P11, DOI 10.1111/j.1749-6632.1984.tb14773.x; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi JY, 1998, J NEUROSCI, V18, P4627; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Ueda H, 1999, J CELL BIOL, V146, P1365, DOI 10.1083/jcb.146.6.1365; Waxman SG, 1998, NEW ENGL J MED, V338, P323, DOI 10.1056/NEJM199801293380510; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Wolswijk G, 1998, J NEUROSCI, V18, P601; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387	38	730	780	1	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					165	173		10.1056/NEJMoa010994	http://dx.doi.org/10.1056/NEJMoa010994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796850				2022-12-28	WOS:000173273600004
J	Mullner, M; Matthews, H; Altman, DG				Mullner, M; Matthews, H; Altman, DG			Reporting on statistical methods to adjust for confounding: A cross-sectional survey	ANNALS OF INTERNAL MEDICINE			English	Article							LOGISTIC-REGRESSION MODELS; JOURNALS; TRIAL	Background: The use of complex statistical models to adjust for confounding is common in medical research. Objective: To determine the frequency and adequacy of adjustment for confounding in medical articles. Design: Cross-sectional survey. Setting: 34 scientific medical journals with a high impact factor. Measurements: Frequency of reporting on methods used to adjust for confounding in 537 original research articles published in January 1998. Results: Of the 537 articles, 169 specified that adjustment for confounding was used. In 1 paper in 10, it was unclear which statistical method was used or for which variables adjustment was made. In 45% of papers, it was not clear how multicategory or continuous variables were treated in the analysis. inadequate reporting was less frequent if an author was affiliated with a department of statistics, epidemiology, or public health and if articles were published in journals with a high impact factor. Conclusions: Details of methods used to adjust for confounding are frequently not reported in original research articles.	BMJ, London, England; ICRF Med Stat Grp, Ctr State Med, Inst Hlth Sci, Oxford OX3 7LF, England	University of Oxford	Mullner, M (corresponding author), Univ Vienna, Allgemeines Krankenhaus Wien, Klin Notfallmed, Waehringer Guertel 18-20 6D, A-1090 Vienna, Austria.	marcus.muellner@univie.ac.at						ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Altman DG, 1998, ENCY BIOSTATISTICS, P1000; Bender R, 1996, BRIT MED J, V313, P628; Bland JM, 1996, BRIT MED J, V312, P770; Brenner H, 1998, EPIDEMIOLOGY, V9, P68, DOI 10.1097/00001648-199801000-00014; Capdevila X, 1998, CRIT CARE MED, V26, P79, DOI 10.1097/00003246-199801000-00020; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; Goodman SN, 1998, J GEN INTERN MED, V13, P753, DOI 10.1046/j.1525-1497.1998.00227.x; Green JRB, 1998, GASTROENTEROLOGY, V114, P15, DOI 10.1016/S0016-5085(98)70627-4; Hennekens C.H., 1987, EPIDEMIOLOGY MED; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; *INT COMM MED J ED, 1997, ANN INTERN MED, V126, P34; Jones RB, 1998, AM J MED, V104, P28, DOI 10.1016/S0002-9343(97)00277-5; Katz MH, 1999, MULTIVARIABLE ANAL P; Khan KS, 1999, OBSTET GYNECOL, V93, P1014, DOI 10.1016/S0029-7844(98)00537-7; Lotze A, 1998, J PEDIATR-US, V132, P40, DOI 10.1016/S0022-3476(98)70482-2; PEKKANEN J, 1995, BRIT MED J, V311, P589, DOI 10.1136/bmj.311.7005.589; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768	19	48	50	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					122	126		10.7326/0003-4819-136-2-200201150-00009	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790063				2022-12-28	WOS:000173333900004
J	Baigent, C; Sudlow, C; Collins, R; Peto, R				Baigent, C; Sudlow, C; Collins, R; Peto, R		Antithromboci Trialists Collaborat	Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; DOUBLE-BLIND TRIAL; LOW-DOSE ASPIRIN; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; SECONDARY PREVENTION; VASCULAR-DISEASE; HEART-FAILURE; CYCLOOXYGENASE; ANGIOPLASTY	Objective To determine the effects of antiplatelet therapy among patients at high risk of occlusive vascular events. Design Collaborative meta-analyses (systematic overviews). Inclusion criteria Randomised trials of an antiplatelet regimen versus control or of one antiplatelet regimen versus another in high risk patients (with acute or previous vascular disease or some other predisposing condition) from which results were available before September 1997. Trials had to use a method of randomisation that precluded prior knowledge of the next treatment to be allocated and comparisons had to be unconfounded-that is, have study groups that differed only in terms of antiplatelet regimen. Studies reviewed 287 studies involving 135 000 patients in comparisons of antiplatelet therapy versus control and 77 000 in comparisons of different antiplatelet regimens. Main outcome measure "Serious vascular event": non-fatal myocardial infarction, non-fatal stroke, or vascular death. Results Overall, among these High risk patients, allocation to antiplatelet therapy reduced the combined outcome of any serious vascular event by about one quarter; non-fatal myocardial infarction was reduced by one third, non-fatal stroke by one quarter, and vascular mortality by one sixth (with no apparent adverse effect on other deaths). Absolute reductions in the risk of having a serious vascular event were 36 (SE 5) per 1000 treated for two years among patients with previous myocardial infarction; 38 (5) per 1000 patients treated for one month among patients with acute myocardial infarction; 36 (6) per 1000 treated for two years among those with previous stroke or transient ischaemic attack; 9 (3) per 1000 treated for three weeks among those with acute stroke; and 22 (3) per 1000 treated for two years among other high risk patients (with separately significant results for those with stable angina (P=0.0005), peripheral arterial disease (P=0.004), and atrial fibrillation (P=0.01)). In each of these high risk categories, the absolute benefits substantially outweighed the absolute risks of major extracranial bleeding. Aspirin was the most widely studied antiplatelet drug, with doses of 75-150 mg daily at least as effective as higher daily doses. The effects of doses lower than 75 mg daily were less certain. Clopidogrel reduced serious vascular events by 10% (4%) compared with aspirin, which was similar to the 12% (7%) reduction observed with its analogue ticlopidine. Addition of dipyridamole to aspirin produced no significant further reduction in vascular events compared with aspirin alone. Among patients at high risk of immediate coronary occlusion, short term addition of an intravenous glycoprotein IIb/IIIa antagonist to aspirin prevented a further 20 (4) vascular events per 1000 (P < 0.0001) but caused 23 major (but rarely fatal) extracranial bleeds per 1000. Conclusions Aspirin (or another oral antiplatelet drug) is protective in most types of patient at increased risk of occlusive vascular events, including those with an acute myocardial infarction or ischaemic stroke, unstable or stable angina, previous myocardial infarction, stroke or cerebral ischaemia, peripheral arterial disease, or atrial fibrillation, Low dose aspirin (75-150 mg daily) is an effective antiplatelet regimen for long term use, but in acute settings an initial loading dose of at least 150 mg aspirin may be required. Adding a second antiplatelet drug to aspirin may produce additional benefits in some clinical circumstances, but more research into this strategy is needed.	Radcliffe Infirm, Clin Trial Serv Unit, Antithrombot Trialists Secretariat, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Baigent, C (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Antithrombot Trialists Secretariat, Oxford OX2 6HE, England.		Mattioli, Annavittoria/G-6001-2012; Sudlow, Cathie LM/F-3420-2010; Catalano, Mariella/F-2708-2017	Mattioli, Annavittoria/0000-0003-1487-9530; Catalano, Mariella/0000-0002-8355-0344	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM DIAB ASS, 1998, DIABETES CARE S1, V21, pS45; [Anonymous], 1988, LANCET, V2, P349; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; BALSANO F, 1993, CIRCULATION, V87, P1563, DOI 10.1161/01.CIR.87.5.1563; Barnett HJM, 1996, STROKE, V27, P588, DOI 10.1161/01.STR.27.4.588; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Bradley BC, 2000, AM J CARDIOL, V85, P568, DOI 10.1016/S0002-9149(99)00813-9; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; CANDELISE L, 1995, LANCET, V346, P1509; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; CHEW EY, 1995, ARCH OPHTHALMOL-CHIC, V113, P52, DOI 10.1001/archopht.1995.01100010054020; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Diener HC, 1997, J NEUROL SCI, V151, pS1, DOI 10.1016/S0022-510X(97)86566-5; DYKEN ML, 1992, STROKE, V23, P1395, DOI 10.1161/01.STR.23.10.1395; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1, P12; Ferguson JJ, 1998, EUR HEART J, V19, pD40; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; FORNARO G, 1993, CIRCULATION, V87, P162, DOI 10.1161/01.CIR.87.1.162; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hankey GJ, 2000, STROKE, V31, P1779, DOI 10.1161/01.STR.31.7.1779; Harker LA, 1999, DRUG SAFETY, V21, P325, DOI 10.2165/00002018-199921040-00007; Heeschen C, 2000, LANCET, V355, P330, DOI 10.1016/S0140-6736(99)00464-X; Herbert JM, 1996, THROMB HAEMOSTASIS, V76, P94; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; KADEL C, 1990, European Heart Journal, V11, P368; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lincoff AM, 2000, J AM COLL CARDIOL, V35, P1103, DOI 10.1016/S0735-1097(00)00554-4; Lip GYH, 1997, BRIT J GEN PRACT, V47, P285; Liu LS, 2000, J CARDIOVASC RISK, V7, P435; Massie BM, 1997, AM HEART J, V133, P703, DOI 10.1016/S0002-8703(97)70173-X; Massie BR, 2000, EUR HEART J SUPPL, V2, pE13; Meade T, 1999, EUR HEART J, V20, P725; More RS, 1997, LANCET, V349, P146, DOI 10.1016/S0140-6736(97)22003-9; O'Brien J, 2000, LANCET, V355, P1295; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PATRONO C, 1989, TRENDS PHARMACOL SCI, V10, P453, DOI 10.1016/S0165-6147(89)80010-0; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; RANKE C, 1994, CLIN INVESTIGATOR, V72, P673, DOI 10.1007/BF00212985; RASMANIS G, 1988, LANCET, V2, P245; REILLY IAG, 1987, BLOOD, V69, P180; RODRIGUEZ LAG, IN PRESS BR J CLIN P; ROMEO F, 1982, P SAT S 83 C IT SOC, P155; Sandercock P, 1997, LANCET, V349, P1569; SANDERCOCK PAG, 1993, J NEUROL NEUROSUR PS, V56, P17, DOI 10.1136/jnnp.56.1.17; Stafford RS, 2000, CIRCULATION, V101, P1097, DOI 10.1161/01.CIR.101.10.1097; Stafford RS, 1998, CIRCULATION, V97, P1231, DOI 10.1161/01.CIR.97.13.1231; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; *UN PHARM CLIN, 1987, ALDUSA ASP LOW DOS U; UTSUMI H, 1984, 0016128 SANF; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; WEICHERT W, 1994, VASA-J VASCULAR DIS, V23, P57; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; Yusuf S, 2001, NEW ENGL J MED, V345, P494	64	5192	5430	9	307	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2002	324	7329					71	86						16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786451	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000173325400016
J	Balasubramanian, M; Schwartz, EL				Balasubramanian, M; Schwartz, EL			The Isomap algorithm and topological stability	SCIENCE			English	Editorial Material									Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; Boston Univ, Dept Elect & Comp Syst, Boston, MA 02215 USA	Boston University; Boston University	Balasubramanian, M (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.							Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; SCHWARTZ EL, 1988, IEEE COMPUT GRAPH, V8, P13, DOI 10.1109/38.7745; SCHWARTZ EL, 1989, IEEE T PATTERN ANAL, V11, P1005, DOI 10.1109/34.35506; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; WOLFSON E, 1989, IEEE T PATTERN ANAL, V11, P1001, DOI 10.1109/34.35505	5	469	544	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778013				2022-12-28	WOS:000173143100001
J	Yacubova, E; Komuro, H				Yacubova, E; Komuro, H			Stage-specific control of neuronal migration by somatostatin	NATURE			English	Article							CEREBELLAR GRANULE CELLS; RAT CEREBELLUM; RECEPTORS; EXPRESSION; CORTEX; K+; PATTERNS; BLOCKS; SYSTEM	Developing neurons transiently express somatostatin and its receptors(1-3), but little is known about their function at these early stages. As we thought that endogenous somatostatin might control the migratory behaviour of immature neurons, we have examined the effects of somatostatin in cerebellar granule cells of early postnatal mice, because these cells express all five types of somatostatin receptors before the initiation of their migration(4,5). Here we show that somatostatin has opposite and stage-specific effects on the migration of cerebellar granule cells. Activation of somatostatin receptors increases the rate of granule cell migration near their birthplace, but decreases the rate near their final destination. Furthermore, somatostatin enhances the size and frequency of spontaneous Ca2+ fluctuations in the early phase of migration, whereas it eliminates spike-like Ca2+ transients in the late phase. Somatostatin-induced changes at both early and late phases are reversed by a blockade of K+ channel activity. These results indicate that somatostatin may provide an essential cue for accelerating the movement of granule cells in the early phase and for terminating the movement in the late phase through altering intracellular Ca2+ concentrations and K+ channel activity.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Komuro, H (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Baumbach WR, 1998, MOL PHARMACOL, V54, P864, DOI 10.1124/mol.54.5.864; Bologna E, 2000, J COMP NEUROL, V420, P466, DOI 10.1002/(SICI)1096-9861(20000515)420:4<466::AID-CNE5>3.0.CO;2-W; DAngelo E, 1997, J NEUROPHYSIOL, V78, P1631, DOI 10.1152/jn.1997.78.3.1631; GONZALEZ B, 1992, P NATL ACAD SCI USA, V89, P9627, DOI 10.1073/pnas.89.20.9627; GONZALEZ BJ, 1988, DEV BRAIN RES, V40, P154, DOI 10.1016/0165-3806(88)90018-1; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; INAGAKI S, 1989, MOL BRAIN RES, V6, P289, DOI 10.1016/0169-328X(89)90074-0; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Komuro H, 1998, J NEUROSCI, V18, P1478; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; KUHAR SG, 1993, DEVELOPMENT, V117, P97; MAUBERT E, 1994, NEUROSCIENCE, V62, P317, DOI 10.1016/0306-4522(94)90335-2; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; Patel YC, 1997, J ENDOCRINOL INVEST, V20, P348, DOI 10.1007/BF03350317; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; Rhie DJ, 1999, DEV BRAIN RES, V112, P267, DOI 10.1016/S0165-3806(98)00175-8; Schindler M, 1996, PROG NEUROBIOL, V50, P9; Shibata R, 2000, J NEUROSCI, V20, P4145; SIMS SM, 1991, J PHYSIOL-LONDON, V441, P615, DOI 10.1113/jphysiol.1991.sp018770; TANIWAKI T, 1995, DEV BRAIN RES, V88, P109, DOI 10.1016/0165-3806(95)00090-Z; Thoss VS, 1996, EUR J PHARMACOL, V297, P145, DOI 10.1016/0014-2999(95)00736-9; VILLAR MJ, 1989, ANAT EMBRYOL, V179, P257, DOI 10.1007/BF00326591; Viollet C, 1997, J NEUROCHEM, V68, P2263	28	87	87	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					77	81		10.1038/415077a	http://dx.doi.org/10.1038/415077a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780120				2022-12-28	WOS:000173028800043
J	Chaudhari, N; Kinnamon, SC				Chaudhari, N; Kinnamon, SC			Molecular basis of the sweet tooth?	LANCET			English	Editorial Material							RECEPTOR GENE; TASTE; SACCHARIN; IDENTIFICATION; TRANSDUCTION; MICE; SAC		Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA; Univ Colorado, Hlth Sci Ctr, Rocky Mt Taste & Smell Ctr, Denver, CO USA; Colorado State Univ, Dept Anat & Neurobiol, Ft Collins, CO 80523 USA	University of Miami; University of Miami; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University	Chaudhari, N (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA.	NChaudhari@miami.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC003013] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; GLENDINNING JI, 2000, NEUROBIOLOGY TASTE S, P315; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Masters-Harte LD, 2001, ANN PHARMACOTHER, V35, P947; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	13	6	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2101	2102		10.1016/S0140-6736(01)07233-6	http://dx.doi.org/10.1016/S0140-6736(01)07233-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784621				2022-12-28	WOS:000172905800006
J	Vandersypen, LMK; Steffen, M; Breyta, G; Yannoni, CS; Sherwood, MH; Chuang, IL				Vandersypen, LMK; Steffen, M; Breyta, G; Yannoni, CS; Sherwood, MH; Chuang, IL			Experimental realization of Shor's quantum factoring algorithm using nuclear magnetic resonance	NATURE			English	Article							COMPUTATION; IMPLEMENTATION; INFORMATION	The number of steps any classical computer requires in order to rnd the prime factors of an l-digit integer N increases exponentially with l, at least using algorithms known at present(1). Factoring large integers is therefore conjectured to be intractable classically, an observation underlying the security of widely used cryptographic codes(1,2). Quantum computers(3), however, could factor integers in only polynomial time, using Shor's quantum factoring algorithm(4-6). Although important for the study of quantum computers(7), experimental demonstration of this algorithm has proved elusive(8-10). Here we report an implementation of the simplest instance of Shor's algorithm: factorization of N=15 (whose prime factors are 3 and 5). We use seven spin-1/2 nuclei in a molecule as quantum bits(11,12), which can be manipulated with room temperature liquid-state nuclear magnetic resonance techniques. This method of using nuclei to store quantum information is in principle scalable to systems containing many quantum bits(13), but such scalability is not implied by the present work. The significance of our work lies in the demonstration of experimental and theoretical techniques for precise control and modelling of complex quantum computers. In particular, we present a simple, parameter-free but predictive model of decoherence effects(14) in our system.	IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA; Stanford Univ, Solid State & Photon Lab, Stanford, CA 94305 USA	International Business Machines (IBM); Stanford University	Chuang, IL (corresponding author), IBM Corp, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.	ichuang@media.mit.edu		/0000-0001-7296-523X				Aho Alfred V, 1986, COMPILERS PRINCIPLES; Beckman D, 1996, PHYS REV A, V54, P1034, DOI 10.1103/PhysRevA.54.1034; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; Braunstein SL, 1999, PHYS REV LETT, V83, P1054, DOI 10.1103/PhysRevLett.83.1054; CHUANG IL, 1995, SCIENCE, V270, P1633, DOI 10.1126/science.270.5242.1633; COPPERSMITH D, 1994, RC19642 IBM TJ WATS; Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Freeman R., 1997, SPIN CHOREOGRAPHY; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; GREEN M, 1968, J CHEM SOC A, P902, DOI 10.1039/j19680000902; JEENER J, 1982, ADV MAGN RESON, V10, P1; Jones JA, 2001, PROG NUCL MAG RES SP, V38, P325, DOI 10.1016/S0079-6565(00)00033-9; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Knill E, 2000, NATURE, V404, P368, DOI 10.1038/35006012; Koblitz N., 1994, COURSE NUMBER THEORY, VVolume 114; KRAUS K, 1983, STATES EFFECS OPERAT; Leung DW, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042310; Linden N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047901; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Schack R, 1999, PHYS REV A, V60, P4354, DOI 10.1103/PhysRevA.60.4354; Schulman L. J., 1999, Proceedings of the Thirty-First Annual ACM Symposium on Theory of Computing, P322, DOI 10.1145/301250.301332; SHOR PW, 1994, AN S FDN CO, P124; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Vandersypen LMK, 2000, APPL PHYS LETT, V76, P646, DOI 10.1063/1.125846; Vandersypen LMK, 2000, PHYS REV LETT, V85, P5452, DOI 10.1103/PhysRevLett.85.5452; VOLD RL, 1978, PROG NUCL MAG RES SP, V12, P79, DOI 10.1016/0079-6565(78)80004-1	30	987	1028	10	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					883	887		10.1038/414883a	http://dx.doi.org/10.1038/414883a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780055	Green Submitted, Green Accepted			2022-12-28	WOS:000172813300038
J	[Anonymous]				[Anonymous]			Time to halt the gravy train	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					829	829						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780013				2022-12-28	WOS:000172813300001
J	Guzick, DS; Overstreet, JW; Factor-Litvak, P; Brazil, CK; Nakajima, ST; Coutifaris, C; Carson, SA; Cisneros, P; Steinkampf, MP; Hill, JA; Xu, D; Vogel, DL; Natl Cooperative Reprod Med Network				Guzick, DS; Overstreet, JW; Factor-Litvak, P; Brazil, CK; Nakajima, ST; Coutifaris, C; Carson, SA; Cisneros, P; Steinkampf, MP; Hill, JA; Xu, D; Vogel, DL; Natl Cooperative Reprod Med Network			Sperm morphology, motility, and concentration in fertile and infertile men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEMEN ANALYSIS; QUALITY; COUNTS	Background: Although semen analysis is routinely used to evaluate the male partner in infertile couples, sperm measurements that discriminate between fertile and infertile men are not well defined. Methods: We evaluated two semen specimens from each of the male partners in 765 infertile couples and 696 fertile couples at nine sites. The female partners in the infertile couples had normal results on fertility evaluation. The sperm concentration and motility were determined at the sites; semen smears were stained at the sites and shipped to a central laboratory for an assessment of morphologic features of sperm with the use of strict criteria. We used classification-and-regression-tree analysis to estimate threshold values for subfertility and fertility with respect to the sperm concentration, motility, and morphology. We also used an analysis of receiver-operating-characteristic curves to assess the relative value of these sperm measurements in discriminating between fertile and infertile men. Results: The subfertile ranges were a sperm concentration of less than 13.5 x 10(sup 6) per milliliter, less than 32 percent of sperm with motility, and less than 9 percent with normal morphologic features. The fertile ranges were a concentration of more than 48.0 x 10(sup 6) per milliliter, greater than 63 percent motility, and greater than 12 percent normal morphologic features. Values between these ranges indicated indeterminate fertility. There was extensive overlap between the fertile and the infertile men within both the subfertile and the fertile ranges for all three measurements. Although each of the sperm measurements helped to distinguish between fertile and infertile men, none was a powerful discriminator. The percentage of sperm with normal morphologic features had the greatest discriminatory power. Conclusions: Threshold values for sperm concentration, motility, and morphology can be used to classify men as subfertile, of indeterminate fertility, or fertile. None of the measures, however, are diagnostic of infertility.	Univ Rochester, Sch Med, Dept Obstet & Gynecol, Rochester, NY 14642 USA; Univ Calif Davis, Davis, CA 95616 USA; Columbia Univ, New York, NY USA; Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Alabama, Birmingham, AL USA; Brigham & Womens Hosp, Boston, MA 02115 USA; NIH, Bethesda, MD 20892 USA	University of Rochester; University of California System; University of California Davis; Columbia University; University of Pennsylvania; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA	Guzick, DS (corresponding author), Univ Rochester, Sch Med, Dept Obstet & Gynecol, Box 668,601 Elmwood Ave, Rochester, NY 14642 USA.		Philibert, Pascal/C-6728-2008	Philibert, Pascal/0000-0001-6384-521X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027049] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD026981, U10HD026975, U10HD033173, U10HD027009, U01HD027006, U10HD033172] Funding Source: NIH RePORTER; NICHD NIH HHS [U10 HD27049, U10 HD33173, U10 HD26975, U10 HD27001, U10 HD33172, U10 HD27009, U01 HD27006, U10 HD26981] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AM FERT SOC, 1994, INV INF COUPL; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Breiman L., 1984, CLASSIFICATION REGRE; DAVID G, 1979, FERTIL STERIL, V31, P453; DUNPHY BC, 1989, FERTIL STERIL, V51, P324; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; MACLEOD J, 1951, J UROLOGY, V66, P436, DOI 10.1016/S0022-5347(17)74358-3; MACLEOD J, 1951, FERTIL STERIL, V2, P187; MACLEOD J, 1951, FERTIL STERIL, V2, P394; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; OVERSTREET JW, 1995, INFERTILITY EVALUATI, P580; Overstreet JW, 1997, INFERTILITY MALE, P487; POLANSKY FF, 1988, FERTIL STERIL, V49, P1059; ROWE PJ, 1993, WHO MANUAL STANDARDI; Stephen EH, 1996, FERTIL STERIL, V66, P205, DOI 10.1016/S0015-0282(16)58439-8; WHO, 1987, OVERALL EVALUATION C; World Health Organization, 1980, WHO LAB MAN EX HUM S; World Health Organization, 1992, WHO LAB MAN EX HUM S; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Zinaman MJ, 2000, J ANDROL, V21, P145; ZUKERMAN Z, 1977, FERTIL STERIL, V28, P1310; 1996, FED REG, V61, P56274	23	823	876	4	74	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1388	1393		10.1056/NEJMoa003005	http://dx.doi.org/10.1056/NEJMoa003005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794171	Bronze			2022-12-28	WOS:000172014200004
J	Van den Berghe, G; Wouters, P; Weekers, F; Verwaest, C; Bruyninckx, F; Schetz, M; Vlasselaers, D; Ferdinande, P; Lauwers, P; Bouillon, R				Van den Berghe, G; Wouters, P; Weekers, F; Verwaest, C; Bruyninckx, F; Schetz, M; Vlasselaers, D; Ferdinande, P; Lauwers, P; Bouillon, R			Intensive insulin therapy in critically ill patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CRITICAL ILLNESS POLYNEUROPATHY; INTERVENTION SCORING SYSTEM; PROTRACTED CRITICAL ILLNESS; ACUTE-RENAL-FAILURE; DIABETES-MELLITUS; GLUCOSE INFUSION; CARDIAC-SURGERY; BLOOD CULTURES; ACUTE STROKE	Background: Hyperglycemia and insulin resistance are common in critically ill patients, even if they have not previously had diabetes. Whether the normalization of blood glucose levels with insulin therapy improves the prognosis for such patients is not known. Methods: We performed a prospective, randomized, controlled study involving adults admitted to our surgical intensive care unit who were receiving mechanical ventilation. On admission, patients were randomly assigned to receive intensive insulin therapy (maintenance of blood glucose at a level between 80 and 110 mg per deciliter) or conventional treatment (infusion of insulin only if the blood glucose level exceeded 215 mg per deciliter and maintenance of glucose at a level between 180 and 200 mg per deciliter). Results: At 12 months, with a total of 1548 patients enrolled, intensive insulin therapy reduced mortality during intensive care from 8.0 percent with conventional treatment to 4.6 percent (P<0.04, with adjustment for sequential analyses). The benefit of intensive insulin therapy was attributable to its effect on mortality among patients who remained in the intensive care unit for more than five days (20.2 percent with conventional treatment, as compared with 10.6 percent with intensive insulin therapy; P=0.005). The greatest reduction in mortality involved deaths due to multiple-organ failure with a proven septic focus. Intensive insulin therapy also reduced overall in-hospital mortality by 34 percent, bloodstream infections by 46 percent, acute renal failure requiring dialysis or hemofiltration by 41 percent, the median number of red-cell transfusions by 50 percent, and critical-illness polyneuropathy by 44 percent, and patients receiving intensive therapy were less likely to require prolonged mechanical ventilation and intensive care. Conclusions: Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.	Catholic Univ Louvain, Dept Intens Care Med, B-3000 Louvain, Belgium; Catholic Univ Louvain, Dept Phys Med & Rehabil, Electromyog Lab, B-3000 Louvain, Belgium; Catholic Univ Louvain, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; KU Leuven; Universite Catholique Louvain	Van den Berghe, G (corresponding author), Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Intens Care Med, B-3000 Louvain, Belgium.		Van den Berghe, Greet/J-6788-2018; wouters, patrick/E-1988-2011	Van den Berghe, Greet/0000-0002-5320-1362; wouters, patrick/0000-0002-3086-7137				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bellomo R, 2000, LANCET, V356, P2139; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bolton CF, 1996, CRIT CARE MED, V24, P1408, DOI 10.1097/00003246-199608000-00022; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Ferrando AA, 1999, ANN SURG, V229, P11, DOI 10.1097/00000658-199901000-00002; FIETSAM R, 1991, AM SURGEON, V57, P551; GARCIAMARIN JJ, 1988, HEPATOLOGY, V8, P332, DOI 10.1002/hep.1840080224; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Hawthorne G, 2000, BMJ-BRIT MED J, V321, P730, DOI 10.1136/bmj.321.7263.730; JONES RS, 1984, DIGEST DIS SCI, V29, P33, DOI 10.1007/BF01296859; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUSS WA, 1995, INTENSIVE CARE WORLD, V11, P102; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lassnigg A, 2000, J AM SOC NEPHROL, V11, P97, DOI 10.1681/ASN.V11197; LEIJTEN FSS, 1994, CLIN NEUROL NEUROSUR, V96, P10, DOI 10.1016/0303-8467(94)90023-X; Levetan CS, 2000, ENDOCRIN METAB CLIN, V29, P745, DOI 10.1016/S0889-8529(05)70162-6; Lewis J, 2000, AM J KIDNEY DIS, V36, P767, DOI 10.1053/ajkd.2000.17659; Losser MR, 1997, J APPL PHYSIOL, V83, P1566, DOI 10.1152/jappl.1997.83.5.1566; Malmberg K, 1999, CIRCULATION, V99, P2626, DOI 10.1161/01.CIR.99.20.2626; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; Oritz A, 1997, J INVEST MED, V45, P50; Rassias AJ, 1999, ANESTH ANALG, V88, P1011, DOI 10.1097/00000539-199905000-00008; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; SAID G, 1992, NEW ENGL J MED, V326, P1257, DOI 10.1056/NEJM199205073261905; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHANGRAW RE, 1989, METABOLISM, V38, P983, DOI 10.1016/0026-0495(89)90010-3; SIDENIUS P, 1982, DIABETES, V31, P356, DOI 10.2337/diab.31.4.356; Souba WW, 1997, NEW ENGL J MED, V336, P41, DOI 10.1056/NEJM199701023360107; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van den Berghe G, 1999, J CLIN ENDOCR METAB, V84, P1311, DOI 10.1210/jc.84.4.1311; Van den Berghe G, 2000, J CLIN ENDOCR METAB, V85, P183, DOI 10.1210/jc.85.1.183; WEBB AR, 1999, OXFORD TXB CRITICAL, P490; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Weinstein MP, 1998, J CLIN MICROBIOL, V36, P2089, DOI 10.1128/JCM.36.7.2089-2092.1998; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; WOLFE RR, 1979, METABOLISM, V28, P210, DOI 10.1016/0026-0495(79)90066-0; ZOCHODNE DW, 1987, BRAIN, V110, P819, DOI 10.1093/brain/110.4.819	47	6183	6442	9	341	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1359	1367		10.1056/NEJMoa011300	http://dx.doi.org/10.1056/NEJMoa011300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794168	Bronze			2022-12-28	WOS:000172014200001
J	Nenner, F				Nenner, F			The knapsack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					417	418		10.1001/jama.287.4.417	http://dx.doi.org/10.1001/jama.287.4.417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798342				2022-12-28	WOS:000173401900001
J	Reardon, DC; Cougle, JR				Reardon, DC; Cougle, JR			Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABORTION; WOMEN		Elliot Inst, Springfield, IL 62791 USA		Reardon, DC (corresponding author), Elliot Inst, POB 7348, Springfield, IL 62791 USA.			Reardon, David/0000-0002-4478-6231				COSTELLO EJ, 1982, J CLIN PSYCHOL, V38, P340, DOI 10.1002/1097-4679(198204)38:2<340::AID-JCLP2270380220>3.0.CO;2-D; JONES EF, 1992, DEMOGRAPHY, V29, P113, DOI 10.2307/2061366; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735	4	87	89	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					151	152		10.1136/bmj.324.7330.151	http://dx.doi.org/10.1136/bmj.324.7330.151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514ZH	11799033	Green Published, Bronze			2022-12-28	WOS:000173470600020
J	Ebert, D; Haag, C; Kirkpatrick, M; Riek, M; Hottinger, JW; Pajunen, VI				Ebert, D; Haag, C; Kirkpatrick, M; Riek, M; Hottinger, JW; Pajunen, VI			A selective advantage to immigrant genes in a Daphnia metapopulation	SCIENCE			English	Article							INBREEDING DEPRESSION; SUBDIVIDED POPULATIONS; DELETERIOUS MUTATIONS; CYCLICAL PARTHENOGEN; ROCK POOLS; EXTINCTION; LOAD; CONSEQUENCES; ENVIRONMENT; DIVERSITY	Immigrants to habitats occupied by conspecific organisms are usually expected to be competitively inferior, because residents may be locally adapted. If residents are inbred, however, mating between immigrants and residents results in offspring that may enjoy a fitness advantage from hybrid vigor. We demonstrate this effect experimentally in a natural Daphnia metapopulation in which genetic bottlenecks and local inbreeding are common. We estimate that in this metapopulation, hybrid vigor amplifies the rate of gene flow several times more than would be predicted from the nominal migration rate. This can affect the persistence of local populations and the entire metapopulation.	Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; Tvarminne Zool Stn, SF-10900 Hango, Finland; Univ Fribourg, Dept Biol, Unite Ecol & Evolut, CH-1700 Fribourg, Switzerland; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, FIN-00014 Helsinki, Finland	University of Basel; University of Fribourg; University of Texas System; University of Texas Austin; University of Helsinki	Ebert, D (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.		Haag, Christoph/B-6488-2009; Ebert, Dieter/B-5502-2009; Ebert, Dieter/P-6134-2019	Haag, Christoph/0000-0002-8817-1431; Ebert, Dieter/0000-0003-2653-3772; Ebert, Dieter/0000-0003-2653-3772				As S, 1992, ECOLOGICAL PRINCIPLE, P201; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; BRYANT EH, 1990, AM NAT, V136, P542, DOI 10.1086/285112; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; CHARLESWORTH B, 1990, NATURE, V347, P380, DOI 10.1038/347380a0; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Darwin CR, 1876, EFFECTS CROSS SELF F; De Meester L, 1999, P ROY SOC B-BIOL SCI, V266, P2471; DEMEESTER L, 1993, OECOLOGIA, V96, P80, DOI 10.1007/BF00318033; Deng HW, 1997, GENETICS, V147, P147; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; Hebert P.D.N, 1993, ZOOLOGY, V32; Ingvarsson PK, 2000, P ROY SOC B-BIOL SCI, V267, P1321, DOI 10.1098/rspb.2000.1145; INNES DJ, 1989, J HERED, V80, P6, DOI 10.1093/oxfordjournals.jhered.a110791; JONES CS, 1995, P ROY SOC B-BIOL SCI, V260, P251, DOI 10.1098/rspb.1995.0088; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; LYNCH M, 1994, AM NAT, V144, P242, DOI 10.1086/285673; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Mayr E., 1963, ANIMAL SPECIES EVOLU; Olivieri Isabelle, 1997, P293, DOI 10.1016/B978-012323445-2/50017-1; PAJUNEN VI, 1986, ANN ZOOL FENN, V23, P131; PAJUNEN VI, UNPUB; Pamilo P, 1999, HEREDITAS, V130, P257, DOI 10.1111/j.1601-5223.1999.00257.x; RANTA E, 1979, ARCH HYDROBIOL, V87, P205; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SINNOCK P, 1970, AM NAT, V104, P469, DOI 10.1086/282681; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Whitlock MC, 2000, HEREDITY, V84, P452, DOI 10.1046/j.1365-2540.2000.00693.x; WILSON CC, 1992, ECOLOGY, V73, P1462, DOI 10.2307/1940690; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	38	191	195	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					485	488		10.1126/science.1067485	http://dx.doi.org/10.1126/science.1067485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799241	Green Submitted			2022-12-28	WOS:000173350700047
J	Ford, ES; Giles, WH; Dietz, WH				Ford, ES; Giles, WH; Dietz, WH			Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; DIABETES-MELLITUS; AFRICAN-AMERICANS; SYNDROME-X; RISK; ATHEROSCLEROSIS; PREVENTION; MORTALITY; EXERCISE; WHITES	Context The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) highlights the importance of treating patients with the metabolic syndrome to prevent cardiovascular disease. Limited information is available about the prevalence of the metabolic syndrome in the United States, however. Objective To estimate the prevalence of the metabolic syndrome in the United States as defined by the ATP III report. Design, Setting, and Participants Analysis of data on 8814 men and women aged 20 years or older from the Third National Health and Nutrition Examination Survey (1988-1994), a cross-sectional health survey of a nationally representative sample of the noninstitutionalized civilian US population. Main Outcome Measures Prevalence of the metabolic syndrome as defined by ATP III (greater than or equal to3 of the following abnormalities): waist circumference greater than 102 cm in men and 88 cm in women; serum triglycerides level of at least 150 mg/dL (1.69 mmol/L); high-density lipoprotein cholesterol level of less than 40 mg/dL (1.04 mmol/L) in men and 50 mg/dL (1.29 mmol/L) in women; blood pressure of at least 130/85 mm Hg; or serum glucose level of at least 110 mg/dL (6.1 mmol/L). Results The unadjusted and age-adjusted prevalences of the metabolic syndrome were 21.8% and 23.7%, respectively. The prevalence increased from 6.7% among participants aged 20 through 29 years to 43.5% and 42.0% for participants aged 60 through 69 years and aged at least 70 years, respectively. Mexican Americans had the highest age-adjusted prevalence of the metabolic syndrome (31.9%). The age-adjusted prevalence was similar for men (24.0%) and women (23.4%). However, among African Americans, women had about a 57% higher prevalence than men did and among Mexican Americans, women had about a 26% higher prevalence than men did. Using 2000 census data, about 47 million US residents have the metabolic syndrome. Conclusions These results from a representative sample of US adults show that the metabolic syndrome is highly prevalent. The large numbers of US residents with the metabolic syndrome may have important implications for the health care sector.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ford, ES (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, 1600 Clifton Rd NE,Mailstop E-17, Atlanta, GA 30333 USA.	esf2@cdc.gov						Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], VITAL HLTH STAT; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; *CDCP, 1996, 3RD NATL HLTH NUTR E; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Haffner SM, 1997, DIABETES, V46, P63, DOI 10.2337/diabetes.46.1.63; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Hulthe J, 2000, ARTERIOSCL THROM VAS, V20, P2140, DOI 10.1161/01.ATV.20.9.2140; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kannel WB, 2000, AM J HYPERTENS, V13, p3S, DOI 10.1016/S0895-7061(99)00252-6; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Liese AD, 1997, ANN EPIDEMIOL, V7, P407, DOI 10.1016/S1047-2797(97)00047-1; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; *NIH, 2001, 013670 NIH; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Schmidt MI, 1996, DIABETES CARE, V19, P414, DOI 10.2337/diacare.19.5.414; Shah BV, 1997, SUDAAN USERS MANUAL; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	23	4835	5264	8	346	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					356	359		10.1001/jama.287.3.356	http://dx.doi.org/10.1001/jama.287.3.356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790215	Bronze			2022-12-28	WOS:000173294700030
J	Brussow, H; Hendrix, RW				Brussow, H; Hendrix, RW			Phage genomics: Small is beautiful	CELL			English	Review							BACTERIOPHAGES; EVOLUTION		Nestec Ltd, Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland; Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Nestle SA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brussow, H (corresponding author), Nestec Ltd, Nestle Res Ctr, Vers Chez Les Blanc, CH-1000 Lausanne 26, Switzerland.							Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; Chopin A, 2001, NUCLEIC ACIDS RES, V29, P644, DOI 10.1093/nar/29.3.644; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Ford ME, 1998, J MOL BIOL, V279, P143, DOI 10.1006/jmbi.1997.1610; Hambly E, 2001, P NATL ACAD SCI USA, V98, P11411, DOI 10.1073/pnas.191174498; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Inagaki Y, 2000, J INFECT DIS, V181, P975, DOI 10.1086/315299; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; Tetart F, 1998, J MOL BIOL, V282, P543, DOI 10.1006/jmbi.1998.2047	20	346	370	3	89	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					13	16		10.1016/S0092-8674(01)00637-7	http://dx.doi.org/10.1016/S0092-8674(01)00637-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792317	Bronze			2022-12-28	WOS:000173280700004
J	Dewandre, N				Dewandre, N			Women in science - European strategies for promoting women in science	SCIENCE			English	Editorial Material									European Commiss Directorate Gen Res, Women & Sci Unit, Brussels, Belgium		Dewandre, N (corresponding author), European Commiss Directorate Gen Res, Women & Sci Unit, Brussels, Belgium.							BROUNS MLM, 1999, QUALITY EVALUATION I; *COMM EUR COMM, 2001, SEC2001771; *COMM EUR COMM, 2001, DEC EUR PARL COUNC M; *COMM EUR COMM, 1999, COMM COMM WOM SCI MO, P76; MIT, 1999, STUD STAT WOM FS; *OFF PUBL EUR COMM, 1998, WOM SCI P C BRUSS 28; *RES DIR GEN EC, 2001, SCI POL EUR UN PROM; Valian V., 1999, WHY SO SLOW ADV WOME, V1 1st; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0	9	21	21	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					278	279		10.1126/science.1063487	http://dx.doi.org/10.1126/science.1063487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786628				2022-12-28	WOS:000173278600029
J	Nakamura, T; Lozano, PR; Ikeda, Y; Iwanaga, Y; Hinek, A; Minamisawa, S; Cheng, CF; Kobuke, K; Dalton, N; Takada, Y; Tashiro, K; Ross, J; Honjo, T; Chien, KR				Nakamura, T; Lozano, PR; Ikeda, Y; Iwanaga, Y; Hinek, A; Minamisawa, S; Cheng, CF; Kobuke, K; Dalton, N; Takada, Y; Tashiro, K; Ross, J; Honjo, T; Chien, KR			Fibulin-5/DANCE is essential for elastogenesis in vivo	NATURE			English	Article							EXTRACELLULAR-MATRIX; ELASTIN; ARTERIES	The elastic fibre system has a principal role in the structure and function of various types of organs that require elasticity, such as large arteries, lung and skin(1,2). Although elastic fibres are known to be composed of microfibril proteins (for example, fibrillins and latent transforming growth factor (TGF)-beta -binding proteins) and polymerized elastin, the mechanism of their assembly and development is not well understood. Here we report that fibulin-5 (also known as DANCE), a recently discovered integrin ligand(3), is an essential determinant of elastic fibre organization. fibulin-5(-/-) mice generated by gene targeting exhibit a severely disorganized elastic fibre system throughout the body. fibulin-5(-/-) mice survive to adulthood, but have a tortuous aorta with loss of compliance, severe emphysema, and loose skin (cutis laxa). These tissues contain fragmented elastin without an increase of elastase activity, indicating defective development of elastic fibres. Fibulin-5 interacts directly with elastic fibres in vitro, and serves as a ligand for cell surface integrins alphav beta3, alphav beta5 and alpha9 beta1 through its aminoterminal domain. Thus, fibulin-5 may provide anchorage of elastic fibres to cells, thereby acting to stabilize and organize elastic fibres in the skin, lung and vasculature.	Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, UCSD Inst Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068501, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kyoto University; Kyoto University	Chien, KR (corresponding author), Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA.		CHENG, Ching-Feng/AAB-8861-2019; Hinek, Aleksander/V-8790-2019; Nakamura, Tomoyuki/AAX-9340-2020; Honjo, Tasuku/N-4470-2016	CHENG, Ching-Feng/0000-0003-0104-0146; takada, yoshikazu/0000-0001-5481-9589; Minamisawa, Susumu/0000-0003-4728-2116; Ikeda, Yasuhiro/0000-0002-2970-7304				Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Dietz HC, 2000, MATRIX BIOL, V19, P481, DOI 10.1016/S0945-053X(00)00101-3; DOBRIN PB, 1990, J SURG RES, V48, P116, DOI 10.1016/0022-4804(90)90202-D; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FAZIO MJ, 1989, CUTIS, V43, P437; FEIGENBAUM H, 1995, ECOCARDIOGRAPHY; LABATROBERT J, 1988, EXP GERONTOL, V23, P5, DOI 10.1016/0531-5565(88)90015-0; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; PIQUETTE CA, 2000, TXB RESP MED, P1187; RAPAPORT E, 2000, TXB RESP MED, P1631; Robb BW, 1999, MOL BIOL CELL, V10, P3595, DOI 10.1091/mbc.10.11.3595; Robert L, 1998, GERONTOLOGY, V44, P307, DOI 10.1159/000022034; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; SENIOR RM, 1998, PULMONARY DIS DISORD, P659; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	23	472	513	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					171	175		10.1038/415171a	http://dx.doi.org/10.1038/415171a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805835				2022-12-28	WOS:000173159300042
J	Wang, QD; Gotthelf, EV; Lang, CC				Wang, QD; Gotthelf, EV; Lang, CC			A faint discrete source origin for the highly ionized iron emission from the Galactic Centre region	NATURE			English	Article							X-RAY-EMISSION; BLACK-HOLE; EVOLUTION; RADIO; LINE	The origin of the X-ray emission for the central region of our Galaxy has remained a mystery(1-4). In particular, the relative spectral contributions of the diffuse emission and discrete sources, which are critical to understanding the high-energy phenomena in this environment, have been unclear because of the lack of sufficient spatial resolution. Here we report the results of a large-scale imaging survey of the Galactic Centre that resolves these components. We rnd that the Ka emission from iron that has been highly ionized (so that it has only two electrons left), which has previously been attributed to the diffuse component(1), actually arises mainly from discrete sources. This suggests that the presence of a large amount of hot gas (T approximate to 10(8) K) is no longer required to explain the iron line emission. The spectra of the discrete sources indicate the presence of numerous accreting white dwarfs, neutron stars, and/or black holes in the region. The diffuse emission dominates over the contribution from the faint point sources, and is shown to be associated globally with interstellar features that have been observed at radio and midinfrared wavelengths, suggesting that it is the product of recent massive star formation.	Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA	University of Massachusetts System; University of Massachusetts Amherst; Columbia University	Wang, QD (corresponding author), Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA.	wqd@astro.umass.edu		Wang, Q. Daniel/0000-0002-9279-4041; Gotthelf, Eric/0000-0003-3847-3957				Almy RC, 2000, ASTROPHYS J, V545, P290, DOI 10.1086/317768; Baganoff FK, 2001, NATURE, V413, P45, DOI 10.1038/35092510; Barret D, 2000, ASTROPHYS J, V533, P329, DOI 10.1086/308651; Boggs SE, 2000, ASTROPHYS J, V544, P320, DOI 10.1086/317167; Ebisawa K, 2001, SCIENCE, V293, P1633, DOI 10.1126/science.1063529; Feng YX, 2001, ASTROPHYS J, V553, P394, DOI 10.1086/320634; Figer DF, 1999, ASTROPHYS J, V525, P750, DOI 10.1086/307937; Fromerth MJ, 2001, ASTROPHYS J, V547, pL129, DOI 10.1086/318906; JACKSON JM, 1996, APJ, V456, P91; Koyama K, 1996, PUBL ASTRON SOC JPN, V48, P249, DOI 10.1093/pasj/48.2.249; MAEDA Y, IN PRESS ASTROPHYS J; Murakami H, 2001, ASTROPHYS J, V558, P687, DOI 10.1086/322282; Price SD, 2001, ASTRON J, V121, P2819, DOI 10.1086/320404; SAKANO M, 2001, IN PRESS ASTROPHYS J; Sidoli L, 2001, ASTRON ASTROPHYS, V368, P835, DOI 10.1051/0004-6361:20010025; Sidoli L, 1999, ASTRON ASTROPHYS, V349, pL49; Sofue Y, 2000, ASTROPHYS J, V540, P224, DOI 10.1086/309297; Tanaka Y, 2000, PUBL ASTRON SOC JPN, V52, pL25, DOI 10.1093/pasj/52.4.L25; Townsley LK, 2000, ASTROPHYS J, V534, pL139, DOI 10.1086/312672; Tsuboi M, 1997, ASTROPHYS J, V481, P263, DOI 10.1086/304053; Valinia A, 2000, ASTROPHYS J, V543, P733, DOI 10.1086/317133; Wang QD, 1999, ASTROPHYS J, V510, pL139, DOI 10.1086/311823; WANG QD, UNPUB ASTROPHYS J; YUSEFZADEH F, 1984, NATURE, V310, P557, DOI 10.1038/310557a0; YusefZadeh F, 1997, ASTROPHYS J, V475, pL119, DOI 10.1086/310484; YUSEFZADEH F, 2000, IN PRESS ASTROPHYS J	26	161	161	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					148	150		10.1038/415148a	http://dx.doi.org/10.1038/415148a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805827				2022-12-28	WOS:000173159300034
J	Akama, TO; Nakagawa, H; Sugihara, K; Narisawa, S; Ohyama, C; Nishimura, SI; O'Brien, DA; Moremen, KW; Millan, JL; Fukuda, MN				Akama, TO; Nakagawa, H; Sugihara, K; Narisawa, S; Ohyama, C; Nishimura, SI; O'Brien, DA; Moremen, KW; Millan, JL; Fukuda, MN			Germ cell survival through carbohydrate-mediated interaction with Sertoli cells	SCIENCE			English	Article							ALPHA-D-MANNOSIDASE; SPERM PLASMA-MEMBRANES; LINKED OLIGOSACCHARIDES; BIOSYNTHESIS; EXPRESSION; EPIDIDYMIS	Spermatogenesis is a precisely regulated process in which the germ cells closely interact with Sertoli cells. The molecular basis of this cell-cell adhesion is unknown. Here, we demonstrate that targeted disruption of Man2a2, a gene encoding alpha -mannosidase IIx (MX), an enzyme that forms intermediate asparagine-linked carbohydrates (N-glycans), results in Man2a2 null mates that are largely infertile. The Man2a2 null spermatogenic cells fail to adhere to Sertoli cells and are prematurely released from the testis to epididymis. We identified an N-glycan structure that plays a key role in germ cell-Sertoli cell adhesion and showed that a specific carbohydrate was required for spermatogenesis.	Burnham Inst, Glycobiol Program, La Jolla, CA 92037 USA; Burnham Inst, Stem Cell Program, La Jolla, CA 92037 USA; Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido, Japan; Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; Tohoku Univ, Dept Urol, Sendai, Miyagi 980, Japan; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Hokkaido University; Keio University; Tohoku University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; University of Georgia	Fukuda, MN (corresponding author), Burnham Inst, Glycobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Moremen, Kelley/AAD-4661-2019; Nishimura, Shinichiro/F-5277-2011; Millan, Jose Luis/B-6580-2008		NCI NIH HHS [CA71932, CA 42595] Funding Source: Medline; NCRR NIH HHS [RR05351] Funding Source: Medline; NICHD NIH HHS [HD05863, U54 HD035041] Funding Source: Medline; NIGMS NIH HHS [GM47533] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042595, P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047533] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAMA T, UNPUB; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEPHILIP RM, 1987, BIOL REPROD, V37, P1271, DOI 10.1095/biolreprod37.5.1271; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Hiramoto S, 1997, BIOCHEM BIOPH RES CO, V241, P439, DOI 10.1006/bbrc.1997.7768; Igdoura SA, 1999, EUR J CELL BIOL, V78, P441, DOI 10.1016/S0171-9335(99)80071-5; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; KERR JB, 1995, MICROSC RES TECHNIQ, V32, P364, DOI 10.1002/jemt.1070320503; KOHNO S, 1983, J REPROD IMMUNOL, V5, P339, DOI 10.1016/0165-0378(83)90243-7; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MISAGO M, 1995, P NATL ACAD SCI USA, V92, P11766, DOI 10.1073/pnas.92.25.11766; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MOREMEN KW, 2000, COMPREHENSIVE HDB, P81; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P138; Oh-eda M, 2001, EUR J BIOCHEM, V268, P1280, DOI 10.1046/j.1432-1327.2001.01992.x; Panter KE, 1999, J NAT TOXINS, V8, P53; SKUDLAREK MD, 1991, BIOCHEM J, V277, P213, DOI 10.1042/bj2770213; STAMENKOVIC I, 1992, CELL, V68, P1003, DOI 10.1016/0092-8674(92)90071-J; TAKAHASHI N, 1992, HDB ENDOGLYCOSIDASES, P199; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; TULSIANI DRP, 1989, J CELL BIOL, V109, P1257, DOI 10.1083/jcb.109.3.1257; TULSIANI DRP, 1990, BIOL REPROD, V42, P843, DOI 10.1095/biolreprod42.5.843; Tulsiani DRP, 1997, BIOL REPROD, V57, P487, DOI 10.1095/biolreprod57.3.487; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936	28	115	118	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					124	127		10.1126/science.1065570	http://dx.doi.org/10.1126/science.1065570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778047				2022-12-28	WOS:000173143100048
J	Bynum, WF				Bynum, WF			Mosquitoes bite more than once	SCIENCE			English	Editorial Material									UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of London; University College London	Bynum, WF (corresponding author), UCL, Wellcome Trust Ctr Hist Med, 24 Eversholt St, London NW1 1AD, England.							Bynum WF, 1998, BEAST MOSQUITO CORRE; CHERNIN E, 1988, MED HIST, V32, P119, DOI 10.1017/S0025727300047967; Harrison G, 1978, MOSQUITOES MALARIA M; Haynes Douglas., 2001, IMPERIAL MED P MANSO; Nye Edwin R., 1997, R ROSS MALARIOLOGIST; Power H.J., 1999, TROPICAL MED 20 CENT; Ross R., 1911, PREVENTION MALARIA; ROSS R, 1923, MEMOIRS FULL ACCOUNT, P226; RUSSELL R, 1955, MANS MASTERY MALARIA	9	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					47	48		10.1126/science.1068205	http://dx.doi.org/10.1126/science.1068205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778027	Bronze			2022-12-28	WOS:000173143100022
J	Dennett-Thorpe, J; de Bruyn, AG				Dennett-Thorpe, J; de Bruyn, AG			Interstellar scintillation as the origin of the rapid radio variability of the quasar J1819+3845	NATURE			English	Article							INTRADAY VARIABILITY	The liberation of gravitational energy as matter falls onto a supermassive black hole at the centre of a galaxy is believed to explain the high luminosity of quasars. The variability of this emission from quasars and other types of active galactic nuclei can provide information on the size of the emitting regions and the physical process of fuelling the black hole. Some active galactic nuclei are variable at optical (and shorter) wavelengths, and display radio outbursts over years and decades. These active galactic nuclei often also show faster intraday variability at radio wavelengths(3,4). The origin of this rapid variability has been extensively debated(5), but a correlation between optical and radio variations in some sources(6,7) suggests that both are intrinsic. This would, however, require radiation brightness temperatures that seem physically implausible, leading to the suggestion that the rapid variations are caused by scattering of the emission by the interstellar medium inside our Galaxy(8,9). Here we show that the rapid variations in the extreme case of quasar J1819+3845 (ref. 10) indeed arise from interstellar scintillation. The transverse velocity of the scattering material reveals the presence of plasma with a surprisingly high velocity close to the Solar System.	Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; ASTRON, NL-7990 AA Dwingeloo, Netherlands	University of Groningen; University of Amsterdam	de Bruyn, AG (corresponding author), Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands.	ger@astron.nl						ALLER HD, 1985, ASTROPHYS J SUPPL S, V59, P513, DOI 10.1086/191083; Bhat NDR, 1998, ASTROPHYS J, V500, P262, DOI 10.1086/305715; BLANDFORD R, 1986, ASTROPHYS J, V301, pL53, DOI 10.1086/184622; CORDES JM, 1985, ASTROPHYS J, V288, P221, DOI 10.1086/162784; COX DP, 1987, ANNU REV ASTRON ASTR, V25, P303; Dennett-Thorpe J, 2000, ASTROPHYS J, V529, pL65, DOI 10.1086/312459; DENNETTTHORPE J, 2000, IAU S, V205, P88; HAMILTON PA, 1987, MON NOT R ASTRON SOC, V224, P1073, DOI 10.1093/mnras/224.4.1073; Hartmann D., 1997, ATLAS GALACTIC NEUTR; HEESCHEN DS, 1984, ASTRON J, V89, P1111, DOI 10.1086/113608; Jauncey D. L., 2000, ASTROPHYSICAL PHENOM, P147; Jauncey DL, 2001, ASTRON ASTROPHYS, V370, pL9, DOI 10.1051/0004-6361:20010299; KedzioraChudczer L, 1997, ASTROPHYS J, V490, pL9, DOI 10.1086/311001; Kraus A., 1999, New Astronomy Reviews, V43, P685, DOI 10.1016/S1387-6473(99)00078-0; LANG KR, 1970, NATURE, V225, P528, DOI 10.1038/225528a0; MORAN JM, 1990, ASTROPHYS J, V348, P147, DOI 10.1086/168222; NARAYAN R, 1992, PHILOS T ROY SOC A, V341, P151, DOI 10.1098/rsta.1992.0090; Peng B, 2000, ASTRON ASTROPHYS, V353, P937; QUIRRENBACH A, 1989, NATURE, V337, P442, DOI 10.1038/337442a0; QUIRRENBACH A, 1992, ASTRON ASTROPHYS, V258, P279; REES MJ, 1984, ANNU REV ASTRON ASTR, V22, P471, DOI 10.1146/annurev.aa.22.090184.002351; RICKETT BJ, 1984, ASTRON ASTROPHYS, V134, P390; RICKETT BJ, 1995, ASTRON ASTROPHYS, V293, P479; Rickett BJ, 2001, ASTROPHYS J, V550, pL11, DOI 10.1086/319493; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Wagner SJ, 1996, ASTRON J, V111, P2187, DOI 10.1086/117954	27	101	102	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					57	60		10.1038/415057a	http://dx.doi.org/10.1038/415057a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780113	Green Submitted			2022-12-28	WOS:000173028800036
J	Jagust, W				Jagust, W			Untangling vascular dementia	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE		Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA	University of California System; University of California Davis	Jagust, W (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.		Jagust, William/ABE-6426-2020					Esiri MM, 1999, LANCET, V354, P919, DOI 10.1016/S0140-6736(99)02355-7; GALASKO D, 1994, ARCH NEUROL-CHICAGO, V51, P888, DOI 10.1001/archneur.1994.00540210060013; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI VC, 1974, LANCET, V2, P207; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Henon H, 1997, STROKE, V28, P2429, DOI 10.1161/01.STR.28.12.2429; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476	11	39	40	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2097	2098		10.1016/S0140-6736(01)07230-0	http://dx.doi.org/10.1016/S0140-6736(01)07230-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784618				2022-12-28	WOS:000172905800003
J	Bauer, KA; Eriksson, BI; Lassen, MR; Turpie, AGG				Bauer, KA; Eriksson, BI; Lassen, MR; Turpie, AGG		Steering Comm Pentasaccharide Majo	Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Hematology	DEC 01-05, 2000	SAN FRANCISCO, CALIFORNIA	Amer Soc Hematol			DEEP-VEIN THROMBOSIS; DOUBLE-BLIND; FACTOR XA; HEPARIN; WARFARIN; PENTASACCHARIDE; ARTHROPLASTY; REPLACEMENT; INHIBITION; GENERATION	Background: Despite thromboprophylaxis, major knee surgery carries a high risk of venous thromboembolism. Fondaparinux, the first of a new class of synthetic antithrombotic agents, may reduce this risk. Methods: In a double-blind study, we randomly assigned 1049 consecutive patients undergoing elective major knee surgery to receive subcutaneous doses of either 2.5 mg of fondaparinux once daily or 30 mg of enoxaparin twice daily, with both treatments initiated postoperatively. The primary efficacy outcome was venous thromboembolism up to postoperative day 11, defined as deep-vein thrombosis detected by mandatory bilateral venography, documented symptomatic deep-vein thrombosis, or documented symptomatic pulmonary embolism. The primary safety outcome was major bleeding. Results: The primary efficacy outcome was assessed in 724 patients. The fondaparinux group had a significantly lower incidence of venous thromboembolism by day 11 (12.5 percent [45 of 361 patients]) than the enoxaparin group (27.8 percent [101 of 363 patients]; reduction in risk, 55.2 percent; 95 percent confidence interval, 36.2 to 70.2; P<0.001). Major bleeding (including overt bleeding with a bleeding index of 2 or more) occurred more frequently in the fondaparinux group (P=0.006), but there were no significant differences between the two groups in the incidence of bleeding leading to death or reoperation or occurring in a critical organ. Conclusions: In patients undergoing elective major knee surgery, postoperative treatment with 2.5 mg of fondaparinux once daily was significantly more effective in preventing deep-vein thrombosis than 30 mg of enoxaparin twice daily. (N Engl J Med 2001;345:1305-10.) Copyright (C) 2001 Massachusetts Medical Society.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Vet Affiars Boston Healthcare Syst, Dept Med, Boston, MA USA; Sahlgrens Univ Hosp Ostra, Dept Orthoped, Gothenburg, Sweden; Hillerod Univ, Dept Orthoped, Hillerod, Denmark; Hamilton Hlth Sci Corp, Gen Div, Dept Med, Hamilton, ON, Canada	Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Sahlgrenska University Hospital; University of Copenhagen; McMaster University	Bauer, KA (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.			Eriksson, Bengt/0000-0001-6894-7434				Eriksson BI, 1996, LANCET, V347, P635, DOI 10.1016/S0140-6736(96)91200-3; Eriksson BI, 2001, NEW ENGL J MED, V345, P1298, DOI 10.1056/NEJMoa011100; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Heit JA, 1997, THROMB HAEMOSTASIS, V77, P32; Hull RD, 2000, ARCH INTERN MED, V160, P2199, DOI 10.1001/archinte.160.14.2199; Lassen MR, 2000, BLOOD, V96, p490A; LECLERC JR, 1992, THROMB HAEMOSTASIS, V67, P417; Leclerc JR, 1996, ANN INTERN MED, V124, P619, DOI 10.7326/0003-4819-124-7-199604010-00001; Lormeau JC, 1995, THROMB HAEMOSTASIS, V74, P1474; Nicolaides AN, 2001, INT ANGIOL, V20, P1; PETITOU M, 1991, NATURE, V350, P30; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; SPIRO TE, 1993, BLOOD, V82, pA410; SPIRO TE, 1994, BLOOD, V84, P246; Turpie AGG, 2001, NEW ENGL J MED, V344, P619, DOI 10.1056/NEJM200103013440901; Turpie G, 2000, BLOOD, V96, p491A; VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; WALENGA JM, 1988, THROMB RES, V51, P23, DOI 10.1016/0049-3848(88)90279-4	19	497	514	1	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1305	1310		10.1056/NEJMoa011099	http://dx.doi.org/10.1056/NEJMoa011099			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794149	Bronze			2022-12-28	WOS:000171896300003
J	Shuldiner, AR; Yang, RZ; Gong, DW				Shuldiner, AR; Yang, RZ; Gong, DW			Resistin, obesity, and insulin resistance - The emerging role of the adipocyte as an endocrine organ.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Shuldiner, AR (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.		Gong, Dawei/AAB-4283-2020	Shuldiner, Alan/0000-0001-9921-4305				Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Harris MI, 2000, DIABETES-METAB RES, V16, P230, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.3.CO;2-N; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000	5	209	242	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1345	1346		10.1056/NEJM200111013451814	http://dx.doi.org/10.1056/NEJM200111013451814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794158				2022-12-28	WOS:000171896300013
J	Bryk, R; Lima, CD; Erdjument-Bromage, H; Tempst, P; Nathan, C				Bryk, R; Lima, CD; Erdjument-Bromage, H; Tempst, P; Nathan, C			Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein	SCIENCE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; TUBERCULOSIS; AHPC; ACETYLTRANSFERASE; DEHYDROGENASE; BACTERIAL	Mycobacterium tuberculosis (Mtb) mounts a stubborn defense against oxidative and nitrosative components of the immune response. Dihydrolipoamide dehydrogenase (Lpd) and dihydrolipoamide succinyltransferase (SucB) are components of alpha-ketoacid dehydrogenase complexes that are central to intermediary metabolism. We find that Lpd and SucB support Mtb's antioxidant defense. The peroxiredoxin alkyl hydroperoxide reductase (AhpC) is linked to Lpd and SucB by an adaptor protein, AhpD. The 2.0 angstrom AhpD crystal structure reveals a thioredoxin-like active site that is responsive to lipoamide. We propose that Lpd, SucB (the only lipoyl protein detected in Mtb), AhpD, and AhpC together constitute a nicotinamide adenine dinucleotide (reduced)-dependent peroxidase and peroxynitrite reductase. AhpD thus represents a class of thioredoxin-like molecules that enables an antioxidant defense.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Sloan Kettering Inst, Prot Ctr, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Struct Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, Box 65,1300 York Ave, New York, NY 10021 USA.			Lima, Christopher/0000-0002-9163-6092; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NHLBI NIH HHS [HL61241] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061241] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argyrou A, 2001, BIOCHEMISTRY-US, V40, P11353, DOI 10.1021/bi010575o; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; CHAN J, 1999, NITRIC OXIDE INFECT, P281; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DANSON MJ, 1988, BIOCHEM SOC T, V16, P87, DOI 10.1042/bst0160087; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; ERJUMENTBROMAGE H, 1998, J CHROMATOGR A, V826, P167; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Haramaki N, 1997, FREE RADICAL BIO MED, V22, P535, DOI 10.1016/S0891-5849(96)00400-5; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MURTHY PS, 1973, AM REV RESPIR DIS, V108, P689; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989	23	299	327	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1073	1077		10.1126/science.1067798	http://dx.doi.org/10.1126/science.1067798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799204				2022-12-28	WOS:000173793000066
J	Winnacker, EL				Winnacker, EL			Science in Europe - European science	SCIENCE			English	Editorial Material									Deutsch Forsch Gemeinschaft, D-53170 Bonn, Germany		Winnacker, EL (corresponding author), Deutsch Forsch Gemeinschaft, Kennedyallee 40, D-53170 Bonn, Germany.								0	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					446	446		10.1126/science.1068921	http://dx.doi.org/10.1126/science.1068921			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799226				2022-12-28	WOS:000173350700030
J	Nesvizhevsky, VV; Borner, HG; Petukhov, AK; Abele, H; Baessler, S; Ruess, FJ; Stoferle, T; Westphal, A; Gagarski, AM; Petrov, GA; Strelkov, AV				Nesvizhevsky, VV; Borner, HG; Petukhov, AK; Abele, H; Baessler, S; Ruess, FJ; Stoferle, T; Westphal, A; Gagarski, AM; Petrov, GA; Strelkov, AV			Quantum states of neutrons in the Earth's gravitational field	NATURE			English	Article								The discrete quantum properties of matter are manifest in a variety of phenomena. Any particle that is trapped in a sufficiently deep and wide potential well is settled in quantum bound states. For example, the existence of quantum states of electrons in an electromagnetic field is responsible for the structure of atoms(16), and quantum states of nucleons in a strong nuclear field give rise to the structure of atomic nuclei(17). In an analogous way, the gravitational field should lead to the formation of quantum states. But the gravitational force is extremely weak compared to the electromagnetic and nuclear force, so the observation of quantum states of matter in a gravitational field is extremely challenging. Because of their charge neutrality and long lifetime, neutrons are promising candidates with which to observe such an effect. Here we report experimental evidence for gravitational quantum bound states of neutrons. The particles are allowed to fall towards a horizontal mirror which, together with the Earth's gravitational field, provides the necessary confining potential well. Under such conditions, the falling neutrons do not move continuously along the vertical direction, but rather jump from one height to another, as predicted by quantum theory(1-3).	Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; Heidelberg Univ, D-69120 Heidelberg, Germany; Petersburg Nucl Phys Inst, R-188350 Gatchina, Leningrad Reg, Russia; Joint Nucl Res Inst, R-141980 Dubna, Moscow Reg, Russia	Institut Laue-Langevin (ILL); Ruprecht Karls University Heidelberg; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Joint Institute for Nuclear Research - Russia	Nesvizhevsky, VV (corresponding author), Inst Max Von Laue Paul Langevin, 6 Rue Jules Horowitz, F-38042 Grenoble, France.	nesvizhevsky@ill.fr	Gagarski, Alexei/ABA-8030-2020; Nesvizhevsky, Valery V/F-7809-2019; Abele, Hartmut A/D-5087-2009	Abele, Hartmut A/0000-0002-6832-9051; Nesvizhevsky, Valery/0000-0002-5364-0197; Stoferle, Thilo/0000-0003-0612-7195; Westphal, Alexander/0000-0003-1578-6539				BARYSHEVSKII VG, 1991, PHYS LETT A, V153, P299, DOI 10.1016/0375-9601(91)90947-7; Bohr A, 1969, NUCL STRUCTURE; BORN M, 1969, ATOMIC PHYSICS; COLELLA R, 1975, PHYS REV LETT, V34, P1472, DOI 10.1103/PhysRevLett.34.1472; Felber J, 1996, PHYS REV A, V53, P319, DOI 10.1103/PhysRevA.53.319; Flugge S., 1971, PRACTICAL QUANTUM ME; Frank A. I., 1991, Soviet Physics - Uspekhi, V34, P980, DOI 10.1070/PU1991v034n11ABEH002485; Golub R., 1991, ULTRACOLD NEUTRONS; IGNATOVICH VK, 1990, PHYSICS ULTRACOLD NE; LANDAU LD, 1976, QUANTUM MECH, P164; LUSCHIKOV VI, 1978, JETP LETT+, V28, P559; LUSHCHIKOV VI, 1969, JETP LETT-USSR, V9, P23; Nesvizhevsky VV, 2000, NUCL INSTRUM METH A, V440, P754, DOI 10.1016/S0168-9002(99)01077-3; NESVIZHEVSKY VV, 2000, ILL ANN REPORT, P64; Peters A, 1999, NATURE, V400, P849, DOI 10.1038/23655; STEYERL A, 1989, NUCL INSTRUM METH A, V284, P200, DOI 10.1016/0168-9002(89)90282-9; STEYERL A, 1969, PHYS LETT B, VB 29, P33, DOI 10.1016/0370-2693(69)90127-0	17	430	433	4	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					297	299		10.1038/415297a	http://dx.doi.org/10.1038/415297a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797001				2022-12-28	WOS:000173293500036
J	Reynolds, T				Reynolds, T			Switching from prescription to over the counter	ANNALS OF INTERNAL MEDICINE			English	Article																			0	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					177	180		10.7326/0003-4819-136-2-200201150-00026	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790082				2022-12-28	WOS:000173333900019
J	Macfarlane, J; Holmes, W; Gard, P; Thornhill, D; Macfarlane, R; Hubbard, R				Macfarlane, J; Holmes, W; Gard, P; Thornhill, D; Macfarlane, R; Hubbard, R			Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet	BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT ILLNESS; GENERAL-PRACTICE; PRESCRIBING ANTIBIOTICS; PATIENTS EXPECTATIONS; SORE THROAT; QUESTIONNAIRE; PHYSICIANS; STRATEGIES; MANAGEMENT; BEHAVIOR	Objective To assess whether sharing the uncertainty of the value of antibiotics for acute bronchitis in the form of written and verbal advice affects the likelihood of patients taking antibiotics. Design Nested, single blind, randomised controlled trial. Setting Three suburban general practices in Nottingham. Participants 259 previously well adults presenting with acute bronchitis. Intervention In group A, 212 patients were judged by their general practitioner not to need antibiotics that day but were given a prescription to use if they got worse and standard verbal reassurance. Half of them (106) were also given an information leaflet. All patients inn group B (47) were judged to need antibiotics and were given a prescription and encouraged to use it. Main outcome measures Antibiotic use in the next two weeks. Reconsultation for the same symptoms in the next month. Results In group A fewer patients who received the information leaflet took antibiotics compared with those who did not receive the leaflet (49 v 63, risk ratio 0.76, 95% confidence interval 0.59 to 0.97, P=0.04). Numbers reconsulting were similar (11 v 14). In group B, 44 patients took the antibiotics. Conclusion Most previously well adults with acute bronchitis were judged not to need antibiotics. Reassuring these patients and sharing the uncertainty about prescribing in a information leaflet supported by verbal advice is a safe strategy and reduces antibiotic use.	City Hosp Nottingham, Resp Infect Res Grp, Nottingham NG5 1PB, England; Sherrington Pk Med Practice, Nottingham NG5 2EJ, England; Arnold Hlth Ctr, Nottingham NG5 7BP, England; Stenhouse Med Ctr, Nottingham NG5 7BP, England; Univ Nottingham, City Hosp Nottingham, Nottingham NG7 2RD, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Macfarlane, J (corresponding author), City Hosp Nottingham, Resp Infect Res Grp, Hucknall Rd, Nottingham NG5 1PB, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arroll B, 2001, BRIT MED J, V322, P939, DOI 10.1136/bmj.322.7292.939; *AUD COMM, 1994, PRESCR IMPR MOR RAT; Cates C, 1999, BRIT MED J, V318, P715, DOI 10.1136/bmj.318.7185.715; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Dowell J, 2001, BRIT J GEN PRACT, V51, P200; GONZALES R, 1995, LANCET, V345, P665, DOI 10.1016/S0140-6736(95)90861-7; Holmes WF, 1997, BRIT J GEN PRACT, V47, P815; Holmes WF, 2001, BRIT J GEN PRACT, V51, P177; HOLMES WF, 1998, AM J RESP CRIT MED, V157, pA500; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Macfarlane J, 1997, BRIT MED J, V315, P1206, DOI 10.1136/bmj.315.7117.1206; Macfarlane J, 2000, THORAX, V55, P153, DOI 10.1136/thorax.55.2.153; Macfarlane J, 1997, RESP MED, V91, P427, DOI 10.1016/S0954-6111(97)90258-4; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Macfarlane JT, 1997, BRIT J GEN PRACT, V47, P719; *OFF POP CENS SURV, 1995, MORB STAT GEN PR MB5, P3; RUTTEN G, 1991, BRIT J GEN PRACT, V41, P289; *STAND MED ADV COM, 1988, PATH LEAST RES; 2000, MEREC B, V11, P1	22	131	131	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					91	94		10.1136/bmj.324.7329.91	http://dx.doi.org/10.1136/bmj.324.7329.91			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786454	Green Published, Bronze			2022-12-28	WOS:000173325400019
J	Salina, D; Bodoor, K; Eckley, DM; Schroer, TA; Rattner, JB; Burke, B				Salina, D; Bodoor, K; Eckley, DM; Schroer, TA; Rattner, JB; Burke, B			Cytoplasmic dynein as a facilitator of nuclear envelope breakdown	CELL			English	Article							INTEGRAL MEMBRANE-PROTEINS; RAT KANGAROO CELLS; PHOSPHORYLATION SITES; MAMMALIAN-CELLS; CYSTEINE-RICH; LIVING CELLS; LAMIN-A; DYNACTIN; MITOSIS; END	During prophase in higher cells, centrosomes localize to deep invaginations in the nuclear envelope in a microtubule-dependent process. Loss of nuclear membranes In prometaphase commences in regions of the nuclear envelope that lie outside of these invaginations. Dynein and dynactin complex components concentrate on the nuclear envelope prior to any changes in nuclear envelope organization. These observations suggest a model in which dynein facilitates nuclear envelope breakdown by pulling nuclear membranes and associated proteins poleward along astral microtubules leading to nuclear membrane detachment. Support for this model is provided by the finding that interference with dynein function drastically alters nuclear membrane dynamics in prophase and prometaphase.	Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Calgary; Johns Hopkins University	Burke, B (corresponding author), Univ Calgary, Dept Cell Biol & Anat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	bburke@anatomy.med.ufl.edu	Eckley, Mark/M-3526-2014; Eckley, David Mark/I-9245-2019	Eckley, Mark/0000-0003-2296-5164; Schroer, Trina/0000-0002-5065-1835	NIGMS NIH HHS [R01 GM044589] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN V, 1995, J CELL BIOL, V128, P879, DOI 10.1083/jcb.128.5.879; ASH JF, 1977, P NATL ACAD SCI USA, V74, P5584, DOI 10.1073/pnas.74.12.5584; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bodoor K, 1999, J CELL SCI, V112, P2253; BURKE B, 1990, EXP CELL RES, V186, P169, DOI 10.1016/0014-4827(90)90223-W; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Collas P, 2000, TRENDS CELL BIOL, V10, P5, DOI 10.1016/S0962-8924(99)01697-9; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Lee IH, 2001, MOL BIOL CELL, V12, P2195, DOI 10.1091/mbc.12.7.2195; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mack GJ, 1998, ARTHRITIS RHEUM, V41, P551; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NUSSE M, 1984, CELL TISSUE KINET, V17, P13, DOI 10.1111/j.1365-2184.1984.tb00564.x; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PFALLER R, 1995, J BIOL CHEM, V270, P19066, DOI 10.1074/jbc.270.32.19066; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; RATTNER JB, 1976, CYTOBIOS, V15, P37; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; ROOS UP, 1973, CHROMOSOMA, V40, P43, DOI 10.1007/BF00319836; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; STICK R, 1988, J CELL BIOL, V107, P397, DOI 10.1083/jcb.107.2.397; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; Vierula PJ, 1997, MOL MICROBIOL, V24, P331, DOI 10.1046/j.1365-2958.1997.3461704.x; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WATERMANSTORER CM, 1993, CELL MOTIL CYTOSKEL, V26, P19, DOI 10.1002/cm.970260104; Whitehead CM, 1996, ARTHRITIS RHEUM, V39, P1635, DOI 10.1002/art.1780391005; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; ZELIGS JD, 1979, J ULTRA MOL STRUCT R, V66, P53, DOI 10.1016/S0022-5320(79)80065-9	59	280	292	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					97	107		10.1016/S0092-8674(01)00628-6	http://dx.doi.org/10.1016/S0092-8674(01)00628-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792324	Bronze			2022-12-28	WOS:000173280700011
J	Schiller, JH; Harrington, D; Belani, CP; Langer, C; Sandler, A; Krook, J; Zhu, JM; Johnson, DH				Schiller, JH; Harrington, D; Belani, CP; Langer, C; Sandler, A; Krook, J; Zhu, JM; Johnson, DH		Eastern Cooperative Oncology Grp	Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE-ONCOLOGY-GROUP; QUALITY-OF-LIFE; RANDOMIZED TRIAL; CISPLATIN; SURVIVAL; COMBINATION; PACLITAXEL; ETOPOSIDE	Background We conducted a randomized study to determine whether any of three chemotherapy regimens was superior to cisplatin and paclitaxel in patients with advanced non-small-cell lung cancer. Methods A total of 1207 patients with advanced non-small-cell lung cancer were randomly assigned to a reference regimen of cisplatin and paclitaxel or to one of three experimental regimens: cisplatin and gemcitabine, cisplatin and docetaxel, or carboplatin and paclitaxel. Results The response rate for all 1155 eligible patients was 19 percent, with a median survival of 7.9 months (95 percent confidence interval, 7.3 to 8.5), a 1-year survival rate of 33 percent (95 percent confidence interval, 30 to 36 percent), and a 2-year survival rate of 11 percent (95 percent confidence interval, 8 to 12 percent). The response rate and survival did not differ significantly between patients assigned to receive cisplatin and paclitaxel and those assigned to receive any of the three experimental regimens. Treatment with cisplatin and gemcitabine was associated with a significantly longer time to the progression of disease than was treatment with cisplatin and paclitaxel but was more likely to cause grade 3, 4, or 5 renal toxicity (in 9 percent of patients, vs. 3 percent of those treated with cisplatin plus paclitaxel). Patients with a performance status of 2 had a significantly lower rate of survival than did those with a performance status of 0 or 1. Conclusions None of four chemotherapy regimens offered a significant advantage over the others in the treatment of advanced non-small-cell lung cancer. (N Engl J Med 2002;346:92-8.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Indiana Univ, Indianapolis, IN 46204 USA; Duluth Clin, Duluth, MN USA; Vanderbilt Univ, Nashville, TN USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fox Chase Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University	Schiller, JH (corresponding author), Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.		Johnson, David H./A-7437-2009	Belani, Chandra/0000-0001-5049-5329	NATIONAL CANCER INSTITUTE [U10CA023318] Funding Source: NIH RePORTER; NCI NIH HHS [CA-23318] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abratt RP, 1995, P AN M AM SOC CLIN, V14, P375; ALBERTI W, 1995, BRIT MED J, V311, P899; Bonomi P, 2000, J CLIN ONCOL, V18, P623, DOI 10.1200/JCO.2000.18.3.623; BONOMI PD, 1989, J CLIN ONCOL, V7, P1602, DOI 10.1200/JCO.1989.7.11.1602; Cox DR., 1989, ANAL BINARY DATA; CRINO L, 1995, P AN M AM SOC CLIN, V14, P352; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; GANDARA DR, 1993, J CLIN ONCOL, V11, P873, DOI 10.1200/JCO.1993.11.5.873; GRILLI R, 1993, J CLIN ONCOL, V11, P1866, DOI 10.1200/JCO.1993.11.10.1866; JOHNSON DH, 1999, P AN M AM SOC CLIN, V18, pA461; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLASTERSKY J, 1989, J CLIN ONCOL, V7, P1087, DOI 10.1200/JCO.1989.7.8.1087; LANGER CJ, 1995, J CLIN ONCOL, V13, P1860, DOI 10.1200/JCO.1995.13.8.1860; LECHEVALIER T, 1995, P AN M AM SOC CLIN, V14, P350; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MARINO P, 1994, CHEST, V106, P861, DOI 10.1378/chest.106.3.861; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; RAMSEY SD, 2000, P AN M AM SOC CLIN, V19, pA489; RAPP E, 1988, J CLIN ONCOL, V6, P633, DOI 10.1200/JCO.1988.6.4.633; RUCKDESCHEL JC, 1986, J CLIN ONCOL, V4, P14, DOI 10.1200/JCO.1986.4.1.14; SANDLER AB, 1995, P AN M AM SOC CLIN, V14, P357	21	4168	4538	9	394	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					92	98		10.1056/NEJMoa011954	http://dx.doi.org/10.1056/NEJMoa011954			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784875				2022-12-28	WOS:000173133400004
J	Mehilli, J; Kastrati, A; Dirschinger, J; Pache, J; Seyfarth, M; Blasini, R; Hall, D; Neumann, FJ; Schomig, A				Mehilli, J; Kastrati, A; Dirschinger, J; Pache, J; Seyfarth, M; Blasini, R; Hall, D; Neumann, FJ; Schomig, A			Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA BLOCKADE; THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; NATIONAL REGISTRY; WOMEN; MORTALITY; MEN; SURVIVAL; REVASCULARIZATION; MANAGEMENT	Context A higher mortality risk for women with acute myocardial infarction (AMI) is a common finding in studies that compare the postinfarction outcome of women vs men. It is not clear, however, whether sex is an independent predictor of death among patients systematically treated with aggressive reperfusion and medical strategies. Objective To assess the impact of patient's sex on outcome in a consecutive series of patients with AMI treated with a reperfusion strategy largely based on percutaneous coronary interventions. Design, Setting, and Patients Inception cohort of 1937 patients (502 women and 1435 men) who were admitted with a diagnosis of AMI to a tertiary referral institution between January 1995 and December 2000. Main Outcome Measures Mortality at 1 year after AMI. Results Compared with men, women were older (70 vs 61 years; P<.001) and had known diabetes or hypertension more often. Both men and women received essentially identical therapy with the majority of patients (86%) receiving reperfusion therapy via percutaneous coronary interventions. There were no significant differences in 1-year Kaplan-Meier death rates with 13.8% (68 cases) among women and 12.9% (184 cases) among men (unadjusted hazard ratio, 1.06; 95% confidence interval, 0.80-1.39; P=.70). After age adjustment, women had a lower risk of death (hazard ratio, 0.65; 95% confidence interval, 0.49-0.87; P=.004). Conclusion Despite their more advanced age and greater prevalence of diabetes or hypertension, women with AMI who were treated with a reperfusion strategy largely based on percutaneous coronary interventions show a similar outcome as men.	Deutsch Herzzentrum Munich, D-80636 Munich, Germany; Tech Univ Munich, Med Klin Rechts Isar 1, D-8000 Munich, Germany	German Heart Centre Munich; Technical University of Munich	Kastrati, A (corresponding author), Deutsch Herzzentrum Munich, Lazarettstr 36, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019					*AM HEART ASS, 2000, 2001 HEART STROK STA, P6; [Anonymous], 1986, LANCET, V2, P57; Antoniucci D, 2001, AM J CARDIOL, V87, P289, DOI 10.1016/S0002-9149(00)01360-6; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; BECKER RC, 1994, ANN INTERN MED, V120, P638, DOI 10.7326/0003-4819-120-8-199404150-00003; Bell DM, 2000, PHARMACOTHERAPY, V20, P1034, DOI 10.1592/phco.20.13.1034.35034; Brener SJ, 1998, CIRCULATION, V98, P734, DOI 10.1161/01.CIR.98.8.734; Cho L, 2000, J WOMEN HEALTH GEN-B, V9, P741, DOI 10.1089/15246090050147718; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; French JK, 1996, BMJ-BRIT MED J, V312, P1637, DOI 10.1136/bmj.312.7047.1637; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; Hannan EL, 2000, J AM COLL CARDIOL, V36, P1194, DOI 10.1016/S0735-1097(00)00866-4; HARRELL FE, 1997, PREDICTING OUTCOMES, P290; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LINCOFF AM, 1993, J AM COLL CARDIOL, V22, P1780, DOI 10.1016/0735-1097(93)90757-R; Malacrida R, 1998, NEW ENGL J MED, V338, P8, DOI 10.1056/NEJM199801013380102; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; STONE GW, 1995, AM J CARDIOL, V75, P987, DOI 10.1016/S0002-9149(99)80709-7; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; VACEK JL, 1995, AM J CARDIOL, V76, P226, DOI 10.1016/S0002-9149(99)80070-8; VACEK JL, 1993, AM HEART J, V126, P521, DOI 10.1016/0002-8703(93)90399-T; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; WHITE HD, 1993, CIRCULATION, V88, P2097, DOI 10.1161/01.CIR.88.5.2097	40	124	130	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					210	215		10.1001/jama.287.2.210	http://dx.doi.org/10.1001/jama.287.2.210			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779263				2022-12-28	WOS:000173114900023
J	Bania, TM; Rood, RT; Balser, DS				Bania, TM; Rood, RT; Balser, DS			The cosmological density of baryons from observations of (3)He(+) in the Milky Way	NATURE			English	Article							INTERSTELLAR-MEDIUM; PRIMORDIAL ABUNDANCE; STELLAR PRODUCTION; PLANETARY-NEBULA; DEEP CIRCULATION; RED GIANTS; EVOLUTION; STARS; REGIONS; OXYGEN	Primordial nucleosynthesis after the Big Bang can be constrained by the abundances of the light elements and isotopes (2)H, (3)He, (4)He and (7)Li (ref. 1). The standard theory of stellar evolution predicts that (3)He is also produced by solar-type stars(2), so its abundance is of interest not only for cosmology, but also for understanding stellar evolution and the chemical evolution of the Galaxy. The (3)He abundance in star-forming (H II) regions agrees with the present value for the local interstellar medium(3), but seems to be incompatible(4-6) with the stellar production rates inferred from observations of planetary nebulae(7), which provide a direct test of stellar evolution theory(8). Here we develop our earlier observations(9,10), which, when combined with recent theoretical developments in our understanding of light-element synthesis and destruction in stars(11-14), allow us to determine an upper limit for the primordial abundance of (3)He relative to hydrogen: (3)He/H = (1.1 +/- 0.2) x 10(-5). The primordial density of all baryons determined from the (3)He data is in excellent agreement with the densities calculated from other cosmological probes. The previous conflict is resolved because most solar-mass stars do not produce enough (3)He to enrich the interstellar medium significantly.	Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; Natl Radio Astron Observ, Green Bank, WV 24944 USA	Boston University; University of Virginia; National Radio Astronomy Observatory (NRAO)	Bania, TM (corresponding author), Boston Univ, Inst Astrophys Res, 725 Commonwealth Ave, Boston, MA 02215 USA.	bania@bu.edu	Bania, Thomas M/H-2318-2014	Bania, Thomas M/0000-0003-4866-460X				Balser DS, 1999, ASTROPHYS J, V510, P759, DOI 10.1086/306598; Balser DS, 1997, ASTROPHYS J, V483, P320, DOI 10.1086/304248; Balser DS, 1999, ASTROPHYS J, V522, pL73, DOI 10.1086/312216; Bania TM, 1997, ASTROPHYS J SUPPL S, V113, P353, DOI 10.1086/313059; Burles S, 2001, ASTROPHYS J, V552, pL1, DOI 10.1086/320251; Charbonnel C, 1998, ASTRON ASTROPHYS, V332, P204; Charbonnel C, 1998, ASTRON ASTROPHYS, V336, P915; Charbonnel C, 1998, SPACE SCI REV, V84, P199, DOI 10.1023/A:1005027519798; Dearborn DSP, 1996, ASTROPHYS J, V465, P887, DOI 10.1086/177472; Deharveng L, 2000, MON NOT R ASTRON SOC, V311, P329, DOI 10.1046/j.1365-8711.2000.03030.x; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; GALLI D, 1997, ASTROPHYS J, V477, P210; Gloeckler G, 1998, SPACE SCI REV, V84, P275, DOI 10.1023/A:1005095907503; HOGAN CJ, 1995, ASTROPHYS J LETT, V441, P17; Izotov YI, 1998, ASTROPHYS J, V500, P188, DOI 10.1086/305698; Olive KA, 1997, ASTROPHYS J, V483, P788, DOI 10.1086/304281; PRYKE C, UNPUB ASTROPHYS J; ROOD RT, 1984, ASTROPHYS J, V280, P629, DOI 10.1086/162036; Rood RT, 1998, SPACE SCI REV, V84, P185, DOI 10.1023/A:1005023402960; ROOD RT, 1992, NATURE, V355, P618, DOI 10.1038/355618a0; ROOD RT, 1976, ASTROPHYS J, V207, pL57, DOI 10.1086/182178; Sackmann IJ, 1999, ASTROPHYS J, V510, P217, DOI 10.1086/306545; SHAVER PA, 1983, MON NOT R ASTRON SOC, V204, P53, DOI 10.1093/mnras/204.1.53; SPITE M, 1982, NATURE, V297, P483, DOI 10.1038/297483a0; Tosi M, 2000, IAU SYMP, P525; WALKER TP, 1991, ASTROPHYS J, V376, P51, DOI 10.1086/170255; WASSERBURG GJ, 1995, ASTROPHYS J, V447, pL37, DOI 10.1086/309555; [No title captured]	29	215	216	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					54	57		10.1038/415054a	http://dx.doi.org/10.1038/415054a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780112				2022-12-28	WOS:000173028800035
J	Tregenza, T; Wedell, N				Tregenza, T; Wedell, N			Polyandrous females avoid costs of inbreeding	NATURE			English	Article							GRYLLUS-BIMACULATUS; FIELD CRICKET; GENETIC INCOMPATIBILITY; SPERM SELECTION; CHOICE; EVOLUTION; BENEFITS; RECOGNITION; CONFLICT; SUCCESS	Why do females typically mate with more than one male? Female mating patterns have broad implications for sexual selection(1,2), speciation(3) and conflicts of interest between the sexes(4), and yet they are poorly understood. Matings inevitably have costs(5), and for females, the benefits of taking more than one mate are rarely obvious. One possible explanation is that females gain benefits because they can avoid using sperm from genetically incompatible males, or invest less in the offspring of such males(6,7). It has been shown that mating with more than one male can increase offspring viability(8-12), but we present the first clear demonstration that this occurs because females with several mates avoid the negative effects of genetic incompatibility(13). We show that in crickets, the eggs of females that mate only with siblings have decreased hatching success. However, if females mate with both a sibling and a non-sibling they avoid altogether the low egg viability associated with sibling matings. If similar effects occur in other species, inbreeding avoidance may be important in understanding the prevalence of multiple mating.	Univ Leeds, Sch Biol, Ecol & Evolut Grp, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Tregenza, T (corresponding author), Univ Leeds, Sch Biol, Ecol & Evolut Grp, Leeds LS2 9JT, W Yorkshire, England.	T.Tregenza@leeds.ac.uk	Tregenza, Tom/B-1078-2014	Tregenza, Tom/0000-0003-4182-2222				Andersson Malte, 1994; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Keil A, 1998, ETHOLOGY, V104, P897; Lorenz MW, 1998, ARCH INSECT BIOCHEM, V38, P32, DOI 10.1002/(SICI)1520-6327(1998)38:1&lt;32::AID-ARCH4&gt;3.0.CO;2-X; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Markow T.A., 1982, P273; Markow TA, 1997, P NATL ACAD SCI USA, V94, P7756, DOI 10.1073/pnas.94.15.7756; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; OLSSON M, 1994, NATURE, V369, P528, DOI 10.1038/369528b0; Parker G.A., 1979, P123; QAYYUM H A, 1969, Pakistan Journal of Scientific Research, V21, P112; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P197, DOI 10.1007/BF00303211; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SIMMONS LW, 1986, ANIM BEHAV, V34, P1463, DOI 10.1016/S0003-3472(86)80217-2; SIMMONS LW, 1990, ANIM BEHAV, V40, P192, DOI 10.1016/S0003-3472(05)80683-9; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P313, DOI 10.1007/BF00299969; Stockley P, 1999, P ROY SOC B-BIOL SCI, V266, P1663, DOI 10.1098/rspb.1999.0829; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 1997, ANIM BEHAV, V54, P979, DOI 10.1006/anbe.1997.0500; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	30	415	424	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					71	73		10.1038/415071a	http://dx.doi.org/10.1038/415071a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780118	Green Accepted			2022-12-28	WOS:000173028800041
J	Shen, XH; Ellis, RE; Lee, K; Liu, CY; Yang, K; Solomon, A; Yoshida, H; Morimoto, R; Kurnit, DM; Mori, K; Kaufman, RJ				Shen, XH; Ellis, RE; Lee, K; Liu, CY; Yang, K; Solomon, A; Yoshida, H; Morimoto, R; Kurnit, DM; Mori, K; Kaufman, RJ			Complementary signaling pathways regulate the unfolded protein response and are required for C-elegans development	CELL			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; STRESS; KINASE; IRE1; ER; IDENTIFICATION	The unfolded protein response (UPR) is a transcriptional and translational intracellular signaling pathway activated by the accumulation of unfolded proteins in the lumen of the endoplasmic reticulum (ER). We have used C. elegans as a genetic model system to dissect UPR signaling in a multicellular organism. C. elegans requires ire-l-mediated splicing of xbp-1 mRNA for UPR gene transcription and survival upon ER stress. In addition, ire-1/xbp-1 acts with pek-1, a protein kinase that mediates translation attenuation, in complementary pathways that are essential for worm development and survival. We propose that UPR transcriptional activation by ire-1 as well as translational attenuation by pek-1 maintain ER homeostasis. The results demonstrate that the UPR and ER homeostasis are essential for metazoan development.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068304, Japan	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Kyoto University	Kaufman, RJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.			Yoshida, Hiderou/0000-0002-5773-1408	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042394] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01 AI-42394-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; BRENNER S, 1974, GENETICS, V77, P71; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Chen PJ, 2000, DEV BIOL, V217, P77, DOI 10.1006/dbio.1999.9521; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall DH, 1997, J NEUROSCI, V17, P1033; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; KOLDIN B, 1995, NUCLEIC ACIDS RES, V23, P4162, DOI 10.1093/nar/23.20.4162; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; LEE K, 2002, IN PRESS GENES DEV; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; MORI K, 1993, CELL, V74, P743; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIGURDSON DC, 1984, GENETICS, V108, P331; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wyllie A.H., 1981, CELL DEATH BIOL PATH, P9; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	53	524	552	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					893	903		10.1016/S0092-8674(01)00612-2	http://dx.doi.org/10.1016/S0092-8674(01)00612-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779465	Bronze			2022-12-28	WOS:000173024200010
J	Washington, MT; Prakash, L; Prakash, S				Washington, MT; Prakash, L; Prakash, S			Yeast DNA polymerase eta utilizes an induced-fit mechanism of nucleotide incorporation	CELL			English	Article							PIGMENTOSUM VARIANT CELLS; THYMINE-THYMINE DIMER; XERODERMA-PIGMENTOSUM; KINETIC MECHANISM; I KLENOW; CRYSTAL-STRUCTURE; BASE-PAIRS; FIDELITY; REPLICATION; BYPASS	DNA polymerase eta (Pol eta) is unique among eukaryotic DNA polymerases in its proficient ability to replicate through distorting DNA lesions, and Pol eta synthesizes DNA with a low fidelity. Here, we use pre-steady-state kinetics to investigate the mechanism of nucleotide incorporation by Pol eta and show that it utilizes an induced-fit mechanism to selectively incorporate the correct nucleotide. Pol eta discriminates poorly between the correct and incorrect nucleotide at both the initial nucleotide binding step and at the subsequent induced-fit conformational change step, which precedes the chemical step of phosphodiester bond formation. This property enables Pol eta to bypass lesions with distorted DNA geometries, and it bestows upon the enzyme a low fidelity.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Blocker Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.	sprakash@scms.utmb.edu	Prakash, Satya/C-6420-2013	Washington, Todd/0000-0001-8680-2992; Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NIGMS NIH HHS [GM 19261] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P7395, DOI 10.1021/bi00419a034; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CIARROCCHI G, 1982, J MOL BIOL, V155, P177, DOI 10.1016/0022-2836(82)90445-4; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Einolf HJ, 2000, J BIOL CHEM, V275, P16316, DOI 10.1074/jbc.M001291200; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Johnson KA, 1998, CURR OPIN BIOTECH, V9, P87, DOI 10.1016/S0958-1669(98)80089-X; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; KATI WM, 1992, J BIOL CHEM, V267, P25988; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; McDonald JP, 1997, GENETICS, V147, P1557; Minko IG, 2001, J BIOL CHEM, V276, P2517, DOI 10.1074/jbc.M007867200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WATERS HL, 1993, J INVEST DERMATOL, V101, P744, DOI 10.1111/1523-1747.ep12371686; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	53	111	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					917	927		10.1016/S0092-8674(01)00613-4	http://dx.doi.org/10.1016/S0092-8674(01)00613-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779467	Bronze			2022-12-28	WOS:000173024200012
J	Lee, WH; Boyer, TG				Lee, WH; Boyer, TG			BRCA1 and BRCA2 in breast cancer	LANCET			English	Article									Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Lee, WH (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.								0	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S5	S5		10.1016/S0140-6736(01)07018-0	http://dx.doi.org/10.1016/S0140-6736(01)07018-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784554	Bronze			2022-12-28	WOS:000172907200005
J	Rose, EA; Gelijns, AC; Moskowitz, AJ; Heitjan, DF; Stevenson, LW; Dembitsky, W; Long, JW; Ascheim, DD; Tierney, AR; Levitan, RG; Watson, JT; Meier, P				Rose, EA; Gelijns, AC; Moskowitz, AJ; Heitjan, DF; Stevenson, LW; Dembitsky, W; Long, JW; Ascheim, DD; Tierney, AR; Levitan, RG; Watson, JT; Meier, P		Randomized Evaluation Mech Assista	Long-term use of a left ventricular assist device for end-stage heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC TRANSPLANTATION; CONTROLLED TRIAL; MENTAL-HEALTH; EXPERIENCE; MORTALITY; VALIDITY; BRIDGE; DESIGN	Background: Implantable left ventricular assist devices have benefited patients with end-stage heart failure as a bridge to cardiac transplantation, but their long-term use for the purpose of enhancing survival and the quality of life has not been evaluated. Methods: We randomly assigned 129 patients with end-stage heart failure who were ineligible for cardiac transplantation to receive a left ventricular assist device (68 patients) or optimal medical management (61). All patients had symptoms of New York Heart Association class IV heart failure. Results: Kaplan-Meier survival analysis showed a reduction of 48 percent in the risk of death from any cause in the group that received left ventricular assist devices as compared with the medical-therapy group (relative risk, 0.52; 95 percent confidence interval, 0.34 to 0.78; P=0.001). The rates of survival at one year were 52 percent in the device group and 25 percent in the medical-therapy group (P=0.002), and the rates at two years were 23 percent and 8 percent (P=0.09), respectively. The frequency of serious adverse events in the device group was 2.35 (95 percent confidence interval, 1.86 to 2.95) times that in the medical-therapy group, with a predominance of infection, bleeding, and malfunction of the device. The quality of life was significantly improved at one year in the device group. Conclusions: The use of a left ventricular assist device in patients with advanced heart failure resulted in a clinically meaningful survival benefit and an improved quality of life. A left ventricular assist device is an acceptable alternative therapy in selected patients who are not candidates for cardiac transplantation.	Columbia Univ, Coll Phys & Surg, New York, NY USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, New York, NY USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA; LDS Hosp, Salt Lake City, UT USA; NHLBI, Bethesda, MD 20892 USA; Univ Minnesota, Minneapolis, MN USA; Texas Heart Inst, Houston, TX 77025 USA; Thoratec Corp, Pleasanton, CA USA	Columbia University; Columbia University; Harvard University; Brigham & Women's Hospital; Sharp Memorial Hospital Rehabilitation & Physical Therapy; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; Texas Heart Institute; Thoratec	Rose, EA (corresponding author), Columbia Univ, Int Ctr Hlth Outcomes & Innovat, 600 W 168th St,7th Fl, New York, NY 10032 USA.		Rose, Eric/AAJ-2281-2020; Heitjan, Daniel F./D-1116-2009	Moskowitz, Alan/0000-0002-4412-9450	NHLBI NIH HHS [HL-53986] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL053986] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Heart Association, 2000, 2001 HEART STROK STA; BARNETTE M, 1987, B SCHROEDER STORY AR, P383; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; Catanese KA, 1996, ANN THORAC SURG, V62, P646, DOI 10.1016/S0003-4975(96)00456-0; Edmunds LH, 1996, ANN THORAC SURG, V62, P932, DOI 10.1016/S0003-4975(96)00531-0; ElAmir NG, 1996, ASAIO J, V42, P150, DOI 10.1097/00002480-199605000-00006; FRAZIER OH, 1992, ANN THORAC SURG, V53, P1080, DOI 10.1016/0003-4975(92)90393-I; Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107; Hogness JR, 1991, ARTIFICIAL HEART PRO, P14; Hosenpud JD, 2000, J HEART LUNG TRANSPL, V19, P909, DOI 10.1016/S1053-2498(00)00138-8; KJEKSHUS J, 1992, AM J CARDIOL, V69, P103, DOI 10.1016/0002-9149(92)90683-P; Korfer R, 2000, J THORAC CARDIOV SUR, V119, P596, DOI 10.1016/S0022-5223(00)70142-5; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; McBride LR, 1999, ANN THORAC SURG, V67, P1233, DOI 10.1016/S0003-4975(99)00246-5; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MEHTA SM, 1995, J HEART LUNG TRANSPL, V14, P585; Moskowitz AJ, 1997, ANN THORAC SURG, V64, P1764, DOI 10.1016/S0003-4975(97)01000-X; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; PENNINGTON DG, 1994, J THORAC CARDIOV SUR, V107, P472, DOI 10.1016/S0022-5223(94)70092-3; PORTNER PM, 1989, ANN THORAC SURG, V47, P142, DOI 10.1016/0003-4975(89)90256-7; Rector T S, 1995, J Card Fail, V1, P201, DOI 10.1016/1071-9164(95)90025-X; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Ries LAG .M.K.C, 2001, SEER CANC STAT REV 1; Rose EA, 1999, ANN THORAC SURG, V67, P723, DOI 10.1016/S0003-4975(99)00042-9; Singer MA, 1999, QUAL LIFE RES, V8, P687, DOI 10.1023/A:1008917016998; Slater JP, 1996, ANN THORAC SURG, V62, P1321, DOI 10.1016/0003-4975(96)00750-3; Spanier T, 1996, J THORAC CARDIOV SUR, V112, P1090, DOI 10.1016/S0022-5223(96)70111-3; Ware J. E., 1993, SF36 HLTH SURVEY MAN; WARE JE, 1994, SF36 PHYSICAL MENTAL; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	33	2772	2848	3	91	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1435	1443		10.1056/NEJMoa012175	http://dx.doi.org/10.1056/NEJMoa012175			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794191				2022-12-28	WOS:000172132700001
J	Chapelle, FH; O'Neill, K; Bradley, PM; Methe, BA; Ciufo, SA; Knobel, LL; Lovley, DR				Chapelle, FH; O'Neill, K; Bradley, PM; Methe, BA; Ciufo, SA; Knobel, LL; Lovley, DR			A hydrogen-based subsurface microbial community dominated by methanogens	NATURE			English	Article							ECOSYSTEMS; DEEP; INDICATOR; DIVERSITY; BACTERIA; ENERGY	The search for extraterrestrial life may be facilitated if ecosystems can be found on Earth that exist under conditions analogous to those present on other planets or moons. It has been proposed, on the basis of geochemical and thermodynamic considerations, that geologically derived hydrogen might support subsurface microbial communities on Mars and Europa in which methanogens form the base of the ecosystem(1-5). Here we describe a unique subsurface microbial community in which hydrogen-consuming, methane-producing Archaea far outnumber the Bacteria. More than 90% of the 16S ribosomal DNA sequences recovered from hydrothermal waters circulating through deeply buried igneous rocks in Idaho are related to hydrogen-using methanogenic microorganisms. Geochemical characterization indicates that geothermal hydrogen, not organic carbon, is the primary energy source for this methanogen-dominated microbial community. These results demonstrate that hydrogen-based methanogenic communities do occur in Earth's subsurface, providing an analogue for possible subsurface microbial ecosystems on other planets.	US Geol Survey, Columbia, SC 29210 USA; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; US Geol Survey, Idaho Falls, ID 83402 USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Energy (DOE); Idaho National Laboratory; United States Department of the Interior; United States Geological Survey	Chapelle, FH (corresponding author), US Geol Survey, Columbia, SC 29210 USA.	dlovley@microbio.umass.edu	Bradley, Paul M./AAC-2451-2020	Bradley, Paul M./0000-0001-7522-8606				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson RT, 1998, SCIENCE, V281, P976, DOI 10.1126/science.281.5379.976; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; BOSTON PJ, 1992, ICARUS, V95, P300, DOI 10.1016/0019-1035(92)90045-9; Carr MH, 1996, CIBA F SYMP, V202, P249; Chapelle FH, 1997, ENVIRON SCI TECHNOL, V31, P2873, DOI 10.1021/es970085c; Embree G. F., 1982, IDAHO BUREAU MINES G, V26, P333; Farmer J.D., 2000, GEOLOGICAL SOC AM TO, V10, P1; Fisk MR, 1999, J GEOPHYS RES-PLANET, V104, P11805, DOI 10.1029/1999JE900010; Fry NK, 1997, APPL ENVIRON MICROB, V63, P1498, DOI 10.1128/AEM.63.4.1498-1504.1997; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Knobel LL, 1999, 99246 US GEOL SURV; LILLEY MD, 2001, LPI CONTRIBUTION, V1088; LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; McCollom TM, 1999, J GEOPHYS RES-PLANET, V104, P30729, DOI 10.1029/1999JE001126; McKay CP, 2001, WILEY S ECO, P315; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871, DOI 10.1128/AEM.60.3.871-879.1994; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; PICARD C, 1992, APPL ENVIRON MICROB, V58, P2717, DOI 10.1128/AEM.58.9.2717-2722.1992; PIERCE KL, 1982, GEOL SOC AM MEM, V179; Shock EL, 1996, CIBA F SYMP, V202, P40; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; SUGISAKI R, 1986, J GEOPHYS RES-SOLID, V91, P2296, DOI 10.1029/JB091iB12p12296; WAKITA H, 1980, SCIENCE, V210, P188, DOI 10.1126/science.210.4466.188	26	318	347	8	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					312	315		10.1038/415312a	http://dx.doi.org/10.1038/415312a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797006				2022-12-28	WOS:000173293500041
J	Sigala, N; Logothetis, NK				Sigala, N; Logothetis, NK			Visual categorization shapes feature selectivity in the primate temporal cortex	NATURE			English	Article							INFEROTEMPORAL CORTEX; RHESUS-MONKEYS; RECOGNITION; SIMILARITY; REPRESENTATION; EXPERTISE; IMAGES; EYE	The way that we perceive and interact with objects depends on our previous experience with them. For example, a bird expert is more likely to recognize a bird as a sparrow, a sandpiper or a cockatiel than a non-expert(1). Neurons in the inferior temporal cortex have been shown to be important in the representation of visual objects; however, it is unknown which object features are represented and how these representations are affected by categorization training. Here we show that feature selectivity in the macaque inferior temporal cortex is shaped by categorization of objects on the basis of their visual features. Specifically, we recorded from single neurons while monkeys performed a categorization task with two sets of parametric stimuli. Each stimulus set consisted of four varying features, but only two of the four were important for the categorization task (diagnostic features). We found enhanced neuronal representation of the diagnostic features relative to the non-diagnostic ones. These findings demonstrate that stimulus features important for categorization are instantiated in the activity of single units (neurons) in the primate inferior temporal cortex.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Sigala, N (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	natasha.sigala@tuebingen.mpg.de	Sigala, Natasha/K-1750-2013; Sigala, Natasha/ABH-3181-2020; Logothetis, Nikos/U-9282-2019	Sigala, Natasha/0000-0002-9456-6093; Sigala, Natasha/0000-0002-9456-6093; 				BRUNER JS, 1957, PSYCHOL REV, V64, P123, DOI 10.1037/h0043805; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SIGALA N, 2001, J COGNITIVE NEUROSCI, V14, P1; Sugihara T, 1998, BIOL CYBERN, V78, P1, DOI 10.1007/s004220050407; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x	20	417	421	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					318	320		10.1038/415318a	http://dx.doi.org/10.1038/415318a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511YC	11797008				2022-12-28	WOS:000173293500043
J	Soares-Weiser, K; Paul, M; Brezis, M; Leibovici, L				Soares-Weiser, K; Paul, M; Brezis, M; Leibovici, L			Evidence based case report - Antibiotic treatment for spontaneous bacterial peritonitis	BRITISH MEDICAL JOURNAL			English	Review							CIRRHOTIC-PATIENTS; RANDOMIZED TRIAL; CEFOTAXIME; INFECTIONS; THERAPY; CEFTRIAXONE; MULTICENTER; AMPICILLIN		Rabin Med Ctr, Dept Med E, IL-49100 Petah Tiqwa, Israel; Hadassah Univ Hosp, Dept Med, IL-91240 Jerusalem, Israel	Rabin Medical Center; Hebrew University of Jerusalem	Soares-Weiser, K (corresponding author), Rabin Med Ctr, Dept Med E, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.		Brezis, Mayer/A-1041-2010					ARIZA J, 1991, HEPATOLOGY, V14, P91, DOI 10.1002/hep.1840140115; Deschenes M, 1999, AM J GASTROENTEROL, V94, P2193, DOI 10.1016/S0002-9270(99)00349-4; FELISART J, 1985, HEPATOLOGY, V5, P457, DOI 10.1002/hep.1840050319; FIGUEIREDO F, 1997, GASTROENTEROLOGIA EN, V16, P231; FONG TL, 1989, HEPATOLOGY, V9, P423, DOI 10.1002/hep.1840090313; GOMEZJIMENEZ J, 1993, ANTIMICROB AGENTS CH, V37, P1587, DOI 10.1128/AAC.37.8.1587; Guarner C, 1997, SEMIN LIVER DIS, V17, P203, DOI 10.1055/s-2007-1007198; McCormick PA, 1997, HEPATOLOGY, V25, P833, DOI 10.1002/hep.510250408; MERCADER J, 1989, CHEMOTHERAPY, V35, P23, DOI 10.1159/000238735; Navasa M, 1996, GASTROENTEROLOGY, V111, P1011, DOI 10.1016/S0016-5085(96)70069-0; PARIENTE E A, 1988, Journal of Hepatology, V7, pS159; Rastegar LA, 1998, HEPATO-GASTROENTEROL, V45, P783; Ricart E, 2000, J HEPATOL, V32, P596, DOI 10.1016/S0168-8278(00)80221-4; RIMOLA A, 1995, HEPATOLOGY, V21, P674, DOI 10.1002/hep.1840210312; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Rimola A, 1984, GASTROENTEROL HEPATO, V7, P235; ROSE B, 2000, UPTODATE 9 1; RUNYON BA, 1991, GASTROENTEROLOGY, V100, P1737, DOI 10.1016/0016-5085(91)90677-D; SIFUENTESOSORNIO J, 1989, AM J MED, V87, pS202, DOI 10.1016/0002-9343(89)90059-4; SILVAIN C, 1989, GASTROEN CLIN BIOL, V13, P335; SOARESWEISER K, 2001, COCHRANE DATABASE SY; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Terg R, 2000, J HEPATOL, V33, P564, DOI 10.1034/j.1600-0641.2000.033004564.x; *UPD SOFTW, 2000, COCHRANE LIB	24	11	12	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					100	102		10.1136/bmj.324.7329.100	http://dx.doi.org/10.1136/bmj.324.7329.100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786457	Green Published			2022-12-28	WOS:000173325400025
J	Hiroeh, U; Appleby, L; Mortensen, PB; Dunn, G				Hiroeh, U; Appleby, L; Mortensen, PB; Dunn, G			Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study	LANCET			English	Article							MORTALITY	Background People with mental illness are at great risk of suicide, but little is known about their risk of death from other unnatural causes. No study has commented on their risk of being victims of homicide; public concern is preoccupied with their role as perpetrators. We aimed to calculate standardised mortality ratios (SMRs) and directly standardised rate ratios for death by homicide, suicide, and accident in people admitted to hospital because of mental illness. Method We did a population-based study in which we linked the data for 72 208 individuals listed in the Danish Psychiatric Case Register between 1973 and 1993, and who died before Dec 31, 1993, with data in the Danish National Register of Causes of Death. Findings 17 892 (25%) patients died from unnatural causes. Our results show raised SMRs for homicide, suicide, and accident for most psychiatric diagnoses irrespective of sex. The all-diagnosis SMRs for women and men, respectively, were: 632 (95% CI 517-773) and 609 (493-753) for homicide, 1356 (1322-1391) and 1212 (1184-1241) for suicide. and 318 (305-332) and 466 (448-484) for accident. We recorded an increased risk of dying by homicide in men with schizophrenia and in individuals with affective psychosis. The highest risks of death by homicide and accident were in alcoholism and drug use, whereas the highest risks of suicide were in drug use. Interpretation People with mental disorders, including severe mental illness, are at increased risk of death by homicide. Strategies to reduce mortality in the mentally ill are correct to emphasise the high risk of suicide, but they should also focus on other unnatural causes of death.	Univ Manchester, Univ S Manchester Hosp, Sch Psychiat & Behav Sci, Manchester M20 8LR, Lancs, England; Psychiat Hosp Arhus, Inst Basic Psychiat Res, Risskov, Denmark; Univ Aarhus, Natl Ctr Register Based Res, Aarhus C, Denmark; Univ Manchester, Sch Epidemiol & Stat, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Aarhus University; Aarhus University; University of Manchester	Appleby, L (corresponding author), Univ Manchester, Univ S Manchester Hosp, Sch Psychiat & Behav Sci, Manchester M20 8LR, Lancs, England.		Mortensen, Preben B/D-2358-2015	Mortensen, Preben B/0000-0002-5230-9865				Appleby L., 1999, SAFER SERVICES REPOR; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; MORTENSEN PB, 1993, BRIT J PSYCHIAT, V163, P183, DOI 10.1192/bjp.163.2.183; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631; STEADMAN HJ, 1981, J HEALTH SOC BEHAV, V22, P310, DOI 10.2307/2136524; Taylor PJ, 1999, BRIT J PSYCHIAT, V174, P9, DOI 10.1192/bjp.174.1.9	9	202	211	0	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2110	2112		10.1016/S0140-6736(01)07216-6	http://dx.doi.org/10.1016/S0140-6736(01)07216-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505GV	11784624				2022-12-28	WOS:000172905800008
J	Moyer, MS; Anupindi, SA; Graeme-Cook, FM; Russell, GJ; Kleinman, RE				Moyer, MS; Anupindi, SA; Graeme-Cook, FM; Russell, GJ; Kleinman, RE			A 17-year-old boy with biliary obstruction. Primary sclerosing cholangitis. Crohn's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLAMMATORY BOWEL-DISEASE; UPPER GASTROINTESTINAL-TRACT; CLOSTRIDIUM-DIFFICILE; CHILDREN; HEPATOBILIARY; LESIONS; LIVER		Yale Univ, Sch Med, New Haven, CT USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA	Yale University; Yale University	Moyer, MS (corresponding author), Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA.							Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Claise C, 1996, LIVER, V16, P28; GRYBOSKI JD, 1991, J PEDIATR GASTR NUTR, V13, P39, DOI 10.1097/00005176-199107000-00007; Heikius B, 1997, SCAND J GASTROENTERO, V32, P153, DOI 10.3109/00365529709000186; HYAMS JS, 1994, J PEDIATR GASTR NUTR, V19, P7, DOI 10.1097/00005176-199407000-00003; JACOBSEN MB, 1990, SCAND J GASTROENTERO, V25, P656, DOI 10.3109/00365529008997589; JACOBSEN MB, 1990, SCAND J GASTROENTERO, V25; LENAERTS C, 1989, PEDIATRICS, V83, P777; LO SK, 1993, GUT, V34, P199, DOI 10.1136/gut.34.2.199; MALLER ES, 1996, PEDIAT GASTROINTESTI, P1289; MASHAKO MNL, 1989, J PEDIATR GASTR NUTR, V8, P442, DOI 10.1097/00005176-198905000-00004; Mieli-Vergani G, 1998, SEMIN LIVER DIS, V18, P271, DOI 10.1055/s-2007-1007163; MOLMENTI EP, 1993, J BIOL CHEM, V268, P14116; Rasmussen HH, 1997, SCAND J GASTROENTERO, V32, P604, DOI 10.3109/00365529709025107; Riegler G, 1998, SCAND J GASTROENTERO, V33, P93; Roberts EA, 1999, J GASTROEN HEPATOL, V14, P588, DOI 10.1046/j.1440-1746.1999.01919.x; RUUSKA T, 1994, J PEDIATR GASTR NUTR, V19, P181, DOI 10.1097/00005176-199408000-00007; THOMAS DW, 1981, GASTROENTEROLOGY, V80, P776; Volta U, 1998, DIGEST DIS SCI, V43, P2190, DOI 10.1023/A:1026650118759	19	1	1	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					271	276		10.1056/NEJMcpc020003	http://dx.doi.org/10.1056/NEJMcpc020003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807152				2022-12-28	WOS:000173398900008
J	Lewis, JD; Brown, A; Localio, AR; Schwartz, JS				Lewis, JD; Brown, A; Localio, AR; Schwartz, JS			Initial evaluation of rectal bleeding in young persons: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CONTRAST BARIUM-ENEMA; COLORECTAL-CANCER; FLEXIBLE SIGMOIDOSCOPY; GENERAL-PRACTICE; COLONOSCOPIC POLYPECTOMY; ASYMPTOMATIC ADULTS; PREDICTIVE-VALUE; LARGE-BOWEL; FOLLOW-UP; POLYPS	Background: Evaluation of rectal bleeding in young patients is a frequent diagnostic challenge. Objective: To determine the relative cost-effectiveness of alternative diagnostic strategies for young patients with rectal bleeding. Design: Cost-effectiveness analysis using a Markov model. Data Sources: Probability estimates were based on published medical literature. Cost estimates were based on Medicare reimbursement rates and published medical literature. Target Population: Persons 25 to 45 years of age with otherwise asymptomatic rectal bleeding. Time Horizon: The patient's lifetime. Perspective: Modified societal perspective. Interventions: Diagnostic strategies included no evaluation, colonoscopy, flexible sigmoidoscopy, barium enema, anoscopy, or any feasible combination of these procedures. Outcome Measures: Life expectancy and costs, Results of Base-Case Analysis: For 35-year-old patients, the no-evaluation strategy yielded the least life expectancy. The incremental cost-effectiveness of flexible sigmoidoscopy compared with no evaluation or with any strategy incorporating anoscopy (followed by further evaluation if no anal disease was found on anoscopy) was less than $5300 per year of life gained. A strategy of flexible sigmoidoscopy plus barium enema yielded the greatest life expectancy, with an incremental cost of $23 918 per additional life-year gained compared with flexible sigmoidoscopy alone. Results of Sensitivity Analysis: As patient age at presentation of rectal bleeding increased, evaluation of the entire colon became more cost-effective. The incremental cost-effectiveness of flexible sigmoidoscopy plus barium enema compared with colonoscopy was sensitive to estimates of the sensitivity of the tests. In a probabilistic sensitivity analysis comparing flexible sigmoidoscopy with anoscopy followed by flexible sigmoidoscopy if needed, the middle 95th percentile of the distribution of the incremental cost-effectiveness ratios ranged from flexible sigmoidoscopy yielding an increased life expectancy at reduced cost to $52 158 per year of life. gained (mean, $11 461 per year of life saved). Conclusions: Evaluation of the colon of persons 25 to 45 years of age with otherwise asymptomatic rectal bleeding increases the life expectancy at a cost comparable to that of colon cancer screening.	Univ Penn, Ctr Canc, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lewis, JD (corresponding author), Univ Penn, Ctr Canc, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Blockley Hall,9th Floor,423 Guardian Dr, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002589] Funding Source: NIH RePORTER; NIDDK NIH HHS [1-K08-DK02589-0] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACOSTA JA, 1994, AM SURGEON, V60, P903; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BRAND EJ, 1980, ANN SURG, V192, P111, DOI 10.1097/00000658-198007000-00019; CHAPUIS PH, 1985, BRIT MED J, V290, P1546, DOI 10.1136/bmj.290.6481.1546; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; DENT OF, 1986, DIS COLON RECTUM, V29, P243, DOI 10.1007/BF02553027; FARQUHARSON SM, 1994, LANCET, V344, P751, DOI 10.1016/S0140-6736(94)92241-1; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; FIJTEN GH, 1994, BRIT J GEN PRACT, V44, P320; FIJTEN GH, 1993, FAM PRACT, V10, P283, DOI 10.1093/fampra/10.3.283; Fine KD, 1999, AM J GASTROENTEROL, V94, P3202, DOI 10.1016/S0002-9270(99)00578-X; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; GOULSTON KJ, 1986, LANCET, V2, P261; GUILLEM JG, 1987, ANN SURG, V206, P606; Helfand M, 1997, JAMA-J AM MED ASSOC, V277, P44, DOI 10.1001/jama.277.1.44; HIXSON LJ, 1989, EUR J RADIOL, V9, P254; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; Hoff G, 1996, SCAND J GASTROENTERO, V31, P1006, DOI 10.3109/00365529609003121; HOFF G, 1986, SCAND J GASTROENTERO, V21, P848, DOI 10.3109/00365528609011129; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; IRVINE EJ, 1988, GUT, V29, P1188, DOI 10.1136/gut.29.9.1188; JARAMILLO E, 1992, GASTROINTEST RADIOL, V17, P81, DOI 10.1007/BF01888514; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; KORETZ RL, 1993, ANN INTERN MED, V118, P63, DOI 10.7326/0003-4819-118-1-199301010-00011; KORKIS AM, 1995, DIGEST DIS SCI, V40, P1520, DOI 10.1007/BF02285201; LEWIS J, IN PRESS DIG DIS SCI; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; MAKELA JT, 1993, SCAND J GASTROENTERO, V28, P1062, DOI 10.3109/00365529309098310; MANT A, 1989, DIS COLON RECTUM, V32, P191, DOI 10.1007/BF02554525; Metcalf JV, 1996, BRIT J GEN PRACT, V46, P161; Parkin D.M., 1992, CANC INCIDENCE 5 CON; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; PROVENZALE D, 1990, ANN INTERN MED, V113, P760, DOI 10.7326/0003-4819-113-10-760; RAFTERY TL, 1980, AM SURGEON, V46, P600; REX DK, 1990, GASTROENTEROLOGY, V98, P855, DOI 10.1016/0016-5085(90)90007-N; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Ries L, 1998, SEER CANC STAT REV 1; ROSEN L, 1993, DIS COLON RECTUM, V36, P1126, DOI 10.1007/BF02052261; Shennak MM, 1997, DIS COLON RECTUM, V40, P208, DOI 10.1007/BF02054990; SHINYA H, 1982, SURG CLIN N AM, V62, P897; SINGARAM C, 1995, AM J GASTROENTEROL, V90, P146; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; STANILAND JR, 1976, GASTROENTEROLOGY, V70, P22; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Talley NJ, 1998, AM J GASTROENTEROL, V93, P2179; THOENI RF, 1983, RADIOLOGY, V146, P603, DOI 10.1148/radiology.146.3.6600844; VENTURA S, 1996, BIRTHS DEATHS US 199; Waye J D, 1993, Gastroenterologist, V1, P158; Waye J D, 1996, Gastrointest Endosc Clin N Am, V6, P343; WAYE JD, 1988, AM J GASTROENTEROL, V83, P120; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; 1999, MMWR MORB MORTAL WKL, V48, P116	60	29	31	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					99	110		10.7326/0003-4819-136-2-200201150-00007	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790061				2022-12-28	WOS:000173333900002
J	Gavin, AC; Bosche, M; Krause, R; Grandi, P; Marzioch, M; Bauer, A; Schultz, J; Rick, JM; Michon, AM; Cruciat, CM; Remor, M; Hofert, C; Schelder, M; Brajenovic, M; Ruffner, H; Merino, A; Klein, K; Hudak, M; Dickson, D; Rudi, T; Gnau, V; Bauch, A; Bastuck, S; Huhse, B; Leutwein, C; Heurtier, MA; Copley, RR; Edelmann, A; Querfurth, E; Rybin, V; Drewes, G; Raida, M; Bouwmeester, T; Bork, P; Seraphin, B; Kuster, B; Neubauer, G; Superti-Furga, G				Gavin, AC; Bosche, M; Krause, R; Grandi, P; Marzioch, M; Bauer, A; Schultz, J; Rick, JM; Michon, AM; Cruciat, CM; Remor, M; Hofert, C; Schelder, M; Brajenovic, M; Ruffner, H; Merino, A; Klein, K; Hudak, M; Dickson, D; Rudi, T; Gnau, V; Bauch, A; Bastuck, S; Huhse, B; Leutwein, C; Heurtier, MA; Copley, RR; Edelmann, A; Querfurth, E; Rybin, V; Drewes, G; Raida, M; Bouwmeester, T; Bork, P; Seraphin, B; Kuster, B; Neubauer, G; Superti-Furga, G			Functional organization of the yeast proteome by systematic analysis of protein complexes	NATURE			English	Article							LARGE-SCALE ANALYSIS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; GENOMIC ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; SUBUNITS; PURIFICATION; GENERATION; NETWORK	Most cellular processes are carried out by multiprotein complexes. The identification and analysis of their components provides insight into how the ensemble of expressed proteins (proteome) is organized into functional units. We used tandem-affinity purification (TAP) and mass spectrometry in a large-scale approach to characterize multiprotein complexes in Saccharomyces cerevisiae. We processed 1,739 genes, including 1,143 human orthologues of relevance to human biology, and purified 589 protein assemblies. Bioinformatic analysis of these assemblies defined 232 distinct multiprotein complexes and proposed new cellular roles for 344 proteins, including 231 proteins with no previous functional annotation. Comparison of yeast and human complexes showed that conservation across species extends from single proteins to their molecular environment. Our analysis provides an outline of the eukaryotic proteome as a network of protein complexes at a level of organization beyond binary interactions. This higher-order map contains fundamental biological information and offers the context for a more reasoned and informed approach to drug discovery.	Cellzome AG, D-69117 Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; CNRS, CGM, F-91198 Gif Sur Yvette, France	GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Gavin, AC (corresponding author), Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg, Germany.	anne-claude.gavin@cellzome.com; giulio.superti-furga@cellzome.com	Kuster, Bernhard/Q-6031-2016; Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Schultz, Joerg/B-9346-2008; Bork, Peer/F-1813-2013	Kuster, Bernhard/0000-0002-9094-1677; Superti-Furga, Giulio/0000-0002-0570-1768; Bork, Peer/0000-0002-2627-833X; Krause, Roland/0000-0001-9938-7126; Seraphin, Bertrand/0000-0002-5168-1921; Gavin, Anne-Claude/0000-0003-4917-2340; Drewes, Gerard/0000-0003-0575-6766; Bauch, Angela/0000-0002-8712-4414				Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	46	3686	3843	3	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					141	147		10.1038/415141a	http://dx.doi.org/10.1038/415141a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805826				2022-12-28	WOS:000173159300033
J	Towbin, JA; Bowles, NE				Towbin, JA; Bowles, NE			The failing heart	NATURE			English	Review							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DOMINANT DILATED CARDIOMYOPATHY; X-LINKED GENE; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ANIMAL-MODELS; CYTOSKELETAL PROTEINS; DELTA-SARCOGLYCAN; ALPHA-TROPOMYOSIN; CARDIAC-MUSCLE	Cardiomyopathies are disorders affecting heart muscle that usually result in inadequate pumping of the heart. They are the most common cause of heart failure and each year kill more than 10,000 people in the United States. In recent years, there have been breakthroughs in understanding the molecular mechanisms involved in this group of conditions, with knowledge of the genetic basis for cardiomyopathies perhaps seeing the largest advance, enabling clinicians to devise improved diagnostic strategies and preparing the stage for new therapies.	Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cardiovasc Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA.	jtowbin@bcm.tmc.edu	Knuuti, Juhani/AAA-7472-2019	Knuuti, Juhani/0000-0003-3156-9593				ABELMANN WH, 1989, J AM COLL CARDIOL, V13, P1219, DOI 10.1016/0735-1097(89)90293-3; Ahmad A, 2000, HUM MOL GENET, V9, P2507, DOI 10.1093/hmg/9.17.2507; Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Barresi R, 2000, J MED GENET, V37, P102, DOI 10.1136/jmg.37.2.102; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; Braunwald E, 2000, CIRCULATION, V102, P14; Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Carlsson L, 2001, ACTA PHYSIOL SCAND, V171, P341, DOI 10.1046/j.1365-201x.2001.00837.x; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Clemens PR, 1996, GENE THER, V3, P965; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Cohn RD, 2001, J CLIN INVEST, V107, pR1, DOI 10.1172/JCI11642; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; Cox GF, 1997, CURR OPIN CARDIOL, V12, P329; DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886; Dalloz F, 2001, J MOL CELL CARDIOL, V33, P9, DOI 10.1006/jmcc.2000.1289; Deng MC, 2001, CIRCULATION, V103, P231; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Fatkin D, 1999, J CLIN INVEST, V103, P147, DOI 10.1172/JCI4631; Furlanello F, 1998, PACE, V21, P331, DOI 10.1111/j.1540-8159.1998.tb01116.x; GILLUM RF, 1986, AM HEART J, V111, P752, DOI 10.1016/0002-8703(86)90111-0; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Heydemann A, 2001, CURR OPIN CARDIOL, V16, P211, DOI 10.1097/00001573-200105000-00009; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ichida F, 2001, CIRCULATION, V103, P1256; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; Jung M, 1999, AM J HUM GENET, V65, P1068, DOI 10.1086/302580; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaprielian RR, 2000, CIRCULATION, V101, P2586, DOI 10.1161/01.CIR.101.22.2586; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; Kittleson MD, 1999, CIRCULATION, V99, P3172, DOI 10.1161/01.CIR.99.24.3172; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; Kushwaha SS, 1997, NEW ENGL J MED, V336, P267, DOI 10.1056/NEJM199701233360407; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; Meng HP, 1996, J BIOL CHEM, V271, P12364, DOI 10.1074/jbc.271.21.12364; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; Stetson SJ, 2000, CIRCULATION, V102, P132; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Towbin J A, 2000, Curr Cardiol Rep, V2, P134, DOI 10.1007/s11886-000-0010-9; Towbin JA, 2001, J CLIN INVEST, V107, P153, DOI 10.1172/JCI11998; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; TOWBIN JA, 2000, MOL CLIN GENETICS CA, P195; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224	73	373	398	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					227	233		10.1038/415227a	http://dx.doi.org/10.1038/415227a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805847				2022-12-28	WOS:000173159300053
J	Cummings, SR; Duong, T; Kenyon, E; Cauley, JA; Whitehead, M; Krueger, KA				Cummings, SR; Duong, T; Kenyon, E; Cauley, JA; Whitehead, M; Krueger, KA		MORE Trial	Serum estradiol level and risk of breast cancer during treatment with raloxifene	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; ESTROGEN-RECEPTOR; HORMONE LEVELS; OLDER WOMEN; FRACTURES; REDUCTION; TAMOXIFEN; TRIAL	Context As endogenous estradiol increases, risk of breast cancer increases. Raloxifene competes with endogenous estrogen for binding to estrogen receptors in breast tissue. A woman's estradiol level may alter the effects of raloxifene on breast cancer and other outcomes. Objective To test the hypothesis that raloxifene reduces breast cancer risk more in women with relatively high estradiol levels than in women with very low estradiol levels. Design Analysis of the Multiple Outcomes of Raloxifene Evaluation, a randomized, double-blind, placebo-controlled trial conducted from 1994 to 1999. Setting One hundred eighty community settings and medical practices in 25 countries including the United States. Participants A total of 7290 postmenopausal women aged 80 years or younger with osteoporosis who had baseline serum estradiol concentrations measured by a central laboratory using a sensitive assay. Women with a history of breast cancer or estrogen use were excluded. Intervention Participants were randomly assigned to receive 60 mg/d or 120 mg/d of raloxifene (n=4843) or matching placebo (n=2447) for 4 years. Main Outcome Measure New cases of histopathologically confirmed breast cancer in the treatment and placebo groups, stratified by estradiol levels. Results In the placebo group, women with estradiol levels greater than 10 pmol/L (2.7 pg/mL) had a 6.8-fold higher rate of breast cancer (3.0% per 4 years; 95% confidence interval [CI], 1.8%-4.1%) than that of women with undetectable estradiol levels (0.6% per 4 years; 95% CI, 0%-1.1%; P=.005 for trend). Women with estradiol levels greater than 10 pmol/L in the raloxifene group had a rate of breast cancer that was 76% (95% CI, 53%-88%) lower than that of women with estradiol levels greater than 10 pmol/L in the placebo group (absolute rate reduction, 2.2% [95% CI, 1.0%-3.5%; number needed to treat=45]). In contrast, women with undetectable estradiol levels had similar breast cancer risk whether or not they were treated with raloxifene (risk difference, -0.1%; 95% CI, -0.8% to 0.6%; P=.02 for the interaction). In this cohort, treating women with estradiol levels greater than 10 pmol/L with raloxifene for 4 years would have avoided 47% of breast cancer cases. Conclusions Measurement of estradiol level by sensitive assay in postmenopausal women identifies those at high risk of breast cancer who may benefit most from raloxifene. If confirmed, this suggests that measuring estradiol and treating women with high estradiol levels could substantially reduce the rate of breast cancer among postmenopausal women.	Univ Calif San Francisco, Coordinating Ctr, San Francisco, CA 94105 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Kings Coll London Hosp, London, England; Eli Lilly & Co, Indianapolis, IN 46285 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; King's College Hospital NHS Foundation Trust; King's College Hospital; Eli Lilly	Cummings, SR (corresponding author), Univ Calif San Francisco, Coordinating Ctr, Suite 600,74 New Montgomery St, San Francisco, CA 94105 USA.	scummings@psg.ucsf.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408				Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cauley JA, 1999, ANN INTERN MED, V130, P270, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00004; Chlebowski RT, 1999, J CLIN ONCOL, V17, P1939, DOI 10.1200/JCO.1999.17.6.1939; Clarke M, 1998, LANCET, V351, P1451; Cummings SR, 1998, NEW ENGL J MED, V339, P733, DOI 10.1056/NEJM199809103391104; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Dorgan JF, 1996, CANCER EPIDEM BIOMAR, V5, P533; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Grese TA, 1997, P NATL ACAD SCI USA, V94, P14105, DOI 10.1073/pnas.94.25.14105; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Herson J., 1975, Journal of Statistical Computation and Simulation, V3, P265, DOI 10.1080/00949657508810091; Lippman ME, 2001, J CLIN ONCOL, V19, P3111, DOI 10.1200/JCO.2001.19.12.3111; TONIOLO PG, 1995, JNCI-J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	19	154	161	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					216	220		10.1001/jama.287.2.216	http://dx.doi.org/10.1001/jama.287.2.216			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779264	Bronze			2022-12-28	WOS:000173114900024
J	Jenkins, HS				Jenkins, HS			The morning after	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					161	162		10.1001/jama.287.2.161	http://dx.doi.org/10.1001/jama.287.2.161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779243				2022-12-28	WOS:000173114900001
J	Arnold, KE; Owens, IPF; Marshall, NJ				Arnold, KE; Owens, IPF; Marshall, NJ			Fluorescent signaling in parrots	SCIENCE			English	Article							PIGMENTS		Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	University of Glasgow; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Queensland	Arnold, KE (corresponding author), Univ Glasgow, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	K.Arnold@bio.gla.ac.uk	Owens, Ian PF/F-1392-2010; Arnold, Kathryn E/F-8683-2016; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Arnold, Kathryn E/0000-0002-6485-6065; Marshall, Justin/0000-0001-9006-6713; Owens, Ian/0000-0001-6080-3321				Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Boles WE, 1990, BIRDS INT, V3, P76; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X	5	112	115	6	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					92	92		10.1126/science.295.5552.92	http://dx.doi.org/10.1126/science.295.5552.92			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778040				2022-12-28	WOS:000173143100038
J	Tatar, M; Rand, DM				Tatar, M; Rand, DM			Aging - Dietary advice on Q	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; CLK-1; LONG		Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Tatar, M (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	marc_tatar@brown.edu; david_rand@brown.edu		Tatar, Marc/0000-0003-3232-6884				Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Jazwinski SM, 2000, TRENDS GENET, V16, P506, DOI 10.1016/S0168-9525(00)02119-3; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	12	6	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					54	55		10.1126/science.1067915	http://dx.doi.org/10.1126/science.1067915			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778030				2022-12-28	WOS:000173143100028
J	Himanen, JP; Rajashankar, KR; Lackmann, M; Cowan, CA; Henkemeyer, M; Nikolov, DB				Himanen, JP; Rajashankar, KR; Lackmann, M; Cowan, CA; Henkemeyer, M; Nikolov, DB			Crystal structure of an Eph receptor-ephrin complex	NATURE			English	Article							LIGAND-BINDING; TRANSMEMBRANE LIGANDS; TYROSINE KINASES; SAM DOMAIN; NUK; DIMERIZATION; ATTACHMENT; PROTEINS; BRAIN; AXONS	The Eph family of receptor tyrosine kinases and their membrane-anchored ephrin ligands are important in regulating cell-cell interactions as they initiate a unique bidirectional signal transduction cascade whereby information is communicated into both the Eph-expressing and the ephrin-expressing cells. Initially identified as regulators of axon pathfinding and neuronal cell migration, Ephs and ephrins are now known to have roles in many other cell-cell interactions, including those of vascular endothelial cells and specialized epithelia(1,2). Here we report the crystal structure of the complex formed between EphB2 and ephrin-B2, determined at 2.7 Angstrom resolution. Each Eph receptor binds an ephrin ligand through an expansive dimerization interface dominated by the insertion of an extended ephrin loop into a channel at the surface of the receptor. Two Eph-Ephrin dimers then join to form a tetramer, in which each ligand interacts with two receptors and each receptor interacts with two ligands. The Eph and ephrin molecules are precisely positioned and orientated in these complexes, promoting higher-order clustering and the initiation of bidirectional signalling.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Brookhaven Natl Lab, Upton, NY 11973 USA; Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Brookhaven National Laboratory; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Henkemeyer, Mark/0000-0002-7525-1061				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; BRUNGER AT, 1993, XPLOR V 3 1 MANUAL; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Hockley D, 1998, JAVA REP, V3, P6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8	29	261	274	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					933	938		10.1038/414933a	http://dx.doi.org/10.1038/414933a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780069				2022-12-28	WOS:000172813300052
J	Ball, P				Ball, P			Statistics: The physics of society	NATURE			English	Editorial Material																		OLSON RG, 1995, SCI DEFIED SCI DEFIE, V2; Porter T. M, 1986, RISE STAT THINKING 1	2	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					371	371		10.1038/415371a	http://dx.doi.org/10.1038/415371a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807529	Bronze			2022-12-28	WOS:000173433600026
J	Dutzler, R; Campbell, EB; Cadene, M; Chait, BT; MacKinnon, R				Dutzler, R; Campbell, EB; Cadene, M; Chait, BT; MacKinnon, R			X-ray structure of a CIC chloride channel at 3.0 angstrom reveals the molecular basis of anion selectivity	NATURE			English	Article							ELECTRON-DENSITY MAPS; TORPEDO ELECTROPLAX; ION-CHANNEL; CLC-0; PERMEATION; TRANSMEMBRANE; CONDUCTION; EXPRESSION; MUTATIONS; PORES	The ClC chloride channels catalyse the selective flow of Cl- ions across cell membranes, thereby regulating electrical excitation in skeletal muscle and the flow of salt and water across epithelial barriers. Genetic defects in ClC Cl- channels underlie several familial muscle and kidney diseases. Here we present the X-ray structures of two prokaryotic ClC Cl- channels from Salmonella enterica serovar typhimurium and Escherichia coli at 3.0 and 3.5 Angstrom, respectively. Both structures reveal two identical pores, each pore being formed by a separate subunit contained within a homodimeric membrane protein. Individual subunits are composed of two roughly repeated halves that span the membrane with opposite orientations. This antiparallel architecture defines a selectivity filter in which a Cl- ion is stabilized by electrostatic interactions with a-helix dipoles and by chemical coordination with nitrogen atoms and hydroxyl groups. These findings provide a structural basis for further understanding the function of ClC Cl- channels, and establish the physical and chemical basis of their anion selectivity.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; ANDERSEN OS, 1975, BIOPHYS J, V15, P795, DOI 10.1016/S0006-3495(75)85856-5; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DELAFORTELLE E, 1997, METHODS ENZYMOLOGY; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN PC, 1983, BIOPHYS J, V41, P189, DOI 10.1016/S0006-3495(83)84419-1; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Ludewig U, 1997, J PHYSIOL-LONDON, V498, P691, DOI 10.1113/jphysiol.1997.sp021893; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Rychkov GY, 2001, J PHYSIOL-LONDON, V530, P379, DOI 10.1111/j.1469-7793.2001.0379k.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vonrhein C, 1999, ACTA CRYSTALLOGR D, V55, P225, DOI 10.1107/S0907444998007914; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; WHITE MM, 1981, J GEN PHYSIOL, V78, P1, DOI 10.1085/jgp.78.1.1; WHITE MM, 1979, J BIOL CHEM, V254, P161; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	49	1257	1292	1	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					287	294		10.1038/415287a	http://dx.doi.org/10.1038/415287a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796999				2022-12-28	WOS:000173293500034
J	Adab, P; Rouse, AM; Mohammed, MA; Marshall, T				Adab, P; Rouse, AM; Mohammed, MA; Marshall, T			Performance league tables: the NHS deserves better	BRITISH MEDICAL JOURNAL			English	Article							BYPASS-SURGERY; OUTCOMES; INDICATORS		Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Adab, P (corresponding author), Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England.		Adab, Peymane/ABC-9651-2021	Adab, Peymane/0000-0001-9087-3945; Marshall, Tom/0000-0001-9277-5214				Anderson, 1999, BMJ, V318, P1772; *BMA SCI DEP HLTH, 2000, CLIN IND LEAG TABL D; Broome JD, 1999, GYNAECOL ENDOSC, V8, P1, DOI 10.1046/j.1365-2508.1999.00229.x; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; CHRISTIE B, 2001, BRIT MED J, V322, P1014; Davies HTO, 1998, QUAL HEALTH CARE, V7, P159, DOI 10.1136/qshc.7.3.159; Deming EW., 1986, OUT CRISIS; Finison L J, 1996, J Healthc Qual, V18, P32; GOLDSTEIN H, 1996, RES INTELLIGENCE, V57, P12; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910; Leyland AH, 1998, LANCET, V351, P555, DOI 10.1016/S0140-6736(97)09362-8; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; MOSTELLER F, 1949, J AM STAT ASSOC, V44, P174, DOI 10.2307/2280595; *NHS EX, 2001, HSC 2000 023 QUAL PE; *NHS EX, 2000, NHS PERF IND JUL 200; Omoigui NA, 1996, CIRCULATION, V93, P27, DOI 10.1161/01.CIR.93.1.27; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; SMITH P, 1990, J ROY STAT SOC A STA, V153, P53, DOI 10.2307/2983096; Smith P., 1995, INT J PUBLIC ADMIN, V18, P277, DOI DOI 10.1080/01900699508525011; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Tymms P, 2000, BRIT MED J, V321, P1467, DOI 10.1136/bmj.321.7274.1467; Wood B., 2001, SUPPLY CHAIN PRACT, V3, P30	25	81	82	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					95	98		10.1136/bmj.324.7329.95	http://dx.doi.org/10.1136/bmj.324.7329.95			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786455	Bronze, Green Published			2022-12-28	WOS:000173325400021
J	Isner, JM				Isner, JM			Myocardial gene therapy	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; LEFT-VENTRICULAR FUNCTION; PROGENITOR CELLS; HEART-FAILURE; IN-VIVO; CALCIUM TRANSIENTS; PLASMID DNA; BLOOD-FLOW; ANGIOGENESIS; EXPRESSION	Gene therapy is proving likely to be a viable alternative to conventional therapies in coronary artery disease and heart failure. Phase 1 clinical trials indicate high levels of safety and clinical benefits with gene therapy using angiogenic growth factors in myocardial ischaemia. Although gene therapy for heart failure is still at the pre-clinical stage, experimental data indicate that therapeutic angiogenesis using short-term gene expression may elicit functional improvement in affected individuals.	St Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Div Cardiol, Brighton, MA 02135 USA; St Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Div Vasc Med, Brighton, MA 02135 USA; St Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Div Cardiovasc Res, Brighton, MA 02135 USA	St. Elizabeth's Medical Center; St. Elizabeth's Medical Center; St. Elizabeth's Medical Center	Isner, JM (corresponding author), St Elizabeths Med Ctr, Tufts Sch Med, Dept Med, Div Cardiol, Brighton, MA 02135 USA.							Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403; Asahara T, 1999, CIRCULATION, V100, P481; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Cherwek DH, 1999, CIRCULATION, V100, P657; Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728; ELLIS MJ, 2000, CARDIAC VASC REGEN, V1, P197; Esakof DD, 1999, HUM GENE THER, V10, P2307, DOI 10.1089/10430349950016951; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; GAL D, 1993, LAB INVEST, V68, P18; GERBER HP, 2000, 2000 KEYST C ANG 3 M; Gerszten RE, 1999, CIRCULATION, V100, P615; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; GRIMES C, 2001, 50 ANN AM COLL CARD; Hajjar RJ, 2000, CIRC RES, V86, P616, DOI 10.1161/01.RES.86.6.616; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; Haunstetter A, 2000, CIRC RES, V86, P371, DOI 10.1161/01.RES.86.4.371; He HP, 1999, CIRCULATION, V100, P974, DOI 10.1161/01.CIR.100.9.974; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; ISNER JM, 1995, CIRCULATION, V91, P2687, DOI 10.1161/01.CIR.91.11.2687; Iwaguro H, 1999, CIRCULATION, V100, P47; Kalka C, 2000, ANN THORAC SURG, V70, P829, DOI 10.1016/S0003-4975(00)01633-7; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kirshenbaum LA, 1997, CIRCULATION, V96, P1580, DOI 10.1161/01.CIR.96.5.1580; Lai NC, 2000, CIRCULATION, V102, P2396, DOI 10.1161/01.CIR.102.19.2396; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; LOSORDO DW, 1994, CIRCULATION, V89, P785, DOI 10.1161/01.CIR.89.2.785; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Mack CA, 1998, J THORAC CARDIOV SUR, V115, P168, DOI 10.1016/S0022-5223(98)70455-6; Maurice JP, 1999, J CLIN INVEST, V104, P21, DOI 10.1172/JCI6026; Menasche P. M., 2000, CARDIAC VASC REGEN, V1, P155; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; O'Donnell JM, 2001, CIRC RES, V88, P415; Periasamy M, 2001, CIRC RES, V88, P373; RAUH G, IN PRESS HUM GENE TH; RISAU W, 1995, FASEB J, V9, P926, DOI 10.1096/fasebj.9.10.7615161; Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468; Rosengart TK, 1999, CIRCULATION, V100, P770; SABBAH HN, 1995, MOL CELL BIOCHEM, V147, P29, DOI 10.1007/BF00944780; Schmidt U, 1998, J MOL CELL CARDIOL, V30, P1929, DOI 10.1006/jmcc.1998.0748; Schratzberger P, 2001, J AM COLL CARDIOL, V37, p266A; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shah AS, 2001, CIRCULATION, V103, P1311; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Su H, 2000, P NATL ACAD SCI USA, V97, P13801, DOI 10.1073/pnas.250488097; Svensson EC, 1999, CIRCULATION, V99, P201, DOI 10.1161/01.CIR.99.2.201; Symes JF, 1999, ANN THORAC SURG, V68, P830, DOI 10.1016/S0003-4975(99)00807-3; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Takeshita S, 1997, CIRCULATION, V95, P805; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Takeshita S, 1996, LAB INVEST, V74, P1061; Taniyama Y, 2000, CIRCULATION, V102, P164; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Tio RA, 1999, HUM GENE THER, V10, P2953, DOI 10.1089/10430349950016366; Tomanek RJ, 1996, CARDIOVASC RES, V31, pE46; Vale PR, 2001, CIRCULATION, V103, P2138; van den Heuvel AFM, 2000, J AM COLL CARDIOL, V35, P19, DOI 10.1016/S0735-1097(99)00499-4; Vincent KA, 2000, CIRCULATION, V102, P2255; WEBER KT, 1990, CIRCULATION, V82, P1387, DOI 10.1161/01.CIR.82.4.1387; Weig HJ, 2000, CIRCULATION, V101, P1578, DOI 10.1161/01.CIR.101.13.1578; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; WHITE FC, 1992, CIRC RES, V71, P1490, DOI 10.1161/01.RES.71.6.1490; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918	70	275	308	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					234	239		10.1038/415234a	http://dx.doi.org/10.1038/415234a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805848				2022-12-28	WOS:000173159300054
J	Olfson, M; Marcus, SC; Druss, B; Elinson, L; Tanielian, T; Pincus, HA				Olfson, M; Marcus, SC; Druss, B; Elinson, L; Tanielian, T; Pincus, HA			National trends in the outpatient treatment of depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR DEPRESSION; PRIMARY-CARE; COMORBIDITY-SURVEY; MENTAL-DISORDERS; ADDICTIVE-DISORDERS; REUPTAKE INHIBITORS; UNITED-STATES; HEALTH; PSYCHOTHERAPY; SERVICES	Context Recent advances in pharmacotherapy and changing health care environments have focused increased attention on trends in outpatient treatment of depression. Objective To compare trends in outpatient treatment of depressive disorders in the United States in 1987 and 1997. Design and Setting Analysis of service utilization data from 2 nationally representative surveys of the US general population, the 1987 National Medical Expenditure Survey (N=34459) and the 1997 Medical Expenditure Panel Survey (N=32636). Participants Respondents who reported making 1 or more outpatient visits for treatment of depression during that calendar year. Main Outcome Measures Rate of treatment, psychotropic medication use, psychotherapy; number of outpatient treatment visits, type of health care professional, and source of payment. Results The rate of outpatient treatment for depression increased from 0.73 per 100 persons in 1987 to 2.33 in 1997 (P<.001). The proportion of treated individuals who used antidepressant medications increased from 37.3% to 74.5% (P<.001), whereas the proportion who received psychotherapy declined (71.1% vs 60.2%, P=.006). The mean number of depression treatment visits per user declined from 12.6 to 8.7 per year (P=.05). An increasingly large proportion of patients were treated by physicians for their condition (68.9% vs 87.3%, P<.001), and treatment costs were more often covered by third-party payers (39.3% to 55.2%, P<.001). Conclusions Between 1987 and 1997, there was a marked increase in the proportion of the population who received outpatient treatment for depression. Treatment became characterized by greater involvement of physicians, greater use of psychotropic medications, and expanding availability of third-party payment, but fewer outpatient visits and less use of psychotherapy. These changes coincided with the advent of better-tolerated antidepressants, increased penetration of managed care, and the development of rapid and efficient procedures for diagnosing depression in clinical practice.	Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; NIOSH, Pittsburgh Res Lab, Pittsburgh, PA USA; RAND Corp, Pittsburgh, PA USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Columbia University; New York State Psychiatry Institute; University of Pennsylvania; Yale University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olfson, M (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	olfsonm@child.cpmc.columbia.edu	Young, Alexander/A-1523-2009; Olfson, Mark/AAA-8547-2021	Young, Alexander/0000-0002-9367-9213; 				[Anonymous], 2000, Am J Psychiatry, V157, P1; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; COHEN S, 1991, 910037 AHCPR; COHEN SB, 2000, 010001 AHRQ; Dana RH, 1996, PSYCHOL REP, V79, P1395, DOI 10.2466/pr0.1996.79.3f.1395; *DEPR GUID PAN, 1993, 930551 AHCPR, V2; EDWARDS WS, 1989, US DHHS PHS893450; Frank RG, 1996, ARCH GEN PSYCHIAT, V53, P933; GOLDMAN R, 1986, SOC SCI MED, V22, P1047, DOI 10.1016/0277-9536(86)90205-4; Greenfield SF, 2000, AM J PSYCHIAT, V157, P1867, DOI 10.1176/appi.ajp.157.11.1867; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kessler RC, 1999, AM J PSYCHIAT, V156, P115, DOI 10.1176/ajp.156.1.115; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kihlstrom LC, 1998, J BEHAV HEALTH SER R, V25, P367, DOI 10.1007/BF02287508; Langer F., 2000, USE ANTIDEPRESSANTS; Leon AC, 1996, J GEN INTERN MED, V11, P426, DOI 10.1007/BF02600191; Markowitz JC, 1999, CAN J PSYCHIAT, V44, P556, DOI 10.1177/070674379904400603; *MED EC CO INC, 1997, PHYS DESK REF; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; NARROW WE, 1993, ARCH GEN PSYCHIAT, V50, P95; Nelson JC, 1999, BIOL PSYCHIAT, V46, P1301, DOI 10.1016/S0006-3223(99)00173-0; Nikelly A G, 1995, Health Care Women Int, V16, P229; Olfson M, 1998, ARCH GEN PSYCHIAT, V55, P310, DOI 10.1001/archpsyc.55.4.310; Peretti S, 2000, ACTA PSYCHIAT SCAND, V101, P17, DOI 10.1111/j.1600-0447.2000.tb10944.x; Persons JB, 1996, ARCH GEN PSYCHIAT, V53, P283; REGIER DA, 1988, AM J PSYCHIAT, V145, P1351; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; *ROP ORG, 1986, ROP REP MED PEOPL MI; Schatzberg AF, 1998, J CLIN PSYCHIAT, V59, P15; Shah BV, 1997, SUDAAN USERS MANUAL; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Sturm R, 1999, J BEHAV HEALTH SER R, V26, P360, DOI 10.1007/BF02287297; Thase ME, 1997, ARCH GEN PSYCHIAT, V54, P1009; Trindade E, 1998, CAN MED ASSOC J, V159, P1245; *US DHHS, 1988, INT CLASS DIS 9 REV; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wells KB, 1999, ARCH GEN PSYCHIAT, V56, P897, DOI 10.1001/archpsyc.56.10.897; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; ZIMMERMAN M, 1994, GEN HOSP PSYCHIAT, V16, P388, DOI 10.1016/0163-8343(94)90114-7; 2001, MENT HLTH REPORT SUR	42	617	628	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					203	209		10.1001/jama.287.2.203	http://dx.doi.org/10.1001/jama.287.2.203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508XK	11779262	Bronze			2022-12-28	WOS:000173114900022
J	Carrell, RW; Lomas, DA				Carrell, RW; Lomas, DA			Mechanisms of disease - Alpha(1)-antitrypsin deficiency - A model for conformational diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEPATIC-ENDOPLASMIC-RETICULUM; HUMAN ALPHA-1-PROTEINASE INHIBITOR; PROTEIN-C DEFICIENCY; ALPHA-1-ANTITRYPSIN DEFICIENCY; LIVER-DISEASE; IN-VIVO; ALPHA1-ANTITRYPSIN DEFICIENCY; NEURODEGENERATIVE DISEASE; MOLECULAR-BASIS; ANTI-THROMBIN		Univ Cambridge, Cambridge Inst Med Res, Dept Hematol, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 2XY, England	University of Cambridge; University of Cambridge	Carrell, RW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Hematol, Hills Rd, Cambridge CB2 2XY, England.	rwe1000@cam.ac.uk						Abboud R T, 2001, Can Respir J, V8, P81; AULAK KS, 1993, J BIOL CHEM, V268, P18088; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beauchamp NJ, 1998, BLOOD, V92, P2696, DOI 10.1182/blood.V92.8.2696.420a43_2696_2706; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BERG NO, 1972, NEW ENGL J MED, V287, P1264, DOI 10.1056/NEJM197212212872502; Bradshaw CB, 2001, ARCH NEUROL-CHICAGO, V58, P1429, DOI 10.1001/archneur.58.9.1429; BRANTLY M, 1988, AM J MED, V84, P13; BRANTLY M, 1988, SCIENCE, V242, P1700, DOI 10.1126/science.2904702; Brennan SO, 2000, AM J PATHOL, V157, P189, DOI 10.1016/S0002-9440(10)64530-0; BRUCE D, 1994, J CLIN INVEST, V94, P2265, DOI 10.1172/JCI117589; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; CALLEA F, 1992, LIVER, V12, P357; CAMPRA JL, 1973, ANN INTERN MED, V78, P233, DOI 10.7326/0003-4819-78-2-233; CARLSON J, 1990, HISTOPATHOLOGY, V16, P309, DOI 10.1111/j.1365-2559.1990.tb01124.x; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; COLP C, 1993, CHEST, V103, P812, DOI 10.1378/chest.103.3.812; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; CRUZ M, 1976, HELV PAEDIATR ACTA, V30, P501; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Davis R, 2000, BRAIN PATHOL, V10, P682; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; Dirksen A, 1999, AM J RESP CRIT CARE, V160, P1468, DOI 10.1164/ajrccm.160.5.9901055; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Eden E, 1997, AM J RESP CRIT CARE, V156, P68, DOI 10.1164/ajrccm.156.1.9508014; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; Elliott PR, 1996, NAT STRUCT BIOL, V3, P910, DOI 10.1038/nsb1196-910; EMMERICH J, 1995, J LAB CLIN MED, V125, P531; EMMERICH J, 1994, THROMB RES, V76, P307, DOI 10.1016/0049-3848(94)90202-X; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; FAGERHOL MK, 1968, ACTA PATHOL MIC SC, V72, P601; FOREMAN RC, 1984, FEBS LETT, V168, P84, DOI 10.1016/0014-5793(84)80211-2; GERHARD L, 1990, AKTUELLE NEUROPADIAT, P56; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Griffith ME, 1996, NEPHROL DIAL TRANSPL, V11, P438; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; HOLMES WE, 1987, SCIENCE, V238, P209, DOI 10.1126/science.2958938; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HULTCRANTZ R, 1984, HEPATOLOGY, V4, P937, DOI 10.1002/hep.1840040526; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JEPPSSON JO, 1976, FEBS LETT, V65, P195, DOI 10.1016/0014-5793(76)80478-4; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815; King MA, 1996, RADIOLOGY, V199, P137, DOI 10.1148/radiology.199.1.8633137; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Lane DA, 1997, THROMB HAEMOSTASIS, V77, P197; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LEWIS JH, 1978, BLOOD, V51, P129; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; Mahadeva R, 1998, THORAX, V53, P501, DOI 10.1136/thx.53.6.501; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; MCCRACKEN AA, 1989, MOL CELL BIOL, V9, P1406, DOI 10.1128/MCB.9.4.1406; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Piitulainen E, 1999, EUR RESPIR J, V13, P247, DOI 10.1183/09031936.99.13224799; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; ROBERTS EA, 1984, AM J CLIN PATHOL, V82, P424, DOI 10.1093/ajcp/82.4.424; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SEYAMA K, 1991, J BIOL CHEM, V266, P12627; SHARP HL, 1969, J LAB CLIN MED, V73, P934; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STORCH W, 1985, VIRCHOWS ARCH B, V48, P155, DOI 10.1007/BF02890124; SVEGER T, 1995, HEPATOLOGY, V22, P514, DOI 10.1002/hep.1840220221; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1978, PEDIATRICS, V62, P22; Takao M, 2000, BRAIN PATHOL, V10, P597; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5; Turino GM, 1996, AM J RESP CRIT CARE, V154, P1718, DOI 10.1164/ajrccm.154.6.8970361; VIDAUD D, 1992, J CLIN INVEST, V89, P1537, DOI 10.1172/JCI115746; Vreim CE, 1998, AM J RESP CRIT CARE, V158, P49; Walker LC, 2000, NEUROBIOL AGING, V21, P559, DOI 10.1016/S0197-4580(00)00160-3; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; YOSHIDA A, 1976, P NATL ACAD SCI USA, V73, P1324, DOI 10.1073/pnas.73.4.1324; Zhou AW, 1999, BLOOD, V94, P3388, DOI 10.1182/blood.V94.10.3388.422k20_3388_3396	100	297	321	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2002	346	1					45	53		10.1056/NEJMra010772	http://dx.doi.org/10.1056/NEJMra010772			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507NB	11778003				2022-12-28	WOS:000173033600009
J	Heilbron, JL; Bynum, WF				Heilbron, JL; Bynum, WF			1902 and all that - This year's offerings - calendars, kites and eruptions.	NATURE			English	Editorial Material									Univ Oxford Worcester Coll, Oxford OX1 2HB, England; UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of Oxford; University of London; University College London	Heilbron, JL (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.								0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					15	18		10.1038/415015a	http://dx.doi.org/10.1038/415015a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780088				2022-12-28	WOS:000173028800016
J	Headon, DJ; Emmal, SA; Ferguson, BM; Tucker, AS; Justice, MJ; Sharpe, PT; Zonana, J; Overbeek, PA				Headon, DJ; Emmal, SA; Ferguson, BM; Tucker, AS; Justice, MJ; Sharpe, PT; Zonana, J; Overbeek, PA			Gene defect in ectodermal dysplasia implicates a death domain adapter in development	NATURE			English	Article							NF-KAPPA-B; TNF RECEPTOR; EDA GENE; PROTEIN; HOMOLOG; MOUSE; FAMILY; INVOLVEMENT; APOPTOSIS; MUTATIONS	Members of the tumour-necrosis factor receptor (TNFR) family that contain an intracellular death domain initiate signalling by recruiting cytoplasmic death domain adapter proteins(1,2). Edar is a death domain protein of the TNFR family that is required for the development of hair, teeth and other ectodermal derivatives(3,4). Mutations in Edar-or its ligand, Eda-cause hypohidrotic ectodermal dysplasia in humans and mice(3-7). This disorder is characterized by sparse hair, a lack of sweat glands and malformation of teeth(8). Here we report the identification of a death domain adapter encoded by the mouse crinkled locus. The crinkled mutant has an hypohidrotic ectodermal dysplasia phenotype identical to that of the edar (downless) and eda (Tabby) mutants(9). This adapter, which we have called Edaradd (for Edar-associated death domain), interacts with the death domain of Edar and links the receptor to downstream signalling pathways. We also identify a missense mutation in its human orthologue, EDARADD, that is present in a family affected with hypohidrotic ectodermal dysplasia. Our findings show that the death receptor/adapter signalling mechanism is conserved in developmental, as well as apoptotic, signalling.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Guys Hosp, Univ London Kings Coll, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Guys Hosp, Univ London Kings Coll, GKT Dent Inst, Dept Craniofacial Dev, London SE1 9RT, England	Baylor College of Medicine; Baylor College of Medicine; Oregon Health & Science University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Overbeek, PA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Tucker, Abigail S/K-1788-2016	Tucker, Abigail S/0000-0001-8871-6094; Sharpe, Paul/0000-0003-2116-9561; Overbeek, Paul/0000-0001-9784-2084	MRC [G9800001] Funding Source: UKRI; Medical Research Council [G9800001] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; FALCONER DS, 1951, J GENET, V50, P324, DOI 10.1007/BF02996227; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LYON MF, 1996, GENETIC VARIANTS STR; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Munoz F, 1997, AM J HUM GENET, V61, P94; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Perou CM, 1997, GENOMICS, V39, P136, DOI 10.1006/geno.1996.4478; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	28	268	283	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					913	916		10.1038/414913a	http://dx.doi.org/10.1038/414913a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780064				2022-12-28	WOS:000172813300047
J	in 't Veld, BA; Ruitenberg, A; Hofman, A; Launer, LJ; van Duijn, CM; Stijnen, T; Breteler, MMB; Stricker, BHC				in 't Veld, BA; Ruitenberg, A; Hofman, A; Launer, LJ; van Duijn, CM; Stijnen, T; Breteler, MMB; Stricker, BHC			Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OCCUPATIONAL EPIDEMIOLOGY; RHEUMATOID-ARTHRITIS; VASCULAR DEMENTIA; RECEPTOR-GAMMA; MENTAL STATE; ROTTERDAM; POPULATION; DIAGNOSIS; INFLAMMATION; ASSOCIATION	Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease. The results, however, have been inconsistent. Methods: We studied the association between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 years of age or older who were free of dementia at base line. The risk of Alzheimer's disease was estimated in relation to the use of NSAIDs as documented in pharmacy records. We defined four mutually exclusive categories of use: nonuse, short-term use (1 month or less of cumulative use), intermediate-term use (more than 1 but less than 24 months of cumulative use), and long-term use (24 months or more of cumulative use). Adjustments were made by Cox regression analysis for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H(sub 2)-receptor antagonists, antihypertensive agents, and hypoglycemic agents. Results: During an average follow-up period of 6.8 years, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia. The relative risk of Alzheimer's disease was 0.95 (95 percent confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95 percent confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95 percent confidence interval, 0.05 to 0.83) in those with long-term use. The risk did not vary according to age. The use of NSAIDs was not associated with a reduction in the risk of vascular dementia. Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia. (N Engl J Med 2001;345:1515-21.) Copyright (C) 2001 Massachusetts Medical Society.	Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; NIA, Epidemiol Demog & Biometry Program, NIH, Bethesda, MD 20892 USA; Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stricker, BHC (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305				Aisen PS, 1996, MOL CHEM NEUROPATHOL, V28, P83, DOI 10.1007/BF02815208; Aisen PS, 1997, GERONTOLOGY, V43, P143; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; BEARD CM, 1991, LANCET, V337, P1426, DOI 10.1016/0140-6736(91)93122-P; Beard CM, 1998, MAYO CLIN PROC, V73, P951, DOI 10.4065/73.10.951; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; BROOKS W, 1998, NEUROBIOL AGING, V19, pS140; CHECKOWAY H, 1990, ARCH ENVIRON HEALTH, V45, P95, DOI 10.1080/00039896.1990.9935932; CHECKOWAY H, 1989, AM J IND MED, V15, P375, DOI 10.1002/ajim.4700150403; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; CORNELIUS C, 1998, NEUROBIOL AGING, V19, pS28; COX DR, 1972, J R STAT SOC B, V34, P187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 1996, J CLIN EPIDEMIOL, V49, P1201, DOI 10.1016/0895-4356(96)00202-8; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GILBERT ES, 1979, RADIAT RES, V79, P122, DOI 10.2307/3575027; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HENDERSON AS, 1992, PSYCHOL MED, V22, P429, DOI 10.1017/S0033291700030373; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P926, DOI 10.1002/(SICI)1099-1166(199709)12:9<926::AID-GPS665>3.3.CO;2-P; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; KUKULL WA, 1994, NEUROLOGY, V44, pA237; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEVEUGLE B, 1994, MOL NEUROBIOL, V9, P25, DOI 10.1007/BF02816102; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7; *WHO, 1994, AN THER CLASS ATC IN	46	955	1008	2	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1515	1521		10.1056/NEJMoa010178	http://dx.doi.org/10.1056/NEJMoa010178			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794217	Green Published, Bronze			2022-12-28	WOS:000172265200001
J	Ferris, TG; Chang, YC; Blumenthal, D; Pearson, SD				Ferris, TG; Chang, YC; Blumenthal, D; Pearson, SD			Leaving gatekeeping behind - Effects of opening access to specialists for adults in a health maintenance organization.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY-CARE; MANAGED CARE; COSTS; HOSPITALIZATIONS; EXPENDITURES; PHYSICIANS; SERVICES; PLAN	Background: Gatekeeping refers to the prior approval of referrals to specialists by a primary care physician. Although many health plans view gatekeeping as an essential tool for controlling costs and coordinating care, many patients and physicians object to it. Methods: On April 1, 1998, Harvard Vanguard Medical Associates, a large, multispecialty, capitated group practice previously known as Harvard Community Health Plan, eliminated a gatekeeping system that had been in place for over 25 years. We determined the effects of opening access to specialists on visits to primary care physicians and specialists by adults. In randomly selected cohorts of 10,000 members each, we analyzed visits during 6-month periods for the 3 years before and 18 months after gatekeeping was eliminated. Results: Adults visited a primary care physician an average of 1.21 times and 1.19 times per six-month period before and after the elimination of gatekeeping, respectively (P=0.05); the average number of visits to a specialist was 0.78 per six-month period both before and after its elimination (P=0.35). There was little change in the percentage of visits to specialists included in the analysis as a proportion of all visits (39.1 percent before the elimination of gatekeeping and 39.5 percent afterward). The percentage of first visits to specialists as a proportion of all visits to specialists included in the analysis increased from 24.7 to 28.2 percent (P<0.001). There were small increases in the numbers of visits to orthopedists and physical or occupational therapists. The proportion of visits to specialists for low back pain that were new consultations increased from 26.6 to 32.9 percent (P=0.01). Conclusions: In a capitated, multispecialty group practice, we found little evidence of substantial changes in the use of specialty services by adults in the first 18 months after the elimination of gatekeeping. (N Engl J Med 2001;345:1312-7.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp Partners Hlth Care Syst, Inst Hlth Policy, Div Gen Internal Med, Boston, MA USA; Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Massachusetts General Hospital	Pearson, SD (corresponding author), Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Fl, Boston, MA 02215 USA.				NICHD NIH HHS [K12-HD00850] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AM MED ASS, 1999, CURR PROC TERM CPT 2; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; BLUMENTHAL D, 1995, HEALTH SERV RES, V30, P253; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; CLANCY CM, 1989, ARCH INTERN MED, V149, P917, DOI 10.1001/archinte.149.4.917; EISENBERG JM, 1986, DOCTORS DECISIONS CO, P190; Etter JF, 1998, J EPIDEMIOL COMMUN H, V52, P370, DOI 10.1136/jech.52.6.370; Ferris TGG, 2001, PEDIATRICS, V108, P283, DOI 10.1542/peds.108.2.283; FRANKS P, 1992, NEW ENGL J MED, V327, P424, DOI 10.1056/NEJM199208063270613; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; Halm EA, 1997, JAMA-J AM MED ASSOC, V278, P1677, DOI 10.1001/jama.278.20.1677; HURLEY RE, 1991, J FAM PRACTICE, V32, P167; Kapur K, 2000, MED CARE RES REV, V57, P161, DOI 10.1177/107755870005700202; Kerr VA, 1999, J GEN INTERN MED, V14, P287, DOI 10.1046/j.1525-1497.1999.00336.x; MARTIN DP, 1989, AM J PUBLIC HEALTH, V79, P1628, DOI 10.2105/AJPH.79.12.1628; MOORE SH, 1983, NEW ENGL J MED, V309, P1400, DOI 10.1056/NEJM198312013092239; Pearson SD, 1999, J GEN INTERN MED, V14, P461, DOI 10.1046/j.1525-1497.1999.06278.x; Richard K, 1999, HEALTH AFFAIR, V18, P174, DOI 10.1377/hlthaff.18.3.174; Schillinger D, 2000, J GEN INTERN MED, V15, P329, DOI 10.1046/j.1525-1497.2000.07010.x; Simon SR, 1999, NEW ENGL J MED, V340, P928, DOI 10.1056/NEJM199903253401206; Starfield B., 1992, PRIMARY CARE CONCEPT; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; 1995, INT CLASSIFICATION D, V1	25	63	65	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1312	1317		10.1056/NEJMsa010097	http://dx.doi.org/10.1056/NEJMsa010097			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487UX	11794151				2022-12-28	WOS:000171896300006
J	Casey, WH				Casey, WH			The fate of chlorine in	SCIENCE			English	Editorial Material							PLANT-MATERIAL		Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Casey, WH (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	whcasey@ucdavis.edu						Dolfing J, 1995, ENVIRON CHEM, V1, P221; DONAILL NO, 1992, FOCLOIR GAEILGE BEAR, P763; Flodin C, 1997, ENVIRON SCI TECHNOL, V31, P2464, DOI 10.1021/es960374l; Grimvall A., 1995, NATURALLY PRODUCED O; Myneni SCB, 1999, SCIENCE, V286, P1335, DOI 10.1126/science.286.5443.1335; Myneni SCB, 2002, SCIENCE, V295, P1039, DOI 10.1126/science.1067153; Thornton J, 2000, PANDORAS POISON; United Nations Environment Programme, 2001, C PLEN STOCKH CONV P; WILLES RF, 1993, REGUL TOXICOL PHARM, V18, P313, DOI 10.1006/rtph.1993.1060	9	5	6	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					985	986		10.1126/science.1068918	http://dx.doi.org/10.1126/science.1068918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799205				2022-12-28	WOS:000173793000034
J	Dickson, D				Dickson, D			Anil Agarwal (1947-2002) - Obituary	NATURE			English	Biographical-Item									SciDevNet, London W1T 1HR, England		Dickson, D (corresponding author), SciDevNet, 11 Rathbone Pl, London W1T 1HR, England.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					384	384		10.1038/415384a	http://dx.doi.org/10.1038/415384a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807539				2022-12-28	WOS:000173433600034
J	Wachter, RM; Goldman, L				Wachter, RM; Goldman, L			The hospitalist movement 5 years later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTENSIVE-CARE-UNIT; PATIENT SATISFACTION; IMPACT; COMMUNITY; SERVICE; FACULTY; MODEL; MEDICINE; BURNOUT; COMMUNICATION	Context We originally described the hospitalist model of inpatient care in 1996; since then, the model has experienced tremendous growth. This growth has important clinical, financial, educational, and policy Implications, Objectives To review data regarding the effect of hospitalists on resource use, quality of care, satisfaction, and teaching; and to analyze the impact of hospitalists on the health care system and frame key Issues facing the movement. Data Sources and Study Selection We searched MEDLINE, BIOSIS, EMBASE, and the Cochrane Library from 1996 to September 2001 for studies comparing hospitalist care with an appropriate control group in terms of resource use, quality, or satisfaction outcomes. Data Extraction We extracted information regarding study design, nature of hospitalist and control groups, analytical strategies, and key outcomes. Data Synthesis Most studies found that implementation of hospitalist programs was associated with significant reductions In resource use, usually measured as hospital costs (average decrease, 13.4%) or average length of stay (average decrease, 16.6%). The few studies that failed to demonstrate reductions usually used atypical control groups. Although several studies found improved outcomes, such as inpatient mortality and readmission rates, these results were inconsistent. Patient satisfaction was generally preserved, while limited data supported positive effects on teaching. Although concerns about inpatient-outpatient information transfer remain, recent physician surveys indicate general acceptance of the model. Conclusions Empirical research supports the premise that hospitalists Improve inpatient efficiency without harmful effects on quality or patient satisfaction. Education may be improved. in part catalyzed by these data, the clinical use of hospitalists is growing rapidly, and hospitalists are also assuming prominent roles as teachers, researchers, and quality leaders. The hospitalist field has now achieved many of the attributes of traditional medical specialties and seems destined to continue to grow.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, Box 0120, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu						Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Auerbach A, 2000, 3 ANN M NAT ASS INP; Auerbach AD, 2000, AM J MED, V109, P648, DOI 10.1016/S0002-9343(00)00597-0; Bellet PS, 2000, PEDIATRICS, V105, P478, DOI 10.1542/peds.105.3.478; Bellet PS, 1999, PEDIATRICS, V103, P473, DOI 10.1542/peds.103.2.473; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Brown MD, 1999, AM J MED, V106, P134; Calkins DR, 1997, ARCH INTERN MED, V157, P1026, DOI 10.1001/archinte.157.9.1026; Carson SS, 1996, JAMA-J AM MED ASSOC, V276, P322, DOI 10.1001/jama.276.4.322; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Craig DE, 1999, ANN INTERN MED, V130, P355, DOI 10.7326/0003-4819-130-4-199902161-00005; Davis KM, 2000, AM J MED, V108, P621, DOI 10.1016/S0002-9343(00)00362-4; Diamond HS, 1998, ANN INTERN MED, V129, P197, DOI 10.7326/0003-4819-129-3-199808010-00006; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; FALK CT, 1998, HOSP PROGRAMS NEW PR, P1; Fernandez A, 2000, ARCH INTERN MED, V160, P2902, DOI 10.1001/archinte.160.19.2902; FIELDS AI, 1995, CRIT CARE MED, V23, P1425, DOI 10.1097/00003246-199508000-00018; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FOUBISTER V, 1999, AMA NEWS, V42, P16; Freese RB, 1999, ANN INTERN MED, V130, P350, DOI 10.7326/0003-4819-130-4-199902161-00004; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; Goldman L, 1999, ANN INTERN MED, V130, P364, DOI 10.7326/0003-4819-130-4-199902161-00007; GOLDMAN L, 2000, ABIM REPORT, P57; Guntupalli KK, 1996, INTENS CARE MED, V22, P625, DOI 10.1007/BF01709737; Guttler S, 1997, NEW ENGL J MED, V336, P444; Hackner D, 2001, CHEST, V119, P580, DOI 10.1378/chest.119.2.580; Halpert AP, 2000, AM J MANAG CARE, V6, P549; Hauer KE, 1999, WESTERN J MED, V171, P367; Hauer KE, 2001, ACAD MED, V76, P324, DOI 10.1097/00001888-200104000-00006; Hoff TH, 2001, ARCH INTERN MED, V161, P851, DOI 10.1001/archinte.161.6.851; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Kelley MA, 1999, ANN INTERN MED, V130, P373, DOI 10.7326/0003-4819-130-4-199902161-00009; Kroger E, 1998, J GEN INTERN MED, V13, pS66; Landrigan C, 2000, PEDIATR RES, V47, p204A; LI TCM, 1984, JAMA-J AM MED ASSOC, V252, P2023, DOI 10.1001/jama.252.15.2023; Lindenauer PK, 1999, ANN INTERN MED, V130, P343, DOI 10.7326/0003-4819-130-4-199902161-00003; Lurie J D, 1999, Eff Clin Pract, V2, P126; Lurie JD, 1999, AM J MED, V106, P441, DOI 10.1016/S0002-9343(99)00045-5; Maggioni Andrea, 2001, Pediatric Research, V49, p124A; MAGUIRE P, 1999, ACP OBSERVER, V19, P1; Manthous CA, 1997, MAYO CLIN PROC, V72, P391, DOI 10.4065/72.5.391; Melzer SM, 2001, PEDIATRICS, V108, P79, DOI 10.1542/peds.108.1.79; Michota F, 1998, CLEV CLIN J MED, V65, P297, DOI 10.3949/ccjm.65.6.297; Molinari C, 2001, AM J MANAG CARE, V7, P1051; MORAN T, 1999, TEX MED, V957, P32; Morrison J., 2001, J GEN INTERN MED S, V16, pS208; MULROW CD, 1997, COCHRANE COLLABORATI; Nakashima WF, 1997, NEW ENGL J MED, V336, P445; Palmer H, 1999, J GEN INTERN MED S, V14, pS116; Palmer H, 2001, J GEN INTERN MED S, V16, pS211; Pantilat SZ, 1999, JAMA-J AM MED ASSOC, V282, P171, DOI 10.1001/jama.282.2.171; Plauth WH, 2001, AM J MED, V111, P247, DOI 10.1016/S0002-9343(01)00837-3; POLLACK MM, 1988, CRIT CARE MED, V16, P11, DOI 10.1097/00003246-198801000-00003; Rifkin W, 2001, J GEN INTERN MED S, V16, pS215; Rifkin W, 1999, J GEN INTERN MED S, V14, pS118; Rubenstein W, 1997, NEW ENGL J MED, V336, P445; Saint S, 1998, AM J MED, V105, P515, DOI 10.1016/S0002-9343(98)00322-2; Schroeder SA, 1999, ANN INTERN MED, V130, P382, DOI 10.7326/0003-4819-130-4-199902161-00011; Shojania K G, 2001, Eff Clin Pract, V4, P82; Showstack J, 1999, ANN INTERN MED, V130, P376, DOI 10.7326/0003-4819-130-4-199902161-00010; Simon SR, 1998, J GEN INTERN MED, V13, P836, DOI 10.1046/j.1525-1497.1998.00247.x; Smith MI, 1997, NEW ENGL J MED, V336, P445; Sox HC, 1999, ANN INTERN MED, V130, P368, DOI 10.7326/0003-4819-130-4-199902161-00008; Srivastava R, 2000, PEDIATR RES, V47, p228A; Srivastava Rajendu, 2001, Pediatric Research, V49, p125A; Stein MD, 1998, J GEN INTERN MED, V13, P774, DOI 10.1046/j.1525-1497.1998.00231.x; Tingle LE, 2001, FAM MED, V33, P511; *US NEWS WORLD REP, 2001, BEST HOSP HON ROLL; Wachter R M, 1999, Healthc Financ Manage, V53, P48; Wachter R M, 2001, Health Forum J, V44, P34; Wachter RM, 2000, AM J MED, V108, P672, DOI 10.1016/S0002-9343(00)00413-7; Wachter RM, 1999, ANN INTERN MED, V130, P338, DOI 10.7326/0003-4819-130-4-199902161-00002; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Wachter RM, 1999, AM J MED, V106, P127; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; WACHTER RM, 2000, HOSP MED; Wald H, 1999, ANN INTERN MED, V131, P544, DOI 10.7326/0003-4819-131-7-199910050-00022; Wolpaw DR, 1998, J GEN INTERN MED, V13, P852, DOI 10.1046/j.1525-1497.1998.00252.x; Young M P, 2000, Eff Clin Pract, V3, P284	79	297	300	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					487	494		10.1001/jama.287.4.487	http://dx.doi.org/10.1001/jama.287.4.487			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798371				2022-12-28	WOS:000173401900026
J	Kirwan, JMJ; Tincello, DG; Herod, JJO; Frost, O; Kingston, RE				Kirwan, JMJ; Tincello, DG; Herod, JJO; Frost, O; Kingston, RE			Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit	BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA; DIAGNOSIS	Objective To examine referral pathways from primary care for patients with epithelial ovarian cancer and to identify, factors related to survival at 18 months. Design Retrospective,e review of patient notes. Setting General practices and receiving hospitals within Mersey region. Subjects 135 patients with epithelial ovarian cancer identified from an audit in the Mersey area between 1992 and 1994. Main outcome measures Delays between onset of symptoms and treatment attributable to patient, general practitioner, and hospital. Results 105 (78%) women first presented to their general practitioner, within four weeks of the onset of symptoms. 99 (73%) women were referred to hospital by their general practitioners within four weeks of presentation, mad 95 (70%) were seen in hospital within two weeks of referral. Multivariate analysis With survival as the dependent variable identified age (odds ratio 0.96, 95% confidence interval 0.93 to 0.99) cancer stage III or more (0.15, 0.05 to 0.43), and non-specific symptoms (0.36, 0.14 to 0.89) as significant variables. Conclusion Most patients attended their general practitioner within four weeks and were referred within two weeks. No evidence was found that delays in referral or diagnosis adversely affected survival at IS months. Stage of disease at surgery was the most important adverse factor. An effective screening programme is the most likely method to improve survival.	Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; Univ Liverpool, Dept Obstet & Gynaecol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Kirwan, JMJ (corresponding author), Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England.							Bell R, 1998, BRIT J OBSTET GYNAEC, V105, P1136, DOI 10.1111/j.1471-0528.1998.tb09966.x; Berrino F, 1999, SURVIVAL CANC PATIEN; FIGO Cancer Committee, 1986, GYNECOL ONCOL, V25, P383; FLAM F, 1988, EUR J OBSTET GYN R B, V27, P53, DOI 10.1016/S0028-2243(88)80010-8; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Kjellgren O, 1977, Lakartidningen, V74, P3333; LEIDERKEN BMJ, 1997, BR J GEN PRACT, V47, P505; LYNN RB, 1995, MED CLIN N AM, V79, P373, DOI 10.1016/S0025-7125(16)30074-8; *NCI, 1998, SEER STAT CANC INC P; *OFF NAT STAT, 1999, CANC 1971 1997; OMURA GA, 1991, J CLIN ONCOL, V9, P1138, DOI 10.1200/JCO.1991.9.7.1138; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Secretary of State for Health, 1997, CM380; SUMMERTON N, 1999, DIAGNOSING CANC PRIM; Wikborn C, 1996, INT J GYNECOL OBSTET, V52, P263, DOI 10.1016/0020-7292(95)02588-X; WIKBORN C, 1993, INT J GYNECOL OBSTET, V42, P261, DOI 10.1016/0020-7292(93)90222-I	17	47	48	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					148	151		10.1136/bmj.324.7330.148	http://dx.doi.org/10.1136/bmj.324.7330.148			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799032	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000173470600019
J	Hoffman, JE; Hudson, EW; Lang, KM; Madhavan, V; Eisaki, H; Uchida, S; Davis, JC				Hoffman, JE; Hudson, EW; Lang, KM; Madhavan, V; Eisaki, H; Uchida, S; Davis, JC			A four unit cell periodic pattern of quasi-particle states surrounding vortex cores in Bi2Sr2CaCu2O8+delta	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; D-WAVE SUPERCONDUCTORS; ELECTRONIC-STRUCTURE; PHASE-DIAGRAM; STRIPE PHASES; MIXED-STATE; DENSITY; ORDER; MODEL; LINES	Scanning tunneling microscopy is used to image the additional quasi-particle states generated by quantized vortices in the high critical temperature superconductor Bi2Sr2CaCu2O8+delta. They exhibit a copper-oxygen bond-oriented "checkerboard" pattern, with four unit cell (4a(o)) periodicity and a similar to30 angstrom decay length. These electronic modulations may be related to the magnetic field-induced, 8a(o) periodic, spin density modulations with decay length of similar to70 angstroms recently discovered in La1.84Sr0.16CuO4. The proposed explanation is a spin density wave localized surrounding each vortex core, General theoretical principles predict that, in the cuprates, a localized spin modulation of wavelength X should be associated with a corresponding electronic modulation of wavelength lambda/2, in good agreement with our observations.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Tokyo, Dept Superconduct, Tokyo 1138656, Japan	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tokyo	Davis, JC (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	jcdavis@socrates.berkeley.edu	Eisaki, Hiroshi/F-6317-2018; Hudson, Eric/C-2746-2008; Hoffman, Jennifer E/H-4334-2011; Hudson, Eric/C-4170-2017	Eisaki, Hiroshi/0000-0002-8299-6416; Hudson, Eric/0000-0001-7064-0351; Hoffman, Jennifer E/0000-0003-2752-5379; Hudson, Eric/0000-0001-7064-0351				ANDO Y, 1995, PHYS REV LETT, V75, P4662, DOI 10.1103/PhysRevLett.75.4662; Arovas DP, 1997, PHYS REV LETT, V79, P2871, DOI 10.1103/PhysRevLett.79.2871; Boebinger GS, 1996, PHYS REV LETT, V77, P5417, DOI 10.1103/PhysRevLett.77.5417; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Demler E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067202; Franz M, 1998, PHYS REV LETT, V80, P4763, DOI 10.1103/PhysRevLett.80.4763; HU JP, IN PRESS J PHYS CHEM; Ichioka M, 1996, PHYS REV B, V53, P15316, DOI 10.1103/PhysRevB.53.15316; Kishine J, 2001, PHYS REV LETT, V86, P5365, DOI 10.1103/PhysRevLett.86.5365; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lake B, 2001, SCIENCE, V291, P1759, DOI 10.1126/science.1056986; LOW U, 1994, PHYS REV LETT, V72, P1918, DOI 10.1103/PhysRevLett.72.1918; MAGGIOAPRILE I, 1995, PHYS REV LETT, V75, P2754, DOI 10.1103/PhysRevLett.75.2754; Mitrovic VF, 2001, NATURE, V413, P501, DOI 10.1038/35097039; Pan SH, 2000, PHYS REV LETT, V85, P1536, DOI 10.1103/PhysRevLett.85.1536; PARK K, 2001, PHYS REV B; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; SOININEN PI, 1994, PHYS REV B, V50, P13883, DOI 10.1103/PhysRevB.50.13883; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Varma CM, 2000, PHYS REV B, V61, pR3804, DOI 10.1103/PhysRevB.61.R3804; Vojta M, 1999, PHYS REV LETT, V83, P3916, DOI 10.1103/PhysRevLett.83.3916; VOLOVIK GE, 1993, JETP LETT+, V58, P469; Wang QH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167004; WANG Y, 1995, PHYS REV B, V52, pR3876, DOI 10.1103/PhysRevB.52.R3876; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; Zaanen J, 2000, NATURE, V404, P714, DOI 10.1038/35008176; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zhu JX, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.147002	32	723	726	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					466	469		10.1126/science.1066974	http://dx.doi.org/10.1126/science.1066974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799234	Green Submitted			2022-12-28	WOS:000173350700040
J	Barouch, DH; Kunstman, J; Kuroda, MJ; Schmitz, JE; Santra, S; Peyerl, FW; Krivulka, GR; Beaudry, K; Lifton, MA; Gorgone, DA; Montefiori, DC; Lewis, MG; Wolinsky, SM; Letvin, NL				Barouch, DH; Kunstman, J; Kuroda, MJ; Schmitz, JE; Santra, S; Peyerl, FW; Krivulka, GR; Beaudry, K; Lifton, MA; Gorgone, DA; Montefiori, DC; Lewis, MG; Wolinsky, SM; Letvin, NL			Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MHC CLASS-I; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; VIREMIA; VARIANTS; SELECTION; PEPTIDE; EPITOPE; PROGRESSION	Potent virus-specific cytotoxic T lymphocyte (CTL) responses elicited by candidate AIDS vaccines have recently been shown to control viral replication and prevent clinical disease progression after pathogenic viral challenges in rhesus monkeys(1-4). Here we show that viral escape from CTL recognition can result in the eventual failure of this partial immune protection. Viral mutations that escape from CTL recognition have been previously described in humans infected with human immunodeficiency virus (HIV)(5-10) and monkeys infected with simian immunodeficiency virus (SIV)(11-13). In a cohort of rhesus monkeys that were vaccinated and subsequently infected with a pathogenic hybrid simian-human immunodeficiency virus (SHIV), the frequency of viral sequence mutations within CTL epitopes correlated with the level of viral replication. A single nucleotide mutation within an immunodominant Gag CTL epitope in an animal with undetectable plasma viral RNA resulted in viral escape from CTLs, a burst of viral replication, clinical disease progression, and death from AIDS-related complications. These data indicate that viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; So Res Inst, Frederick, MD 21701 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; Duke University	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Res E Room 113,330 Brookline Ave, Boston, MA 02215 USA.		Barouch, Dan/Y-3918-2019; Schmitz, Joern/A-4929-2018; Wolinsky, Steven/B-2893-2012	Schmitz, Joern/0000-0001-8803-0922; Wolinsky, Steven/0000-0002-9625-6697	NCI NIH HHS [R01 CA050139] Funding Source: Medline; NIAID NIH HHS [P01 AI035351, U01 AI035351] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035351, U01AI035351] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; MILLER MD, 1991, J IMMUNOL, V147, P320; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Polacino P, 1999, J VIROL, V73, P618, DOI 10.1128/JVI.73.1.618-630.1999; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537	27	577	609	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					335	339		10.1038/415335a	http://dx.doi.org/10.1038/415335a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797012				2022-12-28	WOS:000173293500047
J	Crabtree, RH				Crabtree, RH			Chemistry - A new oxidation state for Pd?	SCIENCE			English	Editorial Material									Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Crabtree, RH (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.							CANTY AJ, 1992, ACCOUNTS CHEM RES, V25, P83, DOI 10.1021/ar00014a005; Chen WZ, 2002, SCIENCE, V295, P308, DOI 10.1126/science.1067027; Cotton F. A., 1988, ADV INORGANIC CHEM; Crabtree R. H., 2001, ORGANOMETALLIC CHEM; KAUFFMAN GB, 1993, COORDIN CHEM REV, V128, P1, DOI 10.1016/0010-8545(93)80022-W; KING RB, 1994, ENCY INORGANIC CHEM, P3011; MALLERON JL, 1997, HDB PALLADIUM CATALY	7	42	42	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					288	289		10.1126/science.1067921	http://dx.doi.org/10.1126/science.1067921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786632				2022-12-28	WOS:000173278600036
J	Gallup, CD; Cheng, H; Taylor, FW; Edwards, RL				Gallup, CD; Cheng, H; Taylor, FW; Edwards, RL			Direct determination of the timing of sea level change during termination II	SCIENCE			English	Article							PENULTIMATE DEGLACIATION; HUON PENINSULA; DEVILS-HOLE; CLIMATE; RECORD; TEMPERATURE; BARBADOS; TERRACES; ISOTOPES; CALCITE	An outcrop within the last interglacial terrace on Barbados contains corals that grew during the penultimate deglaciation, or Termination II. We used combined Th-230 and Pa-231 dating to determine that they grew 135.8+/-0.8 thousand years ago, indicating that sea level was 18+/-3 meters below present sea level at the time. This suggests that sea level had risen to within 20% of its peak last-interglacial value by 136 thousand years ago, in conflict with Milankovitch theory predictions. Orbital forcing may have played a rote in the deglaciation, as may have isostatic adjustments due to large ice sheets, Other corals in the same outcrop grew during oxygen isotope (delta(18)O) substage 6e, indicating that sea level was 38+/-5 meters below present sea level, about 168.0 thousand years ago. When compared to the delta(18)O signal in the benthic V19-30/V19-28 record at that time, the coral data extend to the previous glacial cycle the conclusion that deep-water temperatures were colder during glacial periods.	Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA; Univ Texas, Inst Geophys, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin	Gallup, CD (corresponding author), Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA.	cgallup@d.umn.edu	Edwards, R. Lawrence/I-3124-2014; CHENG, HAI/H-3413-2017; Taylor, Frederick/A-2195-2009	Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458; 				BENDER ML, 1979, GEOL SOC AM BULL, V90, P577, DOI 10.1130/0016-7606(1979)90<577:UDOTPR>2.0.CO;2; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; Edwards RL, 1997, SCIENCE, V276, P782, DOI 10.1126/science.276.5313.782; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; JOHNSON RG, 1991, GEOLOGY, V19, P686, DOI 10.1130/0091-7613(1991)019<0686:MNHDCB>2.3.CO;2; Karner DB, 2000, SCIENCE, V288, P2143, DOI 10.1126/science.288.5474.2143; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; MESOLELL.KJ, 1969, J GEOL, V77, P250, DOI 10.1086/627434; MUHS DR, QUAT SCI REV; PELTIER WR, 1986, J ATMOS SCI, V44, P1351; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; TAYLOR FW, 1991, GEOLOGY, V19, P103, DOI 10.1130/0091-7613(1991)019<0103:LQFOCR>2.3.CO;2; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918; [No title captured]	32	176	186	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					310	313		10.1126/science.1065494	http://dx.doi.org/10.1126/science.1065494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786639				2022-12-28	WOS:000173278600044
J	Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L				Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L			Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface	NATURE			English	Article							CROSS-LINKING ENZYMES; FACTOR-XIII; TRANSGLUTAMINASES; ACTIVATION; TRYPTOPHAN; CONVULXIN; COLLAGEN; RECEPTOR; TISSUES; BINDING	Activated platelets bind numerous adhesive and procoagulant proteins by receptor-mediated processes(1). Although there is little evidence to suggest that these processes are heterogeneous in platelets, we previously found that platelets co-stimulated with collagen and thrombin express functional alpha -granule factor V only on a subpopulation of cells(2). Here we show that these cells, referred to as 'COAT-platelets', bind additional alpha -granule proteins, including fibrinogen, von Willebrand factor, thrombospondin, fibronectin and alpha (2)-antiplasmin. These proteins are all transglutaminase substrates, and inhibitors of transglutaminase prevent the production of COAT-platelets. A synthetic transglutaminase substrate (CP15) also binds to COAT-platelets, and analysis by high performance liquid chromatography/mass spectrometry shows that a product is formed with a relative molecular mass (M-r) equal to CP15 plus 176. Serotonin, an abundant component of platelet-dense granules(3), has an M-r of 176, and fibrinogen isolated from COAT-platelets contains covalently linked serotonin. Synthetic bovine serum albumin-(serotonin)(6) binds selectively to COAT-platelets and also inhibits the retention of procoagulant proteins on COAT-platelets. These data indicate that COAT-platelets use serotonin conjugation to augment the retention of procoagulant proteins on their cell surface through an as yet unidentified serotonin receptor.	Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73104 USA; Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Bern	Dale, GL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA.			Alberio, Lorenzo/0000-0001-9686-9920				AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; CLARKE DD, 1959, ARCH BIOCHEM BIOPHYS, V79, P338, DOI 10.1016/0003-9861(59)90413-8; GORMAN JJ, 1981, J BIOL CHEM, V256, P2712; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; LAAKSO JT, 1983, SCAND J CLIN LAB INV, V43, P463; Lorand L, 1998, EXP EYE RES, V66, P531, DOI 10.1006/exer.1997.0463; MAEDA K, 1984, H-S Z PHYSIOL CHEM, V365, P1183, DOI 10.1515/bchm2.1984.365.2.1183; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Mousa SA, 1998, J CARDIOVASC PHARM, V32, P169, DOI 10.1097/00005344-199808000-00001; Muszbek L, 1996, CRIT REV CL LAB SCI, V33, P357, DOI 10.3109/10408369609084691; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; PIDARD D, 1983, J BIOL CHEM, V258, P2582; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; PUSZKIN EG, 1985, J BIOL CHEM, V260, P6012; REED GL, 1992, THROMB HAEMOSTASIS, V68, P315; REED GL, 1995, THROMB HAEMOSTASIS, V74, P680; SHATTIL SJ, 1987, BLOOD, V70, P307; WAGNER A, 1990, J AFFECT DISORDERS, V20, P101, DOI 10.1016/0165-0327(90)90123-P; [No title captured]	22	246	255	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					175	179		10.1038/415175a	http://dx.doi.org/10.1038/415175a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805836				2022-12-28	WOS:000173159300043
J	Shore, EM; Ahn, J; de Beur, SJ; Li, M; Xu, MQ; Gardner, RJM; Zasloff, MA; Whyte, MP; Levine, MA; Kaplan, FS				Shore, EM; Ahn, J; de Beur, SJ; Li, M; Xu, MQ; Gardner, RJM; Zasloff, MA; Whyte, MP; Levine, MA; Kaplan, FS			Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GS-ALPHA GENE; ALBRIGHT HEREDITARY OSTEODYSTROPHY; STIMULATORY G-PROTEIN; SUBUNIT; LOCUS; OSSIFICATION	Background Progressive osseous heteroplasia (POH), an autosomal dominant disorder, is characterized by extensive dermal ossification during childhood, followed by disabling and widespread heterotopic ossification of skeletal muscle and deep connective tissue. Occasional reports of mild heterotopic ossification in Albright's hereditary osteodystrophy (AHO) and a recent report of two patients with AHO who had atypically extensive heterotopic ossification suggested a common genetic basis for the two disorders. AHO is caused by heterozygous inactivating mutations in the GNAS1 gene that result in decreased expression or function of the alpha subunit of the stimulatory G protein (G(s)alpha) of adenylyl cyclase. Methods We tested the hypothesis that GNAS1 mutations cause POH, using the polymerase chain reaction to amplify GNAS1 exons and exon-intron boundaries in 18 patients with sporadic or familial POH. Results Heterozygous inactivating GNAS1 mutations were identified in 13 of the 18 probands with POH. The defective allele in POH is inherited exclusively from fathers, a result consistent with a model of imprinting for GNAS1. Direct evidence that the same mutation can cause either POH or AHO was observed within a single family, in which the phenotype correlated with the parental origin of the mutant allele. Conclusions Paternally inherited inactivating GNAS1 mutations cause POH. This finding extends the range of phenotypes derived from haploinsufficiency of GNAS1, provides evidence that imprinting is a regulatory mechanism for GNAS1 expression, and suggests that G,a is a critical negative regulator of osteogenic commitment in nonosseous connective tissues. (N Engl J Med 2002;346:99-106.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Ilyssa Ctr Mol & Cellular Endocrinol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Royal Childrens Hosp, Victoria & Murdoch Childrens Res Inst, Genet Hlth Serv, Melbourne, Vic, Australia; Washington Univ, Sch Med, Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA; Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Washington University (WUSTL); Washington University (WUSTL)	Shore, EM (corresponding author), Univ Penn, Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th & Hamilton Walk, Philadelphia, PA 19104 USA.		Shore, Eileen/D-2593-2009	Levine, Michael/0000-0003-0036-7809	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916, R01AR046831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034281] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR46831, R01-AR41916, R01 AR046831] Funding Source: Medline; NIDDK NIH HHS [R01-DK34281] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATHANASOU NA, 1994, BONE, V15, P471, DOI 10.1016/8756-3282(94)90269-0; CAMPBELL R, 1994, J MED GENET, V31, P607, DOI 10.1136/jmg.31.8.607; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DEBEUR SMJ, 2001, PARATHYROIDS BASIC C, P807; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; GARDNER RJM, 1988, J MED GENET, V25, P113, DOI 10.1136/jmg.25.2.113; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Kaplan FS, 1996, ARCH DERMATOL, V132, P815, DOI 10.1001/archderm.132.7.815; Kaplan FS, 2000, J BONE MINER RES, V15, P2084, DOI 10.1359/jbmr.2000.15.11.2084; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; McKusick V.A., 1998, MENDELIAN INHERITANC; MIRIC A, 1993, J CLIN ENDOCR METAB, V76, P1560, DOI 10.1210/jc.76.6.1560; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; PISANI V, 1985, PEDIAT DERMATOL NEWS, V4, P170; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RODRIGUEZJURADO R, 1995, PEDIATR PATHOL LAB M, V15, P813, DOI 10.3109/15513819509027017; ROSENFELD SR, 1995, CLIN ORTHOP RELAT R, P243; SCHMIDT AH, 1994, J BONE JOINT SURG AM, V76A, P907, DOI 10.2106/00004623-199406000-00016; Shapira H, 1996, HUM GENET, V97, P73; Urtizberea JA, 1998, J BONE JOINT SURG BR, V80B, P768, DOI 10.1302/0301-620X.80B5.8626; WEINSTEIN LS, 1992, GENOMICS, V13, P1319, DOI 10.1016/0888-7543(92)90056-X; WHYTE MP, 1999, PRIMER METABOLIC BON, P384; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	31	211	220	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					99	106		10.1056/NEJMoa011262	http://dx.doi.org/10.1056/NEJMoa011262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784876				2022-12-28	WOS:000173133400005
J	Yehuda, R				Yehuda, R			Current concepts - Post-traumatic stress disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRAUMA SURVIVORS; PLASMA-CORTISOL; COMBAT VETERANS; SYMPTOMS; PTSD; NOREPINEPHRINE; SUPPRESSION; EXPOSURE; MEMORY		Bronx Vet Affairs Med Ctr, Bronx, NY 10468 USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; Mt Sinai Sch Med, Div Traumat Stress Studies, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Yehuda, R (corresponding author), Bronx Vet Affairs Med Ctr, 130 Kingsbridge Rd, Bronx, NY 10468 USA.	rachel.yehuda@med.va.gov						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anisman H, 2001, AM J PSYCHIAT, V158, P1509, DOI 10.1176/appi.ajp.158.9.1509; Baker DG, 1999, AM J PSYCHIAT, V156, P585; Boscarino JA, 1996, J CONSULT CLIN PSYCH, V64, P191, DOI 10.1037/0022-006X.64.1.191; BRAUN P, 1990, J CLIN PSYCHIAT, V51, P236; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P81; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Connor KM, 1999, BRIT J PSYCHIAT, V175, P17, DOI 10.1192/bjp.175.1.17; DAVIDSON J, 1990, ARCH GEN PSYCHIAT, V47, P259; Davidson JRT, 2001, ARCH GEN PSYCHIAT, V58, P485, DOI 10.1001/archpsyc.58.5.485; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Foa E. B., 2010, EFFECTIVE TREATMENTS; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foa Edna B., 1999, Journal of Clinical Psychiatry, V60, P1; Gelpin E, 1996, J CLIN PSYCHIAT, V57, P390; Goenjian AK, 1996, AM J PSYCHIAT, V153, P929; GREEN BL, 1990, J APPL SOC PSYCHOL, V20, P1632, DOI 10.1111/j.1559-1816.1990.tb01498.x; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Jeong KH, 2000, ENDOCRINOLOGY, V141, P1142, DOI 10.1210/en.141.3.1142; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KOSTEN TR, 1991, J NERV MENT DIS, V179, P366, DOI 10.1097/00005053-199106000-00011; LANE C, 1992, J CONSULT CLIN PSYCH, V60, P935, DOI 10.1037/0022-006X.60.6.935; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; MASON J, 1994, ARCH GEN PSYCHIAT, V51, P629; MASON JW, 1986, J NERV MENT DIS, V174, P145, DOI 10.1097/00005053-198603000-00003; McFarlane AC, 1997, ANN NY ACAD SCI, V821, P437, DOI 10.1111/j.1749-6632.1997.tb48299.x; Modell S, 1997, NEUROENDOCRINOLOGY, V65, P216, DOI 10.1159/000127275; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; PACAK K, 1995, FRONT NEUROENDOCRIN, V16, P89, DOI 10.1006/frne.1995.1004; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Resick PA., 1993, COGN PROCESS, V4; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; SCHUFF N, IN PRESS BIOL PSYCHI; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; Shemesh E, 2001, GEN HOSP PSYCHIAT, V23, P215, DOI 10.1016/S0163-8343(01)00150-5; Shin LM, 1999, AM J PSYCHIAT, V156, P575; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; STOKES PE, 1984, ARCH GEN PSYCHIAT, V41, P257; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 1998, BIOL PSYCHIAT, V44, P56, DOI 10.1016/S0006-3223(98)80007-3; Yehuda R., 1999, RISK FACTORS POSTTRA; Zatzick DF, 1997, MIL MED, V162, P661, DOI 10.1093/milmed/162.10.661	55	857	886	2	146	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					108	114		10.1056/NEJMra012941	http://dx.doi.org/10.1056/NEJMra012941			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	509EM	11784878				2022-12-28	WOS:000173133400007
J	Epstein, RM; Hundert, EM				Epstein, RM; Hundert, EM			Defining and assessing professional competence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							STRUCTURED CLINICAL EXAMINATION; PERFORMANCE-BASED ASSESSMENT; STANDARDIZED-PATIENT ASSESSMENT; MULTIPLE-STATION EXAMINATION; NBME PART-I; MEDICAL-STUDENTS; GENERAL-PRACTITIONERS; INTERNAL-MEDICINE; PRIMARY-CARE; SATISFACTION RATINGS	Context Current assessment formats for physicians and trainees reliably test core knowledge and basic skills. However, they may underemphasize some important domains of professional medical practice, including interpersonal skills, lifelong learning, professionalism, and integration of core knowledge into clinical practice. Objectives To propose a definition of professional competence, to review current means for assessing it, and to suggest new approaches to assessment. Data Sources We searched the MEDLINE database from 1966 to 2001 and reference lists of relevant articles for English-language studies of reliability or validity of measures of competence of physicians, medical students, and residents. Study Selection We excluded articles of a purely descriptive nature, duplicate reports, reviews, and opinions and position statements, which yielded 195 relevant citations. Data Extraction Data were abstracted by 1 of us (R.M.E.). Quality criteria for inclusion were broad, given the heterogeneity of interventions, complexity of outcome measures, and paucity of randomized or longitudinal study designs. Data Synthesis We generated an inclusive definition of competence: the habitual and judicious use of communication, knowledge, technical skills, clinical reasoning, emotions, values, and reflection in daily practice for the benefit of the individual and the community being served. Aside from protecting the public and limiting access to advanced training, assessments should foster habits of learning and self-reflection and drive institutional change. Subjective, multiple-choice, and standardized patient assessments, although reliable, underemphasize important domains of professional competence: integration of knowledge and skills, context of care, information management, teamwork, health systems, and patient-physician relationships. Few assessments observe trainees in real-life situations, incorporate the perspectives of peers and patients, or use measures that predict clinical outcomes. Conclusions In addition to assessments of basic skills, new formats that assess clinical reasoning, expert judgment, management of ambiguity, professionalism, time management, learning strategies, and teamwork promise a multidimensional assessment while maintaining adequate reliability and validity. Institutional support, reflection, and mentoring must accompany the development of assessment programs.	Univ Rochester, Sch Med & Dent, Dept Family Med, Rochester, NY 14620 USA; Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14620 USA; Univ Rochester, Sch Med & Dent, Dept Med Humanities, Rochester, NY 14620 USA	University of Rochester; University of Rochester; University of Rochester	Epstein, RM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Family Med, 885 South Ave, Rochester, NY 14620 USA.	ronald_epstein@urmc.rochester.edu						ABRAHAMOWICZ M, 1990, ACAD MED, V65, pS25, DOI 10.1097/00001888-199009000-00027; *ACGME OUTC PROJ, 2001, ACCR COUNC GRAD MED; *AM BOARD INT MED, 1999, GUID EV RES INT MED; *AM BOARD INT MED, 1998, PROJ PROF; *AM BOARD INT MED, 2001, PAT PHYS PEER ASS AB; Asch E, 1998, Acad Med, V73, P575, DOI 10.1097/00001888-199805000-00034; BARROWS HS, 1993, ACAD MED, V68, P443, DOI 10.1097/00001888-199306000-00002; BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365; Benner P., 1984, NOVICE EXPERT; BLANE CE, 1985, INVEST RADIOL, V20, P121, DOI 10.1097/00004424-198503000-00003; BORDAGE G, 1984, MED EDUC, V18, P406, DOI 10.1111/j.1365-2923.1984.tb01295.x; BORDAGE G, 1994, ACAD MED, V69, P883, DOI 10.1097/00001888-199411000-00004; Brailovsky C, 2001, MED EDUC, V35, P430, DOI 10.1046/j.1365-2923.2001.00911.x; Broudy H.S., 1964, DEMOCRACY EXCELLENCE; Candib L., 1995, MED FAMILY FEMINIST; CARLINE JD, 1992, J GEN INTERN MED, V7, P506, DOI 10.1007/BF02599454; CARNEY PA, 1993, ANN INTERN MED, V119, P129, DOI 10.7326/0003-4819-119-2-199307150-00007; Carney PA, 1999, J FAM PRACTICE, V48, P965; CARNEY PA, 1995, ACAD MED, V70, P52, DOI 10.1097/00001888-199501000-00014; CASE SM, 1993, ACAD MED, V68, pS51, DOI 10.1097/00001888-199302000-00031; Case SM, 1996, ACAD MED, V71, pS31, DOI 10.1097/00001888-199601000-00035; CASE SM, 1992, ACAD MED, V67, pS13, DOI 10.1097/00001888-199210000-00024; Charlin B, 2000, TEACH LEARN MED, V12, P189, DOI 10.1207/S15328015TLM1204_5; CHOPRA V, 1992, BRIT J ANAESTH, V68, P13, DOI 10.1093/bja/68.1.13; COHEN R, 1991, ACAD MED, V66, P545, DOI 10.1097/00001888-199109000-00012; Colliver J A, 1997, JAMA, V278, P790, DOI 10.1001/jama.278.9.790; COOPER JB, 1978, ANESTHESIOLOGY, V49, P399, DOI 10.1097/00000542-197812000-00004; Cusimano MD, 1998, ACAD MED, V73, pS112, DOI 10.1097/00001888-199810000-00063; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAUPHINEE WD, 1995, JAMA-J AM MED ASSOC, V274, P741, DOI 10.1001/jama.274.9.741; Davies JM, 1997, CAN MED ASSOC J, V157, P1352; Davis D, 1998, INT J PSYCHIAT MED, V28, P21, DOI 10.2190/UA3R-JX9W-MHR5-RC81; DeChamplain AE, 1997, ACAD MED, V72, pS85, DOI 10.1097/00001888-199710001-00029; Dewey John, 1958, EXPERIENCE NATURE, V471; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Downie RS, 2000, CLIN JUDGEMENT EVIDE; DOWNING SM, 1980, ANN EMERG MED, V9, P554, DOI 10.1016/S0196-0644(80)80223-X; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; DUNN MM, 1994, ACAD MED, V69, P683, DOI 10.1097/00001888-199408000-00019; DUNNINGTON G, 1990, AM J SURG, V159, P423, DOI 10.1016/S0002-9610(05)81289-9; DUNNINGTON GL, 1994, AM J SURG, V167, P604, DOI 10.1016/0002-9610(94)90107-4; Ely JW, 1999, J FAM PRACTICE, V48, P23; EMANUEL EJ, 1995, JAMA-J AM MED ASSOC, V273, P323, DOI 10.1001/jama.273.4.323; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; EPSTEIN RM, 1998, PARTNERSHIPS HLTH CA, P171; ERAUT M, 1994, DEV PROFESSIONAL KNO, P100; FEINSTEIN AR, 1994, ANN INTERN MED, V120, P799, DOI 10.7326/0003-4819-120-9-199405010-00012; FERRELL BG, 1993, MED EDUC, V27, P376, DOI 10.1111/j.1365-2923.1993.tb00285.x; Fiscella K, 1999, ANN INTERN MED, V131, P745, DOI 10.7326/0003-4819-131-10-199911160-00005; Frankford DM, 1998, ACAD MED, V73, P138, DOI 10.1097/00001888-199802000-00011; Friedman MH, 1998, ACAD MED, V73, pS19, DOI 10.1097/00001888-199810000-00033; GALE J, 1982, MED EDUC, V16, P22, DOI 10.1111/j.1365-2923.1982.tb01214.x; Goleman D., 1985, EMOTIONAL INTELLIGEN; Gomez JM, 1997, MED EDUC, V31, P94, DOI 10.1111/j.1365-2923.1997.tb02465.x; GONZI A, 1993, 8 NAT OFF EV SKILLS; GORDON MJ, 1991, ACAD MED, V66, P762, DOI 10.1097/00001888-199112000-00012; Gorter S, 2000, ACAD MED, V75, P1130, DOI 10.1097/00001888-200011000-00022; GRANDMAISON P, 1992, CAN MED ASSOC J, V146, P1735; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; Helmreich RL, 2000, CAN J ANAESTH, V47, P391, DOI 10.1007/BF03018965; Helmreich RL, 2000, BRIT MED J, V320, P781, DOI 10.1136/bmj.320.7237.781; Helmreich RL, 1997, CAN J ANAESTH, V44, P907, DOI 10.1007/BF03011959; HERBERS JE, 1989, J GEN INTERN MED, V4, P202, DOI 10.1007/BF02599524; Hodges B, 1999, ACAD MED, V74, P1129, DOI 10.1097/00001888-199910000-00017; HODGES B, 2001, ASSESSMENT BASIC SCI; HOLSGROVE GJ, 1993, BRIT J HOSP MED, V48, P757; Hundert EM, 1996, ACAD MED, V71, P624, DOI 10.1097/00001888-199606000-00014; Institute of Medicine, 2001, CROSSING QUALITY CHA; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; JOORABCHI B, 1991, AM J DIS CHILD, V145, P757; KAISER S, 1995, AM J SURG, V169, P418, DOI 10.1016/S0002-9610(99)80188-3; KALET A, 1992, J GEN INTERN MED, V7, P499, DOI 10.1007/BF02599452; Kane M, 1997, APPL MEAS EDUC, V10, P5, DOI 10.1207/s15324818ame1001_1; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Kassebaum DG, 1999, ACAD MED, V74, P842, DOI 10.1097/00001888-199907000-00020; Kassirer JP, 2001, ANN INTERN MED, V134, P587, DOI 10.7326/0003-4819-134-7-200104030-00012; Kaufman DM, 2000, ACAD MED, V75, P267, DOI 10.1097/00001888-200003000-00018; KEYNAN A, 1987, MED EDUC, V21, P477, DOI 10.1111/j.1365-2923.1987.tb01406.x; Klass D, 2000, AM J PHYS MED REHAB, V79, P481, DOI 10.1097/00002060-200009000-00018; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, DOI 10.17226/9728; KOPELOW ML, 1992, ACAD MED, V67, pS19, DOI 10.1097/00001888-199210000-00026; KRAVITZ RL, 1994, J GEN INTERN MED, V9, P75, DOI 10.1007/BF02600205; KROBOTH FJ, 1992, J GEN INTERN MED, V7, P174, DOI 10.1007/BF02598008; LaDuca A, 1984, Eval Health Prof, V7, P115, DOI 10.1177/016327878400700201; LADUCA A, 1994, EVAL HEALTH PROF, V17, P178, DOI 10.1177/016327879401700204; Langer E. J., 1997, POWER MINDFUL LEARNI; Latif A., 1992, MED TEACH, V14, P179; LOCKIE C, 1990, 46 ROYAL COLL GEN PR; Luck J, 2000, AM J MED, V108, P642, DOI 10.1016/S0002-9343(00)00363-6; MacRae HM, 1997, SURGERY, V122, P335, DOI 10.1016/S0039-6060(97)90025-8; Mandin H, 1997, ACAD MED, V72, P173, DOI 10.1097/00001888-199703000-00009; Margolis MJ, 1998, ACAD MED, V73, pS114, DOI 10.1097/00001888-199810000-00064; Martin JA, 1996, ACAD MED, V71, P170, DOI 10.1097/00001888-199602000-00025; MATSELL DG, 1991, MED EDUC, V25, P293, DOI 10.1111/j.1365-2923.1991.tb00069.x; McKinley RK, 2000, MED EDUC, V34, P573, DOI 10.1046/j.1365-2923.2000.00490.x; McLeod PJ, 1997, JAMA-J AM MED ASSOC, V278, P1164, DOI 10.1001/jama.278.14.1164; MCLEOD PJ, 1994, J GEN INTERN MED, V9, P321, DOI 10.1007/BF02599179; MCWHINNEY IR, 1986, HEADACHE, V26, P285; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; MUMFORD E, 1987, AM J PSYCHIAT, V144, P316; Newble D, 1994, TEACH LEARN MED, V6, P213; NEWBLE DI, 1988, MED EDUC, V22, P325, DOI 10.1111/j.1365-2923.1988.tb00761.x; Norcini J J, 1984, Eval Health Prof, V7, P485, DOI 10.1177/016327878400700409; NORCINI JJ, 1993, EVAL HEALTH PROF, V16, P322, DOI 10.1177/016327879301600305; NORCINI JJ, 1985, MED EDUC, V19, P238, DOI 10.1111/j.1365-2923.1985.tb01314.x; NORCINI JJ, 1995, ANN INTERN MED, V123, P795, DOI 10.7326/0003-4819-123-10-199511150-00008; Norman G.R., 1985, ASSESSING CLIN COMPE, P15; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; PETRUSA ER, 1990, ARCH INTERN MED, V150, P573, DOI 10.1001/archinte.150.3.573; PIETERS HM, 1994, MED EDUC, V28, P226, DOI 10.1111/j.1365-2923.1994.tb02703.x; Polanyi M., 1969, KNOWING BEING ESSAYS, P123; Polanyi M, 1974, PERSONAL KNOWLEDGE P, V2; Ram P, 1999, MED EDUC, V33, P447; Ram P, 1999, MED EDUC, V33, P197, DOI 10.1046/j.1365-2923.1999.00280.x; Ram P, 1999, ACAD MED, V74, P62, DOI 10.1097/00001888-199901000-00020; RAMSEY PG, 1993, JAMA-J AM MED ASSOC, V269, P1655, DOI 10.1001/jama.269.13.1655; RISSER DT, 1999, ERROR REDUCTION HLTH, P235; Ross LP, 1996, ACAD MED, V71, pS4, DOI 10.1097/00001888-199610000-00027; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; ROWLANDMORIN PA, 1991, ACAD MED, V66, P169, DOI 10.1097/00001888-199103000-00011; Sackett D. L., 1997, EVIDENCE BASED MED P; Safran DG, 1998, J FAM PRACTICE, V47, P213; Safran DG, 2001, J FAM PRACTICE, V50, P130; SANSONFISHER RW, 1980, MED EDUC, V14, P249, DOI 10.1111/j.1365-2923.1980.tb02269.x; SCHAEFER HG, 1994, ANESTHESIOLOGY, V80, P479, DOI 10.1097/00000542-199402000-00035; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; Schon D.A, 2017, REFLECTIVE PRACTITIO; Schuwirth LWT, 2001, MED EDUC, V35, P348, DOI 10.1046/j.1365-2923.2001.00771.x; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Singer PA, 1996, ACAD MED, V71, P495, DOI 10.1097/00001888-199605000-00021; SMITH RM, 1993, ACAD MED, V68, P366, DOI 10.1097/00001888-199305000-00020; STARFIELD B, 1981, AM J PUBLIC HEALTH, V71, P127, DOI 10.2105/AJPH.71.2.127; Stewart M, 2000, J FAM PRACTICE, V49, P796; Stewart M, 1999, Cancer Prev Control, V3, P25; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; STILLMAN P, 1991, ANN INTERN MED, V114, P393, DOI 10.7326/0003-4819-114-5-393; STILLMAN RM, 1983, SURGERY, V93, P439; Suchman A.L., 1998, PARTNERSHIPS HEALTHC; Swartz MH, 1999, ACAD MED, V74, P1028, DOI 10.1097/00001888-199909000-00018; Swartz MH, 1997, ACAD MED, V72, P619, DOI 10.1097/00001888-199707000-00014; Tamblyn R, 1998, JAMA-J AM MED ASSOC, V280, P989, DOI 10.1001/jama.280.11.989; Tamblyn R, 1997, ANN INTERN MED, V127, P429, DOI 10.7326/0003-4819-127-6-199709150-00003; TAMBLYN R, 1994, J GEN INTERN MED, V9, P146, DOI 10.1007/BF02600030; TAMBLYN R, 1994, TEACH LEARN MED, V6, P36; TAMBLYN RM, 1992, ACAD MED, V67, pS22, DOI 10.1097/00001888-199210000-00027; Tamblyn RM, 1998, CAN MED ASSOC J, V158, P205; TAMBLYN RM, 1991, MED EDUC, V25, P100, DOI 10.1111/j.1365-2923.1991.tb00035.x; TAMBLYN RM, 1990, ACAD MED, V65, pS55, DOI 10.1097/00001888-199009000-00042; Tate P, 1999, J HEALTH COMMUN, V4, P143, DOI 10.1080/108107399127011; TERNOV S, 1999, ERROR REDUCTION HEAL, P97; TORNOW WW, 1998, MAXIMIZING VALUE 360; Travis TA, 1996, ACAD MED, V71, pS84, DOI 10.1097/00001888-199601000-00051; Tresolini C. P., 1994, HLTH PROFESSIONS ED; Tutton PJM, 1996, ACAD MED, V71, P181, DOI 10.1097/00001888-199602000-00027; van der Vleuten C, 2000, BRIT MED J, V321, P1217, DOI 10.1136/bmj.321.7270.1217; van der Vleuten C.P., 1990, TEACH LEARN MED, V2, P58, DOI [https://doi.org/10.1080/10401339009539432, DOI 10.1080/10401339009539432]; VANDERVLEUTEN CPM, 1991, MED EDUC, V25, P110; Veloski JJ, 1999, ACAD MED, V74, P539, DOI 10.1097/00001888-199905000-00022; Verhoeven BH, 2000, MED EDUC, V34, P525, DOI 10.1046/j.1365-2923.2000.00566.x; Violato C, 1997, ACAD MED, V72, pS82, DOI 10.1097/00001888-199710001-00028; VU NV, 1992, ACAD MED, V67, P42, DOI 10.1097/00001888-199201000-00009; VU NV, 1993, ACAD MED, V68, pS41, DOI 10.1097/00001888-199302000-00029; WANGCHENG RM, 1995, ACAD MED, V70, P324, DOI 10.1097/00001888-199504000-00018; Wass V, 2001, MED EDUC, V35, P321, DOI 10.1046/j.1365-2923.2001.00928.x; Wass V, 2001, MED EDUC, V35, P326, DOI 10.1046/j.1365-2923.2001.00929.x; WESTBURG J, 1993, COLLABORATIVE CLIN E; YANG JC, 1983, J MED EDUC, V58, P864	169	1547	1654	16	442	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					226	235		10.1001/jama.287.2.226	http://dx.doi.org/10.1001/jama.287.2.226			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779266				2022-12-28	WOS:000173114900026
J	Pudritz, RE				Pudritz, RE			Clustered star formation and the origin of stellar masses	SCIENCE			English	Review							FILAMENTARY MOLECULAR CLOUDS; MAGNETIC-FIELDS; HELICAL FIELDS; CORES; ORION; LUMINOSITY; GAS; FRAGMENTATION; EVOLUTION; MODEL	Star clusters are ubiquitous in galaxies of all types and at all stages of their evolution. We also observe them to be forming in a wide variety of environments, ranging from nearby giant molecular clouds to the supergiant molecular clouds found in starburst and merging galaxies. The typical star in our galaxy and probably in others formed as a member of a star cluster, so star formation is an intrinsically clustered and not an isolated phenomenon. The greatest challenge regarding clustered star formation is to understand why stars have a mass spectrum that appears to be universal. This review examines the observations and models that have been proposed to explain these fundamental issues in stellar formation.	McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University	Pudritz, RE (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	pudritz@physics.mcmaster.ca		Pudritz, Ralph/0000-0002-7605-2961				BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Blitz L., 1993, PROTOSTARS PLANETS, P125; Bonnell IA, 1998, MON NOT R ASTRON SOC, V298, P93, DOI 10.1046/j.1365-8711.1998.01590.x; Bonnell IA, 1997, MON NOT R ASTRON SOC, V285, P201, DOI 10.1093/mnras/285.1.201; BONNOR WB, 1956, MON NOT R ASTRON SOC, V116, P351, DOI 10.1093/mnras/116.3.351; Bontemps S, 2001, ASTRON ASTROPHYS, V372, P173, DOI 10.1051/0004-6361:20010474; BOULARES A, 1990, ASTROPHYS J, V365, P544, DOI 10.1086/169509; CARLBERG RG, 1990, MON NOT R ASTRON SOC, V247, P353; CASELLI P, 1995, ASTROPHYS J, V446, P665, DOI 10.1086/175825; CHANDRASEKHAR S, 1953, ASTROPHYS J, V118, P116, DOI 10.1086/145732; CIOLEK GE, 1995, ASTROPHYS J, V454, P194, DOI 10.1086/176477; Clarke C. J., 2000, Protostars and planets 4, P151; Crutcher RM, 1999, ASTROPHYS J, V520, P706, DOI 10.1086/307483; Curry CL, 2000, ASTROPHYS J, V528, P734, DOI 10.1086/308212; DUDOROV AE, 1994, ASTR SOC P, V62, P381; DUTREY A, 1991, ASTRON ASTROPHYS, V247, pL9; Ebert R, 1955, Z ASTROPHYS, V37, P217, DOI DOI 10.3406/RNORD.1955.2187; Efremov YN, 1998, MON NOT R ASTRON SOC, V299, P588, DOI 10.1046/j.1365-8711.1998.01819.x; Eisenhauer F, 1998, ASTROPHYS J, V498, P278, DOI 10.1086/305552; Elmegreen B. G., 2000, Protostars and planets 4, P179; Elmegreen BG, 1997, ASTROPHYS J, V480, P235, DOI 10.1086/303966; Feigelson ED, 1999, ANNU REV ASTRON ASTR, V37, P363, DOI 10.1146/annurev.astro.37.1.363; Fiege JD, 2000, MON NOT R ASTRON SOC, V311, P85, DOI 10.1046/j.1365-8711.2000.03066.x; Fiege JD, 2000, ASTROPHYS J, V544, P830, DOI 10.1086/317228; Fiege JD, 2000, MON NOT R ASTRON SOC, V311, P105, DOI 10.1046/j.1365-8711.2000.03067.x; Gallagher JS, 1999, MON NOT R ASTRON SOC, V304, P540, DOI 10.1046/j.1365-8711.1999.02352.x; HARRIS WE, 1994, ASTROPHYS J, V429, P177, DOI 10.1086/174310; HARRIS WE, 2001, IN PRESS SAAS FEE AD; Hartmann L, 2001, ASTRON J, V121, P1030, DOI 10.1086/318770; Hillenbrand LA, 2000, ASTROPHYS J, V540, P236, DOI 10.1086/309309; Hillenbrand LA, 1998, ASTROPHYS J, V492, P540, DOI 10.1086/305076; Johnstone D, 2000, ASTROPHYS J, V545, P327, DOI 10.1086/317790; Johnstone D, 1999, ASTROPHYS J, V510, pL49, DOI 10.1086/311792; Klessen RS, 2000, ASTROPHYS J SUPPL S, V128, P287, DOI 10.1086/313371; Konigl A., 2000, Protostars and planets 4, P759; Kroupa P, 2002, SCIENCE, V295, P82, DOI 10.1126/science.1067524; LADA CJ, 2000, IN PRESS ORIGINS STA; LADA EA, 1992, ASTROPHYS J, V393, pL25, DOI 10.1086/186442; LARSON RB, 1992, MON NOT R ASTRON SOC, V256, P641, DOI 10.1093/mnras/256.4.641; Luhman KL, 2000, ASTROPHYS J, V540, P1016, DOI 10.1086/309365; Mac Low MM, 1998, PHYS REV LETT, V80, P2754, DOI 10.1103/PhysRevLett.80.2754; MADDALENA RJ, 1986, ASTROPHYS J, V303, P375, DOI 10.1086/164083; Massey P, 1998, ASTROPHYS J, V493, P180, DOI 10.1086/305126; Matthews BC, 2000, ASTROPHYS J, V531, P868, DOI 10.1086/308523; Matzner CD, 2000, ASTROPHYS J, V545, P364, DOI 10.1086/317785; McKee C. F, 1993, PROTOSTARS PLANETS, P327; MCKEE CF, 1989, ASTROPHYS J, V345, P782, DOI 10.1086/167950; McLaughlin DE, 1996, ASTROPHYS J, V457, P578, DOI 10.1086/176754; McLaughlin DE, 1996, ASTROPHYS J, V469, P194, DOI 10.1086/177771; McLaughlin DE, 1997, ASTROPHYS J, V476, P750, DOI 10.1086/303657; Mengel S, 2001, ASTROPHYS J, V550, P280, DOI 10.1086/319704; Mihos JC, 1996, ASTROPHYS J, V464, P641, DOI 10.1086/177353; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; Motte F, 2001, ASTR SOC P, V243, P301; MOUSCHOVIAS TC, 1987, PHYSICAL PROCESSES I, P453; Myers PC, 1998, ASTROPHYS J, V507, pL157, DOI 10.1086/311700; MYERS PC, 1992, ASTROPHYS J, V396, P631, DOI 10.1086/171744; NAGASAWA M, 1987, PROG THEOR PHYS, V77, P635, DOI 10.1143/PTP.77.635; Nakajima Y, 1998, ASTROPHYS J, V497, P721, DOI 10.1086/305493; Nakano T, 1998, ASTROPHYS J, V494, P587, DOI 10.1086/305230; OCONNELL RW, 1995, ASTROPHYS J, V446, pL1, DOI 10.1086/187916; Onishi T, 1998, ASTROPHYS J, V502, P296, DOI 10.1086/305867; Osorio M, 1999, ASTROPHYS J, V525, P808, DOI 10.1086/307929; Ostriker EC, 1999, ASTROPHYS J, V513, P259, DOI 10.1086/306842; Padoan P, 1999, ASTROPHYS J, V526, P279, DOI 10.1086/307956; Palla F, 2000, ASTROPHYS J, V540, P255, DOI 10.1086/309312; Plume R, 1997, ASTROPHYS J, V476, P730, DOI 10.1086/303654; PUDRITZ RE, 2000, IN PRESS ASP C SERIE, V243; PUDRITZ RE, UNPUB; Schleuning DA, 1998, ASTROPHYS J, V493, P811, DOI 10.1086/305139; Scoville N.Z., 1987, INTERSTELLAR PROCESS, P21; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Stone J. M., 2000, Protostars and planets 4, P589; TATEMATSU K, 1993, ASTROPHYS J, V404, P643, DOI 10.1086/172318; Testi L, 1998, ASTROPHYS J, V508, pL91, DOI 10.1086/311724; van der Tak FFS, 2000, ASTROPHYS J, V537, P283, DOI 10.1086/309011; VASQUEZSEMADENI E, 2000, PROTOSTARS PLANETS, V4, P3; VAZQUEZSEMADENI E, 1995, ASTROPHYS J, V441, P702, DOI 10.1086/175393; Wada K, 1999, ASTROPHYS J, V516, pL13, DOI 10.1086/311987; Ward-Thompson D, 2002, SCIENCE, V295, P76, DOI 10.1126/science.1067354; Whitmore BC, 1999, ASTRON J, V118, P1551, DOI 10.1086/301041; WHITMORE BC, 1995, ASTRON J, V109, P960, DOI 10.1086/117334; Williams J.P., 2000, PROTOSTARS PLANETS 4, P97; Wilson CD, 2000, ASTROPHYS J, V542, P120, DOI 10.1086/309504; WILSON CD, 2001, AAS ABSTR; ZINNECKER H, IN PRESS ESO WORKSH; [No title captured]	88	38	38	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					68	76		10.1126/science.1068298	http://dx.doi.org/10.1126/science.1068298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778037				2022-12-28	WOS:000173143100035
J	Zou, HB; Zindler, A; Niu, YL				Zou, HB; Zindler, A; Niu, YL			Constraints on melt movement beneath the East Pacific Rise from Th-230-U-238 disequilibrium	SCIENCE			English	Article							MIDOCEAN RIDGE; OCEANIC-CRUST; SERIES DISEQUILIBRIUM; YOUNG LAVAS; MANTLE; CLINOPYROXENE; GARNET; PERIDOTITE; BASALTS; PA-231	We report Th-230-U-238 disequilibrium data on mid-ocean ridge basalts recovered 5 to 40 kilometers off the ridge axis near 9 degrees 30'N of the East Pacific Rise. These data indicate near-symmetrical eruptions of normal mid-ocean ridge basalts (NMORBs) and incompatible element-enriched mid-ocean ridge basalts (EMORBs) as far as 20 kilometers off axis. Our results suggest large-scale subsurface lateral transport of NMORB melt at 19 to 21 centimeters per year and also provide constraints on the petrogenesis of EMORBs of off-axis origin.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Florida State Univ, Dept Geol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; Cardiff Univ, Dept Earth Sci, Cardiff CF10 3YE, S Glam, Wales	University of California System; University of California Los Angeles; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Cardiff University	Zou, HB (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.		Niu, Yaoling/GPW-9211-2022; Zou, Haibo/A-3933-2009; Niu, Yaoling/A-5448-2008	Zou, Haibo/0000-0001-5825-2428; Niu, Yaoling/0000-0001-9488-2304				Batiza R, 1996, GEOPHYS RES LETT, V23, P221; BEATTIE P, 1993, NATURE, V363, P63, DOI 10.1038/363063a0; BEATTIE P, 1993, EARTH PLANET SC LETT, V117, P379, DOI 10.1016/0012-821X(93)90091-M; Bourdon B, 1996, NATURE, V384, P231, DOI 10.1038/384231a0; BOURDON BP, 1994, THESIS COLUMBIA U NE; CARBOTTE S, 1992, J GEOPHYS RES-SOL EA, V97, P6959, DOI 10.1029/91JB03065; COUSENS BL, 1996, GEOPHYS MONOGR SER, V95, P207; DUNCAN RA, 1994, GEOPHYS RES LETT, V21, P1927, DOI 10.1029/94GL01375; ENGLAND JG, 1992, INT J MASS SPECTROM, V121, P201, DOI 10.1016/0168-1176(92)80063-7; Fialko Y, 2001, EARTH PLANET SC LETT, V190, P31, DOI 10.1016/S0012-821X(01)00376-4; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; GENTE P, 1986, EARTH PLANET SC LETT, V78, P224, DOI 10.1016/0012-821X(86)90063-4; GOLDSTEIN SJ, 1993, EARTH PLANET SC LETT, V115, P151, DOI 10.1016/0012-821X(93)90219-Y; GOLDSTEIN SJ, 1994, NATURE, V367, P157, DOI 10.1038/367157a0; HAURI EH, 1994, CHEM GEOL, V117, P149, DOI 10.1016/0009-2541(94)90126-0; Hirschmann MM, 1996, CONTRIB MINERAL PETR, V124, P185, DOI 10.1007/s004100050184; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; LATOURRETTE TZ, 1992, EARTH PLANET SC LETT, V110, P227, DOI 10.1016/0012-821X(92)90050-6; LUNDSTROM CC, 1995, SCIENCE, V270, P1958, DOI 10.1126/science.270.5244.1958; MCKENZIE D, 1985, EARTH PLANET SC LETT, V72, P149, DOI 10.1016/0012-821X(85)90001-9; Niu YL, 1997, EARTH PLANET SC LETT, V148, P471, DOI 10.1016/S0012-821X(97)00048-4; PERFIT MR, 1994, GEOLOGY, V22, P375, DOI 10.1130/0091-7613(1994)022<0375:SSSATV>2.3.CO;2; REYNOLDS JR, 2000, C3, V1; Salters VJM, 1999, EARTH PLANET SC LETT, V166, P15, DOI 10.1016/S0012-821X(98)00271-4; Spiegelman M, 1999, NATURE, V402, P282, DOI 10.1038/46260; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; Wood BJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1613, DOI 10.1016/S0016-7037(98)00302-0; Zou HB, 2000, GEOCHIM COSMOCHIM AC, V64, P1809, DOI 10.1016/S0016-7037(00)00350-1	30	27	28	6	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					107	110		10.1126/science.1064295	http://dx.doi.org/10.1126/science.1064295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778043				2022-12-28	WOS:000173143100043
J	Yoshida, H; Matsui, T; Yamamoto, A; Okada, T; Mori, K				Yoshida, H; Matsui, T; Yamamoto, A; Okada, T; Mori, K			XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; ACTIVATION; PROTEOLYSIS; INDUCTION; PATHWAY; BINDS	In yeast, the transmembrane protein kinase/endoribonuclease Ire1p activated by endoplasmic reticulum stress cleaves HAC1 mRNA, leading to production of the transcription factor Hac1p that activates the unfolded protein response (UPR). In mammals, no Hac1p counterpart has yet been discovered despite the presence of Ire1p homologs in the endoplasmic reticulum. Instead, the transcription factor ATF6 specific to the mammalian UPR is regulated by intramembrane proteolysis. Here, we identified the transcription factor XBP1, a target of ATF6, as a mammalian substrate of such an unconventional mRNA splicing system and showed that only the spliced form of XBP1 can activate the UPR efficiently. Our results reveal features of the UPR conserved during evolution and clarify the relationship between IRE1- and ATF6-dependent pathways.	Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan	Kyoto University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan.		Longo, Kenneth A/A-5631-2010; Mori, Kazutoshi/K-6106-2015	Yoshida, Hiderou/0000-0002-5773-1408				Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sambrook J., 2002, MOL CLONING LAB MANU; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x	27	2810	2938	12	242	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					881	891		10.1016/S0092-8674(01)00611-0	http://dx.doi.org/10.1016/S0092-8674(01)00611-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779464	Bronze			2022-12-28	WOS:000173024200009
J	Greenberg, DS				Greenberg, DS			Washington - War, bioterrorism, and the political landscape	LANCET			English	News Item																			0	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2137	2137		10.1016/S0140-6736(01)07240-3	http://dx.doi.org/10.1016/S0140-6736(01)07240-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505GV	11784639				2022-12-28	WOS:000172905800023
J	Kuhne, T; Imbach, P; Bolton-Maggs, PHB; Berchtold, W; Blanchette, V; Buchanan, GR				Kuhne, T; Imbach, P; Bolton-Maggs, PHB; Berchtold, W; Blanchette, V; Buchanan, GR		Intercontinental Childhood ITP Stu	Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study	LANCET			English	Article							INTRAVENOUS IMMUNOGLOBULIN; PREDNISONE THERAPY; CHILDREN; MANAGEMENT; GUIDELINES; HEMORRHAGE; LEUKEMIA; TRIAL	Background Diagnosis and management of idiopathic thrombocytopenic purpura (ITP) have been based primarily on expert opinion and practice guidelines rather than on evidence. We have used a registry to prospectively survey the presenting features and the diagnostic evaluation and management practices used for children with ITP worldwide. Methods We used the Intercontinental Childhood ITP Registry which had been widely advertised. 209 physicians from 136 institutions in 38 countries participated by submitting data for each of their newly diagnosed patients. Data from 2031 children with TP was registered between June, 1997, and May, 2000, and we analysed 6-month follow-up data from 1496 children. Findings There was a peak in occurrence of childhood ITP during spring and a nadir in the autumn. Mean initial platelet count was 15.4x10(9)/L (SD 19.7). 1447 (73%) of 1976 children were admitted to hospital. Initial management consisted of no drug treatment in 612 (31%), intravenous immunoglobulin in 576 (29%), corticosteroids in 651 (33%), or both in 137 (7%) patients. Intracranial haemorrhage was reported in two patients. Interpretation The variable approaches to management of childhood ITP demonstrate the need for prospective clinical trials, which should be feasible within such a study group.	Univ Childrens Hosp, Div Oncol, CH-4005 Basel, Switzerland; Univ Childrens Hosp, Div Haematol, CH-4005 Basel, Switzerland; Royal Liverpool Childrens Hosp, Liverpool L7 7DG, Merseyside, England; Univ Appl Sci Aargau, Brugg, Switzerland; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Texas, SW Med Ctr, Dallas, TX USA	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kuhne, T (corresponding author), Univ Childrens Hosp, Div Oncol, Romergasse 8, CH-4005 Basel, Switzerland.		Kuehne, Thomas/I-6143-2019	Kuehne, Thomas/0000-0002-7387-7028				ARONIS S, 1994, PEDIATR HEMAT ONCOL, V11, P487, DOI 10.3109/08880019409141687; BLANCHETTE VS, 1993, J PEDIATR-US, V123, P989, DOI 10.1016/S0022-3476(05)80400-7; BLANCHETTE VS, 1985, J PEDIATR, V108, P326; BoltonMaggs PHB, 1997, LANCET, V350, P620, DOI 10.1016/S0140-6736(97)04143-3; Buchanan GR, 1997, BLOOD, V89, P1464, DOI 10.1182/blood.V89.4.1464; BUCHANAN GR, 1984, AM J PEDIAT HEMATOL, V6, P355; Calpin C, 1998, ARCH PEDIAT ADOL MED, V152, P345; Dickerhoff R, 2000, J PEDIATR-US, V137, P629, DOI 10.1067/mpd.2000.110123; DUBANSKY AS, 1989, PEDIATRICS, V84, P1068; EDEN OB, 1992, ARCH DIS CHILD, V67, P1056, DOI 10.1136/adc.67.8.1056; Gaines AR, 2000, BLOOD, V95, P2523, DOI 10.1182/blood.V95.8.2523.008k13_2523_2529; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; HALPERIN DS, 1988, AM J DIS CHILD, V142, P508, DOI 10.1001/archpedi.1988.02150050046027; IMBACH P, 1985, LANCET, V2, P464; Jayabose S, 1999, J PEDIAT HEMATOL ONC, V21, P514, DOI 10.1097/00043426-199911000-00012; Kuhne T, 2000, PEDIATR RES, V48, P374; Lilleyman JS, 1999, BRIT J HAEMATOL, V105, P871, DOI 10.1046/j.1365-2141.1999.14094195.x; LILLEYMAN JS, 1994, ARCH DIS CHILD, V71, P251, DOI 10.1136/adc.71.3.251; LUSHER JM, 1966, J PEDIATR-US, V68, P971, DOI 10.1016/S0022-3476(66)80218-4; Medeiros D, 1998, J PEDIATR-US, V133, P334, DOI 10.1016/S0022-3476(98)70265-3; REID MM, 1992, ACTA PAEDIATR, V81, P1052, DOI 10.1111/j.1651-2227.1992.tb12175.x; ROBB LG, 1990, ARCH DIS CHILD, V65, P502, DOI 10.1136/adc.65.5.502; SARTORIUS JA, 1984, AM J PEDIAT HEMATOL, V6, P165; Vesely S, 2000, J PEDIAT HEMATOL ONC, V22, P55, DOI 10.1097/00043426-200001000-00011	24	172	176	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2122	2125		10.1016/S0140-6736(01)07219-1	http://dx.doi.org/10.1016/S0140-6736(01)07219-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784627				2022-12-28	WOS:000172905800011
J	Alekseev, V; Lampert, W				Alekseev, V; Lampert, W			Maternal control of resting-egg production in Daphnia	NATURE			English	Article							SEXUAL REPRODUCTION; DIAPAUSING EGGS	Many planktonic organisms produce 'resting' stages when the environmental conditions deteriorate. Like seeds, resting stages can survive unfavourable conditions. The crustacean Daphnia normally reproduces by means of parthenogenetically produced normal, not resting, eggs-but occasionally switches to bisexual reproduction, which results in two resting eggs encased in a robust structure carried on the back of the female. This 'ephippium' is shed with the next moult, and can survive dormant for many years. The induction of resting-egg production requires multiple environmental stimuli, one of them being photoperiod(1,2). The switch from production of parthenogenetic eggs to resting eggs in Daphnia has recently been shown to be influenced by a maternal food effect(3). Here we present evidence that female Daphnia transmit information not only about food but also on photoperiod to their offspring, and influence the production of resting eggs in the next generation. The combined maternal effects can be relevant for the correct timing of resting-egg production-for example, in discriminating between spring and autumn conditions.	Max Planck Inst Limnol, Dept Physiol Ecol, D-24302 Plon, Germany	Max Planck Society	Alekseev, V (corresponding author), Max Planck Inst Limnol, Dept Physiol Ecol, Postfach 165, D-24302 Plon, Germany.		Alekseev, Victor/X-7437-2019; alekseev, victor r/C-7086-2014	Alekseev, Victor/0000-0002-1968-2609; alekseev, victor r/0000-0002-1968-2609				Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.1890/0012-9658(1998)079[1699:IVITAP]2.0.CO;2; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Hill J.C., 1965, SCIENCE, V150, P1463; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; LaMontagne JM, 2001, ECOL LETT, V4, P64, DOI 10.1046/j.1461-0248.2001.00197.x; LAMPERT W, 1988, B MAR SCI, V43, P620; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SPAAK P, 1995, OECOLOGIA, V104, P501, DOI 10.1007/BF00341348; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Webb MLZ, 1998, PHYSIOL ENTOMOL, V23, P184, DOI 10.1046/j.1365-3032.1998.232073.x	17	158	169	2	68	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					899	901		10.1038/414899a	http://dx.doi.org/10.1038/414899a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780060				2022-12-28	WOS:000172813300043
J	Morris, RH				Morris, RH			Thriving with chronic myeloid leukaemia	LANCET			English	Article											Morris, RH (corresponding author), 492 Fulton Court, W New York, NJ 07093 USA.	RMorris@aol.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S12	S12		10.1016/S0140-6736(01)07025-8	http://dx.doi.org/10.1016/S0140-6736(01)07025-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784561				2022-12-28	WOS:000172907200012
J	Mylonakis, E; Calderwood, SB				Mylonakis, E; Calderwood, SB			Medical progress: Infective endocarditis in adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROSTHETIC VALVE ENDOCARDITIS; STAPHYLOCOCCUS-AUREUS ENDOCARDITIS; AMERICAN-HEART-ASSOCIATION; PRACTICE GUIDELINES COMMITTEE; INTRAVENOUS-DRUG-USERS; DUKE CRITERIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; NATIVE VALVE; BACTERIAL-ENDOCARDITIS; CLINICAL-FEATURES		Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Calderwood, SB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.							AGNIHOTRI AK, 1995, J THORAC CARDIOV SUR, V110, P1708, DOI 10.1016/S0022-5223(95)70035-8; Alexiou C, 2000, J HEART VALVE DIS, V9, P327; Alexiou C, 2000, ANN THORAC SURG, V69, P1448, DOI 10.1016/S0003-4975(00)01139-5; Arvay A, 1988, Eur J Cardiothorac Surg, V2, P340; Baumgartner FJ, 2000, ANN THORAC SURG, V70, P442, DOI 10.1016/S0003-4975(00)01363-1; Bayer AS, 1998, CIRCULATION, V98, P2936, DOI 10.1161/01.CIR.98.25.2936; BAYER AS, 1994, AM J MED, V96, P211, DOI 10.1016/0002-9343(94)90144-9; BERLIN JA, 1995, AM J CARDIOL, V76, P933, DOI 10.1016/S0002-9149(99)80264-1; BLUMBERG EA, 1992, CLIN INFECT DIS, V15, P983, DOI 10.1093/clind/15.6.983; BLUMBERG EA, 1995, CHEST, V107, P898, DOI 10.1378/chest.107.4.898; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; CALDERWOOD SB, 1986, J THORAC CARDIOV SUR, V92, P776; CALDERWOOD SB, 1985, CIRCULATION, V72, P31, DOI 10.1161/01.CIR.72.1.31; CHAMBERS HF, 1988, ANN INTERN MED, V109, P619, DOI 10.7326/0003-4819-109-8-619; Cheitlin MD, 1997, J AM COLL CARDIOL, V29, P862, DOI 10.1016/S0735-1097(96)90000-5; CHOUDHURY R, 1992, AM J CARDIOL, V70, P1453, DOI 10.1016/0002-9149(92)90299-E; Choussat R, 1999, EUR HEART J, V20, P232, DOI 10.1053/euhj.1998.1240; CROFT CH, 1983, AM J CARDIOL, V51, P1650, DOI 10.1016/0002-9149(83)90203-5; Dajani AS, 1997, CIRCULATION, V96, P358; DANIEL WG, 1993, AM J CARDIOL, V71, P210, DOI 10.1016/0002-9149(93)90740-4; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; De Castro S, 2000, CLIN INFECT DIS, V30, P825, DOI 10.1086/313762; DINUBILE MJ, 1986, AM J CARDIOL, V58, P1213, DOI 10.1016/0002-9149(86)90384-X; Dodds GA, 1996, AM J CARDIOL, V77, P403, DOI 10.1016/S0002-9149(97)89372-1; DRANCOURT M, 1995, NEW ENGL J MED, V332, P419, DOI 10.1056/NEJM199502163320702; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; EISHI K, 1995, J THORAC CARDIOV SUR, V110, P1745, DOI 10.1016/S0022-5223(95)70038-2; Ellis ME, 2001, CLIN INFECT DIS, V32, P50, DOI 10.1086/317550; ERBEL R, 1988, EUR HEART J, V9, P43; FANG GD, 1993, ANN INTERN MED, V119, P560, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00003; FERNANDEZGUERRERO ML, 1995, CLIN INFECT DIS, V20, P16, DOI 10.1093/clinids/20.1.16; Fowler VG, 1999, CLIN INFECT DIS, V28, P106; Fowler VG, 1997, J AM COLL CARDIOL, V30, P1072, DOI 10.1016/S0735-1097(97)00250-7; Francioli P, 1995, CLIN INFECT DIS, V21, P1406, DOI 10.1093/clinids/21.6.1406; Frontera JA, 2000, CLIN INFECT DIS, V30, P374, DOI 10.1086/313664; Gagliardi JP, 1998, CLIN INFECT DIS, V26, P1165, DOI 10.1086/520304; Gillinov AM, 1996, ANN THORAC SURG, V61, P1125, DOI 10.1016/0003-4975(96)00014-8; Goldenberger D, 1997, J CLIN MICROBIOL, V35, P2733, DOI 10.1128/JCM.35.11.2733-2739.1997; Gouello JP, 2000, CRIT CARE MED, V28, P377, DOI 10.1097/00003246-200002000-00015; GRIFFIN FM, 1972, ANN INTERN MED, V76, P23, DOI 10.7326/0003-4819-76-1-23; GROVER FL, 1994, J THORAC CARDIOV SUR, V108, P207; Gubler JGH, 1999, ANN INTERN MED, V131, P112, DOI 10.7326/0003-4819-131-2-199907200-00007; Habib G, 1999, J AM COLL CARDIOL, V33, P2023, DOI 10.1016/S0735-1097(99)00116-3; HECHT SR, 1992, ANN INTERN MED, V117, P560, DOI 10.7326/0003-4819-117-7-560; Heidenreich PA, 1999, AM J MED, V107, P198, DOI 10.1016/S0002-9343(99)00216-8; Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; HOEN B, 1995, CLIN INFECT DIS, V20, P501, DOI 10.1093/clinids/20.3.501; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; HUSTON J, 1994, AM J NEURORADIOL, V15, P1607; IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223; Jalal S, 1998, Indian Heart J, V50, P516; Jault F, 1997, ANN THORAC SURG, V63, P1737, DOI 10.1016/S0003-4975(97)00117-3; John MDV, 1998, CLIN INFECT DIS, V26, P1302, DOI 10.1086/516378; Kupferwasser LI, 1999, CIRCULATION, V99, P2791, DOI 10.1161/01.CIR.99.21.2791; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lindner JR, 1996, CIRCULATION, V93, P730, DOI 10.1161/01.CIR.93.4.730; LOWRY RW, 1994, AM J CARDIOL, V73, P1089, DOI 10.1016/0002-9149(94)90288-7; Manoff SB, 1996, EPIDEMIOLOGY, V7, P566, DOI 10.1097/00001648-199611000-00001; MATSUSHITA K, 1993, EUR NEUROL, V33, P267, DOI 10.1159/000116952; MILLS J, 1974, CHEST, V66, P151, DOI 10.1378/chest.66.2.151; Nasser RM, 1997, AM J MED, V103, P25, DOI 10.1016/S0002-9343(97)90050-4; *NCCLS, 2001, M100S11 NCCLS; Nettles RE, 1997, CLIN INFECT DIS, V25, P1401, DOI 10.1086/516145; Parrino PE, 1999, ANN THORAC SURG, V67, P59, DOI 10.1016/S0003-4975(98)01230-2; PASCHALIS C, 1990, EUR NEUROL, V30, P87, DOI 10.1159/000117317; Patel R, 2000, J CLIN MICROBIOL, V38, P4262, DOI 10.1128/JCM.38.11.4262-4263.2000; PATTERSON JE, 1995, MEDICINE, V74, P191, DOI 10.1097/00005792-199507000-00003; Perez-Vazquez A, 2000, ARCH INTERN MED, V160, P1185, DOI 10.1001/archinte.160.8.1185; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; Raoult D, 1999, ARCH INTERN MED, V159, P167, DOI 10.1001/archinte.159.2.167; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; RAOULT D, 1997, ANN INTERN MED, V127, P249; Reinhartz O, 1996, J CARDIOVASC SURG, V37, P397; Renzulli A, 2000, EUR J CARDIO-THORAC, V17, P228, DOI 10.1016/S1010-7940(00)00342-0; Rex JH, 2000, CLIN INFECT DIS, V30, P662, DOI 10.1086/313749; Ribera E, 1998, ARCH INTERN MED, V158, P2043, DOI 10.1001/archinte.158.18.2043; RICHARDSON JV, 1978, CIRCULATION, V58, P589, DOI 10.1161/01.CIR.58.4.589; ROBBINS MJ, 1986, AM J MED, V80, P165, DOI 10.1016/0002-9343(86)90004-5; Roder BL, 1997, AM J MED, V102, P379, DOI 10.1016/S0002-9343(97)00090-9; Roder BL, 1999, ARCH INTERN MED, V159, P462, DOI 10.1001/archinte.159.5.462; Rosen AB, 1999, ANN INTERN MED, V130, P810, DOI 10.7326/0003-4819-130-10-199905180-00004; Sekeres MA, 1997, CLIN INFECT DIS, V24, P1185, DOI 10.1086/513657; Sexton DJ, 1998, CLIN INFECT DIS, V27, P1470, DOI 10.1086/515038; SHIVELY BK, 1991, J AM COLL CARDIOL, V18, P391, DOI 10.1016/0735-1097(91)90591-V; Simmons NA, 1998, HEART, V79, P207; SPACH DH, 1995, CLIN INFECT DIS, V20, P1044, DOI 10.1093/clinids/20.4.1044; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; Strom BL, 2000, CIRCULATION, V102, P2842; TING W, 1991, ANN THORAC SURG, V51, P18, DOI 10.1016/0003-4975(91)90439-W; TING W, 1990, CIRCULATION, V82, P105; TORNOS MP, 1992, ANN INTERN MED, V117, P567, DOI 10.7326/0003-4819-117-7-567; Tornos P, 1999, ARCH INTERN MED, V159, P473, DOI 10.1001/archinte.159.5.473; Vlessis AA, 1996, ANN THORAC SURG, V61, P1217, DOI 10.1016/0003-4975(96)00029-X; VUILLE C, 1994, AM HEART J, V128, P1200, DOI 10.1016/0002-8703(94)90752-8; WATANAKUNAKORN C, 1993, MEDICINE, V72, P90, DOI 10.1097/00005792-199303000-00003; Werner GS, 1996, AM J MED, V100, P90, DOI 10.1016/S0002-9343(96)90017-0; WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706; ZUPPIROLI A, 1995, AM J CARDIOL, V75, P1028, DOI 10.1016/S0002-9149(99)80718-8	99	811	860	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1318	1330		10.1056/NEJMra010082	http://dx.doi.org/10.1056/NEJMra010082			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794152				2022-12-28	WOS:000171896300007
J	Zepik, H; Shavit, E; Tang, M; Jensen, TR; Kjaer, K; Bolbach, G; Leiserowitz, L; Weissbuch, I; Lahav, M				Zepik, H; Shavit, E; Tang, M; Jensen, TR; Kjaer, K; Bolbach, G; Leiserowitz, L; Weissbuch, I; Lahav, M			Chiral amplification of oligopeptides in two-dimensional crystalline self-assemblies on water	SCIENCE			English	Article							OLIGOMERIZATION; ARCHITECTURES; POLYPEPTIDES; INTERFACE; DESIGN	Differences in the two-dimensional packing arrangements of racemic and enantiomeric crystalline self-assemblies on the water surface of amphiphilic activated analogs of lysine and glutamic acid have been used to prepare oligopeptides of homochiral sequence and oligopeptides of single handedness from chiral nonracemic mixtures. The crystalline structures on the water surface were determined by grazing incidence x-ray diffraction and the diastereomeric composition of the oligopeptides by matrix-assisted laser desorption time-of-flight mass spectrometry with enantio-labeling. These results suggest that reactivity of ordered clusters at interfaces might have played a role in the generation of early homochiral biopolymers.	Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; Riso Natl Lab, Mat Res Dept, DK-4000 Roskilde, Denmark; Univ Paris 06, Lab Chim Struct Organ & Biol, F-75252 Paris 05, France	Weizmann Institute of Science; Technical University of Denmark; UDICE-French Research Universities; Sorbonne Universite	Lahav, M (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	leslie.leiserowitz@weizmann.ac.il; isabelle.weissbuch@welzmann.ac.il; meir.lahav@weizmann.ac.il		Jensen, Torben Rene/0000-0002-4278-3221				ADDADI L, 1977, ISRAEL J CHEM, V15, P116; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BANIEL A, 1948, J ORG CHEM, V13, P791, DOI 10.1021/jo01164a001; Blocher M, 2001, HELV CHIM ACTA, V84, P842, DOI 10.1002/1522-2675(20010418)84:4<842::AID-HLCA842>3.0.CO;2-1; BLOUT ER, 1957, J AM CHEM SOC, V79, P749, DOI 10.1021/ja01560a068; Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; Bonner WA, 1999, ORIGINS LIFE EVOL B, V29, P329, DOI 10.1023/A:1006511115735; BRACK A, 1981, ORIGINS LIFE EVOL B, V11, P135, DOI 10.1007/BF00928004; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1; Deamer DW, 1997, MICROBIOL MOL BIOL R, V61, P239, DOI 10.1128/.61.2.239-261.1997; FRANCK P, 2000, CHEM 21 CENTURY, P175, DOI DOI 10.1002/9783527612949.CH11; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; Fukuda K, 2000, ADV COLLOID INTERFAC, V87, P113, DOI 10.1016/S0001-8686(99)00041-X; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; Kuzmenko I, 2001, CHEM REV, V101, P1659, DOI 10.1021/cr990038y; LAHAV M, 1976, J AM CHEM SOC, V98, P1620, DOI 10.1021/ja00422a078; MASON S, 1984, NATURE, V310, P546, DOI 10.1038/310546b0; Saghatelian A, 2001, NATURE, V409, P797, DOI 10.1038/35057238; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; SHEEHAN JC, 1952, J AM CHEM SOC, V74, P4726, DOI 10.1021/ja01138a528; SHIBATA A, 1991, LANGMUIR, V7, P2261, DOI 10.1021/la00058a047; Siegel JS, 1998, CHIRALITY, V10, P24, DOI 10.1002/chir.5; Weissbuch I, 1997, J AM CHEM SOC, V119, P933, DOI 10.1021/ja9613926; Weissbuch I, 2000, CHEM-EUR J, V6, P725, DOI 10.1002/(SICI)1521-3765(20000218)6:4<725::AID-CHEM725>3.3.CO;2-5; WEISSBUCH I, 1994, PER SUPRAMOL CHEM, V1, P173; Zhang LS, 1999, J AM CHEM SOC, V121, P3311, DOI 10.1021/ja983859d	28	161	163	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1266	1269		10.1126/science.1065625	http://dx.doi.org/10.1126/science.1065625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11786606				2022-12-28	WOS:000173926000035
J	Schoch, S; Castillo, PE; Jo, T; Mukherjee, K; Geppert, M; Wang, Y; Schmitz, F; Malenka, RC; Sudhof, TC				Schoch, S; Castillo, PE; Jo, T; Mukherjee, K; Geppert, M; Wang, Y; Schmitz, F; Malenka, RC; Sudhof, TC			RIM1 alpha forms a protein scaffold for regulating neurotransmitter release at the active zone	NATURE			English	Article							SYNAPTIC-VESICLE FUSION; C-ELEGANS; RAB3; UNC-13; FAMILY; PROBABILITY; EXOCYTOSIS; EFFECTOR	Neurotransmitters are released by synaptic vesicle fusion at the active zone(1,2). The active zone of a synapse mediates Ca2+-triggered neurotransmitter release, and integrates presynaptic signals in regulating this release. Much is known about the structure of active zones and synaptic vesicles, but the functional relation between their components is poorly understood(3). Here we show that RIM1alpha, an active zone protein that was identified as a putative effector for the synaptic vesicle protein Rab3A(4,5), interacts with several active zone molecules, including Munc13-1 (ref. 6) and alpha-liprins(7,8), to form a protein scaffold in the presynaptic nerve terminal. Abolishing the expression of RIM1alpha in mice shows that RIM1alpha is essential for maintaining normal probability of neurotransmitter release, and for regulating release during short-term synaptic plasticity. These data indicate that RIM1alpha has a central function in integrating active zone proteins and synaptic vesicles into a molecular scaffold that controls neurotransmitter release.	Univ Texas, SW Med Ctr, Ctr Basci Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basci Neurosci, Dallas, TX 75390 USA.		Schoch, Susanne/F-7741-2012	Castillo, Pablo/0000-0002-9834-1801				Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; COWAN WM, 2001, SYNAPSES; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Katz B., 1969, RELEASE NEURAL TRANS; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Sun L, 2001, J BIOL CHEM, V276, P12911, DOI 10.1074/jbc.M011110200; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	28	455	477	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					321	326		10.1038/415321a	http://dx.doi.org/10.1038/415321a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797009				2022-12-28	WOS:000173293500044
J	Percec, I; Bartolomei, MS				Percec, I; Bartolomei, MS			Genetics - Do X chromosomes set boundaries?	SCIENCE			English	Editorial Material							ENHANCER-BLOCKING ACTIVITY; INACTIVATION CENTER; METHYLATION; REGION; MOUSE; CTCF		Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Percec, I (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; Zhan HC, 2001, HUM GENET, V109, P471, DOI 10.1007/s004390100601	11	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					287	288		10.1126/science.1068663	http://dx.doi.org/10.1126/science.1068663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786631				2022-12-28	WOS:000173278600035
J	Tanaka, H; Homma, K; Iwane, AH; Katayama, E; Ikebe, R; Saito, J; Yanagida, T; Ikebe, M				Tanaka, H; Homma, K; Iwane, AH; Katayama, E; Ikebe, R; Saito, J; Yanagida, T; Ikebe, M			The motor domain determines the large step of myosin-V	NATURE			English	Article							LIGHT-CHAIN; ACTIN FILAMENT; MOVEMENT; FORCE; MECHANICS; MOLECULE; BINDING; LEVER; HEAD	Class-V myosin proceeds along actin filaments with large (similar to 36 nm) steps(1-3). Myosin-V has two heads, each of which consists of a motor domain and a long (23 nm) neck domain. In accordance with the widely accepted lever-arm model(4), it was suggested that myosin-V steps to successive (36 nm) target zones along the actin helical repeat by tilting its long neck (lever-arm)(5). To test this hypothesis, we measured the mechanical properties of single molecules of myosin-V truncation mutants with neck domains only one-sixth of the native length. Our results show that the processivity and step distance along actin are both similar to those of full-length myosin-V. Thus, the long neck domain is not essential for either the large steps or processivity of myosin-V. These results challenge the lever-arm model. We propose that the motor domain and/or the actomyosin interface enable myosin-V to produce large processive steps during translocation along actin.	JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan; Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignaling, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Div Biomol Imaging, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Japan Science & Technology Agency (JST); University of Massachusetts System; University of Massachusetts Worcester; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Yanagida, T (corresponding author), JST, ICORP, Single Mol Proc Project, 2-4-14 Senba Higashi, Osaka 5620035, Japan.		Yanagida, Toshio/D-1919-2009					Cooke R, 1999, CURR BIOL, V9, pR773, DOI 10.1016/S0960-9822(00)80010-X; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Ikebe M, 1998, J BIOL CHEM, V273, P17702, DOI 10.1074/jbc.273.28.17702; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; KATAYAMA E, 1989, J BIOCHEM-TOKYO, V106, P751, DOI 10.1093/oxfordjournals.jbchem.a122928; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; STRYER L, 1995, BIOCHEMISTRY-US, P443; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; WAKABAYASHI K, 1992, SCIENCE, V258, P443, DOI 10.1126/science.1411537; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200	28	116	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					192	195		10.1038/415192a	http://dx.doi.org/10.1038/415192a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805840				2022-12-28	WOS:000173159300047
J	Larsen, PL; Clarke, CF				Larsen, PL; Clarke, CF			Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q	SCIENCE			English	Article							C-ELEGANS; INTERMEDIARY METABOLISM; DAUER LARVA; LONGEVITY; DIAPAUSE; MUTANT; DAF-2; GENES; CYCLE	The isoprenylated benzoquinone coenzyme Q is a redox-active lipid essential for electron transport in aerobic respiration. Here, we show that withdrawal of coenzyme Q (Q) from the diet of wild-type nematodes extends adult life-span by similar to 60%. The longevity of clk-1, daf-2, daf-12, and daf-16 mutants is also extended by a Q-less diet. These results establish the importance of Q in life-span determination. The findings suggest that Q and the daf-2 pathway intersect at the mitochondria and imply that a concerted production coupled with enhanced scavenging of reactive oxygen species contributes to the substantial life-span extension.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Larsen, PL (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 951569, Los Angeles, CA 90095 USA.							Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAGAN IVE, 2000, COENZYME Q MOL MECH; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Larsen PL, 2001, NAT GENET, V28, P102, DOI 10.1038/88797; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; ORIORDAN VB, 1989, COMP BIOCHEM PHYS B, V92, P233, DOI 10.1016/0305-0491(89)90271-X; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; Yu H, 2001, J MOL BIOL, V314, P1017, DOI 10.1006/jmbi.2000.5210	24	199	214	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					120	123		10.1126/science.1064653	http://dx.doi.org/10.1126/science.1064653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778046				2022-12-28	WOS:000173143100047
J	Rowan, L; Coontz, R				Rowan, L; Coontz, R			Great balls of fire	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					63	63						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778034				2022-12-28	WOS:000173143100032
J	Pavlidis, I; Eberhardt, NL; Levine, JA				Pavlidis, I; Eberhardt, NL; Levine, JA			Human behaviour: Seeing through the face of deception	NATURE			English	Article									Honeywell Labs, Minneapolis, MN 55418 USA; Mayo Clin, Endocrine Res Unit, Dept Med, Rochester, MN 55905 USA	Honeywell; Mayo Clinic	Pavlidis, I (corresponding author), Honeywell Labs, 3660 Technol Dr, Minneapolis, MN 55418 USA.	levine.james@mayo.edu	Pavlidis, Ioannis/AAH-3817-2019	Pavlidis, Ioannis/0000-0001-8025-2600				BARRETT AH, 1975, SCIENCE, V190, P669, DOI 10.1126/science.1188361; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Gratt Barton M., 1995, Journal of Orofacial Pain, V9, P255; Holden C, 2001, SCIENCE, V291, P967, DOI 10.1126/science.291.5506.967; KIRCHER JC, 1988, LAW HUMAN BEHAV, V12, P79, DOI 10.1007/BF01064275; Levine JA, 2001, LANCET, V357, P1757, DOI 10.1016/S0140-6736(00)04936-9; OTAKE K, 1995, BRAIN RES, V697, P17, DOI 10.1016/0006-8993(95)00749-G	7	134	144	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					35	35		10.1038/415035a	http://dx.doi.org/10.1038/415035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780104				2022-12-28	WOS:000173028800027
J	McManus, I				McManus, I			Charles Dickens: a neglected diagnosis	LANCET			English	Editorial Material							SPATIAL NEGLECT; PAIN; AWARENESS; STIMULATION; INSIGHT; STROKE		UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London	McManus, I (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	i.mcmanus@ucl.ac.uk		McManus, Ian/0000-0003-3510-4814				BOIVIE J, 1991, SYMP PAIN R, P65; Bowen W.H., 1956, C DICKENS HIS FAMILY; Buttner U, 1979, Prog Brain Res, V50, P581; Cantagallo A, 1998, CORTEX, V34, P163, DOI 10.1016/S0010-9452(08)70746-9; CARPENTER K, 1995, BRAIN, V118, P243, DOI 10.1093/brain/118.1.243; Critchley M., 1953, PARIETAL LOBES; Dickens Mami, 1897, MY FATHER I RECALL H; DOGGART J, 1970, PRACTITIONER, V204, P449; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Ellis A. W., 1993, UNILATERAL NEGLECT C, P233; FIELDS HL, 1974, BRAIN, V97, P169, DOI 10.1093/brain/97.1.169; Forster John, 1928, LIFE C DICKENS; Forster John, 1872, LIFE C DICKENS; Garcia Ruiz P J, 1999, Neurologia, V14, P359; Ghika-Schmid F, 1999, NEUROLOGY, V52, P22, DOI 10.1212/WNL.52.1.22; HALLIGAN PW, 1993, UNILATERAL NEGLECT C, P3; Hecaen H., 1962, INTERHEMISPHERIC REL; JACKSON JH, 1876, ROYAL LONDON OPHTHAL, V8, P434; JACOBY NM, 1992, LANCET, V340, P1521, DOI 10.1016/0140-6736(92)92769-C; Johnson Edgar, 1953, CHARLES DICKENS HIS; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Markel H, 1999, LANCET, V354, P673, DOI 10.1016/S0140-6736(98)10108-3; MARKEL H, 1984, ANN INTERN MED, V101, P408, DOI 10.7326/0003-4819-101-3-408; MARSHALL J, 1951, J NEUROL NEUROSUR PS, V14, P187, DOI 10.1136/jnnp.14.3.187; Marshall J.C, 1998, NAT NEUROSCI, V1, P651, DOI https://doi.org/10.1038/3651; MARSHALL JC, 1988, NATURE, V336, P766, DOI 10.1038/336766a0; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MICHEL D, 1990, REV NEUROL-FRANCE, V146, P405; Nasreddine ZS, 1997, NEUROLOGY, V48, P1196, DOI 10.1212/WNL.48.5.1196; Parkin A.J, 1996, EXPLORATIONS COGNITI; Pauli P, 1999, PAIN, V80, P359, DOI 10.1016/S0304-3959(98)00231-0; Porter Roy, 1998, GOUT PATRICIAN MALAD; Rode G, 1998, CORTEX, V34, P253; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; Storey G, 1999, LETT C DICKENS, V11; TRIGGS WJ, 1994, NEUROLOGY, V44, P1164, DOI 10.1212/WNL.44.6.1164; Williamson PD, 1997, EPILEPSY COMPREHENSI, P2405; WILSON A, 1974, INTRO C DICKENS MYST, P11; WRIGHT T, 1935, LIFE C DICKENS; Yates Edmund, 1885, 50 YEARS LONDON LIFE; [No title captured]	41	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2158	2161		10.1016/S0140-6736(01)07227-0	http://dx.doi.org/10.1016/S0140-6736(01)07227-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	505GV	11784649				2022-12-28	WOS:000172905800032
J	Scheimberg, I; Bates, AW; Lee, A				Scheimberg, I; Bates, AW; Lee, A			Getting consent for necropsies - Most relatives give consent once reasons for necropsy are explained	BRITISH MEDICAL JOURNAL			English	Letter									Royal London Hosp, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Scheimberg, I (corresponding author), Royal London Hosp, London E1 1BB, England.							SAVERS GM, 2001, BRIT MED J, V323, P521	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2001	323	7326					1426	1426						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505EX	11778593				2022-12-28	WOS:000172900400034
J	Goodman, S				Goodman, S			Geneticist takes top job at museum	NATURE			English	News Item																		2001, NATURE, V409, P273	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					351	351		10.1038/415351b	http://dx.doi.org/10.1038/415351b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807505	Bronze			2022-12-28	WOS:000173433600004
J	Lang, KM; Madhavan, V; Hoffman, JE; Hudson, EW; Eisaki, H; Uchida, S; Davis, JC				Lang, KM; Madhavan, V; Hoffman, JE; Hudson, EW; Eisaki, H; Uchida, S; Davis, JC			Imaging the granular structure of high-T-c superconductivity in underdoped Bi2Sr2CaCu2O8+delta	NATURE			English	Article							PHASE-SEPARATION; STATES; EXCITATIONS; PSEUDOGAP; DENSITY; OXIDES; MODEL	Granular superconductivity occurs when microscopic superconducting grains are separated by non-superconducting regions; Josephson tunnelling between the grains establishes the macroscopic superconducting state(1). Although crystals of the copper oxide high-transition-temperature (high-T-c) superconductors are not granular in a structural sense, theory suggests that at low levels of hole doping the holes can become concentrated at certain locations resulting in hole-rich superconducting domains(2-5). Granular superconductivity arising from tunnelling between such domains would represent a new view of the under-doped copper oxide superconductors. Here we report scanning tunnelling microscope studies of underdoped Bi2Sr2CaCu2O8+delta that reveal an apparent segregation of the electronic structure into superconducting domains that are similar to3nm in size (and local energy gap <50 meV), located in an electronically distinct background. We used scattering resonances at Ni impurity atoms(6) as 'markers' for local superconductivity(7-9); no Ni resonances were detected in any region where the local energy gap &UDelta;>50+/-2.5 meV. These observations suggest that underdoped Bi2Sr2CaCu2O8+delta is a mixture of two different short-range electronic orders with the long-range characteristics of a granular superconductor.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Tokyo, Dept Supercond, Bunkyo Ku, Tokyo 1138656, Japan; Stanford Univ, Dept Appl Phys, Stanford, CA 94205 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tokyo; Stanford University	Davis, JC (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Hudson, Eric/C-2746-2008; Eisaki, Hiroshi/F-6317-2018; Hudson, Eric/C-4170-2017; Hoffman, Jennifer E/H-4334-2011	Hudson, Eric/0000-0001-7064-0351; Eisaki, Hiroshi/0000-0002-8299-6416; Hudson, Eric/0000-0001-7064-0351; Hoffman, Jennifer E/0000-0003-2752-5379				Barabash S, 2000, PHYS REV B, V61, P14924, DOI 10.1103/PhysRevB.61.R14924; Burgy J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.277202; Channon P. H., 1992, Journal of Systems Engineering, V2, P46; Corson J, 2000, PHYS REV LETT, V85, P2569, DOI 10.1103/PhysRevLett.85.2569; Cren T, 2001, EUROPHYS LETT, V54, P84, DOI 10.1209/epl/i2001-00232-4; Cren T, 2000, PHYS REV LETT, V84, P147, DOI 10.1103/PhysRevLett.84.147; DEUTSCHER G, 1987, PHYS REV LETT, V59, P1745, DOI 10.1103/PhysRevLett.59.1745; EMERY VJ, 1990, PHYS REV LETT, V64, P475, DOI 10.1103/PhysRevLett.64.475; Flatte ME, 2001, NATURE, V411, P901, DOI 10.1038/35082179; Flatte ME, 2000, PHYS REV B, V61, P14920, DOI 10.1103/PhysRevB.61.R14920; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; Ghosal A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014501; GORKOV LP, 1987, JETP LETT+, V46, P420; HOWALD C, 2001, PHYS REV B; Hudson EW, 2001, NATURE, V411, P920, DOI 10.1038/35082019; Krasnov VM, 2001, PHYS REV LETT, V86, P2657, DOI 10.1103/PhysRevLett.86.2657; Kruis HV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054501; LIU JX, 1991, PHYS REV LETT, V67, P2195, DOI 10.1103/PhysRevLett.67.2195; Loram JW, 2000, PHYSICA C, V341, P831, DOI 10.1016/S0921-4534(00)00706-1; Martin I, 2001, PHYSICA C, V357, P46, DOI 10.1016/S0921-4534(01)00192-7; Ovchinnikov YN, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.064524; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Phillips JC, 2001, PHILOS MAG B, V81, P745, DOI 10.1080/13642810110055346; Simanek E., 1994, INHOMOGENEOUS SUPERC; Suzuki M, 2000, PHYS REV LETT, V85, P4787, DOI 10.1103/PhysRevLett.85.4787; TAKIGAWA M, 1994, PHYS REV LETT, V73, P1287, DOI 10.1103/PhysRevLett.73.1287; Vobornik I, 2000, PHYS REV B, V61, P11248, DOI 10.1103/PhysRevB.61.11248; Wang QH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.054501; WANG Z, 2002, IN PRESS PHYS REV B, V65; WANG Z, 2001, CONDMAT0107004; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	32	661	661	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					412	416		10.1038/415412a	http://dx.doi.org/10.1038/415412a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807550	Green Submitted			2022-12-28	WOS:000173433600045
J	Catlett, JP; Alving, BM				Catlett, JP; Alving, BM			Update in hematology	ANNALS OF INTERNAL MEDICINE			English	Review									Washington Hosp Ctr, Hematol Oncol Sect, Washington, DC 20010 USA; NIH, Bethesda, MD USA	MedStar Washington Hospital Center; National Institutes of Health (NIH) - USA	Catlett, JP (corresponding author), Washington Hosp Ctr, Hematol Oncol Sect, 110 Irving St NW, Washington, DC 20010 USA.							ATKINSON K, 1989, BONE MARROW TRANSPL, V4, P247; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Ginsberg JS, 2001, CHEST, V119, p122S, DOI 10.1378/chest.119.1_suppl.122S; Hylck EM, 2000, ARCH INTERN MED, V160, P1612, DOI 10.1001/archinte.160.11.1612; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Stasi R, 2001, BLOOD, V98, P952, DOI 10.1182/blood.V98.4.952	6	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					136	143		10.7326/0003-4819-136-2-200201150-00011	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790066				2022-12-28	WOS:000173333900006
J	Huntley, GW; Benson, DL; Colman, DR				Huntley, GW; Benson, DL; Colman, DR			Structural remodeling of the synapse in response to physiological activity	CELL			English	Review							LONG-TERM POTENTIATION; HIPPOCAMPAL AREA CA1; EXCITATORY SYNAPSES; ACTIN-FILAMENTS; N-CADHERIN; PLASTICITY; LTP		CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Biochem, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Huntley, GW (corresponding author), CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, 1425 Madison Ave, New York, NY 10029 USA.			Benson, Deanna/0000-0001-7037-1147; Huntley, George W./0000-0003-3645-6192	NINDS NIH HHS [R01 NS037731-03, R01 NS037731-02S1, R01 NS037731-05A1, R01 NS037731-01A1, R01 NS037731-06, R01 NS037731-04, R01 NS037731-07, R01 NS037731, R01 NS037731-02, R01 NS037731-08] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037731] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sorra KE, 1998, J NEUROSCI, V18, P658; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	20	33	34	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					1	4		10.1016/S0092-8674(01)00631-6	http://dx.doi.org/10.1016/S0092-8674(01)00631-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792314	Bronze			2022-12-28	WOS:000173280700001
J	Altabet, MA; Higginson, MJ; Murray, DW				Altabet, MA; Higginson, MJ; Murray, DW			The effect of millennial-scale changes in Arabian Sea denitrification on atmospheric CO2	NATURE			English	Article							INDIAN-OCEAN; ICE CORE; CYCLE; MONSOON; OSCILLATIONS; VARIABILITY; ATLANTIC; METHANE; RATIOS	Most global biogeochemical processes are known to respond to climate change, some of which have the capacity to produce feedbacks through the regulation of atmospheric greenhouse gases(1). Marine denitrification-the reduction of nitrate to gaseous nitrogen-is an important process in this regard, affecting greenhouse gas concentrations directly through the incidental production of nitrous oxide, and indirectly through modification of the marine nitrogen inventory and hence the biological pump for CO2. Although denitrification has been shown to vary with glacial-interglacial cycles(2,3), its response to more rapid climate change has not yet been well characterized. Here we present nitrogen isotope ratio, nitrogen content and chlorin abundance data from sediment cores with high accumulation rates on the Oman continental margin that reveal substantial millennial-scale variability in Arabian Sea denitrification and productivity during the last glacial period. The detailed correspondence of these changes with Dansgaard-Oeschger events recorded in Greenland ice cores(4) indicates rapid, century-scale reorganization of the Arabian Sea ecosystem in response to climate excursions, mediated through the intensity of summer monsoonal upwelling. Considering the several-thousand-year residence time of fixed nitrogen in the ocean, the response of global marine productivity to changes in denitrification would have occurred at lower frequency and appears to be related to climatic and atmospheric CO2 oscillations observed in Antarctic ice cores between 20 and 60 kyr ago(5).	Univ Massachusetts, Sch Marine Sci & Technol, New Bedford, MA 02744 USA; Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA	University of Massachusetts System; Brown University	Altabet, MA (corresponding author), Univ Massachusetts, Sch Marine Sci & Technol, 706 S Rodney French Blvd, New Bedford, MA 02744 USA.							ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Altabet MA, 1999, PALEOCEANOGRAPHY, V14, P732, DOI 10.1029/1999PA900035; ANDERSON DM, 1991, FORAMINIFER EVIDENCE; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; DANSGAARD W, 1982, SCIENCE, V218, P1273, DOI 10.1126/science.218.4579.1273; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HIGGINSON MJ, 2000, THESIS U BRISTOL; Honjo S, 1999, DEEP-SEA RES PT II, V46, P1859, DOI 10.1016/S0967-0645(99)00047-8; Howell EA, 1997, GEOPHYS RES LETT, V24, P2549, DOI 10.1029/97GL01538; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; KROM MD, 1993, DEEP-SEA RES PT I, V40, P805, DOI 10.1016/0967-0637(93)90073-C; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Suthhof A, 2001, GLOBAL BIOGEOCHEM CY, V15, P637, DOI 10.1029/2000GB001337; Upstill-Goddard RC, 1999, J GEOPHYS RES-OCEANS, V104, P30067, DOI 10.1029/1999JC900232; von Rad U, 1999, PALAEOGEOGR PALAEOCL, V152, P129, DOI 10.1016/S0031-0182(99)00042-5; WARREN BA, 1994, BIOGEOCHEMISTRY ARAB, P301	30	332	351	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					159	162		10.1038/415159a	http://dx.doi.org/10.1038/415159a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805831				2022-12-28	WOS:000173159300038
J	Corder, R; Douthwaite, JA; Lees, DM; Khan, NQ; dos Santos, ACV; Wood, EG; Carrier, MJ				Corder, R; Douthwaite, JA; Lees, DM; Khan, NQ; dos Santos, ACV; Wood, EG; Carrier, MJ			Endothelin-1 synthesis reduced by red wine - Red wines confer extra benefit when it comes to preventing coronary heart disease.	NATURE			English	Article							MORTALITY; CONSUMPTION; ALCOHOL		Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Corder, R (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.		Corder, Roger/H-2588-2012	Corder, Roger/0000-0003-1712-6841; Lees, Delphine M/0000-0002-2119-3978				Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; CORDER R, 2001, HANDB EXP PHARM, V152, P35; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Goldberg IJ, 2001, CIRCULATION, V103, P472; Kinlay S, 2001, CIRCULATION, V104, P1114, DOI 10.1161/hc3501.095707; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	11	237	258	4	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					863	864		10.1038/414863a	http://dx.doi.org/10.1038/414863a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780050				2022-12-28	WOS:000172813300033
J	Fedullo, PF; Auger, WR; Kerr, KM; Rubin, LJ				Fedullo, PF; Auger, WR; Kerr, KM; Rubin, LJ			Current concepts: Chronic thromboembolic pulmonary hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERFUSION LUNG SCANS; REPERFUSION EDEMA; FOLLOW-UP; THROMBOENDARTERECTOMY; EMBOLISM; DIFFERENTIATION; ANGIOGRAPHY; PREDICTORS; ANGIOSCOPY; MANAGEMENT		Univ Calif San Diego, Med Ctr, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Rubin, LJ (corresponding author), Univ Calif San Diego, Med Ctr, Dept Med, Div Pulm & Crit Care, 9300 Campus Point Dr,MC 7372, La Jolla, CA 92037 USA.							Ando M, 1999, J CARDIAC SURG, V14, P377, DOI 10.1111/j.1540-8191.1999.tb01014.x; Archibald CJ, 1999, AM J RESP CRIT CARE, V160, P523, DOI 10.1164/ajrccm.160.2.9808109; AUGER WR, 1995, AM J MED, V99, P392, DOI 10.1016/S0002-9343(99)80187-9; AUGER WR, 1992, RADIOLOGY, V182, P393, DOI 10.1148/radiology.182.2.1732955; AUGER WR, 1989, CLIN RES, V37, pA145; Bailey CL, 2000, AM J RESP CRIT CARE, V162, P1974, DOI 10.1164/ajrccm.162.5.2003045; Bergin CJ, 1999, RADIOLOGY, V213, P743, DOI 10.1148/radiology.213.3.r99dc40743; Bernstein RJ, 1996, CHEST, V110, P1430, DOI 10.1378/chest.110.6.1430; CHITWOOD WR, 1985, ANN SURG, V201, P11; D'Armini AM, 2000, EUR J CARDIO-THORAC, V18, P696, DOI 10.1016/S1010-7940(00)00584-4; DALONZO GE, 1984, CHEST, V85, P457, DOI 10.1378/chest.85.4.457; Dartevelle P, 1999, EUR J CARDIO-THORAC, V16, P38, DOI 10.1016/S1010-7940(99)00116-5; Egermayer P, 2000, EUR RESPIR J, V15, P440, DOI 10.1034/j.1399-3003.2000.15.03.x; Fedullo P F, 1999, Semin Thorac Cardiovasc Surg, V11, P172; Fedullo PF, 2000, EUR RESPIR J, V15, P435, DOI 10.1034/j.1399-3003.2000.15.01.x; FISHMAN AJ, 1983, CHEST, V84, P679, DOI 10.1378/chest.84.6.679; GARDEBACK M, 1995, BRIT J ANAESTH, V75, P798, DOI 10.1093/bja/75.6.798; Gilbert TB, 1998, WORLD J SURG, V22, P1029, DOI 10.1007/s002689900511; Hartz RS, 1996, ANN THORAC SURG, V62, P1255, DOI 10.1016/0003-4975(96)00460-2; Hartz RS, 1999, WORLD J SURG, V23, P1137, DOI 10.1007/s002689900637; Jamieson SW, 2000, CURR PROB SURG, V37, P170; KAPITAN KS, 1989, AM REV RESPIR DIS, V139, P1149, DOI 10.1164/ajrccm/139.5.1149; Kim H, 2000, EXP LUNG RES, V26, P287; King MA, 1998, AM J ROENTGENOL, V170, P955, DOI 10.2214/ajr.170.4.9530043; Kramm T, 1999, EUR J CARDIO-THORAC, V15, P579, DOI 10.1016/S1010-7940(99)00076-7; LANG IM, 1994, CIRCULATION, V90, P706, DOI 10.1161/01.CIR.90.2.706; LEVINSON RM, 1986, AM REV RESPIR DIS, V134, P1241; Lewczuk J, 2001, CHEST, V119, P818, DOI 10.1378/chest.119.3.818; LISBONA R, 1985, AM J ROENTGENOL, V144, P27, DOI 10.2214/ajr.144.1.27; Mares P, 2000, ANESTH ANALG, V90, P267, DOI 10.1097/00000539-200002000-00006; Mayer E, 1997, Z KARDIOL, V86, P920, DOI 10.1007/s003920050132; Mayer E, 1996, ANN THORAC SURG, V61, P1788, DOI 10.1016/0003-4975(96)00169-5; McLaughlin VV, 1999, ANN INTERN MED, V130, P740, DOI 10.7326/0003-4819-130-9-199905040-00014; Meignan M, 2000, ARCH INTERN MED, V160, P159, DOI 10.1001/archinte.160.2.159; Menzel T, 2000, CHEST, V118, P897, DOI 10.1378/chest.118.4.897; Miller WT, 1998, J THORAC IMAG, V13, P178, DOI 10.1097/00005382-199807000-00003; Mo M, 1999, ANN THORAC SURG, V68, P1770, DOI 10.1016/S0003-4975(99)01043-7; Morris TA, 1996, CHEST, V110, P399, DOI 10.1378/chest.110.2.399; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; MOSER KM, 1990, CIRCULATION, V81, P1735, DOI 10.1161/01.CIR.81.6.1735; MOSER KM, 1987, ANN INTERN MED, V107, P560, DOI 10.7326/0003-4819-107-4-560; MOSER KM, 1987, ANN INTERN MED, V107, P946, DOI 10.7326/0003-4819-107-6-946_5; MOSER KM, 1995, CIRCULATION, V91, P741, DOI 10.1161/01.CIR.91.3.741; NAKAJIMA N, 1997, ANN THORAC CARDIOVAS, V3, P15; Peterson KL, 1999, CIRCULATION, V99, P1280, DOI 10.1161/01.CIR.99.10.1280; Pitton MB, 1996, CIRCULATION, V94, P2485, DOI 10.1161/01.CIR.94.10.2485; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Rubens F, 2000, Can Respir J, V7, P49; Russo A, 1999, CIRCULATION, V100, P1808, DOI 10.1161/01.CIR.100.17.1808; RYAN KL, 1988, CHEST, V93, P1180, DOI 10.1378/chest.93.6.1180; Ryu JH, 1998, MAYO CLIN PROC, V73, P873, DOI 10.4065/73.9.873; SHURE D, 1985, ANN INTERN MED, V103, P844, DOI 10.7326/0003-4819-103-6-844; Sompradeekul S, 1999, AM J RESP CRIT CARE, V159, pA456; Steenhuis LH, 2000, EUR RESPIR J, V16, P276, DOI 10.1034/j.1399-3003.2000.16b15.x; Voelkel MA, 2000, CHEST, V117, P19, DOI 10.1378/chest.117.1.19; Wartski M, 2000, J NUCL MED, V41, P1043; Wolf M, 2000, EUR RESPIR J, V15, P395, DOI 10.1034/j.1399-3003.2000.15b28.x	58	462	492	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1465	1472		10.1056/NEJMra010902	http://dx.doi.org/10.1056/NEJMra010902			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794196				2022-12-28	WOS:000172132700006
J	Delabays, A; Goy, J				Delabays, A; Goy, J			Percutaneous mitral valvuloplasty.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Hosp, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Delabays, A (corresponding author), Univ Hosp, CH-1011 Lausanne, Switzerland.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					E4	E4		10.1056/ENEJMicm970997	http://dx.doi.org/10.1056/ENEJMicm970997			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794167	Green Published			2022-12-28	WOS:000171896300005
J	Hobson, DE; Lang, AE; Martin, WRW; Razmy, A; Rivest, J; Fleming, J				Hobson, DE; Lang, AE; Martin, WRW; Razmy, A; Rivest, J; Fleming, J			Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease - A survey by the Canadian Movement Disorders Group	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FALLING ASLEEP; EPISODES; ATTACKS; DRIVERS; PRAMIPEXOLE; ROPINIROLE; ACCIDENTS	Context Somnolence is a recognized adverse effect of dopamine agonists. Two new dopamine agonists, pramipexole and ropinirole, have been reported to cause sudden-onset sleep spells in patients with Parkinson disease (PD) while they were driving. The frequency of these spells and whether driving should be restricted has yet to be established. Objective To determine the frequency of and predictors for sudden-onset sleep and, particularly, episodes of falling asleep while driving among patients with PD. Design, Setting, and Participants Prospective survey conducted between January and April 2000 in 18 clinics directed by members of the Canadian Movement Disorders Group; 638 consecutive highly functional PD patients without dementia were enrolled, of whom 420 were currently drivers. Main Outcome Measures Excessive daytime sleepiness and sudden-onset sleep as assessed by the Epworth Sleepiness Scale and the Inappropriate Sleep Composite Score. The latter score, designed for this study, addressed falling asleep in unusual circumstances. The 2 scales were combined in 3 separate formats dozing off, sudden unexpected sleep, and sudden blank spells. Results Excessive daytime sleepiness was present overall in 327 (51 %) of the 638 patients and in 213 (51%) of the 420 drivers. Patients taking a variety of different dopamine agonists had no differences in Epworth sleepiness scores, in the composite score, or in the risk of failing asleep while driving. Sixteen patients (3.8%) had experienced at least 1 episode of sudden onset of sleep while driving (after the diagnosis of PD); in 3 (0.7%), it occurred without warning. The 2 risk factors associated with failing asleep at the wheel were the Epworth Sleepiness Scale score (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.06-1.24) and the Inappropriate Sleep Composite Score (OR, 2.54; 95% CI, 1.76-3.66). A standard Epworth Sleepiness Scale score of 7 or higher predicted 75% of episodes of sleep behind the wheel at a specificity of 50% (exclusion of the question related to driving provided 70% sensitivity and 52% specificity), whereas a score of 1 on the Inappropriate Sleep Composite Score generated a sensitivity of 52% and specificity of 82%. Conclusions Excessive daytime sleepiness is common even in patients with PD who are independent and do not have dementia. Sudden-onset sleep without warning is infrequent. The Epworth score has adequate sensitivity for predicting prior episodes of failing asleep while driving and its specificity can be increased by use of the Inappropriate Sleep Composite Score. It is unknown if routinely performing these assessments could be more effective in predicting future risk for these rare sleep attacks. Patients should be warned not to drive if they doze in unusual circumstances.	Univ Manitoba, Dept Med, Div Neurol, Winnipeg, MB, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada; Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	University of Manitoba; University of Toronto; University of Toronto; University of Alberta; University of Sherbrooke; University of British Columbia	Hobson, DE (corresponding author), Winnipeg Clin, 425 St Mary Ave, Winnipeg, MB R3C ON2, Canada.	dhobson@cc.umanitoba.ca	Lang, Anthony/ABF-8114-2021	Martin, WR Wayne/0000-0002-3416-691X; Lang, Anthony/0000-0003-1229-3667				Arnulf I, 2000, NEUROLOGY, V55, P281, DOI 10.1212/WNL.55.2.281; DRACHMAN DA, 1988, ANN NEUROL, V24, P787, DOI 10.1002/ana.410240614; EBERSBACH G, 2000, MOV DISORD S3, V15, P89; FACTOR SA, 1990, MOVEMENT DISORD, V5, P280, DOI 10.1002/mds.870050404; Ferreira JJ, 2000, LANCET, V355, P1333, DOI 10.1016/S0140-6736(00)02119-X; Ferreira JJ, 2000, MOV DISORD S3, V15, P128; Ferreira JJ, 2000, MOV DISORD S3, V15, P187; FERREIRA JJ, 2000, MOVEMENT DISORD, V15, P129; Frucht S, 2000, NEUROLOGY, V54, P276; Frucht S, 1999, NEUROLOGY, V52, P1908, DOI 10.1212/WNL.52.9.1908; Gottwald MD, 1997, ANN PHARMACOTHER, V31, P1205, DOI 10.1177/106002809703101014; Hauser RA, 2000, MOVEMENT DISORD, V15, P658, DOI 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N; Hobson DE, 1999, CAN J NEUROL SCI, V26, pS27, DOI 10.1017/S0317167100000068; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HOMANN CN, 2000, MOVEMENT DISORD, V15, P108; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Horne JA, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00222.x; ITOI A, 1993, CAND RIVERS AVOID FA; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Karlsen K, 1999, MOVEMENT DISORD, V14, P237, DOI 10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.3.CO;2-O; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Maycock G, 1997, ACCIDENT ANAL PREV, V29, P453, DOI 10.1016/S0001-4575(97)00024-9; Montastruc JL, 2000, MOVEMENT DISORD, V15, P361, DOI 10.1002/1531-8257(200003)15:2<361::AID-MDS1034>3.0.CO;2-J; Natl Ctr Sleep Disorders Res Working Grp, 1999, AM FAM PHYSICIAN, V59, P937; NAUSIEDA PA, 1987, HDB PARKINSONS DISEA, P371; Olanow CW, 2000, MOVEMENT DISORD, V15, P212, DOI 10.1002/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO;2-6; PALADINI D, 2000, MOV DISORD S3, V15, P130; Parkinson Study Group, 2000, JAMA, V284, P1931; Partinen R, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160564; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Ryan M, 2000, PHARMACOTHERAPY, V20, P724, DOI 10.1592/phco.20.7.724.35181; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Schapira AHV, 2000, LANCET, V355, P1332, DOI 10.1016/S0140-6736(00)02118-8; Schwab R.S., 1969, 3 S PARK DIS, P152; STIASNY K, 2000, MOV DISORD S3, V15, P114; Stocchi F, 1998, J NEUROL, V245, pS15, DOI 10.1007/PL00007731; Tracik F, 2001, MOVEMENT DISORD, V16, P500, DOI 10.1002/mds.1083	38	411	433	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					455	463		10.1001/jama.287.4.455	http://dx.doi.org/10.1001/jama.287.4.455			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798367	Bronze			2022-12-28	WOS:000173401900022
J	Engdahl, A; Nelander, B				Engdahl, A; Nelander, B			The vibrational spectrum of H2O3	SCIENCE			English	Article							LOW-TEMPERATURE OZONATION; HYDROGEN TRIOXIDE HOOOH; WATER; HO2; REACTIVITY; SINGLET; OXYGEN; OH	This report presents positive infrared spectroscopic identification of H2O3, a higher oxide of hydrogen of importance for the understanding of the chain formation ability of atomic oxygen and a possible intermediate in hydrogen oxygen radical chemistry. All fundamental vibrations of H2O3, isolated in an argon matrix, have been observed. In addition, several bands of HDO3, D2O3, and H-2 O-16(2) O-18 have been measured. One particular mode, the antisymetric O-O stretch at 776 cm(-1), should be observable even in the presence of high water concentrations.	Chem Ctr Lund, S-22100 Lund, Sweden	Lund University	Engdahl, A (corresponding author), Chem Ctr Lund, POB 124, S-22100 Lund, Sweden.		Engdahl, Anders/A-5081-2019	Engdahl, Anders/0000-0001-6562-0639				ARNAU JL, 1974, J CHEM PHYS, V60, P270, DOI 10.1063/1.1680779; CERKOVNIK J, 1993, J AM CHEM SOC, V115, P12169, DOI 10.1021/ja00078a067; DEMORE WB, 1982, J PHYS CHEM-US, V86, P121, DOI 10.1021/j100390a025; ENGDAHL A, 1989, J CHEM PHYS, V91, P6604, DOI 10.1063/1.457379; Engdahl A, 2001, J PHYS CHEM A, V105, P8393, DOI 10.1021/jp011082w; ENGDAHL A, UNPUB; GONZALEZ C, 1991, J PHYS CHEM-US, V95, P6784, DOI 10.1021/j100171a010; HORVATH M, 1985, OZONE, P47; JACKELS CF, 1993, J CHEM PHYS, V99, P5768, DOI 10.1063/1.465928; Lay TH, 1997, J PHYS CHEM A, V101, P9505, DOI 10.1021/jp972103i; Mckay DJ, 1998, J AM CHEM SOC, V120, P1003, DOI 10.1021/ja971534b; Nelander B, 2000, CHEM PHYS LETT, V332, P403, DOI 10.1016/S0009-2614(00)01280-X; Pettersson M, 1997, J PHYS CHEM A, V101, P1166, DOI 10.1021/jp962946u; Plesnicar B, 2000, CHEM-EUR J, V6, P809; SCHWAGER I, 1967, J AM CHEM SOC, V89, P6006, DOI 10.1021/ja01000a002; Speranza M, 1996, INORG CHEM, V35, P6140, DOI 10.1021/ic960549s; TOOHEY DW, 1989, J PHYS CHEM-US, V93, P1049, DOI 10.1021/j100340a008; VINCENT MA, 1995, J PHYS CHEM-US, V99, P3109, DOI 10.1021/j100010a021; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722	19	70	70	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					482	483		10.1126/science.1067235	http://dx.doi.org/10.1126/science.1067235			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799239				2022-12-28	WOS:000173350700045
J	Ives, AR; Whitlock, MC				Ives, AR; Whitlock, MC			Inbreeding and metapopulations	SCIENCE			English	Editorial Material									Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of Wisconsin System; University of Wisconsin Madison; University of British Columbia	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.		Whitlock, Michael C/G-1900-2012; Ives, Anthony/A-5698-2008	Ives, Anthony/0000-0001-9375-9523; Whitlock, Michael/0000-0002-0782-1843				CROW JF, 1948, GENETICS, V33, P477; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Whitlock MC, 2000, HEREDITY, V84, P452, DOI 10.1046/j.1365-2540.2000.00693.x; WHITLOCK MC, IN PRESS GENETICS	7	13	15	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					454	455		10.1126/science.1068916	http://dx.doi.org/10.1126/science.1068916			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799230				2022-12-28	WOS:000173350700036
J	Farrell, RJ; Kelly, CP				Farrell, RJ; Kelly, CP			Current concepts - Celiac sprue	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GLUTEN-SENSITIVE ENTEROPATHY; TISSUE TRANSGLUTAMINASE; REFRACTORY SPRUE; HIGH PREVALENCE; ANTIENDOMYSIUM ANTIBODIES; ANTIGLIADIN ANTIBODIES; DIABETES-MELLITUS; SCREENING-TEST; FREE DIET; T-CELLS		Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Farrell, RJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gastroenterol, Dana 501,330 Brookline Ave, Boston, MA 02215 USA.	rfarrell@caregroup.harvard.edu						ACHKAR E, 1986, GASTROINTEST ENDOSC, V32, P278, DOI 10.1016/S0016-5107(86)71846-4; ADAMS F, 1856, EXTANT WORKS ARCTAEU; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Baldas V, 2000, GUT, V47, P628, DOI 10.1136/gut.47.5.628; Catassi C, 1997, BAILLIERE CLIN GASTR, V11, P485, DOI 10.1016/S0950-3528(97)90028-2; Catassi C, 1996, ACTA PAEDIATR, V85, P29, DOI 10.1111/j.1651-2227.1996.tb14244.x; Cellier C, 2000, LANCET, V355, P806, DOI 10.1016/S0140-6736(99)04855-2; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; Collin P, 1996, GUT, V39, P382, DOI 10.1136/gut.39.3.382; CORAZZA GR, 1995, BAILLIERE CLIN GASTR, V9, P329, DOI 10.1016/0950-3528(95)90034-9; COUNSELL CE, 1994, GUT, V35, P844, DOI 10.1136/gut.35.6.844; Cronin CC, 1997, AM J GASTROENTEROL, V92, P2210; de Bruin PC, 1997, HISTOPATHOLOGY, V31, P578; De Santis A, 1997, J INTERN MED, V242, P421, DOI 10.1046/j.1365-2796.1997.00200.x; deBruin PC, 1997, HISTOPATHOLOGY, V31, P313, DOI 10.1046/j.1365-2559.1997.2660862.x; DICKE WK, 1950, COELIAKIE ONDERZOEK; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Fasano A, 1996, ACTA PAEDIATR, V85, P20, DOI 10.1111/j.1651-2227.1996.tb14242.x; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; FERREIRA M, 1992, GUT, V33, P1633, DOI 10.1136/gut.33.12.1633; Fotoulaki M, 1999, DIGEST DIS SCI, V44, P2133, DOI 10.1023/A:1026651224985; GREFTE JMM, 1988, J CLIN PATHOL, V41, P886, DOI 10.1136/jcp.41.8.886; GRODZINSKY E, 1994, ALLERGY, V49, P593, DOI 10.1111/j.1398-9995.1994.tb00124.x; Hadjivassiliou M, 1996, LANCET, V347, P369, DOI 10.1016/S0140-6736(96)90540-1; HANKEY GL, 1994, GUT, V35, P65, DOI 10.1136/gut.35.1.65; Hardman CMJ, 1997, NEW ENGL J MED, V337, P1884, DOI 10.1056/NEJM199712253372604; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P361, DOI 10.1067/mpd.2000.109003; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; HOLMES GKT, 1988, BRIT MED J, V296, P1552, DOI 10.1136/bmj.296.6636.1552; HOWELL MD, 1986, J EXP MED, V164, P333, DOI 10.1084/jem.164.1.333; JANATUINEN EK, 1995, NEW ENGL J MED, V333, P1033, DOI 10.1056/NEJM199510193331602; Johnston SD, 1998, QJM-MON J ASSOC PHYS, V91, P853, DOI 10.1093/qjmed/91.12.853; Kelly C P, 1990, Adv Intern Med, V35, P341; KRAINICK H G, 1958, Helv Paediatr Acta, V13, P432; LLOYDSTI.JD, 1972, J PEDIATR-US, V81, P1074, DOI 10.1016/S0022-3476(72)80234-8; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; MACDONALD WC, 1965, NEW ENGL J MED, V272, P448, DOI 10.1056/NEJM196503042720903; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Molberg O, 1998, NAT MED, V4, P974, DOI 10.1038/nm0898-974b; MYLOTTE M, 1973, BMJ-BRIT MED J, V3, P498, DOI 10.1136/bmj.3.5878.498-c; Not T, 1998, SCAND J GASTROENTERO, V33, P494; Novacek G, 1999, EUR J GASTROEN HEPAT, V11, P283, DOI 10.1097/00042737-199903000-00012; OGRADY JG, 1984, GASTROENTEROLOGY, V87, P1326; OTLEY C, 1990, DERMATOL CLIN, V8, P759; PINK IJ, 1967, LANCET, V1, P300; Rolny P, 1999, AM J GASTROENTEROL, V94, P219; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Rubesin S E, 1989, Radiographics, V9, P1045; RUBIN CE, 1960, GASTROENTEROLOGY, V38, P28; Ryan BM, 2000, GASTROENTEROLOGY, V119, P243, DOI 10.1053/gast.2000.8530; Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521; Shah VH, 2000, GASTROINTEST ENDOSC, V51, P717, DOI 10.1067/mge.2000.104977; Sjoberg K, 1998, J INTERN MED, V243, P133; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; TRIER JS, 1997, SLEISENGER FORDTRANS, V2, P1557; UIBO O, 1993, DIGEST DIS SCI, V38, P2034, DOI 10.1007/BF01297081; Uil JJ, 1996, NETH J MED, V49, P68, DOI 10.1016/0300-2977(96)00016-2; Vaidya A, 1999, AM J GASTROENTEROL, V94, P1967; Vazquez H, 2000, AM J GASTROENTEROL, V95, P183; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; VOLTA U, 1995, DIGEST DIS SCI, V40, P1902, DOI 10.1007/BF02208653	65	619	650	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					180	188		10.1056/NEJMra010852	http://dx.doi.org/10.1056/NEJMra010852			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796853				2022-12-28	WOS:000173273600007
J	Kemper, F; Jager, C; Waters, LBFM; Henning, T; Molster, FJ; Barlow, MJ; Lim, T; de Koter, A				Kemper, F; Jager, C; Waters, LBFM; Henning, T; Molster, FJ; Barlow, MJ; Lim, T; de Koter, A			Detection of carbonates in dust shells around evolved stars	NATURE			English	Article							INTERSTELLAR SILICATE MINERALOGY; PLANETARY-NEBULA; ISO SPECTRUM; NGC-6302; ICE; BODIES; STEPS; DISKS	Carbonates on large Solar System bodies like Earth and Mars 1,2 (the latter represented by the meteorite ALH84001) form through the weathering of silicates in a watery (CO3)(2-) solution. The presence of carbonates in interplanetary dust particles and asteroids (again, represented by meteorites) is not completely understood, but has been attributed to aqueous alteration on a large parent body, which was subsequently shattered into smaller pieces. Despite efforts(3-5), the presence of carbonates outside the Solar System has hitherto not been established(6,7). Here we report the discovery of the carbonates calcite and dolomite in the dust shells of evolved stars, where the conditions are too primitive for the formation of large parent bodies with liquid water. These carbonates, therefore, are not formed by aqueous alteration, but perhaps through processes on the surfaces of dust or ice grains or gas phase condensation. The presence of carbonates which did not form by aqueous alteration suggests that some of the carbonates found in Solar System bodies no longer provide direct evidence that liquid water was present on large parent bodies early in the history of the Solar System(8).	Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Univ Jena, Inst Astrophys & Univ Observ, D-07745 Jena, Germany; Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Heverlee, Belgium; Georgia Tech, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; ESA, ESTEC, Solar Syst Div, NL-2201 AZ Noordwijk, Netherlands; UCL, Dept Phys & Astron, London WC1E 6BT, England; Rutherford Appleton Lab, Dept Space Sci, Didcot OX11 0QX, Oxon, England	University of Amsterdam; Friedrich Schiller University of Jena; KU Leuven; University System of Georgia; Georgia Institute of Technology; European Space Agency; University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Kemper, F (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1098 SJ Amsterdam, Netherlands.	ciska@science.uva.nl	Kemper, Francisca/AAZ-8274-2020; Henning, Thomas K/O-4372-2018; Barlow, Michael J/A-5638-2009	Kemper, Francisca/0000-0003-2743-8240; Henning, Thomas K/0000-0002-1493-300X; Barlow, Michael J/0000-0002-3875-1171				BERTIE JE, 1969, J CHEM PHYS, V50, P4501, DOI 10.1063/1.1670922; COHEN M, 1986, ASTROPHYS J, V302, P737, DOI 10.1086/164035; CORRADI RLM, 1993, ASTRON ASTROPHYS, V269, P462; Endress M, 1996, NATURE, V379, P701, DOI 10.1038/379701a0; GILLETT FC, 1973, ASTROPHYS J, V183, P87, DOI 10.1086/152211; Gonzalez-Alfonso E, 1999, ASTROPHYS J, V525, P845, DOI 10.1086/307909; Henning T, 1996, ASTRON ASTROPHYS, V311, P291; JAGER C, 1994, ASTRON ASTROPHYS, V292, P641; Jager C, 1998, ASTRON ASTROPHYS, V339, P904; Keane JV, 2001, ASTRON ASTROPHYS, V376, P254, DOI 10.1051/0004-6361:20010936; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; Koike C, 2000, ASTRON ASTROPHYS, V363, P1115; KOIKE C, 1999, P 32 ISAS LUN PLAN S, V32, P175, DOI DOI 10.1051/0004-6361:20053256; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; LESTER DF, 1984, ASTROPHYS J, V281, pL67, DOI 10.1086/184287; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Molster FJ, 1999, NATURE, V401, P563, DOI 10.1038/44085; Molster FJ, 2001, ASTRON ASTROPHYS, V372, P165, DOI 10.1051/0004-6361:20010465; PAYNE HE, 1988, ASTROPHYS J, V326, P368, DOI 10.1086/166098; PENMAN JM, 1976, MON NOT R ASTRON SOC, V176, P539, DOI 10.1093/mnras/176.3.539; POPE KO, 1996, LUNAR PLANET SCI, V27, P1045; Pottasch SR, 1999, ASTRON ASTROPHYS, V347, P975; RIETMEIJER FJM, 1985, NATURE, V313, P293, DOI 10.1038/313293a0; SANDFORD SA, 1985, ASTROPHYS J, V291, P838, DOI 10.1086/163120; Scott ERD, 1998, METEORIT PLANET SCI, V33, P709, DOI 10.1111/j.1945-5100.1998.tb01677.x; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361	28	85	86	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					295	297		10.1038/415295a	http://dx.doi.org/10.1038/415295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797000				2022-12-28	WOS:000173293500035
J	Kulynych, J; Korn, D				Kulynych, J; Korn, D			The effect of the new federal medical-privacy rule on research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Kulynych, J (corresponding author), Assoc Amer Med Coll, 2450 North St NW, Washington, DC 20037 USA.							*AM HOSP ASS, 2001, NOT PRIV PRACT PAT C; *AM HOSP ASS, 2001, MOD AUTH FORM; *AMA, 2001, AMA FIN COMM HHS FIN; Annas GJ, 2002, NEW ENGL J MED, V346, P216, DOI 10.1056/NEJM200201173460320; *APA, 2001, APA COMM PRIV HHS; Brown P, 2000, BRIT MED J, V321, P849, DOI 10.1136/bmj.321.7265.849; *NAT BIOETH ADV CO, 2001, ETH POL ISS RES INV, V1; *NAT COMM VIT HLTH, 1997, HLTH PRIV CONF REC N; Office of Civil Rights U. S. Departmrnt of Health and Human Services, 2000, FED REGISTER, V65, P82462; Silman AJ, 2001, LANCET, V357, P1452, DOI 10.1016/S0140-6736(00)04612-2; THOMPSON, 2001, COMMUNICATION   1120; 2001, REUTERS         0510	12	64	64	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					201	204		10.1056/NEJM200201173460312	http://dx.doi.org/10.1056/NEJM200201173460312			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796857				2022-12-28	WOS:000173273600011
J	Green, RC; Cupples, LA; Go, R; Benke, KS; Edeki, T; Griffith, PA; Williams, M; Hipps, Y; Graff-Radford, N; Bachman, D; Farrer, LA				Green, RC; Cupples, LA; Go, R; Benke, KS; Edeki, T; Griffith, PA; Williams, M; Hipps, Y; Graff-Radford, N; Bachman, D; Farrer, LA		MIRAGE Study Grp	Risk of dementia among white and African American relatives of patients with Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-E GENOTYPE; FAMILIAL AGGREGATION; HEAD-INJURY; AGE; METAANALYSIS; ASSOCIATION; POPULATION; DIAGNOSIS; MIRAGE; STATEMENT	Context Evidence exists that the incidence of Alzheimer disease (AD), as well as risk attributable to specific genetic factors such as apolipoprotein E (APOE) genotype, may vary considerably among ethnic groups. Family studies of probands with AD offer an opportunity to evaluate lifetime risk of dementia among relatives of these probands. Objective To compare lifetime dementia risk estimates among relatives of white and African American probands with probable or definite AD. Design and Setting Risk analysis using data collected by questionnaire and supplemental records between May 1991 and March 2001 at 17 medical centers contributing to the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study. Participants A total of 17639 first-degree biological relatives and 2474 spouses of 2339 white AD probands, and 2281 first-degree biological relatives and 257 spouses of 255 African American AD probands. Main Outcome Measures Cumulative risk of dementia by age 85 years, stratified by ethnicity and sex of relatives and by APOE genotype of probands. Results Cumulative risk of dementia in first-degree biological relatives of African American AD probands by age 85 years was 43.7% (SE, 3.1%), and the corresponding risk in first-degree biological relatives of white AD probands was 26.9% (SE, 0.8%), yielding a relative risk (RR) of 1.6 (95% confidence interval [CI], 1.4-1.9; P<.001). The risk in spouses of African American AD probands of 18.5% (SE, 8.4%) was also higher than the risk in white spouses of 10.4% (SE, 1.7%) but did not reach statistical significance (RR, 1.8; 95% CI, 0.5-6.0; P=.34), likely due to the smaller sample size of African Americans. The proportional increase in risk of dementia among white first-degree biological relatives compared with white spouses of 2.6 (95% CI, 2.1-3.2) was similar to that of 2.4 (95% CI, 1.3-4.4) in African American first-degree biological relatives compared with African American spouses. Female first-degree biological relatives of probands had a higher risk of developing dementia than did their male counterparts, among whites (31.2% vs 20.4%; RR, 1.5; 95% CI, 1.3-1.7; P<.001) as well as among African Americans, although this was not significant among African Americans (46.7% vs 40.1%; RR, 1.2; 95% CI, 0.9-1.7, P=.30). The patterns of risk among first-degree biological relatives stratified by APOE genotype of the probands were similar in white families and African American families. Conclusion First-degree relatives of African Americans with AD have a higher cumulative risk of dementia than do those of whites with AD. However, in this study, the additional risk of dementia conferred by being a first-degree relative, by being female, or by the probability of having an APOE epsilon4 allele appeared similar in African American and white families. These data provide estimates of dementia risk that can be used to offer counseling to family members of patients with AD.	Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA; Morehouse Sch Med, Dept Pharmacol, Atlanta, GA 30310 USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA	Boston University; Boston University; Boston University; Boston University; Boston University; University of Alabama System; University of Alabama Birmingham; Morehouse School of Medicine; Morehouse School of Medicine; Mayo Clinic; Medical University of South Carolina	Green, RC (corresponding author), Boston Univ, Sch Med, Genet Program, 715 Albany St,L-320, Boston, MA 02118 USA.		Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Cupples, L. Adrienne/0000-0003-0273-7965	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009029, P30AG013846] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG/AG02213] Funding Source: Medline; NIA NIH HHS [AG13846, AG09029] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BALLARD EL, 1993, GERONTOLOGIST, V33, P561, DOI 10.1093/geront/33.4.561; BELGRAVE LL, 1993, GERONTOLOGIST, V33, P379, DOI 10.1093/geront/33.3.379; Brodaty H, 1995, ALZ DIS ASSOC DIS, V9, P182; Connell CM, 1997, GERONTOLOGIST, V37, P355, DOI 10.1093/geront/37.3.355; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; Demissie S, 2001, NEUROEPIDEMIOLOGY, V20, P105, DOI 10.1159/000054768; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P72, DOI 10.1001/archneur.57.1.72; Devi G, 1999, NEUROLOGY, V53, P789, DOI 10.1212/WNL.53.4.789; Devi G, 1998, GENET EPIDEMIOL, V15, P215, DOI 10.1002/(SICI)1098-2272(1998)15:3<215::AID-GEPI1>3.0.CO;2-3; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FARRER LA, 1994, NEUROLOGY, V44, P652, DOI 10.1212/WNL.44.4.652; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farrer LA, 1997, NEUROLOGIST, V3, P13, DOI 10.1097/00127893-199701000-00003; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GRAFFRADFORD N, IN PRESS ARCH NEUROL; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; LOVESTONE S, 1995, INT J GERIATR PSYCH, V10, P1; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; McConnell LM, 1998, NAT MED, V4, P757, DOI 10.1038/nm0798-757; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OSUNTOKUN BO, 1995, ANN NEUROL, V38, P463, DOI 10.1002/ana.410380319; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; RELKIN NR, 1996, NEUROL ALERT, V14, P58; Sahota A, 1997, ANN NEUROL, V42, P659, DOI 10.1002/ana.410420418; Sayi JG, 1997, E AFR MED J, V74, P668; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; SILVERMAN JM, 1994, ARCH GEN PSYCHIAT, V51, P577; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; *US BUR CENS, 1991, CENS POP HOUS 1990 S; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	40	250	254	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					329	336		10.1001/jama.287.3.329	http://dx.doi.org/10.1001/jama.287.3.329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511YQ	11790212	Bronze			2022-12-28	WOS:000173294700027
J	Preiser, PR; Khan, S; Costa, FTM; Jarra, W; Belnoue, E; Ogun, S; Holder, AA; Voza, T; Landau, I; Snounou, G; Renia, L				Preiser, PR; Khan, S; Costa, FTM; Jarra, W; Belnoue, E; Ogun, S; Holder, AA; Voza, T; Landau, I; Snounou, G; Renia, L			Stage-specific transcription of distinct repertoires of a multigene family during plasmodium life cycle	SCIENCE			English	Article							YOELII RHOPTRY PROTEIN; MALARIA PARASITE; RODENT MALARIA; FALCIPARUM; VIVAX; GENE; IDENTIFICATION; MEROZOITES; SELECTION; INVASION	Members of a multigene family in the rodent malaria parasite Plasmodium yoelii yoelli code for 235-kilodalton proteins (Py235) that are located in the merozoite apical complex, are implicated in virulence, and may determine red blood cell specificity. We show that distinct subsets of py235 genes are expressed in sporozoites and hepatic and erythrocytic stages, Antibodies to Py235 inhibited sporozoite invasion of hepatocytes, The switch in expression profile occurred immediately after transition from one stage to another, The results suggest that this differential expression is driven by strong biological requirements and provide evidence that hepatic and erythrocytic merozoites differ.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Univ Paris 05, Hop Cochin, Inst Cochin Genet Mol, Dept Immunol,INSERM,U445, F-75014 Paris, France; Natl Museum Nat Hist, Lab Biol Parasitaire, F-75231 Paris, France; Inst Pasteur, Unite Parasitol Biomed, F-75724 Paris 15, France	MRC National Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Preiser, PR (corresponding author), Natl Inst Med Res, Div Parasitol, Ridgeway, London NW7 1AA, England.		Holder, Anthony A/A-7554-2013; Snounou, Georges/F-3352-2011; Costa, Fabio/E-1181-2012; Preiser, Peter R/A-2201-2011; Renia, Laurent/E-2117-2011	Holder, Anthony A/0000-0002-8490-6058; Snounou, Georges/0000-0002-6133-6398; Costa, Fabio/0000-0001-9969-7300; Renia, Laurent/0000-0003-0349-1557; Khan, Shahid/0000-0002-0533-4670; , Peter/0000-0003-4331-7000	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 2000, MOL BIOCHEM PARASIT, V108, P257, DOI 10.1016/S0166-6851(00)00219-X; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; KEEN J, 1990, MOL BIOCHEM PARASIT, V42, P241, DOI 10.1016/0166-6851(90)90167-K; KEEN JK, 1994, MOL BIOCHEM PARASIT, V65, P171, DOI 10.1016/0166-6851(94)90125-2; Khan SM, 2001, MOL BIOCHEM PARASIT, V114, P197, DOI 10.1016/S0166-6851(01)00253-5; Landau Irene, 1998, P401; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; Narum DL, 2001, MOL BIOCHEM PARASIT, V112, P193, DOI 10.1016/S0166-6851(00)00363-7; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Owen CA, 1999, MOL BIOCHEM PARASIT, V99, P183, DOI 10.1016/S0166-6851(99)00015-8; Preiser PR, 1998, EXP PARASITOL, V89, P50, DOI 10.1006/expr.1998.4259; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; PREISER PR, UNPUB; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; RENIA L, UNPUB; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Sinha KA, 1996, MOL BIOCHEM PARASIT, V76, P329, DOI 10.1016/0166-6851(95)02546-4; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Thompson J, 1999, MOL MICROBIOL, V31, P253, DOI 10.1046/j.1365-2958.1999.01167.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001	33	59	61	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					342	345		10.1126/science.1064938	http://dx.doi.org/10.1126/science.1064938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786645				2022-12-28	WOS:000173278600054
J	Fehr, E; Gachter, S				Fehr, E; Gachter, S			Altruistic punishment in humans	NATURE			English	Article							INDIRECT RECIPROCITY; EVOLUTION; COOPERATION; HANDICAP	Human cooperation is an evolutionary puzzle. Unlike other creatures, people frequently cooperate with genetically unrelated strangers, often in large groups, with people they will never meet again, and when reputation gains are small or absent. These patterns of cooperation cannot be explained by the nepotistic motives associated with the evolutionary theory of kin selection and the selfish motives associated with signalling theory or the theory of reciprocal altruism. Here we show experimentally that the altruistic punishment of defectors is a key motive for the explanation of cooperation. Altruistic punishment means that individuals punish, although the punishment is costly for them and yields no material gain. We show that cooperation flourishes if altruistic punishment is possible, and breaks down if it is ruled out. The evidence indicates that negative emotions towards defectors are the proximate mechanism behind altruistic punishment. These results suggest that future study of the evolution of human cooperation should include a strong focus on explaining altruistic punishment.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Univ St Gallen, FEW HSG, CH-9000 St Gallen, Switzerland	University of Zurich; University of St Gallen	Fehr, E (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.		Osuna, Luis E/A-5858-2010; Gachter, Simon/C-9787-2009	Gachter, Simon/0000-0002-7182-8505				Alexander R., 1987, BIOL MORAL SYSTEMS; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BOYD R, IN PRESS EVOLUTION C; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; FISCHBACHER U, 1999, 21 U ZUR I EMP RES E; Frank R. H., 1988, PASSIONS REASON STRA; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heckathorn DD., 1989, RATION SOC, V1, P78, DOI [10.1177/1043463189001001006, DOI 10.1177/1043463189001001006]; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; HIRSHLEIFER J, 1987, LATEST BEST ESSAYS E; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lotem A, 1999, NATURE, V400, P226, DOI 10.1038/22247; NOWAK MA, 1995, SCI AM, V272, P76, DOI 10.1038/scientificamerican0695-76; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Richerson P.J., 1998, INDOCTRINABILITY IDE, P71; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Smuts B. B., 1987, PRIMATE SOC; Sober Elliott, 1998, OTHERS EVOLUTION PSY; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	28	3332	3410	30	1154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					137	140		10.1038/415137a	http://dx.doi.org/10.1038/415137a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509PR	11805825				2022-12-28	WOS:000173159300032
J	Wang, XB; Zuckerman, B; Pearson, C; Kaufman, G; Chen, CZ; Wang, GY; Niu, TH; Wise, PH; Bauchner, H; Xu, XP				Wang, XB; Zuckerman, B; Pearson, C; Kaufman, G; Chen, CZ; Wang, GY; Niu, TH; Wise, PH; Bauchner, H; Xu, XP			Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							S-TRANSFERASE-THETA; LUNG-CANCER; HOMOZYGOUS DELETION; GESTATIONAL-AGE; PRETERM BIRTH; SUSCEPTIBILITY; CYP1A1; OUTCOMES; SMOKERS; RISK	Context Little is known about genetic susceptibility to cigarette smoke in relation to adverse pregnancy outcomes. Objective To investigate whether the association between maternal cigarette smoking and infant birth weight differs by polymorphisms of 2 maternal metabolic genes: CYP1A1 and GSTT1. Design, Setting, and Participants Case-control study conducted in 1998-2000 among 741 mothers (174 ever smokers and 567 never smokers) who delivered singleton live births at Boston Medical Center. A total of 207 cases were preterm or low-birth-weight infants and 534 were non-low-birth-weight, full-term infants (control). Main Outcome Measure Birth weight, gestation, fetal growth by smoking status and CYP1A1 Mspl (AA vs Aa and aa, where Aa and as were combined because of small numbers of as and similar results), and GSTT1 (present vs absent) genotypes. Results Without consideration of genotype, continuous maternal smoking during pregnancy was associated with a mean reduction of 377 g (SE, 89 g) in birth weight (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.2-3.7). When CYP1A1 genotype was considered, the estimated reduction in birth weight was 252 g (SE, 111 g) for the AA genotype group (n = 75; OR, 1.3; 95% CI, 0.6-2.6); but was 520 g (SE, 124 g) for the Aa/aa genotype group (n=43 for Aa, n=6 for aa; OR, 3.2; 95% CI, 1.6-6.4). When GSTT1 genotype was considered, the estimated reduction in birth weight was 285 g (SE, 99 g) (OR, 1.7; 95% CI, 0.9-3.2) and 642 g (SE, 154 g) (OR, 3.5; 95% Cl, 1.5-8.3) for the present and absent genotype groups, respectively. When both CYP1A1 and GSTT1 genotypes were considered, the,greatest reduction in birth weight was found among smoking mothers with the CYP1A1 Aa/aa and GSTT1 absent genotypes (-1285 g; SE, 234 g; P<.001). Among never smokers,, genotype did not independently confer an adverse effect. A similar pattern emerged in analyses stratified by maternal ethnicity and in analyses for gestation. Conclusions In our study, maternal CYP1A1 and GSTT1 genotypes modified the association between maternal cigarette smoking and infant birth weight, suggesting an interaction between metabolic genes and cigarette smoking.	Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Beijing Med Univ, Ctr Ecogenet & Reprod Hlth, Beijing 100083, Peoples R China	Boston University; Boston University; Boston Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Peking University	Wang, XB (corresponding author), Boston Univ, Sch Med, Dept Pediat, 91 E Concord St,Matern 4, Boston, MA 02118 USA.		Wang, Guoying/F-8908-2011	Zuckerman, Barry/0000-0002-0044-2592; Bauchner, Howard/0000-0002-8368-9805				ALEXANDROV K, 1992, CANCER RES, V52, P6248; Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3; BARTSCH H, 1995, PHARMACOGENETICS, V5, pS84, DOI 10.1097/00008571-199512001-00007; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Cnattingius S, 1999, NEW ENGL J MED, V341, P943, DOI 10.1056/NEJM199909233411303; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; DOLANMULLEN P, 1994, AM J OBSTET GYNECOL, V171, P1328, DOI 10.1016/0002-9378(94)90156-2; EVERSON RB, 1988, J NATL CANCER I, V80, P567, DOI 10.1093/jnci/80.8.567; Fennell TR, 2000, CANCER EPIDEM BIOMAR, V9, P705; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; HAYASHI S, 1992, JPN J CANCER RES, V83, P866, DOI 10.1111/j.1349-7006.1992.tb01992.x; Hellerstedt WL, 1997, AM J PUBLIC HEALTH, V87, P591, DOI 10.2105/AJPH.87.4.591; Ishibe N, 1997, CANCER EPIDEM BIOMAR, V6, P1075; KATOH T, 1995, CARCINOGENESIS, V16, P655, DOI 10.1093/carcin/16.3.655; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; Klebanoff MA, 2001, PAEDIATR PERINAT EP, V15, P140, DOI 10.1046/j.1365-3016.2001.00321.x; Kramer MS, 1999, PEDIATRICS, V103, P599, DOI 10.1542/peds.103.3.599; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 1998, JAMA-J AM MED ASSOC, V280, P1849, DOI 10.1001/jama.280.21.1849; LANDI MT, 1994, PHARMACOGENETICS, V4, P242, DOI 10.1097/00008571-199410000-00002; Meis PJ, 1997, PAEDIATR PERINAT EP, V11, P287, DOI 10.1111/j.1365-3016.1997.tb00006.x; NAKACHI K, 1993, CANCER RES, V53, P2994; National Research Council, 1983, POL AR HYDR EV SOURC, P197; NELSON HH, 1995, CARCINOGENESIS, V16, P1243, DOI 10.1093/carcin/16.5.1243; Peacock JL, 1998, INT J EPIDEMIOL, V27, P647, DOI 10.1093/ije/27.4.647; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Perera FP, 1999, ENVIRON HEALTH PERSP, V107, P451, DOI 10.1289/ehp.99107s3451; Pollack H, 2000, AM J PUBLIC HEALTH, V90, P395, DOI 10.2105/AJPH.90.3.395; Prada JA, 1998, EUR J CLIN NUTR, V52, pS21; Sambrook J., 2002, MOL CLONING LAB MANU; SCHRODER KR, 1995, ARCH TOXICOL, V69, P505, DOI 10.1007/s002040050205; TIMBRELL JA, 1991, PRINCIPLES BIOCH TOX; Umbach DM, 2000, AM J EPIDEMIOL, V152, P701, DOI 10.1093/aje/152.8.701; *US DEP HHS, 1990, HLTH BEN SMOK CESS R, P367; Wang XB, 2000, AM J EPIDEMIOL, V152, P693, DOI 10.1093/aje/152.8.693; Wang XB, 1997, INT J EPIDEMIOL, V26, P978, DOI 10.1093/ije/26.5.978; Wang XB, 1995, NEW ENGL J MED, V333, P1744, DOI 10.1056/NEJM199512283332606; WIENCKE JK, 1995, CANCER EPIDEM BIOMAR, V4, P253; Xu XP, 1998, AM J IND MED, V33, P157, DOI 10.1002/(SICI)1097-0274(199802)33:2<157::AID-AJIM7>3.0.CO;2-V; Xu XP, 1996, CANCER EPIDEM BIOMAR, V5, P687	42	436	455	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					195	202		10.1001/jama.287.2.195	http://dx.doi.org/10.1001/jama.287.2.195			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779261	Bronze			2022-12-28	WOS:000173114900021
J	Maeshima, Y; Sudhakar, A; Lively, JC; Ueki, K; Kharbanda, S; Kahn, CR; Sonenberg, N; Hynes, RO; Kalluri, R				Maeshima, Y; Sudhakar, A; Lively, JC; Ueki, K; Kharbanda, S; Kahn, CR; Sonenberg, N; Hynes, RO; Kalluri, R			Tumstatin, an endothelial cell-specific inhibitor of protein synthesis	SCIENCE			English	Article							CAP-DEPENDENT INITIATION; ALPHA(V)BETA(3) INTEGRIN; PHOSPHORYLATION; RAPAMYCIN; KINASE; ANGIOGENESIS; TRANSLATION; TARGET	Tumstatin is a 28-kilodalton fragment of type IV collagen that displays both anti-angiogenic and proapoptotic activity. Here we show that tumstatin functions as an endothelial cell-specific inhibitor of protein synthesis. Through a requisite interaction with alphaV beta3 integrin, tumstatin inhibits activation of focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR), and it prevents the dissociation of eukaryotic initiation factor 4E protein (eIF4E) from 4E-binding protein 1. These results establish a rote for integrins in mediating ceti-specific inhibition of cap-dependent protein synthesis and suggest a potential mechanism for tumstatin's selective effects on endothelial cells.	Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Canc Pharmacol, Boston, MA 02215 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1V6, Canada	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; McGill University; McGill University	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA.	rkalluri@caregroup.harvard.edu	Kahn, Ronald/AAY-2435-2021; Kalluri, Raghu/E-2677-2015	Kahn, Ronald/0000-0002-7583-9228; Kalluri, Raghu/0000-0002-2190-547X	NHLBI NIH HHS [P01-HL66105] Funding Source: Medline; NIDDK NIH HHS [DK-51711, DK-55001] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051711] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Beretta L, 1996, J VIROL, V70, P8993, DOI 10.1128/JVI.70.12.8993-8996.1996; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Bushell M, 1999, FEBS LETT, V451, P332, DOI 10.1016/S0014-5793(99)00614-6; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Kumar V, 2000, J BIOL CHEM, V275, P10779, DOI 10.1074/jbc.275.15.10779; LIVELY JC, UNPUB; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; McBratney S, 1993, CURR OPIN CELL BIOL, V5, P961, DOI 10.1016/0955-0674(93)90077-4; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SUDHAKAR A, UNPUB; Tan SL, 1999, J INTERF CYTOK RES, V19, P543, DOI 10.1089/107999099313677; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Vuori K, 1998, J MEMBRANE BIOL, V165, P191, DOI 10.1007/s002329900433	26	356	408	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					140	143		10.1126/science.1065298	http://dx.doi.org/10.1126/science.1065298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778052	Green Submitted			2022-12-28	WOS:000173143100053
J	Niwa, S; Eswaramoorthy, M; Nair, J; Raj, A; Itoh, N; Shoji, H; Namba, T; Mizukami, F				Niwa, S; Eswaramoorthy, M; Nair, J; Raj, A; Itoh, N; Shoji, H; Namba, T; Mizukami, F			A one-step conversion of benzene to phenol with a palladium membrane	SCIENCE			English	Article							CATALYTIC HYDROXYLATION; HYDROGEN-PEROXIDE; MOLECULAR-OXYGEN; OXIDATION; AROMATICS; CELL	Existing phenol production processes tend to be energy-consuming and produce unwanted by-products. We report an efficient process using a shell-and-tube reactor, in which a gaseous mixture of benzene and oxygen is fed into a porous alumina tube coated with a palladium thin layer and hydrogen is fed into the shell. Hydrogen dissociated on the palladium layer surface permeates onto the back and reacts with oxygen to give active oxygen species, which attack benzene to produce phenol. This one-step process attained phenol formation selectivities of 80 to 97% at benzene conversions of 2 to 16% below 250 degreesC (phenol yield: 1.5 kilograms per kilogram of catalyst per hour at 150 degreesC).	Natl Inst Adv Ind Sci & Technol AIST, Inst Mat & Chem Proc, Tsukuba, Ibaraki 3058565, Japan; Maruzen Petrochem, Res Ctr, Chiba 2908503, Japan; NOK Corp, Tsukuba Tech Lab, Tsukuba, Ibaraki 3004247, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Mizukami, F (corresponding author), Natl Inst Adv Ind Sci & Technol AIST, Inst Mat & Chem Proc, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.		Muthusamy, Eswaramoorthy/B-4671-2012					Bianchi D, 2000, ANGEW CHEM INT EDIT, V39, P4321, DOI 10.1002/1521-3773(20001201)39:23<4321::AID-ANIE4321>3.0.CO;2-5; Choudhary VR, 2001, ANGEW CHEM INT EDIT, V40, P1776, DOI 10.1002/1521-3773(20010504)40:9<1776::AID-ANIE17760>3.3.CO;2-3; Clerici MG, 1998, CATAL TODAY, V41, P351, DOI 10.1016/S0920-5861(98)00025-X; GRYAZNOV VM, 1981, FARADAY DISCUSS, V72, P73; ITOH N, 1993, APPL CATAL A-GEN, V107, P83, DOI 10.1016/0926-860X(93)85117-8; JINTOKU T, 1987, CHEM LETT, P1865, DOI 10.1246/cl.1987.1865; JINTOKU T, 1990, CHEM LETT, P1687, DOI 10.1246/cl.1990.1687; KITANO T, 1990, J CHEM SOC PERK T 2, P1991, DOI 10.1039/p29900001991; KUNAI A, 1988, CHEM LETT, P1967, DOI 10.1246/cl.1988.1967; KUNAI A, 1990, CATAL LETT, V4, P139, DOI 10.1007/BF00765696; Lee CW, 2000, CATAL TODAY, V61, P137, DOI 10.1016/S0920-5861(00)00357-6; Liptakova B, 2000, CATAL TODAY, V61, P143, DOI 10.1016/S0920-5861(00)00359-X; MIYAKE T, 1995, APPL CATAL A-GEN, V131, P33, DOI 10.1016/0926-860X(95)00134-4; Moro-oka Y, 1998, CATAL TODAY, V41, P327, DOI 10.1016/S0920-5861(98)00023-6; NEUMANN MG, 1970, J CHEM SOC B, P167, DOI 10.1039/j29700000167; Notte PP, 2000, TOP CATAL, V13, P387, DOI 10.1023/A:1009015223793; Otsuka K, 2000, CATAL TODAY, V57, P71, DOI 10.1016/S0920-5861(99)00310-7; OTSUKA K, 1990, NATURE, V345, P697, DOI 10.1038/345697a0; Panov G. I., 2000, CATTECH, V4, P18, DOI DOI 10.1023/A:1011991110517; Passoni LC, 1997, J MOL CATAL A-CHEM, V120, P117, DOI 10.1016/S1381-1169(96)00440-2; Perego C., 2000, CATTECH, V4, P4, DOI [10.1023/A:1011905009608, DOI 10.1023/A:1011905009608]; SATO S, 1959, J AM CHEM SOC, V81, P3223, DOI 10.1021/ja01522a016; TATSUMI T, 1992, J CHEM SOC CHEM COMM, P1446, DOI 10.1039/c39920001446; THANGARAJ A, 1990, APPL CATAL, V57, pL1, DOI 10.1016/S0166-9834(00)80718-6; WOOD BJ, 1966, J CATAL, V5, P135, DOI 10.1016/S0021-9517(66)80133-1; Yamanaka I, 1996, J CHEM SOC PERK T 2, P2511, DOI 10.1039/p29960002511; Yamanaka I, 2000, STUD SURF SCI CATAL, V130, P809; YAMANAKA I, 2000, STUD SURF SCI CATAL, V130, P815; YAN SC, 1994, IND ENG CHEM RES, V33, P616, DOI 10.1021/ie00027a019	29	468	493	4	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					105	107		10.1126/science.1066527	http://dx.doi.org/10.1126/science.1066527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778042				2022-12-28	WOS:000173143100042
J	Boustany, AM; Davis, SF; Pyle, P; Anderson, SD; Le Boeuf, BJ; Block, BA				Boustany, AM; Davis, SF; Pyle, P; Anderson, SD; Le Boeuf, BJ; Block, BA			Satellite tagging - Expanded niche for white sharks	NATURE			English	Article							TRACKING; TAGS		Stanford Univ, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Monterey Bay Aquarium, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Point Reyes Bird Observ, Stinson Beach, CA 94970 USA	Stanford University; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz	Boustany, AM (corresponding author), Stanford Univ, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.							Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8; Compagno LJV., 1984, FAO FISH SYNOP, P20; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Goldman KJ, 1996, GREAT WHITE SHARKS, P111, DOI 10.1016/B978-012415031-7/50012-4; Hill Roger D., 1994, P227; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Taylor L., 1985, Memoirs of the Southern California Academy of Sciences, V9, P41; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317	12	180	185	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					35	36		10.1038/415035b	http://dx.doi.org/10.1038/415035b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780105				2022-12-28	WOS:000173028800028
J	High, WA; Weiss, SD				High, WA; Weiss, SD			Pigmentation related to amiodarone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Presbyterian St Lukes Med Ctr, Denver, CO 80218 USA		High, WA (corresponding author), Presbyterian St Lukes Med Ctr, Denver, CO 80218 USA.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1464	1464		10.1056/NEJMicm010106	http://dx.doi.org/10.1056/NEJMicm010106			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794195				2022-12-28	WOS:000172132700005
J	Mohr, JP; Thompson, JLP; Lazar, RM; Levin, B; Sacco, RL; Furie, KL; Kistler, JP; Albers, GW; Pettigrew, LC; Adams, HP; Jackson, CM; Pullicino, P				Mohr, JP; Thompson, JLP; Lazar, RM; Levin, B; Sacco, RL; Furie, KL; Kistler, JP; Albers, GW; Pettigrew, LC; Adams, HP; Jackson, CM; Pullicino, P		Warfarin-Aspirin Recurrent Stroke	A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONRHEUMATIC ATRIAL-FIBRILLATION; SECONDARY PREVENTION; OPTIMAL INTENSITY; RANDOMIZED-TRIAL; THERAPY; RISK; ANTICOAGULATION; MULTICENTER; SUBTYPES	Background: Despite the use of antiplatelet agents, usually aspirin, in patients who have had an ischemic stroke, there is still a substantial rate of recurrence. Therefore, we investigated whether warfarin, which is effective and superior to aspirin in the prevention of cardiogenic embolism, would also prove superior in the prevention of recurrent ischemic stroke in patients with a prior noncardioembolic ischemic stroke. Methods: In a multicenter, double-blind, randomized trial, we compared the effect of warfarin (at a dose adjusted to produce an international normalized ratio of 1.4 to 2.8) and that of aspirin (325 mg per day) on the combined primary end point of recurrent ischemic stroke or death from any cause within two years. Results: The two randomized study groups were similar with respect to base-line risk factors. In the intention-to-treat analysis, no significant differences were found between the treatment groups in any of the outcomes measured. The primary end point of death or recurrent ischemic stroke was reached by 196 of 1103 patients assigned to warfarin (17.8 percent) and 176 of 1103 assigned to aspirin (16.0 percent; P=0.25; hazard ratio comparing warfarin with aspirin, 1.13; 95 percent confidence interval, 0.92 to 1.38). The rates of major hemorrhage were low (2.22 per 100 patient-years in the warfarin group and 1.49 per 100 patient-years in the aspirin group). Also, there were no significant treatment-related differences in the frequency of or time to the primary end point or major hemorrhage according to the cause of the initial stroke. Conclusions: Over a two-year period, we found no difference between aspirin and warfarin in the prevention of recurrent ischemic stroke or death or in the rate of major hemorrhage. Consequently, we regard both warfarin and aspirin as reasonable therapeutic alternatives.	Columbia Presbyterian Med Ctr, Inst Neurol, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Dept Biostat, New York, NY 10032 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA; Univ Kentucky, Med Ctr, Louisville, KY USA; Univ Iowa Hlth Care, Iowa City, IA USA; Univ Calif San Diego, San Diego, CA 92103 USA; SUNY Buffalo, Buffalo, NY 14260 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Massachusetts General Hospital; Stanford University; University of Kentucky; University of Iowa; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mohr, JP (corresponding author), Columbia Presbyterian Med Ctr, Inst Neurol, 710 W 168th St, New York, NY 10032 USA.	jpm10@columbia.edu	Mohr, J/AAO-9694-2020; Sacco, Ralph/Y-9278-2019; pullicino, Patrick/AAO-9018-2021	Albers, Gregory/0000-0003-0263-4632	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028371] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS-28371] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albers CW, 2001, CHEST, V119, p300S, DOI 10.1378/chest.119.1_suppl.300S; ANDERSON CS, 1994, J NEUROL NEUROSUR PS, V57, P1173, DOI 10.1136/jnnp.57.10.1173; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; Bushnell CD, 2000, STROKE, V31, P3067, DOI 10.1161/01.STR.31.12.3067; Chimowitz MI, 1998, STROKE, V29, P1389, DOI 10.1161/01.str.29.7.1389; Diener HC, 1997, J NEUROL SCI, V151, pS1, DOI 10.1016/S0022-510X(97)86566-5; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; EZEKOWITZ MD, 1993, NEW ENGL J MED, V328, P148; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Gorter JW, 1999, NEUROLOGY, V53, P1319, DOI 10.1212/WNL.53.6.1319; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; Huynh T, 2001, CIRCULATION, V103, P3069, DOI 10.1161/01.CIR.103.25.3069; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPPELLE LJ, 1995, J NEUROL NEUROSUR PS, V59, P127, DOI 10.1136/jnnp.59.2.127; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Lind SE, 1999, BLOOD COAGUL FIBRIN, V10, P215, DOI 10.1097/00001721-199907000-00001; LIU M, 2001, COCHRANE LIB; MADDEN KP, 1995, NEUROLOGY, V45, P1975, DOI 10.1212/WNL.45.11.1975; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MCBRIDE R, 1994, LANCET, V343, P687; MOHR JP, 1988, NEW ENGL J MED, V318, P1197, DOI 10.1056/NEJM198805053181810; Mohr JP, 1997, CEREBROVASC DIS, V7, P100; Pengo V, 2001, THROMB HAEMOSTASIS, V85, P418; PETERSEN P, 1989, LANCET, V1, P175; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; ROOS J, 1980, LANCET, V2, P989; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; SANDERCOCK P, 1986, LANCET, V1, P788; SIEGMUND D, 1985, SEQUENTIAL ANAL TEST, P86; THOMPSON JLP, 1994, ANN NEUROL, V36, P305; Witte K, 2000, EUR J HEART FAIL, V2, P455, DOI 10.1016/S1388-9842(00)00127-6; Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817	39	754	780	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1444	1451		10.1056/NEJMoa011258	http://dx.doi.org/10.1056/NEJMoa011258			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794192				2022-12-28	WOS:000172132700002
J	Corey, L; Boeckh, M				Corey, L; Boeckh, M			Perspective: Persistent fever in patients with neutropenia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Corey, L (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.		Boeckh, Michael/AAA-1607-2022					Kaufman D, 2001, NEW ENGL J MED, V345, P1660, DOI 10.1056/NEJMoa010494	1	30	33	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					222	224		10.1056/NEJM200201243460402	http://dx.doi.org/10.1056/NEJM200201243460402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807145				2022-12-28	WOS:000173398900001
J	Goadsby, PJ; Lipton, RB; Ferrari, MD				Goadsby, PJ; Lipton, RB; Ferrari, MD			Drug therapy: Migraine - Current understanding and treatment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PLACEBO-CONTROLLED CROSSOVER; SUMATRIPTAN NASAL SPRAY; BRAIN-STEM ACTIVATION; DOUBLE-BLIND; NEUROGENIC INFLAMMATION; SPREADING DEPRESSION; EFFERVESCENT ASPIRIN; METHYSERGIDE THERAPY; PLASMA SEROTONIN; CLINICAL-TRIALS		Natl Hosp Neurol & Neurosurg, Neurol Inst, London, England; Albert Einstein Coll Med, Dept Neurol, New York, NY USA; Albert Einstein Coll Med, Dept Epidemiol, New York, NY USA; Albert Einstein Coll Med, Dept Social Med, New York, NY USA; Montefiore Headache Unit, New York, NY USA; Innovat Med Res, Towson, MD USA; Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Yeshiva University; Yeshiva University; Yeshiva University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goadsby, PJ (corresponding author), Inst Neurol, Queen Sq, London WC1N 3BG, England.	peterg@ion.ucl.ac.uk	Ferrari, Michel D./ABE-3758-2021; Lipton, Richard B/B-5060-2011; Goadsby, Peter J/Z-1970-2019; Goadsby, Peter J/B-2267-2009; Lipton, Richard Bruce/AAY-2818-2021	Ferrari, Michel D./0000-0001-9691-9449; Goadsby, Peter J/0000-0003-3260-5904; 				*AM AC NEUR, 1995, NEUROLOGY, V45, P585; [Anonymous], 2000, HEADACHES; ANTHONY M, 1967, ARCH NEUROL-CHICAGO, V16, P544, DOI 10.1001/archneur.1967.00470230096013; ARBAB MAR, 1986, NEUROSCIENCE, V19, P695, DOI 10.1016/0306-4522(86)90293-9; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; BARTSCH T, 2001, CEPHALALGIA, V21, P401; Buchan P, 1999, CEPHALALGIA, V19, P365; BUCHAN P, 1998, CEPHALALGIA, V18, P410; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Cabarrocas X., 2000, Cephalalgia, V20, P417; Cabarrocas X., 1997, CEPHALALGIA, V17, P421; Cady RK, 2000, HEADACHE, V40, P792, DOI 10.1046/j.1526-4610.2000.00144.x; Cady RK, 2000, CLIN THER, V22, P1035, DOI 10.1016/S0149-2918(00)80083-1; Cao Y, 1999, ARCH NEUROL-CHICAGO, V56, P548, DOI 10.1001/archneur.56.5.548; Connor HE, 1998, CEPHALALGIA, V18, P392; Cottrell J., 2000, Cephalalgia, V20, P269; CURRAN DA, 1965, BRAIN, V88, P997, DOI 10.1093/brain/88.5.997; Cushing H, 1904, B JOHNS HOPKINS HOSP, V15, P213; Cutrer FM, 1998, ANN NEUROL, V43, P25, DOI 10.1002/ana.410430108; Dahlof C, 1999, CEPHALALGIA, V19, P769, DOI 10.1046/j.1468-2982.1999.1909769.x; Data J, 1998, HEADACHE, V38, P380; del Rio MS, 1999, CEPHALALGIA, V19, P701, DOI 10.1046/j.1468-2982.1999.019008701.x; DIENER HC, 1996, P 6 INT HEAD SEM PHI; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Earl NL, 1999, CEPHALALGIA, V19, P357; EKBOM K, 1991, NEW ENGL J MED, V325, P322, DOI 10.1056/nejm199108013250505; FEINDEL W, 1960, NEUROLOGY, V10, P555, DOI 10.1212/WNL.10.6.555; FENIUK W, 1989, BRIT J PHARMACOL, V96, P83, DOI 10.1111/j.1476-5381.1989.tb11787.x; FERRARI MD, 1991, NEW ENGL J MED, V325, P316; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; FERRARI MD, IN PRESS CEPHALALGIA; Fleishaker JC, 1999, INT J CLIN PHARM TH, V37, P487; FOWLER PA, 1991, EUR NEUROL, V31, P291, DOI 10.1159/000116756; Fuseau E, 1997, CEPHALALGIA, V17, P417; Goadsby PJ, 2000, PROG NEUROBIOL, V62, P509, DOI 10.1016/S0301-0082(00)00010-1; Goadsby PJ, 1996, BRIT MED J, V312, P1279, DOI 10.1136/bmj.312.7041.1279; Goadsby PJ, 1997, J ANAT, V190, P367, DOI 10.1046/j.1469-7580.1997.19030367.x; Goadsby PJ, 1997, PAIN, V73, P23, DOI 10.1016/S0304-3959(97)00074-2; Goadsby PJ, 2001, CEPHALALGIA, V21, P82, DOI 10.1046/j.1468-2982.2001.00175.x; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goadsby PJ, 2001, ANN NEUROL, V49, P4, DOI 10.1002/1531-8249(200101)49:1<4::AID-ANA3>3.0.CO;2-W; GOADSBY PJ, 1997, BLUE BOOKS PRACTICAL, V17; Goldstein DJ, 1997, CEPHALALGIA, V17, P785, DOI 10.1046/j.1468-2982.1997.1707785.x; Goldstein DJ, 2001, LANCET, V358, P1230, DOI 10.1016/S0140-6736(01)06347-4; Goldstein DJ, 2001, CEPHALALGIA, V21, P102, DOI 10.1046/j.1468-2982.2001.00161.x; Goldstein J, 1999, CEPHALALGIA, V19, P684, DOI 10.1046/j.1468-2982.1999.019007684.x; Gomez-Mancilla B, 2001, CEPHALALGIA, V21, P727, DOI 10.1046/j.1468-2982.2001.00208.x; Gowers, 1888, MANUAL DIS NERVOUS S, V2; GRAHAM JR, 1967, AM J MED SCI, V254, P1; GRAHAM JR, 1966, NEW ENGL J MED, V274, P359, DOI 10.1056/NEJM196602172740701; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Harrison SD, 1997, EUR NEUROPSYCHOPHARM, V7, P83, DOI 10.1016/S0924-977X(96)00385-9; Hartig PR, 1996, TRENDS PHARMACOL SCI, V17, P103, DOI 10.1016/0165-6147(96)30002-3; Headache Classification Committee of the International Headache Society, 1998, CEPHALALGIA S7, V8, P1; Hoskin KL, 1999, J ANAT, V194, P579, DOI 10.1046/j.1469-7580.1999.19440579.x; HOYER D, 1994, PHARMACOL REV, V46, P157; HUMPHREY PPA, 1990, ANN NY ACAD SCI, V600, P587, DOI 10.1111/j.1749-6632.1990.tb16912.x; HUMPHREY PPA, 1994, CEPHALALGIA, V14, P401, DOI 10.1046/j.1468-2982.1994.1406401.x; Humphrey PPA, 2001, CEPHALALGIA, V21, P2, DOI 10.1046/j.1468-2982.2001.021s1002.x; Jhee SS, 1998, HEADACHE, V38, P35, DOI 10.1046/j.1526-4610.1998.3801035.x; John GW, 2000, CNS DRUG REV, V6, P278; JOHNSTON BM, 1978, BRIT J PHARMACOL, V63, P541, DOI 10.1111/j.1476-5381.1978.tb07810.x; Kellstein DE, 2000, CEPHALALGIA, V20, P233; Kempsford RD, 1997, CEPHALALGIA, V17, P408; KERR FW, 1961, J NEUROSURG, V18, P605, DOI 10.3171/jns.1961.18.5.0605; KIMBALL RW, 1960, NEUROLOGY, V10, P107, DOI 10.1212/WNL.10.2.107; KORSGAARD AG, 1995, CEPHALALGIA, V16, P98; Kramer MS, 1998, NEUROLOGY, V51, P773, DOI 10.1212/WNL.51.3.773; Lance J W, 1967, Headache, V7, P93, DOI 10.1111/j.1526-4610.1967.hed0703134.x; Lance JW, 2000, MED J AUSTRALIA, V172, P450, DOI 10.5694/j.1326-5377.2000.tb124054.x; Lance JW, 1998, MECH MANAGEMENT HEAD; Lassen LH, 1997, LANCET, V349, P401, DOI 10.1016/S0140-6736(97)80021-9; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lee Y, 1999, BRIT J CLIN PHARMACO, V47, P373; Lipton RB, 2000, JAMA-J AM MED ASSOC, V284, P2599, DOI 10.1001/jama.284.20.2599; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lipton RB, 1998, HEADACHE, V38, P87, DOI 10.1046/j.1526-4610.1998.3802087.x; Lipton RB, 2000, ARCH INTERN MED, V160, P3486, DOI 10.1001/archinte.160.22.3486; Lipton RB, 1998, ARCH NEUROL-CHICAGO, V55, P210, DOI 10.1001/archneur.55.2.210; Lipton RB, 1997, NEUROLOGY, V48, pS4, DOI 10.1212/WNL.48.3_Suppl_3.4S; Lipton RB, 1999, HEADACHE, V39, pS9, DOI 10.1111/j.1526-4610.1999.00003.x; Lipton RB, 2000, HEADACHE, V40, P783, DOI 10.1046/j.1526-4610.2000.00143.x; Longmore J, 1997, CEPHALALGIA, V17, P833, DOI 10.1046/j.1468-2982.1997.1708833.x; MARTINS IP, 1993, HEADACHE, V33, P227, DOI 10.1111/j.1526-4610.1993.hed3305227.x; Mathew NT, 2001, HEADACHE, V41, P119, DOI 10.1046/j.1526-4610.2001.111006119.x; May A, 1998, BRAIN, V121, P1231, DOI 10.1093/brain/121.7.1231; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; May A, 1996, PAIN, V67, P375, DOI 10.1016/0304-3959(96)03137-5; May A, 2001, J CEREBR BLOOD F MET, V21, P1171, DOI 10.1097/00004647-200110000-00005; McNaughton FL, 1977, PHYSL ASPECTS CLIN N, P279; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; Menken M, 2000, ARCH NEUROL-CHICAGO, V57, P418, DOI 10.1001/archneur.57.3.418; MILTON KA, 1997, CEPHALALGIA, V17, P414; Morgan P, 1997, CEPHALALGIA, V17, P414; MOSKOWITZ MA, 1993, ANNU REV MED, V44, P145, DOI 10.1146/annurev.med.44.1.145; MOSKOWITZ MA, 1992, TRENDS PHARMACOL SCI, V13, P307, DOI 10.1016/0165-6147(92)90097-P; NICHOLS FT, 1993, HEADACHE, V33, P87, DOI 10.1111/j.1526-4610.1993.hed3302087.x; Norman B, 1998, CEPHALALGIA, V18, P407; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Ophoff RA, 1998, TRENDS PHARMACOL SCI, V19, P121, DOI 10.1016/S0165-6147(98)01182-1; Palmer KJ, 1997, CNS DRUGS, V7, P468, DOI 10.2165/00023210-199707060-00005; Penfield W, 1940, ARCH NEURO PSYCHIATR, V44, P43, DOI 10.1001/archneurpsyc.1940.02280070051003; PILGRIM AJ, 1991, EUR NEUROL, V31, P295, DOI 10.1159/000116757; PLOSKER GL, 1994, DRUGS, V47, P622, DOI 10.2165/00003495-199447040-00006; Potter DL, 2000, NEUROLOGY, V54, pA15; Pregenzer JF, 1999, BRIT J PHARMACOL, V127, P468, DOI 10.1038/sj.bjp.0702532; Ramadan NM, 2001, CEPHALALGIA, V21, P267; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; Roon KI, 2000, ANN NEUROL, V47, P238, DOI 10.1002/1531-8249(200002)47:2<238::AID-ANA15>3.3.CO;2-C; Rothner A., 1997, Journal of the Neurological Sciences, V150, pS106, DOI 10.1016/S0022-510X(97)85361-0; Sciberras DG, 1997, BRIT J CLIN PHARMACO, V43, P450; Seaber E, 1996, BRIT J CLIN PHARMACO, V41, P141, DOI 10.1111/j.1365-2125.1996.tb00172.x; SICUTERI F, 1961, INT ARCH ALLER A IMM, V19, P55, DOI 10.1159/000229194; Silberstein SD, 2000, NEUROLOGY, V54, P1553, DOI 10.1212/WNL.54.8.1553; Silberstein SD, 1996, HEADACHE, V36, P547, DOI 10.1046/j.1526-4610.1996.3609547.x; Silberstein SD., 1998, HEADACHE CLIN PRACTI; Smith D, 1998, J NEUROSCI METH, V80, P155, DOI 10.1016/S0165-0270(97)00209-4; Steiner TJ, 1999, CEPHALALGIA, V19, P305; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x; Tepper SJ, 1998, INT J CLIN PRACT, V52, P31; Terwindt GM, 2001, NEUROLOGY, V56, P1028, DOI 10.1212/WNL.56.8.1028; Tfelt-Hansen P, 2000, CEPHALALGIA, V20, P765; Tfelt-Hansen P, 2000, BRAIN, V123, P9, DOI 10.1093/brain/123.1.9; TFELTHANSEN P, 1995, LANCET, V346, P923, DOI 10.1016/S0140-6736(95)91554-0; TFELTHANSEN P, 1984, CEPHALALGIA, V4, P107, DOI 10.1046/j.1468-2982.1984.0402107.x; Thomsen LL, 1996, CEPHALALGIA, V16, P270, DOI 10.1046/j.1468-2982.1996.1604270.x; Ueberall MA, 1999, NEUROLOGY, V52, P1507, DOI 10.1212/WNL.52.7.1507; VanDenBrink AM, 1998, CIRCULATION, V98, P25, DOI 10.1161/01.CIR.98.1.25; VISSER WH, 1992, CEPHALALGIA, V12, P308, DOI 10.1046/j.1468-2982.1992.1205308.x; Visser WH, 1996, NEUROLOGY, V47, P46, DOI 10.1212/WNL.47.1.46; VOLANS GN, 1974, BRIT MED J, V4, P265, DOI 10.1136/bmj.4.5939.265; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; WELCH KMA, 1986, CEPHALALGIA, V6, P85, DOI 10.1177/03331024860060S411; WELCH KMA, 1993, NEW ENGL J MED, V329, P1476; Welch KMA, 2001, CEPHALALGIA, V21, P164; Welch KMA, 2000, CEPHALALGIA, V20, P687, DOI 10.1046/j.1468-2982.2000.00116.x; Winner P, 1999, PEDIATRICS, V104, P694; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; [No title captured]	145	1283	1351	3	224	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					257	270		10.1056/NEJMra010917	http://dx.doi.org/10.1056/NEJMra010917			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807151				2022-12-28	WOS:000173398900007
J	Ulusakarya, A				Ulusakarya, A			Aspergilloma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Inst Gustave Roussy, F-94805 Villejuif, France	UNICANCER; Gustave Roussy	Ulusakarya, A (corresponding author), Inst Gustave Roussy, Rue Camille Desmoulins, F-94805 Villejuif, France.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					256	256		10.1056/NEJMicm980601	http://dx.doi.org/10.1056/NEJMicm980601			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807150				2022-12-28	WOS:000173398900006
J	Walsh, TJ; Pappas, P; Winston, DJ; Lazarus, HM; Petersen, F; Raffalli, J; Yanovich, S; Stiff, P; Greenberg, R; Donowitz, G; Lee, J				Walsh, TJ; Pappas, P; Winston, DJ; Lazarus, HM; Petersen, F; Raffalli, J; Yanovich, S; Stiff, P; Greenberg, R; Donowitz, G; Lee, J		Natl Inst Allergy Infect Dis Mycos	Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO ACTIVITY; CANCER-PATIENTS; INVASIVE ASPERGILLOSIS; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; PROLONGED FEVER; FLUCONAZOLE; MULTICENTER; AGENTS; SPECTRUM	Background: Patients with neutropenia and persistent fever are often treated empirically with amphotericin B or liposomal amphotericin B to prevent invasive fungal infections. Antifungal triazoles offer a potentially safer and effective alternative. Methods: In a randomized, international, multicenter trial, we compared voriconazole, a new second-generation triazole, with liposomal amphotericin B for empirical antifungal therapy. Results: A total of 837 patients (415 assigned to voriconazole and 422 to liposomal amphotericin B) were evaluated for success of treatment. The overall success rates were 26.0 percent with voriconazole and 30.6 percent with liposomal amphotericin B (95 percent confidence interval for the difference, -10.6 to 1.6 percentage points); these rates were independent of the administration of antifungal prophylaxis or the use of colony-stimulating factors. There were fewer documented breakthrough fungal infections in patients treated with voriconazole than in those treated with liposomal amphotericin B (8 [1.9 percent] vs. 21 [5.0 percent], P=0.02). The voriconazole group had fewer cases of severe infusion-related reactions (P<0.01) and of nephrotoxicity (P<0.001). The incidence of hepatotoxicity was similar in the two groups. Patients receiving voriconazole had more episodes of transient visual changes than those receiving liposomal amphotericin B (22 percent vs. 1 percent, P<0.001) and more hallucinations (4.3 percent vs. 0.5 percent, P<0.001). Parenteral voriconazole was changed to the oral formulation in 22 percent of the voriconazole group, with a reduction in the mean duration of hospitalization by one day in all patients (P=0.17) but by two days in patients at high risk (P=0.03). Conclusions: Voriconazole is a suitable alternative to amphotericin B preparations for empirical antifungal therapy in patients with neutropenia and persistent fever. (N Engl J Med 2002;346:225-34.) Copyright (C) 2002 Massachusetts Medical Society.	NCI, Immunocompromised Host Sect, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Utah, Salt Lake City, UT USA; New York Med Coll, New York, NY USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA; Loyola Univ, Med Ctr, Chicago, IL 60611 USA; Univ Kentucky, Lexington, KY USA; Univ Virginia, Charlottesville, VA USA; NIAID, Mycoses Study Grp, Birmingham, AL USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Cooper Hosp, Camden, NJ 08103 USA; Univ Florida, Gainesville, FL USA; Mayo Clin, Rochester, MN USA; Med Ctr Delaware, Newark, DE USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; Duke Univ, Durham, NC USA; Univ Ottawa, Ottawa, ON, Canada; Osped ASL Pescara, Pescara, Italy; Univ Arkansas, Little Rock, AR 72204 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; University Hospitals of Cleveland; Utah System of Higher Education; University of Utah; New York Medical College; Virginia Commonwealth University; Loyola University Chicago; University of Kentucky; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of Florida; Mayo Clinic; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Universite de Montreal; Duke University; University of Ottawa; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Walsh, TJ (corresponding author), NCI, Immunocompromised Host Sect, Bldg 10,Rm 13N240, Bethesda, MD 20892 USA.		Stiff, Patrick/S-2676-2019	Wingard, John/0000-0001-7478-5398	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI065296] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-65296] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRIOLE VT, 1993, CLIN INFECT DIS, V17, pS481, DOI 10.1093/clinids/17.Supplement_2.S481; ARNING M, 1995, EUR J CLIN MICROBIOL, V14, P41, DOI 10.1007/BF02112616; ASCIOGLU S, IN PRESS CLIN INFECT; BergogneBerezin E, 1995, PULM PHARMACOL, V8, P65, DOI 10.1006/pulp.1995.1009; Boogaerts M, 2001, ANN INTERN MED, V135, P412, DOI 10.7326/0003-4819-135-6-200109180-00010; Espinel-Ingroff A, 1998, J CLIN MICROBIOL, V36, P198, DOI 10.1128/JCM.36.1.198-202.1998; EspinelIngroff A, 1997, J CLIN MICROBIOL, V35, P139, DOI 10.1128/JCM.35.1.139-143.1997; Gage R, 1998, J PHARMACEUT BIOMED, V17, P1449, DOI 10.1016/S0731-7085(98)00004-1; GUIOT HFL, 1994, CLIN INFECT DIS, V18, P525, DOI 10.1093/clinids/18.4.525; HERBRECHT R, 2001, 41 INT C ANT AG CHEM; Hossain MA, 2000, EXPERT OPIN INV DRUG, V9, P1797, DOI 10.1517/13543784.9.8.1797; Hughes WT, 1997, CLIN INFECT DIS, V25, P551, DOI 10.1086/513764; Johnson MD, 1998, PHARMACOTHERAPY, V18, P1053; KARP JE, 1991, REV INFECT DIS, V13, P592; Malik IA, 1998, AM J MED, V105, P478, DOI 10.1016/S0002-9343(98)00326-X; McGinnis MR, 1998, MED MYCOL, V36, P239, DOI 10.1046/j.1365-280X.1998.00153.x; MEUNIER F, 1989, AM J MED, V86, P668; [NCCLS]National Committee for Clinical Laboratory Standards, 1997, M27A NCCLS; PANNUTI C, 1992, CANCER-AM CANCER SOC, V69, P2653, DOI 10.1002/1097-0142(19920601)69:11<2653::AID-CNCR2820691106>3.0.CO;2-8; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; PERFECT JA, 2000, 38 ANN M INF DIS SOC; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; PIZZO PA, 1982, AM J MED, V72, P101, DOI 10.1016/0002-9343(82)90594-0; Prentice HG, 1997, BRIT J HAEMATOL, V98, P711, DOI 10.1046/j.1365-2141.1997.2473063.x; Rex JH, 2000, CLIN INFECT DIS, V30, P662, DOI 10.1086/313749; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Ribaud P, 1999, CLIN INFECT DIS, V28, P322, DOI 10.1086/515116; RIBRAG V, 1993, LEUKEMIA LYMPHOMA, V10, P317, DOI 10.3109/10428199309148554; SCHLAMM HT, 2000, 38 ANN M INF DIS SOC; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; VARTIVARIAN SE, 1993, CLIN INFECT DIS, V17, pS487, DOI 10.1093/clinids/17.Supplement_2.S487; Viscoli C, 1996, EUR J CANCER, V32A, P814, DOI 10.1016/0959-8049(95)00619-2; Walsh TJ, 1998, ANTIMICROB AGENTS CH, V42, P2391, DOI 10.1128/AAC.42.9.2391; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004; WALSH TJ, 2000, 40 INT C ANT AG CHEM; Winston DJ, 2000, AM J MED, V108, P282, DOI 10.1016/S0002-9343(99)00457-X; Wong-Beringer A, 1998, CLIN INFECT DIS, V27, P603, DOI 10.1086/514704	37	698	747	3	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					225	234		10.1056/NEJM200201243460403	http://dx.doi.org/10.1056/NEJM200201243460403			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807146	Green Published			2022-12-28	WOS:000173398900002
J	Schapowal, A				Schapowal, A		Petasites Study Grp	Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; ST-JOHNS WORT; LEUKOTRIENE-SYNTHESIS; FRENCH VERSION; EXTRACT	Objectives To compare the efficacy and tolerability of butterbur (Petasites hybridus) with cetirizine in patients with seasonal allergic rhinitis (hay fever). Design Randomised, double blind, parallel group comparison. Setting Four outpatient general medicine and allergy clinics in Switzerland and Germany. Participants 131 patients were screened for seasonal allergic rhinitis and 125 patients were randomised (butterbur 61; cetirizine 64). Interventions Butterbur (carbon dioxide extract tablets, ZE 339) one tablet, four dines daily, or cetirizine, one tablet hi the evening, both given for two consecutive weeks. Main outcome measures Scores on SF-36 questionnaire and clinical global impression scale. Results Improvement in SF-36 score was similar in the two treatment groups for all items tested hierarchically. Butterbur and cetirizine were also similarly effective with regard to global improvement scores on the clinical global impression scale (median score 3 in both groups). Both treatments were well tolerated. ha the cetirizine group, two thirds (8/12) of reported adverse events were associated with sedative effects (drowsiness and fatigue) despite the drug being considered a non-sedating antihistamine. Conclusions The effects of butterbur arc similar to those of cetirizine in patients with seasonal allergic rhinitis when evaluated blindly by patients and doctors. Butterbur should be considered for treating seasonal allergic rhinitis when the sedative effects of antihistamines need to be avoided.	Allergy Clin, CH-7302 Landquart, Switzerland		Schapowal, A (corresponding author), Allergy Clin, Hochwangstr 3, CH-7302 Landquart, Switzerland.	andreas.chapowal@freesurf.ch						ABT K, 1987, METHOD INFORM MED, V26, P77; BERMAN BA, 1988, J ALLERGY CLIN IMMUN, V81, P980, DOI 10.1016/0091-6749(88)90165-0; BICKEL D, 1994, PLANTA MED, V60, P318, DOI 10.1055/s-2006-959492; BOUSQUET J, 1994, J ALLERGY CLIN IMMUN, V94, P182, DOI 10.1016/0091-6749(94)90038-8; Bousquet J, 1996, J ALLERGY CLIN IMMUN, V98, P309, DOI 10.1016/S0091-6749(96)70155-0; *BRIT MED ASS ROYA, 1998, BRIT NAT FORM; BRUNE K, 1993, PLANTA MED, V59, P494, DOI 10.1055/s-2006-959746; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; Meier B., 1994, HAGERS HDB PHARMAZEU, P81; Schellenberg R, 2001, BRIT MED J, V322, P134, DOI 10.1136/bmj.322.7279.134; Thomet OAR, 2001, BIOCHEM PHARMACOL, V61, P1041, DOI 10.1016/S0006-2952(01)00552-4; Wheatley D, 1997, PHARMACOPSYCHIATRY, V30, P77, DOI 10.1055/s-2007-979523; Woelk H, 2000, BMJ-BRIT MED J, V321, P536, DOI 10.1136/bmj.321.7260.536	14	79	82	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2002	324	7330					144	146		10.1136/bmj.324.7330.144	http://dx.doi.org/10.1136/bmj.324.7330.144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799030	Green Published, Bronze			2022-12-28	WOS:000173470600017
J	Ghosh, A				Ghosh, A			Learning more about NMDA receptor regulation	SCIENCE			English	Editorial Material							EPH RECEPTORS		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.							Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7	7	27	28	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					449	+		10.1126/science.1069391	http://dx.doi.org/10.1126/science.1069391			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799227				2022-12-28	WOS:000173350700033
J	Kaplan, AP				Kaplan, AP			Chronic urticaria and angioedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC IDIOPATHIC URTICARIA; FC-EPSILON-RI; HISTAMINE-RELEASE; CONTROLLED TRIAL; DOUBLE-BLIND; CETIRIZINE; AUTOANTIBODIES; EFFICACY; PLACEBO; CYCLOSPORINE		Med Univ S Carolina, Dept Med, Div Pulm & Crit Care Med & Allergy & Clin Immunol, Charleston, SC 29425 USA; Med Univ S Carolina, Konishi Med Univ S Carolina Inst Inflammat Res, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Kaplan, AP (corresponding author), Med Univ S Carolina, Dept Med, Div Pulm & Crit Care Med & Allergy & Clin Immunol, 96 Johnathan Lucas St,Suite 812 CSD,POB 250623, Charleston, SC 29425 USA.	kaplana@musc.edu						ANDRI L, 1993, ALLERGY, V48, P358, DOI 10.1111/j.1398-9995.1993.tb02406.x; BRENEMAN D, 1995, J AM ACAD DERMATOL, V33, P192, DOI 10.1016/0190-9622(95)90233-3; Breneman DL, 1996, ANN PHARMACOTHER, V30, P1075, DOI 10.1177/106002809603001001; BRUNET C, 1990, J ALLERGY CLIN IMMUN, V86, P787, DOI 10.1016/S0091-6749(05)80184-8; ELIAS J, 1986, J ALLERGY CLIN IMMUN, V78, P914, DOI 10.1016/0091-6749(86)90240-X; Ellis MH, 1998, J ALLERGY CLIN IMMUN, V102, P876, DOI 10.1016/S0091-6749(98)70032-6; Ferrer M, 1998, J ALLERGY CLIN IMMUN, V101, P672, DOI 10.1016/S0091-6749(98)70176-9; Ferrer M, 1998, J ALLERGY CLIN IMMUN, V101, pS154; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; Finn AF, 1999, J ALLERGY CLIN IMMUN, V104, P1071, DOI 10.1016/S0091-6749(99)70091-6; FRADIN MS, 1991, J AM ACAD DERMATOL, V25, P1065, DOI 10.1016/0190-9622(91)70308-O; Gaig P, 2000, J INVEST ALLERG CLIN, V10, P342; GOLDSOBEL AB, 1986, J ALLERGY CLIN IMMUN, V78, P867, DOI 10.1016/0091-6749(86)90232-0; GRATTAN CEH, 1992, LANCET, V339, P1078, DOI 10.1016/0140-6736(92)90666-Q; Greaves M W., 2001, ALLERGY CLIN IMMUNOL, V13, P23; GRUBER BL, 1988, J INVEST DERMATOL, V90, P213, DOI 10.1111/1523-1747.ep12462239; HARVEY RP, 1981, J ALLERGY CLIN IMMUN, V68, P262, DOI 10.1016/0091-6749(81)90149-4; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; KALIVAS J, 1990, J ALLERGY CLIN IMMUN, V86, P1014, DOI 10.1016/S0091-6749(05)80246-5; Kaplan AP, 1999, CAN J ALLERGY CLIN I, V4, P286; KAPLAN AP, 1998, ALLERGY PRINCIPLES P, V2, P1104; KIKUCHI Y, IN PRESS J ALLERGY C; LEZNOFF A, 1989, J ALLERGY CLIN IMMUN, V84, P66, DOI 10.1016/0091-6749(89)90180-2; LICHTENSTEIN LM, 1975, J PHARMACOL EXP THER, V192, P441; Monroe EW, 1997, CLIN THER, V19, P232, DOI 10.1016/S0149-2918(97)80112-9; Nelson HS, 2000, ANN ALLERG ASTHMA IM, V84, P517, DOI 10.1016/S1081-1206(10)62515-X; O'Donnell BF, 1998, BRIT J DERMATOL, V138, P101; Sabroe RA, 1999, J ALLERGY CLIN IMMUN, V103, P484, DOI 10.1016/S0091-6749(99)70475-6; Spector S, 1998, J ALLERGY CLIN IMMUN, V101, P572; Toubi E, 1997, ALLERGY, V52, P312, DOI 10.1111/j.1398-9995.1997.tb00996.x; WANDERER AA, 2000, ANN ALLERG ASTHMA IM, V85, P521; Weiler JM, 2000, ANN INTERN MED, V132, P354, DOI 10.7326/0003-4819-132-5-200003070-00004	32	249	263	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					175	179		10.1056/NEJMcp011186	http://dx.doi.org/10.1056/NEJMcp011186			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796852				2022-12-28	WOS:000173273600006
J	Barry, MJ				Barry, MJ			Health decision aids to facilitate shared decision making in office practice	ANNALS OF INTERNAL MEDICINE			English	Article							BENIGN PROSTATIC HYPERPLASIA; CONTROLLED-TRIAL; CURRENT CONTROVERSY; BREAST-CANCER; PATIENT PARTICIPATION; INFORMED-CONSENT; RANDOMIZED-TRIAL; ANTIGEN TEST; INFORMATION; CARE	For medical decisions with more than one reasonable option, patient participation in decision making is often necessary to optimally match management decisions with patient preferences. Health decision aids are designed to facilitate shared decision making by helping patients and their physicians choose among: reasonable clinical options. Although these aids vary in content, common denominators are the presentation of more than one reasonable strategy for a clinical management question and a description of the possible outcomes of the various options. Although the number of published randomized trials assessing the impact of health decision aids on the quality of medical decisions is limited (but growing), various types of decision aids do generally appear to inform patients about their treatment options better than "usual care" can. Little evidence is available to determine whether one type of decision aid is optimal, but more complicated programs seem to have larger effects. The cost-effectiveness of decision aids has not been studied, although it is enticing to think that the pattern of more conservative decisions by users of some decision aids could reduce medical care costs in a manner that is dictated by patient preferences.	Massachusetts Gen Hosp, Gen Med Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Gen Med Unit, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	mbarry@partners.org						Barry M.J., 1997, DIS MANAG CLIN OUTCO, V1, P5, DOI DOI 10.1016/S1088-3371(96)00004-6; BARRY MJ, 1995, MED CARE, V33, P771, DOI 10.1097/00005650-199508000-00003; Barry MJ, 1998, ANN ONCOL, V9, P1279, DOI 10.1093/oxfordjournals.annonc.a010952; Bernstein Steven J., 1998, Health Expect, V1, P50, DOI 10.1046/j.1369-6513.1998.00007.x; Braddock CH, 1997, J GEN INTERN MED, V12, P339, DOI 10.1046/j.1525-1497.1997.00057.x; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Chan ECY, 1998, AM J MED, V105, P266, DOI 10.1016/S0002-9343(98)00257-5; CLANCY CM, 1988, AM J MED, V84, P283, DOI 10.1016/0002-9343(88)90426-3; COCKETT ATK, 1992, CANCER, V70, P280, DOI 10.1002/1097-0142(19920701)70:1+<280::AID-CNCR2820701315>3.0.CO;2-E; Davison BJ, 1999, PATIENT EDUC COUNS, V37, P255, DOI 10.1016/S0738-3991(98)00123-2; de Koning HJ, 1998, ANN ONCOL, V9, P1293, DOI 10.1023/A:1008428327309; Deber RB, 1996, ARCH INTERN MED, V156, P1414, DOI 10.1001/archinte.156.13.1414; DEBER RB, 1994, CAN MED ASSOC J, V151, P423; Edwards A, 1999, MED DECIS MAKING, V19, P428, DOI 10.1177/0272989X9901900411; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Entwistle V A, 1998, J Health Serv Res Policy, V3, P100; Fletcher SW, 1997, NEW ENGL J MED, V336, P1180, DOI 10.1056/NEJM199704173361612; Flood AB, 1996, J GEN INTERN MED, V11, P342, DOI 10.1007/BF02600045; Frosch DL, 2001, J GEN INTERN MED, V16, P391, DOI 10.1046/j.1525-1497.2001.016006391.x; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; HERRERA AJ, 1983, PEDIATRICS, V71, P233; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; HolmesRovner M, 1996, MED DECIS MAKING, V16, P58, DOI 10.1177/0272989X9601600114; Kopans DB, 1999, RADIOLOGY, V210, P4, DOI 10.1148/radiology.210.1.r99ja504; Laine C, 1996, ANN INTERN MED, V125, P640, DOI 10.7326/0003-4819-125-8-199610150-00003; Lerman C, 1997, JNCI-J NATL CANCER I, V89, P148, DOI 10.1093/jnci/89.2.148; Levinson W, 1999, SURGERY, V125, P127, DOI 10.1067/msy.2099.94990; LLEWELLYNTHOMAS HA, 1995, MED DECIS MAKING, V15, P101, DOI 10.1177/0272989X9501500201; MAISELS MJ, 1983, PEDIATRICS, V71, P453; Michie S, 1997, BRIT J HEALTH PSYCH, V2, P317, DOI 10.1111/j.2044-8287.1997.tb00545.x; Molenaar S, 2000, MED DECIS MAKING, V20, P112, DOI 10.1177/0272989X0002000114; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; MULLEY AG, 1995, J CLIN OUTCOMES MANA, V2, P9; Neal DE, 1998, ANN ONCOL, V9, P1289, DOI 10.1023/A:1008487912288; O'Connor AM, 1998, MED DECIS MAKING, V18, P295, DOI 10.1177/0272989X9801800307; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; O'Dell KJ, 1999, J FAM PRACTICE, V48, P682; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; PHILLIPS C, 1995, ANGLE ORTHOD, V65, P263; Rothert ML, 1997, RES NURS HEALTH, V20, P377, DOI 10.1002/(SICI)1098-240X(199710)20:5<377::AID-NUR2>3.0.CO;2-L; Schapira MM, 2000, J FAM PRACTICE, V49, P418; STREET RL, 1995, CANCER, V76, P2275, DOI 10.1002/1097-0142(19951201)76:11<2275::AID-CNCR2820761115>3.0.CO;2-S; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Svetec D, 1998, ANN ONCOL, V9, P1283, DOI 10.1023/A:1008446208963; THORNTON JG, 1995, BMJ-BRIT MED J, V311, P1127, DOI 10.1136/bmj.311.7013.1127; Volk RJ, 1998, MED DECIS MAKING, V18, P477; Volk RJ, 2000, J FAM PRACTICE, V49, P425; Volk RJ, 1999, ARCH FAM MED, V8, P333, DOI 10.1001/archfami.8.4.333; Weinstein MC, 1980, CLIN DECISION ANAL; WILKINS E, 1999, MED DECIS MAKING, V19, P525; Wilt T J, 1997, Oncology (Williston Park), V11, P1133; Wolf AMD, 1996, ARCH INTERN MED, V156, P1333, DOI 10.1001/archinte.156.12.1333	53	166	170	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					127	135		10.7326/0003-4819-136-2-200201150-00010	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512PZ	11790064				2022-12-28	WOS:000173333900005
J	Chen, WZ; Shimada, S; Tanaka, M				Chen, WZ; Shimada, S; Tanaka, M			Synthesis and structure of formally hexavalent palladium complexes	SCIENCE			English	Article							TRANSITION-METAL HEXAFLUORIDES; DIPALLADIUM COMPLEXES; BIS-SILYLATION; LIGANDS; BONDS; 1,2-DISILYLBENZENE; CATALYSIS; STATE	Formally hexavalent palladium complexes have been isolated and structurally characterized for the first time. Thermal condensation reaction of three molecules of 1,2-C6H4(SiH2)(2)Pd-11(R2PCH2CH2PR2) (where R is defined as a methyl or ethyl) provided trinuclear palladium complexes. Single-crystal x-ray analysis revealed that each of the central palladium atoms of the complexes is ligated by six silicon atoms and is hexavalent, whereas the other palladium atoms are divalent.	Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki 3058565, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, S (corresponding author), Natl Inst Adv Ind Sci & Technol AIST, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.		Chen, Wanzhi/G-4127-2011; Shimada, Shigeru/S-6057-2016	Chen, Wanzhi/0000-0002-7076-1521; Shimada, Shigeru/0000-0001-7081-6759				BRISDON AK, 1992, J CHEM SOC DALTON, P139, DOI 10.1039/dt9920000139; Brookhart M, 2000, ANGEW CHEM INT EDIT, V39, P1676, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1676::AID-ANIE1676>3.0.CO;2-M; BURKE LD, 1993, J ELECTROCHEM SOC, V140, P1284, DOI 10.1149/1.2220972; CANTY AJ, 1992, ACCOUNTS CHEM RES, V25, P83, DOI 10.1021/ar00014a005; Chen W., UNPUB; Chen WZ, 2001, CHEM LETT, P1096, DOI 10.1246/cl.2001.1096; Corey JY, 1999, CHEM REV, V99, P175, DOI 10.1021/cr9701086; COTTON FA, 1999, ADV INORG CHEM, pCH16; CRABTREE RH, 1993, ANGEW CHEM INT EDIT, V32, P789, DOI 10.1002/anie.199307891; CRABTREE RH, 1994, ORGANOMETALLIC CHEM, pCH15; Elsevier CJ, 1999, COORDIN CHEM REV, V185-6, P809, DOI 10.1016/S0010-8545(99)00038-7; FERNANDEZ MJ, 1982, J CHEM SOC CHEM COMM, P310, DOI 10.1039/c39820000310; Han LB, 1999, CHEM COMMUN, P395, DOI 10.1039/a806537c; JEONG MC, 1993, J ELECTROCHEM SOC, V140, P1986, DOI 10.1149/1.2220750; Kim YJ, 1998, ORGANOMETALLICS, V17, P4929, DOI 10.1021/om9806390; Kim YJ, 2000, J CHEM SOC DALTON, P417, DOI 10.1039/a907745f; LOZA M, 1995, INORG CHEM, V34, P2937, DOI 10.1021/ic00115a022; Marx R, 1996, J CHEM PHYS, V104, P7658, DOI 10.1063/1.471473; MURAKAMI M, 1994, ORGANOMETALLICS, V13, P2900, DOI 10.1021/om00019a055; PAN Y, 1992, ORGANOMETALLICS, V11, P3495, DOI 10.1021/om00059a005; Shimada S, 1999, ORGANOMETALLICS, V18, P291, DOI 10.1021/om980904h; SHIMADA S, 1995, J AM CHEM SOC, V117, P8289, DOI 10.1021/ja00136a035; Shimada S, 2001, ANGEW CHEM INT EDIT, V40, P213, DOI 10.1002/1521-3773(20010105)40:1<213::AID-ANIE213>3.0.CO;2-W; Shimada S, 1996, ANGEW CHEM INT EDIT, V35, P1856, DOI 10.1002/anie.199618561; Suginome M, 1996, B CHEM SOC JPN, V69, P289, DOI 10.1246/bcsj.69.289; Suginome M, 1996, ORGANOMETALLICS, V15, P2170, DOI 10.1021/om950883g; Suginome M, 1998, ORGANOMETALLICS, V17, P495, DOI 10.1021/om9710778; Tanaka Y, 1997, ORGANOMETALLICS, V16, P3246, DOI 10.1021/om970186j; Tsuji J., 1995, PALLADIUM REAGENTS C; WEINSTOCK B, 1957, J AM CHEM SOC, V79, P5832, DOI 10.1021/ja01578a073; Wesendrup R, 2001, INORG CHEM, V40, P3351, DOI 10.1021/ic010169t	31	84	84	3	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					308	310		10.1126/science.1067027	http://dx.doi.org/10.1126/science.1067027			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786638				2022-12-28	WOS:000173278600043
J	Pichler, A; Gast, A; Seeler, JS; Dejean, A; Melchior, F				Pichler, A; Gast, A; Seeler, JS; Dejean, A; Melchior, F			The nucleoporin RanBP2 has SUMO1 E3 ligase activity	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEAR-PORE COMPLEX; UBIQUITIN; RANGAP1; YEAST; TRANSPORT; SUBSTRATE; HOMOLOG; IMPORT; NUP358	Posttranslational modification with SUMO1 regulates protein/protein interactions, localization, and stability. SUMOylation requires the E1 enzyme Aos1/Uba2 and the E2 enzyme Ubc9. A family of E3-like factors, PIAS proteins, was discovered recently. Here we show that the nucleoporin RanBP2/Nup358 also has SUMO1 E3-like activity. RanBP2 directly interacts with the E2 enzyme Ubc9 and strongly enhances SUMO1-transfer from Ubc9 to the SUMO1 target Sp100. The E3-like activity is contained within a 33 kDa domain of RanBP2 that lacks RING finger motifs and does not resemble PIAS family proteins. Our findings place SUMOylation at the cytoplasmic filaments of the NPC and suggest that, at least for some substrates, modification and nuclear import are linked events.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Inst Pasteur, INSERM, U163, Unite Recombinaison & Express Genet, F-75724 Paris 15, France	Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Melchior, F (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Melchior, Frauke/E-2014-2014; Dejean, Anne/L-5145-2018	Melchior, Frauke/0000-0001-9546-8797; Seeler, Jacob-Sebastian/0000-0001-8209-8555				Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 1998, METH MOL B, V88, P265; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; SAITOH H, 2001, IN PRESS J BIOL CHEM; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; STACHDEV S, 2001, GENE DEV, V15, P3088; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	38	627	654	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					109	120		10.1016/S0092-8674(01)00633-X	http://dx.doi.org/10.1016/S0092-8674(01)00633-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792325	Bronze			2022-12-28	WOS:000173280700012
J	Anversa, P; Nadal-Ginard, B				Anversa, P; Nadal-Ginard, B			Myocyte renewal and ventricular remodelling	NATURE			English	Article							STEM-CELL FACTOR; CYCLIN-DEPENDENT KINASES; MYOBLAST TRANSPLANTATION; TELOMERASE ACTIVITY; CARDIAC MYOCYTES; C-KIT; EXPRESSION; PROLIFERATION; HEART; CARDIOMYOPATHY	Remaining young at heart is a desirable but elusive goal. Unbeknown to us, however, myocyte regeneration may accomplish just that. Continuous cell renewal in the adult myocardium was thought to be impossible, but multipotent cardiac stem cells may be able to renew the myocardium and, under certain circumstances, can be coaxed to repair the broken heart after infarction.	New York Med Coll, Dept Med, Cardiovasc Res Inst, Valhalla, NY 10595 USA	New York Medical College	Anversa, P (corresponding author), New York Med Coll, Dept Med, Cardiovasc Res Inst, Valhalla, NY 10595 USA.	piero_anversa@nymc.edu						Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; ANVERSA P, 2001, HDB PHYSL 2, V1, P75; Bakos E, 2000, J CELL SCI, V113, P4451; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bunting Kevin D., 2000, Blood, V96, P902; Demeule M, 2001, BIOCHEM BIOPH RES CO, V281, P827, DOI 10.1006/bbrc.2001.4312; English A, 2000, J IMMUNOL, V165, P3763, DOI 10.4049/jimmunol.165.7.3763; Geick A, 2001, J Biol Chem, V276, P14581; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Hara E, 1996, MOL CELL BIOL, V16, P859; HIRZEL HO, 1976, CIRC RES, V39, P214, DOI 10.1161/01.RES.39.2.214; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Leri A, 2000, J MOL CELL CARDIOL, V32, P385, DOI 10.1006/jmcc.1999.1084; Leri A, 2001, P NATL ACAD SCI USA, V98, P8626, DOI 10.1073/pnas.151013298; Li JM, 1998, AM J PHYSIOL-HEART C, V275, pH814, DOI 10.1152/ajpheart.1998.275.3.H814; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; MAGGIONI AP, 1993, NEW ENGL J MED, V329, P1442, DOI 10.1056/NEJM199311113292002; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Mattson MP, 2001, J NEUROSCI RES, V63, P1; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Setoguchi M, 1999, LAB INVEST, V79, P1545; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Teyssier-Le Discorde M, 1999, BRIT J HAEMATOL, V107, P247, DOI 10.1046/j.1365-2141.1999.01725.x; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; van Dijk Thamar B., 2000, Blood, V96, P3406; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857	46	346	410	0	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					240	243		10.1038/415240a	http://dx.doi.org/10.1038/415240a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805849				2022-12-28	WOS:000173159300055
J	Konner, M				Konner, M			Seeking universals	NATURE			English	Editorial Material									Emory Univ, Atlanta, GA 30322 USA	Emory University	Konner, M (corresponding author), Emory Univ, Atlanta, GA 30322 USA.							Darwin C., 1998, EXPRESS EMOT MAN, V3rd; EIBLEIBESFELDT I, 1989, HUMAN BIOL; Ekman P.E, 1997, WHAT FACE REVEALS BA; GIFFITHS P, 1997, WHAT EMOTIONS REALLY; Greenberg Joseph., 1978, UNIVERSALS HUMAN LAN	5	5	5	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					121	121		10.1038/415121a	http://dx.doi.org/10.1038/415121a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805812	Bronze			2022-12-28	WOS:000173159300021
J	Kirchner, JW				Kirchner, JW			Evolutionary speed limits inferred from the fossil record	NATURE			English	Article							TIME-SERIES ANALYSIS; SPECTRAL-ANALYSIS; EXTINCTION; RECOVERY; BIODIVERSITY; END	The dynamics of extinction and diversification determine the long-term effects of extinction episodes(1). If rapid bursts of extinction are offset by equally rapid bursts of diversification, their biodiversity consequences will be transient. But if diversification rates cannot accelerate rapidly enough, pulses of extinction will lead to long-lasting depletion of biodiversity(2,3). Here I use spectral analysis of the fossil record to test whether diversification rates can accelerate as much as extinction rates, over both short and long spans of geological time. I show that although the long-wavelength variability of diversification rates equals or exceeds that of extinctions, diversification rates are markedly less variable than extinction rates at wavelengths shorter than roughly 25 million years. This implies that there are intrinsic speed limits that constrain how rapidly diversification rates can accelerate in response to pulses of extinction.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kirchner, JW (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.		Kirchner, James W/B-6126-2009; Kirchner, James/AAC-4707-2019	Kirchner, James W/0000-0001-6577-3619; Kirchner, James/0000-0001-6577-3619				Cartwright M, 1990, FOURIER METHODS MATH; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; FOOTE M, 1994, PALEOBIOLOGY, V20, P424, DOI 10.1017/S0094837300012914; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Foster G, 1996, ASTRON J, V111, P541, DOI 10.1086/117805; GILINSKY NL, 1991, ANAL PALEOBIOLOGY, P157; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Jablonski David, 1995, P25; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 1998, NATURE, V395, P337, DOI 10.1038/26384; Miller AI, 1998, SCIENCE, V281, P1157, DOI 10.1126/science.281.5380.1157; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; NEWELL ND, 1967, GEOL SOC AM SPEC PAP, V89, P63; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; RAUP DM, 1992, PALEOBIOLOGY, V18, P80, DOI 10.1017/S0094837300012227; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Wilson EO, 1999, DIVERSITY LIFE	26	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					65	68		10.1038/415065a	http://dx.doi.org/10.1038/415065a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780116				2022-12-28	WOS:000173028800039
J	Tyner, SD; Venkatachalam, S; Choi, J; Jones, S; Ghebranious, N; Igelmann, H; Lu, XB; Soron, G; Cooper, B; Brayton, C; Park, SH; Thompson, T; Karsenty, G; Bradley, A; Donehower, LA				Tyner, SD; Venkatachalam, S; Choi, J; Jones, S; Ghebranious, N; Igelmann, H; Lu, XB; Soron, G; Cooper, B; Brayton, C; Park, SH; Thompson, T; Karsenty, G; Bradley, A; Donehower, LA			p53 mutant mice that display early ageing-associated phenotypes	NATURE			English	Article							REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; STRESS-RESPONSE; DEFICIENT MICE; DNA-BINDING; FIBROBLASTS; CANCER; TUMORS; BONE; SUPPRESSION	The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53(+/m)) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53(+/+)) littermates. As p53(+/)m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.	Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA; Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Sanger Ctr, Cambridge CB10 1SA, Cambs, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Heinrich Pette Institute; University of Hamburg; Wellcome Trust Sanger Institute	Donehower, LA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	larryd@bcm.tmc.edu		Bradley, Allan/0000-0002-2349-8839				ARKING R, 1998, BIOL AGING; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bond J, 1996, ONCOGENE, V13, P2097; BOND JA, 1994, ONCOGENE, V9, P1885; Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chuttani Anjali, 1995, P309; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; GERSTEIN AD, 1993, DERMATOL CLIN, V11, P749, DOI 10.1016/S0733-8635(18)30227-4; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; HARRISON DE, 1988, EXP GERONTOL, V23, P309, DOI 10.1016/0531-5565(88)90034-4; HARRISON DE, 1992, CURR TOP MICROBIOL, V177, P13; Harvey RC, 1999, VET CLIN N AM-SMALL, V29, P683, DOI 10.1016/S0195-5616(99)50055-7; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hogan B., 1994, MANIPULATING MOUSE E, P189; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Kalu Dike N., 1995, P395; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Muravchick Stanley, 1997, P1125; PURDIE CA, 1994, ONCOGENE, V9, P603; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; SHOCK NW, 1983, J CHRON DIS, V36, P137, DOI 10.1016/0021-9681(83)90053-X; Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; WEISS A, 1991, BONE, V12, P165, DOI 10.1016/8756-3282(91)90039-L; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000	44	1117	1177	6	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					45	53		10.1038/415045a	http://dx.doi.org/10.1038/415045a			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780111				2022-12-28	WOS:000173028800034
J	Habas, R; Kato, Y; He, X				Habas, R; Kato, Y; He, X			Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1	CELL			English	Article							PLANAR CELL POLARITY; CONVERGENT EXTENSION MOVEMENTS; SIGNALING SPECIFICITY; TISSUE POLARITY; DORSAL CLOSURE; BETA-CATENIN; SMALL GTPASE; WNT; DROSOPHILA; KINASE	Wnt signaling via the Frizzled (Fz) receptor controls cell polarity and movement during development, but the molecular nature of Wnt/Fz polarity signal transduction remains poorly defined. Here we report that in human cells and during Xenopus embryogenesis, Wnt/Fz signaling activates the small GTPase Rho, a key regulator of cytoskeleton architecture. Wnt/Fz activation of Rho requires the cytoplasmic protein Dishevelled (Dvl) and a novel Formin homology protein Daam1. Daam1 binds to both DvI and Rho, and mediates Wnt-induced DvI-Rho complex formation. Inhibition or depletion of Daam1 prevents Wnt/Fz activation of Rho and of Xenopus gastrulation, but not of beta -catenin signaling. Our study illustrates a molecular pathway from Wnt/Fz signaling to Rho activation in cell polarity signal transduction.	Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; NICHHD, Genet Mol Lab, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	He, X (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA.	xi.he@tch.harvard.edu						ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Djiane A, 2000, DEVELOPMENT, V127, P3091; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; GUBB D, 1993, DEVELOPMENT, P269; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1994, J BIOL CHEM, V269, P62; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kato Y, 1999, J NEUROSCI, V19, P9364; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	61	636	644	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					843	854		10.1016/S0092-8674(01)00614-6	http://dx.doi.org/10.1016/S0092-8674(01)00614-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779461	Bronze			2022-12-28	WOS:000173024200006
J	Boutis, K; Komar, L; Jaramillo, D; Babyn, P; Alman, B; Snyder, B; Mandl, KD; Schuh, S				Boutis, K; Komar, L; Jaramillo, D; Babyn, P; Alman, B; Snyder, B; Mandl, KD; Schuh, S			Sensitivity of a clinical examination to predict need for radiography in children with ankle injuries: a prospective study	LANCET			English	Article							PHYSEAL FRACTURE-SEPARATIONS; GROWTH-PLATE; DECISION RULES; RABBITS; VALIDATION	Background Radiographs are ordered routinely for children with ankle trauma. We assessed the predictive value of a clinical examination to identify a predefined group of low-risk injuries, management of which would not be affected by absence of a radiograph, We aimed to show that no more than 1% of children with low-risk examinations (signs restricted to the distal fibula) would have high-risk fractures (all fractures except avulsion, buckle, and non-displaced Salter-Harris I and II fractures of the distal fibula), and to compare the potential reduction in radiography in children with low-risk examinations with that obtained by application of the Ottawa ankle rules (OAR). Methods Standard clinical examinations and subsequent radiographs were prospectively and independently evaluated in two tertiary-care paediatric emergency departments in North America. Eligible participants were healthy children aged 3-16 years with acute ankle injuries. Sample size, negative and positive predictive values, sensitivity, and specificity were calculated. McNemar's test was used to compare differences in the potential reduction in radiographs between the low-risk examination and the OAR. Findings 607 children were enrolled; 581 (95.7%) received follow-up. None of the 381 children with low-risk examinations had a high-risk fracture (negative predictive value 100% [95% CI 99.2-100]; sensitivity 100% [93.3-100]). Radiographs could be omitted in 62.8% of children with low-risk examinations, compared with only 12.0% reduction obtained by application of the OAR (P<0.0001). Interpretation A low-risk clinical examination in children with ankle injuries identifies 100% of high-risk diagnoses and may result in greater reduction of radiographic referrals than the OAR.	Univ Toronto, Hosp Sick Children, Div Emergency Med, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Div Diagnost Imaging, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Div Orthoped Surg, Toronto, ON M5G 1X8, Canada; Harvard Univ, Childrens Hosp, Sch Med, Div Emergency Med, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Div Diagnost Imaging, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Div Orthoped Surg, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Boutis, K (corresponding author), Univ Toronto, Hosp Sick Children, Div Emergency Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							Anderson A., 2000, TB PAEDIAT EMERGENCY, V4th, P321; CHANDE VT, 1995, ARCH PEDIAT ADOL MED, V149, P255, DOI 10.1001/archpedi.1995.02170150035005; HOPPENFELD S, 1976, PHYSICAL EXAMINATION, P217; JARAMILLO D, 1993, RADIOLOGY, V187, P171, DOI 10.1148/radiology.187.1.8451408; Jaramillo D, 2000, RADIOLOGY, V215, P504, DOI 10.1148/radiology.215.2.r00ap50504; JARAMILLO D, 1992, AM J ROENTGENOL, V158, P1105, DOI 10.2214/ajr.158.5.1566676; JARAMILLO D, 1990, RADIOLOGY, V175, P767, DOI 10.1148/radiology.175.3.2343128; Libetta C, 1999, J ACCID EMERG MED, V16, P342; MCCLAVE J, 1988, ESTIMATION TESTS HYP, P383; MIZUTA T, 1987, J PEDIATR ORTHOPED, V7, P518, DOI 10.1097/01241398-198709000-00003; PIINT A, 1999, ACAD EMERG MED, V6, P1005; SMITH BG, 1994, J PEDIATR ORTHOPED, V14, P526, DOI 10.1097/01241398-199407000-00021; SPIEGEL PG, 1978, J BONE JOINT SURG AM, V60, P1046, DOI 10.2106/00004623-197860080-00004; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1992, ANN EMERG MED, V21, P386; Van Laarhoven C J, 1996, Ned Tijdschr Geneeskd, V140, P2337	17	65	66	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2118	2121		10.1016/S0140-6736(01)07218-X	http://dx.doi.org/10.1016/S0140-6736(01)07218-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784626				2022-12-28	WOS:000172905800010
J	Vinken, P				Vinken, P			How the heart was held in medieval art	LANCET			English	Article											Vinken, P (corresponding author), Bentveldsweg 142, NL-2111 EE Aerdenhout, Netherlands.							BANRET P, 1997, IMAGES IVORY, P227; KAFTAL G, 1952, ICONOGRAPHY SAINTS T, P78; KOECHLIN R, 1924, IVOIRES GOTHIQUES FR, P1109; Muller Markus, 1996, MINNEBILDER FRANZOSI; POPEHENNESSY J, 1974, FRA ANGELICO, P189; VINKEN P, 2000, SHAPE HEART, P34	6	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2155	2157		10.1016/S0140-6736(01)07224-5	http://dx.doi.org/10.1016/S0140-6736(01)07224-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	505GV	11784647				2022-12-28	WOS:000172905800031
J	Muellbacher, W; Ziemann, U; Wissel, J; Dang, N; Kofler, M; Facchini, S; Boroojerdi, B; Poewe, W; Hallett, M				Muellbacher, W; Ziemann, U; Wissel, J; Dang, N; Kofler, M; Facchini, S; Boroojerdi, B; Poewe, W; Hallett, M			Early consolidation in human primary motor cortex	NATURE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON EMISSION TOMOGRAPHY; LONG-TERM POTENTIATION; HORIZONTAL CONNECTIONS; DEPRESSION; PLASTICITY; IMPLICIT; MONKEYS; MEMORY; SAFETY	Behavioural studies indicate that a newly acquired motor skill is rapidly consolidated from an initially unstable state to a more stable state(1), whereas neuroimaging studies demonstrate that the brain engages new regions for performance of the task as a result of this consolidation(2). However, it is not known where a new skill is retained and processed before it is firmly consolidated. Some early aspects of motor skill acquisition involve the primary motor cortex (M1)(3), but the nature of that involvement is unclear. We tested the possibility that the human M1 is essential to early motor consolidation. We monitored changes in elementary motor behaviour while subjects practised fast finger movements that rapidly improved in movement acceleration and muscle force generation. Here we show that low-frequency, repetitive transcranial magnetic stimulation of M1 but not other brain areas specifically disrupted the retention of the behavioural improvement, but did not affect basal motor behaviour, task performance, motor learning by subsequent practice, or recall of the newly acquired motor skill. These findings indicate that the human M1 is specifically engaged during the early stage of motor consolidation.	NINCDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bethesda, MD 20892 USA; Univ Innsbruck Hosp, Dept Neurol, A-6020 Innsbruck, Austria	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Neurological Disorders & Stroke (NINDS); Medical University of Innsbruck	Hallett, M (corresponding author), NINCDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bldg 10,Rm 5N226,10 Ctr Dr MSC 1428, Bethesda, MD 20892 USA.		Ziemann, Ulf/AAY-9125-2020; Kofler, Markus/P-5585-2019	Kofler, Markus/0000-0002-2962-0903	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002669, ZIANS002669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; JENKINS IH, 1994, J NEUROSCI, V14, P3775; KARNI A, 1995, NATURE, V377, P155; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Nudo RJ, 1996, J NEUROSCI, V16, P785; PascualLeone A, 1996, EXP BRAIN RES, V107, P479; Paus T, 1997, J NEUROSCI, V17, P3178; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	23	573	575	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					640	644		10.1038/nature712	http://dx.doi.org/10.1038/nature712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11807497				2022-12-28	WOS:000173709100046
J	Trujillo Bueno, J; Degl'Innocenti, EL; Collados, M; Merenda, L; Sainz, RM				Trujillo Bueno, J; Degl'Innocenti, EL; Collados, M; Merenda, L; Sainz, RM			Selective absorption processes as the origin of puzzling spectral line polarization from the Sun	NATURE			English	Article							MAGNETIC-FIELDS; SCATTERING; DIAGNOSTICS; PROMINENCES; HELIUM	Magnetic fields play a key role in most astrophysical systems, from the Sun to active galactic nuclei(1-3). They can be studied through their effects on atomic energy levels, which produce polarized spectral lines(4,5). In particular, anisotropic radiation 'pumping' processes(6,7) (which send electrons to higher atomic levels) induce population imbalances that are modified by weak magnetic fields(8,9). Here we report peculiarly polarized light in the He I 10,830-Angstrom multiplet observed in a coronal filament located at the centre of the solar disk. We show that the polarized light arises from selective absorption from the ground level of the triplet system of helium, and that it implies the presence of magnetic fields of the order of a few gauss that are highly inclined with respect to the solar radius vector. This disproves the common belief(4,10,11) that population imbalances in long-lived atomic levels are insignificant in the presence of inclined fields of the order of a few gauss, and opens up a new diagnostic window for the investigation of solar magnetic fields.	Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; Univ Florence, Dipartimento Astron & Sci Spazio, I-50125 Florence, Italy; Univ Trent, Dipartimento Fis, I-38050 Povo, Italy; CSIC, E-28006 Madrid, Spain	Instituto de Astrofisica de Canarias; University of Florence; University of Trento; Consejo Superior de Investigaciones Cientificas (CSIC)	Trujillo Bueno, J (corresponding author), Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain.	jtb@ll.iac.es	Collados, Manuel/Z-5865-2019; Bueno, Javier Trujillo/AAE-5264-2019	Collados, Manuel/0000-0002-6210-9648				BLANDFORD R, 2002, ASTROPHYSICAL SPECTR, P177; BOMMIER V, 1980, ASTRON ASTROPHYS, V87, P109; Chandrasekhar S., 1950, RAD TRANSFER; Cohen-Tannoudji C., 1966, PROGR OPTICS, V5, P3; CONDON EU, 1979, THEORY ATOMIC SPECTR; DEGL'INNOCENTI EL, 1983, SOL PHYS, V85, P3, DOI 10.1007/BF00148254; DEGL'INNOCENTI EL, 1982, SOL PHYS, V79, P291, DOI 10.1007/BF00146246; Degl'Innocenti EL, 1998, NATURE, V392, P256, DOI 10.1038/32603; FAUROBERTSCHOLL M, 1991, ASTRON ASTROPHYS, V246, P469; Hanle W, 1924, Z PHYS, V30, P93, DOI 10.1007/BF01331827; HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169; Landi Degl'Innocenti E., 2002, ASTROPHYSICAL SPECTR, P1; LANDOLFI M, 1986, ASTRON ASTROPHYS, V167, P200; Lin HS, 1998, ASTROPHYS J, V493, P978, DOI 10.1086/305130; Parker E.N., 1979, COSMICAL MAGNETIC FI; Pillet VM, 1999, ASTR SOC P, V183, P264; Radzig A. A., 1985, REFERENCE DATA ATOMS; Schrijver C. J., 2000, SOLAR STELLAR MAGNET; SOLTAU D, 1987, ROLE FINE SCALE MAGN, P362; Stenflo J., 1994, SOLAR MAGNETIC FIELD; Stenflo JO, 1997, ASTRON ASTROPHYS, V324, P344; Stenflo JO, 1997, ASTRON ASTROPHYS, V321, P927; Stenflo JO, 2001, ASTR SOC P, V236, P97; Stenflo JO, 2000, ASTRON ASTROPHYS, V355, P789; Trujillo Bueno J, 1999, ASTROPHYS SPACE SC L, V243, P73; Trujillo Bueno J, 1997, ASTROPHYS J, V482, pL183, DOI 10.1086/310713; Trujillo Bueno J., 2001, ASP C SER, P161; VANBALLEGOOIJEN.AA, 2001, ENCY ASTRONOMY ASTRO, P2703	28	161	161	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					403	406		10.1038/415403a	http://dx.doi.org/10.1038/415403a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807547	Green Submitted			2022-12-28	WOS:000173433600042
J	Joughin, I; Tulaczyk, S				Joughin, I; Tulaczyk, S			Positive mass balance of the Ross Ice Streams, West Antarctica	SCIENCE			English	Article							SHEET; FLOW	We have used ice-flow velocity measurements from synthetic aperture radar to reassess the mass balance of the Ross Ice Streams, West Antarctica. We find strong evidence for ice-sheet growth (+ 26.8 gigatons per year), in contrast to earlier estimates indicating a mass deficit (-20.9 gigatons per year), Average thickening is equal to similar to25% of the accumulation rate, with most of this growth occurring on Ice Stream C. Whillans Ice Stream, which was thought to have a significantly negative mass balance, is close to balance, reflecting its continuing slowdown. The overall positive mass balance may signal an end to the Holocene retreat of these ice streams.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Santa Cruz	Joughin, I (corresponding author), CALTECH, Jet Prop Lab, Mailstop 300-235,4800 Oak Grove Dr, Pasadena, CA 91109 USA.	ian@radar-sci.jpl.nasa.gov; tulaczyk@es.ucsc.edu	Tulaczyk, Slawek/O-7375-2018; Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021	Tulaczyk, Slawek/0000-0002-9711-4332; Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X				ALLEY RB, 2001, ANTARCTIC RES SER, V77; Anandakrishnan S, 1997, GEOPHYS RES LETT, V24, P265, DOI 10.1029/96GL04016; Bindschadler R, 1998, SCIENCE, V282, P428, DOI 10.1126/science.282.5388.428; BINDSCHADLER R, 1996, J GLACIOL, V43, P142; BINDSCHADLER R, UNPUB; Blankenship D. D., 2001, ANTARCT RES SER, V77, P105, DOI DOI 10.1029/AR077P0105; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; DENTON GH, 2000, J QUATERNARY SCI, V15, P4; Engelhardt H, 1997, J GLACIOL, V43, P207, DOI 10.3189/S0022143000003166; Fahnestock MA, 2000, J GLACIOL, V46, P652, DOI 10.3189/172756500781832693; GIOINETTO M, 1985, ANTARCT J US, V20, pD4; Giovinetto MB, 2000, ANN GLACIOL-SER, V31, P171, DOI 10.3189/172756400781820200; Jezek KC, 1999, ANN GLACIOL-SER, V29, P286, DOI 10.3189/172756499781820969; Joughin I, 1999, SCIENCE, V286, P283, DOI 10.1126/science.286.5438.283; Joughin IR, 1998, IEEE T GEOSCI REMOTE, V36, P25, DOI 10.1109/36.655315; JOUGHIN IR, UNPUB; LIU H, 1999, J GEOPHYS RES, V104, P10; LYTHE MB, 2001, J GEOPHYS RES, V106, P3; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; MACAYEAL DR, 1986, J GLACIOL, V32, P72, DOI 10.3189/S0022143000006900; MERCER JH, 1968, INT ASS HYDROL SCI P, V179; PAYNE AJ, 1997, J GEOPHYS RES SOLID, V102, pB6; PRICE SF, 2001, J GLACIOL, V47, P157; RETZLAFF R, 1993, J GLACIOL, V39, P133; RIGNOT E, IN PRESS ANN GLACIOL; SHABTAIE S, 1987, J GEOPHYS RES, V92, P2; THOMAS RH, 1984, ANTARCTIC RES SERIES, V42; TULACZYK S, 2000, J GEOPHYS RES, V105, P1; Vaughan DG, 1999, J CLIMATE, V12, P933, DOI 10.1175/1520-0442(1999)012<0933:RONSMB>2.0.CO;2; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; WHILLANS IM, 2001, ANTARCTIC RES SER, V77; WINGHAM DJ, 1998, SCIENCE, V291, P5388	32	151	153	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					476	480		10.1126/science.1066875	http://dx.doi.org/10.1126/science.1066875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799237				2022-12-28	WOS:000173350700043
J	Sharon, D; Grinvald, A				Sharon, D; Grinvald, A			Dynamics and constancy in cortical spatiotemporal patterns of orientation processing	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SIMPLE CELLS; POSTSYNAPTIC POTENTIALS; THALAMIC INPUT; SELECTIVITY; INHIBITION; NEURONS; ORGANIZATION; EXCITATION	How does the high selectivity to stimulus orientation emerge in the visual cortex? Thalamic feedforward-dominated models of orientation selectivity predict constant selectivity during the visual response, whereas intracortical recurrent models predict dynamic improvement in selectivity. We imaged the cat visual cortex with voltage-sensitive dyes to measure orientation-tuning dynamics of a large neuronal population. Tuning-curve width did not narrow after response onset, whereas the difference between preferred and orthogonal responses (modulation depth) first increased, then declined. We identified a suppression of the evoked responses, referred to as the evoked deceleration-acceleration (DA) notch, which was larger for the orthogonal response, Furthermore, peak selectivity of the tuning curves was contemporaneous with the evoked DA notch. These findings suggest that in the cat brain, sustained visual cortical processing does not narrow orientation tuning; rather, intracortical interactions may amplify modulation depth and suppress the orthogonal response relatively more than the preferred, Thus, feedforward models and recurrent models of orientation selectivity must be combined.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Sharon, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							Anderson Jessie Annie, COMMUNICATION; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; SHEVELEV IA, 1993, NEUROSCIENCE, V56, P865, DOI 10.1016/0306-4522(93)90133-Z; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STERKIN, UNPUB; Sterkin A., 1999, Society for Neuroscience Abstracts, V25, P784; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919	31	73	75	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					512	515		10.1126/science.1065916	http://dx.doi.org/10.1126/science.1065916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799249				2022-12-28	WOS:000173350700055
J	Kost, B; Chua, NH				Kost, B; Chua, NH			The plant cytoskeleton: Vacuoles and cell walls make the difference	CELL			English	Review							GENES; ACTIN		Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; Natl Univ Singapore, Inst Mol Agrobiol, Lab Plant Cell Biol, Singapore 117604, Singapore	Rockefeller University; National University of Singapore	Chua, NH (corresponding author), Rockefeller Univ, Plant Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.							Allwood EG, 2001, FEBS LETT, V499, P97, DOI 10.1016/S0014-5793(01)02528-5; Baluska F, 2001, DEV BIOL, V236, P478, DOI 10.1006/dbio.2001.0333; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Furutani I, 2000, DEVELOPMENT, V127, P4443; Kameyama K, 2000, NATURE, V407, P37, DOI 10.1038/35024149; Kost B, 1999, CURR OPIN PLANT BIOL, V2, P462, DOI 10.1016/S1369-5266(99)00024-2; KOST B, 2001, IN PRESS PHILOS T B; Lemichez E, 2001, GENE DEV, V15, P1808, DOI 10.1101/gad.900401; LLOYD CW, 1991, CYTOSKELETAL BASIS P; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; Meagher RB, 1999, PLANT CELL, V11, P995, DOI 10.1105/tpc.11.6.995; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; Otegui MS, 2001, PLANT CELL, V13, P2033, DOI 10.1105/tpc.13.9.2033; Reddy ASN, 2001, INT REV CYTOL, V204, P97, DOI 10.1016/S0074-7696(01)04004-9; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Smith LG, 2001, J CELL BIOL, V152, P231, DOI 10.1083/jcb.152.1.231; TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128	20	51	58	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					9	12		10.1016/S0092-8674(01)00634-1	http://dx.doi.org/10.1016/S0092-8674(01)00634-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792316	Bronze			2022-12-28	WOS:000173280700003
J	Nakashima, K; Zhou, X; Kunkel, G; Zhang, ZP; Deng, JM; Behringer, RR; de Crombrugghe, B				Nakashima, K; Zhou, X; Kunkel, G; Zhang, ZP; Deng, JM; Behringer, RR; de Crombrugghe, B			The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation	CELL			English	Article							VERTEBRATE LIMB DEVELOPMENT; PROMOTER REGION; BINDING-SITES; GENE PROMOTER; CHONDROCYTES; CBFA1; PROTEINS; SEQUENCE; LINEAGE; TISSUES	We have identified a novel zinc finger-containing transcription factor, called Osterix (Osx), that is specifically expressed in all developing bones. In Osx null mice, no bone formation occurs. In endochondral skeletal elements of Osx null mice, mesenchymal cells, together with osteoclasts and blood vessels, invade the mineralized cartilage matrix. However, the mesenchymal cells do not deposit bone matrix. Similarly, cells in the periosteum and in the condensed mesenchyme of membranous skeletal elements cannot differentiate into osteoblasts. These cells do, however, express Runx2/Cbfa1, another transcription factor required for bone formation. In contrast, Osx is not expressed in Runx2/Cbfa1 null mice. Thus, Osx acts downstream of Runx2/Cbfa1. Because Osx null preosteoblasts express typical chondrocyte marker genes, we propose that Runx2/Cbfa1-expressing preosteoblasts are still bipotential cells.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	de Crombrugghe, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Nakashima, Kazuhisa/0000-0003-0491-2149; Kunkel, Gary/0000-0002-4199-369X	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16672] Funding Source: Medline; NIAMS NIH HHS [P01 AR42919] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BILEZIKIAN JP, 1996, PRINCIPLES BONE BIOL; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; CHEN JK, 1992, J BONE MINER RES, V7, P987; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; HOGAN B, 1994, MAIPULATING MOUSE EM; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1	35	2618	2746	6	224	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					17	29		10.1016/s0092-8674(01)00622-5	http://dx.doi.org/10.1016/s0092-8674(01)00622-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792318	Bronze			2022-12-28	WOS:000173280700005
J	Ho, Y; Gruhler, A; Heilbut, A; Bader, GD; Moore, L; Adams, SL; Millar, A; Taylor, P; Bennett, K; Boutilier, K; Yang, LY; Wolting, C; Donaldson, I; Schandorff, S; Shewnarane, J; Vo, M; Taggart, J; Goudreault, M; Muskat, B; Alfarano, C; Dewar, D; Lin, Z; Michalickova, K; Willems, AR; Sassi, H; Nielsen, PA; Rasmussen, KJ; Andersen, JR; Johansen, LE; Hansen, LH; Jespersen, H; Podtelejnikov, A; Nielsen, E; Crawford, J; Poulsen, V; Sorensen, BD; Matthiesen, J; Hendrickson, RC; Gleeson, F; Pawson, T; Moran, MF; Durocher, D; Mann, M; Hogue, CWV; Figeys, D; Tyers, M				Ho, Y; Gruhler, A; Heilbut, A; Bader, GD; Moore, L; Adams, SL; Millar, A; Taylor, P; Bennett, K; Boutilier, K; Yang, LY; Wolting, C; Donaldson, I; Schandorff, S; Shewnarane, J; Vo, M; Taggart, J; Goudreault, M; Muskat, B; Alfarano, C; Dewar, D; Lin, Z; Michalickova, K; Willems, AR; Sassi, H; Nielsen, PA; Rasmussen, KJ; Andersen, JR; Johansen, LE; Hansen, LH; Jespersen, H; Podtelejnikov, A; Nielsen, E; Crawford, J; Poulsen, V; Sorensen, BD; Matthiesen, J; Hendrickson, RC; Gleeson, F; Pawson, T; Moran, MF; Durocher, D; Mann, M; Hogue, CWV; Figeys, D; Tyers, M			Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry	NATURE			English	Article							YEAST; CHECKPOINT; DEGRADATION; PATHWAYS; LIGASE; DOMAIN; REPAIR	The recent abundance of genome sequence data has brought an urgent need for systematic proteomics to decipher the encoded protein networks that dictate cellular function(1). To date, generation of large-scale protein-protein interaction maps has relied on the yeast two-hybrid system, which detects binary interactions through activation of reporter gene expression(2-4). With the advent of ultrasensitive mass spectrometric protein identification methods, it is feasible to identify directly protein complexes on a proteome-wide scale(5,6). Here we report, using the budding yeast Saccharomyces cerevisiae as a test case, an example of this approach, which we term high-throughput mass spectrometric protein complex identification (HMS-PCI). Beginning with 10% of predicted yeast proteins as baits, we detected 3,617 associated proteins covering 25% of the yeast proteome. Numerous protein complexes were identified, including many new interactions in various signalling pathways and in the DNA damage response. Comparison of the HMS-PCI data set with interactions reported in the literature revealed an average threefold higher success rate in detection of known complexes compared with large-scale two-hybrid studies(3,4). Given the high degree of connectivity observed in this study, even partial HMS-PCI coverage of complex proteomes, including that of humans, should allow comprehensive identification of cellular networks.	MDS Proteom, Toronto, ON M9W 7H4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Figeys, D (corresponding author), MDS Proteom, 251 Attwell Dr, Toronto, ON M9W 7H4, Canada.		Hogue, Christopher W V/AAZ-3934-2020; Podtelejnikov, Alexandre/B-6120-2017; Mann, Matthias/A-3454-2013; Hogue, Christopher/B-6726-2008; Tyers, Michael/ABE-3194-2021; Heilbut, Adrian M/J-9427-2012; Bader, Gary/C-1176-2009; Pawson, Tony J/E-4578-2013; Durocher, Daniel/A-7733-2010; Moran, Michael/GYD-3631-2022; Donaldson, Ian/A-2867-2009	Hogue, Christopher W V/0000-0002-3107-5246; Podtelejnikov, Alexandre/0000-0002-8124-6584; Mann, Matthias/0000-0003-1292-4799; Heilbut, Adrian M/0000-0002-8169-7967; Bader, Gary/0000-0003-0185-8861; Durocher, Daniel/0000-0003-3863-8635; Donaldson, Ian/0000-0002-4203-8328; Bennett, Keiryn L./0000-0001-9356-7708; Figeys, Daniel/0000-0002-5373-7546				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen P, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1022, DOI 10.1186/GB-2000-1-3-REVIEWS1022]; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Marsolier MC, 2000, GENETICS, V154, P1523; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pawson T, 2000, GENE DEV, V14, P1027; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tyers M, 1999, P NATL ACAD SCI USA, V96, P12230, DOI 10.1073/pnas.96.22.12230; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	30	2822	2925	4	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					180	183		10.1038/415180a	http://dx.doi.org/10.1038/415180a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805837				2022-12-28	WOS:000173159300044
J	Merbach, MA; Merbach, DJ; Maschwitz, U; Booth, WE; Fiala, B; Zizka, G				Merbach, MA; Merbach, DJ; Maschwitz, U; Booth, WE; Fiala, B; Zizka, G			Carnivorous plants - Mass march of termites into the deadly trap	NATURE			English	Article							BORNEO		Univ Frankfurt, Inst Zool, Fachbereich Biol, D-60054 Frankfurt, Germany; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Univ Frankfurt, D-60325 Frankfurt, Germany; Forschungsinst Senckenberg, D-60325 Frankfurt, Germany	Goethe University Frankfurt; University of Wurzburg; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN)	Merbach, MA (corresponding author), Univ Frankfurt, Inst Zool, Fachbereich Biol, Postfach 111932, D-60054 Frankfurt, Germany.		Fiala, Brigitte/I-3788-2016	Fiala, Brigitte/0000-0002-9625-1933				ADAMJUMAAT H, 1997, PERTANIKA J TROP AGR, V20, P121; Clarke C., 1997, NEPENTHES OF BORNEO; JONES DT, 1995, INSECT SOC, V42, P359, DOI 10.1007/BF01242164; KATO Y, 1993, J HOKKAIDO BRAIN RES, V6, P11; Miura T, 1997, INSECT SOC, V44, P267, DOI 10.1007/s000400050047; Moran JA, 1999, ANN BOT-LONDON, V83, P521, DOI 10.1006/anbo.1999.0857; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474	7	44	46	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					36	37		10.1038/415036a	http://dx.doi.org/10.1038/415036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780106				2022-12-28	WOS:000173028800029
J	Davies, JK; Akhtar, N; Ranasinge, E				Davies, JK; Akhtar, N; Ranasinge, E			A juicy problem	LANCET			English	Editorial Material									King George Hosp, Dept Haematol, Goodmayes, Essex, England; Addenbrookes Hosp, Platelet Immunol Lab, Cambridge, England	King George Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Davies, JK (corresponding author), Royal Free Hosp, Dept Haematol, Pond St, London NW3 2PF, England.							Arnold J, 1998, LANCET, V352, P618, DOI 10.1016/S0140-6736(98)05194-0; CAFFREY EA, 1981, LANCET, V2, P316; Lowe FC, 2001, UROLOGY, V57, P407, DOI 10.1016/S0090-4295(00)01100-6	3	14	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2126	2126		10.1016/S0140-6736(01)07220-8	http://dx.doi.org/10.1016/S0140-6736(01)07220-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784628				2022-12-28	WOS:000172905800012
J	Courtial, J; Leach, J; Padgett, MJ				Courtial, J; Leach, J; Padgett, MJ			Image processing - Fractals in pixellated video feedback	NATURE			English	Article									Univ Glasgow, Dept Phys & Astron, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Courtial, J (corresponding author), Univ Glasgow, Dept Phys & Astron, Glasgow G12 8QQ, Lanark, Scotland.		Courtial, Johannes/B-4597-2009; Padgett, Miles J/B-7625-2008	Courtial, Johannes/0000-0002-5990-7972; Padgett, Miles J/0000-0001-6643-0618				ANDERSEN MC, ULTIMATE VIDEO FEEDB; ANDERSEN MC, 1996, SIMULATION VIDEO FEE; CADMAN J, SPINNING LIGHTS HOME; Courtial J, 2000, J MOD OPTIC, V47, P1469, DOI 10.1080/09500340008235117; Courtial J, 2000, PHYS REV LETT, V85, P5320, DOI 10.1103/PhysRevLett.85.5320; CRUTCHFIELD JP, 1988, IEEE T CIRCUITS SYST, V35, P770, DOI 10.1109/31.1821; CRUTCHFIELD JP, 1984, PHYSICA D, V10, P229, DOI 10.1016/0167-2789(84)90264-1; GOODMANSTRAUSS C, FRACTAL FEEDBACK; HOFSTADTER DR, 1980, GODEL ESCHER BACH ET, P490; PEAK D, 1994, CHAOS CONTROL, P301; PEITGEN HO, 1992, CHAOS FRACTALS NEW F, V20; PEITGEN HO, 1992, CHAOS FRACTALS NEW F, P19	12	15	15	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					864	864		10.1038/414864a	http://dx.doi.org/10.1038/414864a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780051	Green Accepted, Bronze			2022-12-28	WOS:000172813300034
J	Bastacky, S; Lee, RE				Bastacky, S; Lee, RE			Disseminated intravascular coagulopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bastacky, S (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA.								0	0	0	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2001	345	19					1394	1394		10.1056/NEJMicm970644	http://dx.doi.org/10.1056/NEJMicm970644			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489VY	11794172				2022-12-28	WOS:000172014200005
J	Myneni, SCB				Myneni, SCB			Formation of stable chlorinated hydrocarbons in weathering plant material	SCIENCE			English	Article							ABSORPTION	Though several chlorinated organic compounds produced by humans are carcinogenic and toxic, some are also produced by the biotic and abiotic processes in the environment. In situ x-ray spectroscopy data indicate that natural organic matter in soils, sediments, and natural waters contain stable, less volatile organic compounds with chlorinated phenolic and aliphatic groups as the principal Cl forms. These compounds are formed at rapid rates from the transformation of inorganic Cl during humification of plant material and, thus, play a critical role in the cycling of Cl and of several major and trace elements in the environment and may influence human health.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Myneni, SCB (corresponding author), Princeton Univ, Dept Geosci, 151 Guyot Hall, Princeton, NJ 08544 USA.							[Anonymous], 1992, PLANT PHYSIOL; ASPLUND G, 1991, ENVIRON SCI TECHNOL, V25, P1347; CARLSEN L, 1992, ORG GEOCHEM, V18, P477, DOI 10.1016/0146-6380(92)90110-J; DEJONG E, 1994, APPL ENVIRON MICROB, V60, P271, DOI 10.1128/AEM.60.1.271-277.1994; GRIBBLE GW, 1994, J CHEM EDUC, V71, P907, DOI 10.1021/ed071p907; HOEKSTRA EJ, 1995, CHEM BRIT, V31, P127; Hoekstra EJ, 1999, ENVIRON SCI TECHNOL, V33, P2543, DOI 10.1021/es9900104; Keppler F, 2000, NATURE, V403, P298, DOI 10.1038/35002055; Neidleman S.L., 1986, BIOHALOGENATION PRIN; PERERA RCC, 1987, J CHEM PHYS, V86, P4824, DOI 10.1063/1.452675; PERERA RCC, 1991, PHYS REV A, V43, P3609, DOI 10.1103/PhysRevA.43.3609; Porter G, 1996, PURE APPL CHEM, V68, P1683, DOI 10.1351/pac199668091683; Prospero JM, 1999, P NATL ACAD SCI USA, V96, P3396, DOI 10.1073/pnas.96.7.3396; Rompel A, 1997, J AM CHEM SOC, V119, P4465, DOI 10.1021/ja9610951; Schwarzenbach R., 1993, ENV ORGANIC CHEM; SHADLE SE, 1995, J AM CHEM SOC, V117, P2259, DOI 10.1021/ja00113a015; SMITH TA, 1994, J AM CHEM SOC, V116, P3836, DOI 10.1021/ja00088a020; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Stohr J, 2013, SPRINGE SER SURF SCI	19	141	153	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1039	1041		10.1126/science.1067153	http://dx.doi.org/10.1126/science.1067153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799203				2022-12-28	WOS:000173793000056
J	Costa, RM; Federov, NB; Kogan, JH; Murphy, GG; Stern, J; Ohno, M; Kucherlapati, R; Jacks, T; Silva, AJ				Costa, RM; Federov, NB; Kogan, JH; Murphy, GG; Stern, J; Ohno, M; Kucherlapati, R; Jacks, T; Silva, AJ			Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1	NATURE			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; FARNESYLTRANSFERASE INHIBITORS; N-RAS; NF1; GENE; CELLS; GAP; IMPAIRMENT; DROSOPHILA	Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans(1). Mice carrying a heterozygous null mutation of the Nf1 gene (Nf1(+/-)) show important features of the learning deficits associated with NF1 (ref. 2). Although neurofibromin has several known properties and functions, including Ras GTPase-activating protein activity(3,4), adenylyl cyclase modulation(5,6) and microtubule binding(7), it is unclear which of these are essential for learning in mice and humans. Here we show that the learning deficits of Nf1(+/-) mice can be rescued by genetic and pharmacological manipulations that decrease Ras function. We also show that the Nf1(+/-) mice have increased GABA (gamma-amino butyric acid)-mediated inhibition and specific deficits in long-term potentiation, both of which can be reversed by decreasing Ras function. Our results indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in long-term potentiation caused by increased GABA-mediated inhibition. Our findings have implications for the development of treatments for learning deficits associated with NF1.	Univ Calif Los Angeles, BRI, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, BRI, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, BRI, Dept Psychol, Los Angeles, CA 90095 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT)	Silva, AJ (corresponding author), Univ Calif Los Angeles, BRI, Dept Neurobiol, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021; Kucherlapati, Raju/ABC-8807-2021	Silva, Alcino/0000-0002-1587-4558; Costa, Rui M./0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494; Stern, Joel N.H./0000-0002-1259-2256	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS38480] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Chapman CA, 1998, HIPPOCAMPUS, V8, P289, DOI 10.1002/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X; Chorvatova A, 2000, ENDOCRINOLOGY, V141, P684, DOI 10.1210/en.141.2.684; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gibbs JB, 1997, CURR OPIN CHEM BIOL, V1, P197, DOI 10.1016/S1367-5931(97)80010-5; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muthalif MM, 2000, HYPERTENSION, V35, P457, DOI 10.1161/01.HYP.35.1.457; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; TONG J, 2000, SOC NEUR ABSTR; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Xu HM, 1997, BRAIN RES, V759, P149, DOI 10.1016/S0006-8993(97)00328-4; YAN N, 1995, CANCER RES, V55, P3569	30	418	430	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					526	530		10.1038/nature711	http://dx.doi.org/10.1038/nature711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11793011				2022-12-28	WOS:000173564300047
J	Kelch, RP				Kelch, RP			Maintaining the public trust in clinical research.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Iowa, Coll Med, Iowa City, IA 52242 USA	University of Iowa	Kelch, RP (corresponding author), Univ Iowa, Coll Med, Iowa City, IA 52242 USA.							*AM SOC GEN THER, 2000, POL AM SOC GEN THER; *ASS AM MED COLL, 1990, GUID DEAL FAC CONFL; *COMM A AC FREED T, 2001, STAT CORP FUND AC RE; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Moses H, 2001, JAMA-J AM MED ASSOC, V285, P933, DOI 10.1001/jama.285.7.933; NELSON D, 2000, WASHINGTON POST 0131, pA1; *TASK FORC FIN CON, 2001, PROT SUBJ PRES TRUST; Task Force on Research Accountability, 2001, REP IND I FIN CONFL	9	54	54	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					285	287		10.1056/NEJM200201243460413	http://dx.doi.org/10.1056/NEJM200201243460413			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807156				2022-12-28	WOS:000173398900012
J	Reddel, HK; Toelle, BG; Marks, GB; Ware, SI; Jenkins, CR; Woolcock, AJ				Reddel, HK; Toelle, BG; Marks, GB; Ware, SI; Jenkins, CR; Woolcock, AJ			Analysis of adherence to peak flow monitoring when recording of data is electronic	BRITISH MEDICAL JOURNAL			English	Article							PERENNIAL ALLERGIC RHINITIS; QUALITY-OF-LIFE; ST-JOHNS WORT; LEUKOTRIENE-SYNTHESIS; PETASITES-HYBRIDUS; FRENCH VERSION; QUESTIONNAIRE; ASTHMA; TRIAL		Royal Prince Alfred Hosp, Inst Resp Med, Camperdown, NSW 2050, Australia; Univ Sydney, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney	Reddel, HK (corresponding author), Royal Prince Alfred Hosp, Inst Resp Med, POB M77,Missenden Rd, Camperdown, NSW 2050, Australia.		Marks, Guy B./F-5058-2013; Toelle, Brett G/B-1531-2008; Reddel, Helen/ABD-6338-2021; Reddel, Helen/AAC-3394-2020	Marks, Guy B./0000-0002-8976-8053; Toelle, Brett G/0000-0002-7375-0019; Reddel, Helen/0000-0002-6695-6350				ABT K, 1987, METHOD INFORM MED, V26, P77; AUSTEN KF, 1981, HARRISONS PRINCIPLES; BERMAN BA, 1988, J ALLERGY CLIN IMMUN, V81, P980, DOI 10.1016/0091-6749(88)90165-0; BICKEL D, 1994, PLANTA MED, V60, P318, DOI 10.1055/s-2006-959492; BOUSQUET J, 1994, J ALLERGY CLIN IMMUN, V94, P182, DOI 10.1016/0091-6749(94)90038-8; Bousquet J, 1996, J ALLERGY CLIN IMMUN, V98, P309, DOI 10.1016/S0091-6749(96)70155-0; *BRIT MED ASS ROYA, 1998, BRIT NAT FORM; BRUNE K, 1993, PLANTA MED, V59, P494, DOI 10.1055/s-2006-959746; CHOWIENCZYK PJ, 1994, BRIT MED J, V309, P1618, DOI 10.1136/bmj.309.6969.1618; GIBSON PG, 1998, COCHRANE LIB; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; KNAPP HR, 1990, NEW ENGL J MED, V323, P1745, DOI 10.1056/NEJM199012203232506; Meier B., 1994, HAGERS HDB PHARMAZEU, P81; Reddel HK, 2000, EUR RESPIR J, V16, P226, DOI 10.1034/j.1399-3003.2000.16b08.x; Reddel HK, 1998, EUR RESPIR J, V12, P853, DOI 10.1183/09031936.98.12040853; Schellenberg R, 2001, BRIT MED J, V322, P134, DOI 10.1136/bmj.322.7279.134; Thomet OAR, 2001, BIOCHEM PHARMACOL, V61, P1041, DOI 10.1016/S0006-2952(01)00552-4; Verschelden P, 1996, EUR RESPIR J, V9, P880, DOI 10.1183/09031936.96.09050880; Wheatley D, 1997, PHARMACOPSYCHIATRY, V30, P77, DOI 10.1055/s-2007-979523; Woelk H, 2000, BMJ-BRIT MED J, V321, P536, DOI 10.1136/bmj.321.7260.536	20	40	57	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					146	147		10.1136/bmj.324.7330.146	http://dx.doi.org/10.1136/bmj.324.7330.146			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799031	Green Published, Bronze			2022-12-28	WOS:000173470600018
J	Smith, AE; Slepchenko, BM; Schaff, JC; Loew, LM; Macara, IG				Smith, AE; Slepchenko, BM; Schaff, JC; Loew, LM; Macara, IG			Systems analysis of Ran transport	SCIENCE			English	Article							PORE COMPLEX PROTEIN; BINDING PROTEIN; NUCLEAR IMPORT; RCC1; GTPASE; NTF2; ACTIVATION; MECHANISM; BETA; P62	The separate components of nucleocytoplasmic transport have been well characterized, including the key regulatory rote of Ran, a guanine nucleotide triphosphatase. However, the overall system behavior in intact cells is difficult to analyze because the dynamics of these components are interdependent. We used a combined experimental and computational approach to study Ran transport in vivo. The resulting model provides the first quantitative picture of Ran flux between the nuclear and cytoplasmic compartments in eukaryotic cells. The model predicts that the Ran exchange factor RCC1, and not the flux capacity of the nuclear pore complex (NPC), is the crucial regulator of steady-state flux across the NPC. Moreover, it provides the first estimate of the total in vivo flux (520 molecules per NPC per second and predicts that the transport system is robust.	Univ Virginia, Dept Pharmacol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Connecticut, Ctr Hlth, Ctr Biomed Imaging Technol, Farmington, CT 06030 USA	University of Virginia; University of Virginia; University of Connecticut	Macara, IG (corresponding author), Univ Virginia, Dept Pharmacol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.			Loew, Leslie/0000-0002-1851-4646	NCRR NIH HHS [NCRR-RR13186] Funding Source: Medline; NIGMS NIH HHS [GM-50526, NIH-GM-20438] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; CLARKE PR, 1995, J CELL SCI, V108, P1217; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CORDES VC, 1995, EUR J CELL BIOL, V68, P240; Fink C, 1998, BIOPHYS J, V75, P1648, DOI 10.1016/S0006-3495(98)77607-6; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Schaff JC, 2000, METHOD ENZYMOL, V321, P1; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Smith W, 1998, PIANO KEYBOARD, V1, P8	21	150	156	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					488	491		10.1126/science.1064732	http://dx.doi.org/10.1126/science.1064732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799242				2022-12-28	WOS:000173350700048
J	Cleland, JGF				Cleland, JGF			For debate - Preventing atherosclerotic events with aspirin	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England	University of Hull	Cleland, JGF (corresponding author), Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England.	J.G.Cleland@medschool.hull.ac.uk	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P320; *ANT TRIAL COLL, 2001, BMJ-BRIT MED J, V323, P71; *ASP MYOC INF STUD, 1980, CIRCULATION S5, V62, P79; BREDDIN K, 1980, CIRCULATION, V62, P63; CLELAND JGF, 1995, BRIT HEART J, V74, P215; Cleland JGF, 1997, CURR OPIN CARDIOL, V12, P276, DOI 10.1097/00001573-199705000-00009; Cleland JGF, 2001, CURR OPIN NEPHROL HY, V10, P625, DOI 10.1097/00041552-200109000-00012; JONES CG, 1999, EUR J HEART FAIL, V1, P425, DOI DOI 10.1016/S1388-9842(99)00059-8; KLIMT CR, 1986, J AM COLL CARDIOL, V7, P251, DOI 10.1016/S0735-1097(86)80489-2; KROL WF, 1980, CIRCULATION, V62, P449; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; MCMAHON AD, 2001, IMPACT LOW DOSE ASPI, P1; O'Brien J, 2000, LANCET, V355, P1295; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27	16	31	33	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2002	324	7329					103	105		10.1136/bmj.324.7329.103	http://dx.doi.org/10.1136/bmj.324.7329.103			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786458	Green Published			2022-12-28	WOS:000173325400026
J	Donaldson, GC; Keatinge, WR				Donaldson, GC; Keatinge, WR			Excess winter mortality: influenza or cold stress? Observational study	BRITISH MEDICAL JOURNAL			English	Article							DISEASE		Univ London Queen Mary & Westfield Coll, Div Biomed Sci, London E1 4NS, England	University of London; Queen Mary University London	Keatinge, WR (corresponding author), Univ London Queen Mary & Westfield Coll, Div Biomed Sci, Mile End Rd, London E1 4NS, England.		Donaldson, Gavin/M-7992-2017	Donaldson, Gavin/0000-0002-5538-4190				Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1986, BRIT MED J, V293, P732, DOI 10.1136/bmj.293.6549.732-a; KHAW KT, 1995, BRIT MED J, V310, P1559, DOI 10.1136/bmj.310.6994.1559	5	65	68	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					89	90		10.1136/bmj.324.7329.89	http://dx.doi.org/10.1136/bmj.324.7329.89			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786453	Bronze, Green Published			2022-12-28	WOS:000173325400018
J	Bankaitis, VA				Bankaitis, VA			Cell biology - Stick recruitment to the golgi	SCIENCE			English	Editorial Material							PROTEIN; DIACYLGLYCEROL; TRANSPORT		Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bankaitis, VA (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	vytas_bankaitis@med.unc.edu						ALB JG, IN PRESS MOL BIOL CE; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; Philibert RA, 1999, MOL PSYCHIATR, V4, pS77; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613	10	41	41	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					290	291		10.1126/science.1068446	http://dx.doi.org/10.1126/science.1068446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786634				2022-12-28	WOS:000173278600038
J	Forest, CE; Stone, PH; Sokolov, AP; Allen, MR; Webster, MD				Forest, CE; Stone, PH; Sokolov, AP; Allen, MR; Webster, MD			Quantifying uncertainties in climate system properties with the use of recent climate observations	SCIENCE			English	Article							SURFACE AIR-TEMPERATURE; MODEL; OCEAN	We derive joint probability density distributions for three key uncertain properties of the climate system, using an optimal fingerprinting approach to compare simulations of an intermediate complexity climate model with three distinct diagnostics of recent climate observations. On the basis of the marginal probability distributions, the 5 to 95% confidence intervals are 1.4 to 7.7 kelvin for climate sensitivity and -0.30 to -0.95 watt per square meter for the net aerosol forcing. The oceanic heat uptake is not well constrained, but ocean temperature observations do help to constrain climate sensitivity. The uncertainty in the net aerosol forcing is much smaller than the uncertainty range for the indirect aerosol forcing alone given in the Intergovernmental Panel on Climate Change Third Assessment Report.	MIT, Joint Program Sci Policy Global Change, Cambridge, MA 02139 USA; Univ Oxford, Dept Phys, Oxford OX1 3PU, England	Massachusetts Institute of Technology (MIT); University of Oxford	Forest, CE (corresponding author), MIT, Joint Program Sci Policy Global Change, Cambridge, MA 02139 USA.		Forest, Chris E/M-1993-2014; Allen, Myles R/A-5172-2012	Forest, Chris E/0000-0002-2643-0186; 				Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Andronova NG, 2001, J GEOPHYS RES-ATMOS, V106, P22605, DOI 10.1029/2000JD000259; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; BELL TL, 1982, J GEOPHYS RES-OCEANS, V87, P1161, DOI 10.1029/JC087iC13p11161; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Forest CE, 2000, GEOPHYS RES LETT, V27, P569, DOI 10.1029/1999GL010859; FOREST CE, IN PRESS CLIM DYN; Gregory JM, 2000, CLIM DYNAM, V16, P501, DOI 10.1007/s003820000059; HANSEN J, IN PRESS J GEOPHYS R; Hasselmann KF., 1979, METEOROLOGY TROPICAL, P251; Hegerl GC, 2001, J CLIMATE, V14, P198, DOI 10.1175/1520-0442(2001)013<0198:EOOSEO>2.0.CO;2; Johns TC, 1997, CLIM DYNAM, V13, P103, DOI 10.1007/s003820050155; JONES PD, 1994, J CLIMATE, V7, P1794, DOI 10.1175/1520-0442(1994)007<1794:HSATVA>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Knutson TR, 1999, J GEOPHYS RES-ATMOS, V104, P30981, DOI 10.1029/1999JD900965; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Parker DE, 1997, GEOPHYS RES LETT, V24, P1499, DOI 10.1029/97GL01186; Penner JE, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P289; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P349; Raper SCB, 2002, J CLIMATE, V15, P124, DOI 10.1175/1520-0442(2002)015<0124:TROCSA>2.0.CO;2; Sokolov AP, 1998, CLIM DYNAM, V14, P291, DOI 10.1007/s003820050224; Tett SFB, 1996, SCIENCE, V274, P1170, DOI 10.1126/science.274.5290.1170; Titus JG, 1996, CLIMATIC CHANGE, V33, P151, DOI 10.1007/BF00140246; Webster MD, 2000, CLIMATIC CHANGE, V46, P417, DOI 10.1023/A:1005685317358; WEBSTER MD, 2001, MIT JOINT PROGRAM SC, P1; WIGLEY TML, 1990, NATURE, V344, P324, DOI 10.1038/344324a0; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	30	333	340	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					113	117		10.1126/science.1064419	http://dx.doi.org/10.1126/science.1064419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778044				2022-12-28	WOS:000173143100045
J	Yan, H; Zhang, XP; Shen, ZY; Seeman, NC				Yan, H; Zhang, XP; Shen, ZY; Seeman, NC			A robust DNA mechanical device controlled by hybridization topology	NATURE			English	Article							DOUBLE-CROSSOVER MOLECULES; LIGATION; DESIGN	Controlled mechanical movement in molecular-scale devices has been realized in a variety of systems-catenanes and rotaxanes(1-3), chiroptical molecular switches(4), molecular ratchets(5) and DNA(6)- by exploiting conformational changes triggered by changes in redox potential or temperature, reversible binding of small molecules or ions, or irradiation. The incorporation of such devices into arrays(7,8) could in principle lead to complex structural states suitable for nanorobotic applications, provided that individual devices can be addressed separately. But because the triggers commonly used tend to act equally on all the devices that are present, they will need to be localized very tightly. This could be readily achieved with devices that are controlled individually by separate and device-specific reagents. A trigger mechanism that allows such specific control is the reversible binding of DNA strands, thereby 'fuelling' conformational changes in a DNA machine(9). Here we improve upon the initial prototype system that uses this mechanism but generates by-products(9), by demonstrating a robust sequence-dependent rotary DNA device operating in a four-step cycle. We show that DNA strands control and fuel our device cycle by inducing the interconversion between two robust topological motifs, paranemic crossover (PX) DNA(10,11) and its topoisomer JX(2) DNA, in which one strand end is rotated relative to the other by 180 degrees. We expect that a wide range of analogous yet distinct rotary devices can be created by changing the control strands and the device sequences to which they bind.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.							Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Pease AR, 2001, ACCOUNTS CHEM RES, V34, P433, DOI 10.1021/ar000178q; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2001, NANO LETT, V1, P22, DOI 10.1021/nl000182v; Shen Z, 1999, THESIS NEW YORK U; Sun WQ, 1999, J MOL BIOL, V294, P683, DOI 10.1006/jmbi.1999.3155; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yang XP, 1998, J AM CHEM SOC, V120, P9779, DOI 10.1021/ja9817601; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	16	625	646	7	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					62	65		10.1038/415062a	http://dx.doi.org/10.1038/415062a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780115				2022-12-28	WOS:000173028800038
J	Silver, DL; Montell, DJ				Silver, DL; Montell, DJ			Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila	CELL			English	Article							FOCAL ADHESION KINASE; JAK-STAT PATHWAY; CONSTITUTIVE ACTIVATION; IN-VIVO; PROTEIN; GENE; MIGRATION; OOGENESIS; ENCODES; C/EBP	The JAK/STAT signaling pathway, renowned for its effects on cell proliferation and survival, is constitutively active in various human cancers, including ovarian. We have found that JAK and STAT are required to convert the border cells in the Drosophila ovary from stationary, epithelial cells to migratory, invasive cells. The ligand for this pathway, Unpaired (UPD), is expressed by two central cells within the migratory cell cluster. Mutations in upd or jak cause defects in migration and a reduction in the number of cells recruited to the cluster. Ectopic expression of either UPD or JAK is sufficient to induce extra epithelial cells to migrate. Thus, a localized signal activates the JAK/ STAT pathway in neighboring epithelial cells, causing them to become invasive.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Silver, Debra/0000-0001-9189-844X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425, R29GM046425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 46425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010; DAMELL JE, 1997, SCIENCE, V277, P1630; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Han DD, 2000, DEVELOPMENT, V127, P573; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jinks TM, 2000, MOL CELL, V5, P581, DOI 10.1016/S1097-2765(00)80451-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu YR, 1999, DEVELOPMENT, V126, P1869; Liu YR, 2001, DEVELOPMENT, V128, P321; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; MCGREGOR JR, 2002, IN PRESS DEVELOPMENT; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Montell DJ, 2001, MECH DEVELOP, V105, P19, DOI 10.1016/S0925-4773(01)00393-8; Montell DJ, 1999, DEVELOPMENT, V126, P3035; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; Rorth P, 2000, MOL CELL, V6, P23; RORTH P, 1992, GENE DEV, V6, P2299, DOI 10.1101/gad.6.12a.2299; Rorth P, 1998, DEVELOPMENT, V125, P1049; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Spradling Allan C., 1993, P1; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Yan RQ, 1996, P NATL ACAD SCI USA, V93, P5842, DOI 10.1073/pnas.93.12.5842; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	51	228	230	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					831	841		10.1016/S0092-8674(01)00607-9	http://dx.doi.org/10.1016/S0092-8674(01)00607-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779460	Bronze			2022-12-28	WOS:000173024200005
J	Eagles, JM				Eagles, JM			SAD - help arrives with the dawn?	LANCET			English	Editorial Material							WINTER DEPRESSION; LIGHT; SIMULATION		Royal Cornhill Hosp, Dept Psychiat, Aberdeen AB25 2ZH, Scotland		Eagles, JM (corresponding author), Royal Cornhill Hosp, Dept Psychiat, Aberdeen AB25 2ZH, Scotland.							Ando K, 1996, BIOL PSYCHIAT, V39, P22, DOI 10.1016/0006-3223(95)00109-3; Avery DH, 2001, BIOL PSYCHIAT, V50, P205, DOI 10.1016/S0006-3223(01)01200-8; Brainard GC, 2001, J NEUROSCI, V21, P6405; Eagles JM, 1999, BRIT J PSYCHIAT, V175, P472, DOI 10.1192/bjp.175.5.472; Lewy AJ, 1998, ARCH GEN PSYCHIAT, V55, P890, DOI 10.1001/archpsyc.55.10.890; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Lingjaerde O, 1998, ACTA PSYCHIAT SCAND, V98, P73, DOI 10.1111/j.1600-0447.1998.tb10045.x; Michalak EE, 2001, BRIT J PSYCHIAT, V179, P31, DOI 10.1192/bjp.179.1.31; TERMAN M, 1989, BIOL PSYCHIAT, V25, P966, DOI 10.1016/0006-3223(89)90276-X; Thompson C., 2001, SEASONAL AFFECTIVE D, P151	10	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2100	2100		10.1016/S0140-6736(01)07232-4	http://dx.doi.org/10.1016/S0140-6736(01)07232-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784620				2022-12-28	WOS:000172905800005
J	Pepperberg, DR; Crouch, RK				Pepperberg, DR; Crouch, RK			An illuminating new step in visual-pigment regeneration	LANCET			English	Editorial Material									Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical University of South Carolina	Pepperberg, DR (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA.							Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	14	15	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2098	2099		10.1016/S0140-6736(01)07231-2	http://dx.doi.org/10.1016/S0140-6736(01)07231-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784619				2022-12-28	WOS:000172905800004
J	Leonhardt, U				Leonhardt, U			A laboratory analogue of the event horizon using slow light in an atomic medium	NATURE			English	Article							BLACK-HOLE EVAPORATION; RADIATION	Singularities underlie many optical phenomena(1). The rainbow, for example, involves a particular type of singularity-a ray catastrophe-in which light rays become infinitely intense. In practice, the wave nature of light resolves these infinities, producing interference patterns. At the event horizon of a black hole(2), time stands still and waves oscillate with infinitely small wavelengths. However, the quantum nature of light results in evasion of the catastrophe and the emission of Hawking radiation(3). Here I report a theoretical laboratory analogue of an event horizon: a parabolic profile of the group velocity(7) of light brought to a standstill in an atomic medium(4-6) can cause a wave singularity similar to that associated with black holes. In turn, the quantum vacuum is forced to create photon pairs with a characteristic spectrum, a phenomenon related to Hawking radiation(3). The idea may initiate a theory of 'quantum' catastrophes, extending classical catastrophe theory(8,9).	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	University of St Andrews	Leonhardt, U (corresponding author), Univ St Andrews, Sch Phys & Astron, N Haugh, St Andrews KY16 9SS, Fife, Scotland.							Ablowitz M. J., 1997, COMPLEX VARIABLES; Berry M. V., 1980, Progress in optics. Vol.XVIII, P257, DOI 10.1016/S0079-6638(08)70215-4; Birrell N. D., 1982, Quantum fields in curved space; Born M, 2005, PRINCIPLES OPTICS, V7th edn; BROUT R, 1995, PHYS REP, V260, P329, DOI 10.1016/0370-1573(95)00008-5; Chapline G, 2001, PHILOS MAG B, V81, P235, DOI 10.1080/13642810110037102; Dutton Z, 2001, SCIENCE, V293, P663, DOI 10.1126/science.1062527; Erdelyi A., 1981, HIGHER TRANSCENDENTA; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; HAWKING SW, 1974, NATURE, V248, P30, DOI 10.1038/248030a0; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; MANDEL L, 1995, OPTICAL COHERNENCE Q; MISNER CW, 1999, GRAVITATION; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; POSTON T, 1996, CATASTROPHE THEORY I; Schleich W., 1984, NEW TRENDS ATOMIC PH; SCHWINGER J, 1951, PHYS REV, V82, P664, DOI 10.1103/PhysRev.82.664; Scully M.O., 1997, QUANTUM OPT; THORN R, 1972, STABILITE STRUCTUREL; UNRUH WG, 1976, PHYS REV D, V14, P870, DOI 10.1103/PhysRevD.14.870; UNRUH WG, 1981, PHYS REV LETT, V46, P1351, DOI 10.1103/PhysRevLett.46.1351; Visser M, 1998, CLASSICAL QUANT GRAV, V15, P1767, DOI 10.1088/0264-9381/15/6/024; Volovik GE, 1999, JETP LETT+, V69, P705, DOI 10.1134/1.568079; Wang LJ, 2000, NATURE, V406, P277, DOI 10.1038/35018520; Weinberg S., 1999, QUANTUM THEORY FIELD	30	95	97	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					406	409		10.1038/415406a	http://dx.doi.org/10.1038/415406a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807548	Green Submitted			2022-12-28	WOS:000173433600043
J	Arlot-Bonnemains, Y; Prigent, C				Arlot-Bonnemains, Y; Prigent, C			A trigger for centrosome duplication	SCIENCE			English	Editorial Material							CELLS		Univ Rennes 1, Fac Med, Grp Cycle Cellulaire,CNRS, UMR Genet & Dev 6061,IFR Genom Fonct & Sante 97, F-35043 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Arlot-Bonnemains, Y (corresponding author), Univ Rennes 1, Fac Med, Grp Cycle Cellulaire,CNRS, UMR Genet & Dev 6061,IFR Genom Fonct & Sante 97, CS 34317, F-35043 Rennes, France.							BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	12	6	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					455	456		10.1126/science.1068917	http://dx.doi.org/10.1126/science.1068917			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799231				2022-12-28	WOS:000173350700037
J	Bond, DR; Holmes, DE; Tender, LM; Lovley, DR				Bond, DR; Holmes, DE; Tender, LM; Lovley, DR			Electrode-reducing microorganisms that harvest energy from marine sediments	SCIENCE			English	Article							MICROBIAL FUEL-CELLS; 16S RIBOSOMAL-RNA; DESULFUROMONAS-ACETOXIDANS; FE(III) REDUCTION; GEN-NOV; OXIDATION; BACTERIUM; AQUIFER	Energy in the form of electricity can be harvested from marine sediments by placing a graphite electrode (the anode) in the anoxic zone and connecting it to a graphite cathode in the overlying aerobic water. We report a specific enrichment of microorganisms of the family Geobacteraceae on energy-harvesting anodes, and we show that these microorganisms can conserve energy to support their growth by oxidizing organic compounds with an electrode serving as the sole electron acceptor. This finding not only provides a method for extracting energy from organic matter, but also suggests a strategy for promoting the bioremediation of organic contaminants in subsurface environments.	Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	University of Massachusetts System; University of Massachusetts Amherst; United States Department of Defense; United States Navy; Naval Research Laboratory	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.			Bond, Daniel/0000-0001-8083-7107; saravanan, s/0000-0003-1269-1243				EMDE R, 1989, APPL MICROBIOL BIOT, V32, P170, DOI 10.1007/BF00165883; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley D.R., 2000, PROKARYOTES; LOVLEY DR, 1994, NATURE, V370, P128, DOI 10.1038/370128a0; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lovley DR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P3; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Park DH, 2000, APPL ENVIRON MICROB, V66, P1292, DOI 10.1128/AEM.66.4.1292-1297.2000; PFENNIG N, 1976, ARCH MICROBIOL, V110, P3, DOI 10.1007/BF00416962; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; ROLLER SD, 1984, J CHEM TECH BIOT B, V34, P3; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018	17	1040	1169	29	732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					483	485		10.1126/science.1066771	http://dx.doi.org/10.1126/science.1066771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799240				2022-12-28	WOS:000173350700046
J	Radda, G				Radda, G			Science in Europe - Biomedical research and international collaboration	SCIENCE			English	Editorial Material									MRC, London W1N 4AL, England		Radda, G (corresponding author), MRC, London W1N 4AL, England.								0	5	5	2	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					445	446		10.1126/science.1069179	http://dx.doi.org/10.1126/science.1069179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799225				2022-12-28	WOS:000173350700029
J	Asmis, LM; Girardet, C				Asmis, LM; Girardet, C			Systemic mast-cell disease (mastocytosis)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Hosp Geneva, CH-1211 Geneva, Switzerland	University of Geneva	Asmis, LM (corresponding author), Univ Hosp Geneva, CH-1211 Geneva, Switzerland.		Asmis, Lars M/H-4011-2019						0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					174	174		10.1056/NEJMicm000003	http://dx.doi.org/10.1056/NEJMicm000003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796851				2022-12-28	WOS:000173273600005
J	Beck, M; Hofstetter, D; Aellen, T; Faist, J; Oesterle, U; Ilegems, M; Gini, E; Melchior, H				Beck, M; Hofstetter, D; Aellen, T; Faist, J; Oesterle, U; Ilegems, M; Gini, E; Melchior, H			Continuous wave operation of a mid-infrared semiconductor laser at room temperature	SCIENCE			English	Article							QUANTUM CASCADE LASERS; GREATER-THAN	Continuous wave operation of quantum cascade lasers is reported up to a temperature of 312 kelvin. The devices were fabricated as buried heterostructure lasers with high-reflection coatings on both laser facets, resulting in continuous wave operation with optical output power ranging from 17 milliwatts at 292 kelvin to 3 milliwatts at 312 kelvin, at an emission wavelength of 9.1 micrometers. The results demonstrate the potential of quantum cascade lasers as continuous wave mid-infrared light sources for high-resolution spectroscopy, chemical sensing applications, and free-space optical communication systems.	Univ Neuchatel, Inst Phys, CH-2000 Neuchatel, Switzerland; Swiss Fed Inst Technol, Dept Phys, Inst Micro & Optoelect, CH-1015 Lausanne, Switzerland; Swiss Fed Inst Technol, Dept Phys, Inst Quantum Elect, CH-8093 Zurich, Switzerland	University of Neuchatel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich	Beck, M (corresponding author), Univ Neuchatel, Inst Phys, CH-2000 Neuchatel, Switzerland.	Mattlas.Beck@unine.ch	ILEGEMS, Marc/AAN-1873-2021; Faist, Jerome/A-7339-2013; Beck, Mattias/A-7959-2013	Faist, Jerome/0000-0003-4429-7988; Beck, Mattias/0000-0002-0260-5797; Hofstetter, Daniel/0000-0003-4948-0853				Beck M, 2000, IEEE PHOTONIC TECH L, V12, P1450, DOI 10.1109/68.887653; Bewley WW, 2000, APPL PHYS LETT, V76, P256, DOI 10.1063/1.125739; Blaser S, 2001, ELECTRON LETT, V37, P778, DOI 10.1049/el:20010504; Blaser S, 2001, IEEE J QUANTUM ELECT, V37, P448, DOI 10.1109/3.910456; Faist J, 1996, PHYS REV LETT, V76, P411, DOI 10.1103/PhysRevLett.76.411; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Faist J, 1998, IEEE J QUANTUM ELECT, V34, P336, DOI 10.1109/3.658728; Faist J, 1996, APPL PHYS LETT, V68, P3680, DOI 10.1063/1.115741; Feit Z, 1996, APPL PHYS LETT, V68, P738, DOI 10.1063/1.116726; Gmachl C, 2000, ELECTRON LETT, V36, P723, DOI 10.1049/el:20000583; Gmachl C, 1999, IEEE PHOTONIC TECH L, V11, P1369, DOI 10.1109/68.803048; Hofstetter D, 2001, APPL PHYS LETT, V78, P1964, DOI 10.1063/1.1360225; Kosterev AA, 1999, OPT LETT, V24, P1762, DOI 10.1364/OL.24.001762; MARTIN R, 2001, IEE ELECT LETT, V37, P111; Namjou K, 1998, OPT LETT, V23, P219, DOI 10.1364/OL.23.000219; Rochat M, 2001, APPL PHYS LETT, V78, P1967, DOI 10.1063/1.1357444; Sirtori C, 1998, IEEE J QUANTUM ELECT, V34, P1722, DOI 10.1109/3.709589	17	703	748	10	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					301	305		10.1126/science.1066408	http://dx.doi.org/10.1126/science.1066408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786637	Green Submitted			2022-12-28	WOS:000173278600041
J	Bertola, F				Bertola, F			Astronomy - Putting galaxies on the scale	SCIENCE			English	Editorial Material							MILKY-WAY; HALO		Univ Padua, Dipartimento Astron, I-35122 Padua, Italy	University of Padua	Bertola, F (corresponding author), Univ Padua, Dipartimento Astron, I-35122 Padua, Italy.							FOSBURY R, 2001, MESSENGER, V105, P40; McGaugh SS, 2001, ASTRON J, V122, P2381, DOI 10.1086/323448; MERRITT D, IN PRESS CENTRAL KPC; Olling RP, 2000, MON NOT R ASTRON SOC, V311, P361, DOI 10.1046/j.1365-8711.2000.03053.x; Olling RP, 2001, MON NOT R ASTRON SOC, V326, P164, DOI 10.1046/j.1365-8711.2001.04581.x; Wilkinson MI, 1999, MON NOT R ASTRON SOC, V310, P645, DOI 10.1046/j.1365-8711.1999.02964.x; ZIEGLER BL, UNPUB; 2001, WORKSH ORG ESO U STE	9	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					283	284		10.1126/science.1067918	http://dx.doi.org/10.1126/science.1067918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786629				2022-12-28	WOS:000173278600033
J	Hannon, JB; Tersoff, J; Tromp, RM				Hannon, JB; Tersoff, J; Tromp, RM			Surf ace stress and thermodynamic nanoscale size selection	SCIENCE			English	Article							PERIODIC DOMAIN-STRUCTURES; CRYSTAL-SURFACES; NANOSTRUCTURES; TRANSITION; GROWTH	Using the Si(111) surface as an example, we show how temperature can be used to tune the size of domains during a surface phase transition. From analysis of the measured stable domain sizes, we determine key material parameters and clarify the close relationship between nucleation and thermodynamic size selection. More generally, the model we developed describes nanoscale self-assembly processes in contact with a reservoir (for example, liquid- or vapor-phase epitaxy).	IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Hannon, JB (corresponding author), IBM Corp, Div Res, TJ Watson Res Ctr, POB 218, Yorktown Hts, NY 10598 USA.		Gaeid, Khalaf S/G-2784-2015	Gaeid, Khalaf S/0000-0002-8943-3034				Aggarwal S, 2000, SCIENCE, V287, P2235, DOI 10.1126/science.287.5461.2235; ALERHAND OL, 1988, PHYS REV LETT, V61, P1973, DOI 10.1103/PhysRevLett.61.1973; BAUER E, 1994, REP PROG PHYS, V57, P895, DOI 10.1088/0034-4885/57/9/002; Hannon JB, 2000, NATURE, V405, P552, DOI 10.1038/35014569; Hannon JB, 2001, PHYS REV LETT, V86, P4871, DOI 10.1103/PhysRevLett.86.4871; HOSHINO T, 1995, PHYS REV LETT, V75, P2372, DOI 10.1103/PhysRevLett.75.2372; MARCHENKO VI, 1981, JETP LETT, V33, P382; NG KO, 1995, PHYS REV B, V52, P2177, DOI 10.1103/PhysRevB.52.2177; Ross FM, 1999, SCIENCE, V286, P1931, DOI 10.1126/science.286.5446.1931; SEUL M, 1995, SCIENCE, V267, P476, DOI 10.1126/science.267.5197.476; Shchukin VA, 1999, REV MOD PHYS, V71, P1125, DOI 10.1103/RevModPhys.71.1125; TAKAYANAGI K, 1985, SURF SCI, V164, P367, DOI 10.1016/0039-6028(85)90753-8; Tromp RM, 1998, SURF REV LETT, V5, P1189, DOI 10.1142/S0218625X98001523; TWESTEN RD, 1994, PHYS REV B, V50, P17628, DOI 10.1103/PhysRevB.50.17628; VANDERBILT D, 1992, SURF SCI, V268, pL300, DOI 10.1016/0039-6028(92)90939-4; WU CW, 2001, SURF SCI, V487, P191	16	48	48	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					299	301		10.1126/science.1066420	http://dx.doi.org/10.1126/science.1066420			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786636				2022-12-28	WOS:000173278600040
J	Noda, W; Nishiwaki, Y; Kawahara, M; Negoro, S; Sugiura, T; Yokoyama, A; Fukuoka, M; Mori, K; Watanabe, K; Tamura, T; Yamamoto, S; Saijo, N				Noda, W; Nishiwaki, Y; Kawahara, M; Negoro, S; Sugiura, T; Yokoyama, A; Fukuoka, M; Mori, K; Watanabe, K; Tamura, T; Yamamoto, S; Saijo, N		Japan Clin Oncology Grp	Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYCLOPHOSPHAMIDE; DOXORUBICIN; VINCRISTINE; ALTERNATION; ONCOLOGY; REGIMENS; TRIAL	Background Irinotecan hydrochloride, a topoisomerase I inhibitor, is effective against small-cell lung cancer. In a phase 2 study of irinotecan plus cisplatin in patients with extensive small-cell lung cancer, there was a high response rate and a promising median survival time. Methods We conducted a multicenter, randomized, phase 3 study in which we compared irinotecan plus cisplatin with etoposide plus cisplatin in patients with extensive (metastatic) small-cell lung cancer. Results The planned size of the study population was 230 patients, but enrollment was terminated early because an interim analysis found a statistically significant difference in survival between the patients assigned to receive irinotecan and cisplatin and those assigned to receive etoposide and cisplatin; as a result, only 154 patients were enrolled. The median survival was 12.8 months in the irinotecan-plus-cisplatin group and 9.4 months in the etoposide-plus-cisplatin group (P=0.002 by the unadjusted log-rank test). At two years, the proportion of patients surviving was 19.5 percent in the irinotecan-plus-cisplatin group and 5.2 percent in the etoposide-plus-cisplatin group. Severe or life-threatening myelosuppression was more frequent in the etoposide-plus-cisplatin group than in the irinotecan-plus-cisplatin group, and severe or life-threatening diarrhea was more frequent in the irinotecan-plus-cisplatin group than in the etoposide-plus-cisplatin group. Conclusions Irinotecan plus cisplatin is an effective treatment for metastatic small-cell lung cancer. (N Engl J Med 2002;346:85-91.) Copyright (C) 2002 Massachusetts Medical Society.	Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan; Natl Canc Ctr Hosp E, Chiba, Japan; Natl Kinki Cent Hosp Chest Dis, Osaka, Japan; Osaka City Gen Hosp, Osaka, Japan; Niigata Canc Ctr Hosp, Niigata, Japan; Aichi Canc Ctr, Nagoya, Aichi 464, Japan; Kinki Univ, Sch Med, Osaka 589, Japan; Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan; Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan; Natl Canc Ctr, Cent Hosp, Tokyo 104, Japan; Natl Canc Ctr, Res Inst, Canc Informat & Epidemiol Div, Tokyo 104, Japan	Kanagawa Prefectural Cancer Center; National Cancer Center - Japan; Osaka City General Hospital; Aichi Cancer Center; Kindai University (Kinki University); Tochigi Prefectural Cancer Center; National Cancer Center - Japan; National Cancer Center - Japan	Saijo, N (corresponding author), Natl Canc Ctr, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.							AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aisner J, 1996, J CLIN ONCOL, V14, P658, DOI 10.1200/JCO.1996.14.2.658; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; FUKUOKA M, 1991, J NATL CANCER I, V83, P855, DOI 10.1093/jnci/83.12.855; IHDE DC, 1992, NEW ENGL J MED, V327, P1434; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kudoh S, 1998, J CLIN ONCOL, V16, P1068, DOI 10.1200/JCO.1998.16.3.1068; MASUDA N, 1992, J CLIN ONCOL, V10, P1225, DOI 10.1200/JCO.1992.10.8.1225; REBOUSSIN DM, 2001, PROGRAMS COMPUTING G; ROTH BJ, 1992, J CLIN ONCOL, V10, P282, DOI 10.1200/JCO.1992.10.2.282; TOBINAI K, 1993, JPN J CLIN ONCOL, V23, P250, DOI 10.1093/oxfordjournals.jjco.a039642; World Health Organization, 1979, WHO HDB REP RES CANC, V48	12	979	1034	1	12	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					85	91		10.1056/NEJMoa003034	http://dx.doi.org/10.1056/NEJMoa003034			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784874	Bronze			2022-12-28	WOS:000173133400003
J	Boulton, SJ; Gartner, A; Reboul, J; Vaglio, P; Dyson, N; Hill, DE; Vidal, M				Boulton, SJ; Gartner, A; Reboul, J; Vaglio, P; Dyson, N; Hill, DE; Vidal, M			Combined functional genomic maps of the C-elegans DNA damage response	SCIENCE			English	Article							PROTEIN; YEAST; INTERFERENCE; CHECKPOINTS; PATHWAY; REPAIR; LENGTH; RNA	Many human cancers originate from defects in the DNA damage response (DDR). Although much is known about this process, it is likely that additional DDR genes remain to be discovered. To identify such genes, we used a strategy that combines protein-protein interaction mapping and large-scale phenotypic analysis in Caenorhabditis elegans. Together, these approaches identified 12 worm DDR orthologs and 11 novel DDR genes. One of these is the putative ortholog of hBCL3, a gene frequently altered in chronic lymphocytic leukemia. Thus, the combination of functional genomic mapping approaches in model organisms may facilitate the identification and characterization of genes involved in cancer and, perhaps, other human diseases.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Max Planck Society	Vidal, M (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Reboul, Jerome/P-9103-2016	Reboul, Jerome/0000-0002-5513-4546; Gartner, Anton/0000-0003-4639-9902; Vaglio, Philippe/0000-0003-2900-5596	NCI NIH HHS [P01CA80111-02, 7 R33 CA81658-02] Funding Source: Medline; NHGRI NIH HHS [5R01HG01715-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA081658, P01CA080111] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Cai RL, 2000, J BIOL CHEM, V275, P27909; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dernburg AF, 2000, GENE DEV, V14, P1578; di Fagagna FD, 1999, NAT GENET, V23, P76; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; HARTWELL L, 1994, COLD SPRING HARB SYM, V59, P259, DOI 10.1101/SQB.1994.059.01.030; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Sternberg PW, 2001, CELL, V105, P173, DOI 10.1016/S0092-8674(01)00308-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vidal M, 1999, NUCLEIC ACIDS RES, V27, P919, DOI 10.1093/nar/27.4.919; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	225	232	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					127	131		10.1126/science.1065986	http://dx.doi.org/10.1126/science.1065986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778048				2022-12-28	WOS:000173143100049
J	Sharp, MD; Pogliano, K				Sharp, MD; Pogliano, K			Rote of cell-specific SpoIIIE assembly in polarity of DNA transfer	SCIENCE			English	Article							BACILLUS-SUBTILIS SPORULATION; MECHANISM; DIVISION; BACTERIA; PROTEIN	SpoIIIE mediates postseptational chromosome partitioning in Bacillus subtilis, but the mechanism controlling the direction of DNA transfer remains obscure. Here, we demonstrated that SpoIIIE acts as a DNA exporter: When SpoIIIE was synthesized in the larger of the two cells necessary for sporulation, the mother cell, DNA was translocated into the smaller forespore; however, when it was synthesized in the forespore, DNA was translocated into the mother cell. Furthermore, the DNA-tracking domain of SpoIIIE inhibited SpoIIIE complex assembly in the forespore. Thus, during sporulation, chromosome partitioning is controlled by the preferential assembly of SpoIIIE in one daughter cell.	Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pogliano, K (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.			Pogliano, Kit/0000-0002-7868-3345	NIGMS NIH HHS [R01 GM057045-03, R01 GM057045-02, R01 GM057045-04, GM-57045, R01 GM057045] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; POGLIANO J, IN PRESS J BACTERIOL; POGLIANO K, 1995, MOL MICROBIOL, V18, P459, DOI 10.1111/j.1365-2958.1995.mmi_18030459.x; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161	11	78	79	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					137	139		10.1126/science.1066274	http://dx.doi.org/10.1126/science.1066274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778051	Green Accepted			2022-12-28	WOS:000173143100052
J	Greiner, M; Mandel, O; Esslinger, T; Hansch, TW; Bloch, I				Greiner, M; Mandel, O; Esslinger, T; Hansch, TW; Bloch, I			Quantum phase transition from a superfluid to a Mott insulator in a gas of ultracold atoms	NATURE			English	Article							COHERENCE; DYNAMICS; LATTICE	For a system at a temperature of absolute zero, all thermal fluctuations are frozen out, while quantum fluctuations prevail. These microscopic quantum fluctuations can induce a macroscopic phase transition in the ground state of a many-body system when the relative strength of two competing energy terms is varied across a critical value. Here we observe such a quantum phase transition in a Bose-Einstein condensate with repulsive interactions, held in a three-dimensional optical lattice potential. As the potential depth of the lattice is increased, a transition is observed from a superfluid to a Mott insulator phase. In the superfluid phase, each atom is spread out over the entire lattice, with long-range phase coherence. But in the insulating phase, exact numbers of atoms are localized at individual lattice sites, with no phase coherence across the lattice; this phase is characterized by a gap in the excitation spectrum. We can induce reversible changes between the two ground states of the system.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Univ Munich, Sekt Phys, D-80799 Munich, Germany; Swiss Fed Inst Technol, Quantenelektron, CH-8093 Zurich, Switzerland	Max Planck Society; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bloch, I (corresponding author), Univ Munich, Sekt Phys, Schellingstr 4-III, D-80799 Munich, Germany.	imb@mpq.mpg.de	Esslinger, Tilman/M-9022-2016; Bloch, Immanuel/N-9169-2019; Bloch, Immanuel/G-3174-2010; Greiner, Markus/E-9512-2017; Greiner, Markus/A-8502-2010	Esslinger, Tilman/0000-0002-8333-107X; Bloch, Immanuel/0000-0002-0679-4759; 				Bouyer P, 1997, PHYS REV A, V56, pR1083, DOI 10.1103/PhysRevA.56.R1083; BRADLEY RM, 1984, PHYS REV B, V30, P1138, DOI 10.1103/PhysRevB.30.1138; Chow E, 1998, PHYS REV LETT, V81, P204, DOI 10.1103/PhysRevLett.81.204; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; Elstner N, 1999, PHYS REV B, V59, P12184, DOI 10.1103/PhysRevB.59.12184; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; FREERICKS JK, 1994, EUROPHYS LETT, V26, P545, DOI 10.1209/0295-5075/26/7/012; GEERLIGS LJ, 1989, PHYS REV LETT, V63, P326, DOI 10.1103/PhysRevLett.63.326; Greiner M, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.031401; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; HAVILAND DB, 1989, PHYS REV LETT, V62, P2180, DOI 10.1103/PhysRevLett.62.2180; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; KASTBERG A, 1995, PHYS REV LETT, V74, P1542, DOI 10.1103/PhysRevLett.74.1542; ORR BG, 1986, PHYS REV LETT, V56, P378, DOI 10.1103/PhysRevLett.56.378; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Sachdev S., 2001, QUANTUM PHASE TRANSI; SHESHADRI K, 1993, EUROPHYS LETT, V22, P257, DOI 10.1209/0295-5075/22/4/004; Stringari S, 2001, CR ACAD SCI IV-PHYS, V2, P381, DOI 10.1016/S1296-2147(01)01178-7; van Oosten D, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.053601; VANDERZANT HSJ, 1992, PHYS REV LETT, V69, P2971, DOI 10.1103/PhysRevLett.69.2971; vanOudenaarden A, 1996, PHYS REV LETT, V76, P4947, DOI 10.1103/PhysRevLett.76.4947; ZWERGER W, 1989, EUROPHYS LETT, V9, P421, DOI 10.1209/0295-5075/9/5/003	26	4550	4602	12	501	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					39	44		10.1038/415039a	http://dx.doi.org/10.1038/415039a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780110				2022-12-28	WOS:000173028800033
J	Zimmerman, C; Klein, KC; Kiser, PK; Singh, AR; Firestein, BL; Riba, SC; Lingappa, JR				Zimmerman, C; Klein, KC; Kiser, PK; Singh, AR; Firestein, BL; Riba, SC; Lingappa, JR			Identification of a host protein essential for assembly of immature HIV-1 capsids	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNASE-L INHIBITOR; RETROVIRAL MORPHOGENESIS; VIF PROTEIN; TYPE-1; CELLS; PATHWAY; NEF; INFECTIVITY; EXPRESSION	To form an immature HIV-1 capsid, 1,500 HIV-1 Gag (p55) polypeptides must assemble properly along the host cell plasma membrane. Insect cells and many higher eukaryotic cell types support efficient capsid assembly 1, but yeast(2) and murine cells(3,4) do not, indicating that host machinery is required for immature HIV-1 capsid formation. Additionally, in a cell-free system that reconstitutes HIV-1 capsid formation, post-translational assembly events require ATP and a subcellular fraction(5), suggesting a requirement for a cellular ATP-binding protein. Here we identify such a protein (HP68), described previously as an RNase L inhibitor(6), and demonstrate that it associates post-translationally with HIV-1 Gag in a cell-free system and human T cells infected with HIV-1. Using a dominant negative mutant of HP68 in mammalian cells and depletion-reconstitution experiments in the cell-free system, we demonstrate that HP68 is essential for post-translational events in immature HIV-1 capsid assembly. Furthermore, in cells the HP68-Gag complex is associated with HIV-1 Vif, which is involved in virion morphogenesis and infectivity. These findings support a critical role for HP68 in posttranslational events of HIV-1 assembly and reveal a previously unappreciated dimension of host-viral interaction.	Univ Washington, Sch Publ Hlth, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Rutgers State University New Brunswick	Lingappa, JR (corresponding author), Univ Washington, Sch Publ Hlth, Dept Pathobiol, Seattle, WA 98195 USA.		Lingappa, Jairam/N-7760-2017	Firestein, Bonnie/0000-0002-1679-3565				BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Boulanger P, 1996, CURR TOP MICROBIOL, V214, P237; Bukovsky AA, 1997, J VIROL, V71, P1013, DOI 10.1128/JVI.71.2.1013-1018.1997; Cohen EA, 1996, CURR TOP MICROBIOL, V214, P219; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; HOCKLEY DJ, 1994, J GEN VIROL, V75, P2985, DOI 10.1099/0022-1317-75-11-2985; Hynes G, 1996, ELECTROPHORESIS, V17, P1720, DOI 10.1002/elps.1150171109; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; JOWETT JBM, 1992, J GEN VIROL, V73, P3079, DOI 10.1099/0022-1317-73-12-3079; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LINGAPPA JR, 1994, J CELL BIOL, V125, P99, DOI 10.1083/jcb.125.1.99; Lingappa JR, 1997, J CELL BIOL, V136, P567, DOI 10.1083/jcb.136.3.567; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Martinand C, 1999, J VIROL, V73, P290, DOI 10.1128/JVI.73.1.290-296.1999; MORGAN PJ, 1989, J NEUROENDOCRINOL, V1, P1, DOI 10.1111/j.1365-2826.1989.tb00068.x; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; SALEHZADA T, 1991, J BIOL CHEM, V266, P5808; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Singh AR, 2001, VIROLOGY, V279, P257, DOI 10.1006/viro.2000.0706; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	30	189	214	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					88	92		10.1038/415088a	http://dx.doi.org/10.1038/415088a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780123				2022-12-28	WOS:000173028800046
J	Payne, MY				Payne, MY			Too young to be having a heart attack	LANCET			English	Article											Payne, MY (corresponding author), 75 Keel Court, Heathsville, VA 22473 USA.	mpayne@crosslink.net							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S64	S64		10.1016/S0140-6736(01)07076-3	http://dx.doi.org/10.1016/S0140-6736(01)07076-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784613	Bronze			2022-12-28	WOS:000172907200064
J	Wilton, L; Williamson, R; McBain, J; Edgar, D; Voullaire, L				Wilton, L; Williamson, R; McBain, J; Edgar, D; Voullaire, L			Brief report: Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; HUMAN EMBRYOS; SINGLE CELLS; ANEUPLOIDY; DIAGNOSIS; AMPLIFICATION		Melbourne IVF, Melbourne, Vic 3002, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Wilton, L (corresponding author), Melbourne IVF, 320 Victoria Parade, Melbourne, Vic 3002, Australia.							COONEN E, 1994, HUM REPROD, V9, P533, DOI 10.1093/oxfordjournals.humrep.a138540; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Edgar DH, 2000, HUM REPROD, V15, P175, DOI 10.1093/humrep/15.1.175; Fung J, 2000, HUM GENET, V107, P615, DOI 10.1007/s004390000416; Gardner D.K, 2000, HDB VITRO FERTILIZAT, P205; Gianaroli L, 1999, FERTIL STERIL, V72, P837, DOI 10.1016/S0015-0282(99)00377-5; Iwarsson E, 1999, HUM GENET, V104, P376, DOI 10.1007/s004390050971; Kahraman S, 2000, HUM REPROD, V15, P2003, DOI 10.1093/humrep/15.9.2003; Munne S, 1999, HUM REPROD, V14, P2191, DOI 10.1093/humrep/14.9.2191; Munne S, 1998, FERTIL STERIL, V69, P904, DOI 10.1016/S0015-0282(98)00039-9; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030; Voullaire L, 1999, PRENATAL DIAG, V19, P846, DOI 10.1002/(SICI)1097-0223(199909)19:9<846::AID-PD657>3.0.CO;2-#; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Wells D, 1999, NUCLEIC ACIDS RES, V27, P1214, DOI 10.1093/nar/27.4.1214	14	123	154	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1537	1541		10.1056/NEJMoa011052	http://dx.doi.org/10.1056/NEJMoa011052			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794220				2022-12-28	WOS:000172265200004
J	Huikuri, HV; Castellanos, A; Myerburg, RJ				Huikuri, HV; Castellanos, A; Myerburg, RJ			Medical progress: Sudden death due to cardiac arrhythmias	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEART-RATE-VARIABILITY; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; T-WAVE ALTERNANS; SIGNAL-AVERAGED ELECTROCARDIOGRAM; ANTIARRHYTHMIC-DRUG-THERAPY; QT DISPERSION; PROGNOSTIC-SIGNIFICANCE; ELECTRICAL ALTERNANS		Univ Oulu, Dept Med, Div Cardiol, SF-90220 Oulu, Finland; Univ Miami, Sch Med, Div Cardiol, Miami, FL USA	University of Oulu; University of Miami	Huikuri, HV (corresponding author), Univ Oulu, Dept Med, Div Cardiol, Kajaanintie 50, SF-90220 Oulu, Finland.	heikki.huikuri@oulu.fi						AIRAKSINEN KEJ, 1998, PACE, V21, P929; Ananthasubramaniam K, 1998, PROG CARDIOVASC DIS, V41, P237, DOI 10.1016/S0033-0620(98)80058-3; Armoundas AA, 1998, AM J CARDIOL, V82, P1127, DOI 10.1016/S0002-9149(98)00570-0; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; BAUM RS, 1974, CIRCULATION, V50, P1231, DOI 10.1161/01.CIR.50.6.1231; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; BIGGER JT, 1994, SUDDEN CARDIAC DEATH, P190; Block M, 1999, AM J CARDIOL, V83, p74D; Boutitie F, 1999, CIRCULATION, V99, P2268, DOI 10.1161/01.CIR.99.17.2268; BREITHARDT G, 1991, EUR HEART J, V12, P473, DOI 10.1093/oxfordjournals.eurheartj.a059926; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; BRUGADA P, 1984, CIRCULATION, V69, P87, DOI 10.1161/01.CIR.69.1.87; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Buxton AE, 2000, NEW ENGL J MED, V342, P1300; Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8; Cairns JA, 1997, LANCET, V349, P1776; Caruso AC, 1997, CIRCULATION, V96, P1888, DOI 10.1161/01.CIR.96.6.1888; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; CRANDALL BG, 1993, J AM COLL CARDIOL, V21, P1186, DOI 10.1016/0735-1097(93)90244-U; DAVIES MJ, 1992, CIRCULATION, V85, P19; DAY CP, 1990, BRIT HEART J, V63, P342; DELUNA AB, 1989, AM HEART J, V117, P151, DOI 10.1016/0002-8703(89)90670-4; DENTON TA, 1990, AM HEART J, V120, P1419, DOI 10.1016/0002-8703(90)90258-Y; Domanski MJ, 1999, J AM COLL CARDIOL, V34, P1090, DOI 10.1016/S0735-1097(99)00327-7; Doval HC, 1996, CIRCULATION, V94, P3198, DOI 10.1161/01.CIR.94.12.3198; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; ELDAR M, 1987, J AM COLL CARDIOL, V10, P291, DOI 10.1016/S0735-1097(87)80010-4; ELSHERIF N, 1995, J AM COLL CARDIOL, V25, P908, DOI 10.1016/0735-1097(94)00504-J; Epstein AE, 1996, J AM COLL CARDIOL, V27, P433, DOI 10.1016/0735-1097(95)00482-3; Estes NAM, 1997, AM J CARDIOL, V80, P1314, DOI 10.1016/S0002-9149(97)00694-2; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GLANCY JM, 1995, LANCET, V345, P945, DOI 10.1016/S0140-6736(95)90697-5; GOMES JA, 1987, J AM COLL CARDIOL, V10, P349; GOMES JA, 1989, J AM COLL CARDIOL, V13, P377, DOI 10.1016/0735-1097(89)90515-9; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; GRADMAN A, 1989, J AM COLL CARDIOL, V14, P564, DOI 10.1016/0735-1097(89)90093-4; Hartikainen JEK, 1996, J AM COLL CARDIOL, V28, P296, DOI 10.1016/0735-1097(96)00169-6; Hohnloser SH, 1998, J CARDIOVASC ELECTR, V9, P1258, DOI 10.1111/j.1540-8167.1998.tb00101.x; Huikuri HV, 1999, J AM COLL CARDIOL, V34, P1878, DOI 10.1016/S0735-1097(99)00468-4; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; JULIAN DG, 1997, LANCET, V349, P1180; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Klein H, 1999, AM J CARDIOL, V83, p91D; Klingenheben T, 2000, LANCET, V356, P651, DOI 10.1016/S0140-6736(00)02609-X; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; La Rovere MT, 1998, LANCET, V351, P478; LUU M, 1989, CIRCULATION, V80, P1675, DOI 10.1161/01.CIR.80.6.1675; MAGGIONI AP, 1993, CIRCULATION, V87, P312, DOI 10.1161/01.CIR.87.2.312; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MCCLEMENTS BM, 1993, J AM COLL CARDIOL, V21, P1419, DOI 10.1016/0735-1097(93)90319-V; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Mittal S, 1999, J AM COLL CARDIOL, V34, P1082, DOI 10.1016/S0735-1097(99)00323-X; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; MYERBURG RJ, 1992, CIRCULATION, V85, P2; Myerburg RJ, 1997, AM J CARDIOL, V80, pF10, DOI 10.1016/S0002-9149(97)00477-3; MYERBURG RJ, 1989, AM J CARDIOL, V63, P1512, DOI 10.1016/0002-9149(89)90017-9; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Myerburg RJ, 1998, CIRCULATION, V97, P1514; Myerburg RJ, 1997, NEW ENGL J MED, V337, P1621, DOI 10.1056/NEJM199711273372209; Myerburg RJ, 2001, FDN CARDIAC ARRHYTHM, P547; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; PACKER M, 1992, CIRCULATION, V85, P50; PERKIOMAKI JS, 1995, J AM COLL CARDIOL, V26, P174, DOI 10.1016/0735-1097(95)00122-G; Perkiomaki JS, 1997, J AM COLL CARDIOL, V30, P1331, DOI 10.1016/S0735-1097(97)00301-X; Pinski SL, 1999, AM J MED, V106, P446, DOI 10.1016/S0002-9343(99)00047-9; Pratt CM, 1996, CIRCULATION, V93, P519, DOI 10.1161/01.CIR.93.3.519; PRYSTOWSKY EN, 1988, PACE, V11, P225, DOI 10.1111/j.1540-8159.1988.tb04545.x; Rosenbaum DS, 1996, J CARDIOVASC ELECTR, V7, P1095, DOI 10.1111/j.1540-8167.1996.tb00487.x; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; ROY D, 1985, CIRCULATION, V72, P487, DOI 10.1161/01.CIR.72.3.487; RUBERMAN W, 1981, CIRCULATION, V64, P297, DOI 10.1161/01.CIR.64.2.297; Sarter BH, 1996, J AM COLL CARDIOL, V28, P122, DOI 10.1016/0735-1097(96)00123-4; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77; SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201; Singh SN, 1998, J AM COLL CARDIOL, V32, P942, DOI 10.1016/S0735-1097(98)00338-6; SMITH JM, 1988, CIRCULATION, V77, P110, DOI 10.1161/01.CIR.77.1.110; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; STATTERS DJ, 1994, J CARDIOVASC ELECTR, V5, P672, DOI 10.1111/j.1540-8167.1994.tb01190.x; STEINBECK G, 1992, NEW ENGL J MED, V327, P987, DOI 10.1056/NEJM199210013271404; STEINBECK G, 1993, NEW ENGL J MED, V328, P71; STEINBERG JS, 1992, AM J CARDIOL, V69, P13, DOI 10.1016/0002-9149(92)90669-P; Teerlink JR, 2000, CIRCULATION, V101, P40, DOI 10.1161/01.CIR.101.1.40; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Waldo, 1996, LANCET, V348, P416; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Wever EFD, 1996, CIRCULATION, V93, P489, DOI 10.1161/01.CIR.93.3.489; WIT AL, 1992, CIRCULATION, V85, P32; WOOD M, 1994, CURR OPIN CARDIOL, V9, P3, DOI 10.1097/00001573-199401000-00002; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zabel M, 1998, CIRCULATION, V97, P2543, DOI 10.1161/01.CIR.97.25.2543; ZABEL M, 1995, J AM COLL CARDIOL, V25, P746, DOI 10.1016/0735-1097(94)00446-W; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; ZoniBerisso M, 1996, AM J CARDIOL, V77, P673, DOI 10.1016/S0002-9149(97)89198-9; Zuanetti G, 1996, CIRCULATION, V94, P432, DOI 10.1161/01.CIR.94.3.432	101	1031	1066	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1473	1482		10.1056/NEJMra000650	http://dx.doi.org/10.1056/NEJMra000650			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794197				2022-12-28	WOS:000172132700007
J	Drum, CL; Yan, SZ; Bard, J; Shen, YQ; Lu, D; Soelaiman, S; Grabarek, Z; Bohm, A; Tang, WJ				Drum, CL; Yan, SZ; Bard, J; Shen, YQ; Lu, D; Soelaiman, S; Grabarek, Z; Bohm, A; Tang, WJ			Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin	NATURE			English	Article							ELECTRON-DENSITY MAPS; BORDETELLA-PERTUSSIS; BACILLUS-ANTHRACIS; X-RAY; PHOSPHORYLASE-KINASE; CATALYTIC MECHANISM; PEPTIDE COMPLEX; EDEMA FACTOR; BINDING; DOMAIN	Oedema factor, a calmodulin-activated adenylyl cyclase, is important in the pathogenesis of anthrax. Here we report the X-ray structures of oedema factor with and without bound calmodulin. Oedema factor shares no significant structural homology with mammalian adenylyl cyclases or other proteins. In the active site, 39-deoxy-ATP and a single metal ion are well positioned for catalysis with histidine 351 as the catalytic base. This mechanism differs from the mechanism of two-metal-ion catalysis proposed for mammalian adenylyl cyclases. Four discrete regions of oedema factor form a surface that recognizes an extended conformation of calmodulin, which is very different from the collapsed conformation observed in other structures of calmodulin bound to effector peptides. On calmodulin binding, an oedema factor helical domain of relative molecular mass 15,000 undergoes a 15 Angstrom translation and a 30degrees rotation away from the oedema factor catalytic core, which stabilizes a disordered loop and leads to enzyme activation. These allosteric changes provide the first molecular details of how calmodulin modulates one of its targets.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Boston Biomed Res Inst, Watertown, MA 02472 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	University of Chicago; University of Chicago; Boston Biomedical Research Institute; Tufts University	Tang, WJ (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.	bohm@bbri.org; wtang@midway.uchicago.edu	Drum, Chester/A-6089-2015	Drum, Chester/0000-0001-6327-4584; Tang, Wei-Jen/0000-0002-8267-8995; Grabarek, Zenon/0000-0002-3636-5701				BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drum CL, 2001, ACTA CRYSTALLOGR D, V57, P1881, DOI 10.1107/S0907444901014937; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Eldik LV, 1998, CALMODULIN SIGNAL TR; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FARRAR YJK, 1993, J BIOL CHEM, V268, P4120; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GLASER P, 1991, EMBO J, V10, P1683, DOI 10.1002/j.1460-2075.1991.tb07692.x; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LABRUYERE E, 1990, BIOCHEMISTRY-US, V29, P4922, DOI 10.1021/bi00472a024; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; MUNIER H, 1995, ARCH BIOCHEM BIOPHYS, V320, P224, DOI 10.1016/0003-9861(95)90004-7; MUNIER H, 1992, J BIOL CHEM, V267, P9816; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; TREWHELLA J, 1990, BIOCHEMISTRY-US, V29, P9316, DOI 10.1021/bi00492a003; Wang EZ, 1997, BIOCHEMISTRY-US, V36, P15026, DOI 10.1021/bi963075h; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yan SZ, 1997, J BIOL CHEM, V272, P12342, DOI 10.1074/jbc.272.19.12342; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	51	332	348	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					396	402		10.1038/415396a	http://dx.doi.org/10.1038/415396a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807546				2022-12-28	WOS:000173433600041
J	Knudtson, ML; Wyse, DG; Galbraith, PD; Brant, R; Hildebrand, K; Paterson, D; Richardson, D; Burkart, C; Burgess, E				Knudtson, ML; Wyse, DG; Galbraith, PD; Brant, R; Hildebrand, K; Paterson, D; Richardson, D; Burkart, C; Burgess, E		Program Assess Alternative Treat	Chelation therapy for ischemic heart disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY DISEASE; DOUBLE-BLIND; INTERMITTENT CLAUDICATION; MYOCARDIAL-INFARCTION; QUESTIONNAIRE; EDTA	Context Chelation therapy using EDTA is an unproven but widely used alternative therapy for ischemic heart disease. Objective To determine if current EDTA protocols have a favorable impact on exercise ischemia threshold and quality of life measures in patients with stable ischemic heart disease. Design Double-blind, randomized, placebo-controlled trial conducted between January 1996 and January 2000. Setting Participants were recruited from a cohort of cardiac catheterization patients and practices of cardiologists in Calgary, Alberta. Participants We screened 3140 patients, performed a qualifying treadmill test in 171, and enrolled 84. Entry criteria included age at least 21 years with coronary artery disease proven by angiography or a documented myocardial infarction and stable angina while receiving optimal medical therapy. The required treadmill test used a gradual ramping protocol and patients had to demonstrate at least 1-mm ST depression. Interventions Patients were randomly assigned to receive infusion with either weight-adjusted (40 mg/kg) EDTA chelation therapy (n=41) or placebo (n=43) for 3 hours per treatment, twice weekly for 15 weeks and once per month for an additional 3 months. Patients in both groups took oral multivitamin therapy as welt. Main Outcome Measure Change from baseline to 27-week follow-up in time to ischemia (1-mm ST depression). Results Thirty-nine patients in each group completed the 27-week protocol. One chelation patient had therapy discontinued for a transient rise in serum, creatinine. The mean (SD) baseline exercise time to ischemia was 572 (172) and 589 (176) seconds in the placebo and chelation groups, respectively. The corresponding mean changes in time to ischemia at 27 weeks were 54 seconds (95% confidence interval [CI], 23-84 seconds; P<.001) and 63 seconds (95% CI, 29-95 seconds; P<.001), for a difference of 9 seconds (95% CI, -36 to 53 seconds; P=.69). Exercise capacity and quality of life scores improved by similar degrees in both groups. Conclusion Based on exercise time to ischemia, exercise capacity, and quality of life measurements, there is no evidence to support a beneficial effect of chelation therapy in patients with ischemic heart disease, stable angina, and a positive treadmill test for ischemia.	Univ Calgary, Div Cardiol, Calgary, AB, Canada; Calgary Reg Hlth Author, Calgary, AB, Canada	University of Calgary	Knudtson, ML (corresponding author), Foothills Med Ctr, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.			Brant, Rollin/0000-0002-8026-2451				Adams MR, 2000, ANNU REV MED, V51, P149, DOI 10.1146/annurev.med.51.1.149; ADES PA, 1989, AM J CARDIOL, V63, P1032, DOI 10.1016/0002-9149(89)90073-8; BENSON H, 1979, NEW ENGL J MED, V300, P1424; Bienenfeld L, 1996, AM HEART J, V132, P1207, DOI 10.1016/S0002-8703(96)90465-2; Casdorph HR, 1981, J HOLIST MED, V3, P53; CLARKE NE, 1955, AM J MED SCI, V229, P142, DOI 10.1097/00000441-195502000-00004; CLARKE NE, 1960, AM J MED SCI, V232, P654; CRANTON EM, 1984, J HOLISTIC MED, V6, P6; DUDLEY H, 1955, NEW ENGL J MED, V52, P331; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, AM HEART J, V140, P139, DOI 10.1067/mhj.2000.107548; FOLLI G, 1978, ACTA CARDIOL, V33, P231; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; GRIER MT, 1993, ANN PHARMACOTHER, V27, P1504, DOI 10.1177/106002809302701217; GULDAGER B, 1992, J INTERN MED, V231, P261, DOI 10.1111/j.1365-2796.1992.tb00533.x; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; KITCHELL JR, 1963, AM J CARDIOL, V11, P501, DOI 10.1016/0002-9149(63)90011-0; KOEN A, 1963, J CHRON DIS, V16, P329, DOI 10.1016/0021-9681(63)90083-3; Laine C, 1998, AM J MED, V105, P373, DOI 10.1016/S0002-9343(98)00291-5; Lamas GA, 2000, AM HEART J, V140, P4, DOI 10.1067/mhj.2000.107549; LASLETT LJ, 1985, CIRCULATION, V71, P958, DOI 10.1161/01.CIR.71.5.958; MCCANN D, 1962, CIRC RES, V9, P880; OLSZEWER E, 1990, J NATL MED ASSOC, V82, P173; OLSZEWER E, 1989, J ADV MED, V2, P197; Quan H, 2001, AM J MED, V111, P686, DOI 10.1016/S0002-9343(01)00999-8; ROMANO M, 1989, CLIN CARDIOL, V12, P39; ROZEMA TC, 1997, J ADV MED, V10, P1; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; VANRIJ AM, 1994, CIRCULATION, V90, P1194, DOI 10.1161/01.CIR.90.3.1194; Ware J.E, 1994, PHYS MENTAL HLTH SUM; WEBER JR, 1985, AM J CARDIOL, V56, P141	32	79	81	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					481	486		10.1001/jama.287.4.481	http://dx.doi.org/10.1001/jama.287.4.481			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798370	Bronze			2022-12-28	WOS:000173401900025
J	Raji, A				Raji, A			The body politic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					286	286		10.1001/jama.287.3.286	http://dx.doi.org/10.1001/jama.287.3.286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790190				2022-12-28	WOS:000173294700001
J	Glasauer, S; Langley, S; Beveridge, TJ				Glasauer, S; Langley, S; Beveridge, TJ			Intracellular iron minerals in a dissimilatory iron-reducing bacterium	SCIENCE			English	Article							REDUCTION; FE3O4; FE3S4	Among prokaryotes, there are few examples of controlled mineral formation; the formation of crystalline iron oxides and sulfides [magnetite (Fe3O4) or greigite (Fe3S4)] by magnetotactic bacteria is an exception. Shewanella putrefaciens CN32, a Gram-negative, facultative anaerobic bacterium that is capable of dissimilatory iron reduction, produced microscopic intracellular grains of iron oxide minerals during growth on two-line ferrihydrite in a hydrogen-argon atmosphere. The minerals, formed at iron concentrations found in the soil and sedimentary environments where these bacteria are active, could represent an unexplored pathway for the cycling of iron by bacteria.	Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada	University of Guelph	Glasauer, S (corresponding author), Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada.		Glasauer, Susan/AAY-6599-2021					BAUMINGER ER, 1980, BIOCHIM BIOPHYS ACTA, V623, P237, DOI 10.1016/0005-2795(80)90252-4; BAZYLINSKI DA, 1995, APPL ENVIRON MICROB, V61, P3232, DOI 10.1128/AEM.61.9.3232-3239.1995; BAZYLINSKI DA, 1993, NATURE, V366, P218, DOI 10.1038/366218a0; BEVERIDGE TJ, 1989, BACTERIA NATURE, V3, P1; Cornell R.M., 1996, CORROS SCI, DOI [DOI 10.1016/S0010-938X(99)00005-0, DOI 10.1016/S0010-938X(97)00096-6]; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; GORBY YA, 1988, J BACTERIOL, V170, P834, DOI 10.1128/jb.170.2.834-841.1988; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Janney DE, 2000, AM MINERAL, V85, P1180, DOI 10.2138/am-2000-8-910; KUTERBACH DA, 1982, SCIENCE, V218, P695, DOI 10.1126/science.218.4573.695; MEYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; STEIFEL EI, 1979, NATURE, V279, P81; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; Vainshtein MB, 1998, MICROBIOLOGY+, V67, P670	16	125	137	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					117	119		10.1126/science.1066577	http://dx.doi.org/10.1126/science.1066577			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778045				2022-12-28	WOS:000173143100046
J	Janson, C; Chinn, S; Jarvis, D; Zock, JP; Toren, K; Burney, P				Janson, C; Chinn, S; Jarvis, D; Zock, JP; Toren, K; Burney, P		European Community Resp Hlth Surv	Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PULMONARY-FUNCTION; PARENTAL SMOKING; ASTHMA; EXPOSURE; ADULTS; SENSITIZATION; POPULATION; WOMEN; HYPERRESPONSIVENESS	Background Passive smoking is widespread, and environmental tobacco smoke contains many potent respiratory irritants. This analysis aimed to estimate the effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey. Methods This analysis included data from 7882 adults (age 20-48 years) who had never smoked, from 36 centres in.16 countries. Information on passive smoking, respiratory symptoms, asthma, and allergic rhinitis was gathered through a structured interview. Spirometry and methacholine challenge were carried out, and total and specific IgE were measured. The effect of passive smoking was estimated by means of logistic and multiple linear regression for each country and combined across countries by random-effects meta-analysis. Findings In 12 of the 36 centres, more than half the participants were regularly involuntarily exposed to tobacco smoke. The prevalence of passive smoking in the workplace varied from 2.5% in Uppsala, Sweden, to 53.8% in Galdalkao, Spain. Passive smoking was significantly associated with nocturnal chest tightness (odds ratio 1.28 [95% CI 1.02 to 1.60]), nocturnal breathlessness (1.30 [1.01 to 1.67]), breathlessness after activity (1.25 [1.07 to 1.47]), and increased bronchial responsiveness (effect -0.18 [-0.30 to -0.05]). Passive smoking in the workplace was significantly associated with all types of respiratory symptoms and current asthma (odds ratio 1.90 [95% CI 0.90 to 2.88]). No significant association was found between passive smoking and total serum IgE. Interpretation Passive smoking is common but the prevalence varies widely between different countries, Passive smoking increased the likelihood of experiencing respiratory symptoms and was associated with increased bronchial responsiveness. Decreasing involuntary exposure to tobacco smoke in the community, especially in workplaces, is likely to improve respiratory health.	Uppsala Univ, Akad Sjukhuset, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; Kings Coll London, Dept Publ Hlth Sci, London WC2R 2LS, England; IMIM, Resp & Environm Hlth Res Unit, Barcelona, Spain; Sahlgrens Univ Hosp, Sect Occupat & Environm Hlth, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Sect Allergol, S-41345 Gothenburg, Sweden	Uppsala University; Uppsala University Hospital; University of London; King's College London; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Sahlgrenska University Hospital; Sahlgrenska University Hospital	Janson, C (corresponding author), Akad Sjukhuset, Dept Resp Med, SE-75185 Uppsala, Sweden.	christer.janson@medsci.uu.se	Zock, Jan-Paul/P-5034-2018; Jarvis, Martin J/B-1034-2008; Jarvis, Deborah/E-6494-2011	Zock, Jan-Paul/0000-0002-2941-6259; Jarvis, Martin J/0000-0001-9238-8038; Jarvis, Deborah/0000-0002-1753-3896; Burney, Peter/0000-0001-8635-5678				Blanc PD, 1999, AM J RESP CRIT CARE, V160, P2028, DOI 10.1164/ajrccm.160.6.9901033; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Carey IM, 1999, EPIDEMIOLOGY, V10, P319, DOI 10.1097/00001648-199905000-00022; Chinn S, 1997, EUR RESPIR J, V10, P2495, DOI 10.1183/09031936.97.10112495; Chinn S, 1999, EUR RESPIR J, V14, P876, DOI 10.1034/j.1399-3003.1999.14d25.x; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; CORRAO MA, 2000, TOBACCO CONTROL COUN; Coultas DB, 1998, THORAX, V53, P381, DOI 10.1136/thx.53.5.381; DELFINO RJ, 1993, EUR RESPIR J, V6, P1104; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; *EUR COMM COAL STE, 1983, CLIN RESP PHYS S5, V19, P22; Frette C, 1996, AM J EPIDEMIOL, V143, P757; GREER JR, 1993, J OCCUP ENVIRON MED, V35, P909, DOI 10.1097/00043764-199309000-00014; Jarvis D, 1999, J ALLERGY CLIN IMMUN, V104, P934, DOI 10.1016/S0091-6749(99)70071-0; Kogevinas M, 1999, LANCET, V353, P1750, DOI 10.1016/S0140-6736(98)07397-8; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; MASJEDI MR, 1990, THORAX, V45, P27, DOI 10.1136/thx.45.1.27; MENON P, 1992, J ALLERGY CLIN IMMUN, V89, P560, DOI 10.1016/0091-6749(92)90323-T; OLIVIERI M, IN PRESS ARCH ENV HL; Oryszczyn MP, 2000, AM J RESP CRIT CARE, V161, P1241, DOI 10.1164/ajrccm.161.4.9905027; Piitulainen E, 1998, THORAX, V53, P939, DOI 10.1136/thx.53.11.939; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Plaschke PP, 2000, AM J RESP CRIT CARE, V162, P920, DOI 10.1164/ajrccm.162.3.9912030; RANDO RJ, 1992, AM IND HYG ASSOC J, V53, P699, DOI 10.1202/0002-8894(1992)053<0699:AOMMOE>2.0.CO;2; RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476; ROBBINS AS, 1993, INT J EPIDEMIOL, V22, P809, DOI 10.1093/ije/22.5.809; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; Sapigni T, 1998, EUR RESPIR J, V11, P278, DOI 10.1183/09031936.98.11020278; STANKUS RP, 1988, J ALLERGY CLIN IMMUN, V82, P331, DOI 10.1016/0091-6749(88)90003-6; Strachan DP, 1998, THORAX, V53, P117, DOI 10.1136/thx.53.2.117; Sunyer J, 1997, THORAX, V52, P235, DOI 10.1136/thx.52.3.235; Thorn J, 2001, ALLERGY, V56, P287, DOI 10.1034/j.1398-9995.2001.00805.x; XU XP, 1995, AM J RESP CRIT CARE, V151, P41, DOI 10.1164/ajrccm.151.1.7812570	34	153	159	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2103	2109		10.1016/S0140-6736(01)07214-2	http://dx.doi.org/10.1016/S0140-6736(01)07214-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784622				2022-12-28	WOS:000172905800007
J	Fong, YW; Zhou, Q				Fong, YW; Zhou, Q			Stimulatory effect of splicing factors on transcriptional elongation	NATURE			English	Article							RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; C-TERMINAL DOMAIN; HIV-1 TAT; P-TEFB; TAT-SF1; PURIFICATION; AFFINITY; PROTEIN; U2	Transcription and pre-mRNA splicing are tightly coupled gene expression events in eukaryotic cells(1,2). An interaction between the carboxy-terminal domain of the largest subunit of RNA polymerase (Pol) II and components of the splicing machinery is postulated to mediate this coupling(3-5). Here, we show that splicing factors function directly to promote transcriptional elongation, demonstrating that transcription is more intimately coupled to splicing than previously thought. The spliceosomal U small nuclear ribonucleoproteins (snRNPs) interact with human transcription elongation factor TAT-SF1 (refs 6-9) and strongly stimulate polymerase elongation when directed to an intron-free human immunodeficiency virus-1 (HIV-1) template. This effect is likely to be mediated through the binding of TAT-SF1 to elongation factor P-TEFb(10), a proposed component of the transcription elongation complex(11,12). Inclusion of splicing signals in the nascent transcript further stimulates transcription, supporting the notion that the recruitment of U snRNPs near the elongating polymerase is important for transcription. Because the TAT-SF1-UsnRNP complex also stimulates splicing in vitro, it may serve as a dual-function factor to couple transcription and splicing and to facilitate their reciprocal activation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; BACH M, 1990, METHOD ENZYMOL, V181, P232; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Blencowe BJ, 1999, METH MOL B, V118, P275; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Hirose Y, 2000, GENE DEV, V14, P1415; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kim JB, 1999, MOL CELL BIOL, V19, P5960; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Perriman R, 2000, GENE DEV, V14, P97; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	30	271	276	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					929	933		10.1038/414929a	http://dx.doi.org/10.1038/414929a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780068				2022-12-28	WOS:000172813300051
J	Jaeckel, E; Cornberg, M; Wedemeyer, H; Santantonio, T; Mayer, J; Zankel, M; Pastore, G; Dietrich, M; Trautwein, C; Manns, MP				Jaeckel, E; Cornberg, M; Wedemeyer, H; Santantonio, T; Mayer, J; Zankel, M; Pastore, G; Dietrich, M; Trautwein, C; Manns, MP		German Acute Hepatitis C Therapy	Treatment of acute hepatitis C with interferon alfa-2b	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SINGLE-SOURCE OUTBREAK; VIRUS-SPECIFIC CD4(+); T-CELL RESPONSE; NON-B-HEPATITIS; NON-A; RECOMBINANT INTERFERON-ALPHA-2B; INITIAL TREATMENT; IMMUNE-RESPONSES; NATURAL-HISTORY	Background: In people who are infected with the hepatitis C virus (HCV), chronic infection often develops and is difficult to eradicate. We sought to determine whether treatment during the acute phase could prevent the development of chronic infection. Methods: Between 1998 and 2001, we identified 44 patients throughout Germany who had acute hepatitis C. Patients received 5 million U of interferon alfa-2b subcutaneously daily for 4 weeks and then three times per week for another 20 weeks. Serum HCV RNA levels were measured before and during therapy and 24 weeks after the end of therapy. Results: The mean age of the 44 patients was 36 years; 25 were women. Nine became infected with HCV through intravenous drug use, 14 through a needle-stick injury, 7 through medical procedures, and 10 through sexual contact; the mode of infection could not be determined in 4. The average time from infection to the first signs or symptoms of hepatitis was 54 days, and the average time from infection until the start of therapy was 89 days. At the end of both therapy and follow-up, 43 patients (98 percent) had undetectable levels of HCV RNA in serum and normal serum alanine aminotransferase levels. Levels of HCV RNA became undetectable after an average of 3.2 weeks of treatment. Therapy was well tolerated in all but one patient, who stopped therapy after 12 weeks because of side effects. Conclusions: Treatment of acute hepatitis C with interferon alfa-2b prevents chronic infection.	Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany; Univ Bari, Clin Malattie Infett, Bari, Italy; Essex Pharma, Munich, Germany; Bernhard Nocht Inst Trop Med, Hamburg, Germany	Hannover Medical School; Universita degli Studi di Bari Aldo Moro; Bernhard Nocht Institut fur Tropenmedizin	Manns, MP (corresponding author), Hannover Med Sch, Dept Gastroenterol & Hepatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manns.michael@mh-hannover.de	Cornberg, Markus/AAN-6939-2021	Cornberg, Markus/0000-0002-9141-8001				ALBERTI A, 1994, VIRAL HEPATITIS LIVE, P604; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1999, J Hepatol, V30, P956; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Calleri G, 1998, ITAL J GASTROENTEROL, V30, P181; Delwaide J, 1999, HEPATOLOGY, V30, p264A; DETRE KM, 1996, VIRAL HEPATITIS REV, V2, P219; Fried MW, 2001, GASTROENTEROLOGY, V120, pA55, DOI 10.1016/S0016-5085(08)80271-5; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; HWANG SJ, 1994, J HEPATOL, V21, P831, DOI 10.1016/S0168-8278(94)80246-7; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Lam NP, 1997, HEPATOLOGY, V26, P226; LAMPERTICO P, 1994, HEPATOLOGY, V19, P19, DOI 10.1016/0270-9139(94)90047-7; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lee WM, 1996, HEPATOLOGY, V24, P270, DOI 10.1002/hep.510240143; Locasciulli A, 1997, BLOOD, V90, P4628; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; MOSKOPHIDIS D, 1993, NATURE, V364, P262, DOI 10.1038/364262a0; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; OHNISHI K, 1991, AM J GASTROENTEROL, V86, P1041; OMATA M, 1991, LANCET, V338, P914, DOI 10.1016/0140-6736(91)91774-O; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; PALMOVIC D, 1994, INFECTION, V22, P222, DOI 10.1007/BF01716714; Pape GR, 1999, J VIRAL HEPATITIS, V6, P36, DOI 10.1046/j.1365-2893.1999.00006.x; Parana R, 1999, HEPATOLOGY, V30, P289, DOI 10.1002/hep.510300143; Pimstone NR, 2000, GASTROENTEROLOGY, V118, pA960, DOI 10.1016/S0016-5085(00)85982-X; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Rehermann B, 2000, SEMIN LIVER DIS, V20, P127, DOI 10.1055/s-2000-9946; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Santantonio T, 1999, HEPATOLOGY, V30, p205A; SEEF LB, 2000, UPDATE VIRAL HEPATIT, P112; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; TAKANO S, 1994, GASTROENTEROLOGY, V107, P805, DOI 10.1016/0016-5085(94)90130-9; TASSOPOULOS NC, 1993, GUT, V34, pS130, DOI 10.1136/gut.34.2_Suppl.S130; VILADOMIU L, 1992, HEPATOLOGY, V15, P767, DOI 10.1002/hep.1840150504; Vogel W, 1996, DIGEST DIS SCI, V41, pS81, DOI 10.1007/BF02087880; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; Wiese M, 2000, HEPATOLOGY, V32, P91, DOI 10.1053/jhep.2000.8169; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173	47	576	597	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2001	345	20					1452	1457		10.1056/NEJMoa011232	http://dx.doi.org/10.1056/NEJMoa011232			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491WH	11794193				2022-12-28	WOS:000172132700003
J	Chen, J; Korner, S; Craig, SL; Rudkevich, DM; Rebek, J				Chen, J; Korner, S; Craig, SL; Rudkevich, DM; Rebek, J			Chemistry - Amplification by compartmentalization	NATURE			English	Article									Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Duke Univ, Dept Chem, Durham, NC 27708 USA; Univ Texas, Dept Biochem & Chem, Arlington, TX 76019 USA	Scripps Research Institute; Duke University; University of Texas System; University of Texas Arlington	Chen, J (corresponding author), Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Craig, Stephen/AAP-6717-2020; Craig, Stephen L/D-3484-2011	Craig, Stephen/0000-0002-8810-0369; Craig, Stephen L/0000-0002-8810-0369				Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Heinz T, 1998, NATURE, V394, P764, DOI 10.1038/29501; Kornberg A, 1999, XENOTRANSPLANTATION, V6, P187, DOI 10.1034/j.1399-3089.1999.00027.x; Robertson A, 2000, CHEM SOC REV, V29, P141, DOI 10.1039/a803602k; TURRO NJ, 1995, J AM CHEM SOC, V117, P4881, DOI 10.1021/ja00122a020	5	88	88	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					385	386		10.1038/415385b	http://dx.doi.org/10.1038/415385b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807541				2022-12-28	WOS:000173433600036
J	Amowitz, LL; Reis, C; Lyons, KH; Vann, B; Mansaray, B; Akinsulure-Smith, AM; Taylor, L; Iacopino, V				Amowitz, LL; Reis, C; Lyons, KH; Vann, B; Mansaray, B; Akinsulure-Smith, AM; Taylor, L; Iacopino, V			Prevalence of war-related sexual violence and other human rights abuses among internally displaced persons in Sierra Leone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RAPE; WOMEN	Context Sierra Leone's decade-long conflict has cost tens of thousands of lives and all parties to the conflict have committed abuses. Objective To assess the prevalence and impact of war-related sexual violence and other human rights abuses among internally displaced persons (IDPs) in Sierra Leone. Design and Setting A cross-sectional, randomized survey, using structured interviews and questionnaires, of internally displaced Sierra Leone women who were living in 3 IDP camps and 1 town, which were conducted over a 4-week period in 2001. Participants A total of 991 women provided information on 9166 household members. The mean (SE) age of the respondents was 34 (0.48) years (range, 14-80 years). The majority of the women sampled were poorly educated (mean [SE], 1.9 [0.11] years of formal education); 814 were Muslim (82%), and 622 were married (63%). Main Outcome Measures Accounts of war-related sexual assault and other human rights abuses. Results Overall, 13% (1157) of household members reported incidents of war-related human rights abuses in the last 10 years, including abductions, beatings, killings, sexual assaults and other abuses. Ninety-four (9%) of 991 respondents and 396 (8%) of 5001 female household members reported war-related sexual assaults. The lifetime prevalence of non-war-related sexual assault committed by family members, friends, or civilians among these respondents was also 9%, which increased to 17% with the addition of war-related sexual assaults (excluding 1% of participants who reported both war-related and non-war-related sexual assault). Eighty-seven percent of women believed that there should be legal protection for women's human rights. More than 60% of respondents believed a man has a right to beat his wife if she disobeys, and that it is a wife's duty/obligation to have sex with her husband even if she does not want to. Conclusions Sexual violence committed by combatants in Sierra Leone was widespread and was perpetrated in the context of a high level of human rights abuses against the civilian population.	Phys Human Rights, Boston, MA 02116 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; UN Mission Sierra Leone, Freetown, Sierra Leone; Bellevue NYU Program Survivors Torture, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Amowitz, LL (corresponding author), Phys Human Rights, 100 Boylston St,Suite 702, Boston, MA 02116 USA.	phrusa@phrusa.org	Lawry, Lynn/ABE-8391-2021	Lawry, Lynn/0000-0001-8229-8768; Reis, Chen/0000-0003-4647-7149				AMOWITZ LL, 2001, WOMENS HLTH HUMAN RI; Askin Kelly D., 1999, WOMEN INT HUMAN RIGH, VI; ASKINKD, 1997, WAR CRIMES WOMEN PRO; CONTEHMORGAN E, 1999, SIERRA LEONE END 20, P127; *CRIM VICT RES TRE, 1992, RAP AM; DEBRUYN M, 1992, SOC SCI MED, V34, P249, DOI 10.1016/0277-9536(92)90267-T; DEJONG K, 2001, ASSESSING TRAUMA SIE; GILLER JE, 1991, LANCET, V337, P604; GOKER AL, 1998, AFR J REPROD HLTH, V2, P61; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Herman Judith, 2001, TRAUMA RECOVERY; HIRSCH JL, 2001, SIERRA LEONE DIAMOND, P71; *HUM RIGHTS WATCH, 1999, GETT MURD MUT RAP NE; Human Rights Watch, 1994, ZAIR HUM RIGHT DEV; Human Rights Watch/Africa, 1996, SHATT LIV SEX VIOL R; Iacopino V, 2001, AM J PUBLIC HEALTH, V91, P2013, DOI 10.2105/AJPH.91.12.2013; KOSS MP, 1993, J INTERPERS VIOLENCE, V8, P198, DOI 10.1177/088626093008002004; Patton M., 2015, QUALITATIVE RES EVAL, V4th; Pratt David, 2001, SIERRA LEONE DANGER; REIS C, 2002, WAR RELATED SEXUAL V; Resnick HS, 1997, BEHAV MED, V23, P65, DOI 10.1080/08964289709596730; RUBENSTEIN LS, 2001, ENDLESS BRUTALITY WA, P1; SALTZMAN LE, 2001, INTIMATE PARTNER VIO; Schafran LH, 1996, AM J PUBLIC HEALTH, V86, P15, DOI 10.2105/AJPH.86.1.15; Shanks L, 2001, LANCET, V357, P304, DOI 10.1016/S0140-6736(00)03626-6; *STATA CORP, 1997, STATA 5 0 INT WIND; SWISS S, 1993, JAMA-J AM MED ASSOC, V270, P612, DOI 10.1001/jama.270.5.612; Swiss S, 1998, JAMA-J AM MED ASSOC, V279, P625, DOI 10.1001/jama.279.8.625; ULIN PR, 1992, SOC SCI MED, V34, P63, DOI 10.1016/0277-9536(92)90068-2; *UN CHILDR FUND, 2000, STAT WORLDS CHILDR 2, P81; *WORLD MED ASS, 2000, DECL HELS ETH PRINC	31	128	131	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					513	521		10.1001/jama.287.4.513	http://dx.doi.org/10.1001/jama.287.4.513			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	513VX	11798376				2022-12-28	WOS:000173401900031
J	Smet, JH; Deutschmann, RA; Ertl, F; Wegscheider, W; Abstreiter, G; von Klitzing, K				Smet, JH; Deutschmann, RA; Ertl, F; Wegscheider, W; Abstreiter, G; von Klitzing, K			Gate-voltage control of spin interactions between electrons and nuclei in a semiconductor	NATURE			English	Article							OPTICALLY PUMPED NMR; GAAS QUANTUM-WELLS; LEVEL FILLING NU=1; PHASE-TRANSITIONS; COMPUTATION; EXCITATIONS; SKYRMIONS; RESONANCE	Semiconductors are ubiquitous in device electronics, because their charge distributions can be conveniently manipulated with voltages to perform logic operations. Achieving a similar level of control over the spin degrees of freedom, either from electrons or nuclei, could provide intriguing prospects for both information processing and the study of fundamental solid-state physics issues. Here we report procedures that carry out the controlled transfer of spin angular momentum between electrons-confined to two dimensions and subjected to a perpendicular magnetic field-and the nuclei of the host semiconductor, using gate voltages only. We show that the spin transfer rate can be enhanced near a ferromagnetic ground state of the electron system, and that the induced nuclear spin polarization can be subsequently stored and 'read out'. These techniques can also be combined into a spectroscopic tool to detect the low-energy collective excitations in the electron system that promote the spin transfer. The existence of such excitations is contingent on appropriate electron-electron correlations, and these can be tuned by changing, for example, the electron density via a gate voltage.	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany; Univ Regensburg, Inst Expt & Angew Phys, D-93040 Regensburg, Germany	Max Planck Society; Technical University of Munich; University of Regensburg	Smet, JH (corresponding author), Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany.		Wegscheider, Werner H/D-1493-2010; von Klitzing, Klaus/AAH-2988-2022; von Klitzing, Klaus/AFM-0585-2022					ABRAGAM A, 1961, PRINCIPLES NUCL MAGN, P354; ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; BARRETT SE, 1995, PHYS REV LETT, V74, P5112, DOI 10.1103/PhysRevLett.74.5112; Bayot V, 1996, PHYS REV LETT, V76, P4584, DOI 10.1103/PhysRevLett.76.4584; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; BREY L, 1995, PHYS REV LETT, V75, P2562, DOI 10.1103/PhysRevLett.75.2562; Cho H, 1998, PHYS REV LETT, V81, P2522, DOI 10.1103/PhysRevLett.81.2522; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634; Cote R, 1997, PHYS REV LETT, V78, P4825, DOI 10.1103/PhysRevLett.78.4825; Das Sarma S., 1996, PERSPECTIVES QUANTUM; De Poortere EP, 2000, SCIENCE, V290, P1546, DOI 10.1126/science.290.5496.1546; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Eom J, 2000, SCIENCE, V289, P2320, DOI 10.1126/science.289.5488.2320; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Girvin S. M, 1999, TOPOLOGICAL ASPECTS, P53; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Hashimoto K, 2001, PHYSICA B, V298, P191, DOI 10.1016/S0921-4526(01)00299-X; Heinonen O., 1998, COMPOSITE FERMIONS; Jungwirth T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.035305; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kawakami RK, 2001, SCIENCE, V294, P131, DOI 10.1126/science.1063186; Kikkawa JM, 2000, SCIENCE, V287, P473, DOI 10.1126/science.287.5452.473; Kronmuller S, 1999, PHYS REV LETT, V82, P4070, DOI 10.1103/PhysRevLett.82.4070; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Piazza V, 1999, NATURE, V402, P638, DOI 10.1038/45189; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Smet JH, 2001, PHYS REV LETT, V86, P2412, DOI 10.1103/PhysRevLett.86.2412; Steane A, 1998, REP PROG PHYS, V61, P117, DOI 10.1088/0034-4885/61/2/002; TYCKO R, 1995, SCIENCE, V268, P1460, DOI 10.1126/science.7539550; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; WALD KR, 1994, PHYS REV LETT, V73, P1011, DOI 10.1103/PhysRevLett.73.1011	35	190	190	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					281	286		10.1038/415281a	http://dx.doi.org/10.1038/415281a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796998				2022-12-28	WOS:000173293500033
J	Inoue, K; Kohda, T; Lee, J; Ogonuki, N; Mochida, K; Noguchi, Y; Tanemura, K; Kaneko-Ishino, T; Ishino, F; Ogura, A				Inoue, K; Kohda, T; Lee, J; Ogonuki, N; Mochida, K; Noguchi, Y; Tanemura, K; Kaneko-Ishino, T; Ishino, F; Ogura, A			Faithful expression of imprinted genes in cloned mice	SCIENCE			English	Article									Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo 1628640, Japan; Tokyo Inst Technol, Ctr Gene Res, Kanagawa 2268501, Japan; CREST, JST, Saitama 3320012, Japan; Tokai Univ, Sch Hlth Sci, Kanagawa 2591100, Japan	National Institute of Infectious Diseases (NIID); Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokai University	Ishino, F (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	fishino@bio.titech.ac.jp; aogura@nih.go.jp	Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Ogura, Atsuo/J-3916-2014; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kohda, Takashi/0000-0002-6856-5601				Dean W, 1998, DEVELOPMENT, V125, P2273; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Ogura A, 2000, MOL REPROD DEV, V57, P55, DOI 10.1002/1098-2795(200009)57:1&lt;55::AID-MRD8&gt;3.0.CO;2-W; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206	6	157	173	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					297	297		10.1126/science.295.5553.297	http://dx.doi.org/10.1126/science.295.5553.297			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786635				2022-12-28	WOS:000173278600039
J	Fujiyama, A; Watanabe, H; Toyoda, A; Taylor, TD; Itoh, T; Tsai, SF; Park, HS; Yaspo, ML; Lehrach, H; Chen, Z; Fu, G; Saitou, N; Osoegawa, K; de Jong, PJ; Suto, Y; Hattori, M; Sakaki, Y				Fujiyama, A; Watanabe, H; Toyoda, A; Taylor, TD; Itoh, T; Tsai, SF; Park, HS; Yaspo, ML; Lehrach, H; Chen, Z; Fu, G; Saitou, N; Osoegawa, K; de Jong, PJ; Suto, Y; Hattori, M; Sakaki, Y			Construction and analysis of a human-chimpanzee comparative clone map	SCIENCE			English	Article							GREAT APES; DNA-SEQUENCE; HUMAN GENOME; EVOLUTION; PRIMATES	The recently released human genome sequences provide us with reference data to conduct comparative genomic research on primates, which will be important to understand what genetic information makes us human. Here we present a first-generation human-chimpanzee comparative genome map and its initial analysis. The map was constructed through paired alignment of 77,461 chimpanzee bacterial artificial chromosome end sequences with publicly available human genome sequences. We detected candidate positions, including two clusters on human chromosome 21 that suggest large, nonrandom regions of difference between the two genomes.	RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; Natl Inst Genet, Shizuoka 4118450, Japan; Mitsubishi Res Inst, Chiyoda Ku, Tokyo 1008141, Japan; Natl Yang Ming Univ, Taipei 115, Taiwan; Natl Inst Res Inst, Taipei 115, Taiwan; KRIBB, Genome Res Ctr, Taejon 305333, South Korea; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Mitsubishi Research Institute; National Yang Ming Chiao Tung University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Max Planck Society; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Tokyo; University of Tokyo	Fujiyama, A (corresponding author), RIKEN, Genom Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	afujiyam@gsc.riken.go.jp; watanabe@gsc.riken.go.jp; hattori@gsc.riken.go.jp; sakaki@gsc.riken.go.jp	Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Tsai, Shih-Feng/E-3997-2010; Itoh, Takehiko/E-8873-2014	Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; Itoh, Takehiko/0000-0002-6113-557X				Burrows W, 1997, NATURE, V385, P125, DOI 10.1038/385125a0; Butler D, 2001, NATURE, V413, P444, DOI 10.1038/35097234; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Gagneux P, 2001, MOL PHYLOGENET EVOL, V18, P2, DOI 10.1006/mpev.2000.0799; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hacia JG, 1998, NAT GENET, V18, P155, DOI 10.1038/ng0298-155; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Nickerson E, 1998, GENOMICS, V50, P368, DOI 10.1006/geno.1998.5332; Paabo S, 2001, SCIENCE, V291, P1219, DOI 10.1126/science.1056972; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	14	186	204	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					131	134		10.1126/science.1065199	http://dx.doi.org/10.1126/science.1065199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778049				2022-12-28	WOS:000173143100050
J	Muramatsu, T				Muramatsu, T			Development - Carbohydrate recognition in spermatogenesis	SCIENCE			English	Editorial Material							ROLES; MICE		Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan	Nagoya University	Muramatsu, T (corresponding author), Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan.							Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Alper J, 2001, SCIENCE, V291, P2338, DOI 10.1126/science.291.5512.2338; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Muramatsu T, 2000, J BIOCHEM, V127, P171, DOI 10.1093/oxfordjournals.jbchem.a022590; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Varki A., 1999, ESSENTIALS GLYCOBIOL	10	16	16	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					53	54		10.1126/science.1068156	http://dx.doi.org/10.1126/science.1068156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778029				2022-12-28	WOS:000173143100027
J	McKane, RB; Johnson, LC; Shaver, GR; Nadelhoffer, KJ; Rastetter, EB; Fry, B; Giblin, AE; Kielland, K; Kwiatkowski, BL; Laundre, JA; Murray, G				McKane, RB; Johnson, LC; Shaver, GR; Nadelhoffer, KJ; Rastetter, EB; Fry, B; Giblin, AE; Kielland, K; Kwiatkowski, BL; Laundre, JA; Murray, G			Resource-based niches provide a basis for plant species diversity and dominance in arctic tundra	NATURE			English	Article							ALASKAN TUNDRA; AMINO-ACIDS; COMPETITION; NITROGEN; GROWTH; TREES	Ecologists have long been intrigued by the ways co-occurring species divide limiting resources. Such resource partitioning, or niche differentiation, may promote species diversity by reducing competition(1,2). Although resource partitioning is an important determinant of species diversity and composition in animal communities(3), its importance in structuring plant communities has been difficult to resolve(4). This is due mainly to difficulties in studying how plants compete for belowground resources(5). Here we provide evidence from a N-15-tracer field experiment showing that plant species in a nitrogen-limited, arctic tundra community were differentiated in timing, depth and chemical form of nitrogen uptake, and that species dominance was strongly correlated with uptake of the most available soil nitrogen forms. That is, the most productive species used the most abundant nitrogen forms, and less productive species used less abundant forms. To our knowledge, this is the first documentation that the composition of a plant community is related to partitioning of differentially available forms of a single limiting resource.	US EPA, Corvallis, OR 97333 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; US Forest Serv, Inst Pacific Isl Forestry, USDA, Honolulu, HI 96813 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Appalachian Mt Club, Gorham, NH 03581 USA	United States Environmental Protection Agency; Kansas State University; United States Department of Agriculture (USDA); United States Forest Service; Marine Biological Laboratory - Woods Hole; University of Alaska System; University of Alaska Fairbanks	McKane, RB (corresponding author), US EPA, Corvallis, OR 97333 USA.	mckane.bob@epa.gov	Nadelhoffer, Knute/AAE-7744-2020; Laundre, James/P-1968-2016; Giblin, Anne/AAV-6838-2020	Nadelhoffer, Knute/0000-0001-9775-894X; Laundre, James/0000-0002-2061-8655; Giblin, Anne/0000-0003-3851-2178; Rastetter, Edward/0000-0002-8620-5431; Kwiatkowski, Bonnie/0000-0003-0158-9753				[Anonymous], 1975, COMMUNITIES ECOSYSTE; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bliss L.C., 1992, ARCTIC ECOSYSTEMS CH, V59, P89; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; FLANAGAN LB, 1992, PLANT CELL ENVIRON, V15, P831, DOI 10.1111/j.1365-3040.1992.tb02150.x; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kielland K, 1995, BIOGEOCHEMISTRY, V31, P85, DOI 10.1007/BF00000940; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; MCNAUGHTON SJ, 1970, SCIENCE, V167, P131, DOI 10.1126/science.167.3915.131; Owen AG, 2001, SOIL BIOL BIOCHEM, V33, P651, DOI 10.1016/S0038-0717(00)00209-1; PARRISH JAD, 1976, ECOLOGY, V57, P1281, DOI 10.2307/1935052; Raab TK, 1999, ECOLOGY, V80, P2408, DOI 10.1890/0012-9658(1999)080[2408:SAAUAS]2.0.CO;2; RIEGER S, 1979, EXPLORATORY SOIL SUR; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1986, ECOLOGY, V67, P660, DOI 10.2307/1937690; SHAVER GR, 1975, ECOLOGY, V56, P401, DOI 10.2307/1934970; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; Tilman D., 1982, Monographs in Population Biology, pi	26	642	690	13	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					68	71		10.1038/415068a	http://dx.doi.org/10.1038/415068a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780117				2022-12-28	WOS:000173028800040
J	Deshaies, RJ; Ferrell, JE				Deshaies, RJ; Ferrell, JE			Multisite phosphorylation and the countdown to S phase	CELL			English	Review							PROTEIN-KINASE CASCADE; UBIQUITIN-LIGASE; REPLICATION; COMPLEXES; SWITCH; SIC1P	Remarkably, SCFCdc4 ubiquitin ligase binds and ubiquitinates Sic1 decorated with six, but not five, phosphates (Nash et al., 2001). This numerical wizardry suggests how analog inputs can be rectified to digital outputs. Unraveling the counting mechanism promises to generate new insights into the architecture of protein nanoprocessors.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Stanford University; Stanford University; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Deshaies, RJ (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.		Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354				Annan RS, 2001, ANAL CHEM, V73, P393, DOI 10.1021/ac001130t; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; VALLEN EA, 1995, MOL CELL BIOL, V15, P4291; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1	20	112	116	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					819	822		10.1016/S0092-8674(01)00620-1	http://dx.doi.org/10.1016/S0092-8674(01)00620-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779457	Bronze			2022-12-28	WOS:000173024200002
J	Cartron, JP				Cartron, JP			Rh-deficiency syndrome	LANCET			English	Article									Inst Natl Transfus Sanguine, INSERM, U76, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Cartron, JP (corresponding author), Inst Natl Transfus Sanguine, INSERM, U76, 6 Rue Alexandre Cabanel, F-75015 Paris, France.								0	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S57	S57		10.1016/S0140-6736(01)07069-6	http://dx.doi.org/10.1016/S0140-6736(01)07069-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784606	Bronze			2022-12-28	WOS:000172907200057
J	Ahmed, F; Singleton, JA; Franks, AL				Ahmed, F; Singleton, JA; Franks, AL			Influenza vaccination for healthy young adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; GUILLAIN-BARRE-SYNDROME; LONG-TERM-CARE; WORKING ADULTS; VIRUS VACCINE; IMMUNIZATION; IMPACT; TRANSMISSION; POPULATION; MORTALITY		Ctr Dis Control & Prevent, Div Prevent Res & Analyt Methods, Epidemiol Program Off, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ahmed, F (corresponding author), Ctr Dis Control & Prevent, Div Prevent Res & Analyt Methods, Epidemiol Program Off, MS-K73,4770 Buford Hwy, Atlanta, GA 30341 USA.							*ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P916; *ADV COMM IMM PRAC, 2001, MMWR-MORBID MORTAL W, V50, P582; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P888; *AM COLL PHYS AM S, 2001, PREV STRAT INFL; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BATKER WH, 1982, ARCH INTERN MED, V142, P85; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; Couch RB, 2000, NEW ENGL J MED, V343, P1778, DOI 10.1056/NEJM200012143432407; Gershon AA, 1997, CLIN INFECT DIS, V25, P782, DOI 10.1086/515544; Gross PA, 1996, VACCINE, V14, P1280, DOI 10.1016/S0264-410X(96)00004-7; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; HOSKINS TW, 1979, LANCET, V1, P33; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; KEITEL WA, 1988, AM J EPIDEMIOL, V127, P353, DOI 10.1093/oxfordjournals.aje.a114809; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Miller AE, 1997, NEUROLOGY, V48, P312, DOI 10.1212/WNL.48.2.312; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Nichol KL, 2001, ARCH INTERN MED, V161, P749, DOI 10.1001/archinte.161.5.749; POEL A, 2001, NAT IMM C ATL MAY 29; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; SINGLETON JA, 2000, 4 INT C OPT CONTR IN; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Zimmerman RK, 1999, AM FAM PHYSICIAN, V60, P2069; 2001, MMWR MORB MORTAL WKL, V50, P532	38	21	23	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1543	1547		10.1056/NEJMcp011924	http://dx.doi.org/10.1056/NEJMcp011924			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794222				2022-12-28	WOS:000172265200006
J	del Castillo, I; Villamar, M; Moreno-Pelayo, MA; del Castillo, FJ; Alvarez, A; Telleria, D; Menendez, I; Moreno, F				del Castillo, I; Villamar, M; Moreno-Pelayo, MA; del Castillo, FJ; Alvarez, A; Telleria, D; Menendez, I; Moreno, F			A deletion involving the connexin 30 gene in nonsyndromic hearing impairment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIDROTIC ECTODERMAL DYSPLASIA; SENSORINEURAL DEAFNESS; CHILDHOOD DEAFNESS; RAT COCHLEA; MUTATIONS; EXPRESSION; GJB2; POPULATION; FREQUENCY; DFNB1	Background: Inherited hearing impairment affects about 1 in 2000 newborns. Up to 50 percent of all patients with autosomal recessive nonsyndromic prelingual deafness in different populations have mutations in the gene encoding the gap-junction protein connexin 26 (GJB2) at locus DFNB1 on chromosome 13q12. However, a large fraction (10 to 42 percent) of patients with GJB2 mutations have only one mutant allele; the accompanying mutation has not been identified. DFNB1-linked familial cases with no mutation in GJB2 have also been reported. Methods: We evaluated 33 unrelated probands with nonsyndromic prelingual deafness who had only one GJB2 mutant allele. Nine subjects had evidence of linkage to DFNB1. We used haplotype analysis for markers on 13q12 to search for mutations other than the one involving GJB2. Results: We identified a 342-kb deletion in the gene encoding connexin 30 (GJB6), a protein that is reported to be expressed with connexin 26 in the inner ear. The deletion extended distally to GJB2, which remained intact. The break-point junction of the deletion was isolated and sequenced, and a specific diagnostic test was developed for this common mutation. Twenty-two of the 33 subjects were heterozygous for both the GJB6 and GJB2 mutations, including all 9 with evidence of linkage to DFNB1. Two subjects were homozygous for the GJB6 mutation. Conclusions: A 342-kb deletion in GJB6 is the second most frequent mutation causing prelingual deafness in the Spanish population. Our data suggest that mutations in the complex locus DFNB1, which contains two genes (GJB2 and GJB6), can result in a monogenic or a digenic pattern of inheritance of prelingual deafness. (N Engl J Med 2002;346:243-9.) Copyright (C) 2002 Massachusetts Medical Society.	Hosp Ramon y Cajal, Unite Genet Mol, E-28034 Madrid, Spain; Hosp Pediat William Soler, Dept Genet, Havana, Cuba	Hospital Universitario Ramon y Cajal	Moreno, F (corresponding author), Hosp Ramon y Cajal, Unite Genet Mol, Carretera Colmenar Km 9, E-28034 Madrid, Spain.		Villamar, Manuela/AAD-3842-2020; del Castillo, Francisco J./A-6467-2013; del Castillo, Ignacio/B-4314-2013	Villamar, Manuela/0000-0002-5115-4937; del Castillo, Francisco J./0000-0003-0467-4320; del Castillo, Ignacio/0000-0003-1188-3665; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098				Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; COHEN MM, 1995, OXFORD MONOGRAPHS ME, V28, P9; Dahl E, 1996, J BIOL CHEM, V271, P26444; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAJIWARA K, 1994, SCIENCE, V264, P1064; KEEN J, 1991, TRENDS GENET, V7, P5; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelley PM, 1999, GENOMICS, V62, P172, DOI 10.1006/geno.1999.6002; Kibar Z, 2000, EUR J HUM GENET, V8, P372, DOI 10.1038/sj.ejhg.5200471; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Lench N, 1998, LANCET, V351, P415, DOI 10.1016/S0140-6736(98)24006-2; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Loffler J, 2001, EUR J HUM GENET, V9, P226, DOI 10.1038/sj.ejhg.5200607; MAW MA, 1995, AM J HUM GENET, V57, P629; Murgia A, 1999, J MED GENET, V36, P829; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; Sobe T, 2000, HUM GENET, V106, P50, DOI 10.1007/s004390051009; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wilcox SA, 1999, J MED GENET, V36, P383	33	426	445	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					243	U1		10.1056/NEJMoa012052	http://dx.doi.org/10.1056/NEJMoa012052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807148	Bronze			2022-12-28	WOS:000173398900004
J	Milinski, M; Semmann, D; Krambeck, HJ				Milinski, M; Semmann, D; Krambeck, HJ			Reputation helps solve the 'tragedy of the commons'	NATURE			English	Article							INDIRECT RECIPROCITY; COOPERATION; EVOLUTION; PUNISHMENT	The problem of sustaining a public resource that everybody is free to overuse-the 'tragedy of the commons'(1-7)-emerges in many social dilemmas, such as our inability to sustain the global climate. Public goods experiments(4), which are used to study this type of problem, usually confirm that the collective benefit will not be produced. Because individuals and countries often participate in several social games simultaneously, the interaction of these games may provide a sophisticated way by which to maintain the public resource. Indirect reciprocity(8), 'give and you shall receive', is built on reputation and can sustain a high level of cooperation, as shown by game theorists(9-11). Here we show, through alternating rounds of public goods and indirect reciprocity games, that the need to maintain reputation for indirect reciprocity maintains contributions to the public good at an unexpectedly high level. But if rounds of indirect reciprocation are not expected, then contributions to the public good drop quickly to zero. Alternating the games leads to higher profits for all players. As reputation may be a currency that is valid in many social games, our approach could be used to test social dilemmas for their solubility.	Max Planck Inst Limnol, Dept Evolutionary Biol, D-24306 Plon, Germany	Max Planck Society	Milinski, M (corresponding author), Max Planck Inst Limnol, Dept Evolutionary Biol, Postfach 165, D-24306 Plon, Germany.							Alexander R., 1987, BIOL MORAL SYSTEMS; BERKES F, 1989, NATURE, V340, P91, DOI 10.1038/340091a0; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Coleman JS., 1990, FDN SOCIAL THEORY; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Gintis H., 2000, GAME THEORY EVOLVING; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lotem A, 1999, NATURE, V400, P226, DOI 10.1038/22247; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom E., 1999, GOVERNING COMMONS; SEINEN I, 2001, TL20010031 TINB I; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Zahavi A., 1991, COOPERATIVE BREEDING, P105	22	844	867	13	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					424	426		10.1038/415424a	http://dx.doi.org/10.1038/415424a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514HR	11807552				2022-12-28	WOS:000173433600048
J	Kerr, D; Bevan, H; Gowland, B; Penny, J; Berwick, D				Kerr, D; Bevan, H; Gowland, B; Penny, J; Berwick, D			Redesigning cancer care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPROVEMENT		Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; Natl Patients Access Team, Leicester LE1 6TF, Leics, England; Inst Healthcare Improvement, Boston, MA 02215 USA	Radcliffe Infirmary; University of Oxford; Institute for Healthcare Improvement	Kerr, D (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England.	David.Kerr@clinpharm.ox.ac.uk						Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Brock WA, 1998, NEW HORIZ-SCI PRACT, V6, P61; Casarett D, 2000, JAMA-J AM MED ASSOC, V283, P2275, DOI 10.1001/jama.283.17.2275; Langley Gj., 1996, IMPROVEMENT GUIDE PR; NHS Executive, 2000, NHS CANC PLAN; Nolan TW, 1998, ANN INTERN MED, V128, P293, DOI 10.7326/0003-4819-128-4-199802150-00009; Sant M, 1998, INT J CANCER, V77, P679, DOI 10.1002/(SICI)1097-0215(19980831)77:5<679::AID-IJC3>3.0.CO;2-S; Solberg LI, 1997, JOINT COMM J QUAL IM, V23, P135, DOI 10.1016/S1070-3241(16)30305-4; Spurgeon P, 2000, BRIT MED J, V320, P838, DOI 10.1136/bmj.320.7238.838	9	40	40	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2002	324	7330					164	166		10.1136/bmj.324.7330.164	http://dx.doi.org/10.1136/bmj.324.7330.164			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799037	Green Published			2022-12-28	WOS:000173470600024
J	Shiver, JW; Fu, TM; Chen, L; Casimiro, DR; Davies, ME; Evans, RK; Zhang, ZQ; Simon, AJ; Trigona, WL; Dubey, SA; Huang, LY; Harris, VA; Long, RS; Liang, XP; Handt, L; Schleif, WA; Zhu, L; Freed, DC; Persaud, NV; Guan, L; Punt, KS; Tang, A; Chen, MC; Wilson, KA; Collins, KB; Heidecker, GJ; Fernandez, VR; Perry, HC; Joyce, JG; Grimm, KM; Cook, JC; Keller, PM; Kresock, DS; Mach, H; Troutman, RD; Isopi, LA; Williams, DM; Xu, Z; Bohannon, KE; Volkin, DB; Montefiori, DC; Miura, A; Krivulka, GR; Lifton, MA; Kuroda, MJ; Schmitz, JE; Letvin, NL; Caulfield, MJ; Bett, AJ; Youil, R; Kaslow, DC; Emini, EA				Shiver, JW; Fu, TM; Chen, L; Casimiro, DR; Davies, ME; Evans, RK; Zhang, ZQ; Simon, AJ; Trigona, WL; Dubey, SA; Huang, LY; Harris, VA; Long, RS; Liang, XP; Handt, L; Schleif, WA; Zhu, L; Freed, DC; Persaud, NV; Guan, L; Punt, KS; Tang, A; Chen, MC; Wilson, KA; Collins, KB; Heidecker, GJ; Fernandez, VR; Perry, HC; Joyce, JG; Grimm, KM; Cook, JC; Keller, PM; Kresock, DS; Mach, H; Troutman, RD; Isopi, LA; Williams, DM; Xu, Z; Bohannon, KE; Volkin, DB; Montefiori, DC; Miura, A; Krivulka, GR; Lifton, MA; Kuroda, MJ; Schmitz, JE; Letvin, NL; Caulfield, MJ; Bett, AJ; Youil, R; Kaslow, DC; Emini, EA			Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity	NATURE			English	Article							CYTOTOXIC T-LYMPHOCYTES; INFECTED RHESUS-MONKEYS; TYPE-1 INFECTION; DISEASE PROGRESSION; DNA VACCINATION; RESPONSES; VIREMIA; MAMU-A-ASTERISK-01; DOMINANT; EPITOPES	Recent studies of human immunodeficiency virus type 1 (HIV-1) infection in humans and of simian immunodeficiency virus (SIV) in rhesus monkeys have shown that resolution of the acute viral infection and control of the subsequent persistent infection are mediated by the antiviral cellular immune response(1-11). We comparatively assessed several vaccine vector delivery systems-three formulations of a plasmid DNA vector, the modified vaccinia Ankara (MVA) virus, and a replication incompetent adenovirus type 5 (Ad5) vector-expressing the SIV gag protein for their ability to elicit such immune responses in monkeys. The vaccines were tested either as a single modality or in combined modality regimens. Here we show that the most effective responses were elicited by a replication-incompetent Ad5 vector, used either alone or as a booster inoculation after priming with a DNA vector. After challenge with a pathogenic HIV-SIV hybrid virus (SHIV), the animals immunized with Ad5 vector exhibited the most pronounced attenuation of the virus infection. The replication-defective adenovirus is a promising vaccine vector for development of an HIV-1 vaccine.	Merck Res Labs, W Point, PA 19486 USA; Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC 27710 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Viral Pathogenesis, Boston, MA 02215 USA	Merck & Company; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Emini, EA (corresponding author), Merck Res Labs, W Point, PA 19486 USA.		Schmitz, Joern/A-4929-2018	Schmitz, Joern/0000-0001-8803-0922				Allen TM, 1998, J IMMUNOL, V160, P6062; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; GALLIMORE A, 1995, NAT MED, V1, P1167, DOI 10.1038/nm1195-1167; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; MILLER MD, 1991, J IMMUNOL, V147, P320; MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P777, DOI 10.1089/dna.1993.12.777; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Newman MJ, 1998, CRIT REV THER DRUG, V15, P89, DOI 10.1615/CritRevTherDrugCarrierSyst.v15.i2.10; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2	20	1037	1092	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					331	335		10.1038/415331a	http://dx.doi.org/10.1038/415331a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797011				2022-12-28	WOS:000173293500046
J	Esteban, A; Anzueto, A; Frutos, F; Alia, I; Brochard, L; Stewart, TE; Benito, S; Epstein, SK; Apezteguia, C; Nightingale, P; Arroliga, AC; Tobin, MJ				Esteban, A; Anzueto, A; Frutos, F; Alia, I; Brochard, L; Stewart, TE; Benito, S; Epstein, SK; Apezteguia, C; Nightingale, P; Arroliga, AC; Tobin, MJ		Mech Ventilation Int Study G	Characteristics and outcomes in adult patients receiving mechanical ventilation - A 28-day international study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; OBSTRUCTIVE PULMONARY-DISEASE; INTENSIVE-CARE UNITS; ACUTE LUNG INJURY; MEDICAL ICU; FAILURE; DEFINITIONS; MORTALITY; SURVIVAL; MULTICENTER	Context The outcome of patients receiving mechanical ventilation for particular indications has been studied, but the outcome in a large number of unselected, heterogeneous patients has not been reported. Objective To determine the survival of patients receiving mechanical ventilation and the relative importance of factors influencing survival. Design, Setting, and Subjects Prospective cohort of consecutive adult patients admitted to 361 intensive care units who received mechanical ventilation for more than 12 hours between March 1, 1998, and March 31, 1998. Data were collected on each patient at initiation of mechanical ventilation and daily throughout the course of mechanical ventilation for up to 28 days. Main Outcome Measure All-cause mortality during intensive care unit stay. Results Of the 15757 patients admitted, a total of 5183 (33%) received mechanical ventilation for a mean (SD) duration of 5.9 (7.2) days. The mean (SD) length of stay in the intensive care unit was 11.2 (13.7) days. Overall mortality rate in the intensive care unit was 30.7% (1590 patients) for the entire population, 52% (120) in patients who received ventilation because of acute respiratory distress syndrome, and 22% (115) in patients who received ventilation for an exacerbation of chronic obstructive pulmonary disease. Survival of unselected patients receiving mechanical ventilation for more than 12 hours was 69%. The main conditions independently associated with increased mortality were (1) factors present at the start of mechanical ventilation (odds ratio [OR], 2.98; 95% confidence interval [CI], 2.44-3.63; P<.001 for coma), (2) factors related to patient management (OR, 3.67; 95% CI, 2.02-6.66; P<.001 for plateau airway pressure >35 cm H2O), and (3) developments occurring over the course of mechanical ventilation (OR, 8.71; 95% CI, 5.44-13.94; P<.001 for ratio of Pao(2) to fraction of inspired oxygen <100). Conclusion Survival among mechanically ventilated patients depends not only on the factors present at the start of mechanical ventilation, but also on the development of complications and patient management in the intensive care unit.	Hosp Univ Getafe, Unidad Cuidados Intens, Madrid 28905, Spain; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Hop Henri Mondor, F-94010 Creteil, France; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Hosp Santa Creu & Sant Pau, Barcelona, Spain; Tufts Univ New England Med Ctr, Tupper Res Inst, Boston, MA 02111 USA; Hosp Prof Posadas, Buenos Aires, DF, Argentina; Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Hines Vet Affairs Hosp, Maywood, IL USA; Loyola Univ, Chicago, IL 60611 USA	Hospital Universitario de Getafe; University of Texas System; University of Texas Health San Antonio; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Hospital of Santa Creu i Sant Pau; Tufts Medical Center; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	Esteban, A (corresponding author), Hosp Univ Getafe, Unidad Cuidados Intens, Carretera Toledo Km 12 5, Madrid 28905, Spain.		Lapinsky, Stephen/C-4624-2015; Arroliga, Alejandro/AAX-3933-2021	Lapinsky, Stephen/0000-0002-6930-0306; Frutos-Vivar, Fernando/0000-0002-4648-9636; benito, salvador/0000-0002-6333-5823				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 1989, AM REV RESPIR DIS, V139, P1058; Behrendt CE, 2000, CHEST, V118, P1100, DOI 10.1378/chest.118.4.1100; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Croce MA, 1999, J TRAUMA, V46, P361, DOI 10.1097/00005373-199903000-00001; DOYLE RL, 1995, AM J RESP CRIT CARE, V152, P1818, DOI 10.1164/ajrccm.152.6.8520742; Ely EW, 1999, ANN INTERN MED, V131, P96, DOI 10.7326/0003-4819-131-2-199907200-00004; Ely EW, 2000, CRIT CARE MED, V28, P408, DOI 10.1097/00003246-200002000-00020; Epstein SK, 1999, CHEST, V116, P732, DOI 10.1378/chest.116.3.732; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 1997, AM J RESP CRIT CARE, V156, P459, DOI 10.1164/ajrccm.156.2.9610109; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; ESTEBAN A, 1994, CHEST, V106, P1188, DOI 10.1378/chest.106.4.1188; Ferring M, 1997, EUR RESPIR J, V10, P1297, DOI 10.1183/09031936.97.10061297; KNAUS WA, 1994, AM J RESP CRIT CARE, V150, P311, DOI 10.1164/ajrccm.150.2.8049808; Kollef MH, 1997, CHEST, V111, P434, DOI 10.1378/chest.111.2.434; Krafft P, 1996, INTENS CARE MED, V22, P519, DOI 10.1007/s001340050125; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Navarrete-Navarro P, 2000, INTENS CARE MED, V26, P1624, DOI 10.1007/s001340000683; Nevins ML, 2001, CHEST, V119, P1840, DOI 10.1378/chest.119.6.1840; Roupie E, 1999, INTENS CARE MED, V25, P920, DOI 10.1007/s001340050983; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; SLOANE PJ, 1992, AM REV RESPIR DIS, V146, P419, DOI 10.1164/ajrccm/146.2.419; Steiner T, 1997, STROKE, V28, P711, DOI 10.1161/01.STR.28.4.711; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; SUCHYTA M, 2000, AM J RESP CRIT CARE, V161, pA210; SUCHYTA MR, 1992, CHEST, V101, P1074, DOI 10.1378/chest.101.4.1074; Tobin MJ, 2000, NEW ENGL J MED, V342, P1360, DOI 10.1056/NEJM200005043421808; Valta P, 1999, CRIT CARE MED, V27, P2367, DOI 10.1097/00003246-199911000-00008; VASILYEV S, 1995, CHEST, V107, P1083, DOI 10.1378/chest.107.4.1083; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088	36	1077	1173	1	44	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					345	355		10.1001/jama.287.3.345	http://dx.doi.org/10.1001/jama.287.3.345			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790214	Bronze			2022-12-28	WOS:000173294700029
J	Holmboe, ES				Holmboe, ES			Oral anti hyperglycemic therapy for type 2 diabetes - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTENSIVE INSULIN THERAPY; IMPROVED GLYCEMIC CONTROL; QUALITY-OF-LIFE; DOUBLE-BLIND; MELLITUS; SULFONYLUREA; METFORMIN; COMBINATIONS; MANAGEMENT	Oral agents are the mainstay of pharmacologic treatment for type 2 diabetes, and physicians now have a number of agents to choose from. However, more choices translate into more complex decision making. Many patients with diabetes have associated comorbidities, and most diabetic patients will require more than 1 agent to achieve good glycemic control. This article illustrates several of the pharmacologic approaches to type 2 diabetes through 4 situations that use principles of evidence-based medicine. The scenarios also highlight some of the difficulties in choosing the optimal pharmacologic treatment regimen for individual patients. Physicians should also recognize that type 2 diabetes is a multisystem disorder that requires multidisciplinary care, including education and ongoing counseling for effective patient self-management of the disease. Finally, patient preferences are a vital component of informed decision making for pharmacologic treatment of diabetes.	Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Qualidigm Connecticut Peer Review Org, Middletown, CT USA	Yale University	Holmboe, ES (corresponding author), Waterbury Hosp & Hlth Ctr, Yale Primary Care Residency Program, 64 Robbins St, Waterbury, CT 06721 USA.	eholmboe@msn.com						*AM ASS CLIN END, 2000, ENDOCR PRACT, V6, P1; *AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Deber RB, 1996, ARCH INTERN MED, V156, P1414, DOI 10.1001/archinte.156.13.1414; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Erle G, 1999, ACTA DIABETOL, V36, P61, DOI 10.1007/s005920050146; *EXP COMM DIAGN CL, 1999, DIABETES CARE S, V24, pS5; FRANZ MJ, 1995, J AM DIET ASSOC, V95, P1009, DOI 10.1016/S0002-8223(95)00276-6; Gilmer TP, 1997, DIABETES CARE, V20, P1847, DOI 10.2337/diacare.20.12.1847; Goddijn PPM, 1999, DIABETIC MED, V16, P23, DOI 10.1046/j.1464-5491.1999.00002.x; GRIFFIN S, 2000, SYSTEMS ROUTINE SURV; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; HERMANN LS, 1994, DIABETES CARE, V17, P1100, DOI 10.2337/diacare.17.10.1100; *I CLIN SYST IMPR, 2000, MAN TYP 2 DIAB MELL; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Jennings PE, 1997, DRUG AGING, V10, P323, DOI 10.2165/00002512-199710050-00001; KAYASHIMA T, 1995, DIABETES RES CLIN PR, V28, P119, DOI 10.1016/0168-8227(95)01066-M; MAZZUCA SA, 1986, DIABETES CARE, V9, P1, DOI 10.2337/diacare.9.1.1; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; PALUMBO PJ, 1998, ENDOCR PRACT, V4, P428; PEYROT M, 1994, DIABETES EDUCATOR, V20, P143, DOI 10.1177/014572179402000210; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Scheen AJ, 1998, DIABETES METAB, V24, P311; Snoek FJ, 2000, INT J OBESITY, V24, pS12, DOI 10.1038/sj.ijo.0801421; STENMAN S, 1993, ANN INTERN MED, V118, P169, DOI 10.7326/0003-4819-118-3-199302010-00002; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Wandell PE, 2000, J DIABETES COMPLICAT, V14, P25, DOI 10.1016/S1056-8727(99)00066-5; Yale JF, 2001, ANN INTERN MED, V134, P737, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00010; YkiJarvinen H, 1997, DIABETIC MED, V14, pS32, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S32::AID-DIA442>3.3.CO;2-Y	34	24	28	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					373	376		10.1001/jama.287.3.373	http://dx.doi.org/10.1001/jama.287.3.373			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790217	Bronze			2022-12-28	WOS:000173294700032
J	Barton, RA				Barton, RA			How did brains evolve?	NATURE			English	Article							EVOLUTION		Univ Durham, Dept Anthropol, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England	Durham University	Barton, RA (corresponding author), Univ Durham, Dept Anthropol, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England.							Baron G., 1996, COMP NEUROBIOLOGY CH, V1; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Putnam IK, 1927, P R ACAD AMSTERDAM, V31, P155; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963	8	15	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					134	135		10.1038/415134a	http://dx.doi.org/10.1038/415134a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805823				2022-12-28	WOS:000173159300030
J	Ingelfinger, JR				Ingelfinger, JR			Diet and kidney stones	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	6	6	1	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					74	76		10.1056/NEJM200201103460202	http://dx.doi.org/10.1056/NEJM200201103460202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784872				2022-12-28	WOS:000173133400001
J	Sultan, F				Sultan, F			Brain evolution - Analysis of mammalian brain architecture	NATURE			English	Article							CEREBRAL-CORTEX; PRIMATES		Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Sultan, F (corresponding author), Univ Tubingen, Dept Cognit Neurol, Morgenstelle 15, D-72076 Tubingen, Germany.							ANDERSEN BB, 1992, J COMP NEUROL, V326, P549, DOI 10.1002/cne.903260405; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Braitenberg V, 1991, ANATOMY CORTEX; Brodmann K., 1913, VERH GES DTSCH NATUR, V85, P200; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; FRAHM HD, 1982, J HIRNFORSCH, V23, P375; HOFMAN MA, 1985, BRAIN BEHAV EVOLUT, V27, P28, DOI 10.1159/000118718; KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M; MATANO S, 1985, FOLIA PRIMATOL, V44, P171, DOI 10.1159/000156211; Sultan Fahad, 1993, Journal fuer Hirnforschung, V34, P79; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	12	42	42	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					133	134		10.1038/415133b	http://dx.doi.org/10.1038/415133b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805821				2022-12-28	WOS:000173159300029
J	Yanagisawa, H; Davis, EC; Starcher, BC; Ouchi, T; Yanagisawa, M; Richardson, JA; Olson, EN				Yanagisawa, H; Davis, EC; Starcher, BC; Ouchi, T; Yanagisawa, M; Richardson, JA; Olson, EN			Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo	NATURE			English	Article							DEVELOPING MOUSE AORTA; FIBRILLIN-1; FIBER; ORGANIZATION; TROPOELASTIN; MATRIX	Extracellular elastic fibres provide mechanical elasticity to tissues and contribute towards the processes of organ remodelling by affecting cell-cell signalling(1,2). The formation of elastic fibres requires the assembly and crosslinking of tropoelastin monomers, and organization of the resulting insoluble elastin matrix into functional fibres. The molecules and mechanisms involved in this process are unknown. Fibulin-5 (also known as EVEC/DANCE) is an extracellular matrix protein abundantly expressed in great vessels and cardiac valves during embryogenesis, and in many adult tissues including the aorta, lung, uterus and skin, all of which contain abundant elastic fibres(3,4). Here we show that fibulin-5 is a calcium-dependent, elastin-binding protein that localizes to the surface of elastic fibres in vivo. fibulin-5(-/-) mice develop marked elastinopathy owing to the disorganization of elastic fibres, with resulting loose skin, vascular abnormalities and emphysematous lung. This phenotype, which resembles the cutis laxa syndrome in humans(5), reveals a critical function for fibulin-5 as a scaffold protein that organizes and links elastic fibres to cells. This function may be mediated by the RGD motif in fibulin-5, which binds to cell surface integrins, and the Ca2+-binding epidermal growth factor (EGF) repeats, which bind elastin.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas Hlth Ctr, Dept Biochem, Tyler, TX 75708 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Davis, Elaine/F-3449-2012; Yanagisawa, Hiromi/Y-2843-2019	Yanagisawa, Hiromi/0000-0002-7576-9186				Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835; DAVIS EC, 1994, J CELL SCI, V107, P727; DAVIS EC, 1993, LAB INVEST, V68, P89; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Sasaki T, 1999, FEBS LETT, V460, P280, DOI 10.1016/S0014-5793(99)01362-9; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200	18	466	493	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					168	171		10.1038/415168a	http://dx.doi.org/10.1038/415168a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805834				2022-12-28	WOS:000173159300041
J	Ward-Thompson, D				Ward-Thompson, D			Notated star formation: From cloud formation to core collapse	SCIENCE			English	Review							INITIAL MASS FUNCTION; AMBIPOLAR DIFFUSION; DENSE CORES; MOLECULAR CLOUDS; PROTOSTELLAR ENCOUNTERS; NUMERICAL SIMULATIONS; DARK CLOUDS; INTERSTELLAR CLOUDS; MAGNETIC BRAKING; SIZE RELATION	The formation of stars is one of the most fundamental problems in astrophysics, as it underlies many other questions, on scales from the formation of galaxies to the formation of the solar system. The physical processes involve the turbulent behavior of a partially ionized medium containing a non-uniform magnetic field. Current debate centers around the time taken for turbulence to decay and the relative importance of the roles played by magnetic fields and turbulence. Technological advances such as millimeter-wave cameras have made possible observations of the temperature and density profiles, and statistical calculations of the lifetimes, of objects collapsing under their own self-gravity and those on the verge of collapse. increased computing power allows more complex models to be made that include magnetic and turbulent effects. No current model can reproduce all of the observations.	Cardiff Univ, Dept Phys & Astron, Cardiff, S Glam, Wales	Cardiff University	Ward-Thompson, D (corresponding author), Cardiff Univ, Dept Phys & Astron, POB 913, Cardiff, S Glam, Wales.	D.Ward-Thompson@astro.cf.ac.uk		Ward-Thompson, Derek/0000-0003-1140-2761				Alves JF, 2001, NATURE, V409, P159, DOI 10.1038/35051509; Andre P., 2000, Protostars and planets 4, P59; Andre P, 1996, ASTRON ASTROPHYS, V314, P625; ANDRE P, 1993, ASTROPHYS J, V406, P122, DOI 10.1086/172425; ANDRE P, 1994, ASTROPHYS J, V420, P837, DOI 10.1086/173608; Andre P, 1994, MORIOND AST, P179; ANDRE P, 1997, IAU S, V182; Bacmann A, 2000, ASTRON ASTROPHYS, V361, P555; Balsara D, 2001, MON NOT R ASTRON SOC, V327, P715, DOI 10.1046/j.1365-8711.2001.04787.x; Balsara DS, 1996, ASTROPHYS J, V465, P775, DOI 10.1086/177462; Balsara DS, 2001, ASTROPHYS J, V557, P451, DOI 10.1086/323679; Basu S, 2000, ASTROPHYS J, V540, pL103, DOI 10.1086/312885; BASU S, 1994, ASTROPHYS J, V432, P720, DOI 10.1086/174611; BEICHMAN CA, 1986, ASTROPHYS J, V307, P337, DOI 10.1086/164421; BENSON PJ, 1989, ASTROPHYS J SUPPL S, V71, P89, DOI 10.1086/191365; BLITZ L, 1980, ASTROPHYS J, V238, P148, DOI 10.1086/157968; Boffin HMJ, 1998, MON NOT R ASTRON SOC, V300, P1189, DOI 10.1046/j.1365-8711.1998.01986.x; BOK BJ, 1947, ASTROPHYS J, V105, P255, DOI 10.1086/144901; BONNOR WB, 1956, MON NOT R ASTRON SOC, V116, P351, DOI 10.1093/mnras/116.3.351; CASELLI P, 1995, ASTROPHYS J, V446, P665, DOI 10.1086/175825; CASELLI P, IN PRESS ASTROPHYS J; CIOLEK GE, 1993, ASTROPHYS J, V418, P774, DOI 10.1086/173435; Ciolek GE, 2000, ASTROPHYS J, V529, P925, DOI 10.1086/308293; CIOLEK GE, 1994, ASTROPHYS J, V425, P142, DOI 10.1086/173971; Crutcher RM, 1999, ASTROPHYS J, V520, P706, DOI 10.1086/307483; CRUTCHER RM, 1994, ASTROPHYS J, V427, P839, DOI 10.1086/174189; Ebert R, 1955, Z ASTROPHYS, V37, P217, DOI DOI 10.3406/RNORD.1955.2187; Elmegreen BG, 2000, ASTROPHYS J, V530, P277, DOI 10.1086/308361; FALGARONE E, 1991, ASTROPHYS J, V378, P186, DOI 10.1086/170419; FALGARONE E, 1990, ASTROPHYS J, V359, P344, DOI 10.1086/169068; Falle SAEG, 2002, MON NOT R ASTRON SOC, V329, P195, DOI 10.1046/j.1365-8711.2002.04949.x; GAUSTAD JE, 1963, ASTROPHYS J, V138, P1050, DOI 10.1086/147705; Gregersen EM, 2000, ASTROPHYS J, V538, P260, DOI 10.1086/309114; HAYASHI C, 1966, ANNU REV ASTRON ASTR, V4, P171, DOI 10.1146/annurev.aa.04.090166.001131; Heithausen A., 1990, APJ, V353, pL49; Henriksen R, 1997, ASTRON ASTROPHYS, V323, P549; Holland WS, 1999, MON NOT R ASTRON SOC, V303, P659, DOI 10.1046/j.1365-8711.1999.02111.x; Jessop NE, 2001, MON NOT R ASTRON SOC, V323, P1025, DOI 10.1046/j.1365-8711.2001.04289.x; Jijina J, 1999, ASTROPHYS J SUPPL S, V125, P161, DOI 10.1086/313268; KENYON SJ, 1990, ASTRON J, V99, P869, DOI 10.1086/115380; KENYON SJ, 1995, ASTROPHYS J SUPPL S, V101, P117, DOI 10.1086/192235; Kessler MF, 1996, ASTRON ASTROPHYS, V315, pL27; Kirk J., UNPUB; Kroupa P, 2002, SCIENCE, V295, P82, DOI 10.1126/science.1067524; Lada C. J., 1987, IAU S, V115, P1; LADA CJ, 1984, ASTROPHYS J, V287, P610, DOI 10.1086/162719; LARSON RB, 1969, MON NOT R ASTRON SOC, V145, P271, DOI 10.1093/mnras/145.3.271; Lee CW, 1999, ASTROPHYS J SUPPL S, V123, P233, DOI 10.1086/313234; Lee CW, 1999, ASTROPHYS J, V526, P788, DOI 10.1086/308027; Li ZY, 1996, ASTROPHYS J, V472, P211, DOI 10.1086/178056; Lynds B. T., 1962, AP J SUPPL, V7, P1, DOI [10.1086/190072, DOI 10.1086/190072]; Mac Low MM, 1998, PHYS REV LETT, V80, P2754, DOI 10.1103/PhysRevLett.80.2754; MCKEE CF, 1995, ASTROPHYS J, V440, P686, DOI 10.1086/175306; MELROSE DB, 1986, INSTABILITIES SPACE, P123; Motte F, 2001, ASTRON ASTROPHYS, V372, pL41, DOI 10.1051/0004-6361:20010543; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; MOUSCHOVIAS TC, 1995, ASTROPHYS J, V444, pL105, DOI 10.1086/187871; MOUSCHOVIAS TC, 1977, ASTROPHYS J, V211, P147, DOI 10.1086/154912; MOUSCHOVIAS TC, 1991, ASTROPHYS J, V373, P169, DOI 10.1086/170035; MOUSCHOVIAS TC, 1987, PHYSICAL PROCESSES I, P453; MYERS PC, 1983, ASTROPHYS J, V264, P517, DOI 10.1086/160619; MYERS PC, 1983, ASTROPHYS J, V266, P309, DOI 10.1086/160780; Myers PC, 1998, ASTROPHYS J, V496, pL109, DOI 10.1086/311256; Myers PC, 2000, ASTROPHYS J, V530, pL119, DOI 10.1086/312495; MYERS PC, 1983, ASTROPHYS J, V270, P105, DOI 10.1086/161101; NAKANO T, 1976, PUBL ASTRON SOC JPN, V28, P355; Norman CA, 1996, ASTROPHYS J, V467, P280, DOI 10.1086/177603; Ostriker EC, 1999, ASTROPHYS J, V513, P259, DOI 10.1086/306842; PARKER EN, 1966, ASTROPHYS J, V145, P811, DOI 10.1086/148828; PARKER EN, 1979, COSMICAL FIELDS THEI; PENSTON MV, 1969, MON NOT R ASTRON SOC, V144, P425, DOI 10.1093/mnras/144.4.425; Pudritz RE, 2002, SCIENCE, V295, P68, DOI 10.1126/science.1068298; REIPURTH B, 2001, P IAU S, V200; Scalo J. M., 1987, P S INT PROC, P349; SHU FH, 1977, ASTROPHYS J, V214, P488, DOI 10.1086/155274; STAHLER SW, 1980, ASTROPHYS J, V241, P637, DOI 10.1086/158377; Stone JM, 1998, ASTROPHYS J, V508, pL99, DOI 10.1086/311718; Tafalla M, 1998, ASTROPHYS J, V504, P900, DOI 10.1086/306115; Ward-Thompson D, 1999, MON NOT R ASTRON SOC, V305, P143, DOI 10.1046/j.1365-8711.1999.02412.x; Ward-Thompson D, 2000, ASTROPHYS J, V537, pL135, DOI 10.1086/312764; Ward-Thompson D, 2002, MON NOT R ASTRON SOC, V329, P257, DOI 10.1046/j.1365-8711.2002.04969.x; Ward-Thompson D, 2001, MON NOT R ASTRON SOC, V327, P955, DOI 10.1046/j.1365-8711.2001.04782.x; Wardle J, 1996, BRIT J HEALTH PSYCH, V1, P1, DOI 10.1111/j.2044-8287.1996.tb00486.x; WARDTHOMPSON D, 1994, MON NOT R ASTRON SOC, V268, P276, DOI 10.1093/mnras/268.1.276; WardThompson D, 1996, MON NOT R ASTRON SOC, V281, pL53, DOI 10.1093/mnras/281.3.L53; Watkins SJ, 1998, MON NOT R ASTRON SOC, V300, P1214, DOI 10.1046/j.1365-8711.1998.01988.x; Watkins SJ, 1998, MON NOT R ASTRON SOC, V300, P1205, DOI 10.1046/j.1365-8711.1998.01987.x; WHITWORTH A, 1985, MON NOT R ASTRON SOC, V214, P1; Whitworth AP, 1996, MON NOT R ASTRON SOC, V283, P1061, DOI 10.1093/mnras/283.3.1061; Whitworth AP, 2001, ASTROPHYS J, V547, P317, DOI 10.1086/318373; WHITWORTH AP, 1995, MON NOT R ASTRON SOC, V277, P727, DOI 10.1093/mnras/277.2.727; Williams J.P., 2000, PROTOSTARS PLANETS 4, P97; Williams JP, 1999, ASTROPHYS J, V513, pL61, DOI 10.1086/311895; ZHOU SD, 1993, ASTROPHYS J, V404, P232, DOI 10.1086/172271	97	39	39	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					76	81		10.1126/science.1067354	http://dx.doi.org/10.1126/science.1067354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778038				2022-12-28	WOS:000173143100036
J	Pack, CC; Berezovskii, VK; Born, RT				Pack, CC; Berezovskii, VK; Born, RT			Dynamic properties of neurons in cortical area MT in alert and anaesthetized macaque monkeys	NATURE			English	Article							PRIMARY VISUAL-CORTEX; MOTION PERCEPTION; SEGREGATION; SELECTIVITY; COHERENCE; MODEL	In order to see the world with high spatial acuity, an animal must sample the visual image with many detectors that restrict their analyses to extremely small regions of space. The visual cortex must then integrate the information from these localized receptive fields to obtain a more global picture of the surrounding environment. We studied this process in single neurons within the middle temporal visual area (MT) of macaques using stimuli that produced conflicting local and global information about stimulus motion. Neuronal responses in alert animals initially reflected predominantly the ambiguous local motion features, but gradually converged to an unambiguous global representation. When the same animals were anaesthetized, the integration of local motion signals was markedly impaired even though neuronal responses remained vigorous and directional tuning characteristics were intact. Our results suggest that anaesthesia preferentially affects the visual processing responsible for integrating local signals into a global visual representation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Berezovskii, Vladimir/AAB-5253-2022; Born, Richard/M-6454-2019; Berezovskii, Vladimir/B-9866-2013	Born, Richard/0000-0003-4360-427X; Berezovskii, Vladimir/0000-0003-4077-3940				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Alais D, 1997, VISION RES, V37, P143, DOI 10.1016/0042-6989(95)00320-7; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7066, DOI 10.1073/pnas.88.16.7066; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hildreth E., 1984, MEASUREMENT VISUAL M; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Movshon JA, 1996, J NEUROSCI, V16, P7733; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	27	108	108	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					905	908		10.1038/414905a	http://dx.doi.org/10.1038/414905a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780062				2022-12-28	WOS:000172813300045
J	Wilson, AM; McGuigan, MP; Su, A; van den Bogert, AJ				Wilson, AM; McGuigan, MP; Su, A; van den Bogert, AJ			Horses damp the spring in their step	NATURE			English	Article							MUSCLE; LOCOMOTION; SIMULATION; ENERGY; STRAIN; GASTROCNEMIUS; BEHAVIOR; STORAGE; MODEL	The muscular work of galloping in horses is halved by storing and returning elastic strain energy in spring-like muscle-tendon units(1,2). These make the legs act like a child's pogo stick that is tuned to stretch and recoil at 2.5 strides per second. This mechanism is optimized by unique musculoskeletal adaptations: the digital flexor muscles have extremely short fibres and significant passive properties, whereas the tendons are very long and span several joints(3,4). Length change occurs by a stretching of the spring-like digital flexor tendons rather than through energetically expensive length changes in the muscle(5). Despite being apparently redundant for such a mechanism(5), the muscle fibres in the digital flexors are well developed. Here we show that the mechanical arrangement of the elastic leg permits it to vibrate at a higher frequency of 30-40 Hz that could cause fatigue damage to tendon and bone. Furthermore, we show that the digital flexor muscles have minimal ability to contribute to or regulate significantly the 2.5-Hz cycle of movement, but are ideally arranged to damp these high-frequency oscillations in the limb.	Univ London Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA	University of London; University of London Royal Veterinary College; Cleveland Clinic Foundation	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	van den Bogert, Antonie J/A-7809-2009; Su, Anne/M-3246-2013	van den Bogert, Antonie J/0000-0002-3791-3749; Su, Anne/0000-0002-6924-6899; Wilson, Alan/0000-0001-9914-3455				ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Alexander RM., 1988, ELASTIC MECH ANIMAL; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, J EXP BIOL, V201, P1681; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; CHENEY JA, 1973, MED BIOL ENG, V11, P613, DOI 10.1007/BF02477408; DIMERY NJ, 1986, J ZOOL, V210, P415; DOW SM, 1991, EQUINE VET J, V23, P266, DOI 10.1111/j.2042-3306.1991.tb03715.x; ETTEMA GJC, 1994, J BIOMECH, V27, P1015, DOI 10.1016/0021-9290(94)90218-6; GERRITSEN KGM, 1995, J BIOMECH, V28, P661, DOI 10.1016/0021-9290(94)00127-P; GRANDAGE J, 1981, J ANAT, V132, P318; HERMANSON JW, 1992, J MORPHOL, V212, P269, DOI 10.1002/jmor.1052120306; HERRICK WC, 1978, J BIOMED MATER RES, V12, P877, DOI 10.1002/jbm.820120610; Hof AL, 1998, J BIOMECH, V31, P793, DOI 10.1016/S0021-9290(98)00062-1; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; Kurokawa S, 2001, J APPL PHYSIOL, V90, P1349, DOI 10.1152/jappl.2001.90.4.1349; LAKE MJ, 2001, P 18 C INT SOC BIOM, P200; Minetti AE, 1999, J EXP BIOL, V202, P2329; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Piazzesi G, 1996, J MUSCLE RES CELL M, V17, P45, DOI 10.1007/BF00140323; PRATT GA, 1995, P 4 INT S EXP ROB IS, P173; STEPHENS PR, 1989, AM J VET RES, V50, P1089; van den Bogert AJ, 1998, J ELECTROMYOGR KINES, V8, P119, DOI 10.1016/S1050-6411(97)00028-X; VANDENBOGERT AJ, 1993, ACTA ANAT, V146, P95; VANDENBOGERT AJ, 1989, THESIS U UTRECHT NET; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VANWEEREN PR, 1993, ACTA ANAT, V146, P154, DOI 10.1159/000147438; WANG XT, 1995, J EXP BIOL, V198, P847	30	174	174	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					895	899		10.1038/414895a	http://dx.doi.org/10.1038/414895a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780059	Green Submitted			2022-12-28	WOS:000172813300042
J	Vasan, RS; Larson, MG; Leip, EP; Evans, JC; O'Donnell, CJ; Kannel, WB; Levy, D				Vasan, RS; Larson, MG; Leip, EP; Evans, JC; O'Donnell, CJ; Kannel, WB; Levy, D			Impact of high-normal blood pressure on the risk of cardiovascular disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; ISOLATED SYSTOLIC HYPERTENSION; REGRESSION DILUTION; MEN; MORTALITY; WOMEN; RECOMMENDATIONS; METAANALYSIS; POPULATION; PREVENTION	Background: Information is limited regarding the risk of cardiovascular disease in persons with high-normal blood pressure (systolic pressure of 130 to 139 mm Hg, diastolic pressure of 85 to 89 mm Hg, or both). Methods: We investigated the association between blood-pressure category at base line and the incidence of cardiovascular disease on follow-up among 6859 participants in the Framingham Heart Study who were initially free of hypertension and cardiovascular disease. Results: A stepwise increase in cardiovascular event rates was noted in persons with higher base-line blood-pressure categories. The 10-year cumulative incidence of cardiovascular disease in subjects 35 to 64 years of age who had high-normal blood pressure was 4 percent (95 percent confidence interval, 2 to 5 percent) for women and 8 percent (95 percent confidence interval, 6 to 10 percent) for men; in older subjects (those 65 to 90 years old), the incidence was 18 percent (95 percent confidence interval, 12 to 23 percent) for women and 25 percent (95 percent confidence interval, 17 to 34 percent) for men. As compared with optimal blood pressure, high-normal blood pressure was associated with a risk-factor-adjusted hazard ratio for cardiovascular disease of 2.5 (95 percent confidence interval, 1.6 to 4.1) in women and 1.6 (95 percent confidence interval, 1.1 to 2.2) in men. Conclusions: High-normal blood pressure is associated with an increased risk of cardiovascular disease. Our findings emphasize the need to determine whether lowering high-normal blood pressure can reduce the risk of cardiovascular disease. (N Engl J Med 2001;345:1291-7.) Copyright (C) 2001 Massachusetts Medical Society.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 5 Thurber St, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, K24 HL 04334-01A1] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chalmers J, 1999, J HYPERTENS, V17, P151; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOK RJ, 1995, BRIT MED J, V310, P1056; Cox D. R., 1984, ANAL SURVIVAL DATA; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Escudero E, 1996, CAN J CARDIOL, V12, P959; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Kannel W., 1987, FRAMINGHAM HEART STU; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kimura Y, 1999, HYPERTENS RES-CLIN E, V22, P291, DOI 10.1291/hypres.22.291; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22; Lloyd-Jones DM, 1999, ARCH INTERN MED, V159, P2206, DOI 10.1001/archinte.159.18.2206; LONATI L, 1993, CARDIOLOGY, V83, P298, DOI 10.1159/000175985; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Neaton James D., 1995, P127; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Rodgers A, 1998, LANCET, V352, P1801; SAGIE A, 1993, NEW ENGL J MED, V329, P1912, DOI 10.1056/NEJM199312233292602; SAS Institute, 1996, SAS STAT SOFTW CHANG; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wood D, 1998, J HYPERTENS, V16, P1407, DOI 10.1097/00004872-199816100-00003	34	1347	1398	2	78	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1291	1297		10.1056/NEJMoa003417	http://dx.doi.org/10.1056/NEJMoa003417			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794147				2022-12-28	WOS:000171896300001
J	Iams, JD; Newman, RB; Thom, EA; Goldenberg, RL; Mueller-Heubach, E; Moawad, A; Sibai, BM; Caritis, SN; Miodovnik, M; Paul, RH; Dombrowski, MP; McNellis, D				Iams, JD; Newman, RB; Thom, EA; Goldenberg, RL; Mueller-Heubach, E; Moawad, A; Sibai, BM; Caritis, SN; Miodovnik, M; Paul, RH; Dombrowski, MP; McNellis, D		Natl Inst Child Hlth Human Dev Net	Frequency of uterine contractions and the risk of spontaneous preterm delivery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FETAL FIBRONECTIN; PREDICTION; LENGTH; LABOR; TERM	Background: The measurement of the frequency of uterine contractions has not been useful for reducing the rate of preterm delivery in randomized trials. Nonetheless, ambulatory monitoring of contractions continues to be used in clinical practice. Methods: We assessed the frequency of uterine contractions as a predictor of the risk of spontaneous preterm delivery before 35 weeks of gestation. We enrolled women with singleton pregnancies between 22 and 24 weeks of gestation. The women used a contraction monitor at home to record contraction frequency twice daily on 2 or more days per week from enrollment to delivery or 37 weeks of gestation. Results: We obtained 34,908 hours of successful monitoring recordings from 306 women. Although more contractions were recorded from women who delivered before 35 weeks than from women who delivered at 35 weeks or later, we could identify no threshold frequency that effectively identified women who delivered preterm infants. The sensitivity and positive predictive value of a maximal hourly frequency of contractions of four or more between 4 p.m. and 3:59 a.m. were 9 percent and 25 percent, respectively, at 22 to 24 weeks and 28 percent and 23 percent at 27 to 28 weeks. Other proposed screening tests, such as digital and ultrasound evaluations of the cervix and assays for fetal fibronectin in cervicovaginal secretions, also had low sensitivity and positive predictive value for preterm labor. Conclusions: Although the likelihood of preterm delivery increases with an increased frequency of uterine contractions, measurement of this frequency is not clinically useful for predicting preterm delivery. (N Engl J Med 2002;346:250-5.) Copyright (C) 2001 Massachusetts Medical Society.	Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Alabama Birmingham, Birmingham, AL USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Univ Chicago, Chicago, IL 60637 USA; Univ Tennessee, Memphis, TN USA; Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; Univ Cincinnati, Cincinnati, OH USA; Univ Calif Los Angeles, Los Angeles, CA USA; Wayne State Univ, Detroit, MI USA; George Washington Univ, Ctr Biostat, Washington, DC USA; NICHHD, Bethesda, MD 20892 USA; Univ Oklahoma, Oklahoma City, OK USA	University System of Ohio; Ohio State University; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; Wake Forest University; University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; Wayne State University; George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Oklahoma System; University of Oklahoma Health Sciences Center	Iams, JD (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, 1654 Upham Dr, Columbus, OH 43210 USA.			caritis, steve/0000-0002-2169-0712	NICHD NIH HHS [HD 21414, HD 27915, HD 19897, HD 21410, HD 27860, HD 27889, HD 27917, HD 21434, HD 27905, HD 27883, HD 27861, HD 27869] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027917, U10HD027869, U10HD027915, U10HD021410] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027905, U10HD027861, U10HD027883, U01HD021410, U10HD027860, U10HD027889, U01HD021434, U10HD021414, U01HD019897, U10HD021434, U01HD021414] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEPP R, 1993, AM J OBSTET GYNECOL, V169, P352; Dyson DC, 1998, NEW ENGL J MED, V338, P15, DOI 10.1056/NEJM199801013380103; GERMAIN AM, 1993, AM J OBSTET GYNECOL, V168, P1271, DOI 10.1016/0002-9378(93)90379-W; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; GRIMES DA, 1992, OBSTET GYNECOL, V79, P137; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; KATZ M, 1986, AM J OBSTET GYNECOL, V154, P44, DOI 10.1016/0002-9378(86)90390-X; KATZ M, 1986, OBSTET GYNECOL, V68, P773; Leitich H, 1999, AM J OBSTET GYNECOL, V181, P1465, DOI 10.1016/S0002-9378(99)70407-2; Leitich H, 1999, AM J OBSTET GYNECOL, V180, P1169, DOI 10.1016/S0002-9378(99)70612-5; MAIN DM, 1991, AM J OBSTET GYNECOL, V165, P1317; MOORE TR, 1994, OBSTET GYNECOL, V83, P517, DOI 10.1097/00006250-199404000-00006; NAGEOTTE MP, 1988, AM J OBSTET GYNECOL, V158, P1254, DOI 10.1016/0002-9378(88)90353-5; NEWMAN RB, 1997, J SOC GYNECOL INVEST, V4, pA152; SACHS BP, 1991, NEW ENGL J MED, V325, P1374, DOI 10.1056/NEJM199111073251911; WOOLF SH, 1993, JAMA-J AM MED ASSOC, V270, P371	18	139	141	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					250	255		10.1056/NEJMoa002868	http://dx.doi.org/10.1056/NEJMoa002868			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807149				2022-12-28	WOS:000173398900005
J	Perakis, SS; Hedin, LO				Perakis, SS; Hedin, LO			Nitrogen loss from unpolluted South American forests mainly via dissolved organic compounds	NATURE			English	Article							CARBON SEQUESTRATION; TEMPERATE FOREST; ECOSYSTEMS; SOIL; DEPOSITION; SATURATION; PATTERNS; STORAGE; FLUXES	Conceptual(1-4) and numerical(5-8) models of nitrogen cycling in temperate forests assume that nitrogen is lost from these ecosystems predominantly by way of inorganic forms, such as nitrate and ammonium ions. Of these, nitrate is thought to be particularly mobile, being responsible for nitrogen loss to deep soil and stream waters. But human activities-such as fossil fuel combustion, fertilizer production and land-use change-have substantially altered the nitrogen cycle over large regions(9), making it difficult to separate natural aspects of nitrogen cycling from those induced by human perturbations(10). Here we report stream chemistry data from 100 unpolluted primary forests in temperate South America. Although the sites exhibit a broad range of environmental factors that influence ecosystem nutrient cycles(11-13) (such as climate, parent material, time of ecosystem development, topography and biotic diversity), we observed a remarkably consistent pattern of nitrogen loss across all forests. In contrast to findings from forests in polluted regions, streamwater nitrate concentrations are exceedingly low, such that nitrate to ammonium ratios were less than unity, and dissolved organic nitrogen is responsible for the majority of nitrogen losses from these forests. We therefore suggest that organic nitrogen losses should be considered in models of forest nutrient cycling, which could help to explain observations of nutrient limitation in temperate forest ecosystems.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Perakis, SS (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, 3200 SW Jefferson Way, Corvallis, OR 97331 USA.	sperakis@usgs.gov						Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; AGUILAR R, 1985, SOIL SCI SOC AM J, V49, P695, DOI 10.2136/sssaj1985.03615995004900030034x; ALABACK PB, 1991, REV CHIL HIST NAT, V64, P399; ALMEYDA AE, 1958, RECOPILACION DATOS C; Campbell JL, 2000, BIOGEOCHEMISTRY, V49, P123, DOI 10.1023/A:1006383731753; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Goodale CL, 2000, ECOSYSTEMS, V3, P433, DOI 10.1007/s100210000039; GORHAM E, 1961, GEOL SOC AM BULL, V72, P795, DOI 10.1130/0016-7606(1961)72[795:FISOMI]2.0.CO;2; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Jenny H., 1941, FACTORS SOIL FORMATI; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; Mcdowell WH, 1998, WATER AIR SOIL POLL, V105, P175, DOI 10.1023/A:1005032904590; McGuire AD, 1997, GLOBAL BIOGEOCHEM CY, V11, P173, DOI 10.1029/97GB00059; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Nodvin SC, 1995, WATER AIR SOIL POLL, V85, P1647, DOI 10.1007/BF00477216; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Schimel DS, 1997, P NATL ACAD SCI USA, V94, P8280, DOI 10.1073/pnas.94.16.8280; SOLLINS P, 1980, ECOL MONOGR, V50, P261, DOI 10.2307/2937252; STODDARD JL, 1994, ADV CHEM SER, V237, P223; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Veblen Thomas T., 1996, P293; VILLAGRAM C, 1993, QUATERNARY LAKE DIST; Vitousek PM, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P432; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weathers KC, 2000, ECOSYSTEMS, V3, P590, DOI 10.1007/s100210000051	31	498	584	2	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					416	419		10.1038/415416a	http://dx.doi.org/10.1038/415416a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807551				2022-12-28	WOS:000173433600046
J	Zasloff, M				Zasloff, M			Antimicrobial peptides of multicellular organisms	NATURE			English	Review							HUMAN BETA-DEFENSIN-2; INNATE IMMUNITY; BETA-DEFENSIN; HOST-DEFENSE; IN-VITRO; ANTIBACTERIAL PEPTIDE; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; INSECT IMMUNITY; EXPRESSION	Multicellular organisms live, by and large, harmoniously with microbes. The cornea of the eye of an animal is almost always free of signs of infection. The insect flourishes without lymphocytes or antibodies. A plant seed germinates successfully in the midst of soil microbes. How is this accomplished? Both animals and plants possess potent, broad-spectrum antimicrobial peptides, which they use to fend off a wide range of microbes, including bacteria, fungi, viruses and protozoa. What sorts of molecules are they? How are they employed by animals in their defence? As our need for new antibiotics becomes more pressing, could we design anti-infective drugs based on the design principles these molecules teach us?	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Zasloff, M (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd NW, Washington, DC 20007 USA.	maz5@georgetown.edu	akbari, mohammad/O-4200-2017; Abrams, William R/A-5782-2008					AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; BULET P, 1993, J BIOL CHEM, V268, P14893; Chertov O, 2000, IMMUNOL REV, V177, P68, DOI 10.1034/j.1600-065X.2000.17702.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Fehlbaum P, 2000, P NATL ACAD SCI USA, V97, P12723, DOI 10.1073/pnas.220424597; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Giacometti A, 2000, DIAGN MICR INFEC DIS, V38, P115, DOI 10.1016/S0732-8893(00)00175-9; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Groisman EA, 1998, BIOESSAYS, V20, P96, DOI 10.1002/(SICI)1521-1878(199801)20:1<96::AID-BIES13>3.0.CO;2-3; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Hamuro Y, 1999, J AM CHEM SOC, V121, P12200, DOI 10.1021/ja992728p; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; ROMEO D, 1988, J BIOL CHEM, V263, P9573; Russell JP, 1996, INFECT IMMUN, V64, P1565, DOI 10.1128/IAI.64.5.1565-1568.1996; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shinnar A.E., 1996, P 14 PEPT AM S COL O, P189; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tarver AP, 1998, INFECT IMMUN, V66, P1045, DOI 10.1128/IAI.66.3.1045-1056.1998; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Ulvatne H, 2001, SCAND J INFECT DIS, V33, P507, DOI 10.1080/00365540110026692; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff Michael, 2001, P261	74	6503	6883	100	2280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					389	395		10.1038/415389a	http://dx.doi.org/10.1038/415389a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807545				2022-12-28	WOS:000173433600040
J	Beldade, P; Brakefield, PM; Long, AD				Beldade, P; Brakefield, PM; Long, AD			Contribution of Distal-less to quantitative variation in butterfly eyespots	NATURE			English	Article							DROSOPHILA-MELANOGASTER; BRISTLE NUMBER; BICYCLUS-ANYNANA; EVOLUTION; PATTERNS; WINGS; GENETICS; POLYMORPHISMS; LOCUS	The colour patterns decorating butterfly wings provide ideal material to study the reciprocal interactions between evolution and development. They are visually compelling products of selection, often with a clear adaptive value, and are amenable to a detailed developmental characterization(1). Research on wing-pattern evolution and development has focused on the eyespots of the tropical butterfly Bicyclus anynana(2). There is quantitative variation for several features of eyespot morphology(3-5) but the actual genes contributing to such variation are unknown. On the other hand, studies of gene expression patterns in wing primordia have implicated different developmental pathways in eyespot formation(6-11). To link these two sets of information we need to identify which genes within the implicated pathways contribute to the quantitative variation accessible to natural selection. Here we begin to bridge this gap by demonstrating linkage between DNA polymorphisms in the candidate gene Distal-less (Dll) and eyespot size in B. anynana.	Leiden Univ, Inst Evolutionary & Ecol Sci, NL-2300 RA Leiden, Netherlands; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92612 USA	Leiden University; Leiden University - Excl LUMC; University of California System; University of California Irvine	Beldade, P (corresponding author), Leiden Univ, Inst Evolutionary & Ecol Sci, POB 9516, NL-2300 RA Leiden, Netherlands.		Beldade, Patrícia/E-1970-2011	Beldade, Patrícia/0000-0001-7831-979X; Long, Tony/0000-0002-5007-8514				Brakefield PM, 1998, HEREDITY, V80, P265, DOI 10.1038/sj.hdy.6883660; Brakefield PM, 1999, BIOESSAYS, V21, P391, DOI 10.1002/(SICI)1521-1878(199905)21:5&lt;391::AID-BIES6&gt;3.0.CO;2-Q; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CARROLL SB, 1994, DEVELOPMENT, P217; Doerge RW, 1996, GENETICS, V142, P285; EDWARDS MD, 1987, GENETICS, V116, P113; Falconer DS, 1996, INTRO QUANTITATIVE G; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LAI CG, 1994, SCIENCE, V266, P1697, DOI 10.1126/science.7992053; LANDER ES, 1989, GENETICS, V121, P185; Long AD, 2000, GENETICS, V154, P1255; LONG AD, 1995, GENETICS, V139, P1273; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Marec F, 1996, INT J INSECT MORPHOL, V25, P205, DOI 10.1016/0020-7322(96)00009-8; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; Monteiro A, 1997, GENETICS, V146, P287; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI [10.1111/j.1558-5646.1994.tb05301.x, 10.2307/2410374]; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Palopoli MF, 1996, CURR OPIN GENET DEV, V6, P502, DOI 10.1016/S0959-437X(96)80074-8; PANGANIBAN G, 1994, CURR BIOL, V4, P671, DOI 10.1016/S0960-9822(00)00151-2; ROBINSON R, 1971, LEPIDOPTERA GENETICS; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Taylor BA, 2001, MAMM GENOME, V12, P95, DOI 10.1007/s003350010254; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wijngaarden PJ, 2000, HEREDITY, V85, P471, DOI 10.1046/j.1365-2540.2000.00786.x	30	108	111	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					315	318		10.1038/415315a	http://dx.doi.org/10.1038/415315a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797007				2022-12-28	WOS:000173293500042
J	Fraser, DGW; Moody, AR; Morgan, PS; Martel, AL; Davidson, I				Fraser, DGW; Moody, AR; Morgan, PS; Martel, AL; Davidson, I			Diagnosis of lower-limb deep venous thrombosis: A prospective blinded study of magnetic resonance direct thrombus imaging	ANNALS OF INTERNAL MEDICINE			English	Article							VEIN THROMBOSIS; NONINVASIVE DIAGNOSIS; MR; VENOGRAPHY; MANAGEMENT; EFFICACY; COSTS	Background: current magnetic resonance techniques generate high signal from venous blood and show thrombi as filling defects. Magnetic resonance direct thrombus imaging (MRDTI) directly visualizes acute thrombus. Objective: To determine the accuracy of MRDTI for diagnosis of acute symptomatic deep venous thrombosis (DVT) below and above the knee. Design: Prospective, blinded study. Setting: A 1355-bed university hospital. Patients: 101 patients with suspected DVT who had had routine venography. Participants were recruited from a cohort of patients with suspected DVT. All patients with a positive venogram and one quarter of patients with a negative venogram were selected by using a random sequence. Intervention: MRDTI was performed within 48 hours of venography and was interpreted by two reviewers. Measurements: Diagnosis of DVT overall; isolated calf, femoropopliteal, and ileofemoral DVT; and thrombus in the calf, femoropopliteal, and iliac segments. Results: The reports from two readers had sensitivities of 96% and 94% and specificities; of 90% and 92% for diagnosis of DVT. Sensitivities were 92% and 83% for isolated calf DVT, 97% and 97% for femoropopiliteal DVT, and 100% and 100% for ileofemoral DVT. Specificities were 94% and 96% for isolated calf DVT and 100% and 100% for both femoropopliteal and ileofemoral DVT. Similarly, sensitivity and specificity within each of the venous segments ranged from 91% to 100%. Interobserver variability measured by using a weighted kappa statistic ranged from 0.89 to 0.98 for these measures. Conclusion: Magnetic resonance direct thrombus imaging is an accurate noninvasive test for diagnosis of DVT, and its accuracy is maintained below the knee. Comparison of individual venous segments showed that results of MRDTI agreed strongly with findings on venography. Scanning was well tolerated, and interpretation was highly reproducible.	Univ Nottingham Hosp, Sch Med, Dept Acad Radiol, Nottingham NG7 2UH, England	University of Nottingham	Moody, AR (corresponding author), Univ Nottingham Hosp, Sch Med, Dept Acad Radiol, B Floor,Derby Rd, Nottingham NG7 2UH, England.	Alan.Moody@nottingham.ac.uk	Martel, Anne L/A-8546-2008; moody, alan/M-9258-2019; Martel, Anne/AAD-4288-2022	Martel, Anne L/0000-0003-1375-5501; Martel, Anne/0000-0003-1375-5501; Morgan, Paul/0000-0002-5870-1446				Baldt MM, 1996, RADIOLOGY, V200, P423, DOI 10.1148/radiology.200.2.8685336; Burn PR, 1997, CLIN RADIOL, V52, P625, DOI 10.1016/S0009-9260(97)80257-7; CARPENTER JP, 1993, J VASC SURG, V18, P734, DOI 10.1016/0741-5214(93)90325-G; COEL MN, 1980, AM J ROENTGENOL, V134, P163, DOI 10.2214/ajr.134.1.163; DUPAS B, 1995, LANCET, V346, P17, DOI 10.1016/S0140-6736(95)92650-X; Evans AJ, 1996, J MAGN RESON IMAGING, V6, P44, DOI 10.1002/jmri.1880060109; EVENS RG, 1991, AM J ROENTGENOL, V157, P603, DOI 10.2214/ajr.157.3.1872246; Fletcher J, 1999, BRIT J RADIOL, V72, P432, DOI 10.1259/bjr.72.857.10505004; FRASER D, 2000, HEMATOLOGY J S1, V1, P133; FRASER D, 2000, INT ANGIOL S1, V19, P32; Fraser JD, 1999, RADIOLOGY, V211, P9, DOI 10.1148/radiology.211.1.r99ap459; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; HILLNER BE, 1992, ARCH INTERN MED, V152, P165, DOI 10.1001/archinte.152.1.165; Kalodiki E, 1998, INT ANGIOL, V17, P83; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; KENT DL, 1994, ANN INTERN MED, V120, P856, DOI 10.7326/0003-4819-120-10-199405150-00007; Kraaijenhagen R A, 1997, Curr Opin Pulm Med, V3, P268, DOI 10.1097/00063198-199707000-00006; Lebowitz JA, 1997, AM J ROENTGENOL, V169, P755, DOI 10.2214/ajr.169.3.9275892; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Levin DC, 1998, AM J ROENTGENOL, V170, P557, DOI 10.2214/ajr.170.3.9490930; Line BR, 1997, J NUCL MED, V38, P89; MCLACHLAN MSF, 1979, AM J ROENTGENOL, V132, P227, DOI 10.2214/ajr.132.2.227; Moody AR, 1998, RADIOLOGY, V209, P349, DOI 10.1148/radiology.209.2.9807558; Moody AR, 1997, LANCET, V350, P1073, DOI 10.1016/S0140-6736(97)24041-9; Moody AR, 1997, INVEST RADIOL, V32, P431, DOI 10.1097/00004424-199708000-00001; Nichols JS, 1997, J TRAUMA, V42, P520, DOI 10.1097/00005373-199703000-00021; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Polak JF, 1999, SEMIN ULTRASOUND CT, V20, P36, DOI 10.1016/S0887-2171(99)90005-7; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; ROSE SC, 1990, RADIOLOGY, V175, P639, DOI 10.1148/radiology.175.3.2188293; RUEHM SG, 1999, P INT SOC MAGNETIC R, V1, P13; Walter SD, 1999, J CLIN EPIDEMIOL, V52, P943, DOI 10.1016/S0895-4356(99)00086-4	32	175	192	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					89	98		10.7326/0003-4819-136-2-200201150-00006	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790060				2022-12-28	WOS:000173333900001
J	Hayden, M; Pignone, M; Phillips, C; Mulrow, C				Hayden, M; Pignone, M; Phillips, C; Mulrow, C			Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; RISK; METAANALYSIS; BENEFIT; PREDICTION; HEMORRHAGE; STROKE; TRIAL	Background: The use of aspirin to prevent cardiovascular disease events in patients without a history of cardiovascular disease is controversial. Purpose: To examine the benefits and harms of aspirin chemoprevention. Data Sources: MEDLINE (1966 to May 2001). Study Selection: 1) Randomized trials at least 1 year in duration that examined aspirin chemoprevention in patients without previously known cardiovascular disease and 2) systematic reviews, recent trials, and observational studies that examined rates of hemorrhagic strokes and gastrointestinal bleeding secondary to aspirin use. Data Extraction: One reviewer read and extracted data from each included article and constructed evidence tables. A second reviewer checked the accuracy of the data extraction. Discrepancies were resolved by consensus. Data Synthesis: Meta-analysis was performed, and the quantitative results of the review were then used to model the consequences of treating patients with different levels of baseline risk for coronary heart disease. Five trials examined the effect of aspirin on cardiovascular events in patients with no previous cardiovascular disease. For patients similar to those enrolled in the trials, aspirin reduces the risk for the combined end point of nonfatal myocardial infarction and fatal :coronary heart disease (summary odds ratio, 0.72 [95% Cl, 0.60 to 0.87]). Aspirin increased the risk for hemorrhagic strokes (summary odds ratio, 1.4 [Cl, 0.9 to 2.0]) and major gastrointestinal bleeding (summary odds ratio, 1.7 [Cl, 1.4 to 2.1]). All-cause mortality (summary odds ratio, 0.93 [Cl, 0.84 to 1.02]) was not significantly affected For 1000 patients with a 5% risk for coronary heart disease events over 5 years, aspirin would prevent 6 to 20 myocardial infarctions but would cause 0 to 2 hemorrhagic strokes and 2 to 4 major gastrointestinal bleeding events. For patients with a risk of 1% over 5 years, aspirin would prevent 1 to 4 myocardial infarctions but would cause 0 to 2 hemorrhagic strokes and 2 to 4 major gastrointestinal bleeding events. Conclusions: The net benefit of aspirin increases with increasing cardiovascular risk. In the decision to use aspirin chemoprevention, the patient's cardiovascular risk and relative utility for the different clinical outcomes prevented or caused by aspirin use must be considered.	Univ N Carolina, Chapel Hill, NC 27599 USA; USAF, Med Operat Agcy, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA	University of North Carolina; University of North Carolina Chapel Hill; United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio	Hayden, M (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.			Pignone, Michael/0000-0002-6657-7342				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; *AM HEART ASS, 1998, 1999 HEART STROK STA; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; CAPPELLERI JC, 1995, ONLINE J CURR CLIN T, P174; *COCHR COLL, 1999, REV MAN REVMAN; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Dickinson JP, 1998, QJM-INT J MED, V91, P523, DOI 10.1093/qjmed/91.8.523; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hart RG, 2000, ARCH NEUROL-CHICAGO, V57, P326, DOI 10.1001/archneur.57.3.326; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hebert PR, 2000, ARCH INTERN MED, V160, P3123, DOI 10.1001/archinte.160.20.3123; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Hoyert Donna L., 1999, DEATHS FINAL DATA 19; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Kjeldsen SE, 2000, J HYPERTENS, V18, P629, DOI 10.1097/00004872-200018050-00017; MCBRIDE R, 1994, LANCET, V343, P687; Meade TW, 1998, LANCET, V351, P233; Meade TW, 2000, BMJ-BRIT MED J, V321, P13, DOI 10.1136/bmj.321.7252.13; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; RODERICK PJ, 1993, BRIT J CLIN PHARMACO, V35, P219, DOI 10.1111/j.1365-2125.1993.tb05689.x; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; SILAGY CA, 1993, CLIN PHARMACOL THER, V54, P84, DOI 10.1038/clpt.1993.115; STALNIKOWICZDARVASI R, 1995, J CLIN GASTROENTEROL, V21, P13; SUDLOW C, 2001, CLIN EVIDENCE; Thrift AG, 1999, BMJ-BRIT MED J, V318, P759, DOI 10.1136/bmj.318.7186.759; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	34	459	481	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					161	172		10.7326/0003-4819-136-2-200201150-00016	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00016			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790072				2022-12-28	WOS:000173333900011
J	Wodak, A				Wodak, A			For and against - Cannabis control: costs outweigh the benefits - For	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia; Univ Calif Santa Cruz, Dept Sociol, Santa Cruz, CA 95064 USA; Univ Amsterdam, Ctr Drug Res, NL-1091 GM Amsterdam, Netherlands	St Vincents Hospital Sydney; University of California System; University of California Santa Cruz; University of Amsterdam	Wodak, A (corresponding author), St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia.		Drummond, Colin/H-5459-2011					[Anonymous], 1961, SINGL CONV NARC DRUG; CARTER J, 1978, FEDERAL STRATEGY DRU, P66; Departmental Committee on Morphine and Heroin Addiction, 1926, REP; European Monitorning Centre for Drugs and Drug Addiction, 2000, ANN REP STAT DRUGS P; Lenton S, 2000, DRUG ALCOHOL REV, V19, P257, DOI 10.1080/713659365; *NAT COMM MAR DRUG, 1972, MAR SIGN MIS, P150; Reinarman C., 1997, CRACK AM DEMON DRUGS, P345; REINARMAN C, 2000, 11 INT C RED DRUG RE; SINGLE E W, 1989, Journal of Public Health Policy, V10, P456, DOI 10.2307/3342518; Strang J, 2000, BMJ-BRIT MED J, V320, P108, DOI 10.1136/bmj.320.7227.108; TREBACH A, 1989, DRUG POLICY LETT SEP, P5; Wood J. I, 1997, FINAL REPORT ROYAL C	12	34	34	1	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					105	106		10.1136/bmj.324.7329.105	http://dx.doi.org/10.1136/bmj.324.7329.105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786459	Green Published			2022-12-28	WOS:000173325400027
J	Rockman, HA; Koch, WJ; Lefkowitz, RJ				Rockman, HA; Koch, WJ; Lefkowitz, RJ			Seven-transmembrane-spanning receptors and heart function	NATURE			English	Review							BETA-BLOCKER THERAPY; IN-VIVO; BETA(2)-ADRENERGIC RECEPTOR; G-PROTEIN; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; KINASE 1; PHOSPHOINOSITIDE 3-KINASE; DIFFERENTIALLY AFFECT; TRANSGENIC MICE	Understanding precisely how the heart can recognize and respond to many different extracellular signalling molecules, such as neurotransmitters, hormones and growth factors, will aid the identification of new therapeutic targets through which cardiovascular diseases can be combated. In recent years, we have learned more about the complex interactions that occur between the receptors and the signalling pathways of the heart and its environment. Most of these discoveries have focused on the most common type of cardiac receptor - the seven-transmembrane-spanning receptor or G-protein-coupled receptor.	Duke Univ, Med Ctr, Dept Med & Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Rockman, HA (corresponding author), Duke Univ, Med Ctr, Dept Med & Cell Biol, Durham, NC 27710 USA.	h.rockman@duke.edu	Lefkowitz, Robert/AAW-2649-2021					Akhter SA, 1997, P NATL ACAD SCI USA, V94, P12100, DOI 10.1073/pnas.94.22.12100; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; [Anonymous], 1990, Lancet, V336, P1; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bristow MR, 1998, LANCET, V352, P8; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Choukroun G, 1999, J CLIN INVEST, V104, P391, DOI 10.1172/JCI6350; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P6400, DOI 10.1073/pnas.96.11.6400; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; EPSTEIN SE, 1966, ANN INTERN MED, V65, P20, DOI 10.7326/0003-4819-65-1-20; Esposito G, 2002, CIRCULATION, V105, P85, DOI 10.1161/hc0102.101365; Esposito G, 2001, CIRCULATION, V103, P1453, DOI 10.1161/01.CIR.103.10.1453; Esposito G, 2000, AM J PHYSIOL-HEART C, V279, pH3101, DOI 10.1152/ajpheart.2000.279.6.H3101; FELDMAN AM, 1988, J CLIN INVEST, V82, P189, DOI 10.1172/JCI113569; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Hjalmarson A, 1999, LANCET, V353, P2001; Hoffman B.B., 1996, GOODMAN GILMANS PHAR, P199; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lechat P, 1999, LANCET, V353, P9; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LEIMBACH WN, 1986, CIRCULATION, V73, P913, DOI 10.1161/01.CIR.73.5.913; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liggett SB, 2000, CIRCULATION, V101, P1707; Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MacMahon S, 1997, LANCET, V349, P375; Maurice JP, 1999, J CLIN INVEST, V104, P21, DOI 10.1172/JCI6026; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McNamara DM, 2001, CIRCULATION, V103, P1644, DOI 10.1161/01.CIR.103.12.1644; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Podlowski S, 2000, J MOL MED-JMM, V78, P87, DOI 10.1007/s001090000080; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rapacciuolo A, 2001, J AM COLL CARDIOL, V38, P876, DOI 10.1016/S0735-1097(01)01433-4; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rohrer DK, 1998, J MOL MED-JMM, V76, P764, DOI 10.1007/s001090050278; Roth DM, 1999, CIRCULATION, V99, P3099, DOI 10.1161/01.CIR.99.24.3099; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shah AS, 2001, CIRCULATION, V103, P1311; Shah AS, 2000, CIRCULATION, V101, P408, DOI 10.1161/01.CIR.101.4.408; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; Wagoner LE, 2000, CIRC RES, V86, P834, DOI 10.1161/01.RES.86.8.834; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	77	701	738	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					206	212		10.1038/415206a	http://dx.doi.org/10.1038/415206a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805844				2022-12-28	WOS:000173159300050
J	Zoccali, C; Bode-Boger, SM; Mallamaci, F; Benedetto, FA; Tripepi, G; Malatino, LS; Cataliotti, A; Bellanuova, I; Fermo, I; Frolich, JC; Boger, RH				Zoccali, C; Bode-Boger, SM; Mallamaci, F; Benedetto, FA; Tripepi, G; Malatino, LS; Cataliotti, A; Bellanuova, I; Fermo, I; Frolich, JC; Boger, RH			Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study	LANCET			English	Article							NITRIC-OXIDE SYNTHESIS; L-ARGININE; ENDOGENOUS INHIBITOR; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; HEMODIALYSIS; SYNTHASE; IMPROVES; SERUM	Background The plasma concentration of asymmetrical dimethylarginine (ADMA), an inhibitor of nitric-oxide synthase, which has been linked to endothelial dysfunction and atherosclerosis in the general population, is raised in patients with end-stage renal disease and could contribute to the high cardiovascular risk in patients with chronic renal failure. We investigated the relation between cardiovascular risk factors and plasma ADMA concentration in a cohort of haemodialysis patients (n=225), and tested the predictive power of ADMA for mortality and cardiovascular outcomes. Methods Patients had standard dialysis three times a week. We accurately recorded cardiovascular events over a mean follow-up of 33.4 months (SID 14.6); these events were reviewed by a panel of physicians. We identified correlates of plasma ADMA by univariate and multivariate analyses. Findings On univariate analysis, ADMA concentration in plasma was directly related to concentrations of fibrinogen and L-arginine in plasma, duration of dialysis treatment, and serum cholesterol concentration, and was inversely related to serum albumin concentration. On multivariate analysis, only plasma fibrinogen (p=0.0001) and serum albumin (p=0.04) concentrations were independently related to plasma ADMA concentration (multiple r=0.44, p=0.0001). 83 patients died, 53 (64%) by cardiovascular causes. In a Cox's proportional-hazards model, plasma ADMA ranked as the second factor predicting overall mortality (hazard ratio 1.26, 95% CI 1.11-1.41, p=0.0001) and cardiovascular events (1.17, 1.04-1.33, p=0.008). Interpretation In haemodialysis patients, plasma ADMA is a strong and independent predictor of overall mortality and cardiovascular outcome. These findings lend support to the hypothesis that accumulation of ADMA is an important risk factor for cardiovascular disease in chronic renal failure.	Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pahrmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany; Hosp San Raffaele, Lab Cromatog & Tecn Separaz, I-20132 Milan, Italy; Univ Catania, Dept Internal Med, I-95124 Catania, Italy; CNR, Ctr Clin Physiol, Reggio Di Calabria, Italy; CNR, Renal Unit, Reggio Di Calabria, Italy	Hannover Medical School; University of Hamburg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Boger, RH (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	boeger@uke.uni-hamburg.de	Malatino, Lorenzo/I-7319-2018; fermo, isabella/AAN-3999-2020; Zoccali, Carmine/B-9445-2009; Cataliotti, Alessandro/G-7607-2012	Malatino, Lorenzo/0000-0003-2944-2729; fermo, isabella/0000-0003-2947-1933; Cataliotti, Alessandro/0000-0001-5476-8523; Bode-Boger, Stefanie/0000-0002-5132-6591; Zoccali, Carmine/0000-0002-6616-1996				Anderstam B, 1997, J AM SOC NEPHROL, V8, P1437; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Boger RH, 1997, CIRCULATION, V96, P1282, DOI 10.1161/01.CIR.96.4.1282; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Boger RH, 1998, J AM COLL CARDIOL, V32, P1336, DOI 10.1016/S0735-1097(98)00375-1; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; CAYATTE AJ, 1994, ARTERIOSCLER THROMB, V14, P753, DOI 10.1161/01.ATV.14.5.753; COOKE JP, 1992, J CLIN INVEST, V90, P1168, DOI 10.1172/JCI115937; DREXLER H, 1991, LANCET, V338, P1546, DOI 10.1016/0140-6736(91)92372-9; FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522, DOI 10.1152/ajpheart.1995.269.5.H1522; Hand MF, 1998, KIDNEY INT, V53, P1068, DOI 10.1046/j.1523-1755.1998.00851.x; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Kari JA, 1997, KIDNEY INT, V52, P468, DOI 10.1038/ki.1997.354; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; Levey AS, 1998, AM J KIDNEY DIS, V32, pS5, DOI 10.1053/ajkd.1998.v32.pm9820463; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MacAllister RJ, 1996, NEPHROL DIAL TRANSPL, V11, P2449, DOI 10.1093/oxfordjournals.ndt.a027213; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; *NIH, 1997, US REN DAT SYST 1997; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; VALLANCE P, 1992, LANCET, V339, P572; YU XJ, 1994, LIFE SCI, V54, P753, DOI 10.1016/0024-3205(94)00443-9; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P454, DOI 10.1093/ndt/15.4.454; Zoccali C, 1999, J HYPERTENS, V17, P1751, DOI 10.1097/00004872-199917120-00013	29	899	926	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2113	2117		10.1016/S0140-6736(01)07217-8	http://dx.doi.org/10.1016/S0140-6736(01)07217-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784625				2022-12-28	WOS:000172905800009
J	Oh, K; Jeong, KS; Moore, JS				Oh, K; Jeong, KS; Moore, JS			Folding-driven synthesis of oligomers	NATURE			English	Article							VIRTUAL COMBINATORIAL LIBRARIES; MOLECULES; POLYMERS	The biological function of biomacromolecules such as DNA and enzymes depends on their ability to perform and control molecular association, catalysis, self-replication or other chemical processes. In the case of proteins in particular, the dependence of these functions on the three-dimensional protein conformation is long known(1) and has inspired the development of synthetic oligomers and polymers with the capacity to fold in a controlled manner(2-7), but it remains challenging to design these so-called 'foldamers' so that they are capable of inducing or controlling chemical processes and interactions(8,9). Here we show that the stability gained from folding can be used to control the synthesis of oligomers from short chain segments reversibly ligated through an imine metathesis reaction. That is, folding shifts the ligation equilibrium(10-13) in favour of conformationally ordered sequences, so that oligomers having the most stable solution structures form preferentially. Crystallization has previously been used to shift an equilibrium in order to indirectly influence the synthesis of small molecules(14), but the present approach to selectively prepare macromolecules with stable conformations directly connects folding and synthesis, emphasizing molecular function rather than structure in polymer synthesis.	Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Moore, JS (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.			Jeong, Kyu-Sung/0000-0003-1023-1796				Berl V, 2000, NATURE, V407, P720, DOI 10.1038/35037545; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GOODMAN M, 1969, P NATL ACAD SCI USA, V64, P444, DOI 10.1073/pnas.64.2.444; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Huc I, 1997, P NATL ACAD SCI USA, V94, P2106, DOI 10.1073/pnas.94.6.2106; Katz TJ, 2000, ANGEW CHEM INT EDIT, V39, P1921, DOI 10.1002/1521-3773(20000602)39:11<1921::AID-ANIE1921>3.0.CO;2-F; Kirshenbaum K, 1999, CURR OPIN STRUC BIOL, V9, P530, DOI 10.1016/S0959-440X(99)80075-X; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Lehn JM, 1999, CHEM-EUR J, V5, P2455; Mirsky AE, 1936, P NATL ACAD SCI USA, V22, P439, DOI 10.1073/pnas.22.7.439; Moore JS, 2000, ORG LETT, V2, P915, DOI 10.1021/ol0055723; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Nowick JS, 1999, ACCOUNTS CHEM RES, V32, P287, DOI 10.1021/ar970204t; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Prince RB, 1999, J AM CHEM SOC, V121, P3114, DOI 10.1021/ja983995i; Stigers KD, 1999, CURR OPIN CHEM BIOL, V3, P714, DOI 10.1016/S1367-5931(99)00030-7; TOTH G, 1974, TETRAHEDRON LETT, V15, P735; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; WOODWARD RB, 1952, J AM CHEM SOC, V74, P4223, DOI 10.1021/ja01137a001; ZHANG JS, 1994, J AM CHEM SOC, V116, P4227, DOI 10.1021/ja00089a012	20	160	161	0	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					889	893		10.1038/414889a	http://dx.doi.org/10.1038/414889a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780057				2022-12-28	WOS:000172813300040
J	MacInnis, BL; Campenot, RB				MacInnis, BL; Campenot, RB			Retrograde support of neuronal survival without retrograde transport of nerve growth factor	SCIENCE			English	Article							RAT SYMPATHETIC NEURONS; AXONAL-TRANSPORT; TRKA; BINDING; KINASE; SIGNAL; PHOSPHORYLATION; INTERNALIZATION; ENDOCYTOSIS	Application of nerve growth factor (NGF) covalently cross-linked to beads increased the phosphorylation of TrkA and Akt, but not of mitogen-activated protein kinase, in cultured rat sympathetic neurons. NGF beads or iodine-125-labeled NGF beads supplied to distal axons resulted in the survival of over 80% of the neurons for 30 hours, with little or no retrograde transport of iodine-125-labeled NGF; whereas application of free iodine-125-labeled NGF (0.5 nanograms per milliliter) produced 20-fold more retrograde transport, but only 29% of the neurons survived. Thus, in contrast to widely accepted theory, a neuronal survival signal can reach the cell bodies unaccompanied by the NGF that initiated it.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Campenot, RB (corresponding author), Univ Alberta, Dept Cell Biol, 6-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	bob.campenot@ualberta.ca						CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; CAMPENOT RB, 2001, PROTOCOLS NEURAL CEL, P49; CLAUDE P, 1982, J NEUROSCI, V2, P431; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HENDRY IA, 1991, NEUROSCI LETT, V133, P29, DOI 10.1016/0304-3940(91)90049-Y; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; PALMATIER MA, 1984, J NEUROSCI, V4, P751; POPOV S, 1992, J NEUROSCI, V12, P77; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Ure DR, 1997, J NEUROSCI, V17, P1282; URE DR, 1994, DEV BIOL, V162, P339, DOI 10.1006/dbio.1994.1091; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Viahos CJ, 1994, J BIOL CHEM, V269, P5241; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	26	211	214	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1536	1539		10.1126/science.1064913	http://dx.doi.org/10.1126/science.1064913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11799202				2022-12-28	WOS:000173981300057
J	Campbell, EG; Clarridge, BR; Gokhale, NN; Birenbaum, L; Hilgartner, S; Holtzman, NA; Blumenthal, D				Campbell, EG; Clarridge, BR; Gokhale, NN; Birenbaum, L; Hilgartner, S; Holtzman, NA; Blumenthal, D			Data withholding in academic genetics - Evidence from a national survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-SCIENCE; INDUSTRY; FACULTY	Context The free and open sharing of information, data, and materials regarding published research is vital to the replication of published results, the efficient advancement of science, and the education of students. Yet in daily practice, the ideal of free sharing is often breached. Objective To understand the nature, extent, and consequences of data withholding in academic genetics. Design, Setting, and Participants Mailed survey (March-July 2000) of geneticists and other life scientists In the 100 US universities that received the most funding from the National Institutes of Health in 1998. Of a potential 3000 respondents, 2893 were eligible and 1849 responded, yielding an overall response rate of 64%. We analyzed a subsample of 1240 self-identified geneticists and made a limited number of comparisons with 600 self-identified nongeneticists. Main Outcome Measures Percentage of faculty who made requests for data that were denied; percentage of respondents who denied requests; influences on and consequences of withholding data; and changes over time in perceived willingness to share data. Results Forty-seven percent of geneticists who asked other faculty for additional information, data, or materials regarding published research reported that at least I of their requests had been denied In the preceding 3 years. Ten percent of all post-publication requests for additional information were denied. Because they were denied access to data, 28% of geneticists reported that they had been unable to confirm published research. Twelve percent said that in the previous 3 years, they had denied another academician's request for data concerning published results, Among geneticists who said they had Intentionally withheld data regarding their published work, 80% reported that it required too much effort to produce the materials or information; 64%, that they were protecting the ability of a graduate student, post-doctoral fellow, or junior faculty member to publish; and 53%, that they were protecting their own ability to publish. Thirty-five percent of geneticists said that sharing had decreased during the last decade; 14%, that sharing had increased. Geneticists were as likely as other life scientists to deny others' requests (odds ratio [OR], 1.39; 95% confidence interval [CI], 0.81-2.40) and to have their own requests denied (OR, 0.97; 95% CI, 0.69-1.40). However, other life scientists were less likely to report that withholding had a negative impact on their own research as well as their field of research. Conclusions Data withholding occurs in academic genetics and it affects essential scientific activities such as the ability to confirm published results. Lack of resources and issues of scientific priority may play an important role in scientists' decisions to withhold data, materials, and information from other academic geneticists.	Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD USA; Cornell Univ, Dept Sci & Technol Studies, Ithaca, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cornell University	Campbell, EG (corresponding author), Inst Hlth Policy, 50 Staniford St,9th Floor, Boston, MA 02114 USA.				NHGRI NIH HHS [1R01HG01789-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001789] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Blumenthal D, 1997, NAT GENET, V16, P104, DOI 10.1038/ng0597-104; Campbell EG, 1998, JAMA-J AM MED ASSOC, V279, P995, DOI 10.1001/jama.279.13.995; COHEN J, 1995, SCIENCE, V268, P1715, DOI 10.1126/science.7792594; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Dong BJ, 1997, JAMA-J AM MED ASSOC, V277, P1205, DOI 10.1001/jama.277.15.1205; Fowler FJ., 2013, SURV RES METHODS-GER, V5; KING RT, 1996, WALL STREET J   0425, pA1; Knox R, 1997, BOSTON GLOBE    0225, pA1; MARCUS AD, 1999, WALL STREET J   0624, pA1; NAT'L RESEARCH COUNCIL, 1997, INT PROP RIGHTS RES; NIH, 1999, NIH PUBL, V99-4494; *PET GUID, 1999, GRAD PROGR BIOL SCI; POLANYI M, 1962, MINERVA, V1, P54, DOI 10.1007/BF01101453; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P922, DOI 10.1001/jama.277.11.922; Sudman Seymour, 1982, ASKING QUESTIONS PRA; WEINBERG RA, 1993, REFLECTIONS CURRENT, V2	18	293	298	0	30	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					473	480		10.1001/jama.287.4.473	http://dx.doi.org/10.1001/jama.287.4.473			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798369				2022-12-28	WOS:000173401900024
J	Etzel, RA				Etzel, RA			Mycotoxins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEURAL-TUBE DEFECTS; PULMONARY HEMORRHAGE; ERGOTAMINE TARTRATE; MEXICO BORDER; STACHYBOTRYS; FUMONISINS; METABOLISM; AFLATOXIN; OUTBREAK		George Washington Univ, Sch Publ Hlth & Hlth Serv, Div Environm & Occupat Hlth, Washington, DC USA	George Washington University	Etzel, RA (corresponding author), US PHS, Alaska Nat Med Ctr, 4320 Diplomacy Dr, Anchorage, AK 99508 USA.	retzel@earthlink.net	Bulboaca, Adriana-Elena I/S-8093-2017; Etzel, Ruth A./N-5700-2019; Dvorska, Julia/N-4866-2019; Kravchenko, Lidiya V/Q-8486-2017; Fletcher, Mary T./G-9584-2019; Fletcher, Mary T/A-8469-2011; Vandenbosch, Guy A/J-3209-2012	Bulboaca, Adriana-Elena I/0000-0001-7748-382X; Etzel, Ruth A./0000-0002-5236-3976; Kravchenko, Lidiya V/0000-0002-9316-4527; Fletcher, Mary T./0000-0003-0189-3376; Fletcher, Mary T/0000-0003-0189-3376; 				[Anonymous], 2000, ENV HLTH CRITERIA, V219; BANE DP, 1992, MYCOPATHOLOGIA, V117, P121, DOI 10.1007/BF00497288; BARGER G, 1931, ERGOT ERGOTISM; BHAT RV, 1989, LANCET, V1, P35; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; CaballeroGranado FJ, 1997, ANTIMICROB AGENTS CH, V41, P1207, DOI 10.1128/AAC.41.5.1207; CAMPBELL TC, 1983, ENV ASPECTS CANC ROL, P187; *CDC, 2001, PULM HEM HEM INF; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P210; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P180; CREASIA DA, 1998, TRICHOTHECENE MYCOTO, P161; Drobotko V. G., 1945, AMER REV SOVIET MED, V2, P238; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elidemir O, 1999, PEDIATRICS, V104, P964, DOI 10.1542/peds.104.4.964; Etzel R, 2000, EPIDEMIOLOGY, V11, pS158; Etzel RA, 1998, ARCH PEDIAT ADOL MED, V152, P757; ETZEL RA, 2002, INVESTIGATOR TEAMS R; FDA (U.S. Food and Drug Administration), 2000, GUID IND FUM LEV HUM; Flappan SM, 1999, ENVIRON HEALTH PERSP, V107, P927, DOI 10.2307/3454483; FORGACS J, 1972, MICROBIAL TOXINS, V3; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Hendricks K, 1999, EPIDEMIOLOGY, V10, P198, DOI 10.1097/00001648-199903000-00022; Hendricks KA, 1999, AM J EPIDEMIOL, V149, P1119; HENDRY KM, 1993, J TOXICOL ENV HEALTH, V38, P183, DOI 10.1080/15287399309531711; Jackson PE, 1999, BEST PRACT RES CL GA, V13, P545, DOI 10.1053/bega.1999.0047; JAFFE AZ, 1983, HDB FOODBORNE DIS BI, P351; Joffe A. Z, 1986, FUSARIUM SPECIES THE; KRISHNAMACHARI KAVR, 1975, LANCET, V1, P1061; LEWIS WH, 1977, MED BOTANY, P416; Luo X.Y., 1988, TOXICOLOGY FORUM CHI, P56; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; Pitt JI, 2000, BRIT MED BULL, V56, P184, DOI 10.1258/0007142001902888; Rosenthal E, 1999, JAMA-J AM MED ASSOC, V281, P987, DOI 10.1001/jama.281.11.987; Ross P F, 1991, J Vet Diagn Invest, V3, P238; ROSS PF, 1990, APPL ENVIRON MICROB, V56, P3225, DOI 10.1128/AEM.56.10.3225-3226.1990; Smith John E., 1995, Natural Toxins, V3, P187, DOI 10.1002/nt.2620030404; Stevens VL, 1997, J BIOL CHEM, V272, P18020, DOI 10.1074/jbc.272.29.18020; Suarez L, 2000, AM J EPIDEMIOL, V152, P1017, DOI 10.1093/aje/152.11.1017; VANRENSBURG SJ, 1977, MYCOTOXINS HUMAN ANI, P699; Wang JS, 1999, JNCI-J NATL CANCER I, V91, P347, DOI 10.1093/jnci/91.4.347; WOGAN GN, 1967, CANCER RES, V27, P2370	42	84	87	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					425	427		10.1001/jama.287.4.425	http://dx.doi.org/10.1001/jama.287.4.425			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798344				2022-12-28	WOS:000173401900002
J	McPhee, SJ				McPhee, SJ			Caring for a 70-year-old Vietnamese woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CROSS-CULTURAL ISSUES; PRIMARY-CARE; HEALTH-CARE; HEPATITIS-B; DEPRESSIVE SYMPTOMS; SCREENING PRACTICES; CANCER PREVENTION; AMERICAN WOMEN; BREAST-CANCER; LANGUAGE		Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Vietnamese Community Hlth Promot Project, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	McPhee, SJ (corresponding author), 400 Parnassus Ave,A-405, San Francisco, CA 94143 USA.	smcphee@medicine.ucsf.edu						Baker DW, 1996, JAMA-J AM MED ASSOC, V275, P783, DOI 10.1001/jama.275.10.783; Barnes DM, 1998, NURS ETHICS, V5, P412; Bird JA, 1998, PREV MED, V27, P821, DOI 10.1006/pmed.1998.0365; BOUVIER LF, 1987, NEW IMMIGRATION ASIA, P285; BOUVIER LF, 1985, POPULATION CHANGE CA; BUCHWALD D, 1995, WESTERN J MED, V163, P341; BUCHWALD D, 1993, J GEN INTERN MED, V8, P76, DOI 10.1007/BF02599987; CANALES S, 1995, QUAL LIFE RES, V4, P3, DOI 10.1007/BF00434377; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P69; Chachkes E, 1996, PATIENT EDUC COUNS, V27, P13, DOI 10.1016/0738-3991(95)00785-7; Cheek J, 1999, AUST NZ J PUBL HEAL, V23, P72, DOI 10.1111/j.1467-842X.1999.tb01208.x; Chen MS, 1998, CANCER, V83, P1856, DOI 10.1002/(SICI)1097-0142(19981015)83:8+<1856::AID-CNCR38>3.3.CO;2-S; David RA, 1998, MT SINAI J MED, V65, P393; Del Mar C, 1998, AUST NZ J PUBL HEAL, V22, P824; DIEHL AK, 1993, AM J MED SCI, V305, P383, DOI 10.1097/00000441-199306000-00005; Evans CA, 1996, GERIATR NURS, V17, P105, DOI 10.1016/S0197-4572(96)80090-5; FOX SA, 1991, MED CARE, V29, P1065, DOI 10.1097/00005650-199111000-00001; Frisbie WP, 2001, AM J EPIDEMIOL, V153, P372, DOI 10.1093/aje/153.4.372; GAVIRIA M, 1982, J NATL MED ASSOC, V74, P983; GINSBERG C, 1995, INTERPRETATION TRANS; GOLD SJ, 1992, WESTERN J MED, V157, P290; Grizzell S, 1980, Mich Med, V79, P624; GUNBY P, 1995, JAMA-J AM MED ASSOC, V274, P1002, DOI 10.1001/jama.274.13.1002; Hiatt RA, 1996, BREAST CANCER RES TR, V40, P37, DOI 10.1007/BF01806001; Hinton L, 1998, J NERV MENT DIS, V186, P677, DOI 10.1097/00005053-199811000-00003; HINTON WL, 1994, J GEN INTERN MED, V9, P202, DOI 10.1007/BF02600124; HOANG GN, 1985, ANNU REV MED, V36, P229; Jackson JC, 1997, J GEN INTERN MED, V12, P292, DOI 10.1046/j.1525-1497.1997.012005292.x; Jenkins Christopher N.H., 1998, Asian Am Pac Isl J Health, V6, P216; Jenkins CNH, 1999, PREV MED, V28, P395, DOI 10.1006/pmed.1998.0444; JENKINS CNH, 1990, WESTERN J MED, V153, P34; Jenkins CNH, 1997, AM J PUBLIC HEALTH, V87, P1031, DOI 10.2105/AJPH.87.6.1031; Jenkins CNH, 1996, SOC SCI MED, V43, P1049, DOI 10.1016/0277-9536(95)00368-1; Jenkins CNH, 2001, CANCER, V91, P252, DOI 10.1002/1097-0142(20010101)91:1+<252::AID-CNCR14>3.0.CO;2-Y; JENKINS CNH, 2000, AM PUBL HLTH ASS NAT; Kagawa-Singer M, 2000, CANCER, V89, P696, DOI 10.1002/1097-0142(20000801)89:3<696::AID-CNCR27>3.0.CO;2-7; Kagawa-Singer M, 1997, Oncol Nurs Forum, V24, P1705; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; KUO J, 1998, ADV DATA, V298, P1; Lai KQ, 2000, TOB CONTROL, V9, P56; LAI KQ, 1995, AM PUBL HLTH ASS NAT; LAM T, 2001, AM PUBL HLTH ASS NAT; LAUNER J, 1978, BRIT MED J, V2, P934, DOI 10.1136/bmj.2.6142.934; Lesjak M, 1999, AUST NZ J PUBL HEAL, V23, P168, DOI 10.1111/j.1467-842X.1999.tb01229.x; LEVINSON JM, 1974, AM J CHINESE MED, V2, P159, DOI 10.1142/S0192415X74000201; MANSON A, 1988, MED CARE, V26, P1119, DOI 10.1097/00005650-198812000-00003; MARCOS LR, 1979, AM J PSYCHIAT, V136, P171; McLeod R P, 1996, Adv Pract Nurs Q, V2, P10; McPhee SJ, 1997, CANCER DETECT PREV, V21, P510; McPhee SJ, 1997, AM J PREV MED, V13, P205, DOI 10.1016/S0749-3797(18)30195-8; MCPHEE SJ, 1996, HLTH ED Q S4, V23, pS59; MCPHEE SJ, 2000, ASIAN AM PACIFIC ISL, V8, P19; MCPHEE SJ, 1995, TOBACCO CONTROL S1, V4, pS16; McPhee Stephen J., 1998, Asian Am Pac Isl J Health, V6, P344; MILLER BA, 1996, NAT CANC I PUBLICATI; Mitchell JL, 1998, CANCER PRACT, V6, P153, DOI 10.1046/j.1523-5394.1998.006003153.x; MUECKE MA, 1983, AM J PUBLIC HEALTH, V73, P431, DOI 10.2105/AJPH.73.4.431; MUECKE MA, 1983, WESTERN J MED, V139, P835; NGUYEN ATQ, 1993, AM PUBL HLTH ASS ANN; Nguyen BH, 2000, J CANCER EDUC, V15, P82; NGUYEN MD, 1985, WESTERN J MED, V142, P409; Nguyen T, 2001, CANCER, V91, P267, DOI 10.1002/1097-0142(20010101)91:1+<267::AID-CNCR17>3.0.CO;2-9; Office of Minority Health, 2000, FED REGISTER, V65, P80865; Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005; Perez-Stable EJ, 2000, AM J MED, V108, P509, DOI 10.1016/S0002-9343(00)00317-X; Pham C T, 1992, J Cancer Educ, V7, P305; Phipps E, 1999, Health Care Women Int, V20, P195; Rivadeneyra R, 2000, AM J MED, V108, P470, DOI 10.1016/S0002-9343(99)00445-3; Rothschild SK, 1998, DM-DIS MON, V44, P293, DOI 10.1016/S0011-5029(98)90010-4; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Shapiro J, 1999, J COMMUN HEALTH, V24, P95, DOI 10.1023/A:1018702323648; Shapiro J, 1996, Fam Med, V28, P249; SOLIS JM, 1990, AM J PUBLIC HEALTH, V80, P11, DOI 10.2105/AJPH.80.Suppl.11; Stolk Y, 1998, AUST NZ J PSYCHIAT, V32, P434, DOI 10.3109/00048679809065538; STRAND PJ, 1983, MED CARE, V21, P1089, DOI 10.1097/00005650-198311000-00005; Taylor VM, 2000, J CANCER EDUC, V15, P51; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; WATT IS, 1993, J PUBLIC HEALTH MED, V15, P129; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Woloshin S, 1997, J GEN INTERN MED, V12, P472, DOI 10.1046/j.1525-1497.1997.00085.x; WOLOSHIN S, 1995, JAMA-J AM MED ASSOC, V273, P724, DOI 10.1001/jama.273.9.724; Yi J K, 1994, J Community Health, V19, P189, DOI 10.1007/BF02260379; Yi J. K., 1994, J WOMENS HEALTH, V3, P205; Yi JK, 1998, CANCER NURS, V21, P335, DOI 10.1097/00002820-199810000-00004; 1998, QUAL LETT HEALTHCARE, V10, P8	86	21	21	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					495	504		10.1001/jama.287.4.495	http://dx.doi.org/10.1001/jama.287.4.495			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	513VX	11798372				2022-12-28	WOS:000173401900027
J	Santiago, ML; Rodenburg, CM; Kamenya, S; Bibollet-Ruche, F; Gao, F; Bailes, E; Meleth, S; Soong, SJ; Kilby, JM; Moldoveanu, Z; Fahey, B; Muller, MN; Ayouba, A; Nerrienet, E; McClure, HM; Heeney, JL; Pusey, AE; Collins, DA; Boesch, C; Wrangham, RW; Goodall, J; Sharp, PM; Shaw, GM; Hahn, BH				Santiago, ML; Rodenburg, CM; Kamenya, S; Bibollet-Ruche, F; Gao, F; Bailes, E; Meleth, S; Soong, SJ; Kilby, JM; Moldoveanu, Z; Fahey, B; Muller, MN; Ayouba, A; Nerrienet, E; McClure, HM; Heeney, JL; Pusey, AE; Collins, DA; Boesch, C; Wrangham, RW; Goodall, J; Sharp, PM; Shaw, GM; Hahn, BH			SIVcpz in wild chimpanzees	SCIENCE			English	Article							VIRUS		Univ Alabama, Birmingham, AL 35294 USA; Gombe Stream Res Ctr, Kigoma, Tanzania; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Nottingham, Nottingham NG7 2UH, England; Harvard Univ, Cambridge, MA 02138 USA; Ctr Pasteur Cameroun, Yaounde, Cameroon; Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Rijswijk ZH, Primate Res Ctr, NL-2288 GJ Rijswijk, Netherlands; Univ Minnesota, St Paul, MN 55108 USA; Max Planck Inst, D-04301 Leipzig, Germany; Jane Goodall Inst, Silver Spring, MD 20911 USA	University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Nottingham; Harvard University; Centre Pasteur du Cameroun; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society	Hahn, BH (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.		Ayouba, Ahidjo/G-8775-2017; Sharp, Paul/Y-3787-2019; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010	Ayouba, Ahidjo/0000-0002-5081-1632; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887; Kilby, J. Michael/0000-0003-3222-1003; Heeney, Jonathan/0000-0003-2702-1621; Santiago, Mario L./0000-0001-7792-2706; Pusey, Anne/0000-0002-2280-8954				Butynski Thomas M., 2001, P3; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Teleki G., 1989, P312; VandenHaesevelde MM, 1996, VIROLOGY, V221, P346, DOI 10.1006/viro.1996.0384	6	161	165	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					465	465		10.1126/science.295.5554.465	http://dx.doi.org/10.1126/science.295.5554.465			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799233				2022-12-28	WOS:000173350700039
J	Wigzell, H				Wigzell, H			Science in Europe - Framework programmes evolve	SCIENCE			English	Editorial Material									Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Wigzell, H (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.								0	7	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					443	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799224				2022-12-28	WOS:000173350700028
J	Inzucchi, SE				Inzucchi, SE			Oral antihyperglycemic therapy for type 2 diabetes - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMPROVES GLYCEMIC CONTROL; PLACEBO-CONTROLLED TRIAL; ARTERIAL-WALL THICKNESS; CORONARY-HEART-DISEASE; DOUBLE-BLIND; INSULIN-RESISTANCE; COMBINATION THERAPY; PIOGLITAZONE HYDROCHLORIDE; TROGLITAZONE MONOTHERAPY; METABOLIC ABNORMALITIES	Context Care of patients with type 2 diabetes has been revolutionized throughout the past several years-first, by the realization of the importance of tight glycemic control in forestalling complications, and second, by the availability of several unique classes of oral antidiabetic agents. Deciphering which agent to use in certain clinical situations is a new dilemma facing the primary care physician. Objective To systematically review available data from the literature regarding the efficacy of oral antidiabetic agents, both as monotherapy and in combination. Data Sources A MEDLINE search was performed to identify ail English-language reports of unique, randomized controlled clinical trials involving recently available oral agents for type 2 diabetes. Bibliographies were also reviewed to find additional reports not otherwise identified. Study Selection and Data Extraction Studies (63) were included in the analysis if they had a study period of at least 3 months; if each group contained at least 10 subjects at the study's conclusion and if hemoglobin A(1c) was reported. When multiple dosages of a drug were tested, the results of the highest approved dosage were used. In placebo-controlled trials, hemoglobin A(1c) data are presented as the difference between the change in treated vs placebo subjects. Data Synthesis Five distinct oral drug classes are now available for the treatment of type 2 diabetes. Compared with placebo treatment, most of these agents lower hemoglobin A(1c) levels approximately 1% to 2%. Equivalent efficacy is usually demonstrated when different agents are compared with one another in the same study population. When they are used in combination, there are additional glycemic benefits. Long-term vascular risk reduction has been demonstrated only with sulfonylureas and metformin. Conclusions With few exceptions, the available oral antidiabetic agents are equally effective at lowering glucose concentrations. Their mechanisms of action are different, however, and as a result they appear to have distinct metabolic effects. These are reflected in their adverse effect profiles and their effect on cardiovascular risk, which may influence drug choice.	Yale Univ, Sch Med, Endocrinol Sect, TMP 534,Box 208020, New Haven, CT 06520 USA	Yale University	Inzucchi, SE (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, TMP 534,Box 208020, New Haven, CT 06520 USA.	silvio.inzucchi@yale.edu	Inzucchi, Silvio/ABF-4121-2021					*AM DIAB ASS, 1997, DIABETES CARE, V20, P106; *AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Axelsen M, 1999, ANN INTERN MED, V131, P27, DOI 10.7326/0003-4819-131-1-199907060-00006; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Bando Y, 1999, J INT MED RES, V27, P53, DOI 10.1177/030006059902700201; Bergeron DR, 1999, TRANSGENICS, V3, P71; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; BIRKELAND KI, 1994, DIABETES CARE, V17, P45, DOI 10.2337/diacare.17.1.45; Braun D, 1996, ENDOCRINOL METAB, V3, P275; Buchanan TA, 2000, DIABETES, V49, P782, DOI 10.2337/diabetes.49.5.782; Buse John, 2000, American Journal of Medicine, V108, p23S; Buysschaert M, 1999, DIABETIC MED, V16, P147, DOI 10.1046/j.1464-5491.1999.00029.x; Campbell IW, 2000, DRUGS, V60, P1017, DOI 10.2165/00003495-200060050-00004; CAMPBELL IW, 1994, DIABETES METAB, V20, P394; CARLSON RF, 1993, CLIN THER, V15, P788; Cavaghan MK, 1997, J CLIN INVEST, V100, P530, DOI 10.1172/JCI119562; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; CHIASSON JL, 1994, ANN INTERN MED, V121, P928, DOI 10.7326/0003-4819-121-12-199412150-00004; CLARKE BF, 1977, BRIT MED J, V2, P1576, DOI 10.1136/bmj.2.6102.1576; COHEN KL, 1987, DIABETES CARE, V10, P555, DOI 10.2337/diacare.10.5.555; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; CONIFF RF, 1994, ARCH INTERN MED, V154, P2442; CONIFF RF, 1995, DIABETES CARE, V18, P817, DOI 10.2337/diacare.18.6.817; CONIFF RF, 1995, AM J MED, V98, P443, DOI 10.1016/S0002-9343(99)80343-X; Costa B, 1997, DIABETES RES CLIN PR, V38, P33, DOI 10.1016/S0168-8227(97)00083-1; Cusi K, 1998, DIABETES REV, V6, P89; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Dills DG, 1996, HORM METAB RES, V28, P426, DOI 10.1055/s-2007-979831; DOAR JWH, 1976, BRIT MED J, V1, P498, DOI 10.1136/bmj.1.6008.498; DONAHUE RP, 1987, DIABETES, V36, P689, DOI 10.2337/diabetes.36.6.689; DORNAN TL, 1991, DIABETES CARE, V14, P342, DOI 10.2337/diacare.14.4.342; Einhorn D, 2000, CLIN THER, V22, P1395, DOI 10.1016/S0149-2918(00)83039-8; Erle G, 1999, ACTA DIABETOL, V36, P61, DOI 10.1007/s005920050146; Fagan Timothy C., 1998, American Journal of Medicine, V105, p77S, DOI 10.1016/S0002-9343(98)00216-2; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Fischer S, 1998, ACTA DIABETOL, V35, P34, DOI 10.1007/s005920050098; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Fonseca VA, 1998, J CLIN ENDOCR METAB, V83, P3169, DOI 10.1210/jc.83.9.3169; Fontbonne A, 1996, DIABETES CARE, V19, P920, DOI 10.2337/diacare.19.9.920; Frias JP, 2000, DIABETES CARE, V23, P64, DOI 10.2337/diacare.23.1.64; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Garratt KN, 1999, J AM COLL CARDIOL, V33, P119, DOI 10.1016/S0735-1097(98)00557-9; Gegick C G, 2001, Endocr Pract, V7, P162; Ginsberg H, 1999, J CARDIOVASC RISK, V6, P337; Goke B, 1998, DIABETES METAB REV, V14, pS31, DOI 10.1002/(SICI)1099-0895(199809)14:1+<S31::AID-DMR226>3.3.CO;2-V; Goldberg RB, 1998, DIABETES CARE, V21, P1897, DOI 10.2337/diacare.21.11.1897; GOLDNER MG, 1971, J AMER MED ASSOC, V218, P1400, DOI 10.1001/jama.218.9.1400; Grant PJ, 1996, DIABETES CARE, V19, P64, DOI 10.2337/diacare.19.1.64; HANEFELD M, 1991, DIABETES CARE, V14, P732, DOI 10.2337/diacare.14.8.732; Hanefeld M, 2000, DIABETES CARE, V23, P202, DOI 10.2337/diacare.23.2.202; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Hasche H, 1999, DIABETES NUTR METAB, V12, P277; Henry Robert R., 1998, American Journal of Medicine, V105, p20S, DOI 10.1016/S0002-9343(98)00207-1; Herman WH, 1998, DIABETES CARE, V21, pC19, DOI 10.2337/diacare.21.3.C19; HERMANN LS, 1994, DIABETES CARE, V17, P1100, DOI 10.2337/diacare.17.10.1100; Hirschberg Y, 2000, DIABETES CARE, V23, P349, DOI 10.2337/diacare.23.3.349; Hoffmann J, 1997, AM J MED, V103, P483, DOI 10.1016/S0002-9343(97)00252-0; HOFFMANN J, 1994, DIABETES CARE, V17, P561, DOI 10.2337/diacare.17.6.561; Holman RR, 1999, DIABETES CARE, V22, P960, DOI 10.2337/diacare.22.6.960; Horton ES, 1998, DIABETES CARE, V21, P1462, DOI 10.2337/diacare.21.9.1462; Horton ES, 2000, DIABETES CARE, V23, P1660, DOI 10.2337/diacare.23.11.1660; HOTTA N, 1993, DIABETIC MED, V10, P134, DOI 10.1111/j.1464-5491.1993.tb00030.x; Hsueh WA, 2001, DIABETES CARE, V24, P392, DOI 10.2337/diacare.24.2.392; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Imano E, 1998, DIABETES CARE, V21, P2135, DOI 10.2337/diacare.21.12.2135; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Ishikawa M, 1998, DIABETES, V47, P788, DOI 10.2337/diabetes.47.5.788; Iwamoto Y, 1996, DIABETIC MED, V13, P365, DOI 10.1002/(SICI)1096-9136(199604)13:4<365::AID-DIA19>3.0.CO;2-M; Johansen K, 1999, DIABETES CARE, V22, P33, DOI 10.2337/diacare.22.1.33; Johnston PS, 1998, DIABETES CARE, V21, P416, DOI 10.2337/diacare.21.3.416; JOHNSTON PS, 1994, DIABETES CARE, V17, P20, DOI 10.2337/diacare.17.1.20; Jovanovic L, 2000, J CLIN PHARMACOL, V40, P49, DOI 10.1177/00912700022008694; Kahn SE, 2001, J NUTR, V131, p354S, DOI 10.1093/jn/131.2.354S; Keilson L, 2000, J CLIN ENDOCR METAB, V85, P1081, DOI 10.1210/jc.85.3.1081; Kelly IE, 1999, DIABETES CARE, V22, P288, DOI 10.2337/diacare.22.2.288; KILO C, 1980, DIABETOLOGIA, V18, P179, DOI 10.1007/BF00251913; KILO C, 1992, CLIN THER, V14, P801; Kirk JK, 1999, J FAM PRACTICE, V48, P879; Kitabchi AE, 2000, AM J MED SCI, V319, P143, DOI 10.1097/00000441-200003000-00003; Klepzig H, 1999, EUR HEART J, V20, P439, DOI 10.1053/euhj.1998.1242; KOLATA GB, 1979, SCIENCE, V203, P1094, DOI 10.1126/science.424735; Kolterman O G, 1983, Am J Med, V74, P82, DOI 10.1016/0002-9343(83)90655-1; Koshiyama H, 2001, J CLIN ENDOCR METAB, V86, P3452, DOI 10.1210/jc.86.7.3452; Kotchen TA, 1996, AM J PHYSIOL-REG I, V270, pR660, DOI 10.1152/ajpregu.1996.270.3.R660; Kruszynska YT, 2000, DIABETES, V49, P633, DOI 10.2337/diabetes.49.4.633; Kumar S, 1996, DIABETOLOGIA, V39, P701; Kuzuya T, 1998, DIABETES RES CLIN PR, V41, P121, DOI 10.1016/S0168-8227(98)00069-2; Landgraf R, 1999, EUR J CLIN PHARMACOL, V55, P165, DOI 10.1007/s002280050613; Lebovitz HE, 1998, DIABETES REV, V6, P132; Lebovitz HE, 2001, J CLIN ENDOCR METAB, V86, P280, DOI 10.1210/jc.86.1.280; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lindeman RD, 1998, DIABETES CARE, V21, P959, DOI 10.2337/diacare.21.6.959; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; Marbury T, 1999, DIABETES RES CLIN PR, V43, P155, DOI 10.1016/S0168-8227(99)00002-9; Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9; Minamikawa J, 1998, J CLIN ENDOCR METAB, V83, P1818, DOI 10.1210/jc.83.5.1818; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Moses R, 1999, DIABETES CARE, V22, P119, DOI 10.2337/diacare.22.1.119; Mudaliar S, 2001, ANNU REV MED, V52, P239, DOI 10.1146/annurev.med.52.1.239; Murphy EJ, 2000, DIGEST DIS SCI, V45, P549, DOI 10.1023/A:1005405526283; NAGI DK, 1993, DIABETES CARE, V16, P621, DOI 10.2337/diacare.16.4.621; Nattrass M, 2000, INT J OBESITY, V24, pS21, DOI 10.1038/sj.ijo.0801422; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; Perfetti R, 2000, TRENDS ENDOCRIN MET, V11, P218, DOI 10.1016/S1043-2760(00)00269-1; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Petersen KF, 2000, DIABETES, V49, P827, DOI 10.2337/diabetes.49.5.827; Phillips LS, 2001, DIABETES CARE, V24, P308, DOI 10.2337/diacare.24.2.308; Pigon J, 1996, J CLIN ENDOCR METAB, V81, P3702, DOI 10.1210/jc.81.10.3702; RANDLE PJ, 1963, LANCET, V1, P785; Raskin P, 2000, DIABETES CARE, V23, P979, DOI 10.2337/diacare.23.7.979; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; ROSENSTOCK J, 1993, CLIN THER, V15, P1031; Rosenstock J, 1996, DIABETES CARE, V19, P1194, DOI 10.2337/diacare.19.11.1194; Rosenstock J, 1998, DIABETES CARE, V21, P2050, DOI 10.2337/diacare.21.12.2050; SANTEUSANIO F, 1993, DIABETES NUTR METAB, V6, P147; Schade DS, 1998, J CLIN PHARMACOL, V38, P636, DOI 10.1002/j.1552-4604.1998.tb04471.x; Scorpiglione N, 1999, EUR J CLIN PHARMACOL, V55, P239, DOI 10.1007/s002280050623; Scott R, 1999, DIABETES RES CLIN PR, V43, P179, DOI 10.1016/S0168-8227(99)00009-1; Segal P, 1997, DIABETES CARE, V20, P687, DOI 10.2337/diacare.20.5.687; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Simonson DC, 1997, DIABETES CARE, V20, P597, DOI 10.2337/diacare.20.4.597; SIMONSON DC, 1984, DIABETES, V33, P838, DOI 10.2337/diabetes.33.9.838; Standl E, 2001, DIABETES RES CLIN PR, V51, P205, DOI 10.1016/S0168-8227(00)00231-X; STENMAN S, 1993, ANN INTERN MED, V118, P169, DOI 10.7326/0003-4819-118-3-199302010-00002; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Stern M, 1999, DIABETES CARE, V22, pC2; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Sunayama S, 1999, ATHEROSCLEROSIS, V146, P187, DOI 10.1016/S0021-9150(99)00138-0; Sung BH, 1999, HYPERTENSION, V34, P83, DOI 10.1161/01.HYP.34.1.83; Tack CJJ, 1998, DIABETES CARE, V21, P796, DOI 10.2337/diacare.21.5.796; Takagi T, 2000, J AM COLL CARDIOL, V36, P1529, DOI 10.1016/S0735-1097(00)00895-0; Tessier D, 1999, METABOLISM, V48, P897, DOI 10.1016/S0026-0495(99)90226-3; TINKER LF, 1994, J AM DIET ASSOC, V94, P507, DOI 10.1016/0002-8223(94)90212-7; Turner RC, 1998, DIABETES CARE, V21, pC35, DOI 10.2337/diacare.21.3.C35; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2000, DIABETES, V49, P2094, DOI 10.2337/diabetes.49.12.2094; Willms B, 1999, DIABETIC MED, V16, P755, DOI 10.1046/j.1464-5491.1999.00149.x; Wolffenbuttel BHR, 1999, DIABETES CARE, V22, P463, DOI 10.2337/diacare.22.3.463; Wolffenbuttel BHR, 2000, DIABETIC MED, V17, P40, DOI 10.1046/j.1464-5491.2000.00224.x; Yale JF, 2001, ANN INTERN MED, V134, P737, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00010; YkiJarvinen H, 1997, DIABETIC MED, V14, pS32, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S32::AID-DIA442>3.3.CO;2-Y; Yu JG, 1999, DIABETES, V48, P2414, DOI 10.2337/diabetes.48.12.2414; Zimmerman BR, 1997, ENDOCRIN METAB CLIN, V26, P511, DOI 10.1016/S0889-8529(05)70264-4; IN PRESS ENDOCR PRAC	152	785	851	2	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					360	372		10.1001/jama.287.3.360	http://dx.doi.org/10.1001/jama.287.3.360			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790216	Bronze			2022-12-28	WOS:000173294700031
J	Greenfield, S; Kaplan, SH; Kahn, R; Ninomiya, J; Griffith, JL				Greenfield, S; Kaplan, SH; Kahn, R; Ninomiya, J; Griffith, JL			Profiling care provided by different groups of physicians: Effects of patient case-mix (bias) and physician-level clustering on quality assessment results	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; GLYCEMIC CONTROL; OF-CARE; RANDOMIZATION TRIALS; MEDICAL OUTCOMES; ELDERLY-PATIENTS; SPECIALTY; DISEASE; COSTS	Background: Patient characteristics (case-mix bias) and physician-level variation (clustering) are often overlooked in profiling the quality of care provided by different groups of physicians, such as specialties. Objective: To examine the effect of case-mix bias and physician-level clustering on differences in quality of diabetes care between specialty groups participating in the American Diabetes Association's Provider Recognition Program. Design: Retrospective record review of both process and outcome measures over 1 year and a cross-sectional patient survey. The sample included 29 solo and group practice sites in diverse regions of the United States. Of the 29 sites, 15 were, endocrinology sites and 14 were primary care sites. Patients: 1750 adults with diabetes. Measurements: Process measures included frequency of hemoglobin A,, lipid, and urine protein testing; blood pressure measurement; and foot and eye examinations. Outcome measures included A,c level, blood pressure, lipid levels, and patient satisfaction. Patient case-mix variables included age, sex, health status, level of education, ethnic minority status, and duration of diabetes. Results: Unadjusted differences between endocrinologists and generalists were statistically significant for most process and outcome measures. Inclusion of patient case-mix variables reduced the statistical significance of specialty differences for some quality measures. After accounting for the substantial physician-level clustering, observed differences between specialties were no longer statistically significant for any of the quality measures except patient satisfaction. Conclusions: The findings underscore the: importance of designing physician profiling studies with sufficient power to account for physician-level variation (clustering) as well as patient case-mix. Studies that are not designed with both sufficient numbers of physicians and patients per physician may distort differences in quality of care between physician groups.	Tufts Univ, Sch Med, Primary Care Outcomes Res Inst, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Amer Diabet Assoc Natl Off, Alexandria, VA USA; Univ Calif San Diego, San Diego, CA 92103 USA	Tufts University; Tufts Medical Center; American Diabetes Association; University of California System; University of California San Diego	Greenfield, S (corresponding author), Tufts Univ, Sch Med, Primary Care Outcomes Res Inst, M&V 1,136 Harrison Ave, Boston, MA 02111 USA.	sheldon.greenfield@tufts.edu		Kaplan, Sherrie/0000-0002-8644-5849; Greenfield, Sheldon/0000-0003-4628-1998				Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Campbell M, 2000, J Health Serv Res Policy, V5, P12; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; CARR GJ, 1993, BIOMETRICS, V49, P779, DOI 10.2307/2532199; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; DIVINE GW, 1992, J GEN INTERN MED, V7, P623, DOI 10.1007/BF02599201; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Donner A, 1998, J R STAT SOC C-APPL, V47, P95, DOI 10.1111/1467-9876.00100; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; GATSONIS CA, 1995, MED CARE, V33, P625, DOI 10.1097/00005650-199506000-00005; GOLDSTEIN H, 1999, J R STAT SOC A GEN, V159, P385; GREENFIELD S, 1994, DIABETES CARE, V17, P32; GREENFIELD S, 1995, JAMA-J AM MED ASSOC, V274, P1436; GREENFIELD S, 1995, MED CARE, V33, pAS47; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Ho M, 1997, DIABETES CARE, V20, P472, DOI 10.2337/diacare.20.4.472; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; LLOYD CE, 1993, DIABETES RES CLIN PR, V21, P187, DOI 10.1016/0168-8227(93)90068-G; MCNEIL BJ, 1992, INQUIRY-J HEALTH CAR, V29, P298; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Murray DM, 1997, ADDICT BEHAV, V22, P1, DOI 10.1016/0306-4603(95)00099-2; Nathan DM, 1996, AM J MED, V100, P157, DOI 10.1016/S0002-9343(97)89453-3; NATHAN DM, 1986, DIABETES, V35, P797, DOI 10.2337/diabetes.35.7.797; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Poses RM, 2000, ANN INTERN MED, V133, P10, DOI 10.7326/0003-4819-133-1-200007040-00003; PRINGLE M, 1993, BRIT MED J, V306, P630, DOI 10.1136/bmj.306.6878.630; Reilly M, 1997, STAT MED, V16, P5, DOI 10.1002/(SICI)1097-0258(19970115)16:1<5::AID-SIM469>3.0.CO;2-8; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; *SAS I, 2000, STAT AN SYST VERS 8; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; SIMPSON JM, 1995, AM J PUBLIC HEALTH, V85, P1378, DOI 10.2105/AJPH.85.10.1378; Solomon DH, 2000, MED CARE, V38, P383, DOI 10.1097/00005650-200004000-00005; STIRATELLI R, 1984, BIOMETRICS, V40, P961, DOI 10.2307/2531147; Streja DA, 1999, ARCH INTERN MED, V159, P294, DOI 10.1001/archinte.159.3.294; Wagner E H, 1996, Manag Care Q, V4, P12; WINKLEBY MA, 1990, PREV MED, V19, P1, DOI 10.1016/0091-7435(90)90001-Z; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002	48	191	191	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					111	121		10.7326/0003-4819-136-2-200201150-00008	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512PZ	11790062				2022-12-28	WOS:000173333900003
J	Finotto, S; Neurath, MF; Glickman, JN; Qin, SX; Lehr, HA; Green, FHY; Ackerman, K; Haley, K; Gatte, PR; Szabo, SJ; Drazen, JM; De Sanctis, GT; Glimcher, LH				Finotto, S; Neurath, MF; Glickman, JN; Qin, SX; Lehr, HA; Green, FHY; Ackerman, K; Haley, K; Gatte, PR; Szabo, SJ; Drazen, JM; De Sanctis, GT; Glimcher, LH			Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet	SCIENCE			English	Article							HYPERRESPONSIVENESS; INFLAMMATION; CELLS; TH2	Human asthma is associated with airway infiltration by T helper 2 (T(H)2) lymphocytes. We observed reduced expression of the T(H)1 transcription factor, T-bet, in T cells from airways of patients with asthma compared with that in T cells from airways of nonasthmatic patients, suggesting that loss of T-bet might be associated with asthma. Mice with a targeted deletion of the T-bet gene and severe combined immunodeficient mice receiving CD4(+) cells from T-bet knockout mice spontaneously demonstrated multiple physiological and inflammatory features characteristic of asthma, Thus, T-bet deficiency, in the absence of allergen exposure, induces a murine phenotype reminiscent of both acute and chronic human asthma.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Millenium Pharmaceut, Cambridge, MA 02138 USA; Univ Mainz, Dept Pathol, D-55131 Mainz, Germany; Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada; Univ Mainz, Med Clin 1, D-55131 Mainz, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Johannes Gutenberg University of Mainz; University of Calgary; Johannes Gutenberg University of Mainz	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.		Finotto, Susetta/H-2753-2019; Drazen, Jeffrey M/E-5841-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36110] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Cohn L, 1998, J IMMUNOL, V161, P3813; De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Finotto S, 1999, DEVELOPMENT, V126, P2935; FINOTTO S, UNPUB; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; LI XM, 1996, J IMMUNOL, V157, P2316; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; Robinson DS, 2000, BRIT MED BULL, V56, P956, DOI 10.1258/0007142001903625; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543	16	492	567	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					336	338		10.1126/science.1065544	http://dx.doi.org/10.1126/science.1065544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786643				2022-12-28	WOS:000173278600052
J	Thery, M; Casas, J				Thery, M; Casas, J			Predator and prey views of spider camouflage - Both hunter and hunted fail to notice crab-spiders blending with coloured petals	NATURE			English	Article							PERCEPTION; EVOLUTION; ECOLOGY		Museum Natl Hist Nat, Lab Ecol Gen, CNRS, UMR 8571, F-91800 Brunoy, France; Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Thery, M (corresponding author), Museum Natl Hist Nat, Lab Ecol Gen, CNRS, UMR 8571, F-91800 Brunoy, France.	thery@mnhn.fr	Casas, Jérôme/D-9620-2011	Casas, Jérôme/0000-0003-1666-295X				Bradbury Jack W., 1998, pi; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHEN DM, 1986, J COMP PHYSIOL A, V159, P473, DOI 10.1007/BF00604167; Chittka L, 2001, ENTOMOL GEN, V25, P181; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098	7	180	186	1	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					133	133		10.1038/415133a	http://dx.doi.org/10.1038/415133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805822				2022-12-28	WOS:000173159300028
J	Feibelman, PJ				Feibelman, PJ			Partial dissociation of water on Ru(0001)	SCIENCE			English	Article							ABINITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; ULTRASOFT PSEUDOPOTENTIALS; BASIS-SET; ADSORPTION; H2O; CLUSTERS; BILAYER; METALS	Initial water deposition on the moderately reactive precious metal surface Ru(0001) has been thought to produce an ice-like bilayer. However, calculations from first principles show that the wetting layer observed on Ru(0001) cannot be formed of undissociated water molecules. An energetically favorable alternative, consistent with the remarkable observation that the wetting layer's oxygen atoms are nearly coplanar, is a half-dissociated monolayer wherein water molecules and hydroxyl fragments are hydrogen-bonded in a hexagonal structure and hydrogen atoms bind directly to the metal.	Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Feibelman, PJ (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.		Feibelman, Peter/AAW-4636-2020	Feibelman, Peter/0000-0002-5816-2921				BARTEAU MA, 1983, SURF SCI, V133, P443, DOI 10.1016/0039-6028(83)90012-2; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; CHOU MY, 1989, PHYS REV B, V39, P5623, DOI 10.1103/PhysRevB.39.5623; DOERING DL, 1982, SURF SCI, V123, P305, DOI 10.1016/0039-6028(82)90331-4; FEIBELMAN PJ, 1987, SURF SCI, V179, P153, DOI 10.1016/0039-6028(87)90126-9; Hamann DR, 1997, PHYS REV B, V55, P10157, DOI 10.1103/PhysRevB.55.R10157; HELD G, 1995, PHYS REV LETT, V74, P4221, DOI 10.1103/PhysRevLett.74.4221; HELD G, 1994, SURF SCI, V316, P92, DOI 10.1016/0039-6028(94)91131-2; HELD G, 1995, SURF SCI, V327, P301, DOI 10.1016/0039-6028(94)00836-1; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015; Kresse G., 2015, VASP GUIDE; KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2; LAASONEN K, 1993, PHYS REV B, V47, P10142, DOI 10.1103/PhysRevB.47.10142; Lilach Y, 2001, J PHYS CHEM B, V105, P2736, DOI 10.1021/jp003511g; METHFESSEL M, 1989, PHYS REV B, V40, P3616, DOI 10.1103/PhysRevB.40.3616; Nakamura M, 2000, CHEM PHYS LETT, V325, P293, DOI 10.1016/S0009-2614(00)00663-1; NEUGEBAUER J, 1992, PHYS REV B, V46, P16067, DOI 10.1103/PhysRevB.46.16067; PASQUARELLO A, 1992, PHYS REV LETT, V69, P1982, DOI 10.1103/PhysRevLett.69.1982; Perdew J., 1991, ELECT STRUCTURE SOLI; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PIRUG G, 1991, SURF SCI, V241, P289, DOI 10.1016/0039-6028(91)90089-B; THIEL PA, 1984, J CHEM PHYS, V80, P5326, DOI 10.1063/1.446561; THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Whalley E., 1976, Hydrogen bond. Recent developments in theory and experiments. III. Dynamics, thermodynamics and special systems, P1425; WILLIAMS ED, 1983, J VAC SCI TECHNOL A, V1, P1188, DOI 10.1116/1.571895	31	449	454	7	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					99	102		10.1126/science.1065483	http://dx.doi.org/10.1126/science.1065483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778041				2022-12-28	WOS:000173143100040
J	Lemon, B; Inouye, C; King, DS; Tjian, R				Lemon, B; Inouye, C; King, DS; Tjian, R			Selectivity of chromatin-remodelling cofactors for ligand-activated transcription	NATURE			English	Article							IN-VITRO; GLUCOCORTICOID RECEPTOR; COMPLEX; COACTIVATOR; BINDING; ACETYLATION; ENHANCEMENT; REQUIRES; FAMILY; GENES	An array of regulatory protein and multi-subunit cofactors has been identified(1) that directs eukaryotic gene transcription. However, establishing the specific functions of various related cofactors has been difficult owing to the limitations inherent in assaying transcription in animals and cells indirectly. Here we describe, using an integrated chromatin-dependent reconstituted transcription reaction, the purification and identification of a multi-subunit cofactor (PBAF)(2) that is necessary for ligand-dependent transactivation by nuclear hormone receptors. A highly related cofactor, human SWI/SNF3, and the ISWI-containing chromatin-remodelling complex ACF(4) both fail to potentiate transcription. We also show that transcriptional activation mediated by nuclear hormone receptors requires TATA-binding protein (TBP)-associated factors (TAFs) as well as the multi-subunit cofactors ARC(5)/CRSP6. These studies demonstrate functional selectivity amongst highly related complexes involved in gene regulation and help define a more complete set of factors and cofactors required to activate transcription.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.							Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kal AJ, 2000, GENE DEV, V14, P1058; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	30	207	213	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					924	928		10.1038/414924a	http://dx.doi.org/10.1038/414924a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780067				2022-12-28	WOS:000172813300050
J	Shaffer, LG; Heilstedt, HA				Shaffer, LG; Heilstedt, HA			Terminal deletion of 1p36	LANCET			English	Article									Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, Houston, TX 77030 USA	Baylor College of Medicine	Shaffer, LG (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, 1 Baylor Plaza,Room S801, Houston, TX 77030 USA.	lshaffer@bcm.tmc.edu							0	27	27	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S9	S9		10.1016/S0140-6736(01)07022-2	http://dx.doi.org/10.1016/S0140-6736(01)07022-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784558	Bronze			2022-12-28	WOS:000172907200009
J	Cyranoski, D				Cyranoski, D			Satellite set to keep track of whales	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					354	354		10.1038/415354a	http://dx.doi.org/10.1038/415354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807511	Bronze			2022-12-28	WOS:000173433600010
J	Cyranoski, D				Cyranoski, D			Japanese forum urges rethink over patents	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					354	354		10.1038/415354a	http://dx.doi.org/10.1038/415354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807511	Bronze			2022-12-28	WOS:000173433600009
